Citrus Sinensis ID: 019506
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 340 | 2.2.26 [Sep-21-2011] | |||||||
| Q39012 | 407 | Shaggy-related protein ki | yes | no | 0.841 | 0.702 | 0.891 | 1e-151 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.844 | 0.696 | 0.885 | 1e-149 | |
| Q39011 | 380 | Shaggy-related protein ki | no | no | 0.752 | 0.673 | 0.917 | 1e-138 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.785 | 0.652 | 0.814 | 1e-129 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.752 | 0.624 | 0.855 | 1e-129 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.838 | 0.703 | 0.762 | 1e-129 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.782 | 0.647 | 0.809 | 1e-128 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.752 | 0.625 | 0.820 | 1e-126 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.747 | 0.618 | 0.831 | 1e-125 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.752 | 0.622 | 0.808 | 1e-124 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 534 bits (1376), Expect = e-151, Method: Compositional matrix adjust.
Identities = 263/295 (89%), Positives = 274/295 (92%), Gaps = 9/295 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 286
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 529 bits (1362), Expect = e-149, Method: Compositional matrix adjust.
Identities = 262/296 (88%), Positives = 276/296 (93%), Gaps = 9/296 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 288
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 235/256 (91%), Positives = 245/256 (95%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKV 295
FPGENAVDQLVEIIKV
Sbjct: 241 FPGENAVDQLVEIIKV 256
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 219/269 (81%), Positives = 240/269 (89%), Gaps = 2/269 (0%)
Query: 29 DNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVG 86
D D L DM DKEM A ++ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 21 DADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVG 80
Query: 87 TGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146
GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KD
Sbjct: 81 HGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD 140
Query: 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
EL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+YIH GVCHRD+K
Sbjct: 141 ELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIK 200
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
PQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSA
Sbjct: 201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSA 260
Query: 267 GCVLAELLLGQPLFPGENAVDQLVEIIKV 295
GCVLAELLLGQPLFPGE+ VDQLVEIIKV
Sbjct: 261 GCVLAELLLGQPLFPGESGVDQLVEIIKV 289
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 219/256 (85%), Positives = 234/256 (91%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCL
Sbjct: 35 IKDDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YRV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQV
Sbjct: 155 TVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQV 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKV 295
FPGE+ VDQLVEIIKV
Sbjct: 275 FPGESGVDQLVEIIKV 290
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 460 bits (1184), Expect = e-129, Method: Compositional matrix adjust.
Identities = 225/295 (76%), Positives = 248/295 (84%), Gaps = 10/295 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+ + P P P + ND+ R DKEM A V+ GN TGH
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEM----NDMKIR------DDKEMEATVVDGNGTETGH 50
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
II TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRE
Sbjct: 51 IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 110
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV+KHY+ +NQRMPLIYV
Sbjct: 111 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYV 170
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQVKLCDFGSAKVLVKGE NISYI
Sbjct: 171 KLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 230
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKV
Sbjct: 231 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 285
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1179), Expect = e-128, Method: Compositional matrix adjust.
Identities = 217/268 (80%), Positives = 239/268 (89%), Gaps = 2/268 (0%)
Query: 30 NDLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGT 87
+D+L DM D+EM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 24 DDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGH 83
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDE
Sbjct: 84 GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE 143
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
L+LNLV+EYVPET++RV+KHYS +NQRMP+IYVKLYTYQIFR L+YIH GVCHRD+KP
Sbjct: 144 LYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKP 203
Query: 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAG 267
QNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WS G
Sbjct: 204 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVG 263
Query: 268 CVLAELLLGQPLFPGENAVDQLVEIIKV 295
CVLAELLLGQPLFPGE VDQLVEIIKV
Sbjct: 264 CVLAELLLGQPLFPGERGVDQLVEIIKV 291
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 210/256 (82%), Positives = 235/256 (91%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKE+ AA++ GN TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCL
Sbjct: 34 IRDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCL 93
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+ LKHCFFSTT KDE++LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPE 153
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T++RV+KHY+ +NQRMPLI VKLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQV 213
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPL 273
Query: 280 FPGENAVDQLVEIIKV 295
FPGE+ VDQLVEIIKV
Sbjct: 274 FPGESGVDQLVEIIKV 289
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1154), Expect = e-125, Method: Compositional matrix adjust.
Identities = 212/255 (83%), Positives = 233/255 (91%), Gaps = 1/255 (0%)
Query: 42 SDKEMSAA-VIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLE 100
DKEM AA ++ GN TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLE
Sbjct: 36 DDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE 95
Query: 101 TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET 160
TGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET
Sbjct: 96 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET 155
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
+ RV++HY+ MNQRMP+IYVKLY+YQI R LAYIH GVCHRD+KPQNLLV+P THQ+K
Sbjct: 156 VSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLK 215
Query: 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
+CDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLF
Sbjct: 216 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLF 275
Query: 281 PGENAVDQLVEIIKV 295
PGE+ VDQLVEIIKV
Sbjct: 276 PGESGVDQLVEIIKV 290
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/256 (80%), Positives = 230/256 (89%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM A V+ GN GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCL
Sbjct: 35 IKDDKEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV++LKHCFFSTT KDEL+LNLV+E+VPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T++RV++HYS MNQRMPLIYVKLY+YQI R LAYIH GV HRD+KPQNLLV+P THQ+
Sbjct: 155 TVHRVIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQL 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWSAGCVL ELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKV 295
FPG + VDQLVEIIKV
Sbjct: 275 FPGASGVDQLVEIIKV 290
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 340 | ||||||
| 312282053 | 322 | unnamed protein product [Thellungiella h | 0.85 | 0.897 | 0.901 | 1e-153 | |
| 15221476 | 407 | Shaggy-related protein kinase iota [Arab | 0.841 | 0.702 | 0.891 | 1e-149 | |
| 222423077 | 407 | AT1G06390 [Arabidopsis thaliana] | 0.841 | 0.702 | 0.888 | 1e-149 | |
| 297826527 | 412 | hypothetical protein ARALYDRAFT_902112 [ | 0.844 | 0.696 | 0.885 | 1e-148 | |
| 15224593 | 412 | Shaggy-related protein kinase zeta [Arab | 0.844 | 0.696 | 0.885 | 1e-148 | |
| 21593135 | 412 | putative shaggy-like protein kinase dzet | 0.844 | 0.696 | 0.878 | 1e-147 | |
| 297843440 | 410 | hypothetical protein ARALYDRAFT_470656 [ | 0.85 | 0.704 | 0.888 | 1e-146 | |
| 1225913 | 412 | shaggy-like kinase dzeta [Arabidopsis th | 0.844 | 0.696 | 0.875 | 1e-146 | |
| 359485302 | 411 | PREDICTED: shaggy-related protein kinase | 0.832 | 0.688 | 0.857 | 1e-145 | |
| 302143450 | 354 | unnamed protein product [Vitis vinifera] | 0.832 | 0.799 | 0.857 | 1e-145 |
| >gi|312282053|dbj|BAJ33892.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-153, Method: Compositional matrix adjust.
Identities = 266/295 (90%), Positives = 276/295 (93%), Gaps = 6/295 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS PLGPQP PP PPSQQ H D D LKR RP++DSDKEMSAAV +GNDAVTGH
Sbjct: 1 MASFPLGPQPHVLAPP----PPSQQLH-DGDALKR-RPELDSDKEMSAAVTEGNDAVTGH 54
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 55 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 114
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMRLMDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 115 LQLMRLMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 174
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIH VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI
Sbjct: 175 KLYTYQIFRGLAYIHAVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 234
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 235 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 289
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221476|ref|NP_172127.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|42571361|ref|NP_973771.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|11133004|sp|Q39012.1|KSG9_ARATH RecName: Full=Shaggy-related protein kinase iota; AltName: Full=ASK-iota gi|8927676|gb|AAF82167.1|AC068143_9 Contains a very strong similarity to a shaggy-like kinase iota from Arabidopsis thaliana gb|X99696 and contains an eukaryotic protein kinase PF|00069 domain. EST gb|N37432 comes from this gene [Arabidopsis thaliana] gi|1480078|emb|CAA68027.1| shaggy-like protein kinase iota [Arabidopsis thaliana] gi|2444277|gb|AAB71545.1| GSK3/shaggy-like protein kinase [Arabidopsis thaliana] gi|14334750|gb|AAK59553.1| putative shaggy kinase [Arabidopsis thaliana] gi|15293239|gb|AAK93730.1| putative shaggy kinase [Arabidopsis thaliana] gi|332189859|gb|AEE27980.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|332189860|gb|AEE27981.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1376), Expect = e-149, Method: Compositional matrix adjust.
Identities = 263/295 (89%), Positives = 274/295 (92%), Gaps = 9/295 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 286
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222423077|dbj|BAH19519.1| AT1G06390 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 262/295 (88%), Positives = 274/295 (92%), Gaps = 9/295 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPG+N+VDQLVEIIKV
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGKNSVDQLVEIIKV 286
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297826527|ref|XP_002881146.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] gi|297326985|gb|EFH57405.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1364), Expect = e-148, Method: Compositional matrix adjust.
Identities = 262/296 (88%), Positives = 275/296 (92%), Gaps = 9/296 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLG PQPP + AP Q PH D LKR RPDMD+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLG-HPQPP----SLAP--QPPHLHGGDALKR-RPDMDTDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 288
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15224593|ref|NP_180655.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] gi|147744570|sp|Q39010.2|KSG6_ARATH RecName: Full=Shaggy-related protein kinase zeta; AltName: Full=ASK-zeta gi|3201623|gb|AAC20732.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] gi|17381128|gb|AAL36376.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|20453108|gb|AAM19796.1| At2g30980/F7F1.19 [Arabidopsis thaliana] gi|20465727|gb|AAM20332.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|330253376|gb|AEC08470.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1362), Expect = e-148, Method: Compositional matrix adjust.
Identities = 262/296 (88%), Positives = 276/296 (93%), Gaps = 9/296 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 288
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|21593135|gb|AAM65084.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 526 bits (1355), Expect = e-147, Method: Compositional matrix adjust.
Identities = 260/296 (87%), Positives = 276/296 (93%), Gaps = 9/296 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
ICSRYYR+PELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VD+LVEIIKV
Sbjct: 233 ICSRYYRSPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDRLVEIIKV 288
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843440|ref|XP_002889601.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] gi|297335443|gb|EFH65860.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 524 bits (1349), Expect = e-146, Method: Compositional matrix adjust.
Identities = 262/295 (88%), Positives = 272/295 (92%), Gaps = 6/295 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLG QP PP Q D D LKR RP+MDSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGHQPH-----ALAPPPPQPQLHDGDALKR-RPEMDSDKEMSAAVIEGNDAVTGH 54
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 55 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 114
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 115 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 174
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI
Sbjct: 175 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 234
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 235 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 289
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1225913|emb|CAA64408.1| shaggy-like kinase dzeta [Arabidopsis thaliana] gi|1669653|emb|CAA70483.1| serine/threonine kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1348), Expect = e-146, Method: Compositional matrix adjust.
Identities = 259/296 (87%), Positives = 274/296 (92%), Gaps = 9/296 (3%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRD+KPQNLLVDP THQ KLCDFGSAKVLVKGE NISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDIKPQNLLVDPHTHQCKLCDFGSAKVLVKGEPNISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKV 288
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485302|ref|XP_002281788.2| PREDICTED: shaggy-related protein kinase zeta-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1341), Expect = e-145, Method: Compositional matrix adjust.
Identities = 258/301 (85%), Positives = 270/301 (89%), Gaps = 18/301 (5%)
Query: 1 MASMPLGPQPQP-----PPPPQAQAPPSQQPHFDNDLLKRHRPD-MDSDKEMSAAVIQGN 54
MAS+PLGPQ PP PP + RPD +DSDKEMSAAVI+GN
Sbjct: 1 MASLPLGPQTHHHHHHLPPEHDPLKPPFR------------RPDHLDSDKEMSAAVIEGN 48
Query: 55 DAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR 114
D VTGHIISTTIGGKNGEPKQTISYMAER+VGTGSFGIVFQAKCLETGETVAIKKVLQDR
Sbjct: 49 DPVTGHIISTTIGGKNGEPKQTISYMAERIVGTGSFGIVFQAKCLETGETVAIKKVLQDR 108
Query: 115 RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR 174
RYKNRELQL+RLMDHPNV++LKHCFFSTTS+DELFLNLVMEYVPETMYRVLKHYS+ NQR
Sbjct: 109 RYKNRELQLLRLMDHPNVVTLKHCFFSTTSRDELFLNLVMEYVPETMYRVLKHYSNANQR 168
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN+LVDPLTHQVKLCDFGSAKVLVKGE
Sbjct: 169 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNVLVDPLTHQVKLCDFGSAKVLVKGE 228
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV AELLLGQPLFPGE+AVDQLVEIIK
Sbjct: 229 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVFAELLLGQPLFPGESAVDQLVEIIK 288
Query: 295 V 295
V
Sbjct: 289 V 289
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143450|emb|CBI22011.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 258/301 (85%), Positives = 270/301 (89%), Gaps = 18/301 (5%)
Query: 1 MASMPLGPQPQP-----PPPPQAQAPPSQQPHFDNDLLKRHRPD-MDSDKEMSAAVIQGN 54
MAS+PLGPQ PP PP + RPD +DSDKEMSAAVI+GN
Sbjct: 1 MASLPLGPQTHHHHHHLPPEHDPLKPPFR------------RPDHLDSDKEMSAAVIEGN 48
Query: 55 DAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR 114
D VTGHIISTTIGGKNGEPKQTISYMAER+VGTGSFGIVFQAKCLETGETVAIKKVLQDR
Sbjct: 49 DPVTGHIISTTIGGKNGEPKQTISYMAERIVGTGSFGIVFQAKCLETGETVAIKKVLQDR 108
Query: 115 RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR 174
RYKNRELQL+RLMDHPNV++LKHCFFSTTS+DELFLNLVMEYVPETMYRVLKHYS+ NQR
Sbjct: 109 RYKNRELQLLRLMDHPNVVTLKHCFFSTTSRDELFLNLVMEYVPETMYRVLKHYSNANQR 168
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN+LVDPLTHQVKLCDFGSAKVLVKGE
Sbjct: 169 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNVLVDPLTHQVKLCDFGSAKVLVKGE 228
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV AELLLGQPLFPGE+AVDQLVEIIK
Sbjct: 229 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVFAELLLGQPLFPGESAVDQLVEIIK 288
Query: 295 V 295
V
Sbjct: 289 V 289
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 340 | ||||||
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.782 | 0.653 | 0.932 | 4.8e-133 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.776 | 0.640 | 0.932 | 1.3e-132 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.752 | 0.673 | 0.917 | 4.8e-126 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.785 | 0.652 | 0.814 | 2e-118 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.779 | 0.654 | 0.823 | 3.3e-118 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.744 | 0.617 | 0.865 | 1.4e-117 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.744 | 0.536 | 0.754 | 1.3e-107 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.767 | 0.619 | 0.701 | 3.8e-101 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.752 | 0.584 | 0.699 | 1.2e-99 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.694 | 0.561 | 0.65 | 3e-85 |
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 4.8e-133, P = 4.8e-133
Identities = 249/267 (93%), Positives = 259/267 (97%)
Query: 29 DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D D LKR RP++DSDKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG
Sbjct: 21 DGDALKR-RPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 79
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DEL
Sbjct: 80 SFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDEL 139
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
FLNLVMEYVPET+YRVL+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ
Sbjct: 140 FLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 199
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLVDPLTHQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT SIDIWSAGC
Sbjct: 200 NLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGC 259
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKV 295
VLAELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 260 VLAELLLGQPLFPGENSVDQLVEIIKV 286
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1300 (462.7 bits), Expect = 1.3e-132, P = 1.3e-132
Identities = 247/265 (93%), Positives = 259/265 (97%)
Query: 31 DLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 90
D LKR RPD+D+DKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF
Sbjct: 25 DSLKR-RPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 83
Query: 91 GIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
GIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFL
Sbjct: 84 GIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFL 143
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
NLVMEYVPET+YRVLKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNL
Sbjct: 144 NLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNL 203
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270
LVDPLTHQ KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVL
Sbjct: 204 LVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVL 263
Query: 271 AELLLGQPLFPGENAVDQLVEIIKV 295
AELLLGQPLFPGEN+VDQLVEIIKV
Sbjct: 264 AELLLGQPLFPGENSVDQLVEIIKV 288
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-126, P = 4.8e-126
Identities = 235/256 (91%), Positives = 245/256 (95%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKV 295
FPGENAVDQLVEIIKV
Sbjct: 241 FPGENAVDQLVEIIKV 256
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 2.0e-118, P = 2.0e-118
Identities = 219/269 (81%), Positives = 240/269 (89%)
Query: 29 DNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVG 86
D D L DM DKEM A ++ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 21 DADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVG 80
Query: 87 TGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146
GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KD
Sbjct: 81 HGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD 140
Query: 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
EL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+YIH GVCHRD+K
Sbjct: 141 ELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIK 200
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
PQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSA
Sbjct: 201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSA 260
Query: 267 GCVLAELLLGQPLFPGENAVDQLVEIIKV 295
GCVLAELLLGQPLFPGE+ VDQLVEIIKV
Sbjct: 261 GCVLAELLLGQPLFPGESGVDQLVEIIKV 289
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 3.3e-118, P = 3.3e-118
Identities = 220/267 (82%), Positives = 239/267 (89%)
Query: 31 DLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D L DM DKEM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG G
Sbjct: 19 DKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHG 78
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL
Sbjct: 79 SFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 138
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
+LNLV+EYVPET++RV+KHY+ +NQRMPLIYVKLYTYQIFR L+YIH GVCHRD+KPQ
Sbjct: 139 YLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQ 198
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGC
Sbjct: 199 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGC 258
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKV 295
VLAELLLGQPLFPGE+ VDQLVEIIKV
Sbjct: 259 VLAELLLGQPLFPGESGVDQLVEIIKV 285
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.4e-117, P = 1.4e-117
Identities = 219/253 (86%), Positives = 233/253 (92%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETG
Sbjct: 38 DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETG 97
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
ETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 98 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVY 157
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
RV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 158 RVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLC 217
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPG
Sbjct: 218 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPG 277
Query: 283 ENAVDQLVEIIKV 295
E+ VDQLVEIIKV
Sbjct: 278 ESGVDQLVEIIKV 290
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 191/253 (75%), Positives = 225/253 (88%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DK+M V+ G+ TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETG
Sbjct: 102 DKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETG 161
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
E VAIKKVLQD+RYKNRELQ+MRL DHPNV+ L+H FFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 162 EQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVY 221
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
R KHY+ MNQ MP+I+V+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 222 RASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKIC 281
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAK+LV GE NISYICSRYYRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPG
Sbjct: 282 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPG 341
Query: 283 ENAVDQLVEIIKV 295
E+ +DQLVEIIK+
Sbjct: 342 ESGIDQLVEIIKI 354
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1003 (358.1 bits), Expect = 3.8e-101, P = 3.8e-101
Identities = 183/261 (70%), Positives = 222/261 (85%)
Query: 35 RHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVF 94
R + + D +++ +I G A GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VF
Sbjct: 39 RDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVF 98
Query: 95 QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
QAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN ++LKH FFS T +E++LNLV+
Sbjct: 99 QAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVL 158
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
E+VPET+ RV + YS NQ MPLIYVKLYTYQI R LAYIH G+CHRD+KPQNLLV+P
Sbjct: 159 EFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNP 218
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
THQ+K+CDFGSAKVLVKGE N+SYICSRYYRAPELIFGA+EYTT+IDIWS GCV+AELL
Sbjct: 219 HTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELL 278
Query: 275 LGQPLFPGENAVDQLVEIIKV 295
LGQPLFPGE+ VDQLVEIIKV
Sbjct: 279 LGQPLFPGESGVDQLVEIIKV 299
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
Identities = 179/256 (69%), Positives = 216/256 (84%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DK+M +I+GN +G II+T G N + +TISY AE V+GTGSFG+VFQAKCL
Sbjct: 70 LGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCL 129
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT KDEL+LNLV+EYVPE
Sbjct: 130 ETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPE 189
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YR + Y+ MNQ MPLIY++LYTYQI R + Y+H V GVCHRD+KPQNLLV+ +TH+V
Sbjct: 190 TIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEV 249
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK+L+ GE NISYICSRYYRAPELIFGATEYT++ID+WS GCV+AEL LG PL
Sbjct: 250 KICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPL 309
Query: 280 FPGENAVDQLVEIIKV 295
FPGE +VDQLVEIIK+
Sbjct: 310 FPGETSVDQLVEIIKI 325
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 3.0e-85, P = 3.0e-85
Identities = 156/240 (65%), Positives = 201/240 (83%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + +Q ++Y +V+G GSFG+V+QAK +TGE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQAL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P+IYVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PIIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6016 | 0.6852 | 0.6020 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8915 | 0.8411 | 0.7027 | yes | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9179 | 0.7529 | 0.6736 | no | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6102 | 0.7352 | 0.6906 | yes | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.8203 | 0.7529 | 0.6259 | N/A | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8097 | 0.7823 | 0.6472 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8085 | 0.7529 | 0.6228 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8313 | 0.7470 | 0.6180 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 340 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-94 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-71 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-67 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-67 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-66 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-65 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-64 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-58 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-57 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-56 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-54 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-52 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-51 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-51 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-50 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-50 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-49 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-48 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-47 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-47 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-47 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-45 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-45 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-45 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-44 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-44 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-44 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-44 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-44 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-44 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-43 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-42 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-42 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-42 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-41 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-40 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-39 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-39 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-38 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-38 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-38 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-37 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-37 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-34 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-33 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-33 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-33 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-33 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-32 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-32 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-31 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-29 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-29 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-28 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-22 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.004 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 288 bits (737), Expect = 1e-94
Identities = 124/221 (56%), Positives = 174/221 (78%), Gaps = 4/221 (1%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 137
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 138 CFFSTTSKDE---LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+++ K +FLN+VME++P+T+++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H+ +CHRD+KPQNLL+DP TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+V
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286
|
Length = 440 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 6e-71
Identities = 81/222 (36%), Positives = 125/222 (56%), Gaps = 18/222 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +DE L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H+ G+ HRD+KP+N+L+D VKL DFG A+ L GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
G Y ++DIWS G +L ELL G+P FPG++ + +L + I
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 4e-67
Identities = 84/227 (37%), Positives = 133/227 (58%), Gaps = 16/227 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + +D + +V E + +++V+K Q + +++ + YQI RGL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAP 248
Y+H+ V HRD+KP N+LV+ +K+CDFG A+ + E Y+ +R+YRAP
Sbjct: 118 YLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
EL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++V
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 4e-67
Identities = 83/224 (37%), Positives = 131/224 (58%), Gaps = 17/224 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRLMDHPNV 132
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ G+ HRD+KP+NLL++ +KL DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 6e-67
Identities = 83/221 (37%), Positives = 124/221 (56%), Gaps = 17/221 (7%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F KD L+L VMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGA 254
+ G+ HRD+KP+N+L+D VK+ DFG AK L+K + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y +D+WS G +L ELL G+P F GEN +DQL I ++
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI 214
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 4e-66
Identities = 86/222 (38%), Positives = 126/222 (56%), Gaps = 20/222 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLK 136
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+KP NLL+ +K+ DFG A++ E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + +
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 8e-65
Identities = 79/223 (35%), Positives = 131/223 (58%), Gaps = 27/223 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVISLK 136
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
++ +L+L V EY LK Y + +K YQ+ RGLAY H
Sbjct: 65 DVI---HTERKLYL--VFEY----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ + HRD+KPQN+L++ +KL DFG A+ G +Y + + +YRAPE++
Sbjct: 116 SH-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 9e-64
Identities = 85/220 (38%), Positives = 133/220 (60%), Gaps = 18/220 (8%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F K L+L V EYV T+ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + +KLCDFG A+ L A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-58
Identities = 79/224 (35%), Positives = 124/224 (55%), Gaps = 20/224 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDH 129
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN+I L F K +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRYYRAP 248
GL Y+H + HRD+KP NLL+ +KL DFG A+ +++ + +R+YRAP
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
EL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 6e-57
Identities = 84/221 (38%), Positives = 132/221 (59%), Gaps = 19/221 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRLMDHPNVIS 134
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L +L +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
LK F DEL+ V EY+ +Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHI 115
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H G HRD+KP+NLLV VK+ DFG A+ + Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I V
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-56
Identities = 75/222 (33%), Positives = 127/222 (57%), Gaps = 22/222 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
TSK + + +V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 ---VTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+K N+L++ + +KL DFG A+ K + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-54
Identities = 83/228 (36%), Positives = 131/228 (57%), Gaps = 24/228 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 131 NVISLKHCFFSTTSKDELFLN--LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
NVI L F +S ++ F + LV + + ++K Q++ +++ YQI
Sbjct: 75 NVIGLLDVFTPASSLED-FQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQIL 128
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRA 247
RGL YIH+ G+ HRD+KP N+ V+ ++K+ DFG A+ + ++ Y+ +R+YRA
Sbjct: 129 RGLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLAR---HTDDEMTGYVATRWYRA 183
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ +
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-52
Identities = 81/217 (37%), Positives = 131/217 (60%), Gaps = 17/217 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F + + L+LV EY T+ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ Q+KLCDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+D+W+ GCV AELL GQPL+PG++ VDQL I K
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 9e-52
Identities = 67/196 (34%), Positives = 109/196 (55%), Gaps = 16/196 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+DE L LVMEY ++ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY 257
G+ HRD+KP+N+L+D +VKL DFG +K+L ++ + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 258 TTSIDIWSAGCVLAEL 273
+ DIWS G +L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 92/238 (38%), Positives = 147/238 (61%), Gaps = 23/238 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKH 137
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F K L+L V E+V T+ L+ Y + +++ V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + VKLCDFG A+ L GE Y+ +R+YRAPEL+ G T
Sbjct: 119 -HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VSNIIYAKTIYQGLFCSN 312
+Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK + N+I +Q +F N
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI---PRHQEIFQKN 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 86/232 (37%), Positives = 135/232 (58%), Gaps = 27/232 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQ-LMRLMDH 129
Y + +G G++GIV++A T E VA+KK+ D R + RE+ L L DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L + + KD + LV EY+ ++ V++ + ++ + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILED-----VHKRYIMYQLLK 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------YICSR 243
L YIH+ V HRD+KP N+L++ VKL DFG A+ L + E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 86/224 (38%), Positives = 136/224 (60%), Gaps = 13/224 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I++K + + +V E + ++++++ +Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLK 122
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
YIH+ V HRD+KP NLL++ +K+CDFG A+ KG+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 78/228 (34%), Positives = 126/228 (55%), Gaps = 20/228 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + + + +V E + +Y+++K Q + +++ + YQI RGL
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ +K+CDFG A++ + Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ V
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 5e-50
Identities = 74/217 (34%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLK 136
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ S +++ LN+ +EYV L ++P ++ YT QI GLAY+H+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRAPELIFG 253
G+ HRD+K N+LVD VKL DFG AK L GE S + Y+ APE+I G
Sbjct: 120 -NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
EY + DIWS GC + E+ G+P + +
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 79/231 (34%), Positives = 128/231 (55%), Gaps = 22/231 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPN 131
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 132 VISLKHCFFSTTSKDELFLN--LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+I+++ F + +VM+ + ++ ++ +S +Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDLMESDLHHII--HS--DQPLTEEHIRYFLYQLLR 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRY 244
GL YIH+ V HRD+KP NLLV+ +++ DFG A+ L Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ V
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 86/223 (38%), Positives = 134/223 (60%), Gaps = 19/223 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+RL+ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ +KH + ++ + +V E + +++V+K N + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANI---SYICSRYYRAP 248
YIHT V HRD+KP+N+L + ++K+CDFG A+V I Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 249 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 82/225 (36%), Positives = 120/225 (53%), Gaps = 33/225 (14%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
D +FL VMEY + + +L +M VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHE-N 127
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC--------SRYYRAP 248
+ HRD+K NLL LT + +K+ DFG A+ + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
EL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-47
Identities = 87/228 (38%), Positives = 131/228 (57%), Gaps = 23/228 (10%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLM 127
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 247
RGL Y+H+ GV HRD+KP N+L++ +K+CDFG A++ + Y+ +RYYRA
Sbjct: 118 LRGLKYVHSA-GVVHRDLKPSNILINE-NCDLKICDFGLARI--QDPQMTGYVSTRYYRA 173
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 8e-47
Identities = 77/220 (35%), Positives = 118/220 (53%), Gaps = 23/220 (10%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMR-LMDHPNVISLKH 137
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R L HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRGLAYIH 195
F + L LV E + +Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+N+L+ +KL DFGS + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y +DIW+ GCV E+L PLFPG N +DQ+ +I V
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 81/220 (36%), Positives = 128/220 (58%), Gaps = 20/220 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL+D +KL DFG A+ V + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRT 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 78/218 (35%), Positives = 130/218 (59%), Gaps = 23/218 (10%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHCFFS 141
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
+ D++++ VMEYV + +++ M Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 202 HRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATE 256
HRD+K NLL L + +K+CDFG A+ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 77/224 (34%), Positives = 121/224 (54%), Gaps = 22/224 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 131
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H+ + HRD+KPQN+LV QVK+ DFG A++ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 89/230 (38%), Positives = 134/230 (58%), Gaps = 23/230 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDHP 130
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S S DE LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 248
GL YIH+ G+ HRD+KP NL V+ ++K+ DFG A+ +A ++ Y+ +R+YRAP
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRAP 183
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298
E+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV+ +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-44
Identities = 86/222 (38%), Positives = 130/222 (58%), Gaps = 22/222 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D LVM ++ + +++KH R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
G+ HRD+KP NL V+ ++K+ DFG A+ + ++ ++ Y+ +R+YRAPE+I
Sbjct: 136 AA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV+
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 83/229 (36%), Positives = 133/229 (58%), Gaps = 25/229 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM-----NQRMPLIYVKLYTYQI 187
+ L+ S E L LV EY+ + KH S N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYR 246
RG+AY H+ V HRD+KPQNLL+D T+ +KL DFG A+ + + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI 219
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 3e-44
Identities = 77/220 (35%), Positives = 129/220 (58%), Gaps = 20/220 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ L LV E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHTENK-----LYLVFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-44
Identities = 71/233 (30%), Positives = 129/233 (55%), Gaps = 23/233 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRLMDHPNVIS 134
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 135 LKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI----C 241
Q+ RGL YIH+ V HRD+KP N+ ++ +K+ DFG A+++ ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ I++
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 84/224 (37%), Positives = 130/224 (58%), Gaps = 28/224 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY---ICSRYYRAPELIF 252
V HRD+KPQNLL++ ++KL DFG A+ + V+ Y + + +YR P+++F
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLF 172
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 295
GA Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-43
Identities = 83/228 (36%), Positives = 129/228 (56%), Gaps = 27/228 (11%)
Query: 85 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-LMDHPNVI 133
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 134 SLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +EL+L E + ++++++ Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLK 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANIS-YICSRYYRA 247
YIH+ V HRD+KP NLLV+ ++K+CDFG A+ + ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++V
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 88/220 (40%), Positives = 131/220 (59%), Gaps = 19/220 (8%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + +L+L V EYV + M +L+ M +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK- 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANIS-YICSRYYRAPELIFGAT 255
+ HRD+KP+NLL+ +KLCDFG A+ L +G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KV
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 3e-42
Identities = 79/261 (30%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
I + FF +DE L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-------SYICSR 243
L Y+H+ G+ HRD+KP+N+L+D VKL DFG AK+L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 244 YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301
Y APE++ G + ++S DIWS G L ELL G P F GE + +K+ +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 302 KTIYQGLFCSNNHEIMCELGS 322
++ L SN I
Sbjct: 233 PSLASPLSPSNPELISKAASD 253
|
Length = 384 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-42
Identities = 81/220 (36%), Positives = 129/220 (58%), Gaps = 20/220 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHT 196
T +K L LV EY M + LK Y + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL DFG A+ + + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I ++
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 8e-42
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ KDEL+ +VME+ ++ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+K N+L LT +VKL DFG + L +A + + + Y+ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 256 EYTTSIDIWSAGCVLAELLLGQP 278
Y DIWS G EL G+P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 72/219 (32%), Positives = 122/219 (55%), Gaps = 10/219 (4%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 139 FFSTTSKD-ELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K+ + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
GV HRD+KPQNLLVD +K+ D G + + ++ I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 81/240 (33%), Positives = 119/240 (49%), Gaps = 36/240 (15%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYI 194
F K + L+ +Y +++++K + + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 195 HTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA-------KVLVKGEANISYICSRY 244
H+ V HRD+KP N+LV P VK+ D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 295
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 73/222 (32%), Positives = 123/222 (55%), Gaps = 23/222 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L+ E L L+ E++ + + L Q M VK Y YQI +G+ +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFG 253
H+ V HRD+KPQNLL+D +KL DFG A+ + + + +YRAPE++ G
Sbjct: 118 HS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F +++ L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPEL 250
Y+H+ + HRD+KPQN+ + VKL DFG +KVL + + + + YY +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
Y DIWS GCVL EL + F GEN
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-39
Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 34/234 (14%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVISL 135
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 136 KHCFFS---TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + +V Y+ + +L S+ I K Y Q+ G+
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEGIN 129
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---------VKGEANISY---I 240
Y+H + HRD+K N+L+D +K+ DFG A+ G Y +
Sbjct: 130 YLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 44/244 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRL 126
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ H N++ L + D F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVY---VEGD--FINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-----VLVKGEANISYIC 241
I GL +H HRD+ P N+ ++ K+ DFG A+ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 242 SR----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 292 IIKV 295
I ++
Sbjct: 246 IFEL 249
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 77/228 (33%), Positives = 126/228 (55%), Gaps = 23/228 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
AY H V HRD+KPQNLL+ ++KL DFG A+ K + +Y + + +YR P
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKV 295
+++ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +V
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 80/230 (34%), Positives = 124/230 (53%), Gaps = 34/230 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRLMDHPNVI 133
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 134 S--------LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
S F +E+++ V E M L Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSR 243
QI RGL Y+H+ G+ HRD+KP NLLV+ +K+CDFG A+V E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
YYRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 8e-38
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 23/210 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F + E L LV+EY P E ++ L ++ + Y +I L Y+H
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
++ G+ +RD+KP+N+L+D H +KL DFG AK L + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
Y ++D WS G +L E+L G+P F E+
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 79/224 (35%), Positives = 124/224 (55%), Gaps = 16/224 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F TS + + LV + + ++K Q++ +V+ YQ+ RGL
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH+ G+ HRD+KP N+ V+ ++++ DFG A+ + Y+ +R+YRAPE++
Sbjct: 132 KYIHSA-GIIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIM 187
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y ++DIWS GC++AELL G+ LFPG + +DQL I++V
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 83/231 (35%), Positives = 128/231 (55%), Gaps = 30/231 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM+L++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRV----LKHYSSMNQRMPLIYVKLYTY 185
N+I L + F S +E + LVME + + +V L H +RM + Y
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-----ERMSYL-----LY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
Q+ G+ ++H+ G+ HRD+KP N++V T +K+ DFG A+ Y+ +RY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+
Sbjct: 183 YRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 81/220 (36%), Positives = 125/220 (56%), Gaps = 20/220 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S +E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y ++DIWS GC++AELL G+ LFPG + +DQL I+++
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 71/237 (29%), Positives = 111/237 (46%), Gaps = 44/237 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRLMDH 129
+ +++G GSF V AK ET + AI K+L R+ Y E L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +I L + F +DE L V+EY P + + ++ Y S++++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRY 244
L Y+H+ G+ HRD+KP+N+L+D H +K+ DFG+AKVL
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 245 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 26/206 (12%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVIS 134
++G G+FG+V++ LETG+ VAIK++ K +E L +M HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ L +++EY ++ +++K + + + V +Y YQ+ +GLAY
Sbjct: 64 YIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAY 114
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H GV HRD+K N+L VKL DFG A L + S + + Y+ APE+I
Sbjct: 115 LHE-QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQP 278
+ +T+ DIWS GC + ELL G P
Sbjct: 173 M-SGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRLMDHPNVI 133
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T ++E L + +E VP ++ ++LK Y S + P+I +LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVI--RLYTRQILLGLE 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H HRD+K N+LVD VKL DFG AK +V+ S+ S Y+ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQP 278
Y + DIWS GC + E+ G+P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 67/212 (31%), Positives = 115/212 (54%), Gaps = 25/212 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ L+ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ ++++ + MEY T+ +L+H +++ + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIF 252
G+ HRD+KP N+ +D +KL DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 253 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPG 282
G + + DIWS GCV+ E+ G+ +
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 19/223 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH- 137
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++L+ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 138 CFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISY---ICSRYYRAPEL 250
+ HRD+K N+L+ +KL DFG A+ K Y + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
+ G +Y ID+W AGC++AE+ P+ G QL I
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 73/215 (33%), Positives = 117/215 (54%), Gaps = 29/215 (13%)
Query: 88 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISLKHCFF 140
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S K L+L VMEY+P + +L++ S+++ + ++Y +I L Y+H+ G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISY--------ICSRYYRAPEL 250
+ HRD+KP N+L+D H +KL DFG +KV LV+ + N++ + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
I G ++ ++D WS GC+L E L+G P F GE
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 71/229 (31%), Positives = 120/229 (52%), Gaps = 26/229 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 138 CFFSTTS-----KDELFLNLVMEYVPETMYRVLK----HYSSMNQRMPLIYVKLYTYQIF 188
KD+ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYR 246
GL Y H HRD+K N+L++ Q+KL DFG A++ E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHC 138
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+ +++V+EY+ ++ +LK + + + + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIF 252
+ HRD+KP NLL++ +VK+ DFG +KVL N C+ + Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENA 285
G + Y+ + DIWS G L E LG+ P P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-33
Identities = 72/224 (32%), Positives = 118/224 (52%), Gaps = 22/224 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLM---DHPN 131
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + HRD+KP+N+LV QVKL DFG A++ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 72/224 (32%), Positives = 125/224 (55%), Gaps = 16/224 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + + ++ M + VK++ YQI RGLA
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++KL DFG A+ V + + + + +YR P+++
Sbjct: 119 YCHRRK-VLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 73/226 (32%), Positives = 128/226 (56%), Gaps = 20/226 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L H T E L LV EY+ + + L + ++ M + VK++ +Q+ RGL+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H + HRD+KPQNLL++ ++KL DFG A+ V K +N + + +YR P+
Sbjct: 118 YCHKRK-ILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSN--EVVTLWYRPPD 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 80/222 (36%), Positives = 127/222 (57%), Gaps = 17/222 (7%)
Query: 85 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRLMD---HPNVIS 134
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 135 L-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 23/228 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 132
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY---VKLYTYQIFR 189
+ L + + L V EY M+ L Y M Q ++ V+L+ +Q+ R
Sbjct: 66 VLLHDIIHTKET-----LTFVFEY----MHTDLAQY--MIQHPGGLHPYNVRLFMFQLLR 114
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
GLAYIH + HRD+KPQNLL+ L ++KL DFG A+ + + S + + +YR P
Sbjct: 115 GLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKV 295
+++ GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I V
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 70/226 (30%), Positives = 124/226 (54%), Gaps = 20/226 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + L + + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H V HRD+KPQNLL++ ++KL DFG A+ + K +N + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSN--EVVTLWYRPPD 174
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 76/226 (33%), Positives = 125/226 (55%), Gaps = 20/226 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 135 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 26/208 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +K+ DFG AK + +C + Y APE+I
Sbjct: 117 LHSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKG---RTYTLCGTPEYLAPEIIL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF 280
Y ++D W+ G ++ E+L G P F
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKH 137
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F++ +++ MEY+ K + R+P + + +GL Y+H
Sbjct: 67 AFYNNGD-----ISICMEYMDGGSLD--KILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ Q+KLCDFG + LV A +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIK 294
+ DIWS G L EL G+ +P EN + L I+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 44/236 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L T ++ L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +N LV VK+ DFG ++ L + YY+
Sbjct: 116 MEYLESKN-FIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RLMDHPNVISL 135
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ L ++MEY R L + ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFGA 254
V GV HRD+K N+LV T VKLCDFG A +L + + +++ + Y+ APE+I
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y T DIWS G + E+ G P + +A ++ I K
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 75/212 (35%), Positives = 120/212 (56%), Gaps = 20/212 (9%)
Query: 85 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
EL+ GA YT +IDIW+ GC+ AELL +P+F
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-29
Identities = 76/226 (33%), Positives = 121/226 (53%), Gaps = 19/226 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L + + L LV EYV + + + KH ++ VKL+ +Q+ RGL
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
+YIH + HRD+KPQNLL+ T ++KL DFG A+ V + + + +YR P++
Sbjct: 117 SYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKV 295
+ G+TEY+T +D+W GC+ E++ G FPG + DQL I V
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH- 195
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 196 -TVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
+ PG V HRD+KP N+ +D + VKL DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 65/235 (27%), Positives = 113/235 (48%), Gaps = 43/235 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L T ++ L+ +VMEY+ L Y ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N LV VK+ DFG ++ L + YYR
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYRKRGGK 164
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
APE + ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 74/212 (34%), Positives = 121/212 (57%), Gaps = 20/212 (9%)
Query: 85 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
EL+ GA YT +IDIW+ GC+ AELL +P+F
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 75/225 (33%), Positives = 124/225 (55%), Gaps = 20/225 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+I L + F S +E + +VME + + +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 42/241 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 125
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
+ H N++ S D LN+ +EYVP ++ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI------- 237
QI +GL Y+H G+ HRD+K N+LVD +K+ DFG +K K EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISK---KLEANSLSTKTNG 167
Query: 238 ---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
S S ++ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 295 V 295
+
Sbjct: 224 I 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 76/225 (33%), Positives = 125/225 (55%), Gaps = 20/225 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 130
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 71/242 (29%), Positives = 128/242 (52%), Gaps = 27/242 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNV 132
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + T +D F NL +E++ ++ +L Y + + + + YT Q+ RGL
Sbjct: 66 IRM----LGATCEDSHF-NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYR 246
+Y+H + HRDVK NLL+D ++++ DFG+A L GE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K+++ A +I +
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 307 GL 308
L
Sbjct: 235 HL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 79/253 (31%), Positives = 119/253 (47%), Gaps = 36/253 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L H F T KD LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H +K+ DFG K + G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AK 302
++ Y ++D W+ G +L E+L GQ F G++ D+L + I + Y AK
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSILEDEVRYPRWLSKEAK 224
Query: 303 TIYQGLFCSNNHE 315
+I + N +
Sbjct: 225 SILKSFLTKNPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRLMDHPN 131
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F + LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ + HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 141 STTSKDELFLNLVMEYVPETMYR------VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
DEL+ +VMEY M + +++ MN+ + YV ++ +GL Y+
Sbjct: 86 ---VGDELW--VVMEY----MDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYL 132
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELI 251
H+ V HRD+K N+L L+ VKL DFG A L K ++ S + + Y+ APE+I
Sbjct: 133 HSQ-NVIHRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQP 278
+Y +DIWS G + E+ G+P
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 88 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLM---DHPNVISLKHCF 139
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 140 FSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S SKD L+L VMEY+ ++ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+NLL+D H +KL DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGE 283
+ D WS GCV+ E L G P F E
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 75/230 (32%), Positives = 117/230 (50%), Gaps = 28/230 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +D+ +L L MEYVP +R +L + +++ + + Y ++F + +H
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G HRD+KP+N L+D H +KL DFG +K +V AN S + S Y APE++ G
Sbjct: 120 L-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KG 174
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306
Y ++D WS GC+L E L G P F G + N+ Y K Q
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C +D+ L++ MEY+P ++ LK Y ++ + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L G S + Y+ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
E+I G Y D+WS GC + E+L +P
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 75/235 (31%), Positives = 117/235 (49%), Gaps = 30/235 (12%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 122
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL 182
++ + HPN I K C+ + LVMEY + +L+ + + PL V++
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVH-----KKPLQEVEI 117
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ +GLAY+H+ HRD+K N LL +P VKL DFGSA + AN S+
Sbjct: 118 AAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SF 171
Query: 240 ICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+ + Y+ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 140 FSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 199 GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+K N LLV VK+ D G +KVL K A + I + +Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 66/233 (28%), Positives = 121/233 (51%), Gaps = 30/233 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 124
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLY 183
+ +DH N++ E +L++ +EYVP ++ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---LVKGEANISYI 240
T Q+ GLAY+H+ G+ HRD+K NLLVD K+ DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 241 CSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S ++ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFS 141
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 142 TTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T L +VMEY V + M N+ + + YQ +GL Y+H+
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIM-------KITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 255
HRD+K N+L++ Q KL DFG + L A + I + ++ APE+I
Sbjct: 118 N-KKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y DIWS G E+ G+P + + + + I
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHPNVISLKH 137
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 138 CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ ++ ++MEY ++ +L+ ++ + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
G+ +RD+KP+NLL+D VKL DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII 299
Y S+D WS G +L ELL G+P F GE+ D +++ N I
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDP----MEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L T + L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N LV VK+ DFG ++ + + + YYR
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F DEL+ LVM Y+ ++ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 197 VPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKG-----EANISYICSRYYRAPEL 250
G HRD+K N+L+ VK+ DFG + L G + +++ + + APE+
Sbjct: 121 -NGQIHRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ Y DIWS G EL G +
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y RVVG G+FGIV + + V IK++ +R E Q+++L+ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F + L +VMEY P T+ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++HT + HRD+K QN+L+D VK+ DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-24
Identities = 73/231 (31%), Positives = 122/231 (52%), Gaps = 25/231 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+++G GSFG VF A+ T + AIK + +D + +++ L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H + + +K+ LF VMEY+ + M+ H S + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMF----HIQSCH-KFDLPRATFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302
G +Y TS+D WS G +L E+L+GQ F G + ++L + I++ N Y +
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 20/230 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPNVISL 135
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE + LV++ + + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ G+ HRD+KP N+L+D H V + DF A + S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPG--ENAVDQLVEIIKVSNIIYAKT 303
Y+ ++D WS G E L G+ + G DQ+ + ++++Y T
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-24
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 50/230 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVIS 134
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY---------SSMNQRMPLIYVKLYTY 185
L T ++ L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
QI +G+ Y+ + V HRD+ +N LV VK+ DFG ++ + + YY
Sbjct: 113 QIAKGMEYLASKKFV-HRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 246 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 76/233 (32%), Positives = 119/233 (51%), Gaps = 25/233 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ T E AIK + +D ++ +++ L +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H F + +K+ LF VMEY+ + M+ H S + R + Y +I GL
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGDLMF----HIQS-SGRFDEARARFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H G+ +RD+K N+L+D H +K+ DFG K + GE S C + Y APE++
Sbjct: 111 FLHK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
G +Y S+D WS G +L E+L+GQ F GE+ D+L + I + + I
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C+ E LVMEY + +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRDVK N LL +P VKL DFGSA ++ AN ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSASIM--APAN-XFVGTPYWMAPEVILAM 186
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-23
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRLMDHPNVISLKHC 138
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F D+ LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGA 254
+ HRD+K NL +D VK+ D G AK+L + + + + YY +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELC-ED 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y D+W+ G VL E G+ F N +++II+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-23
Identities = 75/233 (32%), Positives = 121/233 (51%), Gaps = 25/233 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ GE A+K + +D + +++ L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +C F T K+ LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+++D H +K+ DFG K V G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V Y + I
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 75/220 (34%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K C+ E LVMEY + +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRD+K N LL +P QVKL DFGSA + AN S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSASIA--SPAN-SFVGTPYWMAPEVILAM 196
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
E Y +D+WS G EL +P NA+ L I
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKH 137
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
C+ + LVMEY + +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHS- 139
Query: 198 PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+K N LL +P QVKL DFGSA AN S++ + Y+ APE+I E
Sbjct: 140 HNMIHRDIKAGNILLTEP--GQVKLADFGSASKS--SPAN-SFVGTPYWMAPEVILAMDE 194
Query: 257 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +D+WS G EL +P NA+ L I
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++MEY L +++ Y+ ++ GL Y
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDET----YIAFILREVLLGLEY 113
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YYR 246
+H G HRD+K N+L+ VKL DFG V G+ S + R ++
Sbjct: 114 LHE-EGKIHRDIKAANILLSE-EGDVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
APE+I + Y DIWS G EL G+P
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 24/209 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T D+ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT 255
+ +RD+KP+N+L+D H +KL DFG AK L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRLMDHPNVI 133
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T D+ +++ ME+VP ++ +L + + P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI-------CSRYY 245
Y+H V HRD+K N+++ P +KL DFG A+ L + ++ + Y+
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 32/209 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 141 STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S +D+L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFG 253
G HRD+K N+L LT VKL DFG + L A S+I + Y+ APE+
Sbjct: 120 T-GKIHRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQP 278
A E Y DIW+ G EL QP
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 8e-22
Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 25/212 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMR-LMDHPNVISLKHCF 139
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 140 F---STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ D+L+ LVME ++ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 196 TVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIF 252
V HRD+K QN+L LT +VKL DFG SA++ ++I + Y+ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185
Query: 253 GATE------YTTSIDIWSAGCVLAELLLGQP 278
A + Y D+WS G EL G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 50/239 (20%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LM---DHPNVISLK 136
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----------- 244
+ G HRD+KP N+L+D H +KL DFG K + K + Y+ +
Sbjct: 119 KL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 245 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 51/247 (20%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNV 132
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ K L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----------VKGEANISYIC 241
Y+ + HRD+ +N+LV+ VK+ DFG AKVL GE+ I
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---- 176
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVD 287
+Y APE + + + S D+WS G L EL + L G+ V
Sbjct: 177 -FWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 288 QLVEIIK 294
+L+E++K
Sbjct: 234 RLLELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 85/272 (31%), Positives = 127/272 (46%), Gaps = 39/272 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+L HC F T KD LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H GV +RD+K N+L+D H KL DFG K + + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AK 302
I EY S+D W+ G ++ E++ GQP F +N D L E I +++Y A
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDVLYPVWLSKEAV 224
Query: 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHE 334
+I + N ++ LG S G +++ +
Sbjct: 225 SILKAFMTKNPNK---RLGCVASQGGEDAIKQ 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 82 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRLMDHPNVISLK 136
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + ME VP L + + I YT QI GL Y+
Sbjct: 72 GSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI-F 252
H + HRD+K N+LV+ + VK+ DFG++K L ++ + Y APE+I
Sbjct: 125 HDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF 280
G Y DIWS GC + E+ G+P F
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-21
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
Y+ RV+G G+FG + E V K+V L RR E+ ++ L+ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I+ + F + L + MEY T+Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPEL 250
+YIH G+ HRD+K N+ + +KL DFG +K+L + + + + YY +PEL
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLTK-AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G +Y DIW+ GCVL ELL + F N ++ +V+I+
Sbjct: 173 CQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-21
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C + L++ ME++P ++ LK Y ++ + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
E+I G Y DIWS GC + E+L +P
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 83/260 (31%), Positives = 116/260 (44%), Gaps = 39/260 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRLMDHPNV 132
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L CF + D LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H KL DFG K + S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AK 302
I Y S+D W+ G +L E+L G F EN D L E I ++Y A
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVYPTWLSQDAV 224
Query: 303 TIYQGLFCSNNHEIMCELGS 322
I + N LGS
Sbjct: 225 DILKAFMTKNP---TMRLGS 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 74/232 (31%), Positives = 118/232 (50%), Gaps = 25/232 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
H F T + L VMEYV + MY H + + + P Y +I GL +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEP--QAVFYAAEISVGLFF 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIF 252
+H G+ +RD+K N+++D H +K+ DFG K +V G ++ + Y APE+I
Sbjct: 117 LHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
Y S+D W+ G +L E+L GQP F GE+ D+L + I N+ Y K++
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145
G G++G+V + + + TG +A+K++ R N + Q LMD + C ++ T
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 146 DELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
LF + ME + ++ + K +P + I + L Y+H+ V
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE---YT 258
HRDVKP N+L++ QVKLCDFG + LV A + Y APE I Y
Sbjct: 127 HRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYD 185
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGEN 284
D+WS G + EL G+ FP ++
Sbjct: 186 VKSDVWSLGITMIELATGR--FPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ Y ++D W G VL E+L G P F
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 136
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F S LF+ VMEY + M R+ + + ++ + QI GL +I
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIF 252
H + HRD+K QN+ + KL DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y DIWS GCVL EL + F G N + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
+ ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFF 140
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 141 STTSKDELFLNLVMEYVP----ETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S + + MEY +++Y +V K + ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELI 251
+ + HRD+KP N+L+ QVKLCDFG V GE S + + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
G Y+ + D+WS G L E+ + FP E
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 72/231 (31%), Positives = 116/231 (50%), Gaps = 23/231 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T D L+ VMEYV + MY + + + + Y +I GL ++
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
Y S+D W+ G +L E+L GQP F GE+ D+L + I N+ Y K++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 27/206 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 138
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ S DEL++ VME++ + ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGA 254
GV HRD+K ++L LT +VKL DFG A+V + S + + Y+ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLF 280
Y T +DIWS G ++ E++ G+P +
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +++ ME++ ++ +VLK R+P + + + RGL Y+
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENA 285
T DIWS G L E+ +G+ P +A
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-19
Identities = 66/230 (28%), Positives = 115/230 (50%), Gaps = 24/230 (10%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLM 127
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
H ++ C + E L + MEY+P ++ LK Y ++ + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICS 242
I G++Y+H+ + HRD+K N+L D VKL DFG++K L + G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y+ +PE+I G Y D+WS GC + E+L +P + A+ + +I
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C K L++ +EY+P ++ LK Y ++ + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K + + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
E+I G Y D+WS C + E+L +P
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-19
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F +KD+L L + + + Y H ++ + P Y QI GL ++H
Sbjct: 60 YAF---ETKDDLCLVMTLMNGGDLKY----HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ +RD+KP+N+L+D + V++ D G A L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLF 280
Y S+D ++ GC L E++ G+ F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENA 285
DIWS G L EL +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH------- 137
+G+G+ G V++ + +TG +A+K++ RR N+E LMD +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMD-LDVVLKSHDCPYIVK 78
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
C+ + ++F+ ME + + ++LK + +P + T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT- 255
GV HRDVKP N+L+D + VKLCDFG + LV +A S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 256 --EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+Y D+WS G L EL GQ FP +N
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS----F 68
Query: 140 FSTTSKDELFLN-----LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ FLN + ME++ ++ R+ K + P+ + + GL Y
Sbjct: 69 YGA------FLNENNICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
++ V + HRD+KP N+LV+ Q+KLCDFG + L+ A+ +++ + Y +PE I G
Sbjct: 119 LYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQG 176
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFP 281
+YT D+WS G + EL LG+ FP
Sbjct: 177 G-KYTVKSDVWSLGISIIELALGK--FP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F TT K L V+++V E + + + S P + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K + + + ++ + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
I Y ++D W G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 21/228 (9%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRY 244
+ R L+Y+H GV HRD+K ++L+ ++KL DFG A+V + S + + Y
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+ APE+I Y T +DIWS G ++ E++ G+P + E + + I
Sbjct: 184 WMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 59/258 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE +L L+MEY+P M +L + + Y+ + + I
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA----ETILAIDSI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------------VKGEANISYI 240
H + G HRD+KP NLL+D H +KL DFG L + +I
Sbjct: 118 HKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 241 CSRY-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLL 275
Y APE +F T Y D WS G ++ E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 276 GQPLFPGENAVDQLVEII 293
G P F +N + +II
Sbjct: 235 GYPPFCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLKH 137
+G GSFG V Q + +T A+K + + E+ ++ ++ P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
FS S ++L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATE 256
V +RD+KP+N+L+D H + LCDFG K+ +K + + C + Y APEL+ G
Sbjct: 113 -NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGEN 284
YT ++D W+ G +L E+L G P F EN
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHC----- 138
+G G+FG V + +G +A+K++ R E + RL MD V+ C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 139 FFSTTSKD-------ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
F+ ++ EL M+ + Y+ + Y + +P + + L
Sbjct: 68 FYGALFREGDCWICMEL-----MDISLDKFYKYV--YEVLKSVIPEEILGKIAVATVKAL 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+ + HRDVKP N+L+D +KLCDFG + LV A R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 252 --FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294
Y D+WS G L E+ G+ +P N+V DQL +++K
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-18
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
F + + + MEY+ L + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI-----FGA 254
+ HRDVKP N+LV+ QVKLCDFG + LV A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEII 293
YT D+WS G + E+ LG+ +P E N QL I+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV 223
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 79/325 (24%), Positives = 136/325 (41%), Gaps = 91/325 (28%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-------MDHPNVISL 135
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D +L L+ME++P + M ++K Y + ++ + + Y + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDV----TRFYMAECVLAIEA 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------SAKVLVKGEANISYIC 241
+H + G HRD+KP N+L+D H +KL DFG + L++G++N + I
Sbjct: 117 VHKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 242 SRY------------------------------------YRAPELIFGATEYTTSIDIWS 265
+R Y APE IF Y D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY----------AKTIYQGLFCSNNHE 315
G ++ E L+G P F EN+ + +II +Y A+ + + L + +
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENR 293
Query: 316 IMCELGSWYSYSGRNSMHESKLYGF 340
+ GR HE K + F
Sbjct: 294 L-----------GRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENA 285
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT--------Y 185
+ K F + + L +VMEY + Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDG---------GDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVK-GEANISYICS 242
Q+ G+ +IH V HRD+K +N+ LT +VKL DFGSA++L G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
YY PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 70/231 (30%), Positives = 115/231 (49%), Gaps = 23/231 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T + L VMEYV + MY++ R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G ++ + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
Y S+D W+ G +L E+L GQ F GE+ D+L + I N+ Y K++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNVAYPKSM 224
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 38/210 (18%)
Query: 85 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVIS 134
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
K +S ++ L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------VK--GEANISYICSR 243
+ + V HRD+ +N+LV+ VK+ DFG KVL V+ GE+ I
Sbjct: 124 LGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
++ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 28/248 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLV----EIIKVSNIIYAKTI 304
YT S D W GC++ E++ G+ F V++ V E A++I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235
Query: 305 YQGLFCSN 312
+ L +
Sbjct: 236 CRQLLTKD 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-17
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
K C + + L L+MEYVP R + KH ++ Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE-- 249
AY+H+ + HRD+ +N+L+D VK+ DFG AK + +G YYR E
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170
Query: 250 ---LIFGATE------YTTSIDIWSAGCVLAELL 274
+ + A E ++ + D+WS G L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 25/221 (11%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 242
+ + L+ +H GV HRD+K ++L LTH +VKL DFG A+V + S + +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
Y+ APELI Y +DIWS G ++ E++ G+P + E
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 36/225 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISL 135
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
C F T L +VMEYV +LK+ ++ P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--------------- 239
H G+ HRD+KP NLL+ + H +KL DFG +K+ + Y
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
+C + Y APE+I Y +D W+ G +L E L+G F G+
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ QVKLCDFG + LV A +Y+ + Y APE I G +Y
Sbjct: 116 -ILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 259 TSIDIWSAGCVLAELLLGQPLFP 281
D+WS G EL LG+ +P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 59/230 (25%), Positives = 116/230 (50%), Gaps = 32/230 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF T S+ LF V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 293
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +D+L++ ME+ + + H + + YV T Q GL Y+H+ G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ H VKL DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQP 278
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 25/227 (11%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRLMDHP 130
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++L H F T +K L+L+++YV + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYVNGG--ELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAP 248
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E S+ + Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 249 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
E+I G + + ++D WS G + ELL G F + + EI +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQ--------LMRLMDHPNVI 133
+V+G GSFG V A+ + E KVLQ + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++Y+ E Y + + + R + Y +I L
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
+ Y ++D W G VL E+L G P F N + I+
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 19/227 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
HPN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
APE++ Y +DIWS G + E++ G+P + EN + L I
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 52/284 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+V+G G+FG V + + + A+K + + K E +M + ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F +D+ +L +VMEY+P + ++ +Y +P + + YT ++ L I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPE 249
H++ G HRDVKP N+L+D H +KL DFG+ +K +AN C Y +PE
Sbjct: 159 HSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213
Query: 250 LIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII------- 299
++ G Y D WS G L E+L+G F ++ V +I+ N +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273
Query: 300 ---YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340
AK + + GRN + E K + F
Sbjct: 274 ISKQAKDLICAFLTDREVRL-----------GRNGVDEIKSHPF 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRLMDHPNVISLK 136
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +DE + ++E+V + H R P K Y ++ Y+H+
Sbjct: 85 CSF-----QDENRVYFLLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ +RD+KP+NLL+D H VK+ DFG AK + + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 257 YTTSIDIWSAGCVLAELLLGQPLF 280
+ ++D W+ G +L E + G P F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRLMDHPNVIS 134
+G G+FG V+Q + +T A+K + + +E L L + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK FS + +L+L V +Y+ E + + K R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D H + LCDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
YT +D WS G ++ E+ G F E+ Q+ I + + K +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H +RD+KP+N+L+D H +++ D G A + +GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPG 282
YT S D W GC++ E++ GQ F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L + F +D+ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
L IH++ G HRDVKP N+L+D H +KL DFG+ + K E + + + + Y +
Sbjct: 155 LDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 211
Query: 248 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN 297
PE++ G Y D WS G L E+L+G F ++ V +I+ N
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 9e-16
Identities = 65/224 (29%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +PN+++ F DELF+ VMEY+ + + M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
APE++ Y +DIWS G + E++ G+P + EN + L
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S +EL++ +ME++ + + +N+ + + + L Y+H+ G
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
V HRD+K ++L+ L +VKL DFG A++ S + + Y+ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
T +DIWS G ++ E++ G+P + ++ V +
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 27/225 (12%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRLMDHPNV 132
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPE 249
L ++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C Y APE
Sbjct: 111 LDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ +T S D WS G ++ E+L G F G++ + + I+K
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 40/292 (13%)
Query: 9 QPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMD---SDKEMSAAV---IQGNDAVTGHII 62
+P PPP ++ R RPD+ ++ S AV + + +
Sbjct: 2 KPIQPPPGVPLPSTARH---TTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58
Query: 63 STTIGGKNGEPKQTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RR 115
S++ G +++S + ERV +G+G+ G V++ TG A+K + + RR
Sbjct: 59 SSSASGSAPSAAKSLSEL-ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR 117
Query: 116 YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
RE++++R ++HPNV+ H F + ++ L E M + +
Sbjct: 118 QICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLL--------EFMDGGSLEGTHIADEQ 168
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-E 234
L V QI G+AY+H V HRD+KP NLL++ VK+ DFG +++L + +
Sbjct: 169 FLADV---ARQILSGIAYLHRRHIV-HRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223
Query: 235 ANISYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF---QTESRLFF--VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 111 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 293
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY----VKLYTYQIF 188
+ + F + L +VM+Y Y +N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKG-EANISYICSRYY 245
L ++H + HRD+K QN+ LT +KL DFG A+VL E + I + YY
Sbjct: 112 LALKHVHDRK-ILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296
+PE I Y DIW+ GCVL E+ + F N + +++II+ S
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S S+++L+ + MEY + + H + + + YV T Q GLAY+H+ G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ VKL DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQP 278
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 25/232 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L C F +D+ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANI-SYICSRYYRAP 248
L IH++ G+ HRDVKP N+L+D H +KL DFG+ K+ G + + + Y +P
Sbjct: 155 LDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 249 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN 297
E++ G Y D WS G L E+L+G F ++ V +I+ N
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K V+ E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ Y ++D W G VL E+L G P F
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRLMDHP 130
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L F T K L L++EY+ ++ L+ + Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT----ACFYLSEISL 111
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N+L+D H VKL DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
E I + + ++D WS G ++ ++L G P F EN + +I+K
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLK 136
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +D+ L LVMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--ICSRYYRAPELI- 251
H + G HRD+KP+N+L+D H +KL DFGSA L + S + + Y APE++
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 63/228 (27%), Positives = 115/228 (50%), Gaps = 30/228 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH--------PNVIS 134
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K L G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEII 293
G EY S+D W+ G ++ E++ G+ F P N D L ++I
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL----------MDHPNVI 133
V+G G FG V A+ +TGE AIK + + E++ + HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+L CF ++D + VMEY + M + S + Y + GL
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H + +RD+K NLL+D VK+ DFG K + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ T YT ++D W G ++ E+L+G+ FPG++
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 9e-15
Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
APE++ Y +DIWS G + E++ G+P + EN + L
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 29/235 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 132
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + I + +T+
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIRFPRTL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 131
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ + S +D L L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRE---SWEGEDGL-LYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L Y+H + HRD+K QN+ + T+ +K+ D G A+VL + + + I + YY +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 250 LIFGATEYTTSIDIWSAGCVLAEL 273
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
APE++ Y +DIWS G + E++ G+P + EN + L
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 63/237 (26%), Positives = 113/237 (47%), Gaps = 30/237 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNV 132
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + I + +T+
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIRFPRTLSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F S T L LVM + + H ++ +R + + V Y+ QI G+ ++H
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKY--HIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+N+L+D +L D G A L G+ + Y APE I
Sbjct: 113 SM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLF 280
Y+ +D ++ GC + E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ L +++E+ P + P I ++ Q+ L Y+H++
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSMK- 130
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT--- 255
+ HRD+K N+L+ L +KL DFG SAK + + S+I + Y+ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 256 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y DIWS G L E+ +P N + L++I K
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKHC 138
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 139 FFSTTSKDELFLNLVMEYVP--------ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+F +++L++ ++E+ + R L ++ Q+
Sbjct: 71 YFY---ENKLWI--LIEFCDGGALDSIMLELERGLTEP----------QIRYVCRQMLEA 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPE 249
L ++H+ V HRD+K N+L+ L VKL DFG SAK + ++I + Y+ APE
Sbjct: 116 LNFLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 250 LI----FGATEYTTSIDIWSAGCVLAELLLGQP 278
++ F Y DIWS G L EL +P
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 83 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
P +++L H F T +K L+L+++YV M+ L + ++ V+ Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE----VRFYSGEI 114
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYY 245
L ++H + G+ +RD+K +N+L+D H V L DFG +K + + E S+ + Y
Sbjct: 115 ILALEHLHKL-GIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
APE+I G + ++D WS G ++ ELL G F E + E+ +
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 83 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRLMDHPNVIS 134
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F KDE +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
++ + +RD+KP+NLL+D +K+ DFG AKV+ + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLF 280
YT S D W+ GC+L E++ GQ F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 61/215 (28%), Positives = 111/215 (51%), Gaps = 29/215 (13%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----------KVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF + + ++G+ A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIV 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E +Y C Y
Sbjct: 116 LALEHLHKL-GIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 247 APELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 280
AP+++ G + ++D WS G ++ ELL G F
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 85 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K E + LVME P L Y + +P+ +K +Q+ G+AY+ +
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLG---PLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 197 VPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
V HRD+ +N LLV+ HQ K+ DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 247 ---APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
APE I +++ D+WS G L E G
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 8e-14
Identities = 61/232 (26%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F +KD L VMEYV E + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ + +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
+Y ++D W G V+ E++ G+ F ++ ++L E+I + +I + +T+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEDIKFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RLMDHPN---VIS 134
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ +RD+KP+N+L+D H +++ D G A + +GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLF 280
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H M + Y +I GL
Sbjct: 60 VCMSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG----- 129
Query: 148 LFLNLVMEYVPETMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
VL HYSS ++ +P+ + QI GL Y+H
Sbjct: 130 -----------AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR- 177
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ HRDVK +N+ ++ + QV + D G+A+ V A + + APE + +Y +
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235
Query: 260 SIDIWSAGCVLAELL 274
DIWSAG VL E+L
Sbjct: 236 KADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H + M + Y +I GL
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCF 139
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 140 FSTTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D+L+ LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH 138
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 139 -AHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 195
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQP 278
Y DIWS G E+ G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 5e-13
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRLMDHPNV 132
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F + ++ L ++ME+ + R ++ M ++ + T Q+ L
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 192 AYIHTVPG------VCHRDVKPQNLL-------VDPLTHQV---------KLCDFGSAKV 229
AY H + V HRD+KPQN+ + +T Q K+ DFG +K
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 230 LVKGEANISYIC--SRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ G ++++ C + YY +PEL+ T+ Y D+W+ GC++ EL G+ F N
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 287 DQLVEIIK 294
QL+ +K
Sbjct: 250 SQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 50/285 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LM--DHPNVISL 135
+V+G G+FG V K TG+ A+K + + K E R L+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKG--EANIS-----YICSRYYR 246
H + G HRD+KP N+L+D H ++L DFGS ++L G ++N++ YI +
Sbjct: 119 HQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY------ 300
A E G Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 301 -----AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340
AK + + L CS + GRN + + K + F
Sbjct: 235 DVSEEAKDLIRRLICSPETRL-----------GRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 142
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 143 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T +DE +L LVM+Y +L S R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF---- 252
V HRD+KP N+L+D H ++L DFGS K+ G S + + Y +PE++
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----------VSNIIY-A 301
G +Y D WS G + E+L G+ F E+ V+ +I+ ++++ A
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240
Query: 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340
K + Q L CS + G+N + + K + F
Sbjct: 241 KDLIQRLICSRERRL-----------GQNGIEDFKKHAF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 53/228 (23%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 85 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-LMD 128
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTY 185
HPN++ F D L++ VM+ + +H++S+ QR +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
Q+ L Y+H + HRD+ P N+++ +V + DFG AK S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
PE++ Y D+W+ GC+L ++ QP F N + +I+
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 48/240 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHPNVISL 135
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDF-------------------GSAKVLVKGEA 235
H + G+ +RD+KP+N+L+ H + L DF GS + V
Sbjct: 120 HLL-GIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 236 NISYICS-----------RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++ Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 60/232 (25%), Positives = 113/232 (48%), Gaps = 24/232 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F + D L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF---QTHDRLCF--VMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
+Y ++D W G V+ E++ G+ F ++ ++L E+I + I + +T+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEIRFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 35/230 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RLMDHPNVISLKH 137
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 138 C--FFSTTSKDELFLNLVM-EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+F + + +VM +Y P + ++KH + R ++ +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247
Query: 195 HTVPGVCHRDVKPQNLL-------VDPLTHQ--------VKLCDFGSAKVLVKGEANISY 239
HT + H D+KP+N+L VDP+T++ V++CD G + + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
+ +R+YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354
|
Length = 467 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 83 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRLMDHPNVIS 134
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
L +++ ++ +VME P L+ Y +N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 194 IHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRA 247
+ + V HRD+ +N+LV P VKL DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 248 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 284
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 140 FSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + L +++E+ V M + + + +++ Q L Y+
Sbjct: 72 YYENN-----LWILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFG 253
H + HRD+K N+L L +KL DFG SAK + S+I + Y+ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
T Y D+WS G L E+ +P N + L++I K
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YY 245
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + E + Y + ++
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 55/228 (24%), Positives = 112/228 (49%), Gaps = 22/228 (9%)
Query: 79 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDH 129
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSRYYR 246
G+ Y+H + HRD+K +N+ + + +K+ DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE + Y + DIWS GC+L E+ F G+N + ++ I++
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 69/258 (26%), Positives = 119/258 (46%), Gaps = 33/258 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPN--VISL 135
+V+G G+FG V K + A+K + + K E R L++ N + +L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVM+Y +L S R+P + Y ++ + +H
Sbjct: 67 HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF- 252
+ V HRD+KP N+L+D + ++L DFGS K++ G S + + Y +PE++
Sbjct: 120 QLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------KVSNII 299
G +Y D WS G + E+L G+ F E+ V+ +I+ +V+++
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 300 Y-AKTIYQGLFCSNNHEI 316
AK + + L CS H +
Sbjct: 238 EDAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 55/247 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRLM-DHPNVI 133
+G G+FG V +A+ + TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIYV 180
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ YQ+ RG+ ++ + + HRD+ +N+LV H +K+ DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVTE-DHVMKIADFGLAR-------DIHHI 185
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241
Query: 288 QLVEIIK 294
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
T L ++MEY+ L ++ +K +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYT 258
+ HRD+K N+L+ VKL DFG A L + +++ + ++ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 259 TSIDIWSAGCVLAELLLGQP 278
+ DIWS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
F L++ +Y Y + + + + + + R + Y+H + HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 208 QNLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYY--------RAPELIFGATEY 257
+N+ ++ H +C DFG+A V AN +YY APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 258 TTSIDIWSAGCVLAELLLGQ 277
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 195
T L ++MEY L S+++ + PL ++ T +I +GL Y+H
Sbjct: 72 LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
+ + HRD+K N+L+ +VKL DFG A L + + ++ + ++ APE+I
Sbjct: 119 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQP 278
+ Y + DIWS G EL G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLM-RLMDHPN 131
+ +G G+FG V +A ++ VA+K + R EL++M L +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYICS 242
G+A++ + + HRD+ +N+L+ VK+CDFG A+ +VKG A +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YT D+WS G +L E+ LG +PG
Sbjct: 208 -KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMP-LIYVKLYTYQI 187
++ L ++ S++E +V EY+ + ++ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--- 244
G+AY+ + HRD+ +N+LV K+ DFG A+++ E + +++
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYT-AREGAKFPIK 169
Query: 245 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCFF 140
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 141 STTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ D+L+ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF-- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 253 --GATEYTTSIDIWSAGCVLAELLLGQP 278
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 91/325 (28%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++S KD L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG---------SAKVLVKGE---------- 234
+H + G HRD+KP N+L+D L +KL DFG ++K KG
Sbjct: 117 VHKM-GFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 235 ------ANI-----------------------SYICSRYYRAPELIFGATEYTTSIDIWS 265
+N S + + Y APE++ YT D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY----------AKTIYQGLFCSNNHE 315
G +L E+L+GQP F + +++I N ++ A + L CS
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293
Query: 316 IMCELGSWYSYSGRNSMHESKLYGF 340
+ GRN + K + F
Sbjct: 294 L-----------GRNGADDIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 100 ETGETVAIKKVLQD-----RRYK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
V EYVP R L+ + + +P Q+ LA H G+ HRD+KPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 213 DP--LTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYRAPELIFGATEYTTSID 262
+ K+ DFG +L + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 263 IWSAGCVLAELLLGQPLFPGENAVD 287
+++ G + E L GQ + G + +
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRGLAYIH 195
T L ++MEY L S+++ P Y+ +I +GL Y+H
Sbjct: 72 LKGTK-----LWIIMEY--------LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIF 252
+ + HRD+K N+L L+ Q VKL DFG A L + +++ + ++ APE+I
Sbjct: 119 SERKI-HRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQP 278
+ Y DIWS G EL G+P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LMDHPNVISLKHC 138
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +D+L L L+ME++P M +L ++ + + Y + + IH +
Sbjct: 67 FYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE----TQFYIAETVLAIDSIHQL 120
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------------------------ 233
G HRD+KP NLL+D H VKL DFG L K
Sbjct: 121 -GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 234 ------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
+ S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 282 GE 283
E
Sbjct: 238 SE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLM 127
P + ++ +G G++G VF+ + G A+K +L + E++ L L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
DHPNV+ ++ K+ L LV+E ++ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSR 243
GL ++H V HRDVK N+L LT + VKL DFG SA++ + + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 244 YYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 278
++ APE+I + Y D+WS G EL G P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI---YVKLYTYQIFRGLAY 193
+ F + T L LVM + R H ++++ P YT QI GL +
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D + V++ D G A L G++ Y + + APEL+
Sbjct: 113 LHQ-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 253 GATEYTTSIDIWSAGCVLAELL 274
G EY S+D ++ G L E++
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 132
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 182
I L + S+D L L++EY Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 183 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+ +QI RG+ Y+ + V HRD+ +N+LV ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 229 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPNVISLKH 137
+V+G G+FG V + +TG A+K + + + ++ +R L++ +K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK- 65
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F+S K L+L +ME++P M +L ++++ + Y + + IH
Sbjct: 66 MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA----TQFYIAETVLAIDAIHQ 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------------------------- 225
+ G HRD+KP NLL+D H VKL DFG
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 226 ---SAKVLVKGEANISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
A+ K ++Y + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 281 PGE 283
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYV 180
QLM+ D+PN I L + TT K + L+M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLFDLLK----KEGKLSEAEV 111
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
K Q+ L +H + H D+K +N+L D ++ LCD+G K+ +
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTP------ 163
Query: 241 CSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S Y Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 164 -SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRLMDHPNVISLKH 137
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYI 194
F+ S E + E M + L + S Q +P+ + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-----IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 195 HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVL-----VKGEANISYICSRYYRAP 248
HRD+ +N+LV + L K+ DFG A+++ + + I Y + AP
Sbjct: 121 EE-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY----KWTAP 173
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 291
E ++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 174 EAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 68/244 (27%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 118
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ----- 173
+E +LM + HPN++ C +K++ ++ EY+ + L + N
Sbjct: 57 QEAELMSDLQHPNIV----CLLGVCTKEQP-TCMLFEYLA---HGDLHEFLVRNSPHSDV 108
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+ L QI G+ Y+ + HRD+ +N LV VK+
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKIS 166
Query: 223 DFGSAKVLVKGEANISYICSRYYR------------APELI-FGATEYTTSIDIWSAGCV 269
DFG ++ + + YYR PE I +G ++TT DIWS G V
Sbjct: 167 DFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVV 215
Query: 270 LAEL 273
L E+
Sbjct: 216 LWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G G++G V++ + G A+K +L + E++ L L +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV+E ++ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ HRDVK N+L LT + VKL DFG SA++ + + + ++ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 256 EYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+Y S D+WS G EL G P + V L +I
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 71/262 (27%), Positives = 107/262 (40%), Gaps = 66/262 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 121
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-------SMNQ 173
+L+ H N++ T D +V EY+ + + L+ + S +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 174 RM-PLIYVKLY--TYQIFRGLAYI---HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGS 226
M L +L QI G+ Y+ H V HRD+ +N LV L VK+ DFG
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV----HRDLATRNCLVGYDLV--VKIGDFGM 168
Query: 227 AKVLVKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL 274
++ + Y YYR PE I +TT D+WS G VL E+
Sbjct: 169 SRDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIF 218
Query: 275 L--GQPLFPGENAVDQLVEIIK 294
QP + N ++++E I
Sbjct: 219 TYGKQPWYGLSN--EEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 133
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L S T + LV + +P + V +H ++ ++ L + QI +G+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ + HRD+ +N+LV H VK+ DFG A++L E + + + A
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL--GQP 278
E I ++T D+WS G + EL+ G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 79 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRLMDHPNVI 133
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 134 SLKHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRG 190
KH F S D+L L +MEY + + +K + + +P V L YQI
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRA 247
L +H+ + HRD+K N+ + P T +KL DFG +K V + S+ + YY A
Sbjct: 182 LDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
PEL + Y+ D+WS G +L ELL F G
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 55 DAVTGHIIST---TIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV 110
DA+ G + T T K Q Y RV+G+G+ G V AK + GE A+K V
Sbjct: 6 DAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV 65
Query: 111 ------LQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPETM 161
D+ E+ + D +++ F ++ L + LV++Y
Sbjct: 66 DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD 125
Query: 162 YRV-LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
R +K + N+ L Q+ + ++H+ + HRD+K N+L+ VK
Sbjct: 126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVK 183
Query: 221 LCDFGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
L DFG +K+ V + ++ + YY APE I+ Y+ D++S G +L ELL +
Sbjct: 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 278 PLFPGEN 284
F GEN
Sbjct: 243 RPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ V HRD+ +N+LV H VK+ DFG AK+L E + + A
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNVISLKH 137
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-------APE- 249
HRD+ +N LV + +K+ DFG + + E Y S + APE
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L +G YT+ D+WS G +L E LG +PG
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 88 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 145 KDELFLNLVMEYVPETMYRVLKH----YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
+ + + +VM K Y + +PL ++ LAY+H G+
Sbjct: 156 RWKSTVCMVM--------PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGI 206
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIFGAT 255
HRDVK +N+ +D + V L DFG+A L + C + +PEL+
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALD 262
Query: 256 EYTTSIDIWSAGCVLAELLLGQ-PLFPGEN--AVDQLVEIIK 294
Y DIWSAG VL E+ + LF + + QL II+
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 52/228 (22%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 85 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ +V E P + + + + + + Y QI G+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N+L+ +VK+ DFG + L + E + Y+ + +
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166
Query: 247 -APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 76/315 (24%), Positives = 122/315 (38%), Gaps = 70/315 (22%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
+P P P P APP + L+R D+E + A+ +G
Sbjct: 115 LPGDGAPDHDPAPCGPAPPGG---LTPEELER------LDREAARAISRG---------- 155
Query: 64 TTIGGKNGEPKQTIS-------YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
+P ++ + R + GS G VF++ + + V +K
Sbjct: 156 -------CKPPSEVAKVVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS-- 206
Query: 117 KNRELQLMRLMDHPNVISL--KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR 174
E +L+R + HP V++L T LV+ +Y L + +
Sbjct: 207 SVHEARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRP 256
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+ L V Q+ + YIH G+ HRD+K +N+LV+ + L DFG+A +G
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG- 312
Query: 235 ANISYICSRYY--------RAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQPLF 280
S+ +Y APE++ G YT S+DIWSAG V+ E L
Sbjct: 313 ---SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368
Query: 281 PGENAVD-QLVEIIK 294
D Q++ II+
Sbjct: 369 DERRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 55/235 (23%)
Query: 82 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKLY 183
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 184 TY--QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYI 240
+I G+AY+ HRD+ +N +V + LT VK+ DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ YYR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 7/104 (6%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 243 RY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 48/214 (22%), Positives = 77/214 (35%), Gaps = 29/214 (13%)
Query: 83 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVIS 134
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLA 192
F EL+ +V + L H+ + +P + + + L
Sbjct: 64 YVTSF---IVDSELY--VVSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALD 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI 251
YIH+ G HR VK ++L+ +V L + ++K G+ L
Sbjct: 116 YIHSK-GFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 252 FGATE--------YTTSIDIWSAGCVLAELLLGQ 277
+ + E Y DI+S G EL G
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 56/243 (23%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRLMDHPN 131
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
++ L ++ME + RV + + L+ + L
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL-- 113
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----VKLCDFGSAKVLVKGEANISYI 240
+ +G Y+ + + HRD+ +N LV + VK+ DFG A+ + K
Sbjct: 114 -DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-------- 163
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
S YYR APE L+ G +TT D+WS G ++ E+L LGQ +P N
Sbjct: 164 -SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 287 DQL 289
+ L
Sbjct: 221 EVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L+ T S+ + + ME L + N + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 246
Y+ + V HRD+ +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 44/217 (20%)
Query: 84 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYT--YQI 187
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ ++ V HRD+ +N LV +VK+ S L K N S YY+
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175
Query: 247 ----------APELIFGATEYTTSIDIWSAGCVLAEL 273
APE + +++T D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 44/257 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRLMDHPNVIS 134
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRG 190
L E + +P + L+++ P LI L Q+ +G
Sbjct: 61 L----LGICLPSE---GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
+ Y+ + V HRD+ +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLASKKFV-HRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 251 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ------G 218
Query: 302 KTIYQGLFCSNN-HEIM 317
+ + Q +C + +E+M
Sbjct: 219 RRLLQPEYCPDPLYEVM 235
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
++ Q+ +G+ ++ HRDV +N+L+ K+CDFG A+ +VKG A
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQL------MRLMDHPNVISLKHCFF 140
G+FG V+ + + A+K V + D KN Q+ + L P ++ L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S S + ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H G
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ HRD+KP N+L+ H +KL DFG +KV + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 15/108 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + KG+A
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + APE IF YT D+WS G +L E+ LG +PG
Sbjct: 242 RLPL----KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 47/244 (19%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 181 KLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L TYQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTE-NNVMKIADFG----LARDVNNID 191
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 291 EIIK 294
+++K
Sbjct: 250 KLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 40/122 (32%), Positives = 63/122 (51%), Gaps = 19/122 (15%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAK-------VLVKG 233
++YQ+ +G++++ HRD+ +N+L LTH K+CDFG A+ +VKG
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
A + + APE IF YT D+WS G +L E+ LG +PG + ++
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 293 IK 294
IK
Sbjct: 330 IK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L C ST + LV + +P Y L Y N+ R+ + + QI +G+
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
+Y+ V V HRD+ +N+LV H VK+ DFG A++L E + + A
Sbjct: 123 SYLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 37/107 (34%), Positives = 59/107 (55%), Gaps = 13/107 (12%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYK---DPDYVRK 232
Query: 243 RYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
L+ T SK + +V EY+ + R KH + + +I + I
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLR--KH----DGQFTVIQLVGMLRGIAS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----Y 244
G+ Y+ + G HRD+ +N+LV+ K+ DFG ++VL + + +Y
Sbjct: 118 GMKYLSDM-GYVHRDLAARNILVNS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIR 174
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ APE I ++T++ D+WS G V+ E++
Sbjct: 175 WTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
++S KD L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
+H + G HRD+KP N+L+D H +KL DFG
Sbjct: 117 VHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L+ +K + ++ EY+ ++ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQV-KLCDFGSAKVLVKGEANISY------ICSRYY 245
Y+ + HRD+ +N+LV+ ++ V K+ DFG ++ L ++ +Y I R+
Sbjct: 121 YLSEM-NYVHRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 123 LMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYV-PETMYRVLKHYSSMNQ------- 173
LM DHPN++ L C + L+ EY+ + L+H S Q
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+PL + Q+ G+AY+ V HRD+ +N LV VK+
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIA 172
Query: 223 DFGSAKVLVKGEANISYICSRYYRA------------PELIFGATEYTTSIDIWSAGCVL 270
DFG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 173 DFGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVL 222
Query: 271 AEL 273
E+
Sbjct: 223 WEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-- 238
+TYQ+ RG+ ++ + V HRD+ +N+L L VK+CDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVL---LAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 239 -YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 139 FFSTTSKDE--LFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIH 195
++ + +E + +M+Y ++ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIF 252
+ HRD+ +N+LV + K+ DFG A+V+ + + +++ + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTVPG 199
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 70 VCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KN 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++ L+ G+ ++ +++ + APE + +
Sbjct: 125 FIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181
Query: 257 YTTSIDIWSAGCVLAEL-LLGQPLFPG 282
++ D+W+ G +L E+ G +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 47/244 (19%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLMD-HPN 131
+G G FG V +A+ + TVA+K + + K+ E++LM+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 132 VISLK---------HCFFSTTSKDEL--FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
+I+L + +K L FL P+ + + K L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-----QLSFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L +G +I
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTE-DNVMKIADFG----LARGVHDID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIK 294
++++
Sbjct: 247 KLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 40/189 (21%)
Query: 106 AIKKVLQDRRYKNRELQLMRLMDHPNVISL-------KHCFFSTTSKDELFLN-LVMEYV 157
A +D +E++++ + PN+ L + LN + ++V
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
ET L S L+Y+ QI G+ Y+ ++ V HRD+ +N LV +
Sbjct: 115 AET--SGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-Y 167
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYY----RAP--------ELIFGATEYTTSIDIWS 265
+K+ DFG ++ L Y YY RAP E + ++TT D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217
Query: 266 AGCVLAELL 274
G L E+L
Sbjct: 218 FGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ L ++ +++ +++ + EY+ ++ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYR 246
G+A+I HRD++ N+LV K+ DFG A+++ E A +
Sbjct: 113 EGMAFIE-RKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 247 APELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 171 APEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVI 133
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ S++ +++ V EY+ + ++ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 193 YIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPE 249
YI + + HRD++ N+LV D L K+ DFG A+++ E A + APE
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 250 L-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292
++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 9/69 (13%)
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY- 244
QI L +H+ G+ HRDVKPQN++ + K+ D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 245 ----YRAPE 249
Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 58/234 (24%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRL---MDHPNVISL 135
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPL---------------IY 179
+S S + + M Y+ T+ +LK S+ Q+ L I+
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLK---SVWQKESLSKELAEKTSVGAFLSIF 119
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVK 232
K I + Y+H+ GV HRD+KP N+L+ L +V + D+G+A L+
Sbjct: 120 HK-----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 233 GEANISYICSRY------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + IC Y APE + G + S DI++ G +L ++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 47/244 (19%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVTE-DNVMKIADFG----LARDVHNID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIK 294
+++K
Sbjct: 247 KLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L H + S+D +FL V+++ L + S +P VK + ++
Sbjct: 45 PNMVCL-HKYI--VSEDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK---GEANISYICSRYYR 246
L +H VC RD+ P N+L+D H ++L F + GEA Y
Sbjct: 97 ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYC 149
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
APE + G +E T + D WS G +L ELL G+ L
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 71/279 (25%), Positives = 110/279 (39%), Gaps = 63/279 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIY 179
+ F D L +V EY+ P+ M V + L
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 240 ICSRYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENA 285
+ YYR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF----- 227
Query: 286 VDQLVEIIKVSNIIYAKTIYQGLFCSNN-HEIMCELGSW 323
QL + I + + + C ++IM LG W
Sbjct: 228 --QLSNTEVIECITQGRVLERPRVCPKEVYDIM--LGCW 262
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 49/266 (18%)
Query: 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ------RMPLIYVKLYTYQI 187
L + +K L + +V+ +P + L + M++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ Y+ + HRD+ +N +++ V + DFG +K + G+ YYR
Sbjct: 123 ASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 247 --APELIFG--ATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIK 294
A +L A E YTT D+W+ G + E++ GQ + G EN+ EI
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EI-- 224
Query: 295 VSNIIYAKTIYQGLFCSNN-HEIMCE 319
+ +I + Q C + +E+MC+
Sbjct: 225 YNYLIKGNRLKQPPDCLEDVYELMCQ 250
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 27/155 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM---PLIYVKLYTYQIFRG 190
++S KD L+ VM+Y+P + M S+ RM P + Y ++
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMM--------SLLIRMGIFPEDLARFYIAELTCA 113
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
+ +H + G HRD+KP N+L+D H +KL DFG
Sbjct: 114 VESVHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 56/236 (23%), Positives = 113/236 (47%), Gaps = 29/236 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N LV VK+ DFG + ++ + S +++ + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFSK 177
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVSNIIY-----AKTIYQ 306
Y++ D+WS G ++ E + + P EN + ++VE I +Y ++++Y+
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYE 232
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L+ T K + + ME + + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ + V HRD+ +N+LV+ + K+ DFG ++VL + + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM---DHPNVISLKHC 138
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGAT 255
HRD+ +N LV + +K+ DFG ++ G + + I ++ L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-- 169
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y++ D+WS G +L E LG +PG
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 26/197 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRLMDHPNVISLKHCFFS 141
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 72 GNP-----LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 124 V-HRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 257 YTTSIDIWSAGCVLAEL 273
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 39/117 (33%), Positives = 63/117 (53%), Gaps = 9/117 (7%)
Query: 171 MNQRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+N+ L Y+ L ++YQ+ G+ ++ + V HRD+ +N+L+ VK+CDFG A+
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLAR 287
Query: 229 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFP 281
+++ IS + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYP 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 133
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L C ++ L LV + P + V +H S++ + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYR 246
+ Y+ + HR++ +N+L+ V++ DFG A +L + Y ++
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
++FG YT D+WS G + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 52/224 (23%)
Query: 85 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 135
+G G+FG VF A+C E + + K L++ R+ RE +L+ ++ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK------HYSSMNQRMPLIYVKL-----Y 183
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICS 242
QI G+ Y+ ++ V HRD+ +N LV L VK+ DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTD-------- 176
Query: 243 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 274
YYR PE I ++TT DIWS G VL E+
Sbjct: 177 -YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRLMDHPNV 132
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L F +S ++ +V M++ + + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
G+ Y+ HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 249 ELI-----FGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 285
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 177
+L + +L L +EY P + + + +S L
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 234
++ + + RG+ Y+ + HRD+ +N+LV + K+ DFG ++ V VK
Sbjct: 127 LH---FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 179
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + R+ L + YTT+ D+WS G +L E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 57/249 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTE-DNVMKIADFGLAR-------DIH 191
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 247
Query: 286 VDQLVEIIK 294
V++L +++K
Sbjct: 248 VEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 50/237 (21%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 122
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLI 178
+M+ +V+ L SK + L +VME + ++ R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 179 YVK---LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
++ +I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 278
YYR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 23/54 (42%), Positives = 34/54 (62%), Gaps = 2/54 (3%)
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233
+K Q+ GL +H + G+ HRD+KP+NLLV + QVK+ DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S++ +++ V E++ + ++ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 201 CHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPEL-IFGATE 256
HRD++ N+LV D L K+ DFG A+++ E A + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--R 179
Query: 257 YTTSIDIWSAGCVLAELLL-GQPLFPG 282
+T D+WS G +L EL+ G+ +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 45/195 (23%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI- 122
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYT 258
HRD+ +N LVD VK+ DFG ++ ++ E S + S++ + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 259 TSIDIWSAGCVLAEL 273
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 18/179 (10%)
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQR 174
E M+ DHPNV+ L T + +V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+P + + I G+ Y+ + HRD+ +N +++ V + DFG +K + G+
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNGD 166
Query: 235 ANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 285
Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 167 ---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 125
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 126 L-MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSS----------- 170
+ HPN++ C +K++ L+++ Y + + V++ S
Sbjct: 63 SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKV 229
+ P +V + T QI G+ ++ + V H+D+ +N+LV D L VK+ D G +
Sbjct: 118 KSTLEPADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFRE 173
Query: 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + S + R+ +++G +++ DIWS G VL E+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY-------SSMNQRMPLIYVKLY- 183
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 184 -TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ + +
Sbjct: 125 IAQQIAAGMVYLASQHFV-HRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 243 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 288
YYR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 289 LVEIIKVSNII 299
++E I ++
Sbjct: 231 VIECITQGRVL 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
E V+G G+FG V +A + G AIK + + D R EL+++ +L HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQI 187
+L ++ +L + +EY P S + + P + L + Q+
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 188 FR-------GLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY 239
+ G+ Y+ + HRD+ +N+LV + L K+ DFG L +GE Y
Sbjct: 122 LQFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLA--SKIADFG----LSRGEE--VY 172
Query: 240 ICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL 274
+ R P + + A E YTT D+WS G +L E++
Sbjct: 173 VKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 42/260 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RLMDHPNVIS-L 135
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM------PLIYVKLYTYQIFR 189
C S LV+E+ P LK+Y N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 190 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---Y 245
GL ++H + H D+ +N L L+ VK+ D+G A + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 246 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVSN 297
APEL I G + T +IWS G + EL QP +P + L ++++ +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVREQD 227
Query: 298 IIYAKTIYQGLFCSNNHEIM 317
I K + +E+M
Sbjct: 228 IKLPKPQLDLKYSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 70 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 111
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 112 QDRRY-KNRELQLMRL--MDHPNVISLKHC-FFSTTSKDELFLNLVMEYVPETMYRVLKH 167
+ Y ++ + +DH + C F F+ ++E + E + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI--LLEKLVENTKEIFKR 119
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227
N+ LI K + L YIH G+ H D+KP+N++VD ++ + D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 269
+ +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 5/43 (11%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF----PGE 283
Y APE++ T YT D WS G +L E+L+GQP F P E
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 105 VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
VA+K + D R E+++M + +PN+I L D+ L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101
Query: 160 ---TMY---RVLKHYSSMNQRMPLIYVKLYTY---QIFRGLAYIHTVPGVCHRDVKPQNL 210
+ R ++ + +P + + Y QI G+ Y+ ++ V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNC 160
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
LV + +K+ DFG ++ L G+ + + R+ ++ G ++TT+ D+W+
Sbjct: 161 LVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAF 217
Query: 267 GCVLAELL 274
G L E+
Sbjct: 218 GVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 29/121 (23%)
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
QI G+ Y+ ++ V HRD+ +N LV +K+ DFG ++ L G+ YY
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 246 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 290
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 291 E 291
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 84 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVISL 135
V+G G+FG V +A+ + G AIK++ + D R EL+++ +L HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQIFR 189
+ +L L +EY P S + + P + L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 190 -------GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY 239
G+ Y+ + HRD+ +N+LV + K+ DFG ++ V VK +
Sbjct: 117 FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK--KTMGR 172
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 173 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 340 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.64 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.25 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.78 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PLN02236 | 344 | choline kinase | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.11 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.09 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.04 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.01 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.92 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.53 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.98 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.08 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.54 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.34 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-58 Score=389.66 Aligned_cols=279 Identities=63% Similarity=0.990 Sum_probs=245.1
Q ss_pred eeeeecCCCCCCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeee
Q 019506 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFF 140 (340)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 140 (340)
.......+..........|.-.+++|.|+||.||.|....+++.||||++..+.+...+|+.+|+++.|||||++..+|.
T Consensus 8 ~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~ 87 (364)
T KOG0658|consen 8 VIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFS 87 (364)
T ss_pred EEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence 33444445555555667899999999999999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.....+..++.+||||++.+|.+.++++...+.+++...++.+..||++||.|||+ .||+||||||.|+|+|..++.+|
T Consensus 88 ~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 88 SSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred ecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEE
Confidence 77766677889999999999999999988889999999999999999999999999 79999999999999999889999
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|||||.|+.+..+..+.+..+|++|+|||.+.|.+.|+.+.||||.||++.||+-|++.|.|.+..+++..|++..++|.
T Consensus 167 icDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhccc--------------------cccCChhh--HhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGL--------------------FCSNNHEI--MCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~--------------------~~~~~~~~--~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..++.... ....+.+. +..-...++|.+|.++.|++.|||
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 65542111 11111111 222334457999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=399.52 Aligned_cols=245 Identities=29% Similarity=0.450 Sum_probs=207.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+|..++.||+|||+.||.+++..+|+.||+|++.+. +....+|+++.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999999753 23335799999999999999999999 77888
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|||+|+|.. +|.+++++ .+.++|.+++.+++||+.||.|||+ .+|||||||..|+|++. +.++||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecccceee
Confidence 9999999995 55555442 5789999999999999999999999 79999999999999995 8899999999999
Q ss_pred ccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
....+ ....+.+||+.|.|||++.. ..++..+||||+||+||.||+|++||+..+-.+.+.+|... .+..+..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-~Y~~P~~---- 240 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-EYSMPSH---- 240 (592)
T ss_pred eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-Ccccccc----
Confidence 88744 77788999999999999964 55899999999999999999999999988877766666654 4433322
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-+.+...+..-++..+|.+|||+++|++|+|
T Consensus 241 --ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 241 --LSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred --cCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 1333444455555556679999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-57 Score=388.04 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=211.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.. ....+|+++|++++|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4556999999999999999999999999999999986431 1225899999999999999999999
Q ss_pred CCCceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEE
Q 019506 144 SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK 220 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~k 220 (340)
......|+||||++|| |++.+. .++.+.+...+.+++||+.||.|||+ +||+||||||+|||+..+ +-.+|
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence 5555579999999975 444333 36888999999999999999999999 799999999999999742 25799
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|+|||+|+.........+.+||+.|.|||++.+.+ .+..++|+|||||+||-+|+|.+||.+......+.+++..+.+
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999999998888888899999999999996533 3455899999999999999999999988776657777777777
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+-...|...-. -...+...++..+|+.|+|++|.++|||
T Consensus 400 ~f~p~~w~~Ise--ea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 400 AFGPLQWDRISE--EALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred cccChhhhhhhH--HHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 766555554322 2233556666778999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=370.04 Aligned_cols=252 Identities=35% Similarity=0.625 Sum_probs=217.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+.|+...++|+|+||.||+|+++.||+.||||++....+. ..||+++|++++|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 3588888999999999999999999999999999765443 35899999999999999999999 667778
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|+|||+.++++.|.++ ...++...++.++.|++.|+.|||+ +++|||||||+|||++. ++.+||||||+|+.+
T Consensus 77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence 999999999988888764 4678999999999999999999999 79999999999999995 999999999999998
Q ss_pred c-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 V-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
. +++.-+.++.|++|+|||.+.|...|+..+||||+||++.||++|.+.|++..+.+++..|.+..+.-.++.. ++|
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq--~iF 229 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ--SIF 229 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH--HHh
Confidence 7 6666677889999999999999889999999999999999999999999999999999999997764322111 112
Q ss_pred ccC--------------------------ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSN--------------------------NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~--------------------------~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+| ..-.+..-|+..+|++|++.+|++.|||
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 222 1223455566778999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-57 Score=392.29 Aligned_cols=254 Identities=33% Similarity=0.582 Sum_probs=223.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh-----HHHHHHHHhCC-CCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|.+.++||.|+||.||+|+.+.+|..||||.+++.-... .||+..|++++ ||||+++.+++.+.+ . .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~---~-~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND---R-I 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC---c-e
Confidence 457999999999999999999999999999999998654332 48999999999 999999999994322 1 6
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|||||+.+|+++++.. ++.|++..++.|+.||++||+|+|. +|+.||||||+|||+.. +..+||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEecccccccc
Confidence 9999999999999998863 6899999999999999999999999 79999999999999994 78899999999999
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
......-+.++.|++|+|||+++....|+.+.||||+|||++|+++-++.|+|.++.+++.+|....+.|....+
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 998888889999999999999999999999999999999999999999999999999999999999988764333
Q ss_pred --------------------hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 --------------------YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------------------~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.+ ....-.+.+.+++.| +|++|||++|.++|||
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~W-DP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAW-DPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcC-CCccCccHHHHhcCcc
Confidence 222 122234555566665 8999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=375.83 Aligned_cols=245 Identities=29% Similarity=0.502 Sum_probs=207.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.++||+|+||+||.++.+++++.+|+|++++.. +....|..+|..++||+||+++..| ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 3457999999999999999999999999999999887543 2334789999999999999999988 777
Q ss_pred eeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+|+||+.|| |...|. .++.+++..++.++.+|+.||.|||+ +|||||||||+|||+|. .|.++|+|||+
T Consensus 98 ~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDFgL 171 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDFGL 171 (357)
T ss_pred CeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecccc
Confidence 7799999999985 444443 37899999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-------C
Q 019506 227 AKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN-------I 298 (340)
Q Consensus 227 a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------~ 298 (340)
|+... .+....+.+||+.|||||++.+.+ |+..+|+|||||++|||++|.+||.+.+......+|.+... .
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls 250 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS 250 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC
Confidence 98554 445555679999999999998764 89999999999999999999999999999888888888662 2
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+++++.++..+|..|+. ..-++++|+.|||
T Consensus 251 ~~ardll~~LL~rdp~~RLg---------~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLG---------GPGDAEEIKRHPF 283 (357)
T ss_pred HHHHHHHHHHhccCHHHhcC---------CCCChHHhhcCcc
Confidence 23456666666666665443 2357888999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=371.95 Aligned_cols=213 Identities=31% Similarity=0.589 Sum_probs=187.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+.. +....|+.+|+.++|||||.+++++ ....
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 3457999999999999999999999999999999987653 3335799999999999999999999 5666
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--C---CcEEEE
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--T---HQVKLC 222 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~---~~~kl~ 222 (340)
++|+|||||.| +|.+.+.. .+++++..++.++.||+.||++||+ ++||||||||.|||++.. + -.+||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 79999999996 45555443 4689999999999999999999999 899999999999999752 1 369999
Q ss_pred eeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|||+|+....+....+.+|++.|||||++.. ..|+.|+|+||+|+|||+|++|+.||...+..+.+..+.+....
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~ 232 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI 232 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence 9999999998888889999999999999964 55999999999999999999999999999998888877765544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=361.07 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=206.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+.+.++.||+|..|+||+++++.|++.+|+|++... ++...+|+++++.++||+||.+|++|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3567788999999999999999999999999999433 3344689999999999999999999976432 488
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
|+||||+++.++.+.. ..+++++.....++.++++||.|||+.++||||||||+|||++. .++|||||||.++.+.
T Consensus 155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGILV 230 (364)
T ss_pred eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHhh
Confidence 9999999754444432 13789999999999999999999995369999999999999996 8999999999999886
Q ss_pred cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
.. ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||... +..+.+..|.. ...|.++.-
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~-- 305 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEG-- 305 (364)
T ss_pred hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcc--
Confidence 66 66688999999999999765 5999999999999999999999999874 33444444444 233333221
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.++.....+...|+..+|.+|++++|++.|||
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 35566677888899999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=374.40 Aligned_cols=249 Identities=29% Similarity=0.507 Sum_probs=207.8
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.+...+|..++.||+|+|++|++|+++.+++.||||++.+. ..+..+|-.+|.+| .||.|++++..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----- 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----- 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence 34556899999999999999999999999999999988543 45566899999999 899999999998
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
+|...+|+|+||+++ .|++.+.++ +.|++..++.++.||+.||+|||+ +|||||||||+|||+|. ++++||+|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITD 217 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITD 217 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEee
Confidence 666779999999995 677777664 789999999999999999999999 79999999999999995 99999999
Q ss_pred eccccccccCCc--------------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019506 224 FGSAKVLVKGEA--------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289 (340)
Q Consensus 224 fg~a~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 289 (340)
||.|+.+.+... ..+++||..|.+||+|.. ...+..+|||+||||||+|+.|.+||.+.++.-.+
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 999988743221 145899999999999955 45899999999999999999999999999999999
Q ss_pred HHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 290 VEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++|++. .+.+++.+ ...- ..+.+-.+..+|.+|+|.+||+.|||
T Consensus 297 qkI~~l-~y~fp~~f-----p~~a-~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 297 QKIQAL-DYEFPEGF-----PEDA-RDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHHh-cccCCCCC-----CHHH-HHHHHHHHccCccccccHHHHhhCcc
Confidence 999884 33333332 1111 22233334456779999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=349.39 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=210.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+.+.||.|+||+|.+++.+.+|..+|+|++.+.. ....+|.++|+.+.||+++++.+.| .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 44568999999999999999999999999999999887543 2234799999999999999999988 77
Q ss_pred ceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++++||||++|+ +...++. .+++++..++.++.||+.||+|||+ .+|++|||||+|||+|. +|.+||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEEecc
Confidence 77799999999974 5555543 5799999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC------CC
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN------II 299 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------~~ 299 (340)
+|+..... ..+.+||+.|+|||+++.. .|+.++|+|||||++|||+.|.+||.+.+....+.+|++..- .+
T Consensus 190 FAK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 190 FAKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSS 266 (355)
T ss_pred ceEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCH
Confidence 99987443 6678999999999999765 489999999999999999999999999999888888887432 23
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+++++++++.+-..|+.. .....++|++|||
T Consensus 267 ~~kdLl~~LL~vD~t~R~gn--------lknG~~dIk~H~w 299 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKRFGN--------LKNGVEDIKNHPW 299 (355)
T ss_pred HHHHHHHHHHhhhhHhhhcC--------cCCCccccccCcc
Confidence 46788888888777766443 4677899999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=372.53 Aligned_cols=259 Identities=33% Similarity=0.529 Sum_probs=220.0
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
+...+.|+..++||+|+||.||+|++..+|+.||+|++..+. ....|||.+|++|+||||+++.+..++. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence 445667999999999999999999999999999999997554 2235899999999999999999998653 3
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...+|+|+|||+.+|..++.. ..-.|++.+++.++.||+.||+|||+ +||+|||||.+|||+|. ++.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEeccccc
Confidence 455999999999987777653 34589999999999999999999999 89999999999999995 89999999999
Q ss_pred ccccccCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 227 AKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 227 a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
|+++.... ..+..+.|.+|.|||+++|...|+.++|+||.||||.||++|++.|++.++.+++..|.+.++.|....|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99765544 3456788999999999999999999999999999999999999999999999999999999998865442
Q ss_pred hc--ccc-----cc--------------CC--hhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQ--GLF-----CS--------------NN--HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~--~~~-----~~--------------~~--~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ++. .. -+ .-.+.+-++.++|.+|.|+++.++++|
T Consensus 345 -~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 345 -PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred -ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 2 110 00 01 223455567778999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=340.10 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=215.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+|...++||+|.||.||+|++..+|+.||||+++.... ...||+..|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 368889999999999999999999999999999975432 234899999999999999999999 445558
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
.||+||++.+|...+++ .+..++..+++.++.++++||+|||+ +.|+||||||.|+|+++ ++.+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence 89999999998888774 35788999999999999999999999 79999999999999995 999999999999998
Q ss_pred ccCCccce-eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 231 VKGEANIS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 231 ~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
........ .+.|++|+|||.+.|...|+..+||||.|||+.||+.|.+.|.|.++.+++..|.+..+.|....|
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 65544433 477999999999999999999999999999999999999999999999999999999988764332
Q ss_pred --------------hccccccCChhhHhhh--cccccccCCCCcCcccccCC
Q 019506 305 --------------YQGLFCSNNHEIMCEL--GSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------------~~~~~~~~~~~~~~~l--~~~~~~~~R~~~~~i~~hpf 340 (340)
...+++....+.+.-+ +..++|..|+|+.|.++|+|
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 2223444333333322 33456899999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=349.18 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=218.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--C----hHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--Y----KNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+.|+.+..|++|+||.||+|++++|++.||+|+++-+.. . ..||+.+|.+++|||||.+.++.+... -
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~ 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M 149 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence 456679999999999999999999999999999999975432 2 248999999999999999999886643 3
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..+|+|||||+.+|..++.. ..++|...+++.++.|+++||+|||. +.|+|||||++|+|++. .|.+||+|||+|
T Consensus 150 d~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDFGLA 224 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADFGLA 224 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecccchh
Confidence 33899999999988887765 34789999999999999999999999 79999999999999994 889999999999
Q ss_pred cccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh--
Q 019506 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI-- 304 (340)
Q Consensus 228 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (340)
+.+..... .+..+-|.+|+|||.+++...|+.++|+||+|||+.||+++++.|.|....+++.+|.+..++|....|
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 99866643 345677999999999999999999999999999999999999999999999999999999887753221
Q ss_pred -----------------------hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -----------------------YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -----------------------~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+....-+..-..+..-...++|.+|.|++|-++|+|
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 011100112223444456678999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-52 Score=367.47 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=202.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh-------HHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.++++||+|+||.||+|+.+.||..+|+|++++..... ..|-++|...+.+.||+++..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 35678999999999999999999999999999999998764333 3477788888999999999999 78
Q ss_pred ceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++||||||++|| +..+|. ..+.+++.+++.++.+++.|++.+|+ .|+|||||||+|+|||. .|++||+|||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFG 286 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFG 286 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeecccc
Confidence 88899999999986 333333 36889999999999999999999999 69999999999999996 8899999999
Q ss_pred ccccccc------------------------CC-----cc-------------------ceeeeeccccCcccccCCCCC
Q 019506 226 SAKVLVK------------------------GE-----AN-------------------ISYICSRYYRAPELIFGATEY 257 (340)
Q Consensus 226 ~a~~~~~------------------------~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~ 257 (340)
++.-+.. .. .. .+.+|||.|+|||++++.+ |
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y 365 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-Y 365 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-C
Confidence 9854311 00 00 1357999999999998866 8
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CchhhhhccccccCChhhHhhhcccccccCCC---CcC
Q 019506 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI-IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN---SMH 333 (340)
Q Consensus 258 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~---~~~ 333 (340)
+..+|+||||||+||||.|.+||.++++.+...+|+..... .++.+. -....-.+.+++|+. ++..|+ +++
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~---~~s~eA~DLI~rll~--d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV---DLSDEAKDLITRLLC--DPENRLGSKGAE 440 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC---cccHHHHHHHHHHhc--CHHHhcCcccHH
Confidence 99999999999999999999999999999999999876532 121111 011223455555554 566666 499
Q ss_pred cccccCC
Q 019506 334 ESKLYGF 340 (340)
Q Consensus 334 ~i~~hpf 340 (340)
||+.|||
T Consensus 441 EIK~HPf 447 (550)
T KOG0605|consen 441 EIKKHPF 447 (550)
T ss_pred HHhcCCc
Confidence 9999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=368.29 Aligned_cols=250 Identities=29% Similarity=0.408 Sum_probs=208.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc---------ccChHHHHHHHHhCC-CCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 144 (340)
..+.|.+++.||+|+||+|++|++..+|..||+|++.+. .....+|+.++++++ ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 345799999999999999999999999999999977653 112347999999999 99999999999
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
.....+++|||||.| .|++.+.. .+++.+..++.+++|++.|++|||+ +||+||||||+|||++...+.+||+|
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEec
Confidence 444458999999997 56655543 5889999999999999999999999 79999999999999996328999999
Q ss_pred ecccccc-ccCCccceeeeeccccCcccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 224 FGSAKVL-VKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 224 fg~a~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
||++... ..+....+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||.+.+....+.+|.+ .....+
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~-~~~~~p 243 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK-GEFKIP 243 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-CCccCC
Confidence 9999988 4666677889999999999998766 557999999999999999999999999777666666444 444443
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. +.....+.+-++..+|..|+++++|+.|||
T Consensus 244 ~~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 244 SYLL-----SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred CCcC-----CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 3321 334455666667778889999999999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=346.40 Aligned_cols=246 Identities=30% Similarity=0.457 Sum_probs=203.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..+|.+.++||+|+||+||++.+..+|..+|.|.+.-+ +...-.|+.+|++|+|||||++++.-+. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 34699999999999999999999999999999988632 3444579999999999999999884432 33344
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHc--CC-CceecCCCCCCeEecCCCCcEEEEeec
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT--VP-GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
++||||||+ |+|...+.++....+.+++..+|.++.|++.||.+||+ .+ -|+||||||.||+++. ++.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccch
Confidence 789999999 58888999999999999999999999999999999998 22 3999999999999995 8999999999
Q ss_pred cccccccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh-h
Q 019506 226 SAKVLVKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK-T 303 (340)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 303 (340)
+++.+...... .+.+|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.+.+- ..+.+.+++++.+... +
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~-~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNL-LSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccH-HHHHHHHHcCCCCCCcHH
Confidence 99998665443 4579999999999997655 99999999999999999999999999854 5555555556665433 2
Q ss_pred hhccccccCChhhHhhhcccccccCCCCc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSM 332 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~ 332 (340)
. .+.....+...|...++..||+.
T Consensus 252 ~-----YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 H-----YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred H-----hhhHHHHHHHHHccCCcccCCCc
Confidence 2 23344556667777778889874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=368.86 Aligned_cols=247 Identities=31% Similarity=0.454 Sum_probs=210.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+-|++++.||.|+.|.|.+|++..||+.+|||++.+. ....++|+-+|+.+.|||++++++++ .+..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 34599999999999999999999999999999999766 34567999999999999999999999 6777
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
++|+|+||+++ .|++++.. .+++++.++..+++||+.|+.|||. -+|+||||||+|+|+|. .++|||+|||+|
T Consensus 86 ~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMA 159 (786)
T ss_pred eEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeecccee
Confidence 79999999996 56666554 6899999999999999999999999 59999999999999996 555999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.....+....+.||++.|.|||++.|..+.+.++||||+|||||.||||+.||.+++....+.++ +.+....+.++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV-~~G~f~MPs~I--- 235 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV-QRGVFEMPSNI--- 235 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH-HcCcccCCCcC---
Confidence 98888888888999999999999999998899999999999999999999999977765555544 44554444332
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+.+..-++-.+|..|.|++||+.|||
T Consensus 236 ---s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 236 ---SSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---CHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 122234444555566779999999999999
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=343.57 Aligned_cols=257 Identities=37% Similarity=0.601 Sum_probs=214.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.|...+.||+|+||.|+.|.++.+|+.||||++... .+..-||+.+|+.++|+||+.+.+++......+-..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 466679999999999999999999999999988632 12234899999999999999999998653334445589
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|+|+|+.+|...++. ++.++...++.++.|+++||+|+|+ .||+||||||+|+|++. +-.+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceeecc
Confidence 9999998877777764 4569999999999999999999999 79999999999999996 7789999999999885
Q ss_pred c---CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 232 K---GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 232 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
. ....+..+.|.+|.|||+++....|+.+.||||+|||+.||++|++.|.|.+..+++..|+...++|....+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 334456788999999999998889999999999999999999999999999999999999999988753222
Q ss_pred -------hccccccC-----------C--hhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -------YQGLFCSN-----------N--HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -------~~~~~~~~-----------~--~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++++-... . .-.+.+-++..+|.+|+|++|.+.|||
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 22211111 1 223444577778999999999999997
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=370.54 Aligned_cols=264 Identities=48% Similarity=0.869 Sum_probs=219.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecC---CCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l 152 (340)
..+|.++++||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++|+... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 45799999999999999999999999999999999877666778999999999999999998875432 123456789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887766667889999999999999999999999 79999999999999986556799999999987765
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh-------
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY------- 305 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 305 (340)
........||+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+.++++..+.+....+.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 5555567789999999998776678999999999999999999999999998888888888766554322110
Q ss_pred ------------cccc---ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ------------QGLF---CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ------------~~~~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..+ .+.....+..-|+.++|.+|+|+.|++.|||
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000 0111234555667778999999999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=354.47 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=201.7
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------------cChHHHHHHHHhCCCCceee
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRLMDHPNVIS 134 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~~l~~l~h~~iv~ 134 (340)
.+....|++.+.||+|.||+|-+|++..+++.||||++.+.. +...+|+.+|+++.|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345567999999999999999999999999999999986432 12247999999999999999
Q ss_pred cceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 135 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
++++. ++.....+|||+|||..+-... ...... +++.+++.|+++++.||+|||. +|||||||||+|+|++
T Consensus 173 LiEvL---DDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVL---DDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEee---cCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEc
Confidence 99987 4456667999999999652222 122344 8999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeeccccccccC------CccceeeeeccccCcccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 019506 214 PLTHQVKLCDFGSAKVLVKG------EANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284 (340)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~ 284 (340)
. ++++||+|||.+.....+ ......+||+.|+|||.+.+ ....+.+.||||+||+||.|+.|+.||.++.
T Consensus 245 ~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 245 S-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred C-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 6 799999999999876222 22334689999999999976 3346789999999999999999999999999
Q ss_pred hHHHHHHHHHhcC-CC-------chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 285 AVDQLVEIIKVSN-II-------YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 285 ~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.+.+|+...- .| ..++++..+|+++|. .|+++.+|+.|||
T Consensus 324 ~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~-------------~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPE-------------QRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChh-------------heeehhhheecce
Confidence 9888888887542 22 234555555555554 8999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=362.46 Aligned_cols=247 Identities=29% Similarity=0.479 Sum_probs=204.7
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCC-CCceeecceeeeecCC
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 144 (340)
....++|++.++||+|+||+|+++..+.+++.+|||.++++.- ....|.+++.... ||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 3456789999999999999999999999999999999987532 2345777777665 99999999999
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+...++|+||||+.|+. +.+. ...+.|++..++.|+.+++.||.|||+ +||||||||.+|||+|. .|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~~-~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMHH-IHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEEE-EecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence 77778999999999884 3322 235789999999999999999999999 79999999999999996 888999999
Q ss_pred ccccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc---
Q 019506 225 GSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY--- 300 (340)
Q Consensus 225 g~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 300 (340)
|+++... .+....+++||+.|||||++.+ ..|+.++|+|||||+|||||.|+.||.++++++.+..|+.. ++.+
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~yP~~ 590 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRF 590 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCCc
Confidence 9998865 5667778999999999999966 45999999999999999999999999999988877777763 3333
Q ss_pred ----hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 ----AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ----~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+++.++.++|..|+.. .--++++|+.|||
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~--------~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGS--------GERDAEDIKKHPF 626 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCC--------CCCCchhhhhCCc
Confidence 4555666666666643331 1123688999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=347.00 Aligned_cols=252 Identities=31% Similarity=0.488 Sum_probs=202.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|..++.||+|+||.||++.+.++|..+|||.+... .....+|+.+|+.++|||||+++|..... +...+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeEe
Confidence 4688899999999999999999999999999988765 33357899999999999999999864221 1145889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
.|||+++ ++.+.+..+ ++.+++..++.+.+||++||.|||+ +|||||||||+|||++..++.+||+|||+++...
T Consensus 94 ~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999996 555555442 2279999999999999999999999 8999999999999999546889999999998765
Q ss_pred c----CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 K----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
. ........||+.|||||++..+...+.++|||||||++.||+||..||.. ....+.+..+......|.....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~-- 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS-- 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc--
Confidence 3 22234578999999999997533334599999999999999999999987 4555556666555544432222
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+.+.|...+|..|||++++++|||
T Consensus 248 ---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 248 ---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 2344566777788888999999999999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=334.35 Aligned_cols=262 Identities=30% Similarity=0.555 Sum_probs=216.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCc-eeecceeeeecCC-CCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPN-VISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~ 148 (340)
..|...++||+|+||+||+|+.+.+|+.||+|++..+.+ ...+|+.+++.++|+| ||.+++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 357788889999999999999999999999999975543 2368999999999999 9999999854331 2223
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++|+||++.++...+.........++...++.+++||+.||+|||+ ++|+||||||.|||+++ ++.+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchHH
Confidence 688999999998888887755433567889999999999999999999 79999999999999996 8999999999999
Q ss_pred ccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh---
Q 019506 229 VLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI--- 304 (340)
Q Consensus 229 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 304 (340)
... +....+..++|..|.|||++++...|+..+||||+|||++||++++..|.+..+.+++..|.+..++|..+.+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 3344556788999999999999988999999999999999999999999999999999999999888753332
Q ss_pred ------------------hccccccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------------------YQGLFCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------------------~~~~~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+... ....+...++.++|..|.|++..+.|||
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y 304 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY 304 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence 11111111 2223334455567889999999999997
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=357.18 Aligned_cols=212 Identities=39% Similarity=0.688 Sum_probs=188.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChH---HHHHHHHhCC-C-----CceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMD-H-----PNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.|.+|.+..|++.||||++++...+.. .|+.+|..++ | -|+|+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 58999999999999999999999999999999988766554 5888888887 3 4899999999 6677
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-CCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~~~~~kl~Dfg~a 227 (340)
++|||+|+++.+|+++++... -.+++...++.++.||+.||.+||+ .||||+||||+||||.. ....|||+|||.|
T Consensus 262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 799999999999999998743 4679999999999999999999999 69999999999999953 2347999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+.....-. +.+.+++|+|||+++|.+ |+.+.||||||||++||++|.+.|.|.++.+++..|++..+.|.
T Consensus 339 c~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 339 CFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 88644433 778899999999999865 89999999999999999999999999999999999999888765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=355.99 Aligned_cols=245 Identities=29% Similarity=0.474 Sum_probs=204.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+. ..+|+++++.++|||||.++++| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 3688889999999999999999999999999998765433 35899999999999999999999 667779
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+|.|||.|+|...+.. ++.++++.++.++.|++.||.|||+ .+|+|||+||.|||++. ++.+|+||||+|+..
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence 99999999988877765 6899999999999999999999999 79999999999999995 899999999999988
Q ss_pred ccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..+..- +...||+.|||||++.+ ..|+..+|+||||||+|||++|++||...........|.+... .++...
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~----- 223 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTA----- 223 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccc-----
Confidence 665543 34578999999999975 5599999999999999999999999987776665666655433 332221
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+.+-.+..+|..|.+--+++.|||
T Consensus 224 -S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 224 -SSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred -cHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 122233344444556778999999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=315.94 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=207.5
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+++.||+|.||.||+|+.+.++..||+|++-+++ ....+|+++...|+||||++++++| .+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ec
Confidence 45568999999999999999999999999999999886542 3446899999999999999999999 67
Q ss_pred ceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+++||.. |.++..|.. ....++++..++.++.|++.||.|||. +++|||||||+|+|++. .+.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCC
Confidence 777999999998 567777663 235779999999999999999999999 89999999999999996 8889999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
.+.... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||...+..+.+++|.+... .++..
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~-- 244 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPST-- 244 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcc--
Confidence 997764 5556678999999999999664 489999999999999999999999999887777777776433 22222
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...-.+.+.. +.-.+|.+|+...|+++|||
T Consensus 245 ---is~~a~dlI~~-ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 245 ---ISGGAADLISR-LLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---cChhHHHHHHH-HhccCccccccHHHHhhhHH
Confidence 22333333333 34446889999999999999
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=337.64 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=212.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..-+|++.+.||+|.||+|-+|+....|+.||||.++++.- ...+|+++|..|+||||+.++++| ++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 34579999999999999999999989999999999876532 235899999999999999999999 666
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.-+.|||||..+ .|++++.. .+.+++.+++.+++||++|+.|||. ++++|||||.+|||+|. ++.+||+|||+
T Consensus 126 dKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGL 199 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGL 199 (668)
T ss_pred ceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccch
Confidence 668999999985 56666654 5789999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+..+.++....+++|++.|.+||++.|.++-++.+|-|||||+||.|+.|..||.+.+....+.+|.. +.+-.+.
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~-GaYrEP~---- 274 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR-GAYREPE---- 274 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc-ccccCCC----
Confidence 99999999999999999999999998888779999999999999999999999999887666555554 3322221
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+..-.+.+++++.+|.+|-|+++|.+|=|
T Consensus 275 ---~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 275 ---TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2334456677888888889999999999976
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=334.81 Aligned_cols=254 Identities=29% Similarity=0.549 Sum_probs=204.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..+|.+.++||+|+||.||+|++..++..||+|.++... ....+|+++++.++|+||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 357999999999999999999999999999999886432 2335799999999999999999988 444568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeec
Confidence 89999999987776653 23457899999999999999999999 79999999999999995 788999999999765
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc-
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL- 308 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (340)
.... ......+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+....+....+ ...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-PGIT 232 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh-hccc
Confidence 3322 2233567899999999877666899999999999999999999999998888888887776554432211 110
Q ss_pred ---------cc--------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 ---------FC--------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ---------~~--------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+. ......+..-++..+|.+|+|++|+++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 00 011223445566678999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=342.35 Aligned_cols=244 Identities=30% Similarity=0.415 Sum_probs=197.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcE-EEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce-e
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL-F 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~-~ 149 (340)
...+.+.||+|+||+||+|.+ .|.. ||+|++.... ..+.+|+.+|++++|||||+++|++. +.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~-----~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT-----SPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCc
Confidence 345566799999999999998 5666 9999887532 35678999999999999999999983 333 5
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-ceecCCCCCCeEecCCCC-cEEEEeeccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKPQNLLVDPLTH-QVKLCDFGSA 227 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-iiH~dlkp~Nill~~~~~-~~kl~Dfg~a 227 (340)
+++||||++++.+..+.+.. ....+++..+..++.||++||.|||+ ++ |||||||++|||++. ++ ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCccc
Confidence 78999999965444443321 46889999999999999999999999 79 999999999999996 65 9999999999
Q ss_pred cccccC-CccceeeeeccccCcccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 228 KVLVKG-EANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 228 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
+..... ...+...||..|||||++.+ ...|+.++|||||||+||||+||+.||.+.........+......+....-
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~- 270 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE- 270 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc-
Confidence 887554 33334688999999999974 356999999999999999999999999999886666666665555553332
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
|......+.+.|+.-+|..||++.+|.
T Consensus 271 ----~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 271 ----CPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred ----CCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 455556666778888899999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=331.90 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=206.2
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
....+|++.+.||.|.-|+||+|+...++..+|+|++.++... ...|-++|+.++||.+.++|+.| +.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence 3445799999999999999999999999999999999765322 23588899999999999999999 77
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+.|+|||||+|+-+..+++. +.++.+++..++.++.+++.||+|||. -|||+|||||+||||.+ +|.|.|+||.+
T Consensus 149 ~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFDL 225 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFDL 225 (459)
T ss_pred cceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeeccc
Confidence 7789999999998766666653 457889999999999999999999999 59999999999999995 88999999998
Q ss_pred cccccc---------------------------------C-C-----------------------ccceeeeeccccCcc
Q 019506 227 AKVLVK---------------------------------G-E-----------------------ANISYICSRYYRAPE 249 (340)
Q Consensus 227 a~~~~~---------------------------------~-~-----------------------~~~~~~~~~~y~aPE 249 (340)
+..... . . ...+++||-.|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 743200 0 0 011357888999999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CC-------chhhhhccccccCChhhHhhhc
Q 019506 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN-II-------YAKTIYQGLFCSNNHEIMCELG 321 (340)
Q Consensus 250 ~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~l~ 321 (340)
++.|.+ .+.++|+|+|||++|||+.|..||.|.+..+.+..|+.... .+ ..+++++++|.++|..|+.
T Consensus 306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg--- 381 (459)
T KOG0610|consen 306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG--- 381 (459)
T ss_pred eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc---
Confidence 997765 79999999999999999999999999999999999987532 22 3577788888777775444
Q ss_pred ccccccCCCCcCcccccCC
Q 019506 322 SWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 322 ~~~~~~~R~~~~~i~~hpf 340 (340)
-+-.+.||+.|||
T Consensus 382 ------~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 382 ------SKRGAAEIKRHPF 394 (459)
T ss_pred ------cccchHHhhcCcc
Confidence 2344999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=347.01 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=206.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...|....+||+|+.|.||.|+...+++.||||.+.... +...+|+.+|+..+|+|||++++.|... ..+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeE
Confidence 345888899999999999999999999999999986443 3345799999999999999999998543 3489
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||++|+.+..+.. ...++|.++..|++++++||+|||. +||||||||.+|||++. ++.+||+|||+|..+.
T Consensus 347 VVMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeeccc
Confidence 9999999754433322 3569999999999999999999999 89999999999999995 8889999999998876
Q ss_pred cCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
... ...+.+||++|||||++. ...|++++||||||++++||+-|++||-..+....++.|...+.... +.. -.-
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l-k~~---~kl 495 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL-KNP---EKL 495 (550)
T ss_pred cccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc-CCc---ccc
Confidence 665 555679999999999995 45699999999999999999999999998888888888777554332 110 112
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.-...+.+.|+..++..|+++.|++.|||
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 223455666677778889999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=329.55 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=209.5
Q ss_pred CCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 71 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+.....|++..+||.|..++||+|+++.+++.||||++..+. ....+|+..|+.++||||++++.+|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv---- 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV---- 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----
Confidence 34455668999999999999999999999999999999996442 445689999999999999999999844
Q ss_pred Cceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
...+|+||.||. |++++.+..+.. ..++|..+..|++++++||.|||. +|.||||||+.|||++. +|.|||+||
T Consensus 96 -~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~VkLadF 170 (516)
T KOG0582|consen 96 -DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGTVKLADF 170 (516)
T ss_pred -cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCcEEEcCc
Confidence 334999999999 477777776543 569999999999999999999999 79999999999999995 899999999
Q ss_pred ccccccccCCcc-----ceeeeeccccCcccc-cCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 225 GSAKVLVKGEAN-----ISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 225 g~a~~~~~~~~~-----~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|.+..+.+.... ...+||++|||||++ +....|+.|+|||||||+..||.+|..||....+...+...++..-+
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 987655433221 345789999999994 45556999999999999999999999999988887776666654332
Q ss_pred Cc-----hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IY-----AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~-----~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ..+-. ..+ ..-+..+...|+..+|.+|||+++++.|+|
T Consensus 251 ~~~t~~~~~d~~-k~~-~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 251 TLLTSGLDKDED-KKF-SKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred CcccccCChHHh-hhh-cHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 11 11110 111 123456778889999999999999999998
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=334.72 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=201.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999886432 2345799999999999999999988 444568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence 99999999988777653 23568899999999999999999999 79999999999999995 788999999998754
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCchhh-----
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYAKT----- 303 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~----- 303 (340)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+......+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 3222 223456789999999987666689999999999999999999999987543 445555554333221100
Q ss_pred --------------------hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 --------------------IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 --------------------~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+......+....+.+.|+.++|.+|+|++|+++|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0111111123345667777889999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=320.36 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=204.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+.|.+.++||+|.|+.||++.+..+|+.+|+|++... .+..++|+++.+.|+|||||++.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 456799999999999999999999999999999987532 34457899999999999999999988 6667
Q ss_pred eeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC--CcEEEEeec
Q 019506 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~--~~~kl~Dfg 225 (340)
+.|+|+|++.|+ +...+-. ...+++..+..+++||+.||.|+|. +||||||+||+|+++-++. --+||+|||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 789999999974 4433332 1457889999999999999999999 8999999999999996433 369999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
+|....++.......||+.|||||++.. ..|+..+|||+.|||||-||.|.+||.+.+....+++|++ ..+......|
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~-g~yd~~~~~w 236 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA-GAYDYPSPEW 236 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-cccCCCCccc
Confidence 9999887777778899999999999965 5599999999999999999999999999887666666665 4433333223
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... .....+.+-|+..+|++|.|+.|-++|||
T Consensus 237 ~~is--~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 237 DTVT--PEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CcCC--HHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 3221 12233445556667889999999999999
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=344.94 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=192.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 6999999999999999999999999999999986532 2234688999999999999999988 555668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCccc
Confidence 999999986 45555443 4679999999999999999999999 79999999999999995 78899999999875
Q ss_pred cccCC------------------------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHH
Q 019506 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (340)
Q Consensus 230 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (340)
..... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 43211 01234789999999999654 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCC-CchhhhhccccccCChhhHhhhc-ccccccCCCCcCcccccCC
Q 019506 274 LLGQPLFPGENAVDQLVEIIKVSNI-IYAKTIYQGLFCSNNHEIMCELG-SWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~R~~~~~i~~hpf 340 (340)
++|+.||.+.+..+.+.++...... ..+... -++....+.+.+++ ...++..||+++||++|||
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEV---PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcccCCCcC---CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence 9999999988877777776653221 111110 01122223333322 2223456799999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=338.84 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=210.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCC-CCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 146 (340)
....|.+.+.||+|.||.||+|+.+.+|+.+|+|.+.+... ...+|+++|+++. |||||.+++.| ++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 34579999999999999999999999999999999975432 5568999999999 99999999999 55
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC---CcEEEE
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLC 222 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~---~~~kl~ 222 (340)
...+++|||+|.| .|++.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+.... +.+|++
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEe
Confidence 5569999999996 566655543 39999999999999999999999 7999999999999997543 479999
Q ss_pred eeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
|||++.....+......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......+.+ ....+..
T Consensus 182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-~~~~f~~ 259 (382)
T KOG0032|consen 182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-GDFDFTS 259 (382)
T ss_pred eCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-CCCCCCC
Confidence 9999999877666778899999999999954 4599999999999999999999999999998777776655 4444444
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..|... +.....+.+-+...+|..|+++.+.+.|||
T Consensus 260 ~~w~~i--s~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 260 EPWDDI--SESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCcccc--CHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 444443 344455555566667889999999999999
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=330.82 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=203.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcC-CCcEEEEEEecccc------cChHHHHHHHHhC---CCCceeecceeeeecCCCCc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~ 147 (340)
+|++.+.||+|+||+||+|++.. ++..||+|.+.... ....+|+++++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999864 46889999886432 1234577776665 69999999998854433445
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..+++||||+++++.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccce
Confidence 568899999999887777542 23468999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.............++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..++.....+...++...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876554444456789999999999654 4899999999999999999999999999988888888876655443332111
Q ss_pred ------ccc--------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 ------LFC--------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ------~~~--------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+. ......+..-|...+|.+|||+.|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 000 111234455566668999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=337.93 Aligned_cols=257 Identities=35% Similarity=0.591 Sum_probs=200.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|+||.||+|++..+|..||||.+.... ....+|+++++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4899999999999999999999999999999886421 2245799999999999999999988654444445688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence 9999999887776653 4578999999999999999999999 79999999999999995 8899999999997643
Q ss_pred cCCc----cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh--
Q 019506 232 KGEA----NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI-- 304 (340)
Q Consensus 232 ~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (340)
.... .....+++.|+|||++.+. ..++.++|||||||++|+|+||+.||.+.+....+..+....+.+....+
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1234689999999998542 45899999999999999999999999988776666555444333321110
Q ss_pred ---------hcccc-------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------YQGLF-------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------~~~~~-------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..+. .......+..-|+..+|.+||+++|+++|||
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00000 0111234566667778999999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=327.37 Aligned_cols=252 Identities=35% Similarity=0.616 Sum_probs=200.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 6999999999999999999999999999999886432 2335799999999999999999988 4455689
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++...+.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCccccc
Confidence 9999999887766543 24578999999999999999999999 79999999999999995 8889999999998764
Q ss_pred cCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 232 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
.... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.........+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 3322 22346899999999996644 899999999999999999999999988777766665554332211100
Q ss_pred --------hccc------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 --------YQGL------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------~~~~------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+... ..+.....+.+.|+..+|.+|+|++|+++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0000 01112445666777788999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=337.45 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=187.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
...+|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++|+||+++++++ .....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 3456889999999999999999999999999999886432 2345799999999999999999988 44556
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++||||+.++.+. . .....+..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 147 ~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~~ 217 (353)
T PLN00034 147 IQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRI 217 (353)
T ss_pred EEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccccccee
Confidence 88999999976332 1 2345677888999999999999999 79999999999999995 78899999999987
Q ss_pred cccCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCchh
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEIIKVSNIIYAK 302 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~ 302 (340)
..... ......|+..|+|||++.. ....+.++|||||||++|||++|+.||......+. +...+.....+...
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP 297 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC
Confidence 64332 2234578999999999742 23345789999999999999999999974432221 11111111111111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ........+...|+..+|.+||+++|++.|||
T Consensus 298 ~-----~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 298 A-----TASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred C-----ccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0 11223345566677778999999999999999
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=335.58 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=202.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
..+|++.+.||+|+||.||+|++..+|..||+|.+.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 357999999999999999999999999999999986431 223478999999999999999998854322 1223
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+|+||||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCcc
Confidence 578999999998776553 357889999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
............+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+.....
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 76444444456789999999999654 5899999999999999999999999988877776666655443321100
Q ss_pred ---------------------hccc----------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------------------YQGL----------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------------------~~~~----------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+... ........+..-|+..+|.+|||++|+++|||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000 01112234556667778999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=343.17 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=196.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCC------ceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~ 145 (340)
...+|++.++||+|+||+||+|++..+++.||||+++... .....|+++++.++|. ++++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~---- 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN---- 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----
Confidence 3568999999999999999999999999999999986432 2334678888777654 57888777632
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC--------
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------- 217 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-------- 217 (340)
+..++|+|||++++++.+.+.. .+.+++..++.++.||+.||+|||+..|||||||||+|||++..+.
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 2346889999999888877654 3578999999999999999999997139999999999999985322
Q ss_pred -------cEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 019506 218 -------QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (340)
Q Consensus 218 -------~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (340)
.+||+|||.+... ........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4999999988643 2233456789999999999764 48999999999999999999999999988888777
Q ss_pred HHHHhcCCCchhh-----------hhc------------------------cccccCChhhHhhhcccccccCCCCcCcc
Q 019506 291 EIIKVSNIIYAKT-----------IYQ------------------------GLFCSNNHEIMCELGSWYSYSGRNSMHES 335 (340)
Q Consensus 291 ~~~~~~~~~~~~~-----------~~~------------------------~~~~~~~~~~~~~l~~~~~~~~R~~~~~i 335 (340)
.+.+..+...... ++. ..........+...|+.++|.+|+|++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 7766544322110 000 00001112245566777889999999999
Q ss_pred cccCC
Q 019506 336 KLYGF 340 (340)
Q Consensus 336 ~~hpf 340 (340)
++|||
T Consensus 436 L~Hp~ 440 (467)
T PTZ00284 436 TTHPY 440 (467)
T ss_pred hcCcc
Confidence 99999
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=323.33 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=203.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhC---CCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|++.+.||+|+||.||+|+++.+++.||+|.++... ....+|+++++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4889999999999999999999999999999886431 1234577776655 799999999988654444556
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++||||+.+++.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence 68899999998877776542 23458999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc--
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ-- 306 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 306 (340)
............++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++......+....+-.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76544444455778999999999654 489999999999999999999999998888888877776544332222110
Q ss_pred ----------------cccccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 ----------------GLFCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ----------------~~~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.... ....+..-|+..+|.+|||++|++.|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000001 1124455566778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=302.26 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=206.6
Q ss_pred CCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh-----HHHHHHHHh-CCCCceeecceeeeecCC
Q 019506 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRL-MDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 71 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~E~~~l~~-l~h~~iv~~~~~~~~~~~ 144 (340)
.......+...+..||.|+.|.|++++.+.+|..+|||.+.+..... ...++++.+ -..|.||+.+|+|....+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 33444556677788999999999999999999999999997543221 123333333 348999999999965443
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+++.||.|..-...++.+. .++++|..+..+...++.||.||.+.+||||||+||+|||+|. .+++|||||
T Consensus 166 -----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDF 236 (391)
T KOG0983|consen 166 -----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDF 236 (391)
T ss_pred -----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeecc
Confidence 7799999987666666543 4789999999999999999999998789999999999999995 889999999
Q ss_pred ccccccccCCccceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCch
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYA 301 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~ 301 (340)
|.+.++.+...++...|.+.|||||.+- ....|+.++||||||++|+||+||+.||.+.+. -+.+.+++. ...|-+
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L 315 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLL 315 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCC
Confidence 9999998888888889999999999984 235689999999999999999999999998654 455555555 444432
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ..-.+..+..+.+.|+..++.+||.+.+++.|||
T Consensus 316 ~~---~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 316 PG---HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred Cc---ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 22 1114555677888899999999999999999998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=333.88 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=195.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 457999999999999999999999999999999886432 2245799999999999999999988 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccCc
Confidence 68999999986 55555543 4678999999999999999999999 79999999999999995 888999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... ....+..
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~p~~---- 237 (329)
T PTZ00263 166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKFPNW---- 237 (329)
T ss_pred eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CcCCCCC----
Confidence 876333 2345789999999999654 4799999999999999999999999887766655555432 2221111
Q ss_pred ccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|++ ++++++|||
T Consensus 238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 1122334555566667778886 799999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=333.50 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=205.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|+..+.||+|+||.||+|.+..+++.||+|++.-+. ....+|+.+|..++++||.++|+.|+.. ..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHHH
Confidence 5888899999999999999999999999999997543 3345799999999999999999999543 34889
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||.|+ ..+.+. ....+.+..+..++++++.||.|||. ++.+|||||+.|||+.. ++.+||+|||.+....
T Consensus 89 iMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeeeee
Confidence 99999975 334333 24455888889999999999999999 79999999999999996 6899999999998775
Q ss_pred cCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..... .+++||++|||||++.+ ..|+.++||||||++.+||++|.+||.+..+...+..|-+.. +|.... -+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~-----~~ 235 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDG-----DF 235 (467)
T ss_pred chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCcccc-----cc
Confidence 54433 57899999999999974 559999999999999999999999999988866666665532 222222 34
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.+...+...|+-.+|..||++.+++.|+|
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 566788999999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=328.08 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=195.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 6899999999999999999999999999999886421 2345799999999999999999887 455678
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcchh
Confidence 999999986 55555543 4678999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .......+
T Consensus 151 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~----- 221 (291)
T cd05612 151 LRDR--TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEFPRHL----- 221 (291)
T ss_pred ccCC--cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CcCCCccC-----
Confidence 6432 234568999999999965 44799999999999999999999999988776666665543 22221111
Q ss_pred ccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
......+.+.|+..+|.+|++ ++|+++|||
T Consensus 222 -~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 222 -DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred -CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 122334555566667888994 999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=338.98 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=190.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|.+.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999986432 2235789999999999999999998 445568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence 999999986 55555443 4578999999999999999999999 79999999999999995 78899999999753
Q ss_pred cccCC------------------------------------------------ccceeeeeccccCcccccCCCCCCCcc
Q 019506 230 LVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTSI 261 (340)
Q Consensus 230 ~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 261 (340)
..... .....+||..|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01234689999999999654 489999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhh-cccccccCCCCcCcccccCC
Q 019506 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCEL-GSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~R~~~~~i~~hpf 340 (340)
|||||||++|||+||..||...+..+....++........... .-+.....+.+.++ +...++..|++++|++.|||
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 9999999999999999999988776666665542221111000 00111222333332 22333556999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=323.88 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=192.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3788999999999999999999999999999886432 1234689999999999999999888 444568
Q ss_pred eeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||++++ +...+.. .....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence 9999999965 4434432 223468999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---hcCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~ 306 (340)
...........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.+ .........
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 227 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--- 227 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc---
Confidence 654444445678999999999965 4589999999999999999999999987654332222222 111111111
Q ss_pred cccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.+.....+.+.|+..+|.+|++ ++++++|||
T Consensus 228 ---~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 228 ---FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 1223344556666677888986 899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=333.15 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=191.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCC-cEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 3457999999999999999999876655 689999886431 2234699999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+.+ +|.+.+.. +..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecCC
Confidence 5568999999986 55555543 4678999999999999999999999 79999999999999985 8899999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..... ..+..
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~-- 250 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKF-- 250 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCC--
Confidence 9987533 2335678999999999965 4479999999999999999999999998877666666554321 11111
Q ss_pred ccccccCChhhHhhhcccccccCC-----CCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGR-----NSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R-----~~~~~i~~hpf 340 (340)
+ ......+.+.|...+|.+| ++++++++|||
T Consensus 251 ---~-~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 251 ---L-DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ---C-CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 1 1112233344444456666 59999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=333.55 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=200.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc-EEEEEEeccc---ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE-TVAIKKVLQD---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~-~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..+++.+.||+|.||+||+|++ .+. .||+|.++.. ...+.+|+++|++|+|+|||++++++. ...-++|
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~--~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piyI 278 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKW--NGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIYI 278 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEE--cCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceEE
Confidence 3466778999999999999998 444 7999988753 244568999999999999999999994 3335899
Q ss_pred eecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||++ |+|.+.|+. .....+.......++.|||+|++||.+ +++|||||...||||+. +..+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccC
Confidence 999999 678888875 446788999999999999999999999 79999999999999995 8899999999999655
Q ss_pred cCCccceee--eeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEANISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
++....... ....|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+.+.-..+.+.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~------ 427 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE------ 427 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC------
Confidence 554433322 2566999999955 458999999999999999998 999999999988888887766655543
Q ss_pred cccCChhhHhhhcccccccCCCCcCccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
.|..-...++..|+..+|.+||||+.+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 3677777788888888899999998653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=339.95 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=187.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||+||+|++..+++.||||++.+.. ....+|+++++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 6999999999999999999999999999999886432 2235689999999999999999988 455668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeecccccc
Confidence 999999986 55555543 4678999999999999999999999 79999999999999995 88999999999863
Q ss_pred cccCCc------------------------------------------------cceeeeeccccCcccccCCCCCCCcc
Q 019506 230 LVKGEA------------------------------------------------NISYICSRYYRAPELIFGATEYTTSI 261 (340)
Q Consensus 230 ~~~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~ 261 (340)
...... ....+||+.|+|||++.+ ..++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCce
Confidence 311000 012468999999999965 4589999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccC---CCCcCccccc
Q 019506 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSG---RNSMHESKLY 338 (340)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---R~~~~~i~~h 338 (340)
|||||||++|||++|..||.+.+..+.+..+..........+.. -+...-.+.+..+. . ++.. |++++|++.|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~s~~~~dli~~lL-~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLI-T-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCC--CCCHHHHHHHHHHh-c-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999888777766666432211110000 00011122222222 2 2333 6799999999
Q ss_pred CC
Q 019506 339 GF 340 (340)
Q Consensus 339 pf 340 (340)
||
T Consensus 306 p~ 307 (377)
T cd05629 306 PF 307 (377)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.46 Aligned_cols=246 Identities=29% Similarity=0.477 Sum_probs=192.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|+||++++++| .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 6999999999999999999999999999999986432 2234699999999999999999988 555668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeeccccee
Confidence 999999986 44444433 4578999999999999999999999 79999999999999995 88899999999875
Q ss_pred cccCCc---------------------------------------cceeeeeccccCcccccCCCCCCCcchhHHHHHHH
Q 019506 230 LVKGEA---------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270 (340)
Q Consensus 230 ~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 270 (340)
...... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHH
Confidence 432110 112358999999999965 4589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCc-hhhhhccccccCChhhHhhhcccccccCCCC---cCcccccCC
Q 019506 271 AELLLGQPLFPGENAVDQLVEIIKVSNIIY-AKTIYQGLFCSNNHEIMCELGSWYSYSGRNS---MHESKLYGF 340 (340)
Q Consensus 271 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~---~~~i~~hpf 340 (340)
|||++|..||.+.+..+.+..+........ .... -+.....+.+..+ . .+|.+|++ ++|++.|||
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~l-l-~~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV---PLSPEAKDLIKRL-C-CEAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCC---CCCHHHHHHHHHH-c-cCHhhcCCCCCHHHHhcCCC
Confidence 999999999998887777666654322111 1110 0111222333333 2 26888887 999999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=331.36 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=202.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
.++|.+.+.||+|+||.||+|++..+++.||||.+.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 457999999999999999999999999999999886432 223468999999999999999998854322 2234
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCcccc
Confidence 578999999998776654 357888999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
............+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++....+.....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 76554444456789999999999654 4899999999999999999999999988877777766665443321100
Q ss_pred ------h----------------cccc---------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------Y----------------QGLF---------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~----------------~~~~---------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ...+ .......+...|+..+|.+|||++|++.|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 0 0000 0011234566677778999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=334.70 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=203.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|++..+|+.||||.+.... ....+|+++++.++|+||+++++++..........++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3778899999999999999999999999999886431 2345799999999999999999988543322223688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence 9999999877766543 4678999999999999999999999 79999999999999995 8899999999997653
Q ss_pred cCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc--
Q 019506 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG-- 307 (340)
Q Consensus 232 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 307 (340)
.... .....++..|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..+.+..+.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3221 223457889999999977666899999999999999999999999999888888887776555443222110
Q ss_pred ---------------------ccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 ---------------------LFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ---------------------~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. ......+...|+..+|.+|||++|++.|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000 111224555667778999999999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=331.91 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=204.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 457999999999999999999999999999999886432 223478999999999999999998744322 2234
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+|+||||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCcc
Confidence 578999999998776664 347888899999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh-----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT----- 303 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 303 (340)
............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++....+....
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 7655444445678999999999965 4589999999999999999999999999888888887776554432110
Q ss_pred --------------------hhcccc----------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 --------------------IYQGLF----------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 --------------------~~~~~~----------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..... .......+..-|+..+|.+|||++|++.|||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000 0111234566677778999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=308.21 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=202.1
Q ss_pred cccCeeEe-eeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHH-HHhCCCCceeecceeeeecCCCCceeeee
Q 019506 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 75 ~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+++|.+. ++||-|-.|+|..+.++.||+.+|+|++.. .....+|+++ +..-.|+|||.++++|.... .+..++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEe
Confidence 34567764 679999999999999999999999996644 4445678887 44557999999999984433 45667889
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeeccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a~~ 229 (340)
|||.++|+ |++.+.. .....|++.++..|++||+.|+.|||+ .+|.||||||+|+|... .+-.+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence 99999975 4444433 345679999999999999999999999 59999999999999963 244799999999998
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
........+.+.|++|.|||++ +..+|+..+|+||+||++|-||+|.+||.... ...-++..++...+.++..=|.
T Consensus 214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 8766666778889999999999 77779999999999999999999999997543 3445666666676665443333
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ++ ..+.+.+.++.-+|.+|+|++|.++|||
T Consensus 293 ~V-Se-~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 293 CV-SE-AAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HH-HH-HHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 21 12 2233344444456779999999999999
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.71 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=191.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|.+.++||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||++++++| .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5899999999999999999999999999999886432 2345799999999999999999998 445568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence 999999986 45555543 3578999999999999999999999 79999999999999995 88999999999753
Q ss_pred cccC------------------------------------------------CccceeeeeccccCcccccCCCCCCCcc
Q 019506 230 LVKG------------------------------------------------EANISYICSRYYRAPELIFGATEYTTSI 261 (340)
Q Consensus 230 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 261 (340)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001124689999999999654 589999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCC---cCccccc
Q 019506 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS---MHESKLY 338 (340)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~---~~~i~~h 338 (340)
|||||||++|||++|+.||.+.+..+....++.......... ..-+...-.+.+..++ .+|.+|++ ++|+++|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~--~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc--cCHhHcCCCCCHHHHhcC
Confidence 999999999999999999998887666666654322111110 0011222234444443 36788887 9999999
Q ss_pred CC
Q 019506 339 GF 340 (340)
Q Consensus 339 pf 340 (340)
||
T Consensus 306 p~ 307 (382)
T cd05625 306 PF 307 (382)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=334.36 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=195.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
..+|.+.+.||+|+||.||+|++..+++.||+|.... ....+|+++++.++||||++++++| ......++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEe
Confidence 3579999999999999999999999999999996543 3456899999999999999999988 33445889999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC--
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-- 233 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-- 233 (340)
++.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence 999887766653 3578999999999999999999999 79999999999999995 788999999999754322
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCchhh---
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVSNIIYAKT--- 303 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-------~~~~~~~~~~~~~~~~~~~~--- 303 (340)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||... ....++..+++..+......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22234578999999999965 45899999999999999999999776432 23445555555443221100
Q ss_pred -------h-----------------hccccc-cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 -------I-----------------YQGLFC-SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 -------~-----------------~~~~~~-~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. +..+.. ......+...|+..+|.+|||++|+++|||
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0 000000 012334566677788999999999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=330.41 Aligned_cols=239 Identities=24% Similarity=0.372 Sum_probs=189.4
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999887532 1234688999999999999999988 45556899999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-C
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 233 (340)
|++++ |...+.. +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence 99964 4444432 4678999999999999999999999 79999999999999995 78899999999875422 2
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+.. .....+..+ ...
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~p~~~------~~~ 221 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRFPRTL------SPE 221 (323)
T ss_pred CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCC------CHH
Confidence 23334678999999999965 4589999999999999999999999988776555444433 222222111 122
Q ss_pred hhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
...+.+.|+..+|.+|+ +++++++|||
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 34455666667888999 8999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=328.03 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=212.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
-|.+.+.||+|.|+.|-+|++.-||..||||++.+.+.. ..+|++.|+.++|||||++|++. ....-+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence 489999999999999999999999999999999776432 35799999999999999999988 5555689
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||+|+-++ +|++++..+ ...+.+..++.+++||+.|+.|||++ .+|||||||+|+.+.++-|-+||+|||++..+
T Consensus 94 LiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999886 777777653 57899999999999999999999995 89999999999999878899999999999999
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.++....+.+|+..|.|||+++|..+..+++||||||||||.|++|++||+..++.+.+..|+........ . +.
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs-h-----vS 243 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS-H-----VS 243 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch-h-----hh
Confidence 99999999999999999999999888888999999999999999999999999999999999875543321 1 11
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+ +..-|+..+|.+|-++|+|-.|+|
T Consensus 244 ~eCrd-LI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 244 KECRD-LIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HHHHH-HHHHHHhcCchhhccHHHHhcccc
Confidence 22222 223344556779999999999999
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.57 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=191.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||.||+|++..+++.||||++.+. .....+|+++++.++|+||+++++.| .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 699999999999999999999999999999988642 12345799999999999999999988 455568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence 999999986 55555543 4578999999999999999999999 79999999999999995 88899999999753
Q ss_pred cccC--------------------------------------------CccceeeeeccccCcccccCCCCCCCcchhHH
Q 019506 230 LVKG--------------------------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWS 265 (340)
Q Consensus 230 ~~~~--------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 265 (340)
+... ......+||+.|+|||++.+ ..++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence 2100 00112468999999999965 44899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCC---CcCcccccCC
Q 019506 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN---SMHESKLYGF 340 (340)
Q Consensus 266 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~---~~~~i~~hpf 340 (340)
|||++|+|++|+.||.+.+..+....+........... ..-+.....+.+..++ .+|.+|+ +++|+++|||
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~--~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS--QAKLSREASDLILRLC--CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCC--CCCCCHHHHHHHHHHh--cCHhhcCCCCCHHHHhCCCC
Confidence 99999999999999998887666655543221111110 0001122233344432 4799999 9999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.04 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=195.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++|+||+++++++ .+....
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 6999999999999999999999999999999986432 2234688999999999999999988 455568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCcc
Confidence 999999986 55555433 4578999999999999999999999 79999999999999995 88899999999976
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc-cc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ-GL 308 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 308 (340)
... ......|++.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+.............. ..
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence 543 23345789999999999665 589999999999999999999999998887776666554322111111100 00
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.+.....+...|+..++.+|+++++++.|||
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 00111222333344567899999999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=333.03 Aligned_cols=250 Identities=27% Similarity=0.466 Sum_probs=192.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|++.+.||+|+||.||++++..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 345799999999999999999999999999999988642 12245789999999999999999988 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+||||+++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEeccc
Confidence 668999999986 55555432 468999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-c
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII-Y 300 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~ 300 (340)
+........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+....+.+++...... .
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF 268 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC
Confidence 987643322 22456899999999996432 37889999999999999999999999888777777776543221 1
Q ss_pred hhhhhccccccCChhhHhhhcccccc--cCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSY--SGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~--~~R~~~~~i~~hpf 340 (340)
+... .+.....+.+..+. ...+ ..|++++|+++|||
T Consensus 269 p~~~---~~s~~~~~li~~~L-~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 269 PEDV---EISKHAKNLICAFL-TDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred CCcc---cCCHHHHHHHHHHc-cCchhccCCCCHHHHhcCcc
Confidence 1110 01111122222222 1222 34899999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=332.57 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=193.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|.+.+.||+|+||.||+|++..+++.||+|.+.+.. ....+|+.+++.++|+||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4457999999999999999999999999999999986421 2234789999999999999999888 555
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ +|.+.+. +..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEeccc
Confidence 668999999986 4555443 2468899999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+........ .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+....+.++.........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 268 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC
Confidence 977543321 2245689999999998643 24789999999999999999999999988877777777653221111
Q ss_pred hhhhccccccCChhhHhhhcccccccC--CCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSG--RNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~--R~~~~~i~~hpf 340 (340)
.. ....+.....+..-++..+|.+ |++++|+++|||
T Consensus 269 ~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 269 PD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 10 0001111122222233345665 999999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.98 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=192.5
Q ss_pred eeeeeeecceEEEEEEEc--CCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
+++||+|+||+||+|+++ .+++.||+|.+.... ....+|+++++.++||||+++++++.. .....+++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence 467999999999999965 467899999886543 234689999999999999999998854 2334588999999
Q ss_pred cchHHHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec---CCCCcEEEEeeccccc
Q 019506 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (340)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~---~~~~~~kl~Dfg~a~~ 229 (340)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988877653221 12358999999999999999999999 7999999999999994 2356899999999987
Q ss_pred cccCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 019506 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVS 296 (340)
Q Consensus 230 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~~~~~~ 296 (340)
..... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||..... ..++..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 64332 122356799999999997766689999999999999999999999975432 24455555544
Q ss_pred CCCchhhhh----------------cccc---------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 297 NIIYAKTIY----------------QGLF---------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~----------------~~~~---------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.+....+- +... .......+..-|+..+|.+|+|++|+++|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 433221110 0000 0001223555667778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=333.03 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=196.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 6999999999999999999999999999999986432 2345789999999999999999988 455668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCcc
Confidence 999999986 55555543 3678999999999999999999999 79999999999999995 88899999999987
Q ss_pred cccCC------------------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 019506 230 LVKGE------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (340)
Q Consensus 230 ~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (340)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 64433 22345689999999999664 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCC-cCcccccCC
Q 019506 280 FPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS-MHESKLYGF 340 (340)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~-~~~i~~hpf 340 (340)
|.+.+......++............. .+.....+.+..+. . +|.+|++ ++|++.|||
T Consensus 230 f~~~~~~~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll-~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 230 FYSDTLQETYNKIINWKESLRFPPDP--PVSPEAIDLICRLL-C-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCCHHHHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHc-c-ChhhcCCCHHHHhcCCC
Confidence 99888766666666522111110000 01222233344433 3 7999999 999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.81 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=201.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|++++++++|+||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeE
Confidence 357999999999999999999999999999999886432 23457999999999999999999883 44458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 80 TLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAK 154 (309)
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECccccceec
Confidence 89999999987776653 23468899999999999999999999 79999999999999995 788999999999765
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+....+.... +..+.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET-WPGIS 233 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH-Hhhhc
Confidence 33222 22346788999999987666689999999999999999999999998888777777776554433211 11100
Q ss_pred ------------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 ------------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ------------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|...+|.+|+|++|++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 0011123445556668999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=306.38 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=204.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.|.-.+.||.|..++|.++.++.+|..+|+|++.... ....+|+.+|+++ .||+|+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 5777788999999999999999999999999885211 1223689999987 599999999999
Q ss_pred CCceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
+...++++|+|+|+ |.|++.|.. .-.++++..+.|++|++.|++|||. ++||||||||+|||++. +.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEEec
Confidence 77778999999999 567776654 5679999999999999999999999 79999999999999994 89999999
Q ss_pred eccccccccCCccceeeeeccccCccccc-----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
||+|+.+..+......+||++|+|||.+. +.+.|+..+|+||+|||+|.|+.|.+||......-.+. ++..++.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR-~ImeGky 245 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR-MIMEGKY 245 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH-HHHhccc
Confidence 99999999999999999999999999984 34568999999999999999999999998765444444 4444555
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+...-|.+. +...++.+.++ +..+|..|.|++|.+.|||
T Consensus 246 qF~speWadi-s~~~KdLIsrl-LqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 246 QFRSPEWADI-SATVKDLISRL-LQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ccCCcchhhc-cccHHHHHHHH-HeeCchhcccHHHHhcChH
Confidence 5544334432 23344444443 4447889999999999998
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=328.28 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=212.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|..++++|+|+||.+++++++.++..+++|.+.-. ++....|+.+++++.|||||.+.+.|+ .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4799999999999999999999999999999998643 334467999999999999999999984 444559
Q ss_pred eeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|||+||+|+ +.+.+.... ..-++++.+..|+.|++.|+.|||+ ++|+|||||+.|||++. ++.|||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhhh
Confidence 9999999974 555554422 4679999999999999999999999 79999999999999996 77789999999999
Q ss_pred cccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... ...+.+||+.||.||++.+ ..|+.++|||||||++|||++-+++|.+.+....+.+|.+....|.+..
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~----- 229 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSM----- 229 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcc-----
Confidence 98777 6677899999999999966 4599999999999999999999999999999999999998775554333
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-++..+|..||++.+++.+|.
T Consensus 230 -ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 230 -YSSELRSLVKSMLRKNPEHRPSALELLRRPH 260 (426)
T ss_pred -ccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence 2344466667777777889999999998873
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=329.62 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=194.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
...|.+.+.||+|+||.||+|++..+++.||||.... ....+|++++++++|+|||++++++. .....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEE
Confidence 3469999999999999999999999999999996432 33568999999999999999999873 3445789999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (340)
++.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 999887777653 23478999999999999999999999 79999999999999995 78899999999976533222
Q ss_pred ---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCC-CCC------ChHHHHHHHHHhcCCCchh---
Q 019506 236 ---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGE------NAVDQLVEIIKVSNIIYAK--- 302 (340)
Q Consensus 236 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~------~~~~~~~~~~~~~~~~~~~--- 302 (340)
.....||..|+|||++.+. .++.++|||||||+||||++|..++ ... ....++.++++........
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1234689999999999664 4899999999999999999987544 322 1234555555543321100
Q ss_pred ------------------------hhhccccc-cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 ------------------------TIYQGLFC-SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ------------------------~~~~~~~~-~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..|..... ......+...|+..+|.+|||++|++.|||
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 00111011 113445666777889999999999999998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.12 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=191.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.++..++|+||+++++.+ .+...+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 6899999999999999999999999999999886421 2234688899999999999999988 555668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCcc
Confidence 999999986 45554433 4678999999999999999999999 79999999999999995 88999999999875
Q ss_pred cccCC------------------------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHH
Q 019506 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (340)
Q Consensus 230 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (340)
..... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42211 01134689999999999654 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcC-CCchhhhhccccccCChhhHhhhcccccccCCC---CcCcccccCC
Q 019506 274 LLGQPLFPGENAVDQLVEIIKVSN-IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN---SMHESKLYGF 340 (340)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~---~~~~i~~hpf 340 (340)
+||+.||.+.+..+.+..+..... ...+... .+.....+.+.+++ .+|..|+ +++|+++|||
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~--~~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEV---PISEKAKDLILRFC--TDSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCceecCCCC---CCCHHHHHHHHHhc--cChhhcCCCCCHHHHhcCCC
Confidence 999999998887777666654221 1111110 01122233444433 2677787 5789999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.84 Aligned_cols=255 Identities=33% Similarity=0.534 Sum_probs=201.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46999999999999999999999999999999886432 223479999999999999999998743221 22244
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++++|++++++...+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCcccee
Confidence 78999999887766554 3579999999999999999999999 79999999999999995 88899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
.... .....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+....+
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 5432 334578999999999977566899999999999999999999999988877777777665443322110
Q ss_pred ------hcc-----------ccccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------YQG-----------LFCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~~~-----------~~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. .+... ....+..-|+..+|.+|||++|+++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000 00000 1123445566778999999999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=327.32 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=194.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||+||+|++..+|+.||+|+++... ....+|+.+++.++|+||+++++++ .+....
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 6999999999999999999999999999999987532 2345788899999999999999888 445568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCeE
Confidence 999999986 555555432 3578999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCCcc--ceeeeeccccCcccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 230 LVKGEAN--ISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 230 ~~~~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
....... ....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+.++..........
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence 6443322 22467999999999853 3457899999999999999999999999888777777666532211100
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ..-.+.....+.+.+.. +|.+|+++++++.|||
T Consensus 232 ~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 232 E---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred C---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 0 00001112223333444 7999999999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=326.09 Aligned_cols=239 Identities=24% Similarity=0.378 Sum_probs=186.5
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.||+|+||.||++++..+|+.||+|++.+.. ....+|+++++.++||||+++++++ .....+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986532 2234688999999999999999888 45556899999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC-
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 233 (340)
|++++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence 99864 4444432 4678999999999999999999999 79999999999999995 888999999998764322
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.. .....+.. + +..
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~p~~-----~-~~~ 221 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIKFPRT-----L-SAD 221 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCccCCCC-----C-CHH
Confidence 222345689999999999654 489999999999999999999999988776555544432 22222111 1 112
Q ss_pred hhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
...+.+-|+..+|.+|+ +++|+++|||
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 23444455566677886 8999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.50 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=191.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3467999999999999999999999999999999886421 2234788999999999999999988 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCCc
Confidence 668999999986 4554443 2468999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+........ .....||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+....+.++.........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 268 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 987643322 2245689999999998643 23789999999999999999999999988877777776653321110
Q ss_pred hhhhccccccCChhhHhhhcccccc--cCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSY--SGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~--~~R~~~~~i~~hpf 340 (340)
... .-+...-.+.+..+.. ..+ ..|++++||++|||
T Consensus 269 ~~~--~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 269 PDD--NDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCc--CCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcc
Confidence 000 0011111222222222 222 23889999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=323.29 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=194.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
..+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++|+||+++++++. .....++|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEE
Confidence 34699999999999999999999999999999975433 2356999999999999999999884 3445789999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (340)
++.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence 999988777653 24678999999999999999999999 79999999999999995 78899999999976544444
Q ss_pred cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhcCCCch----
Q 019506 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENA---------VDQLVEIIKVSNIIYA---- 301 (340)
Q Consensus 236 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~---------~~~~~~~~~~~~~~~~---- 301 (340)
.....||..|+|||++.+. .++.++|||||||++|||+++. .+|.+... ...+..++........
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999999654 4899999999999999999855 55543221 2333333333221110
Q ss_pred -------hhhh----------------ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 -------KTIY----------------QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 -------~~~~----------------~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..++ ...-.......+...|+..+|.+|||++|+++|||
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 0000 00011112233666778889999999999999999
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=322.50 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=190.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||.||++++..+++.||+|++.+. .....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 699999999999999999999999999999998642 12245688899999999999999988 455668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCceee
Confidence 999999986 55555543 24578999999999999999999999 79999999999999985 88899999999876
Q ss_pred cccCCcc--ceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 230 LVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 230 ~~~~~~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+...........
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 5433322 22468999999999853 24478899999999999999999999998877776666654322111100
Q ss_pred hhccccccCChhhHhhhc-ccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELG-SWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~-~~~~~~~R~~~~~i~~hpf 340 (340)
.... +...-.+.+..+. ...++..|++++++++|||
T Consensus 232 ~~~~-~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 232 DVTD-VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred ccCC-CCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0000 0111122222211 1112344889999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.27 Aligned_cols=239 Identities=24% Similarity=0.355 Sum_probs=186.4
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.||+|+||.||++++..+|..||+|++.... ....+|+++++.++||||++++++| .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 36999999999999999999999999986532 1224688999999999999999988 44456899999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC-
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 233 (340)
|++++ |...+. .+..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence 99964 444433 24678999999999999999999999 79999999999999995 888999999998754222
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.... ...+.. ....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~------~~~~ 221 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRT------LSPE 221 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCC------CCHH
Confidence 222345689999999999654 58999999999999999999999998877766555554322 111111 1122
Q ss_pred hhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
...+..-|+..+|.+|+ ++.++++|||
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 23444455555677887 8999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.98 Aligned_cols=254 Identities=29% Similarity=0.533 Sum_probs=203.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 457999999999999999999999999999999886432 2345799999999999999999998 444568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++...+.. ....+++..++.++.|++.||+|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhcc
Confidence 89999999887776653 23568899999999999999999999 79999999999999995 788999999998765
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....++..|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+......+....+ ..++
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGIL 233 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc-hhhh
Confidence 33222 223456889999999876666889999999999999999999999988887777776665444332111 1100
Q ss_pred ------------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 ------------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ------------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+..-|...+|.+|||++|+++|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0112234666677778999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.34 Aligned_cols=237 Identities=27% Similarity=0.450 Sum_probs=187.2
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||.||+|++..+++.||+|++.... ....+|+.++++++||||+++++++ .+....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999999999999999886431 2234688999999999999999888 4445688999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-c
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-A 235 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 235 (340)
++ +|.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...... .
T Consensus 76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence 96 45455443 4678999999999999999999999 79999999999999995 8889999999997643322 2
Q ss_pred cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChh
Q 019506 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHE 315 (340)
Q Consensus 236 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (340)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.. ...... ......
T Consensus 150 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~------~~~~~~ 221 (312)
T cd05585 150 TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDG------FDRDAK 221 (312)
T ss_pred cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCc------CCHHHH
Confidence 234568999999999965 458999999999999999999999999887766666555421 111111 112234
Q ss_pred hHhhhcccccccCCCC---cCcccccCC
Q 019506 316 IMCELGSWYSYSGRNS---MHESKLYGF 340 (340)
Q Consensus 316 ~~~~l~~~~~~~~R~~---~~~i~~hpf 340 (340)
.+...|+..+|.+|++ +.|+++|||
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 4555666777889975 688999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=335.34 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC---CC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 146 (340)
..+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.++..++|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 358999999999999999999999999999999886432 223568889999999999998887643322 12
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEecc
Confidence 2347899999995 6766666544455679999999999999999999999 79999999999999995 8889999999
Q ss_pred cccccccC---CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 226 SAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 226 ~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......+...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 99765332 12234578999999999965 448999999999999999999999999887766666665533322221
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .......+...|+..+|.+||++.++++|||
T Consensus 268 ~------~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 268 S------ISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred C------CCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 1 1223445666677778999999999999986
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=319.33 Aligned_cols=244 Identities=28% Similarity=0.428 Sum_probs=189.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCC-ceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 149 (340)
+|++.+.||+|+||.||+|++..+++.||||++.+.. .....|+++++.+.|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4889999999999999999999999999999986532 2234678888888765 577888877 44456
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence 8899999986 44444432 4578999999999999999999999 79999999999999995 7889999999987
Q ss_pred cccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ........||..|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.+.. ...+..
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~---- 223 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKS---- 223 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCC----
Confidence 5322 2223345689999999999654 48999999999999999999999999888776666665432 221111
Q ss_pred ccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
.+.....+...|+..+|.+|++. ++++.|||
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 11122334455666678899987 79999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=313.36 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=194.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|++.+.||+|+||+||++.+..+++.||||.+.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3889999999999999999999999999999886431 2234699999999999999999988 445568
Q ss_pred eeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+.++ +...+.. .....+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 9999999864 4444432 223568999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc---CCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS---NIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 306 (340)
...........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... .......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 227 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--- 227 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc---
Confidence 654444344578899999999965 448999999999999999999999998776544433333221 1111111
Q ss_pred cccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|+ ++++++.|||
T Consensus 228 ---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 228 ---FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred ---cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 122234556667777899999 8889999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=319.93 Aligned_cols=239 Identities=28% Similarity=0.422 Sum_probs=186.7
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||.||+|+++.+++.||||++.+.. .....|..+++.+ +|+||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999886432 1223577777765 699999999988 4455689999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (340)
||++++ |...+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence 999974 4444432 4678999999999999999999999 79999999999999995 88899999999875422
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ...... ...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~------~~~ 221 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTW------LSQ 221 (320)
T ss_pred CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCC------CCH
Confidence 223334568999999999965 458999999999999999999999999888766666665422 221111 111
Q ss_pred ChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
....+...|+..+|.+|+++ ++++.|||
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 22344555666678899998 89999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=318.83 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=188.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHH---HHhCCCCceeecceeeeecCCCCce
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL---MRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~---l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
|++.+.||+|+||.||+|.+..+|+.||||++++.. ....+|+++ ++.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678999999999999999999999999999986432 112345444 4567899999999988 4455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..|+||||++++.+..... ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCCc
Confidence 6899999999753322221 3578999999999999999999999 79999999999999995 7899999999987
Q ss_pred ccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
..... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... ..+..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~---- 223 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF---- 223 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCC----
Confidence 54222 22334578999999999965 4589999999999999999999999998887766666655322 12111
Q ss_pred ccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|| ++++++.|||
T Consensus 224 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 224 --LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 111223345555666788898 6888999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=319.21 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=193.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|+||.||++++..+|..+|+|.+..+. ....+|+++++.++|+||+++++++. +...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 357999999999999999999999999999999886432 23457999999999999999999884 33458
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence 899999997 55555443 3568999999999999999999998336999999999999995 78899999999976
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc---------
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY--------- 300 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------- 300 (340)
..... .....|+..|+|||++.+. .++.++|||||||++|+|+||+.||...+..+ +..++.......
T Consensus 154 ~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 154 LIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ccccc-cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccC
Confidence 64332 2345689999999999654 48999999999999999999999997665533 222221100000
Q ss_pred ----------------------hhhhhc-----------cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 ----------------------AKTIYQ-----------GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ----------------------~~~~~~-----------~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+++. ....+.....+...|+..+|.+|||++|+++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000000 0011223445667788888999999999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.95 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=199.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCC-CcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++ .....+|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 499999999999999999998877 7889999764332 2345699999999999999999998 44456899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCceecC
Confidence 9999985 6666665544445678999999999999999999999 79999999999999995 8889999999998764
Q ss_pred cCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+....
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 294 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP----- 294 (478)
T ss_pred CccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-----
Confidence 3322 234568999999999965 4589999999999999999999999988877666666655333222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|..||++++++.|||
T Consensus 295 -~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 295 -VSSGMKALLDPLLSKNPALRPTTQQLLHTEF 325 (478)
T ss_pred -CCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence 1223445556667778999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=321.27 Aligned_cols=240 Identities=25% Similarity=0.431 Sum_probs=183.6
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++||+|+||.||+|++..+++.||+|++++.. ....+|..+++.+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999987532 1234678888887 799999999988 4455689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc-c
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 232 (340)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++... .
T Consensus 76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence 99986 44444432 4679999999999999999999999 79999999999999995 7889999999987532 2
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHhcCCCchhhh
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------NAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~ 304 (340)
........||..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+.+.+.......+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~- 227 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS- 227 (329)
T ss_pred CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC-
Confidence 333345678999999999965 45899999999999999999999999631 12233333333332222111
Q ss_pred hccccccCChhhHhhhcccccccCCCC------cCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNS------MHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~------~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|++ ++++++|||
T Consensus 228 -----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 228 -----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred -----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 1122334555566667888987 679999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=320.71 Aligned_cols=239 Identities=28% Similarity=0.419 Sum_probs=186.8
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++||+|+||.||+|++..+++.||+|++.++. .....|.++++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 36999999999999999999999999987542 1123577777755 799999999998 4455689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence 99996 44444432 4678999999999999999999999 79999999999999995 888999999998754322
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... ..+.. .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~------~~~ 221 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVW------LSK 221 (321)
T ss_pred CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCC------CCH
Confidence 22334568999999999965 4589999999999999999999999998887777766655322 11111 112
Q ss_pred ChhhHhhhcccccccCCC-------CcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRN-------SMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~-------~~~~i~~hpf 340 (340)
....+..-|+..+|.+|+ +++++++|||
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 223344555566788898 8899999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=323.31 Aligned_cols=240 Identities=25% Similarity=0.364 Sum_probs=186.1
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.||+|+||.||++++..+|+.||+|++.... ....+|+++++.++|+||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999987532 2234688899999999999999888 44556899999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-C
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 233 (340)
|++++ +...+. ....+++..++.++.||+.||.|||+.+||+||||||+|||++. ++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence 99975 433333 24678999999999999999999996259999999999999995 88899999999875432 2
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.......||..|+|||++.+. .++.++|||||||++|+|+||..||.+.+.......+.. .....+.. ....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~~~~p~~------~~~~ 222 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRFPRT------LSPE 222 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CCCCCCCC------CCHH
Confidence 222345689999999999654 589999999999999999999999988776555554433 22221111 1112
Q ss_pred hhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
...+.+-|+..+|.+|+ ++++++.|||
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 23444555666778886 8999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=320.12 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=188.2
Q ss_pred CeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhCC-CCceeecceeeeecCCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSK 145 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 145 (340)
+|++.+.||+|+||.||++++. .+++.||+|++.+.. ....+|+.+++.++ |+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999886421 12346888999994 99999999888 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
....+++||||+++ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence 45568899999996 55555433 4678999999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCC
Q 019506 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNII 299 (340)
Q Consensus 225 g~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~ 299 (340)
|+++....... .....||..|+|||++.+...++.++|||||||++|+|+||..||.... ....+...+.....+
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 99976533322 2245689999999999765557899999999999999999999997432 223333322222222
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.... .......+..-|+..+|.+|+ +++++++|||
T Consensus 230 ~~~~------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 230 FPSF------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCC------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 1111 112234455566667788999 7889999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.67 Aligned_cols=244 Identities=29% Similarity=0.426 Sum_probs=189.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhC-CCCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+|.+.+.||+|+||.||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48899999999999999999999999999998875421 123466666666 588899998888 44456
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+++||||+++ +|...+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence 8899999986 55444432 4578999999999999999999999 79999999999999995 8889999999997
Q ss_pred cccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+..+.+..+... ....+..+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~--- 224 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKSM--- 224 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCcC---
Confidence 5432 222334568999999999965 45899999999999999999999999988876666666553 22222211
Q ss_pred ccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
+.....+..-|...+|.+|++. +++++|||
T Consensus 225 ---s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 225 ---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred ---CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence 1122334455556678889875 78999987
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=313.76 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=190.3
Q ss_pred eeeeeeecceEEEEEEEcC--CCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
+.+||+|+||.||+|++.. ++..||+|.+.... ....+|+++++.++|+||+++++++.. .....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence 4679999999999999654 56889999886543 234679999999999999999998854 2334578999999
Q ss_pred cchHHHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec---CCCCcEEEEeeccccc
Q 019506 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (340)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~---~~~~~~kl~Dfg~a~~ 229 (340)
++++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 9988877653211 12358899999999999999999999 7999999999999993 2356899999999987
Q ss_pred cccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 019506 230 LVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVS 296 (340)
Q Consensus 230 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~~~~~~ 296 (340)
...... .....+|..|+|||++.+...++.++|||||||++|||+||++||..... ..++.++....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 643321 22346789999999997766689999999999999999999999975432 23334444433
Q ss_pred CCCchhhhh---------------cccc----------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 297 NIIYAKTIY---------------QGLF----------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~---------------~~~~----------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.+....+. .... .......+..-|...+|.+|||++|++.|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 322211110 0000 0011223455677888999999999999999
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=309.38 Aligned_cols=255 Identities=30% Similarity=0.539 Sum_probs=199.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|++|.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4889999999999999999999999999999886432 23457999999999999999999984 445688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+.... .+..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 999999988777665432 24678999999999999999999999 79999999999999995 8889999999987653
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh------
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI------ 304 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 304 (340)
.... .....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+....+....+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 2221 122356888999999876666789999999999999999999999988776666655543322211000
Q ss_pred --------------hcccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 --------------YQGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------------~~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.... .+.....+.+-|+..+|.+|||++++++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 00000 1112224666677778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=316.91 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=185.5
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHh-CCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||.||+|++..+|+.||+|.++... .....|..++.. ++|+||+++++++ .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999987532 122356666664 5899999999988 4555689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ +|...+.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||+++.....
T Consensus 76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence 99986 44444432 4678999999999999999999999 79999999999999995 788999999998753222
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.. ........ .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~------~~~ 221 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-DTPHYPRW------ITK 221 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCC------CCH
Confidence 223345689999999999654 589999999999999999999999988776555544433 22222111 122
Q ss_pred ChhhHhhhcccccccCCCCc-CcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSM-HESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~-~~i~~hpf 340 (340)
....+.+.|+..+|.+|+++ +++++|||
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 23445566667788899998 58999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=307.08 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=202.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChH-------HHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|...++||+|.||+|.+++.+.+|+.+|+|+++++.-..+ .|-++|+..+||.+..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 45678889999999999999999999999999999887643332 467799999999999998888 667
Q ss_pred eeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.++|+||||..|+ |+-.| +..+.+++..++.+..+|+.||.|||+ ++||+||||.+|.|+|. ++.+||+|||+
T Consensus 241 drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGL 314 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGL 314 (516)
T ss_pred ceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeeccc
Confidence 7799999999975 33333 336789999999999999999999999 89999999999999995 88999999999
Q ss_pred ccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc------CCC
Q 019506 227 AKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS------NII 299 (340)
Q Consensus 227 a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------~~~ 299 (340)
++.-. .+....+++||+.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+..|+... -.+
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP 393 (516)
T ss_pred chhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH
Confidence 98643 4455567899999999999965 559999999999999999999999999888766666555321 234
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.++.++.+++.++|.+|+.- .--+++||..|+|
T Consensus 394 eAktLLsGLL~kdP~kRLGg--------GpdDakEi~~h~F 426 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGG--------GPDDAKEIMRHRF 426 (516)
T ss_pred HHHHHHHHHhhcChHhhcCC--------CchhHHHHHhhhh
Confidence 57888888888888876552 2345667777765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.51 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=187.8
Q ss_pred eeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+.||+|+||.||++++. .+++.||+|++.... ....+|+.+++.++||||++++++| .....+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 478899999886431 1234689999999999999999988 3445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCeec
Confidence 99999997 45444433 4568889999999999999999999 79999999999999995 889999999998754
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... .......|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+.+... ..+..
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~------ 222 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPY------ 222 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCC------
Confidence 322 223345689999999999654 478999999999999999999999998887666666654321 11111
Q ss_pred ccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.......+...|+..+|.+|+ +++++++|||
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 122234555666667788999 8999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.91 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=202.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
....+|.+.+.||+|+||+||+|++..++..||+|.+.... ..+.+|+.+++.++|||||+++++|+.. ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 34458999999999999999999999999999999886431 2345799999999999999999988642 33
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCceecCCCCCCeEecCC-----
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------PGVCHRDVKPQNLLVDPL----- 215 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~iiH~dlkp~Nill~~~----- 215 (340)
..+||||||+++ +|.+.+.........+++..++.|+.||+.||.|||+. ++||||||||+||||+..
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 458899999985 77777765544456799999999999999999999982 249999999999999631
Q ss_pred -----------CCcEEEEeeccccccccCCccceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 216 -----------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 216 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
...+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|+||..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999999876544444456789999999998643 34789999999999999999999999877
Q ss_pred ChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 284 NAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+....+...+......... ........+...|+..+|.+||++.|++.|||
T Consensus 247 ~~~~qli~~lk~~p~lpi~------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPIK------GKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcHHHHHHHHhcCCCCCcC------CCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 7666655555432211111 01223445666677778999999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=307.39 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=207.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCC--C----ceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDH--P----NVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~ 146 (340)
..+|.+.+.||+|.||+|-.+.+..++..||||+++.-. ....-|++++.++.+ | -+|.+.++| .-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 568999999999999999999999999999999887543 334468999998842 2 366777777 66
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC------------
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------ 214 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~------------ 214 (340)
..++|||+|.++.++++.+.. +...+++...++.|+.|+++++++||+ .+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 777999999999999998875 334689999999999999999999999 69999999999999832
Q ss_pred -------CCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 019506 215 -------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (340)
Q Consensus 215 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (340)
.+..|+|+|||.|+.. .......+.|..|.|||++++-+ ++..+||||+||||+|++||...|++.++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1235999999999875 34446778899999999998865 9999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCchhhhhccc------------------------------------cccC----ChhhHhhhccccccc
Q 019506 288 QLVEIIKVSNIIYAKTIYQGL------------------------------------FCSN----NHEIMCELGSWYSYS 327 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~----~~~~~~~l~~~~~~~ 327 (340)
.+..+.+..+... ..++... .+.+ +...+.+-++.++|.
T Consensus 317 HLaMMerIlGp~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 HLAMMERILGPIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHhhCCCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 9988888877433 2222222 1111 244566677888999
Q ss_pred CCCCcCcccccCC
Q 019506 328 GRNSMHESKLYGF 340 (340)
Q Consensus 328 ~R~~~~~i~~hpf 340 (340)
+|+|+.|++.|||
T Consensus 396 ~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 396 RRITLREALSHPF 408 (415)
T ss_pred ccccHHHHhcCHH
Confidence 9999999999998
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=308.49 Aligned_cols=251 Identities=32% Similarity=0.477 Sum_probs=197.7
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh------HHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++++.||+|+||+||++++..+++.||+|.+....... .+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 789999999999999999999999999999987553221 248899999999999999999843 555889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc-
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL- 230 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~- 230 (340)
|||++.+ ++.+.+. ....+++..+..++.||+.||++||+ +||+|+||||+||+++ .++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEES-TTSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccc-ccccccccccccccccc
Confidence 9999998 7777666 24778999999999999999999999 7999999999999999 4889999999999753
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........++..|+|||++.....++.++||||||+++|+|++|..||......+....+.+................
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK 229 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence 22333334567889999999863456899999999999999999999999987544444444443332222111111001
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+||+++++++|||
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred HHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 123445556666777899999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=348.09 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=202.3
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.++++||+|+||.|.+++++.+++.||+|++.+- ...+..|-.+|..-+.+-|+.++..| ++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD 146 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QD 146 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cC
Confidence 3456899999999999999999999999999999988652 23456788889888999999999998 88
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++|+||||++| +|..++.. ..++++.+++.|+..|+.||+-||++ |+|||||||+|||+|. .|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccch
Confidence 8899999999997 45555544 24899999999999999999999995 9999999999999995 8899999999
Q ss_pred cccccccCC-c-cceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 019506 226 SAKVLVKGE-A-NISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI- 298 (340)
Q Consensus 226 ~a~~~~~~~-~-~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 298 (340)
.|-.+..+. . ....+|||.|.+||++. +.+.|+..+|+||+||++|||+.|..||..++-.+.+.+|+.+...
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence 997775333 2 23468999999999995 2256899999999999999999999999999999999999876321
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCC---cCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS---MHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~---~~~i~~hpf 340 (340)
.++.+. . .+..-.+.+..+.. ++..|+. +++|++|||
T Consensus 301 ~FP~~~-~--VSeeakdLI~~ll~--~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 301 SFPDET-D--VSEEAKDLIEALLC--DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred CCCccc-c--cCHHHHHHHHHHhc--ChhhhcccccHHHHHhCcc
Confidence 122111 0 22233333333332 2455665 999999999
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=315.23 Aligned_cols=239 Identities=28% Similarity=0.437 Sum_probs=183.4
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHh-CCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||+|+++.+.. ....|..++.. .+||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 369999999999999999999999999875421 12245555554 5899999999888 4455689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|...+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence 99986 44444432 4578999999999999999999999 79999999999999995 788999999999764332
Q ss_pred C-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... ....+.. ...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~------~~~ 221 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRW------ISK 221 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCC------CCH
Confidence 2 23345689999999999654 4899999999999999999999999988876666555432 1111111 111
Q ss_pred ChhhHhhhcccccccCCCCcC-cccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMH-ESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~-~i~~hpf 340 (340)
....+...|+..+|.+|+++. ++++|||
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 223444555666788999875 7889998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.25 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=181.9
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||+|++++.. ....+|+.++..+ +||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999987532 1234577777665 899999999988 4445689999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (340)
||++++ |...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence 999974 433333 24679999999999999999999999 79999999999999995 78899999999875322
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHhcCCCchhhh
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------NAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~ 304 (340)
........||..|+|||++.+ ..++.++|||||||++|+|++|+.||... .....+.+.+.......+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~- 227 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS- 227 (329)
T ss_pred CCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC-
Confidence 223334578999999999965 45899999999999999999999999521 12233333333322222111
Q ss_pred hccccccCChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
.+.....+.+-|+..+|.+|+++ +++++|||
T Consensus 228 -----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 228 -----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred -----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 11222345555666678899984 69999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=318.02 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=189.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.++||+|+||.||++++..+++.+|+|++.+.. ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 6999999999999999999999999999999885421 2245688889999999999999988 455568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhee
Confidence 999999985 55555543 23578999999999999999999999 79999999999999995 88899999999876
Q ss_pred cccCCcc--ceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-Cchh
Q 019506 230 LVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI-IYAK 302 (340)
Q Consensus 230 ~~~~~~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~ 302 (340)
....... ....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+...... ..+.
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 231 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA 231 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC
Confidence 5333221 23468999999999852 345789999999999999999999999988877777766543211 1110
Q ss_pred hhhccccccCChhhHhhhcc-cccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGS-WYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~-~~~~~~R~~~~~i~~hpf 340 (340)
. ... ......+.+.++.. ..+...|++++|++.|||
T Consensus 232 ~-~~~-~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 232 Q-VTD-VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred c-ccc-CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0 000 01111122222111 112345789999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=308.65 Aligned_cols=253 Identities=32% Similarity=0.521 Sum_probs=197.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+++++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4889999999999999999999999999999886431 2345799999999999999999988 4455689
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|+||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence 9999999987776553 24568999999999999999999999 79999999999999995 7889999999997654
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
.... .....++..|+|||++.+...++.++|||||||++|+|+||..| |.+.+..+.+..+.+....+....+
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 3322 22345688899999987766679999999999999999999877 4555556666666554332221100
Q ss_pred ---------h------cccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------Y------QGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------~------~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .... .+.....+.+.|+..+|.+|||+++++.|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0 0000 1112234666677778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=313.54 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=206.4
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
.+.....|+.-++||+|+||.||-++...||+.+|+|.+.+.+. ....|..+|.+++.+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 34455678999999999999999999999999999998855432 223688899999999999998888
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+....+|+||..|.|+-+..- -+...+..|++..++.++.+|+.||++||+ .+||+|||||+|||+|. .|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfH-iyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFH-IYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEE-eeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeecc
Confidence 555569999999998733211 122334689999999999999999999999 79999999999999995 889999999
Q ss_pred ccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcC----
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVSN---- 297 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~---- 297 (340)
|+|..+..+......+||.+|||||++.+.. |+...|+|||||+||||+.|+.||...... +.+.+.+....
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence 9999999999888889999999999996655 999999999999999999999999865432 23333333322
Q ss_pred ---CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 298 ---IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 298 ---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+..+++++.+++++|.+|+.. +.-++++++.|||
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc--------rg~ga~evk~Hpf 448 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC--------RGEGAQEVKEHPF 448 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC--------CCcCcchhhhCcc
Confidence 2346778888888888876663 3358889999997
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=309.57 Aligned_cols=245 Identities=25% Similarity=0.300 Sum_probs=184.8
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||+||++.+..+++.||+|.+.... .....|+++++.++|+||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999886432 1234689999999999999998888 4445688999999
Q ss_pred cch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
+++ |...+......+..+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence 864 444443333345679999999999999999999999 79999999999999995 788999999999765443322
Q ss_pred -ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChh
Q 019506 237 -ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHE 315 (340)
Q Consensus 237 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (340)
....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.+..... ...+. . -.+....
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-~-~~~~~~~ 229 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYP-D-KFSPASK 229 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCc-c-cCCHHHH
Confidence 234678999999999654 58999999999999999999999998654322222222111100 00000 0 0112234
Q ss_pred hHhhhcccccccCCC-----CcCcccccCC
Q 019506 316 IMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 316 ~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+...|+..+|.+|+ +++++++|||
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 455566667788999 6788999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=324.31 Aligned_cols=234 Identities=26% Similarity=0.432 Sum_probs=194.9
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeecccc-ch
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ET 160 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 160 (340)
.+-||.|+.|.||+|+. .++.||||+++. ..+.+|.-|++|+|+||+.+.|+| ....++|||||||. |-
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 35699999999999987 788999997654 334588899999999999999999 66777999999999 45
Q ss_pred HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccceee
Q 019506 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240 (340)
Q Consensus 161 l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 240 (340)
|...|+. .+.+.......|..+|+.|+.|||. +.|||||||.-|||+.. +..|||+|||.++...+......+.
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhhhh
Confidence 6666654 5788888899999999999999999 69999999999999995 8889999999999988887788899
Q ss_pred eeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCchhhhhccccccCChhhHhh
Q 019506 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VSNIIYAKTIYQGLFCSNNHEIMCE 319 (340)
Q Consensus 241 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (340)
||..|||||++.+ ...+.|+|||||||+|||||||..||.+-+...++--+=. .+..+.+ --|.+-+..+.+
T Consensus 273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP------stcP~GfklL~K 345 (904)
T KOG4721|consen 273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP------STCPDGFKLLLK 345 (904)
T ss_pred hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc------ccCchHHHHHHH
Confidence 9999999999965 5589999999999999999999999987655433221111 1111222 135666788888
Q ss_pred hcccccccCCCCcCccccc
Q 019506 320 LGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 320 l~~~~~~~~R~~~~~i~~h 338 (340)
+|+.-.|..||+|.+|+.|
T Consensus 346 qcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHhcCCCCCccHHHHHHH
Confidence 8888889999999999987
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=321.54 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=195.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc--CCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+++++.++|+||+++++++ .....+|+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence 347999999999999999999754 35678999987654 3456899999999999999999988 445568899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||++.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++......
T Consensus 165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCcc
Confidence 99999888777632 4678999999999999999999999 79999999999999995 788999999999765433
Q ss_pred Cc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCchh-----
Q 019506 234 EA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIYAK----- 302 (340)
Q Consensus 234 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~----- 302 (340)
.. .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ....+..+++..+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 224568999999999965 448999999999999999999999997653 345555555543321110
Q ss_pred ----------------------hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 ----------------------TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ----------------------~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+++.........+...|+..+|.+||++.|++.|||
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00000000112223445666778999999999999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=319.85 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=181.3
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHH-HHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+|+.||+|++.+... ...+|.. +++.++||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 369999999999999999999999998864321 1123333 57789999999999888 4445688999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (340)
||+.++ +...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence 999974 444433 24678999999999999999999999 79999999999999995 78899999999875422
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..... .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~------~~~ 221 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPG------ASL 221 (325)
T ss_pred CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCC------CCH
Confidence 223334578999999999965 4489999999999999999999999998877666665554221 11111 111
Q ss_pred ChhhHhhhcccccccCCCCc----CcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSM----HESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~----~~i~~hpf 340 (340)
....+.+-+...+|.+||++ +++++|||
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~ 253 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEHPF 253 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcCCC
Confidence 12233344444556677766 48999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.56 Aligned_cols=239 Identities=27% Similarity=0.406 Sum_probs=183.7
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHH-HHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+|+.||+|++..... ....|.. +++.++||||+++++++ .+....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 369999999999999999999999999864321 1122333 56789999999999888 4445688999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ +|...+.. +..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence 99997 44444432 4678999999999999999999999 79999999999999995 888999999998754322
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..... ..... + ..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~-----~-~~ 221 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPN-----I-SV 221 (323)
T ss_pred CCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCC-----C-CH
Confidence 22334568999999999965 4589999999999999999999999998877666666554221 11111 1 22
Q ss_pred ChhhHhhhcccccccCCCCc----CcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSM----HESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~----~~i~~hpf 340 (340)
....+.+-|+..+|.+|+++ +|+++|||
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 23344555566677888887 58999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.20 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=188.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|.+.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 36999999999999999999999999999999886421 2234678889999999999999988 45566
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.|+||||+.+ +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence 8999999986 55555543 23578999999999999999999999 79999999999999995 7889999999997
Q ss_pred ccccCCcc--ceeeeeccccCcccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 229 VLVKGEAN--ISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 229 ~~~~~~~~--~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
........ ....|++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 66433322 224689999999998542 347889999999999999999999999887777666665432211111
Q ss_pred hhhccccccCChhhHhhhcccccc--cCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSY--SGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~--~~R~~~~~i~~hpf 340 (340)
..+.. +...-.+.+.+++ ...+ ..|++++++++|||
T Consensus 231 ~~~~~-~~~~~~~li~~ll-~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 231 SHITD-VSEEAKDLIQRLI-CSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred Ccccc-CCHHHHHHHHHHc-cCchhhcCCCCHHHHhcCCC
Confidence 11100 0111122222221 1122 22678999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=313.30 Aligned_cols=239 Identities=28% Similarity=0.454 Sum_probs=184.3
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHh-CCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||+|.+.... .....|..+++. ++||||+++++++ .+...+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999887542 122346667765 5899999999988 4445588999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|...+.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence 99986 55544432 3578999999999999999999999 79999999999999995 788999999998754222
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.. .....+.. .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~~~~------~~~ 221 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-DNPCYPRW------LTR 221 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCcc------CCH
Confidence 223345689999999999654 489999999999999999999999988876655555433 22221111 112
Q ss_pred ChhhHhhhcccccccCCCCcC-cccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMH-ESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~-~i~~hpf 340 (340)
....+..-|...+|.+|+++. ++++|||
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 223344455566788999996 8999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.10 Aligned_cols=239 Identities=28% Similarity=0.440 Sum_probs=187.8
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||||++++.. ....+|..+++.+ +|+||+++++++ .+...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999987532 2234677788777 699999999988 4455689999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (340)
||++++ |...+.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence 999864 4444332 4579999999999999999999999 79999999999999995 88899999999875322
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+.. .....+.. ...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-~~~~~~~~------~~~ 221 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-DEVRYPRW------LSK 221 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCc------CCH
Confidence 2223345689999999999654 589999999999999999999999988776555554443 22222111 122
Q ss_pred ChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
....+.+.|+..+|.+||++ .+++.|||
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence 33455666777789999999 99999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.98 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=203.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC-CCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+. |+||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6999999999999999999999999999999876432 23457999999995 6999999998855443334457
Q ss_pred eeeeccccchHHHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999888777653332 3568999999999999999999999 79999999999999996578999999999876
Q ss_pred cccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh---
Q 019506 230 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY--- 305 (340)
Q Consensus 230 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 305 (340)
...... .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+.+..+.+....+....+-
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 532211 1223567889999998765667999999999999999999999999888877777776644332211110
Q ss_pred ----------------cccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ----------------QGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ----------------~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... .......+...|+..+|.+||+++|++.|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0000 1112334556667778999999999999999
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=315.22 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=182.1
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++.++ +|+||+.+++++ .+...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999987532 1234677887777 699999999988 4455689999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc-c
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 232 (340)
||++++ |...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.... .
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence 999864 4444432 4679999999999999999999999 79999999999999995 7889999999987532 2
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHhcCCCchhhhhc
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE------NAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+.+.+.+.......+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--- 225 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--- 225 (327)
T ss_pred CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC---
Confidence 233344678999999999965 45899999999999999999999999532 23334444443332222111
Q ss_pred cccccCChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
+ +.....+..-++..+|.+|+++ ++|++|||
T Consensus 226 --~-~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 226 --L-SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred --C-CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 1 1112334444555677888874 69999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.20 Aligned_cols=239 Identities=25% Similarity=0.391 Sum_probs=182.8
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHH-HHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||+||+|++..+++.||+|++.+... ....| ..+++.++|+||+++++++ .....+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11123 3356789999999999888 4445688999
Q ss_pred ccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||++++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence 999974 4444432 4678899999999999999999999 79999999999999995 788999999998754322
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..... ...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~------~~~ 221 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPN------ITN 221 (325)
T ss_pred CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCC------CCH
Confidence 22334578999999999965 4589999999999999999999999998887766666554321 11111 112
Q ss_pred ChhhHhhhcccccccCCCCcC----cccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMH----ESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~----~i~~hpf 340 (340)
....+.+-+...+|.+|+++. ++++|+|
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 223344455556677888876 7889987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=320.64 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=206.2
Q ss_pred CCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 71 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
........|.+.+.||+|.|++|.+|++..++..||+|.+.+.... ..+|+++|+.++|||||+++.+.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~----- 124 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI----- 124 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 3445566799999999999999999999999999999999765322 45899999999999999999998
Q ss_pred CCceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
.....+|+||||+.++ +++.+. .++++.+..++.++.|+++|++|||+ ++|+|||||.+|||++. +..+||+|
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaD 198 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIAD 198 (596)
T ss_pred eecceeEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeec
Confidence 4445599999999864 444444 46778889999999999999999999 89999999999999995 77799999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCchh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS-NIIYAK 302 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~ 302 (340)
||++..+..+....+++|++.|.|||++.+..+.++++|+||+|++||.|+.|..||.+.+-.+.-.+.+... .+++
T Consensus 199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-- 276 (596)
T KOG0586|consen 199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-- 276 (596)
T ss_pred cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--
Confidence 9999999888888899999999999999988888999999999999999999999999887644433333211 1221
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+..+..+.+ +-.+..+|.+|+++++|..|.|
T Consensus 277 -----~ms~dce~lL-rk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 277 -----YMSCDCEDLL-RKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred -----eeechhHHHH-HHhhccCccccCCHHHhhhhcc
Confidence 2222333222 2234457889999999999998
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=271.71 Aligned_cols=252 Identities=32% Similarity=0.555 Sum_probs=208.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.-.++||+|.||+||+|++..+++.||+|.++.+... ..+|+-+++.++|.|||+++++. .....+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 466678899999999999999999999999998754322 35899999999999999999987 4444477
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|+|||...+...+. +.++.++.+.++.++.|+++||.++|+ +++.||||||.|.|++. ++.+|++|||+++.+.
T Consensus 78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcC
Confidence 999999987665554 457889999999999999999999999 79999999999999995 9999999999999875
Q ss_pred cCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 232 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 232 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
-.-.. ...+-|.+|.+|.++.+..-|+...|+||.|||+.|+.. |++.|++.+..+++.+|.+..+.+....+
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 44322 234669999999999999889999999999999999996 88999999999999999998887643221
Q ss_pred ---------------hcccc---ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------------YQGLF---CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------------~~~~~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
|.++. .+--.+ +.+-...|+|..|.+++..+.|||
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grd-llqkll~cnp~qrisaeaalqhpy 285 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRD-LLQKLLKCNPAQRISAEAALQHPY 285 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHH-HHHHHhccCcccccCHHHHhcCcc
Confidence 11111 111122 334455678999999999999997
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.81 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=197.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..+|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999886432 1235799999999999999999988 344468
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+.+++...+.. ....+++..++.++.|++.||.|||+ .||+|+||||+||+++. ++.++|+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence 89999999887766543 23467888899999999999999999 79999999999999995 888999999998764
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCch-------
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYA------- 301 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~------- 301 (340)
.... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+. .+.+.++......+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3222 122345688899999987655678899999999999999999999976543 3444444332222211
Q ss_pred ------------------hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 ------------------KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ------------------~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+..+........+...|...+|.+|||++|++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 111112222233445667777888999999999999999
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=312.93 Aligned_cols=244 Identities=29% Similarity=0.428 Sum_probs=187.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCC-CCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+|...+.||+|+||.||+|++..+|+.||+|++.+.. .....|..+++.+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3778899999999999999999999999999887532 12335777887776 56777888877 44456
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|+||||+++ +|...+. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence 8899999986 4444443 24679999999999999999999999 79999999999999995 8889999999987
Q ss_pred ccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.... ...+..+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~--- 224 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSL--- 224 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccC---
Confidence 643222 2234568999999999965 458999999999999999999999999887766666665532 2222111
Q ss_pred ccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
+.....+..-|+..+|.+|++. ++++.|||
T Consensus 225 ---~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 225 ---SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred ---CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence 1122334444556668888874 67999988
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.57 Aligned_cols=258 Identities=31% Similarity=0.564 Sum_probs=201.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|.+.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++..........+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357999999999999999999999999999999886321 223468999999999999999998755443444568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|+||+++++.+.+. ...+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceeec
Confidence 8999999987766554 3579999999999999999999999 79999999999999995 888999999998765
Q ss_pred ccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh--
Q 019506 231 VKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI-- 304 (340)
Q Consensus 231 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (340)
...... ....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+......+...++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 22467889999999866556899999999999999999999999887766666665554443322111
Q ss_pred ---------hcc-----------cc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------YQG-----------LF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------~~~-----------~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. +. .+.....+...|+..+|.+|||+.|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000 00 0122334556666778999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=316.09 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=187.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
..++|++.++||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 3457999999999999999999752 345789999886432 2345799999999 89999999998742
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc----------------------------------------------------
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (340)
....+++||||+++ +|.+.+.....
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 23347899999996 55555543211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeee
Q 019506 171 ------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYIC 241 (340)
Q Consensus 171 ------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~ 241 (340)
....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++........ ....+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCC
Confidence 02357888899999999999999999 79999999999999995 788999999999765332211 12234
Q ss_pred eccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhh
Q 019506 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCEL 320 (340)
Q Consensus 242 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 320 (340)
+..|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...++......... .+......+..-
T Consensus 239 ~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~ 312 (338)
T cd05102 239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE-----NATPEIYRIMLA 312 (338)
T ss_pred CccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHH
Confidence 6789999999654 48999999999999999997 9999988665555555554433222111 122234556666
Q ss_pred cccccccCCCCcCcccc
Q 019506 321 GSWYSYSGRNSMHESKL 337 (340)
Q Consensus 321 ~~~~~~~~R~~~~~i~~ 337 (340)
|+..+|.+|||+.|+..
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 77778999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=314.38 Aligned_cols=239 Identities=26% Similarity=0.373 Sum_probs=181.1
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHH-HHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++||+|+||.||+|++..+++.||+|++.+... ...+|. .+++.++|+||+++++++ .+....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 369999999999999999999999998864321 112333 367889999999999888 4455688999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc-
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (340)
||+++ ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence 99996 44444432 4678999999999999999999999 79999999999999995 88899999999875322
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.... ...... ...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~------~~~ 221 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGG------KTV 221 (321)
T ss_pred CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCC------CCH
Confidence 222334568999999999965 458999999999999999999999999887655555554321 111111 111
Q ss_pred ChhhHhhhcccccccCCCCcC----cccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMH----ESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~----~i~~hpf 340 (340)
....+...|+..+|.+|++.. ++++|||
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 223344455555677887654 8999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=303.34 Aligned_cols=251 Identities=34% Similarity=0.613 Sum_probs=198.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ ......+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 6999999999999999999999899999999886432 2235799999999999999999988 4445588
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||++++++..+.. ....+++..++.++.|++.+|.|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceecC
Confidence 9999999876655532 24568999999999999999999999 79999999999999995 7889999999998764
Q ss_pred cCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh--------
Q 019506 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK-------- 302 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 302 (340)
... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+........
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 443 22234567889999998765668899999999999999999999999888777766665433211000
Q ss_pred ------------------hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 ------------------TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ------------------~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.. + ......+...|+..+|.+||+++|++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPN-I-SSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred cccccccCCCcccccCHHHHhcc-C-CHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 00000 0 122334556677778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.27 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=184.1
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||.||++++..+|+.||+|.+.... .....|+++++.++||||+++++++ .+....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999886421 1224589999999999999999888 4455689999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ ++...+.. .....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence 86 44444432 223458889999999999999999999 79999999999999995 888999999999876554444
Q ss_pred ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhh
Q 019506 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEI 316 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (340)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+.+............ ..+.....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 228 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ--NFTEESKD 228 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc--cCCHHHHH
Confidence 4456789999999996655 89999999999999999999999976543222122222111000000000 01223455
Q ss_pred HhhhcccccccCCCCc----CcccccCC
Q 019506 317 MCELGSWYSYSGRNSM----HESKLYGF 340 (340)
Q Consensus 317 ~~~l~~~~~~~~R~~~----~~i~~hpf 340 (340)
+...|+..+|.+||++ ++++.|||
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~~~~h~~ 256 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDDPRKHEF 256 (277)
T ss_pred HHHHHhccCHhhCCCCccchhhhhcChh
Confidence 5666777789999999 66778988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.25 Aligned_cols=258 Identities=32% Similarity=0.509 Sum_probs=203.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
...+|.+.+.||+|+||.||+|.+..+|+.||+|.+..+. ....+|+.++++++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 3457999999999999999999999999999999886432 1234799999999999999999988532 223
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++||||+++++.+.+... ...+++..++.++.||+.||.|||+ .|++||||||+||+++. ++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~ 156 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLAR 156 (309)
T ss_pred eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceee
Confidence 47899999998877776542 3578999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh---
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI--- 304 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 304 (340)
....... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 7644322 222345778999999876666899999999999999999999999998888888877775544322110
Q ss_pred ------------------hcccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------------------YQGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------------------~~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+ .+.....+...|...+|.+|||++|++.|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000 0111233556666778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=320.22 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=203.9
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
|.-.+.||.|+||.||-|++..+.+.||||++.-.. .+..+|++.|++++|||++.+.+||.-.. ..|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence 666788999999999999999999999999986332 23347999999999999999999995432 267
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||||-|+-.+.+.-. ..++.+.++..|+.+.+.||.|||+ .+.||||||..|||++. .+.|||+|||.|....
T Consensus 103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhcC
Confidence 99999999877776643 3788999999999999999999999 69999999999999995 8999999999998763
Q ss_pred cCCccceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 232 KGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...+++|||+|||||+++ ..+.|+-++|||||||+..||...++|+-..+....++.|..+.-+.....-|...
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~- 253 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY- 253 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH-
Confidence 344679999999999996 34569999999999999999999999999999999999988755433322222222
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+-.+.+.|+..-|.+|||.++++.|+|
T Consensus 254 ----F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 254 ----FRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred ----HHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 244566777777999999999999998
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.28 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=188.4
Q ss_pred eeeeeecceEEEEEEEc---CCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
+.||+|+||.||++++. .+|+.||+|++.... ....+|++++++++|+||+++++++ .+....|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 57999999999999863 578999999986432 2234689999999999999999988 444568899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccCC
Confidence 999985 55554432 4578999999999999999999999 79999999999999995 78899999999976544
Q ss_pred C-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 G-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+... ..+.. ..
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~~p~~------~~ 222 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQF------LS 222 (318)
T ss_pred CCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-CCCCC------CC
Confidence 3 22334568999999999965 4478999999999999999999999998877666666554321 11111 12
Q ss_pred CChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.....+.+.|+..+|.+|++ ++++++|||
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 22345566677778889999 555999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.47 Aligned_cols=239 Identities=25% Similarity=0.399 Sum_probs=182.3
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHHHHhC---CCCceeecceeeeecCCCCceeeeeee
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLM---DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
||+|+||+||+|++..+++.||||++.+.... ...|..++... +||||+++++++ .+...+++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 69999999999999999999999998643211 12355555544 699999999988 4455689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99986 44444432 5679999999999999999999999 79999999999999995 788999999998764332
Q ss_pred -CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.......||..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+... ........ .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~-----~~~ 223 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPKNV-----LSD 223 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCCCcc-----CCH
Confidence 22334578999999999976556899999999999999999999999887765555544432 22211111 112
Q ss_pred ChhhHhhhcccccccCCC----CcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRN----SMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~----~~~~i~~hpf 340 (340)
....+..-|+..+|.+|+ +++++++|||
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 223344555556677887 7899999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.56 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=191.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++|+||++++++|. +...++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEEE
Confidence 57999999999999999999999999999999876542 23457999999999999999999984 344688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++. ++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchhh
Confidence 99999986 55555543 4568899999999999999999997237999999999999985 788999999999765
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--C---------
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI--I--------- 299 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~--------- 299 (340)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ..+...... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCccc
Confidence 332 2223467899999999965 4589999999999999999999999986554322 222110000 0
Q ss_pred ------------c------hhhhhccc-------c----ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 ------------Y------AKTIYQGL-------F----CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ------------~------~~~~~~~~-------~----~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ...+.... + .......+..-|+..+|.+|||++|++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0 00000000 0 0112345677788888999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.21 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=194.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHH-HHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||++++..+|+.||+|.++.... ....|+. .++.++|+||+++++++. .....+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 68999999999999999999999999999998865422 1223444 467789999999999884 334488
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|||+++++.+.+.........+++..++.++.|++.||+|||+ + +++||||||+||+++. ++.+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeeccccccc
Confidence 999999998888777655555789999999999999999999998 6 9999999999999995 888999999999876
Q ss_pred ccCCccceeeeeccccCcccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCchhhhhc
Q 019506 231 VKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||... +..+.+..+............
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK-- 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc--
Confidence 443333335678889999998542 33688999999999999999999999753 334444444432222111110
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|...+|..||++++++.|||
T Consensus 233 ---~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 233 ---FSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred ---cCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 1122344556677778999999999999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.03 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=191.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+.+++.+ .+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 3778899999999999999999999999999886432 1234689999999999999999888 444568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence 999999986 45554433 223468999999999999999999999 79999999999999995 78899999999976
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 306 (340)
...........|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.... +....+.+.......
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS----- 225 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC-----
Confidence 6444433445789999999999654 4899999999999999999999999865432 222222221111111
Q ss_pred cccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.. .......+.+.|+..+|.+|+| ++|+++|||
T Consensus 226 ~~-~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 226 EK-FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred cc-CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 11 1222345556677778999999 889999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.09 Aligned_cols=256 Identities=31% Similarity=0.516 Sum_probs=202.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
..+|++.+.||+|+||.||+|++..+|+.||+|.+.+.. ....+|+.++++++|+||++++++|..... .+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 357999999999999999999999999999999886431 123469999999999999999998854322 2234
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..|+||||+.+++.+.+.. .+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccce
Confidence 5789999999987776642 38889999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh-----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT----- 303 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 303 (340)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+++....+...-
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 7654444344567889999999965 4589999999999999999999999998887777777766554432110
Q ss_pred -----h-----------hcccc---------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 -----I-----------YQGLF---------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 -----~-----------~~~~~---------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+ +...+ .......+..-|+..+|.+||+++|+++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 0 00000 0011234566667778999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=302.09 Aligned_cols=253 Identities=37% Similarity=0.621 Sum_probs=203.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999886543 2345789999999999999999988 4455688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+... ...+++..++.++.||+.||+|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence 99999976777766532 3678999999999999999999999 79999999999999995 8889999999998765
Q ss_pred cCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 232 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
.... .....++..|+|||.+.+...++.++|||||||++|+|++|.++|.+.+....+..++.....+....+
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4432 233467889999999876666789999999999999999999999988887877777765544322111
Q ss_pred ----------------hccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ----------------YQGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ----------------~~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+. ......+.+.|...+|.+||++++++.|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 011111 122234556666778999999999999999
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.38 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=193.7
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+.+++++ ......+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 778899999999999999999999999999886432 2235699999999999999998888 4445689
Q ss_pred eeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+.++ +...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCcceec
Confidence 999999975 4434332 223579999999999999999999999 79999999999999995 788999999999765
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+.+...... ..+... .
T Consensus 153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~ 228 (285)
T cd05632 153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-EVYSAK--F 228 (285)
T ss_pred CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-cccCcc--C
Confidence 444443445789999999999654 589999999999999999999999987766544444433221111 111111 1
Q ss_pred cCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
......+.+.|+..+|.+|++ +++++.|+|
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 122345566677778999999 779999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=301.94 Aligned_cols=254 Identities=31% Similarity=0.567 Sum_probs=199.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||.|++|.||+|++..+|+.||||.+..+. ....+|++++++++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4889999999999999999999999999999886432 2345799999999999999999988 4445688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+.+++...+.. .....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence 9999998877666643 224578999999999999999999999 79999999999999995 8889999999987654
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh------
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI------ 304 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 304 (340)
.... .....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+.++.+....+....+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3322 122345788999999876665788999999999999999999999988877777777665544321100
Q ss_pred --------------hccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 --------------YQGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------------~~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..... ......+..-|...+|.+||++++++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 000000 011123455566668999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=316.27 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=200.8
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
.++||+|.||+||-|+++.+|+.||||++.+.+ .....|+++|+.+.||.||.+--.| +....+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 378999999999999999999999999986532 3445799999999999999987766 44455889999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC--CcEEEEeeccccccccC
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~--~~~kl~Dfg~a~~~~~~ 233 (340)
-+.|++++.+.. +..+++++...+.+..||+.||.|||. +||+|+||||+|||+.+.+ -++||||||+|+.+...
T Consensus 644 Kl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 644 KLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999998887764 456899999999999999999999999 7999999999999997533 37999999999999988
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
....+.+||+.|+|||++++.+ |...-|+||.|||+|--|.|..||..+ +.+...+++-...++.+=|+.. ...-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~PW~ei-s~~A 795 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNPWSEI-SPEA 795 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCchhhc-CHHH
Confidence 8888999999999999997655 899999999999999999999999644 4455555555555544444432 2333
Q ss_pred hhhHhhhcccccccCCCCcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.+..|... ...+|.+.+.-++|||
T Consensus 796 idlIn~LLqV-km~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 796 IDLINNLLQV-KMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHHHHH-HHHHhcchHhhccchh
Confidence 3444444333 3668999999999999
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=299.37 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=194.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|++++++++|+||+++++++ .+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 5899999999999999999999999999999876432 2245689999999999999999998 4444
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++|+||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ .||+||||+|+||+++. ++.++|+|||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~~ 151 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGAS 151 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence 68999999986 55555543 3568899999999999999999999 79999999999999995 888999999998
Q ss_pred cccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
......... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc
Confidence 765332221 2235678899999997644 89999999999999999999999987766555555443322221111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+..-|+..+|.+|||++|++.|||
T Consensus 231 -----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 231 -----HVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -----cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 12233455666677778999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=301.10 Aligned_cols=255 Identities=31% Similarity=0.517 Sum_probs=197.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|++|.||+|++..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 357999999999999999999998899999999886432 2235799999999999999999988 445568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence 999999998877766532 3478999999999999999999999 79999999999999995 788999999998754
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCchhhh----
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~---- 304 (340)
..... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+..+.+....+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 32211 1223457889999998765668899999999999999999999998765 44555555444333221110
Q ss_pred ---------------------hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------------------YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------------------~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..+-.......+..-|+..+|.+||+++|++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000000012234555667778999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=295.09 Aligned_cols=261 Identities=24% Similarity=0.304 Sum_probs=205.4
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHH-HHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
+..++.+-...||.|+||+|++..++.+|+.+|||.++.... .+..|.+. ++.-+.||||+++|+.+..+.
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--- 137 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--- 137 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc---
Confidence 334455566779999999999999999999999999975432 22345554 555679999999999875443
Q ss_pred eeeeeeeccccchHHHHHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.|+.||+|.-++..+... +...+..++|..+..|....+.||.||.....|||||+||+|||++. .|.+||||||.
T Consensus 138 --cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 --CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGI 214 (361)
T ss_pred --eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccc
Confidence 679999999877665543 34456789999999999999999999997568999999999999995 88999999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
+..+.+.-..+.-.|...|||||.+..... |+.++|+||||++|||+.||..||.+-++.-....++-.+..|.+..-.
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 988877666666788999999999964443 8999999999999999999999999876532222233334444332222
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+-.+.++-++..+|+..+-+.||++++++.|||
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 22334556778889999999999999999999998
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=303.31 Aligned_cols=253 Identities=32% Similarity=0.561 Sum_probs=199.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC---------hHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... ...|+++++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 488899999999999999999989999999998754322 24689999999999999999998 4455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++||||+.+++.+.+... ...+++..++.++.||++||.|||+ +||+|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence 68899999976776666431 1368999999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc-
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ- 306 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (340)
....... .....++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++.+....+....+-.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 7644322 22334577899999986656688999999999999999999999988887777777665443332211100
Q ss_pred ------------------ccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 ------------------GLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ------------------~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+ .+.....+.+.|+..+|.+|||++|++.|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 000 0112234566677778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.11 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=189.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.......++..||+|.||+||+|+|.. .||||++..+ .+.+++|+.++++-+|.||+-+.|++. +.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NP 460 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CC
Confidence 334457788999999999999999854 5999988643 245678999999999999999999983 33
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.+ .||..+|+| +|+..+.. ....|.....+.|++||++|+.|||. ++|||||||..|||+.+ +++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccc
Confidence 33 699999998 55555442 34788999999999999999999999 89999999999999995 79999999999
Q ss_pred ccccccCC---ccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGE---ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+....... ......|...|||||+++. ...|++.+|||||||++|||+||..||...+.+.++..+=+....+..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 86543221 1223456788999999953 345899999999999999999999999955444433333332222333
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... ...|..-..++...|+.+++.+||.|-+|++
T Consensus 615 s~~--~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKI--RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhh--hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 222 1123334567777788888999999998875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=300.23 Aligned_cols=253 Identities=32% Similarity=0.534 Sum_probs=198.2
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++.+.||+|+||.||+|.+..+++.||+|.++.... ...+|+.+++++. |+||+++++++.+. .....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6788999999999999999999999999998875422 1235888888885 99999999988542 2245789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 999999887776653 23568999999999999999999999 79999999999999995 8899999999987655
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh--------
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI-------- 304 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 304 (340)
........++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444444567889999998766566789999999999999999999999988877776666654433222000
Q ss_pred ------------hcccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------------YQGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------------~~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..+. .+.....+..-|+..+|.+||++++++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00000 1122334455567777999999999999999
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=291.66 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=207.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..|++...||+|+||.||+|..+.++. .+|||.++.+.+. .-||+.+++.++|+|++.+..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 469999999999999999997665543 6899999765332 24899999999999999999998643
Q ss_pred ceeeeeeeccccchHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC---CCcEEEE
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLC 222 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~---~~~~kl~ 222 (340)
...+++++||.+.+|++.+..... ..+.++...++.|+.||+.|+.|||+ +-|+||||||.|||+..+ .|.|||+
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEee
Confidence 445899999999999999886543 33568889999999999999999999 789999999999999741 3899999
Q ss_pred eeccccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 019506 223 DFGSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQL 289 (340)
Q Consensus 223 Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---------~~~~~ 289 (340)
|||+++.+.+.-.. ...+-|.+|.|||.++|...|+.+.||||+|||+.||+|-++.|.+.. ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987554322 235679999999999999999999999999999999999999997642 35788
Q ss_pred HHHHHhcCCCchhhh--------------------hccc---------cccCC-hhhHhhhcccccccCCCCcCcccccC
Q 019506 290 VEIIKVSNIIYAKTI--------------------YQGL---------FCSNN-HEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~--------------------~~~~---------~~~~~-~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
.+|.+..+.|..+++ ..++ -.+++ ...+..-++.++|.+|.|+++.++|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 899998887754332 1111 11122 23344445566899999999999998
Q ss_pred C
Q 019506 340 F 340 (340)
Q Consensus 340 f 340 (340)
|
T Consensus 339 y 339 (438)
T KOG0666|consen 339 Y 339 (438)
T ss_pred c
Confidence 7
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=305.30 Aligned_cols=259 Identities=32% Similarity=0.492 Sum_probs=195.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcC--CCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++.. .+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 48899999999999999999988 89999999887632 233579999999999999999999843 2235
Q ss_pred eeeeeeccccchHHHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC---CCCcEEEEee
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDF 224 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~---~~~~~kl~Df 224 (340)
.+++||||+++++.+.+....... ..+++..++.++.|++.||.|||+ +||+||||||+||+++. .++.+||+||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 689999999998887776544333 378999999999999999999999 79999999999999983 1678999999
Q ss_pred ccccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 019506 225 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE 291 (340)
Q Consensus 225 g~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~~ 291 (340)
|++........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.. ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 122356888999999876666899999999999999999999999865432 22333
Q ss_pred HHHhcCCCchhhh----------------hccc--------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 292 IIKVSNIIYAKTI----------------YQGL--------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 292 ~~~~~~~~~~~~~----------------~~~~--------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++.....+....+ .... ..+.....+...|+..+|.+|||++|++.|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 3332221111000 0000 01111223455566678999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.43 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=200.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC---CC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 146 (340)
.++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+|++++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4579999999999999999999999999999998854321 22469999999999999999998754322 22
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
....++||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcCCC
Confidence 345689999999887766643 23468999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc-----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+......... ....++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+....+..+.+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432221 23356788999999866555788999999999999999999999888776655555543321110
Q ss_pred h-------------------------hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 K-------------------------TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~-------------------------~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ..+...........+...|+..+|.+|||++|+++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 0 00011111222334666777788999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=321.99 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=204.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+.|.|+..||.|+||+||+|.++.++...|.|++.... ....-|+++|..+.||+||++++.|+..+. ++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence 446899999999999999999999898888999885432 233458999999999999999998854333 88
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc-
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL- 230 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~- 230 (340)
|+.|||+||-.+.+.- ..++.+.+.++..+++|++.||.|||+ ++|||||||..|||++- +|.++|+|||.+...
T Consensus 106 iliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccch
Confidence 9999999986665543 446899999999999999999999999 89999999999999995 889999999987443
Q ss_pred ccCCccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 231 VKGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
.......+++||++|||||+..+ ...|+.++||||||++|.||..+.+|-..-+....+.+|.+... |. +++
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-PT---Llq 257 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PT---LLQ 257 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-Cc---ccC
Confidence 22233456899999999999853 34699999999999999999999999999999888888887432 22 111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..--+..+..+..-|+..+|..||++.+|+.|||
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 1111223445566677778889999999999999
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.42 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=201.2
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
....++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+.+++.+ +|+||+++++++......+..
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 345568999999999999999999999999999999876432 2345688889888 699999999988655444556
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~ 171 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVS 171 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCce
Confidence 78999999986 5555555444445678999999999999999999999 79999999999999995 778999999998
Q ss_pred cccccCCc-cceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEA-NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
........ .....++..|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+..+.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 248 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT--- 248 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc---
Confidence 76543322 223467889999999843 2347889999999999999999999998776555444333221110
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....-........+..-|...+|.+|||++|+++|+|
T Consensus 249 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 249 -LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred -ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0000011223445566677778999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=307.76 Aligned_cols=258 Identities=34% Similarity=0.578 Sum_probs=202.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+|.+.+.||+|+||+||+|++..++..||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4699999999999999999999999999999987642 1223468999999999999999998754433333458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|+||+++++.+.+.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCcccccc
Confidence 89999999887766643 4679999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 433 22233467888999999865455899999999999999999999999887766666655554433222111
Q ss_pred ------hc-----------cc--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------YQ-----------GL--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~~-----------~~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .. -.+.....+.+.|+..+|.+|||++|++.|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 00 00 01122235566677778999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.27 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=199.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|.+.+.||+|++|.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 46999999999999999999999999999999885432 2345799999999999999999998 444568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+... ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999999998877766532 23346888899999999999999999 799999999999999865678999999999765
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc-
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL- 308 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (340)
..... .....++..|+|||++.+...++.++|||||||++|+|+||..||.+.+..+.+.++......+... .+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE-TWPGVT 232 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh-hccccc
Confidence 33221 2234568889999998765567899999999999999999999999888777777776654433211 11100
Q ss_pred ------------c----------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 ------------F----------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ------------~----------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|...+|.+||++++++.|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0 0111223445566668999999999999998
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=301.34 Aligned_cols=256 Identities=32% Similarity=0.529 Sum_probs=202.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|.+.+.||+|+||.||+|.+..+++.+|+|.++.... ...+|+.++++++|+||+++++++... +....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 469999999999999999999999999999998864321 224699999999999999999988543 22568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+... ...+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceeec
Confidence 899999998777766542 2368999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.++......+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 544 22233456888999999876555789999999999999999999999988877777776654443222110
Q ss_pred ----------------hccccc----cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ----------------YQGLFC----SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ----------------~~~~~~----~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+. ......+.+.|+..+|.+|||++|++.|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 001111 122334556677778999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=298.84 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=199.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC-CCCceeecceeeeecCCCCceee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..++|.+.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++++ +|+|++++++++...........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 4568999999999999999999999999999999886432 2334688888888 79999999999865443344568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ ++.+.+.........+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchh
Confidence 899999986 5555555443445678999999999999999999999 79999999999999985 78899999999876
Q ss_pred cccCCc-cceeeeeccccCcccccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 230 LVKGEA-NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 230 ~~~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
...... .....++..|+|||++.... .++.++|||||||++|+|++|+.||...+....+..+.+...... ..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~- 255 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-LH- 255 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-Cc-
Confidence 543322 12345788899999985432 268899999999999999999999987766555555443221110 00
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..-.......+...|+..+|.+||+++||++|||
T Consensus 256 --~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 256 --PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred --ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 0000112344556677778999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.14 Aligned_cols=255 Identities=32% Similarity=0.540 Sum_probs=202.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||.|++|.||+|++..+|..||||.+.... ....+|+.+++.++|+||+++++++. +....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 4889999999999999999999999999999886542 23347899999999999999999984 3445789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+.... ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence 99999998777765432 23568999999999999999999999 79999999999999995 88899999999976533
Q ss_pred CCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh------
Q 019506 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY------ 305 (340)
Q Consensus 233 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 305 (340)
... .....++..|++||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+....+....+-
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 221 1234567889999998766667899999999999999999999999888877777776654433221110
Q ss_pred --------------cccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 --------------QGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 --------------~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. .......+...|...+|.+||+++|++.|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0000 1122334556677778999999999999999
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.30 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=203.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC---CC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 146 (340)
.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999885321 234579999999999999999998754332 23
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...+++||||+.+++...+.. ....+++..++.++.|+++||.|||+ +||+|+||||+||+++. ++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCcc
Confidence 446789999999876665543 24579999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc------------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019506 227 AKVLVKGEAN------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 227 a~~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 294 (340)
+......... ....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765332211 2235678899999987666689999999999999999999999998888777777766
Q ss_pred hcCCCchhhhh---------------------ccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIY---------------------QGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~---------------------~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+....+- ...+. ......+...|+..+|.+|||++|++.|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 54432211100 00000 011234666677778999999999999999
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=289.71 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=204.0
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHHHH-hCCCCceeecceeeeecCC
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMR-LMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 144 (340)
.....+|.+.++||+|+|++|.+++.+.|.+.+|+|+++++.-. .+.|..+.. .-+||.+|.++.||
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----- 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----- 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence 34556899999999999999999999999999999998765322 223444444 34799999999999
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+.+..+++|.||++|+ ++ ......++.++++.++.+..+|+.||.|||+ +|||+||||.+|+|+|. .+.+||+|+
T Consensus 321 qtesrlffvieyv~gg--dl-mfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGG--DL-MFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCc--ce-eeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeeccc
Confidence 6677799999999986 22 2223346899999999999999999999999 89999999999999996 888999999
Q ss_pred cccccc-ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC-------CCChHHHHHHHHHhc
Q 019506 225 GSAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-------GENAVDQLVEIIKVS 296 (340)
Q Consensus 225 g~a~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~-------~~~~~~~~~~~~~~~ 296 (340)
|.++.- .+++...+++||+.|.|||++.+ ..|+..+|+|+|||+++||+.|+.||. +.+.++.+.+++-..
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 999764 55666778899999999999966 559999999999999999999999995 345677777776554
Q ss_pred CCC-------chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 297 NII-------YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~-------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++- .+..+++.++.++|.+++... .-..+.+|+.|+|
T Consensus 475 qiriprslsvkas~vlkgflnkdp~erlgc~-------~~~g~~dik~h~f 518 (593)
T KOG0695|consen 475 QIRIPRSLSVKASHVLKGFLNKDPKERLGCR-------PQTGFSDIKSHAF 518 (593)
T ss_pred cccccceeehhhHHHHHHhhcCCcHHhcCCC-------cccchhhhhcchh
Confidence 432 245668888999999876632 2347889999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=299.02 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=193.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|.+.+.||+|+||.||+|++..+++.||+|.++... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 46999999999999999999999999999999886442 22356899999999999999999883 3445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.. .+.+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEcc
Confidence 9999996 55554432 4578999999999999999999999 79999999999999995 7889999999987653
Q ss_pred cCCc-cceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEA-NISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... .....|+..|+|||++. ....++.++|+|||||++|+|++|..||........+..+......+. ......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKDKM 235 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--cccccC
Confidence 3222 22346789999999974 233478899999999999999999999976655444443333221111 110001
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+...|...+|.+||+++++++|||
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 11223445666677778999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=296.45 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=194.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC-CCCceeecceeeeecCCC-Cceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~ 150 (340)
.+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++++ +|+||+++++++...... .....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 346889999999999999999999999999999886542 2345788888888 699999999998654322 23467
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence 899999986 55555543 223568999999999999999999999 79999999999999995 78899999999976
Q ss_pred cccCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
..... ......|+..|+|||++.+ ...++.++|||||||++|+|++|..||...........+.........
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 237 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK--- 237 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC---
Confidence 53322 2233567889999999853 234788999999999999999999999766554444433322111110
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ..+.....+...|+..+|.+||+++|++.|||
T Consensus 238 -~~-~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 238 -SK-KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred -CC-CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 00 11122344556666678999999999999999
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=322.24 Aligned_cols=258 Identities=19% Similarity=0.276 Sum_probs=185.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCC-cEEEEE------------------Eeccc---ccChHHHHHHHHhCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---RRYKNRELQLMRLMDHPNV 132 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK------------------~~~~~---~~~~~~E~~~l~~l~h~~i 132 (340)
...+|++.+.||+|+||+||+|..+... ...++| .+... .....+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3467999999999999999998764322 222222 11111 1224579999999999999
Q ss_pred eecceeeeecCCCCceeeeeeeccccchHHHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeE
Q 019506 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (340)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nil 211 (340)
+++++++ ......|+|+|++.+++...+.... ..........++.++.||+.||+|||+ +|||||||||+|||
T Consensus 226 v~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NIL 299 (501)
T PHA03210 226 LKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIF 299 (501)
T ss_pred CcEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEE
Confidence 9999998 3444578999999988777664321 112334567788999999999999999 79999999999999
Q ss_pred ecCCCCcEEEEeeccccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCC-CCCCC--ChH
Q 019506 212 VDPLTHQVKLCDFGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP-LFPGE--NAV 286 (340)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~-pf~~~--~~~ 286 (340)
++. ++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|||++|.. ||.+. ...
T Consensus 300 l~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 300 LNC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred ECC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 995 78899999999987644332 2245789999999999654 58999999999999999999885 45432 344
Q ss_pred HHHHHHHHhcCCCch-------------------------hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 287 DQLVEIIKVSNIIYA-------------------------KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.++.+++........ ..+++.+........+...|+.++|.+|||++|++.|||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 555555543321110 111111111122233345577889999999999999998
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=298.25 Aligned_cols=253 Identities=35% Similarity=0.644 Sum_probs=198.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+....+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 6899999999999999999998899999999875432 2235799999999999999999998 4555689
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||++++++..+.. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeecc
Confidence 9999999876554433 23458999999999999999999999 79999999999999995 8889999999987654
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh-------
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT------- 303 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 303 (340)
.... .....++..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 3322 22345788899999987656678899999999999999999999988877666666654332211000
Q ss_pred -hhccc----------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 -IYQGL----------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 -~~~~~----------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+ -.......+...|+..+|.+||++++++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 00000 01122445666777778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=292.65 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=198.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||.|+||.||+|.+..++..||+|.+.... .....|+++++.++|+||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4889999999999999999999999999999886432 223468899999999999999987753 2334578
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
++|||+++ ++.+.+.........+++..++.++.||+.||.||| + .+++|+||||+||+++. ++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence 99999985 676777665555678999999999999999999999 8 69999999999999995 7899999999
Q ss_pred cccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+ .....+....-
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKFRRIPYR 233 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCCCCCccc
Confidence 9987755443 334567889999999965 44789999999999999999999999887754433333 32222211110
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|...+|.+||++++|++|||
T Consensus 234 -----~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 234 -----YSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred -----cCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 1223344555666678999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.68 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=201.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC-CCCceeecceeeeecCC-CCce
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
...++|++.+.||+|++|.||+|.+..+++.+++|++.... ....+|+.+++++ +|+||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34578999999999999999999998899999999886543 3345799999998 69999999999865443 3355
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+++ ++.+.+......+..+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCccc
Confidence 68899999997 5555554433345688999999999999999999999 79999999999999995 788999999998
Q ss_pred cccccCCc-cceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEA-NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
........ .....++..|+|||++.. ...++.++|||||||++|+|++|..||.+......+.++.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 238 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL-- 238 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC--
Confidence 76533222 223457888999999843 23467899999999999999999999987666666655554321111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
............+.+-|+..+|.+|||++|++.|||
T Consensus 239 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 239 --KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred --CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 000001122345666677778999999999999999
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=291.58 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=199.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 4889999999999999999999999999999886432 2345789999999999999999987 3445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+... ....+++..+..++.|++.+|+|||+ +|++|+||||+||+++..++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999986 566665432 23458999999999999999999999 799999999999999865667899999999877
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+......+.... .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 225 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR------Y 225 (256)
T ss_pred CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCC------c
Confidence 55544445567889999999965 4478999999999999999999999988777665555554332222111 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+|||++|++.|||
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 223445666677778999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=294.12 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=196.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||.|+||+||+|.+..++..+++|++.... ....+|+.+++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 6999999999999999999998899999999886432 2345789999999999999999887 33445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
|||++++ ++.+.+... .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHhc
Confidence 9999986 454444432 123568999999999999999999999 79999999999999995 7889999999987765
Q ss_pred cCCcc-----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... ....++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.+............. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 232 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA-D 232 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc-c
Confidence 44322 23457888999999876546899999999999999999999999887766655555543221111100 0
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.--.......+...|...+|.+||++++++.|||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 0001122345556666778999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.80 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=189.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 6899999999999999999999999999999875321 224568999999999999999988743 2234
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++++||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCCc
Confidence 57899999986 55555543 3468899999999999999999999 79999999999999995 788999999998
Q ss_pred cccccCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCch
Confidence 7653211 1122456888999999965 4589999999999999999999999987765555554443332222111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .. .....+.. |...+|.+||+++|+++|||
T Consensus 233 ~----~~-~~~~~li~-~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 233 H----IS-EHARDFLG-CIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred h----cC-HHHHHHHH-HhcCChhhCcCHHHHhcCcc
Confidence 1 11 11222333 33458999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.52 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=193.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+.|++.+.||+|+||.||+|++..+++.+++|.+.... ....+|+.+++.++|+||+++++++. .....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 46999999999999999999999999999999886442 22346889999999999999999884 3345889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||++++.+..+.. .....+++..+..++.|++.+|.|||+ .|++||||||+||+++. ++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceeccc
Confidence 999999764443322 223568999999999999999999999 79999999999999985 88899999999865433
Q ss_pred CC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 233 GE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 233 ~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.. ......++..|+|||++.+ ...++.++|+|||||++|+|++|..||...+....+.++.+....... ..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 238 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS----QP 238 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC----CC
Confidence 22 1234467889999999852 234688999999999999999999999877765555444432221110 00
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
--.+.....+...|+..+|.+||+++|+++|||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 001122344556667778999999999999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.52 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=188.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCC-CCceeeccee-eeecCCCC-ceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKHC-FFSTTSKD-ELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~-~~~~ 150 (340)
+++|.++|.+|||+.||+|.+...|..||+|++... .....+|+++|++|. |+|||.+++. .....+.. ...+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 578999999999999999999888899999987543 233468999999997 9999999994 33322333 4567
Q ss_pred eeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.|.||||. |+|.+.+..... .+|++.++++|+.|+++|+.+||. .. |||||||-||||++. ++..||||||.|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeCccccc
Confidence 89999999 599999886543 569999999999999999999998 45 999999999999995 889999999998
Q ss_pred cccccCCcc----------ceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 019506 228 KVLVKGEAN----------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (340)
Q Consensus 228 ~~~~~~~~~----------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 295 (340)
......... ....-|+.|+|||++- .+...+.|+|||||||+||-|+....||++..... |+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln- 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN- 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe-
Confidence 765333211 1234588999999972 44558999999999999999999999998774322 222
Q ss_pred cCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 296 SNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.++.. --.++.+..+...|+..+|.+||++-|++.
T Consensus 269 g~Y~~P~~----p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 GNYSFPPF----PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred ccccCCCC----ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 11111110 002233455666666667778998877654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=305.07 Aligned_cols=258 Identities=28% Similarity=0.516 Sum_probs=197.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCC-------
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK------- 145 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------- 145 (340)
.+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57999999999999999999999999999999886432 2345799999999999999999877432211
Q ss_pred --CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 146 --DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 146 --~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
+....++||||+++++.+.+. ...+++..++.++.||+.||.|||+ .||+||||||+||+++..+..++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 123578999999987665553 2568999999999999999999999 79999999999999986577899999
Q ss_pred eccccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 019506 224 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 224 fg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
||++........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+++.....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876532211 1123568889999988665668899999999999999999999999888766666655433222
Q ss_pred chhhh---------------------hccccccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTI---------------------YQGLFCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~---------------------~~~~~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..... ...++... ....+.+.|...+|.+||+++|++.|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 11000 00001011 1223556666778999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.69 Aligned_cols=245 Identities=18% Similarity=0.211 Sum_probs=187.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++... ..+.+|+.++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 346999999999999999999865 356789999887542 23457999999999999999999883 34
Q ss_pred eeeeeeeccccchHHH-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||++++.+. .+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence 4588999999975444 4432 23578999999999999999999999 79999999999999995 88999999998
Q ss_pred ccccccCCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 227 AKVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 227 a~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
+.......... ...++..|+|||++.+ ..++.++|||||||++||+++ |..||.+.+..+.+..+......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 231 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR- 231 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC-
Confidence 76543222111 1234567999999865 458999999999999999775 999998887766655554332222211
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+......+...|+..+|.+||++++|..
T Consensus 232 -----~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 232 -----NCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 12233455566677778999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=296.74 Aligned_cols=242 Identities=27% Similarity=0.476 Sum_probs=193.6
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||.||++++..+++.||+|.+.... ....+|++++++++|+||+++++++ .+....
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 6999999999999999999999999999999886432 2345689999999999999999988 445568
Q ss_pred eeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCccc
Confidence 89999996 566665543 3678999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.. .....+.. +
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-----~ 221 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-GKVRFPSF-----F 221 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCccCCcc-----C
Confidence 6444 3344678899999998654 478999999999999999999999987775555555442 22222211 1
Q ss_pred ccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
......+..-|+..+|.+|+ +++|+++|||
T Consensus 222 -~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 222 -SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred -CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 22233445556666788888 8999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.72 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=194.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHHHHhCC-CCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLMD-HPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.-. ...|-++|.... -|.+++++.+| +.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 34688999999999999999999999999999998876422 235667777664 67888999888 555
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..+|+||||+.|+ +++ .....-+++.+..+..++.+|+-||-+||+ +|||+||||.+|||++. .+.+||+|||++
T Consensus 423 DRLyFVMEyvnGG--DLM-yhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~DFGmc 497 (683)
T KOG0696|consen 423 DRLYFVMEYVNGG--DLM-YHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMC 497 (683)
T ss_pred hheeeEEEEecCc--hhh-hHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeeecccc
Confidence 5699999999986 222 222335788999999999999999999999 89999999999999996 888999999999
Q ss_pred cccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc------
Q 019506 228 KVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY------ 300 (340)
Q Consensus 228 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------ 300 (340)
+.-. .+....+++||+.|+|||++. ...|+.++|+||+||+||||+.|++||.+.++.+.++.|... ...+
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-nvsyPKslSk 575 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-NVSYPKSLSK 575 (683)
T ss_pred cccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-cCcCcccccH
Confidence 8643 334455789999999999995 455999999999999999999999999999987777777664 3333
Q ss_pred -hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 -AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 -~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..++..++.+.|.+|+.. . +-.-.+|..|||
T Consensus 576 EAv~ickg~ltK~P~kRLGc-----g---~~ge~di~~H~F 608 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGC-----G---PEGERDIREHPF 608 (683)
T ss_pred HHHHHHHHHhhcCCccccCC-----C---CccccchhhCcc
Confidence 3455666666777654442 1 222367888987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=291.97 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=195.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
++|.+.+.||.|+||.||+|.+..+++.+++|.+.... ....+|+++++.++|+||+++++++ .+...+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 47999999999999999999998899999999887542 3346789999999999999999988 34445889
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||++++ +.+.+.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus 78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhhh
Confidence 99999974 4433332 23578999999999999999999999 79999999999999995 7889999999987654
Q ss_pred cCC-ccceeeeeccccCcccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGE-ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ......++..|+|||.+.+. ..++.++|+|||||++|+|+||..||.+.+.......+.+....+.... ...
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 230 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK--DKE 230 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc--chh
Confidence 332 22234678889999998544 2578899999999999999999999988776555554444311111000 000
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+.+.|+..+|..|||+++|+.|+|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00122346667777778999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=290.08 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=195.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+++++.++|+||+++++++ .+....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 488899999999999999999999999999987532 23345688999999999999999988 4445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence 99999986 555555432 24578899999999999999999999 79999999999999995 788999999998876
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+.+....+.. . .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~ 224 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-Q-----M 224 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-c-----c
Confidence 44332 2234578889999999654 4789999999999999999999999887765555555442221111 1 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+.+.|+..+|.+||++.+++.|||
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 1223455666677778999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=300.92 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=202.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
-|.++.+||+|+||.||+|.++.+|..+|||.+.-+. ....+|+.+|+++..+++|++||.|+-..+ +++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 3778899999999999999999999999999987554 344579999999999999999999865433 899999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE- 234 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 234 (340)
||+.+....+.+. .+..+++.++..+++..+.||+|||.+ .-||||||..|||++. ++..||+|||.|..+.+--
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhhhHH
Confidence 9996444444432 358899999999999999999999995 7899999999999996 8889999999998764432
Q ss_pred ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCCh
Q 019506 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNH 314 (340)
Q Consensus 235 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (340)
...+..||+.|||||++..-+ |+.++||||||++..||..|++||.+-.+...+..|-.. |. +.+-..-+-++.+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~---PP-PTF~KPE~WS~~F 259 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK---PP-PTFKKPEEWSSEF 259 (502)
T ss_pred hhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC---CC-CCCCChHhhhhHH
Confidence 234578999999999996544 899999999999999999999999877665544444322 21 1222222334556
Q ss_pred hhHhhhcccccccCCCCcCcccccCC
Q 019506 315 EIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 315 ~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.+-|+..+|.+|-|+-++.+|||
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 77788888889999999999999998
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=295.45 Aligned_cols=253 Identities=34% Similarity=0.573 Sum_probs=203.9
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|.+.+.||+|++|+||+|++..+++.|+||.+..... ...+|+..+++++ |+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6788999999999999999988999999998865432 2246888999999 999999999883 3555889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+.... ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 99999888777765421 3478999999999999999999999 79999999999999995 88999999999987755
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh-------
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY------- 305 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 305 (340)
........++..|+|||++.+...++.++|+||||+++|+|++|+.||...+..+.+.++......+....+.
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 4444455678899999998666668999999999999999999999999888877777776654443321110
Q ss_pred --------------ccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 --------------QGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 --------------~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+. ......+.+.|+..+|.+||+++|+..|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 00010 123446667777778999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.18 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=190.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||+|+||.||++.+..++..||+|.+.... ....+|+.++++++|+||+++++++ ......++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 5889999999999999999999899999999886432 2345799999999999999999988 34456889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||++++.+..+.........+++..+..++.|++.||.|||+..||+|+||||+||+++. ++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccccC
Confidence 99999975333333222223478999999999999999999996249999999999999996 88899999999876533
Q ss_pred CCccceeeeeccccCcccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 233 GEANISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.. .....++..|+|||.+.+.. .++.++|+|||||++|+|++|+.||...+.......+......... .+...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (286)
T cd06622 156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-TLPSG 233 (286)
T ss_pred Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-CCCcc
Confidence 22 22345778899999985432 2578999999999999999999999766554443333322211110 11000
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+..-|+..+|..||+++++++|||
T Consensus 234 --~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 234 --YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred --cCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 1112234445566678999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.12 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=188.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeec
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 142 (340)
...++|.+.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+++++.+ +|+||+++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--- 111 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--- 111 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe---
Confidence 3455799999999999999999986543 3579999886532 2245799999999 899999999988
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhh----------------------------------------------------
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYS---------------------------------------------------- 169 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------------------------------------------------- 169 (340)
.....+++||||+.+ +|.+.+....
T Consensus 112 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 --THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred --cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 444568899999985 5655554311
Q ss_pred --------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc
Q 019506 170 --------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (340)
Q Consensus 170 --------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (340)
....++++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCcc
Confidence 012357888999999999999999999 79999999999999995 88899999999976543322
Q ss_pred cc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 236 NI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 236 ~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
.. ...++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+++.......... ..
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 341 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDF-----AP 341 (374)
T ss_pred eeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCC-----CC
Confidence 11 1223567999999965 448999999999999999997 99999877665555555554322211111 12
Q ss_pred CChhhHhhhcccccccCCCCcCcccc
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.....+...|+..+|.+||+++++.+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23345566677778999999999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.64 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=193.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|++|.||++.+..+++.||+|.+..+. ....+|++++++++|+|++++++.+. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4899999999999999999999999999999886432 23456889999999999999988762 2334578
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|||+++ ++.+.+... ....+++..++.++.|++.||.+||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence 99999986 555555432 23568999999999999999999999 79999999999999995 888999999999766
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+...........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 225 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD------ 225 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccc------
Confidence 4322 22234578899999999654 478999999999999999999999987776555555444222111111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|...+|..||++.+++.|||
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1122344556666667999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=297.35 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=203.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-----
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS----- 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 144 (340)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 457999999999999999999999999999999886432 123479999999999999999998854321
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.+...+++|+||+++++...+.. ....+++..++.++.|++.||.|||+ .||+|+||||+||+++. ++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCcc
Confidence 12336889999999987766543 23578999999999999999999999 79999999999999995 888999999
Q ss_pred ccccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 225 g~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
|++........ .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+....+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99987644332 1223457789999998665557899999999999999999999999888777777776654433211
Q ss_pred hh---------------------hccc--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TI---------------------YQGL--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~---------------------~~~~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+ ++.. ........+...|+..+|.+||++++++.|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 10 0000 01223445566677778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=304.82 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=190.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC-CCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|++.+.||+||.++||++... +...||+|++.... .....|+.+|.+|+ |.+|++++++-+ ...++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCceE
Confidence 5999999999999999999853 44566776564322 23458999999985 999999999873 35679
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+||||-+.+|-..|.... .-.+..+++.+..||+.|+.+.|. .||||.||||.|+|+- .|.+||+|||.|..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhccc
Confidence 9999999888888887532 333435889999999999999999 7999999999999998 678999999999988
Q ss_pred ccCCcc---ceeeeeccccCcccccCCC----------CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 019506 231 VKGEAN---ISYICSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 231 ~~~~~~---~~~~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 297 (340)
..+... .+.+||..||+||.+.... +.++++||||||||||+|+.|++||..-. ..+.++.....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~ 587 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD 587 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC
Confidence 665543 3568999999999994321 25789999999999999999999996443 23444444333
Q ss_pred CCchhhhhccccccC-ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 298 IIYAKTIYQGLFCSN-NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. .+-.+-..++ +...++..|+..+|++|+++.++++|||
T Consensus 588 P~~--~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 588 PNH--EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred CCc--cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 311 1111112223 2567788889999999999999999998
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=294.14 Aligned_cols=245 Identities=29% Similarity=0.461 Sum_probs=191.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------------cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
+|.+++.||+|++|.||+|.+..+++.+|+|.+.... ....+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 4788899999999999999998899999999886432 12346889999999999999999883
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
+....++||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d 149 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD 149 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence 34458899999986 55555543 3568899999999999999999999 79999999999999985 88899999
Q ss_pred eccccccccCCc-------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 019506 224 FGSAKVLVKGEA-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 224 fg~a~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 296 (340)
||.++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999877642211 1123467889999999654 47899999999999999999999998876655554444422
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....... .......+.+.|+..+|.+||+++|+++|||
T Consensus 229 ~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 229 SPEIPSN------ISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred CCcCCcc------cCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 1111111 1222344556667777999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=294.61 Aligned_cols=253 Identities=31% Similarity=0.552 Sum_probs=199.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++|+||+++++++ .+....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 567889999999999999999999999999886432 2345799999999999999999988 44466889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
+|||+++++.+.+.... ...+++..+..++.|++.||+|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence 99999887777665421 2468999999999999999999999 79999999999999996 88999999999976532
Q ss_pred CCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-------
Q 019506 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI------- 304 (340)
Q Consensus 233 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 304 (340)
... .....++..|+|||++.+...++.++||||||+++|+|++|+.||.+.+....+.++.+....+....+
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 221 122355788999999866555789999999999999999999999988887777776665433321110
Q ss_pred -----hc--------ccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -----YQ--------GLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -----~~--------~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ... .+.....+...|...+|.+||+++|+++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 00 000 0112334566677778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=301.83 Aligned_cols=257 Identities=34% Similarity=0.575 Sum_probs=206.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4889999999999999999998899999999886532 2345799999999999999999988554323334688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence 9999999876666543 3489999999999999999999999 79999999999999995 7899999999998765
Q ss_pred cCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh--
Q 019506 232 KGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY-- 305 (340)
Q Consensus 232 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 305 (340)
... ......++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+......+....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 23345678899999999766468999999999999999999999999998888887777765544432211
Q ss_pred ---------cc-----------cc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ---------QG-----------LF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ---------~~-----------~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .. .......+.+.|+..+|.+||++++++.|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 00 00 0111234666777778999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.25 Aligned_cols=257 Identities=31% Similarity=0.508 Sum_probs=201.6
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhC---CCCceeecceeeeecCCCCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
|++.+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++++ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999986432 1233577776655 6999999999986654434455
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++++|||+.+++.+.+.... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence 88999999988777665422 2468999999999999999999999 79999999999999996 78999999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc--
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG-- 307 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 307 (340)
...........++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+.++......+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 6554444445578889999999664 4799999999999999999999999998888888877765443221111000
Q ss_pred ----------------ccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 ----------------LFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ----------------~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
... ......+.+.|+..+|.+||+++|++.|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 000 112234566778888999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=302.01 Aligned_cols=253 Identities=33% Similarity=0.496 Sum_probs=199.2
Q ss_pred cCee-EeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------------------ChHHHHHHHHhCCCCceeecce
Q 019506 77 ISYM-AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRLMDHPNVISLKH 137 (340)
Q Consensus 77 ~~y~-~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~ 137 (340)
++|. +.+.||+|+||.||+|++..+++.||||.+..... ...+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3565 45779999999999999999999999998864321 2347999999999999999999
Q ss_pred eeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC
Q 019506 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~ 217 (340)
++ ....+.++||||+.+++.+.+.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++. ++
T Consensus 88 ~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~-~~ 156 (335)
T PTZ00024 88 VY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS-KG 156 (335)
T ss_pred EE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC-CC
Confidence 88 34456889999999887777653 4568999999999999999999999 79999999999999995 78
Q ss_pred cEEEEeeccccccccC---------------CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 019506 218 QVKLCDFGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (340)
Q Consensus 218 ~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (340)
.++|+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8999999998765411 1111234577899999997666679999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCchhhhhc-------------------ccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 283 ENAVDQLVEIIKVSNIIYAKTIYQ-------------------GLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+..+.+..+......+....+-. ... .+.....+..-|+..+|.+||+++|++.|||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 888888877776554333221100 000 1122334556666678999999999999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.83 Aligned_cols=243 Identities=28% Similarity=0.401 Sum_probs=184.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||+|+||.||+|++..+++.||+|.+..+. ....+|++++++++|+||+++++.+.. ....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 5788899999999999999999999999999886442 223468999999999999999999843 345789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||++++.+... ..+++..+..++.|++.||.|||+ .||+|+||||+||+++. ++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceeccc
Confidence 9999998644332 357888899999999999999999 79999999999999995 88899999999976543
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHhcCCCchhhhhc
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD------QLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~ 306 (340)
.. .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||......+ ...+.+.....+.. ..
T Consensus 148 ~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 222 (279)
T cd06619 148 SI-AKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL---PV 222 (279)
T ss_pred cc-ccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC---CC
Confidence 32 2345788899999999654 48999999999999999999999996532111 11111111111110 00
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .......+..-|+..+|.+||+++|+++|||
T Consensus 223 ~~-~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 GQ-FSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred Cc-CCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 00 0111233444566667999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=296.12 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=195.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.|++.+.||+|+||.||++.+..++..+++|.+.... ....+|+++++.++|+||+++++++. .....++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 3788899999999999999999999999999886432 23456899999999999999999884 34458899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|||++++.+..+.. .....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 81 IEFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEcccccccccccc
Confidence 99999764443322 224578999999999999999999999 79999999999999985 888999999998765332
Q ss_pred Cc-cceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 234 EA-NISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 234 ~~-~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.. .....++..|+|||++. ....++.++|||||||++|+|++|+.||...+..+....+.+........ ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 232 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ----PS 232 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCC----cc
Confidence 21 22345788999999984 23347789999999999999999999998877766666665533221110 01
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+..-|+..+|..||++++++.|||
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 12233456667777778999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.90 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=190.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence 46999999999999999999999999999999886432 22457899999999999999999884 3345889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceeec
Confidence 9999996 45444432 3578999999999999999999999 79999999999999985 7889999999998654
Q ss_pred cCCc-cceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... .....++..|+|||.+.+ ...++.++|+|||||++|+|++|+.||...+..+....+.+....+. ......
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP--KLKDKT 235 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC--CCcccc
Confidence 3321 233467889999999842 33467899999999999999999999976554443333322211111 000000
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.+.....+.+.|+..+|.+||++++|++|+|
T Consensus 236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 01112334455566678999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=302.43 Aligned_cols=257 Identities=32% Similarity=0.558 Sum_probs=201.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.++++++|+||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 57999999999999999999999999999999886532 22346899999999999999999874432 334568
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+.+++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEecccccceee
Confidence 89999998876655532 4568999999999999999999999 79999999999999995 889999999998765
Q ss_pred ccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-
Q 019506 231 VKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI- 304 (340)
Q Consensus 231 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 304 (340)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 123467888999999866556899999999999999999999999988777766666655443321110
Q ss_pred ----------hccc-----------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ----------YQGL-----------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ----------~~~~-----------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+... . .+.....+.+.|+..+|.+||++++++.|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000 0 1122334556666778999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.49 Aligned_cols=253 Identities=34% Similarity=0.593 Sum_probs=200.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 699999999999999999999999999999987642 1234579999999999999999999843 44588
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++...+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeecccccC
Confidence 9999999887665543 23568999999999999999999999 79999999999999995 8899999999998765
Q ss_pred cCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 232 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
... ......++..|+|||++.+...++.++||||||+++|+|++|+.||.+.+..+.+..+............
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 2334567888999999977646899999999999999999999999988776666655443321111000
Q ss_pred -----------------h-ccc--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -----------------Y-QGL--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -----------------~-~~~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+ ... ..+.....+.+.|+..+|.+||++++++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 0 000 01222345566677778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=294.34 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=200.9
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|.+.+.||+|+||.||+|++..+++.+|+|.+.... ....+|+++++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999999999999997552 22456999999999999999999884321 256889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+.. ....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence 999999877666543 12578999999999999999999999 79999999999999995 88999999999987654
Q ss_pred CCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh------
Q 019506 233 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI------ 304 (340)
Q Consensus 233 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 304 (340)
... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.+....+..+.+....+....+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 431 223456788999998876566899999999999999999999999988877777777665443322111
Q ss_pred -------------------hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -------------------YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -------------------~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+... ++.....+.+.|+..+|.+||++++++.|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHL-IDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hhhhhccccccchhHHHHHhccc-CCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 0110 1222334556667778999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=287.27 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=194.8
Q ss_pred CeeE-eeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCC-CCceeecceeeeecCCCCceeee
Q 019506 78 SYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~-~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
-|++ .+.||+|+|+.|-.+....+|..||||++.+. +...-+|++++..++ |+||+.++++| ++....|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 3554 46799999999999999999999999998764 233457999988875 99999999999 6677789
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC--cEEEEeecccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAK 228 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~--~~kl~Dfg~a~ 228 (340)
||||-+.| .++..+.. ...|++.++..+.++|+.||+|||. +||.||||||+|||....+. -+|||||.+..
T Consensus 153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999996 44444433 4789999999999999999999999 89999999999999975343 49999998875
Q ss_pred ccccCCc--------cceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------------
Q 019506 229 VLVKGEA--------NISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------------ 284 (340)
Q Consensus 229 ~~~~~~~--------~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~------------ 284 (340)
.+..... ..+.+|+..|||||+.. ....|+.++|.||||||||-||.|.+||.+..
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 5432221 23457888899999973 34569999999999999999999999997642
Q ss_pred --hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 285 --AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 285 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-...+..-++.+.+.++..-|..+ ++...+ +....+..++..|+++.+.++|||
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahI-S~eakd-lisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHI-SSEAKD-LISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHh-hHHHHH-HHHHHHhccHHhhhhhhhccCCcc
Confidence 234556666667766654444432 222222 333333467889999999999999
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=291.96 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=187.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|++.+.||+|+||.||++++..++..||+|.+.... ....+|++++++++|+||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 6999999999999999999999999999999875321 133568999999999999999998732 2234
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.++++|||+++ +|.+.+.. ...+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCccc
Confidence 57899999986 55555443 3457889999999999999999999 79999999999999995 888999999998
Q ss_pred cccccCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+.++......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP- 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc-
Confidence 7653211 1122457888999999965 447999999999999999999999998766555554443322211111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+...-.+.+.++ . .+|..||+++||+.|||
T Consensus 232 ---~~~~~~~~~~i~~~-l-~~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 232 ---PHVSDHCRDFLKRI-F-VEAKLRPSADELLRHTF 263 (265)
T ss_pred ---hhhCHHHHHHHHHH-h-cChhhCCCHHHHhcCcc
Confidence 01111112223332 2 37899999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=294.36 Aligned_cols=251 Identities=34% Similarity=0.633 Sum_probs=201.3
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|.+.+.||+|++|.||+|.+..+++.+++|.+..... ...+|+.+++.++|+||+++++++ ......++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 5677899999999999999988999999998865432 245789999999999999999988 34456889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|+||+++++.+.+... ...+++..+..++.|++.||.|||+ .||+|+||||+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence 9999999877766542 3578999999999999999999999 79999999999999995 78899999999977654
Q ss_pred CC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc--
Q 019506 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF-- 309 (340)
Q Consensus 233 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 309 (340)
.. ......++..|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+.+..+......+.... +..+.
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV-WPKFTSL 229 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh-cccchhh
Confidence 43 222345678899999997664689999999999999999999999998888887777766544432211 11110
Q ss_pred ----------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 ----------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ----------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+||++++++.|||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 1122334566666778999999999999999
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=298.81 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=196.6
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+++++.++|+||+++++.+ .+....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 69999999999999999999999999999998865422 234689999999999999999988 455568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+.+ +|.+.+.. .....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhhc
Confidence 999999986 55555442 224578999999999999999999999 79999999999999995 78899999999875
Q ss_pred cccCCcc------------------------------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 019506 230 LVKGEAN------------------------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (340)
Q Consensus 230 ~~~~~~~------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (340)
....... ....|+..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 4322111 123568889999999654 479999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCC----cCcccccCC
Q 019506 280 FPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS----MHESKLYGF 340 (340)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~----~~~i~~hpf 340 (340)
|.+.+....+..+..... ..... .........+.+.|+..+|.+||+ ++|+++|||
T Consensus 232 f~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 232 FKGSNRDETFSNILKKEV-TFPGS----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred CCCCchHHHHHHHhcCCc-cCCCc----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 988887766666553221 11111 002233456667777778999999 999999998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.52 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=187.8
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
...+++|.-.+.||+|+||.||+|.. .+|..||||++.... ..+.+|++++.+++|+|+|+++|+|.+...
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~---- 145 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE---- 145 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----
Confidence 34567888889999999999999985 455899999886533 347899999999999999999999954321
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CceecCCCCCCeEecCCCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..+||+||++. +|.+.|..... . .++|....+|+.++++||+|||... .|||||||++|||+|. +.++||+|||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~-~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFG 222 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKG-E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFG 222 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCC-C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCcc
Confidence 47799999995 66666543211 1 8899999999999999999999842 3999999999999995 9999999999
Q ss_pred ccccccc-CCcccee-eeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHH----HHHHhcC
Q 019506 226 SAKVLVK-GEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLV----EIIKVSN 297 (340)
Q Consensus 226 ~a~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~----~~~~~~~ 297 (340)
+|+.... ....... .||.+|+|||++.. +..+.++|||||||+|.||+||+.+..... ....+. ..++..
T Consensus 223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~- 300 (361)
T KOG1187|consen 223 LAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG- 300 (361)
T ss_pred CcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-
Confidence 9977654 3333333 78999999999965 458999999999999999999998886432 111122 222222
Q ss_pred CCchhhhhccccc--cCC-------hhhHhhhcccccccCCCCcCcc
Q 019506 298 IIYAKTIYQGLFC--SNN-------HEIMCELGSWYSYSGRNSMHES 335 (340)
Q Consensus 298 ~~~~~~~~~~~~~--~~~-------~~~~~~l~~~~~~~~R~~~~~i 335 (340)
...+++..-+. ..+ ...+...|...++..||++.|+
T Consensus 301 --~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V 345 (361)
T KOG1187|consen 301 --KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQV 345 (361)
T ss_pred --chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence 33333333322 111 2334445566668889999885
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.45 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=192.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|.+.+.||+|+||.||+|++..++..|++|.+.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 47999999999999999999999999999999886533 23457899999999999999999884 3445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ ++.+.+. +..+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++....
T Consensus 95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhcc
Confidence 9999986 5555443 2467899999999999999999999 79999999999999985 8889999999987653
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..... +.... ..-+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~~- 242 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN--PEKL- 242 (296)
T ss_pred ccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCC--cccc-
Confidence 3322 223467889999999865 4478999999999999999999999988776555544443221 11100 0000
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+..-|+..+|.+||+++||++|||
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 112334455566778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=298.04 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=190.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||+|+||.||++.+..++..+|+|.+..+. ....+|+++++.++|+||+++++++. +...+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence 5999999999999999999999999999999886432 22457999999999999999999983 4456899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+++||||||+|||++. ++.+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCccccc
Confidence 9999986 55555543 3678999999999999999999997248999999999999995 7889999999987653
Q ss_pred cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch----------
Q 019506 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA---------- 301 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 301 (340)
... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.. .+..+.........
T Consensus 152 ~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DSM-ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccc-cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccC
Confidence 322 234567889999999855 44889999999999999999999999765532 22222221100000
Q ss_pred -----------hhhhccc-----------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 -----------KTIYQGL-----------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 -----------~~~~~~~-----------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+ ........+...|+..+|.+||+++|++.|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000 01112345566677778999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.49 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=195.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+.+.||+|+||.||++.+..++..+|+|.+.... ....+|+.+++.++|+||+++++.+. .....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 346999999999999999999998899999999886432 23457899999999999999999883 444588
Q ss_pred eeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||++++ +.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence 999999974 4444432 23568999999999999999999999 79999999999999995 889999999998665
Q ss_pred ccCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 231 VKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
.... ......++..|+|||++.. ...++.++|+|||||++|+|++|+.||.+.+....+.++.+.......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 229 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD---- 229 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC----
Confidence 3322 2233467889999999842 234678999999999999999999999887766555555432211110
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..-..+.....+...|+..+|.+||++++++.|||
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 00011223445566677778999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=294.40 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=195.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC-CCCceeecceeeeecCC-CCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~ 150 (340)
.+.|++.+.||.|+||.||+|++..+++.+|+|.+.... .....|+.+++++ +|+||+++++++..... ......
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 356999999999999999999999999999999886442 2345678888887 69999999998854322 234568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|||+++ ++.+.+... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhh
Confidence 899999986 555555432 23468888899999999999999999 79999999999999995 78899999999876
Q ss_pred cccCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
..... ......++..|+|||++.. ...++.++|+|||||++|+|++|..||........+..+.+.........
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 249 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK- 249 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc-
Confidence 53221 2233567889999999852 23478899999999999999999999987665554444333222111100
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+.+-|+..+|.+||+++||++|||
T Consensus 250 ----~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 250 ----KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred ----ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 11223455666777778999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=294.61 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=194.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|.+.+.||.|+||.||+|++..+++.||+|.+..+. ....+|+++++.++|+||+++++++. +....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5888999999999999999999999999999886442 23457899999999999999999884 3356889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
|+||+++ ++.+.+.. ..+++..++.++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceeec
Confidence 9999987 45544432 378999999999999999999999 79999999999999995 8889999999998765
Q ss_pred cCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
... ......++..|+|||.+.+.. ++.++|||||||++|+|+||..||...+....+..+.+... +..... + .
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~--~--~ 223 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-PSLEGN--K--F 223 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-CCCccc--c--c
Confidence 442 223456788899999996544 89999999999999999999999987765555544444322 111110 0 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+||++++++.|||
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 223344556667778999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.84 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=193.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|.+.+.||.|+||.||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++++ ......++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 46999999999999999999999999999999886432 2234689999999999999999988 34456889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|+||+.++.+..+.. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhccc
Confidence 999998754333322 2468999999999999999999999 79999999999999995 88899999999876544
Q ss_pred CCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 GEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
.... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..... +.... ..-..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~---~~~~~ 242 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQN---PEKLS 242 (296)
T ss_pred ccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCC---cccCC
Confidence 3322 23457888999999865 4478999999999999999999999988877666555443221 11100 00011
Q ss_pred CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.+-|+..+|.+||++++|+.|||
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 12334456667778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=294.61 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=187.9
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
..||+|++|.||+|.+ +|+.||||.+.... ..+.+|+.++++++||||+++++++.+.. .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5689999999999998 79999999886532 22348999999999999999999885421 22345789999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
|+.++ |.+.+.. ...+++.....++.|++.||.|||+..+++||||||+|||++. ++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSPP 177 (283)
T ss_pred eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhcccc
Confidence 99975 5554432 4678899999999999999999997348999999999999995 8899999999998653322
Q ss_pred ccceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 235 ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 235 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
....++..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+.+........ .-+...
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~ 250 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP-----LDCPLE 250 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-----CcCcHH
Confidence 234678899999998542 458999999999999999999999999887766666555433222111 012334
Q ss_pred hhhHhhhcccccccCCCCcCcccc
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+.+.|+..+|.+|||++|++.
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHH
Confidence 566777788888999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=298.10 Aligned_cols=254 Identities=23% Similarity=0.287 Sum_probs=191.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCC-CCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|...+.||+|+||.||++.+..+++.||+|.+.... ....+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 5677788999999999999999999999999886432 22346888888886 9999999998843 33477
Q ss_pred eeeccccchHHHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|||+..++.+..... ...+..+++..+..++.|++.||+|||+..|++||||||+||+++. ++.++|+|||++...
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHHh
Confidence 99999987665544322 2234679999999999999999999997249999999999999995 788999999999776
Q ss_pred ccCCccceeeeeccccCcccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..........++..|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+.+...... ..+....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-~~~~~~~ 235 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP-PILSNSE 235 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-CcCCCcC
Confidence 544444445678899999999655 3589999999999999999999999976542 2222222111111 0110000
Q ss_pred --cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 --FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 --~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+.+.|+..+|.+||++++|+.|||
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 01223455666777778999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=289.74 Aligned_cols=247 Identities=30% Similarity=0.452 Sum_probs=194.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|+..+.||+|+||+||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4778899999999999999998899999999875432 2345789999999999999999987 4445
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++++||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence 58899999986 55555443 3568899999999999999999999 79999999999999995 788999999998
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.............++..|+|||.+.....++.++|+|||||++|+|++|+.||......+....+.+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 226 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH--- 226 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCC---
Confidence 87654443344567888999999855434789999999999999999999999877655555544442222221110
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+||++++++.|||
T Consensus 227 --~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 227 --LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred --cCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 1122234455666678999999999999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=305.51 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=192.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHh-CCCCceeecceeeeecCCCCceeeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
..+.|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++.+ -+|+||+++.+.+ .+...+|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 4567999999999999999999999999999999998876666778866544 4699999999999 777789999
Q ss_pred eccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||++.|+ +++.+.. .+.....+..|+++|+.|+.|||+ +|+|||||||+|||++...++++|+|||.++....
T Consensus 395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999975 2332221 233337788899999999999999 89999999999999953478899999999988754
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||........+...+...... ..-+.
T Consensus 469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--------~~vS~ 537 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--------ECVSD 537 (612)
T ss_pred h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--------cccCH
Confidence 4 33445688899999996 5669999999999999999999999998776653333333322211 11233
Q ss_pred ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+.+.++..+|.+|+++++|..|||
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcc
Confidence 4445555566667779999999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=296.50 Aligned_cols=253 Identities=20% Similarity=0.250 Sum_probs=185.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC----------------CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeec
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL 135 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~ 135 (340)
++|++.++||+|+||.||+|.+.. ++..||+|.+.... ..+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 479999999999999999998532 34579999886532 234579999999999999999
Q ss_pred ceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 019506 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS---------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199 (340)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 199 (340)
++++. +....++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ .|
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 99884 33448899999986 56655543211 11346778899999999999999999 79
Q ss_pred ceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-
Q 019506 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 275 (340)
Q Consensus 200 iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt- 275 (340)
|+||||||+|||++. ++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 159 ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence 999999999999995 788999999999765433221 122346789999998654 48999999999999999986
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCc-hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 276 -GQPLFPGENAVDQLVEIIKVSNIIY-AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 276 -g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+..||.+.+..+.+..+........ .........+......+...|+..+|.+|||++||..
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 5688987766555544433211110 0001111122333456667777778999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=286.41 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=197.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|+..+.||+|+||.||.+++..+++.+++|.+.... ....+|++++++++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 4899999999999999999999999999999875432 23457999999999999999999984 445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|||+++ ++.+.+... ....+++..+..++.|++.+|.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence 99999985 666655532 13568999999999999999999999 79999999999999995 788999999999766
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......+... .
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 224 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS------V 224 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc------c
Confidence 4433 22335678899999998654 47899999999999999999999998877777666665432222211 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+||+++++++|||
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 1122344555566668999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=291.37 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=193.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|...+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||++++++|.. .....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence 5889999999999999999999999999999886432 234579999999999999999998854 23345789
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeecccccccc
Confidence 9999986 5655555444445678999999999999999999999 79999999999999995 7889999999987653
Q ss_pred cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCchhhhhc-
Q 019506 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVSNIIYAKTIYQ- 306 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~- 306 (340)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ....+...+.....+.......
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 3222 23456788999999855 458999999999999999999999998652 1222222222211111111000
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..........+...|+..+|.+|||++|++.|||
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000111235566677778999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=305.58 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=188.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEE-----cCCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
...+|++++.||+|+||.||+|.+ ..++..||||+++... ....+|+++++.+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---- 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC---- 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee----
Confidence 345799999999999999999974 3456789999886432 2345799999999 899999999988
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhh-----------------------------------------------------
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYS----------------------------------------------------- 169 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----------------------------------------------------- 169 (340)
.+....++||||+++ +|.+.+....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 444558899999995 5655554311
Q ss_pred ------------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 170 ------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 170 ------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
.....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceecc
Confidence 012257888899999999999999999 79999999999999995 7889999999997654
Q ss_pred cCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 232 KGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 232 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ...++..|+|||++.+. .++.++|||||||++|+|++ |..||.+......+.+.++.........
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 340 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE---- 340 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC----
Confidence 332211 12235679999999654 58999999999999999998 8999987766555555555432221111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+...|+..+|.+||++.||+.
T Consensus 341 -~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 341 -CAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12223456667777778999999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=290.51 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=194.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||.|+||.||+|++..+++.||+|.+.+.. ....+|++++++++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4899999999999999999999899999999886432 2345789999999999999999888 555668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence 999999987 44444432 3578999999999999999999999 79999999999999995 88899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCchhhhhcc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+. .+.+..............
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 224 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT---- 224 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCccc----
Confidence 6555444455678889999999654 489999999999999999999999987764 333333333211111111
Q ss_pred ccccCChhhHhhhcccccccCCCCc--CcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSM--HESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~--~~i~~hpf 340 (340)
.......+.+.|+..+|.+|+++ +|+++|||
T Consensus 225 --~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 225 --WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred --CcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 12334455666777789999999 99999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.66 Aligned_cols=256 Identities=33% Similarity=0.596 Sum_probs=200.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhC-CCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|.+.+.||+|+||.||+|.+..+|+.+|+|.+... .....+|+.+++++ +|+||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 345799999999999999999999889999999987532 12234699999999 99999999998743 233
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
...++||||+++++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g~~ 154 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFGLA 154 (337)
T ss_pred ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccch
Confidence 45789999999877666543 377888899999999999999999 79999999999999995 889999999999
Q ss_pred cccccCCc------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 228 KVLVKGEA------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 228 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+.++......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 76643321 123457889999999876666889999999999999999999999988877777766665443321
Q ss_pred hh-----------hhcc-----------cc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KT-----------IYQG-----------LF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~-----------~~~~-----------~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ++.. .+ .......+...|+..+|.+|||+.++++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 11 0000 00 1122344556667778999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=287.41 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred CCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh---HHHHHHHHhCC--------CCceeecceee
Q 019506 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMD--------HPNVISLKHCF 139 (340)
Q Consensus 71 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~E~~~l~~l~--------h~~iv~~~~~~ 139 (340)
|..+...+|.+.++||.|.|++||+|++.++.+.||+|+.+....+. ..||.+|++++ ..+||++++.|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34455578999999999999999999999999999999998776554 46999999874 35799999988
Q ss_pred eecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec------
Q 019506 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD------ 213 (340)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~------ 213 (340)
... +.+..++|+|+|+++..|+.++... ..+.++...++.|++||+.||.|||+..||||.||||+|||+.
T Consensus 152 khs-GpNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 152 KHS-GPNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred eec-CCCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence 554 4678899999999999999998863 4578999999999999999999999878999999999999980
Q ss_pred --------------------------------------------------------------------------------
Q 019506 214 -------------------------------------------------------------------------------- 213 (340)
Q Consensus 214 -------------------------------------------------------------------------------- 213 (340)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred ----------------------------CC--------------------------------------------------
Q 019506 214 ----------------------------PL-------------------------------------------------- 215 (340)
Q Consensus 214 ----------------------------~~-------------------------------------------------- 215 (340)
..
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence 00
Q ss_pred -CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC------CChHHH
Q 019506 216 -THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG------ENAVDQ 288 (340)
Q Consensus 216 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~------~~~~~~ 288 (340)
+-++||+|||-|+.. ....+.-+.|+.|+|||++++.+ |+..+||||++|++|||+||...|.- ..+++.
T Consensus 389 ~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 003688888888765 23334456788999999999876 89999999999999999999999963 246788
Q ss_pred HHHHHHhcCCCchhhh-----hccccccC------------------------------ChhhHhhhcccccccCCCCcC
Q 019506 289 LVEIIKVSNIIYAKTI-----YQGLFCSN------------------------------NHEIMCELGSWYSYSGRNSMH 333 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~-----~~~~~~~~------------------------------~~~~~~~l~~~~~~~~R~~~~ 333 (340)
+..|++.++....+-. .+.+|.+. .+..+..-++...|.+|+|+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 9999887664432111 11111111 122233334455699999999
Q ss_pred cccccCC
Q 019506 334 ESKLYGF 340 (340)
Q Consensus 334 ~i~~hpf 340 (340)
+.++|||
T Consensus 546 ~cl~hPw 552 (590)
T KOG1290|consen 546 QCLKHPW 552 (590)
T ss_pred HHhcCcc
Confidence 9999999
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=295.56 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=192.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 357999999999999999999999999999999886432 2235688999999999999999988 3445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceEc
Confidence 99999986 4444443 2567889999999999999999999 79999999999999995 888999999998765
Q ss_pred ccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..... +.... .. .
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~-~ 240 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQN--PE-R 240 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCC--cc-c
Confidence 433322 23467888999999965 4578999999999999999999999987765444433332211 11000 00 0
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+..-|+..+|.+||+++++++|||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0111234555666678999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.31 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=188.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
+|++++.||+|+||.||+|.+ .+++.+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 478899999999999999985 578899999876432 2245689999999999999999988 444
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ +|.+.+.. ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence 568899999987 45444433 3568899999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccC-------CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 019506 227 AKVLVKG-------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI- 298 (340)
Q Consensus 227 a~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 298 (340)
+...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM 227 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence 8764221 11123457888999999865 44789999999999999999999999876655544444332111
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.... ........+.+.|+..+|.+||+++|++.|||
T Consensus 228 ~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 228 PRLPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CCCCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 11111 01122334556666667999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.29 Aligned_cols=255 Identities=33% Similarity=0.527 Sum_probs=197.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|++++++++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 357999999999999999999999999999999886432 223469999999999999999998743221 1223
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..+++++++++++.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence 4779999998777665542 468999999999999999999999 79999999999999995 7889999999987
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+.+....+.. .++..+
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA-ELLKKI 245 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH-HHHhhc
Confidence 6532 2234567889999999866556889999999999999999999999887776666666554432211 110000
Q ss_pred -----------------------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 -----------------------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 -----------------------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+ .......+..-|...+|.+|+++.+++.|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0 0111223444566778999999999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.93 Aligned_cols=204 Identities=27% Similarity=0.414 Sum_probs=171.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecC-CCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~ 151 (340)
.|...+.||+|+||.||+++++.+|+.||||.+.+. ++...+|+++|++++|+|||++.++-.... ..-.....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 467778999999999999999999999999988753 333457999999999999999987642211 00123356
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC---CCcEEEEeeccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLCDFGSA 227 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~---~~~~kl~Dfg~a 227 (340)
+|||||.| +|...+.. .....++++.+++.++.+++.||.|||+ +||+||||||.||++-.. ....||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999996 55555543 3456789999999999999999999999 799999999999998532 235899999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
+.+.++....+.+||..|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999999999999999999975577999999999999999999999999643
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.90 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=189.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
+|+..+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4788899999999999999999999999999886432 2345799999999999999999998 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++..+..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 568899999996 45554443 3578899999999999999999999 79999999999999986455799999999
Q ss_pred ccccccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---cCC
Q 019506 227 AKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---SNI 298 (340)
Q Consensus 227 a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~ 298 (340)
+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.+. ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC
Confidence 877643311 122456888999999865 45799999999999999999999999765543333333222 111
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..... .......+...|...+|.+||++.++++|||
T Consensus 230 ~~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 230 PSIPEH-----LSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred CCCchh-----hCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 111110 1112233445566667999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.87 Aligned_cols=255 Identities=33% Similarity=0.538 Sum_probs=201.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
.++|.+.+.||+|++|.||+|++..++..||+|++.... ....+|+.++++++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457999999999999999999999999999999876421 223469999999999999999987743322 2233
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++|+||+++++.+.+.. ..+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEccccccc
Confidence 4789999998887776653 578999999999999999999999 79999999999999995 8889999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..++.....+... ++.+.
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~ 243 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE-LLQKI 243 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH-HHhhc
Confidence 75332 2334678889999998655567899999999999999999999999888877777776654433211 11100
Q ss_pred c-------------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 F-------------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~-------------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+.+-|+..+|.+|||++|++.|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 0 0122334555566778999999999999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.13 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=191.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--------------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 5889999999999999999998899999999875311 1234688999999999999999987
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
......++||||+.+ ++.+.+.. ...+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~ 150 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS 150 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence 344558899999986 55555543 3578999999999999999999999 79999999999999995 8899999
Q ss_pred eeccccccccCCc---cceeeeeccccCcccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 223 DFGSAKVLVKGEA---NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 223 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|||++........ .....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+....+.++......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 9999976532211 22345688899999986543 4789999999999999999999999766655444443322221
Q ss_pred C-chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 I-YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ...... .. .......+...|+..+|..||++++++.|||
T Consensus 231 ~~~~~~~~-~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 231 PPIPPDVS-MN-LSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred CcCCcccc-cc-CCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 1 111111 11 1223344556667778999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=296.09 Aligned_cols=256 Identities=34% Similarity=0.524 Sum_probs=199.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCC--CcEEEEEEecccc------cChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||++++..+ +..||+|.+.... ....+|+++++++ +|+||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488999999999999999999887 8999999886431 2234688999988 5999999988754322 2234
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++++||++++|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence 5789999999887766643 4678999999999999999999999 79999999999999995 7889999999997
Q ss_pred ccccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 229 VLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 12346788999999986655689999999999999999999999998887777777766554433211
Q ss_pred hh----------------------ccc--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IY----------------------QGL--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~----------------------~~~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+. ... ........+..-|...+|.+|||++|++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00 000 01223445556666778999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=285.10 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=195.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|++.+.||+|+||.||++++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 4899999999999999999999999999999886321 2345789999999999999999988 4555689
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence 99999986 55555543 123467899999999999999999999 79999999999999985 788999999999766
Q ss_pred ccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...... ....++..|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....++..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 224 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH------ 224 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCccc------
Confidence 443222 123567889999998654 478999999999999999999999988877776666654332222111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+||+++|++.|||
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 1112334455556668999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=317.68 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=200.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+-+..+.||+|+||+||+|+... +...||||.++.+ +.+++||++++..++|||||+++|++ .+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 345677889999999999998643 3467999988754 45678999999999999999999999 55
Q ss_pred ceeeeeeecccc-chHHHHHHHhhc------CCC----CCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 147 ELFLNLVMEYVP-ETMYRVLKHYSS------MNQ----RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~------~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
..-+|+|+|||. |+|-+.|+.... .+. .++..+...|+.||+.|++||-+ +.+|||||..+|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge- 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE- 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-
Confidence 555899999999 567676664322 122 37888999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (340)
+..|||+|||+++.....+.... ..-...||+||.++-+ +++.++||||+||+|||+++ |+.||.+..+.+.++.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 88999999999988755544321 2336789999999754 59999999999999999998 9999999999888888
Q ss_pred HHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 292 IIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
+....-.+-+++ |..-...++..|+...|.+||+|+||.
T Consensus 718 i~~g~lL~~Pe~------CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQLLSCPEN------CPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCcccCCCC------CCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 887665444433 445556666777777799999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=295.90 Aligned_cols=254 Identities=35% Similarity=0.555 Sum_probs=197.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
.+|.+.+.||+|+||.||+|++..+|+.||||.+.... ....+|+++++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 47999999999999999999999999999999886431 123579999999999999999998854322 12234
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++|+||+..++.... ...+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence 6899999987544332 2468999999999999999999999 79999999999999995 88999999999876
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh------
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT------ 303 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 303 (340)
... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..++.....+....
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 532 223456788899999987655688999999999999999999999998877777766666443322100
Q ss_pred -----hhc-----------ccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 -----IYQ-----------GLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 -----~~~-----------~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. ..+ .......+.+.|+..+|.+||+++|++.|||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000 000 0111234556677778999999999999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=295.56 Aligned_cols=247 Identities=27% Similarity=0.355 Sum_probs=191.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.|.....||+|+||.||++.+..++..||||.+.... ....+|+.+++.++|+||+++++.+. .....++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 4555677999999999999998899999999875432 23457899999999999999999883 44558899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|||++++.+..+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhcccc
Confidence 99999754433332 2468899999999999999999999 79999999999999995 788999999998765332
Q ss_pred Cc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 EA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.. .....++..|+|||.+.+ ..++.++|+||||+++|||++|..||.+.+....+..+...... .... ....+.
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~ 246 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKD---SHKVSS 246 (292)
T ss_pred cccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-cccc---ccccCH
Confidence 22 223567889999999855 44799999999999999999999999877765555444332211 1111 011223
Q ss_pred ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+.+.|+..+|.+|||++|++.|||
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 3455666777788999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=276.08 Aligned_cols=257 Identities=25% Similarity=0.309 Sum_probs=193.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc----cccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+|++.+.||+|||+.||+++...++..||+|++.- +.....+|++..++++|||+++++++............|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3479999999999999999999999999999998863 233445899999999999999999877554444455688
Q ss_pred eeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
|+++|.. |++++.+......+..+++.++..|+.++++||++||+ .. ++||||||.|||+.. .+.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCcc
Confidence 9999988 67999998888878899999999999999999999999 67 999999999999995 7899999999987
Q ss_pred ccccCCcc----------ceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh
Q 019506 229 VLVKGEAN----------ISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKV 295 (340)
Q Consensus 229 ~~~~~~~~----------~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~ 295 (340)
...-.-.. ....+|..|+|||.+.. ....+.++|||||||+||+|+.|..||...-. ..-+...+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 64211111 12357889999999842 22368899999999999999999999952110 0001111111
Q ss_pred cCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 296 SNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.....+.+ --.+...-.+.+.|...+|.+||++.+++.+
T Consensus 258 ~q~s~P~~----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNS----SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCC----CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111111 0011122334455666678899999987653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.76 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=184.8
Q ss_pred Eeeeeeee--cceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 81 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 81 ~~~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+.++||+| +|++||++++..+|+.||+|.+..+. ....+|+++++.++||||+++++++. .....++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45779999 78999999999999999999986532 23457899999999999999999884 3445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ ++.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence 9999996 455555432 12458999999999999999999999 79999999999999995 7889999998654332
Q ss_pred cCCc--------cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc--
Q 019506 232 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-- 300 (340)
Q Consensus 232 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 300 (340)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+....... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 231 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT-VPCLL 231 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC-ccccc
Confidence 1111 1112456779999999653 358899999999999999999999998765444333332211 110
Q ss_pred ------hhhhhcc------------------------------c--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 ------AKTIYQG------------------------------L--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ------~~~~~~~------------------------------~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+... . ........+.+.|+..+|.+|||++|+++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0000000 0 00112335677788888999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=287.13 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=193.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++|.+.+.||+|+||.||+|.+..++..+++|.+.... ....+|++++++++|+||+++++++. +....++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence 46999999999999999999998889999999886543 44568999999999999999999884 345588999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence 99997 44444432 24678999999999999999999999 79999999999999995 788999999999876444
Q ss_pred C-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+......... ..-....
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 227 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS----DPEKWSP 227 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCC----chhhcCH
Confidence 3 22234568889999998654 5899999999999999999999999876654443332221111000 0000111
Q ss_pred ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+...|+..+|.+|||++|++.|||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 2344555666678999999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.46 Aligned_cols=241 Identities=26% Similarity=0.414 Sum_probs=187.4
Q ss_pred eeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc
Q 019506 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (340)
+||+|.||+||.|++..+...+|||.+... .....+|+.+.+.++|.|||+++|++ .+..++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999988633 34456899999999999999999997 566678899999998
Q ss_pred hHHHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc-c
Q 019506 160 TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-N 236 (340)
Q Consensus 160 ~l~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~ 236 (340)
+.+..|.+. .-+++ .+.++..+.+||++||.|||+ +.|||||||-+|+|++...|.+||+|||.++.+..-.. .
T Consensus 657 GSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 657 GSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 666555542 33555 889999999999999999999 79999999999999998899999999999988744433 3
Q ss_pred ceeeeeccccCccccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC----CCchhhhhcccccc
Q 019506 237 ISYICSRYYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN----IIYAKTIYQGLFCS 311 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 311 (340)
.++.||..|||||++- |...|+.++|||||||++.||.||++||..-.+.. ..+.+.+- ++.+.++ ..
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmyKvHP~iPeel-----sa 806 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMYKVHPPIPEEL-----SA 806 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--HhhhhhcceecCCCCcHHH-----HH
Confidence 4578999999999994 44569999999999999999999999997544322 22333322 2222221 11
Q ss_pred CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. +.+..-|-..+|..||++++++.-||
T Consensus 807 ea-k~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 807 EA-KNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred HH-HHHHHHHcCCCcccCccHHHhccCcc
Confidence 11 11222233344668999999999887
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=293.36 Aligned_cols=246 Identities=29% Similarity=0.424 Sum_probs=194.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++.. ...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 35999999999999999999998899999999885321 223478999999999999999999843 344
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||||+.+++.+.+... ...+++..+..++.|++.||.|||+ .||+||||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence 7899999999877666432 3468999999999999999999999 79999999999999995 88899999999876
Q ss_pred cccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ....++..|+|||++.+ ...++.++||||||+++|+|+||..||.+.+....+..+............
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND--- 238 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh---
Confidence 5332 23457888999999852 345788999999999999999999999887766655554432221111110
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+.+-|+..+|.+||++.+|+.|||
T Consensus 239 --~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 239 --WSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred --hCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 1122344556666677999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=286.73 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=188.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||+|++..++..||+|.+.... ....+|++++++++|+||+++++++.. .+..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence 6999999999999999999999999999999874321 233568999999999999999998743 2234
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.++++|||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECccccc
Confidence 57799999986 55555543 3458899999999999999999999 79999999999999995 788999999999
Q ss_pred cccccC----CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 230 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML-- 230 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC--
Confidence 765321 111234578889999999654 4789999999999999999999999877665555544432221111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+...-.+.+.+++. ++..||++.++++|||
T Consensus 231 --p~~~~~~~~~~i~~~l~--~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 231 --PDGVSDACRDFLKQIFV--EEKRRPTAEFLLRHPF 263 (264)
T ss_pred --CcccCHHHHHHHHHHhc--CcccCccHHHHhcCCC
Confidence 11122222333333333 3689999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=291.45 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=191.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCC-----cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46899999999999999999876555 679999886432 2345799999999999999999988 34
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
....+++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 4457899999985 66666654211 11467889999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 019506 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (340)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (340)
. ++.++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 ~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 E-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred C-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 78899999999976533321 1223457789999998654 48999999999999999998 99999887776555
Q ss_pred HHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 290 VEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+.+ ........ .+......+...|+..+|.+||+++||.++
T Consensus 237 ~~i~~-~~~~~~~~-----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRS-RQLLPCPE-----DCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHc-CCcCCCcc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44443 22221111 133445566777888889999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=295.41 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=186.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcE----EEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||.||+|++..++.. ||+|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 4699999999999999999998766654 8999876432 234568899999999999999998742 1
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..++|+||+.+ ++.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEccccc
Confidence 25689999985 56555543 23468888999999999999999999 79999999999999985 78899999999
Q ss_pred ccccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++.......... ..++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ +..++.........
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 233 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQP 233 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCC
Confidence 987654333221 223567999999965 458999999999999999997 999998766544 34444433222111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
. .+......+...|+..+|..||++.+++.+
T Consensus 234 ~-----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 234 P-----ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred C-----CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 233445666777788889999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.41 Aligned_cols=253 Identities=35% Similarity=0.626 Sum_probs=196.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+.+. .....+|+++++.++||||++++++|... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 456799999999999999999999999999999987542 22345799999999999999999987432 23
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++||||+++++...+. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++. ++.++|+|||++.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence 477999999887666554 2568888899999999999999999 79999999999999995 8889999999987
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh-----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT----- 303 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 303 (340)
.... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+.+....+..+.
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6432 223346688899999986655689999999999999999999999988776555555444333221100
Q ss_pred ------hhccc-----------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 ------IYQGL-----------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ------~~~~~-----------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++..+ . .......+.+.|+..+|.+||++++++.|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 00000 0 1122334556667778999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=284.35 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=192.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||++.+..+|..+|+|.+... .....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 488999999999999999999999999999988543 23345799999999999999999988 4455689
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ ++.+.+... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++..+..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999986 665555431 22357899999999999999999999 799999999999999864456899999999776
Q ss_pred ccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...... ....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+.+..+.......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~- 225 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-----N- 225 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCC-----C-
Confidence 443322 123578889999998654 47899999999999999999999998777655555444322111110 0
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|++.|||
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 1122334445556667999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.43 Aligned_cols=256 Identities=34% Similarity=0.554 Sum_probs=197.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCC-Cce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 148 (340)
.++|.+.+.||+|+||.||+|.+..+|..||||.+.... ....+|+++++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 347999999999999999999999999999999885432 1234799999999999999999988543221 123
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++||||+++++...+. ...+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccccc
Confidence 468999999777665553 2578999999999999999999999 79999999999999995 7889999999997
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch-------
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA------- 301 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------- 301 (340)
..... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+....+..+.+.......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 65332 223456888999999866455889999999999999999999999988877777776664433211
Q ss_pred ----hhhhccc-----------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 ----KTIYQGL-----------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ----~~~~~~~-----------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+...+ . .......+..-|...+|.+|||+.+++.|||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000000 0 0111223444566778999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=286.30 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=191.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+++++.++|+||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 46999999999999999999999999999999775321 223569999999999999999998843 345
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ ++.+.+.........+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 7899999996 5665665544445668999999999999999999999 79999999999999995 7889999999987
Q ss_pred ccccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCchhhhhc
Q 019506 229 VLVKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 229 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 306 (340)
........ ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ...+...+.....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT--- 230 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh---
Confidence 76433221 234578889999998654 478999999999999999999999965432 223333333322222110
Q ss_pred cccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
. ........+...|+..+|.+||++++++++
T Consensus 231 ~-~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 231 E-HYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred h-hcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0 012234455566777789999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=284.20 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=191.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|.+.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+ .+...+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4889999999999999999999999999999885322 2335688899999999999999988 44556899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence 9999986 55555543 224568899999999999999999999 79999999999999985 8889999999997664
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.... .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+......+.... .
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~ 224 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH------Y 224 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcc------c
Confidence 3322 2345678889999998554 489999999999999999999999988776555555544322221111 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccc
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......+..-|+..+|.+||++++|+.
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 122344555666678999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=298.00 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=186.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.++|++.+.||+|+||.||+|++.. +++.||+|++.... ....+|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 4579999999999999999997543 45789999886432 1234689999999 79999999998753
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhc-----------------------------------------------------
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSS----------------------------------------------------- 170 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 170 (340)
....++++|||+++ ++.+.+.....
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 23357899999996 55555432111
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeeeec
Q 019506 171 ----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSR 243 (340)
Q Consensus 171 ----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~ 243 (340)
....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++......... ....++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 02367899999999999999999999 79999999999999995 788999999999876433221 1223466
Q ss_pred cccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcc
Q 019506 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGS 322 (340)
Q Consensus 244 ~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (340)
.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...++......... ........+...|+
T Consensus 240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl 313 (337)
T cd05054 240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE-----YATPEIYSIMLDCW 313 (337)
T ss_pred cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCc-----cCCHHHHHHHHHHc
Confidence 79999999664 48999999999999999998 9999987655555555554332222111 11122234445566
Q ss_pred cccccCCCCcCccccc
Q 019506 323 WYSYSGRNSMHESKLY 338 (340)
Q Consensus 323 ~~~~~~R~~~~~i~~h 338 (340)
..+|.+||+++|+.+|
T Consensus 314 ~~~p~~RPs~~ell~~ 329 (337)
T cd05054 314 HNNPEDRPTFSELVEI 329 (337)
T ss_pred cCChhhCcCHHHHHHH
Confidence 6679999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.99 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=192.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|...+.||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 4788899999999999999999899999999886432 2345788999999999999999998 44456899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ ++.+.+. ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceecc
Confidence 9999987 5554443 2568889999999999999999999 79999999999999995 7889999999997764
Q ss_pred cCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..... ....++..|+|||++.+. .++.++|+|||||++|+|+||..||...+.......+.. ...+.... ..
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~-----~~ 225 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTG-----EF 225 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCch-----hh
Confidence 43322 233567889999998654 479999999999999999999999987766554443322 11111111 01
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|..||++++++.|||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 223445666677778999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.36 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=185.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
......||+|+||.||+|++..++..|++|.+.... ....+|+.+++.++|+||+++++++ ......++|+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEE
Confidence 334467999999999999999899999999876432 2346799999999999999999988 4445688999
Q ss_pred ccccc-hHHHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||+++ +|.+.+... ...+ ++..+..++.|++.||.|||+ +||+||||||+||+++..++.++|+|||++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99986 555555431 1334 788888999999999999999 7999999999999998656789999999987653
Q ss_pred cCCc-cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCchhhhhccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... .....++..|+|||++.+. ..++.++|+||||+++|+|++|..||........ ...+......+....
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 235 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE----- 235 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc-----
Confidence 3222 2234578899999998543 2378899999999999999999999976443222 211111111111000
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+.+.|+..+|.+|||++|++.|||
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 01112334556666778999999999999999
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.00 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=191.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||+|.+..+++.|++|.+..... ...+|+.+++.++|+||+++++.+ .+....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 48899999999999999999988999999998875433 335789999999999999999987 4445588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++. ++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence 99999996 45544432 3458899999999999999999999 79999999999999996 888999999999876
Q ss_pred ccCCccc-----eeeeeccccCcccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 231 VKGEANI-----SYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 231 ~~~~~~~-----~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ...++..|+|||++.+.. .++.++||||||+++|+|++|+.||............+.....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 4433321 235678899999986433 278899999999999999999999976543333333333222222111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .-.......+..-|+..+|.+||+++||+.|||
T Consensus 230 ~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 230 S---LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred c---cccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 1 011223345566666777999999999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.06 Aligned_cols=244 Identities=26% Similarity=0.347 Sum_probs=190.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|...+.||+|+||.||+|.+..++..||+|.+.... ....+|+++++.++|+||+++++++ ......++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4777888999999999999998899999999886432 2345799999999999999999988 44556889
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||++++ +.+.+. ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEcccccccccc
Confidence 99999974 444332 3568899999999999999999999 79999999999999995 8889999999997664
Q ss_pred cCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..... ....++..|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.... .+.... ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~-----~~ 225 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEG-----QY 225 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCc-----cc
Confidence 33221 223568889999999654 57899999999999999999999998665544443332221 111100 11
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+||++.|++.|||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 223445566677778999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=288.65 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=186.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEc----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||+||+|.+. .++..|++|.+.... ....+|+++++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 46899999999999999999853 456789999886422 2345799999999999999999987 344
Q ss_pred eeeeeeeccccc-hHHHHHHHhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYS-------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
...++||||+++ ++.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 458899999986 5555553211 012357888899999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 019506 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (340)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (340)
. ++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 E-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred C-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 78899999999976543321 1223346679999998654 48999999999999999998 99999877665444
Q ss_pred HHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 290 VEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+......+.... +......+...|+..+|.+||++.+|..+
T Consensus 237 ~~~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLLPCSED------CPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCCCCCC------CCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44433222221111 22233455566777789999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=284.13 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=189.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..+.. ...+|+++++.++|+||+++++++ .....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence 358999999999999999999999999999998875432 345799999999999999999988 344457899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ ++.+.+.. .....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence 999985 55555543 223468899999999999999999999 79999999999999985 88899999999987644
Q ss_pred CCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...........
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG------ 229 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC------
Confidence 32211 1123557999999865 458999999999999999998 9999988776555444443222221111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+||+++++.+
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1223444566677778999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=287.04 Aligned_cols=252 Identities=32% Similarity=0.567 Sum_probs=200.8
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++.+.||+|++|.||+|++..+++.||+|.+.... .....|+.+++.++|+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567788999999999999999999999999887542 12346899999999999999999883 3456889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
||||+++++.+.+... ...+++..+..++.|++.||.|||+ +||+||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence 9999998887777642 1478999999999999999999999 79999999999999995 88899999999977644
Q ss_pred CC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh------
Q 019506 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY------ 305 (340)
Q Consensus 233 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 305 (340)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+.++.+....+....+-
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 22233457789999998766568999999999999999999999999988877777777654433322110
Q ss_pred --c------------cccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 --Q------------GLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 --~------------~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ..+. ......+.+-|+..+|.+||+++++.+|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 0 0000 122345566677778999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=277.66 Aligned_cols=258 Identities=28% Similarity=0.492 Sum_probs=207.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc--ccc----ChHHHHHHHHhCCCCceeecceeeeecCC---CCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRR----YKNRELQLMRLMDHPNVISLKHCFFSTTS---KDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~ 147 (340)
..|.-..+||+|.||.||+|+.+.+|+.||+|++.- +.. ...+|+.+|..++|+|++.+++.+-.... .+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 357778899999999999999999999999996643 222 22489999999999999999988743322 234
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..+|+||++|+.+|...|.. ...+++..++..++.+++.||.|+|+ ..|+|||+|++|+|++. ++.+||+|||++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeeccccc
Confidence 45889999999988777753 34789999999999999999999999 69999999999999994 899999999999
Q ss_pred cccccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
+.+..... .+..+-|.+|.+||.++|...|+++.|||+.|||+.||.||.+.|.++++..++..|...++....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk- 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK- 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc-
Confidence 77643322 234566999999999999999999999999999999999999999999999888888776654321
Q ss_pred hhhcc-----------------------------ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQG-----------------------------LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~-----------------------------~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.|.+ ....+-.-.+.+.+..++|.+|+++++.++|.|
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11111 111111223455667778999999999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=301.25 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=207.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+++++..||-|+||.|-++........+|+|++++.. ...-.|-++|..++.+.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 45677788999999999999876555568999886542 1123578899999999999999999 88888
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|++||-|-| .+|..|+. .+.|+...++.++..+++|++|||+ +|||+|||||+|.+++. ++-+||.|||+|+
T Consensus 495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhHH
Confidence 9999999875 67777765 5789999999999999999999999 79999999999999995 8889999999999
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.+..+..+.+++||+.|.|||++++.+ .+.++|.||||+++|||++|.+||.+.+....+..|++..+...- ..-
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~----Pr~ 643 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF----PRR 643 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc----ccc
Confidence 999999999999999999999998766 799999999999999999999999999999999999886553321 122
Q ss_pred cccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
..+...+.+..||.. .|.+|+. +.||+.|-|
T Consensus 644 I~k~a~~Lik~LCr~-~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRD-NPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred cchhHHHHHHHHHhc-CcHhhhccccCChHHHHhhhh
Confidence 355566666666665 4777766 678888887
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.65 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=194.7
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEecc-----c---ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----D---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+...+||+|+|-+||+|.|..+|..||.-.++. . ...+..|+.+|+.|+|+||++++..+++... ..+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 455779999999999999999999998654431 1 2445679999999999999999999976433 4577
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+|++.. +|..+++. .+++..+.++.|++||++||.|||+. ..|||||||.+||||+...|.|||+|+|+|..
T Consensus 120 ~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 99999985 55555544 57788899999999999999999983 36999999999999998789999999999988
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
....... ..+|||.|||||++. ..|+..+||||||+++.||+|+.+||....+..++++.+-.+..|..-.. .
T Consensus 196 ~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k---V- 268 (632)
T KOG0584|consen 196 LRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK---V- 268 (632)
T ss_pred hhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc---c-
Confidence 7554443 479999999999994 56999999999999999999999999998888888777765554432111 1
Q ss_pred ccCC-hhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNN-HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~-~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++| ...+.+-|+.. ..+|+|+.|+++|||
T Consensus 269 -~dPevr~fIekCl~~-~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 269 -KDPEVREFIEKCLAT-KSERLSAKELLKDPF 298 (632)
T ss_pred -CCHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence 111 12233333333 568999999999998
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=279.29 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=197.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
+|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+++++.++|+||+++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4888999999999999999998899999999886554 34567999999999999999999884 33458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
+||+++ ++.+.+... ...+++..+..++.|++.||.+||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence 999995 555554431 2578999999999999999999999 79999999999999995 88899999999987755
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+....+..+.. ...+... .......
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~ 225 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLR---NPEKWSD 225 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcC---cccccCH
Confidence 44334456788999999996544 78999999999999999999999987765555554443 2111111 1111123
Q ss_pred ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+...|+..+|.+|||++|++.|||
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 3455666777778999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.55 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=191.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHHHHhC-CCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 147 (340)
...++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+|+.++.+. .|+||+++++++ .+.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 345679999999999999999999988899999999865321 123455555555 599999999998 444
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
...++||||+++.+...+... ...+++..+..++.|++.||.|||+..||+||||+|+||+++. ++.+||+|||++
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccc
Confidence 458899999988666655442 3478999999999999999999996249999999999999995 889999999999
Q ss_pred cccccCCccceeeeeccccCcccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 303 (340)
.............++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+..+..... +....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 241 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPP 241 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-CCCCC
Confidence 776544433344567889999998643 2378899999999999999999999976433 233333333221 11110
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..........+...|+..+|.+||++++++.|||
T Consensus 242 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 242 ---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0011223445566777778999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.24 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=191.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+|.+.+.||+|+||.||++.+..+++.|++|.+.... ....+|+++++.++|+||+++++.+ .....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999886432 2234688999999999999999888 445568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCccc
Confidence 999999997 45555433 3578999999999999999999999 79999999999999995 88999999999864
Q ss_pred cccCC----------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 019506 230 LVKGE----------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (340)
Q Consensus 230 ~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 293 (340)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21000 01123467789999998654 48999999999999999999999998877665555544
Q ss_pred HhcCCCchhhhhccccccCChhhHhhhcccccccCCCC---cCcccccCC
Q 019506 294 KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS---MHESKLYGF 340 (340)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~---~~~i~~hpf 340 (340)
... ...+... . -.......+..-|+..+|.+||+ +.++++|||
T Consensus 230 ~~~-~~~~~~~--~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 230 SDD-IEWPEGD--E-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred hcc-cCCCCcc--c-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 422 1111100 0 11223455667777778999998 688899998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.75 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=199.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||++.+..++..|++|++.... ....+|+++++.++|+|++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 4889999999999999999999899999999986542 22457899999999999999999884 335688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ ++.+.+.........+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence 99999986 6666666543335789999999999999999999999 79999999999999995 788999999999776
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+......... ...... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-----~ 226 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS-----Q 226 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC-----C
Confidence 4443 22234678889999998654 47899999999999999999999998777655555544332 222111 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+.+.|+..+|.+||+++|+++|||
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 2233445666777778999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=284.18 Aligned_cols=239 Identities=27% Similarity=0.443 Sum_probs=188.2
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||.|++|.||+|++..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+ .+....++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 689999999999998889999999886432 2345789999999999999999987 3445588999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ +|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence 85 55555543 3568999999999999999999999 79999999999999995 788999999999877555433
Q ss_pred ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCchhhhhccccccCCh
Q 019506 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVSNIIYAKTIYQGLFCSNNH 314 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (340)
....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.... ..+.+..+.........+.. .....
T Consensus 150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 223 (262)
T cd05572 150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY-----IDKAA 223 (262)
T ss_pred ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcc-----cCHHH
Confidence 44567889999999855 447999999999999999999999998776 44444444431221111111 12233
Q ss_pred hhHhhhcccccccCCCC-----cCcccccCC
Q 019506 315 EIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 315 ~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
..+..-|+..+|.+|++ ++|+++|||
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 45555666677999999 999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.55 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=187.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34579999999999999999998642 45679999875432 1234788999999999999999987
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~ 217 (340)
......++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CC
Confidence 444568899999986 565555432211 2345778889999999999999999 79999999999999995 88
Q ss_pred cEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 019506 218 QVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (340)
Q Consensus 218 ~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 293 (340)
.++|+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999998765332221 11234677999999965 448999999999999999999 789998877665555554
Q ss_pred HhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 294 KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......... .+......+...|...+|.+||++.|++.
T Consensus 236 ~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 236 EGGLLDKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred cCCcCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 432221111 12223455666777778999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=267.56 Aligned_cols=254 Identities=27% Similarity=0.483 Sum_probs=207.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|++.+++|+|.++.||.|.+..+++.++||+++.- .+...+|+.+|+.+. |+||++++++..+. ......+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCchhH
Confidence 45799999999999999999999999999999988743 344578999999987 99999999988543 33346699
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
+||+...-+..+- ..++...++.++.|++.||.|||+ .||+|||+||.|+++|.....++|+|+|+|.+...+
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999986443332 567788899999999999999999 699999999999999987889999999999999888
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCchhhh--------
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVSNIIYAKTI-------- 304 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~-------- 304 (340)
..-.-.+.+++|--||.+..-..|+..-|+|||||+|..|++.+-| |.|.++.+++.+|.+..++......
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 7766778899999999999888899999999999999999998755 5688899999999998776432111
Q ss_pred ---------------hccccccC--------ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------------YQGLFCSN--------NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------------~~~~~~~~--------~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
|..+..+. -.+. .+-.+.++..+|+|++|.+.|||
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl-ldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL-LDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHH-HHHHHhhccccccchHHHhcCch
Confidence 22222111 1222 33344557889999999999997
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.20 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=164.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|++.++||+|+||.||+|++..+|+.||+|++..+. ....+|+++++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 47999999999999999999999999999999986432 2245799999999999999999988 44456
Q ss_pred eeeeeccccc-hHHHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
.++||||++| +|.+.+..... ....++...+..++.||+.||+|||+ +||+||||||+||+++. ++.++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence 8899999996 55555543211 12345667788999999999999999 79999999999999995 788999
Q ss_pred EeeccccccccCC-------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 019506 222 CDFGSAKVLVKGE-------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (340)
Q Consensus 222 ~Dfg~a~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (340)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 00124689999999999654 489999999999999999999999987
Q ss_pred CChH
Q 019506 283 ENAV 286 (340)
Q Consensus 283 ~~~~ 286 (340)
.+..
T Consensus 234 ~~~~ 237 (932)
T PRK13184 234 KKGR 237 (932)
T ss_pred cchh
Confidence 5543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=290.46 Aligned_cols=246 Identities=25% Similarity=0.334 Sum_probs=189.3
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 555567999999999999998899999999885422 23347889999999999999999883 344588999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
||++++.+..+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.......
T Consensus 98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhccccc
Confidence 9999753333322 2568999999999999999999999 79999999999999995 8899999999987653332
Q ss_pred c-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 235 A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 235 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
. .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.... ....... . .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~--~~~~~ 246 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNA-H--KISPV 246 (297)
T ss_pred ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCcccc-C--CCCHH
Confidence 2 2335678899999999654 48999999999999999999999998777655554443221 1111100 0 01112
Q ss_pred hhhHhhhcccccccCCCCcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+.+.|+..+|.+||+++++++|||
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 344566667778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.30 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=190.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.++... ....+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 468899999999999999998743 46789999886532 234579999999999999999998843
Q ss_pred ceeeeeeeccccc-hHHHHHHHhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYS----------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
....++||||+++ +|.+.+.... .....+++..+..++.|++.||.|||+ +|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~- 157 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY- 157 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC-
Confidence 3458899999986 5555554321 123457888999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (340)
++.+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 78999999999876433221 1123346789999999654 48999999999999999998 9999988777665555
Q ss_pred HHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 292 IIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+.......... ........+.+-|+..+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGRLLQRPR------TCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCcCCCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54322211111 12334456677777788999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=288.85 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=189.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+|++.+.||+|+||+||++.+..+|+.||+|++.... ....+|+++++.++|+||+++++++. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 46899999999999999999999999999999876432 23457899999999999999999983 445688
Q ss_pred eeeccccchHH-HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||++++.+ ..+.. .+.+++..++.++.|++.+|.|||+..|++||||||+||+++. ++.++|+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~~ 154 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccch
Confidence 99999997533 33322 3578999999999999999999996348999999999999995 888999999998654
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHHhcCCC
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-----------DQLVEIIKVSNII 299 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~ 299 (340)
.... .....++..|+|||++.+. .++.++|+|||||++|+|+||..||...... +.+..++......
T Consensus 155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd06620 155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232 (284)
T ss_pred hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC
Confidence 3222 2234678899999998654 5899999999999999999999999865432 1222222211111
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... ........+...|...+|.+||+++|+++|||
T Consensus 233 ~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 233 LPSS-----DFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCch-----hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 01122345566677778999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.99 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=187.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+++++.++|+||+++++++ .+....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence 35889999999999999999864 45689999876432 2345799999999999999999988 344458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ ++.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence 999985 55554432 22468899999999999999999999 79999999999999995 88899999999876533
Q ss_pred CCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... ...++..|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+.+..+.+..+.+......+ . .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~-----~ 225 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-K-----L 225 (256)
T ss_pred CceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC-C-----C
Confidence 32221 1233557999999864 458999999999999999999 99999888776666666553322111 1 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|+..+|.+||++++++.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1222355666677778999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.84 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=187.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEecccc-----cChHHHHHHHHhCC-CCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 143 (340)
..++|++++.||+|+||.||+|.+... +..||||++.... ....+|+++++++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 456799999999999999999987433 3579999886432 23457999999996 99999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc----------------------------------------------------
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (340)
.+...+++|||||++ +|.+.+.....
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 445568999999985 55555543110
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 171 ----------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 171 ----------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
....+++..+..++.||+.||.|||+ +||+||||||+||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni 268 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence 12357888889999999999999999 7999999999999
Q ss_pred EecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 019506 211 LVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 286 (340)
|++. ++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 269 ll~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 269 LLAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9995 788999999999765433221 123456789999999654 48999999999999999997 99999876655
Q ss_pred HHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 287 DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+.+...++......... .+......+...|+..+|.+||++.++.+
T Consensus 347 ~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRMAKPD-----HATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCCCCCc-----cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 55555554432221111 11223345666677778999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.99 Aligned_cols=245 Identities=29% Similarity=0.432 Sum_probs=194.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|...+.||+|+||.||++++..++..+|+|.+.... ....+|+++++.++|+|++++++++. +....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 3788899999999999999999999999999886432 12346899999999999999999884 33457
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+.+++.+.+... ...+++..+..++.|++.||.|||+ +||+||||+|+||+++. ++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence 899999999877665432 3568999999999999999999999 79999999999999985 788999999998764
Q ss_pred ccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ....++..|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.+..........
T Consensus 176 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 248 (317)
T cd06635 176 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE---- 248 (317)
T ss_pred CCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc----
Confidence 322 23467888999999742 344789999999999999999999999887776777766664433322111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+||++++++.|+|
T Consensus 249 -~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 249 -WSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -ccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1112234455566667999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=286.20 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=190.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCC---CCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.|.+.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+.+++.++ |+|++++++++. +...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4778899999999999999999999999999886432 23456888888886 999999999883 3445
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 8899999987 4444433 2478899999999999999999999 79999999999999995 8889999999998
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
....... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+... ..+. +...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~ 225 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPR---LEDN 225 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCC---CCcc
Confidence 7654432 223467888999999866556789999999999999999999999876654433322221 1111 1000
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .......+...|+..+|.+||+++|++.|||
T Consensus 226 ~-~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 226 G-YSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred c-CCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 0 1123344556677778999999999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.14 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=196.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC-----
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK----- 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----- 145 (340)
..+|+..+.||+||||.||+++++-+|+.||||++.... ....+|+.++.+|+|||||+++..+.+....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346788899999999999999999999999999997542 2234799999999999999998544211100
Q ss_pred --------------------------------------------------------------------------------
Q 019506 146 -------------------------------------------------------------------------------- 145 (340)
Q Consensus 146 -------------------------------------------------------------------------------- 145 (340)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------Cc-------eeeeeeeccccchHHHHHHHhhcCCCCC-CHHHHHHHHHHHHHHHHHHH
Q 019506 146 ----------------------DE-------LFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYIH 195 (340)
Q Consensus 146 ----------------------~~-------~~~~lv~e~~~~~l~~~l~~~~~~~~~~-~~~~~~~i~~qi~~~l~~LH 195 (340)
+. ..+||-||||+.+++..+.+.. ... ....+|++++||+.||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 4578999999998777766532 222 46789999999999999999
Q ss_pred cCCCceecCCCCCCeEecCCCCcEEEEeeccccccc-------------------cCCccceeeeeccccCcccccCCC-
Q 019506 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-------------------KGEANISYICSRYYRAPELIFGAT- 255 (340)
Q Consensus 196 ~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~- 255 (340)
+ +|||||||||.||++++ ++.|||+|||+|+... .....++.+||..|+|||++.+..
T Consensus 715 ~-~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 D-QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred h-CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 79999999999999995 7889999999998721 111345678999999999997655
Q ss_pred -CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCc
Q 019506 256 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHE 334 (340)
Q Consensus 256 -~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~ 334 (340)
.|+.|+|+|||||||+||+. ||...-+.......++....|...+++.+.. .-...+.++++..+|++|||+.|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~--~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH--PEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc--hHHHHHHHHHhcCCCccCCCHHH
Confidence 69999999999999999985 5865544444444455555565544443322 12456778888889999999999
Q ss_pred ccccCC
Q 019506 335 SKLYGF 340 (340)
Q Consensus 335 i~~hpf 340 (340)
++++.|
T Consensus 868 LL~s~l 873 (1351)
T KOG1035|consen 868 LLNSEL 873 (1351)
T ss_pred HhhccC
Confidence 998865
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.17 Aligned_cols=251 Identities=17% Similarity=0.200 Sum_probs=178.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC---CcEEEEEEecccccChHH---------------HHHHHHhCCCCceeeccee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKNR---------------ELQLMRLMDHPNVISLKHC 138 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~---------------E~~~l~~l~h~~iv~~~~~ 138 (340)
.+|.+.+.||+|+||+||+|.+..+ +..+|+|+.......... +...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4699999999999999999998777 667788864332222111 2223456689999999987
Q ss_pred eeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc
Q 019506 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (340)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~ 218 (340)
..... ....+.++++|++..++.+.+.. ....++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence 64322 12234578899887766655543 2345788899999999999999999 79999999999999985 788
Q ss_pred EEEEeeccccccccCC--------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 019506 219 VKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (340)
++|+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999997653221 1122468999999999865 458999999999999999999999998774333322
Q ss_pred HHHHhcC---CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 291 EIIKVSN---IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 291 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+... ....+..+.. +......+.+.|+..+|.+||++++|..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKN--ANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhccCC--CCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222110 0000000111 1222445667777778999999999864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=290.73 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=184.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcE--EEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|.+.+.||+|+||.||+|.+..++.. +++|.+.... ....+|++++.++ +|+||+++++++ ....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 4799999999999999999998877764 5777665321 2234689999999 899999999988 4445
Q ss_pred eeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
..++||||+++ ++.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~- 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE- 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecC-
Confidence 68999999985 66666543211 12357899999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
++.+||+|||++.............++..|+|||++.+ ..++.++|||||||++|+|+| |..||.+.+..+....+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 78899999999864322211112223567999999854 448999999999999999998 9999987766554443322
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....... .-.......+...|+..+|.+||++++++.
T Consensus 239 ~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 239 GYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred CCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111 012233445666777778999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.66 Aligned_cols=246 Identities=29% Similarity=0.414 Sum_probs=194.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|.+.+.||+|++|.||+|++..+++.|++|++.... ....+|+..++.++|+||+++++++ ......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 5889999999999999999999999999999887543 3345789999999999999999988 34456889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ . |++||||+|+||+++. ++.++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~ 150 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKVL 150 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCccceec
Confidence 9999995 56555543 3678999999999999999999998 6 9999999999999995 889999999999876
Q ss_pred ccCCccc-eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--h-HHHHHHHHHhcCCCchhhhhc
Q 019506 231 VKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--A-VDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 231 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 306 (340)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|+||..||.... . .+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 226 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE--- 226 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc---
Confidence 5444332 45678899999998654 58999999999999999999999998764 3 333333332211111111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+.+.|+..+|.+||+++|+++|||
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 02233455556666778999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.97 Aligned_cols=248 Identities=20% Similarity=0.256 Sum_probs=187.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+|++.+.||+|+||+||+|++..+ +..||+|++..... ...+|+.+++.++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 3588899999999999999987543 57899998875432 245688899999999999999988 34
Q ss_pred ceeeeeeeccccc-hHHHHHHHh------------hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHY------------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
....++++||+.+ ++...+... ......+++..+..++.|++.||.|||+ +||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 4457899999986 444444311 0112457888899999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 019506 214 PLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (340)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (340)
. ++.+||+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+.+
T Consensus 159 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C-CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 788999999998765433221 122346789999998654 48999999999999999998 88999887776655
Q ss_pred HHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 290 VEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+......+...+ +......+..-|+..+|.+||++++|...
T Consensus 237 ~~i~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVLPCPDD------CPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcCCCCCC------CCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 55554332222111 22334566677777789999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.99 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=186.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCc--EEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
|.+++.||+|+||.||+|++..++. .+|+|.++... ....+|+++++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877765 68999875431 233568899999999999999987754322 12234
Q ss_pred eeeeeccccc-hHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.+++|||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence 6799999985 5554443211 123458899999999999999999999 79999999999999985 88899999999
Q ss_pred ccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+....+....+.+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9876433221 12234667999999855 458999999999999999999 899998776655444443322222111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
-+......+...|+..+|.+|||++++.+
T Consensus 238 ------~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 238 ------DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred ------CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12233456677778888999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=284.91 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=191.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+++++.++|+||+++++.+. .....++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence 5788899999999999999999999999999886542 22357889999999999999999883 3456889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
++||+++ +|.+.+... ...+++..+..++.|++.||.|||+..|++|+||||+||+++. ++.++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhhH
Confidence 9999995 665555432 2678999999999999999999999339999999999999996 8889999999987664
Q ss_pred cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... ...++..|+|||.+.+. .++.++||||||+++|+|++|..||...+ ..+.+..+............
T Consensus 153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 228 (265)
T cd06605 153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK-- 228 (265)
T ss_pred HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh--
Confidence 33222 25678889999999654 58999999999999999999999997542 22233333222111111110
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+|||+.|++.|||
T Consensus 229 ---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 229 ---FSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred ---cCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 1223445566677778999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.78 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=185.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc--EEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
++|.+.+.||+|+||.||+|++..++. .+++|.++... ....+|+.+++++ +||||+++++++ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 368999999999999999999877765 46888776321 2345789999888 799999999988 4445
Q ss_pred eeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
.+++||||+++ ++.+.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence 58899999985 66666643211 12358899999999999999999999 79999999999999985
Q ss_pred CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
++.+||+|||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 78899999999864322211111222456999999865 448999999999999999997 9999988877666655544
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........ .+......+...|+..+|.+||+++++..
T Consensus 234 ~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 234 GYRMEKPR------NCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 32221111 12223345666677778999999999853
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=283.05 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=188.4
Q ss_pred eeEeeeeeeecceEEEEEEEcCC---CcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 79 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
|.+++.||+|+||.||+|....+ +..||+|.++.+.. ...+|+..++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 47899998875422 23568999999999999999998754332 2334
Q ss_pred eeeeeeccccc-hHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..+++|||+.+ ++...+.... .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence 57899999996 5555543321 123468999999999999999999999 79999999999999995 7889999999
Q ss_pred cccccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+++......... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998764332211 1223567999999854 458999999999999999999 89999887776655555443322221
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
. .+......+..-|+..+|.+||++.|+..+
T Consensus 238 ~------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 E------DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred c------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 122334455556777889999999998653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.45 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=189.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 3469999999999999999999877 77889999876432 234568899999999999999998743
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC--CcE
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQV 219 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~--~~~ 219 (340)
....++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ ++++||||||+||+++..+ ..+
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 3346899999975 66666654321 12358899999999999999999999 7999999999999998422 369
Q ss_pred EEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 019506 220 KLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 295 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 295 (340)
||+|||+++........ .....+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876322211 112234579999999654 48999999999999999997 99999987776655544443
Q ss_pred cCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 296 SNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.....+.. .......+.+-|+..+|.+||++.++++|
T Consensus 238 ~~~~~~~~------~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRLDPPKG------CPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcCCCCCC------CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22222111 22344566777888889999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=284.06 Aligned_cols=244 Identities=26% Similarity=0.352 Sum_probs=189.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
-|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence 3778899999999999999998899999999875432 2345788999999999999999988 44455889
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||++++ +.+.+. ...+++..+..++.|++.++.+||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecc
Confidence 99999974 444433 2568899999999999999999999 79999999999999995 7889999999987654
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. ...+.... ..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-----~~ 225 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEG-----NY 225 (277)
T ss_pred cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCc-----cc
Confidence 3322 122456888999999865 4478999999999999999999999987665544444332 22211110 01
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|..||++++++.|||
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 122344556667778999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=284.84 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=189.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|.+.+.||+|+||.||+|++..++..+|||.+... .....+|+.+++.++|+||+++++++. +...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 3688999999999999999999999999999977532 123346899999999999999999884 3445
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++|||+++ ++.+.+.........+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence 8899999986 6666665544445678999999999999999999999 79999999999999995 8889999999987
Q ss_pred ccccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCC-chhhhh
Q 019506 229 VLVKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVSNII-YAKTIY 305 (340)
Q Consensus 229 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~-~~~~~~ 305 (340)
........ ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... ..+.+.+.....+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD-- 231 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcc--
Confidence 66433321 234678899999999654 4789999999999999999999999765432 2222222211111 1111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
-.......+...|+..+|.+|||+++|.+
T Consensus 232 ---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 232 ---HYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---cccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01223445555667778999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=286.87 Aligned_cols=244 Identities=28% Similarity=0.427 Sum_probs=194.2
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
|...+.||+|+||+||+|++..+|..|++|.+.... ....+|+++++.++|+|++++++++. +....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 667788999999999999999999999999886422 12346889999999999999999984 344588
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+.+++.+.+.. ....+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCcccC
Confidence 9999999887776653 23568899999999999999999999 79999999999999985 7889999999986532
Q ss_pred cCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 232 KGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 232 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
. .....++..|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+............
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 244 (313)
T cd06633 173 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE----- 244 (313)
T ss_pred C---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc-----
Confidence 2 224567889999999842 345788999999999999999999999887776666666543322211111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+..-|+..+|.+||++++++.|||
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1122445666677778999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=284.49 Aligned_cols=239 Identities=24% Similarity=0.341 Sum_probs=177.0
Q ss_pred eeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHH---HHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.||+|+||.||+|++..+++.||+|.+.+.... ...|. ..++...|+||+.+++++ .+....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 389999999999999999999999988653211 12232 334456799999999888 444568899
Q ss_pred eccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+.++ |...+. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 9999975 333332 24679999999999999999999999 79999999999999995 78899999999876543
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCchhhhhccccc
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
... ....|+..|+|||++.+...++.++|||||||++|+|++|+.||.+... ................. ..
T Consensus 150 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~- 222 (278)
T cd05606 150 KKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD-----SF- 222 (278)
T ss_pred cCC-cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC-----cC-
Confidence 322 2346889999999997655689999999999999999999999986632 12222222211111111 01
Q ss_pred cCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
+.....+.+-+...+|.+|+ +++++++|||
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 22233334445555678899 9999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.77 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=188.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..+|++.+.||+|++|.||+|.+. +++.||+|.++... ....+|+.++++++|+||+++++++ ......++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence 456999999999999999999864 55789999887543 3345799999999999999999987 33445789
Q ss_pred eecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||++ +++.+.+... ....+++..+..++.|++.||.+||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEcc
Confidence 999996 5666665432 13568999999999999999999999 79999999999999995 7889999999998764
Q ss_pred cCCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
...... ....+..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+.+....+..+.+....+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG----- 228 (261)
T ss_pred CCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc-----
Confidence 322211 1122357999999865 458999999999999999999 9999988777666655544322222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
.......+...|+..+|.+||+++++.
T Consensus 229 -~~~~~~~li~~~l~~~P~~Rp~~~~l~ 255 (261)
T cd05068 229 -CPKELYDIMLDCWKEDPDDRPTFETLQ 255 (261)
T ss_pred -CCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 223344555667777899999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.66 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=174.9
Q ss_pred eeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHH---hCCCCceeecceeeeecCCCCceeeeee
Q 019506 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.||+|+||.||++.+..+++.+|+|.+.+... ...+|..+++ ..+|+||+.+++.+ ......++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 38999999999999999999999998864321 1123333333 34799999998888 334458899
Q ss_pred eccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||++++ |...+. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 9999975 444333 24679999999999999999999999 79999999999999995 78899999999876533
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCchhhhhccccc
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.. .....++..|+|||.+.+...++.++|||||||++|+|++|..||..... ...+.............. .
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~ 222 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS------F 222 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccc------c
Confidence 32 22346789999999986555589999999999999999999999975432 222222221111110000 1
Q ss_pred cCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
......+.+-|+..+|.+|+ +++|+++|||
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 12223334445556678898 6999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.35 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=190.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|.+.+.||+|+||.||+|.+... +..||+|.+..... ...+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 45799999999999999999987643 47899998764421 235788999999999999999988 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~ 218 (340)
.....++||||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCC
Confidence 44558899999984 66666654221 12346888899999999999999999 79999999999999995 889
Q ss_pred EEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999876543321 1223456789999998654 48999999999999999998 9999988776555554442
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........ .+......+.+.|+..+|.+|||++++.+
T Consensus 237 -~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 -GGHLDLPE-----NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CCCCCCCC-----CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22221111 12344556677778888999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=280.35 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=188.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.++||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 357999999999999999999854 56789999876432 2345799999999999999999887 44455789
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||+++ ++.+.+... ....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence 9999985 666655432 24568888999999999999999999 79999999999999995 8889999999998764
Q ss_pred cCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|+| |..||.+.+..+....+......+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN----- 228 (261)
T ss_pred CCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC-----
Confidence 33221 12234567999999865 447899999999999999998 9999988777666655544322221111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+..-|+..+|.+||+++++.+
T Consensus 229 -~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 229 -CPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1223344566667778999999999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=281.65 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=180.0
Q ss_pred CeeEeeee--eeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 78 SYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 78 ~y~~~~~L--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+|.+.+.+ |+|+||.||++++..++..+|+|.+...... ..|+.....+ +|+||+++++.|. .....++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence 45565555 9999999999999999999999988654221 2244433333 6999999999984 344688999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|.+.+.. +..+++..++.++.|++.||.|||+ .|++||||||+||+++..++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99985 66655543 3488999999999999999999999 799999999999999963338999999998765332
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCchhhhhccccccC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
....++..|+|||++.+. .++.++|||||||++|+|++|..||........ ........ . ......+ ..+.
T Consensus 164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~--~~~~ 235 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-KKLPFIK--NVSK 235 (267)
T ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-ccCCccc--ccCH
Confidence 234578899999999654 479999999999999999999999986543321 11221111 1 1101111 1122
Q ss_pred ChhhHhhhcccccccCCCC-cCcccccCC
Q 019506 313 NHEIMCELGSWYSYSGRNS-MHESKLYGF 340 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~-~~~i~~hpf 340 (340)
....+...|+..+|..|++ ++||++|||
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 3344556666677899995 699999999
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=278.75 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=195.6
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|+||.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4889999999999999999999999999999886432 22346889999999999999999884 335688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 99999976 6666666544445678999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.. ...+..... .
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~-----~ 225 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPI-----Y 225 (256)
T ss_pred ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchh-----h
Confidence 554 3333567888999999965 4478999999999999999999999988776554444433 332222111 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+..-|...+|.+||+++|++.|||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 226 SQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 111234444555567899999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.66 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=187.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+|++++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 46999999999999999999853 345679999886432 2345799999999999999999988 344
Q ss_pred eeeeeeeccccc-hHHHHHHHhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~ 217 (340)
...++||||+++ +|.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-CC
Confidence 558899999985 5555554321 112358999999999999999999999 79999999999999995 88
Q ss_pred cEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 019506 218 QVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (340)
Q Consensus 218 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 293 (340)
.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999976533221 112234667999999865 458999999999999999998 999998877666665554
Q ss_pred HhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 294 KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
......... ........+..-|+..+|.+|||++|+.
T Consensus 237 ~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 237 QGRVLQRPR------TCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred cCCcCCCCC------CCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 432221111 1222345566667777899999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=283.72 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=184.2
Q ss_pred eEeeeeeeecceEEEEEEEc----CCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 80 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+.+.||.|.||.||+|.+. ..+..|+||.++.. ...+.+|++.+++++|+||+++++++.. ....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----cccc
Confidence 46788999999999999987 45678999999542 2344579999999999999999999962 2227
Q ss_pred eeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+. ++|.+.+... ....+++..+..|+.||+.||.|||+ ++++|+||+++||+++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence 89999998 5777777653 24678999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 230 LVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 230 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
...... .........|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDN-- 229 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTT--
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceeccc--
Confidence 622211 12234577899999996544 7999999999999999999 7899998877776666644333332221
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+||++++|.+
T Consensus 230 ----~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 230 ----CPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----SBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----hhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 3445567788888888999999999863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.90 Aligned_cols=244 Identities=19% Similarity=0.276 Sum_probs=187.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++||||+++++++ ......++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 369999999999999999998643 4569999887543 2345799999999999999999988 334457899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+.+ ++.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.++....
T Consensus 78 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecCC
Confidence 999986 45555443 12368999999999999999999999 79999999999999995 78899999999876544
Q ss_pred CCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......... . .
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~ 225 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP-H-----L 225 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC-C-----C
Confidence 33211 12345679999999654 48999999999999999998 99999877766655555443222111 1 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCccccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.....+...|+..+|.+||++.+|+.+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 22333455566777789999999998753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.09 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=192.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++||||+++++.+. .....+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 357999999999999999999998899999999886432 22356888999999999999999884 344588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ ++.+.+. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceecc
Confidence 99999986 4444443 2467888999999999999999999 79999999999999995 788999999988765
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+.......... ...
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~- 240 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN---PEK- 240 (293)
T ss_pred cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCC---ccc-
Confidence 43322 223457888999999865 457899999999999999999999998776655444333322111100 000
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+.+-|+..+|.+||++++++.|||
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0112344566677778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=279.29 Aligned_cols=238 Identities=21% Similarity=0.308 Sum_probs=180.5
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 36899999999999999999999999875432 2345799999999999999999988 3444588999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence 86 44444432 23468899999999999999999999 79999999999999995 788999999998765332211
Q ss_pred ce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 237 IS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 237 ~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
.. ...+..|+|||.+.+. .++.++|||||||++|+|++ |..||...+.......+.......... .+..
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 223 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE------LCPD 223 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcc------cCCH
Confidence 10 1123469999998654 48999999999999999998 889998766655444443322222111 1223
Q ss_pred ChhhHhhhcccccccCCCCcCcccc
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+...|+..+|.+|||++++..
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3445666777778999999998753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=278.48 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=190.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|.+.+.||+|+||.||+|.+..+|+.||+|.++.. .....+|++++++++|+||+++++++. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 4799999999999999999999989999999987531 223457999999999999999999884 3345
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|...+.........+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence 7899999986 6766666544445678999999999999999999999 79999999999999995 8889999999987
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 305 (340)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+....+......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD-- 231 (267)
T ss_pred eccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChh--
Confidence 6543322 223467888999999865 4489999999999999999999999965432 122222222111111110
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+...|+..+|.+||++.+|++
T Consensus 232 ---~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 232 ---HYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---hcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01223344556677778999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=280.38 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=188.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC---CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
++|++.+.||+|+||+||+|++..+ ...||+|.+.... ..+.+|+.+++.++|+||+++++.+ .+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4699999999999999999998654 4579999876432 2234689999999999999999987 3444
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccchh
Confidence 58899999986 55555443 23478999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.......... ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 231 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM- 231 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC-
Confidence 8764222111 1223567999999865 458999999999999999998 999998777666555554432222221
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+......+...|+..+|.+||+++|+.++
T Consensus 232 -----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 232 -----DCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122334556667777789999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.73 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=190.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||++++..++..+++|.++... ....+|+.+++.++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 4889999999999999999998877777777654311 12346888999999999999999883 344
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ ++...+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++ ++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~--~~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEee--cCCEeecccCce
Confidence 57899999986 6655565544455689999999999999999999999 7999999999999997 456999999998
Q ss_pred cccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 227 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP-E--- 227 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc-c---
Confidence 76543322 223456888999999854 44788999999999999999999999877665555544432211111 1
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+..-|+..+|.+||+++|++.|||
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 228 --TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred --hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 11122334555666678999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=297.33 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=191.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
-|..++.||-|+||+|.+++...|...||.|.+.+.. ...+.|-.+|.....+-||+++..| ++...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 3888899999999999999988899999999886542 2234688899999999999999888 666779
Q ss_pred eeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+||||++|+ +..+|.+ -+-|+|..++.++.++..|+++.|.+ |+|||||||+|||+|. +|.|||+|||+|.-
T Consensus 705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDr-dGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEcc-CCceeeeecccccc
Confidence 9999999974 4455544 36799999999999999999999995 9999999999999995 88999999999864
Q ss_pred cc---------cCCc----------------------------------cceeeeeccccCcccccCCCCCCCcchhHHH
Q 019506 230 LV---------KGEA----------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSA 266 (340)
Q Consensus 230 ~~---------~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 266 (340)
+. .++. .-..+||+.|+|||++... .|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHh
Confidence 41 0000 0135789999999999654 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---CCchhhhhccccccCChhhHhhhccccc-ccCCCCcCcccccCC
Q 019506 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVSN---IIYAKTIYQGLFCSNNHEIMCELGSWYS-YSGRNSMHESKLYGF 340 (340)
Q Consensus 267 G~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~R~~~~~i~~hpf 340 (340)
|||||||+.|++||-+++..+...+++.... ++.--+ |.+...+.+.+||..-+ -..+-..+|++.|||
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~-----ls~e~~~li~kLc~sad~RLGkng~d~vKaHpf 930 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGN-----LSKEALDLIQKLCCSADSRLGKNGADQVKAHPF 930 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccc-----cCHHHHHHHHHHhcChhhhhcccchhhhhcCcc
Confidence 9999999999999998887776666654332 232222 23334455555544322 223556789999998
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=284.46 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=188.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCC-----cEEEEEEeccccc-----ChHHHHHHHHhC-CCCceeecceeeeec
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST 142 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 142 (340)
....+|.+.+.||+|+||.||++.+...+ ..+|+|.+..... ...+|+++++++ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--- 85 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--- 85 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 34457999999999999999999876443 7899998865322 234688999999 799999999988
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCC
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~N 209 (340)
.....++++|||+++ ++...+.... .....+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus 86 --~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~N 162 (293)
T cd05053 86 --TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARN 162 (293)
T ss_pred --cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceee
Confidence 344458899999985 5555554321 234578899999999999999999999 799999999999
Q ss_pred eEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 019506 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (340)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 285 (340)
|+++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 163 il~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 163 VLVTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEEcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 99995 889999999999876433221 11223567999999855 458999999999999999997 9999988776
Q ss_pred HHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 286 VDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+....+.......... -+......+..-|+..+|.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRMEKPQ------NCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCCCCC------CCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 55554443322211111 122233445556777789999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.98 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=185.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|.+.++||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 79 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----S 79 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence 4579999999999999999997642 355899998764322 234688899999999999999987 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~ 218 (340)
+....++||||+++ +|.+.+...... ....+...+..++.|++.||.|||+ +||+||||||+||+++. ++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CCc
Confidence 34457899999985 666666543211 1334667888999999999999999 79999999999999995 888
Q ss_pred EEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 219 VKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
++|+|||+++........ ....++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+.+..+.+..+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999998765332211 112345679999998654 47999999999999999998 7899988776665555443
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........ .+......+...|+..+|.+||++.++.+
T Consensus 237 ~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 237 GGYLDQPD------NCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 32222111 11233456666777778999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=282.79 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=181.9
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||+||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999999999999885421 2234689999999999999999888 4445688999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence 96 555555432 22468999999999999999999999 79999999999999995 788999999998776544333
Q ss_pred ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhh
Q 019506 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEI 316 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (340)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.+... .....+ ...+ +.....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~-~~~~~~ 227 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEY-PDKF-SPEAKD 227 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccC-CccC-CHHHHH
Confidence 4456678899999986644 89999999999999999999999976654222222221111 000000 0001 222334
Q ss_pred HhhhcccccccCCC-----CcCcccccCC
Q 019506 317 MCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 317 ~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
+.+-|+..+|.+|| +++++++|||
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChh
Confidence 44555566788999 6666999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=280.76 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=186.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+.... ..+..|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 358999999999999999999877665 59999886432 2345789999999999999999987 4445
Q ss_pred eeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||++++ +.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccc
Confidence 578999999874 4444432 23568999999999999999999999 79999999999999985 788999999998
Q ss_pred cccccCCcccee---e---eeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 228 KVLVKGEANISY---I---CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 228 ~~~~~~~~~~~~---~---~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
............ . .+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 765433221111 1 1346999999965 458999999999999999886 9999988777666665543322222
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+ +......+..-|+..+|.+||+++++..
T Consensus 233 ~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 PMD------CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccc------CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 211 1223345566677778999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.00 Aligned_cols=212 Identities=35% Similarity=0.602 Sum_probs=184.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCC------CCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMD------HPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~ 146 (340)
..+|.+....|+|-|++|.+|.+...|..||||+|.+... .-.+|+++|++|+ --|+++++..| ..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence 3468888899999999999999999999999999987643 2347999999996 35788988888 56
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.+++|||+|.+.-+|.++|..+.. +-.+....++.++.|+..||..|.. .||+|+||||+||||+.....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcc
Confidence 677999999999999999998754 6789999999999999999999999 79999999999999998888999999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 296 (340)
|.....+... .+..+..|.|||+++|-+ |+...|+||.||+||||+||+..|+|.++...+...+...
T Consensus 584 A~~~~eneit-PYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 584 ASFASENEIT-PYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cccccccccc-HHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 9887555433 445688899999999866 8999999999999999999999999999888877766543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.56 Aligned_cols=242 Identities=18% Similarity=0.276 Sum_probs=186.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+|++.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+++++.++|+||+++++++ ......++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5889999999999999999875 56789999886532 2345799999999999999999887 4445588999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+++...+.
T Consensus 79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceecccc
Confidence 99986 55555543 12468999999999999999999999 79999999999999995 888999999998765433
Q ss_pred Cccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 234 EANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 234 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.... ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+....+.......... .+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~ 226 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK------LA 226 (256)
T ss_pred cccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCC------CC
Confidence 2211 1122446999999865 448999999999999999999 899998777666555544322222111 13
Q ss_pred cCChhhHhhhcccccccCCCCcCcccc
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......+..-|+..+|.+||+++|++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 334555666677778999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=283.31 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=189.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 46899999999999999999854 345678999876442 3456799999999999999999988 444
Q ss_pred eeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~ 214 (340)
...++||||+++ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 558899999985 56555543211 12458899999999999999999999 79999999999999995
Q ss_pred CCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019506 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (340)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (340)
++.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|+| |..||...+..+.+.
T Consensus 159 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred -CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 78899999999976543321 122345778999999865 448999999999999999999 999998777655554
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+.. ........ .+......+...|+..+|.+||+++++.+
T Consensus 237 ~~~~-~~~~~~~~-----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQ-GRVLERPR-----VCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhC-CCCCCCCc-----cCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 4332 22222111 12334566777788888999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=286.02 Aligned_cols=245 Identities=28% Similarity=0.421 Sum_probs=193.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|...+.||+|+||.||+|++..++..+|+|.+.... ....+|+++++.++|+|++++++++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 4778889999999999999999999999999885321 123468999999999999999998843 3457
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+.+++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCcccceee
Confidence 89999999887666543 23568899999999999999999999 79999999999999985 788999999998765
Q ss_pred ccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+.+..+.+.........
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 237 (308)
T cd06634 166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG----- 237 (308)
T ss_pred cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcc-----
Confidence 332 23457888999999852 23478899999999999999999999987766555555554332221111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+.+-|+..+|.+||++++++.|||
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11222345556667778999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.23 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=190.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+|.+.+.||.|+||.||+|.+.. +..+++|.+..... ...+|+.+++.++|+||+++++++ .+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 4569999999999999999999877 89999998865432 345789999999999999999987 4444588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhc
Confidence 99999986 666666532 24568999999999999999999999 79999999999999995 888999999999776
Q ss_pred ccCCccc-eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
....... ...++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||.+.+..+.+..+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 227 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA------ 227 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCC------
Confidence 4332211 2234567999999855 458999999999999999998 899998877766666665432222211
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+......+...|+..+|.+|||+.+|.+
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 12223344555666777999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=279.06 Aligned_cols=240 Identities=30% Similarity=0.469 Sum_probs=182.9
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHH-HHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||.||+|.+..+|+.||+|.+.+... ....|..+ ....+|+||+++++++ ......++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 468999999999999999999999998864321 11223333 4456899999999988 4445689999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence 99986 45444432 3578999999999999999999999 79999999999999995 78899999999876533
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+....+..+... .......... .....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~ 223 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-RINWPEEVKE--FCSPE 223 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccCCCCcccc--cCCHH
Confidence 22345778899999997654 799999999999999999999999887765555544332 2111111111 12334
Q ss_pred hhhHhhhcccccccCCCCc---CcccccCC
Q 019506 314 HEIMCELGSWYSYSGRNSM---HESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~---~~i~~hpf 340 (340)
...+..-|+..+|.+||++ +|++.|||
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence 4556666777789999955 69999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=281.54 Aligned_cols=243 Identities=19% Similarity=0.320 Sum_probs=183.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||+||+|.+..++. .+++|.+.... .....|+..++.++|+||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence 468999999999999999999887776 46777664321 12234666788999999999999762 2
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++++||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCcc
Confidence 225688999985 66665543 23568999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++........ ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..... +.+++.....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 233 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQP 233 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCC
Confidence 9865433221 123456789999999654 48999999999999999998 999998776543 34444433332222
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. .+......+...|+..+|.+||+++|+.+
T Consensus 234 ~-----~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 234 Q-----ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred C-----CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 23334455666778888999999999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=280.28 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=177.2
Q ss_pred eeeeecceEEEEEEEcC--CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeecc
Q 019506 84 VVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
.||+|+||.||+|.... ....+++|.+.... ..+.+|+.+++.++|+||+++++.+ ......++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence 58999999999996533 34578888765332 2235688999999999999999988 344558899999
Q ss_pred ccc-hHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 157 VPE-TMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 157 ~~~-~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
+++ +|.+.+..... .....++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccch
Confidence 986 66666554322 12345678889999999999999999 79999999999999995 8899999999986543222
Q ss_pred c---cceeeeeccccCcccccC------CCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 235 A---NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 235 ~---~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
. .....++..|+|||++.. ...++.++|||||||++|||++ |..||......+.+..++...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 112234667999999742 2346889999999999999999 78999888777777776665443322221
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+... .+.....+...|+ .+|.+||+++|+.+
T Consensus 235 ~~~~-~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLK-YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccc-CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1111 1112223333343 58999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.69 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=191.6
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++. .....++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3555678999999999999998899999999875332 22357889999999999999999883 34457899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
+||+.+ ++.+.+.. .++++..+..++.|++.||+|||+ +||+||||+|+||+++. ++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence 999986 55544432 568899999999999999999999 79999999999999995 88999999998876533
Q ss_pred CCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+....+..+... ..+.... .-...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~ 242 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKN---LHKVS 242 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcc---cccCC
Confidence 222 2234578899999998654 4899999999999999999999999877765555544433 2111111 00012
Q ss_pred CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.+.|+..+|.+||++++++.|||
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 23456667777778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.84 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=199.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC-----cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
...-.+.+.||+|+||.||.|...... ..||+|.+.+.. ..+.+|..+|+.++|||||+++|+++..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 445678899999999999999876433 248999887543 3455799999999999999999999652
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYS---SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
...+|++|||.+ +|...|+... .....++..+...++.||++|+.||++ +++|||||..+|+|++. ...+||
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKI 843 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKI 843 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEE
Confidence 236799999996 5666665421 124568889999999999999999999 79999999999999996 688999
Q ss_pred EeeccccccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 222 CDFGSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
+|||+|+.+.+.+.... ..-...|||||.+.. ..++.++|||||||+|||++| |..||.+.++.+.+....+...
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 99999996544433221 122457999999976 458999999999999999998 9999999999888888888775
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+.+.. |..+...++..|+..+|.+||+|..|.+
T Consensus 923 L~~P~~------CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSY------CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCC------CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 555443 6777777788888888999999988753
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=277.33 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=189.7
Q ss_pred eeeeeecceEEEEEEEcCC---CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||.||+|.+... +..|++|.+.... ....+|+++++.++|+||+++++++. +...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 3689999999999998765 8999999887543 23457899999999999999999883 355588999
Q ss_pred cccc-chHHHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 155 EYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 155 e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
||++ +++.+.+...... ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence 9996 5666666543211 3678999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 229 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 231 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY- 231 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCcc-
Confidence 765432 12234567889999998654 58999999999999999999 6999998876665555554222221111
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.....+...|+..+|.+||+++|+.++
T Consensus 232 -----~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 -----CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 23344555666777789999999998765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.42 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=185.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|++.++||+|+||.||+|++..+ ..||+|.+.... ....+|+++++.++|+||+++++.+. + ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 4699999999999999999987655 469999887533 23467999999999999999988752 2 236799
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ ++.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccc
Confidence 999986 665555431 23467889999999999999999999 79999999999999995 78899999999976643
Q ss_pred CCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... ...++..|+|||++.+ ..++.++|||||||++|+|+| |..||.+....+.+..+......+....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE------ 227 (262)
T ss_pred cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccc------
Confidence 33221 2234667999999854 448999999999999999999 8899988776665555443222222111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+..-|+..+|.+||+++++.+
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1222345666677778999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.62 Aligned_cols=246 Identities=20% Similarity=0.212 Sum_probs=177.7
Q ss_pred eeeeeecceEEEEEEEc--CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++ .+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 35899999999999864 345679999886432 2345689999999999999999988 34445789999
Q ss_pred cccc-hHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 156 YVPE-TMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 156 ~~~~-~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|+++ ++.+.+..... .....++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence 9995 56555543222 12345677888899999999999999 79999999999999995 788999999998754332
Q ss_pred Cc---cceeeeeccccCcccccCC------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 234 EA---NISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 234 ~~---~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.. .....++..|+|||++.+. ..++.++|||||||++|||++ |+.||...+..+.+...+..........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 1123457789999998532 135789999999999999996 9999987776655544444332222211
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+.. ........+.+.|+ .+|.+|||++||..
T Consensus 234 ~~~~-~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKL-PLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCC-CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1111 11222334555554 57999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=289.52 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=184.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.++|++.+.||+|+||.||+|.+. .+++.||||.++.+. ....+|+.++..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 457999999999999999999853 467899999886532 2234799999999 68999999997743
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhc-----------------------------------------------------
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSS----------------------------------------------------- 170 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 170 (340)
....+++||||+++ +|.+.+.....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 22347799999996 55555543110
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccc---
Q 019506 171 ----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--- 237 (340)
Q Consensus 171 ----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--- 237 (340)
....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcC
Confidence 01246788889999999999999999 79999999999999995 8899999999997653322111
Q ss_pred eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhh
Q 019506 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEI 316 (340)
Q Consensus 238 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (340)
...++..|+|||++.+. .++.++|||||||++|+|++ |..||.+......+...+........... .......
T Consensus 240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 313 (343)
T cd05103 240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-----TTPEMYQ 313 (343)
T ss_pred CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCC-----CCHHHHH
Confidence 12235679999998654 48999999999999999997 99999876554444444443332221111 1122344
Q ss_pred HhhhcccccccCCCCcCccccc
Q 019506 317 MCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 317 ~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+..-|+..+|.+||+++||++|
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 4555666789999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.90 Aligned_cols=248 Identities=31% Similarity=0.459 Sum_probs=194.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... ....+|+.++++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4788899999999999999998899999999886543 23457999999999999999999884321 25688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ ++.+.+.. ...+++..+..++.|++.+|.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence 99999965 55555543 2388999999999999999999999 79999999999999995 788999999999877
Q ss_pred ccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCchhhhhc
Q 019506 231 VKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 231 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||..... ......+......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 228 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH-- 228 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcc--
Confidence 55543 33456788899999985544 79999999999999999999999987662 2222222221111111111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ......+...|...+|.+||++.|++.|||
T Consensus 229 --~-~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 229 --L-SEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred --c-CHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 1 233455556677778999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.62 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=178.5
Q ss_pred eeeecceEEEEEEEc--CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||.||+|.+. .++..||+|++.... ....+|+.++++++|+||+++++++. . ...++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEeC
Confidence 899999999999765 345679999886542 22457899999999999999998762 2 2468999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.........
T Consensus 77 ~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 77 SGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCccc
Confidence 86 45444432 24578999999999999999999999 79999999999999995 788999999999765433221
Q ss_pred c----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 237 I----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 237 ~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
. ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.+........ .+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 224 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA------ECP 224 (257)
T ss_pred eeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC------CCC
Confidence 1 1122467999999855 448999999999999999996 999998877666554444332221111 123
Q ss_pred CChhhHhhhcccccccCCCCcCcccc
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.....+..-|+..+|.+||++++|.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 34455677778888999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=276.97 Aligned_cols=234 Identities=23% Similarity=0.316 Sum_probs=178.8
Q ss_pred eeeeecceEEEEEEE--cCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 84 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
.||+|+||.||+|.+ ..++..+|+|+++... ....+|+.+++.++|+||+++++++. +. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999965 4577899999886442 22356889999999999999998762 22 3579999
Q ss_pred cccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
|++++ +.+.+.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence 99964 5555432 3568999999999999999999999 79999999999999995 7889999999997764333
Q ss_pred cc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 235 AN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 235 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.. ....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+....+.+. ..+..+. .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~-----~ 222 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQ-----R 222 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCC-----C
Confidence 21 11223568999999854 458899999999999999998 99999887765555544432 2222111 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
+......+...|+..+|.+||++++|.
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~ 249 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVE 249 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHH
Confidence 233445677777777899999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=282.40 Aligned_cols=254 Identities=19% Similarity=0.218 Sum_probs=188.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC----------------cEEEEEEecccc-----cChHHHHHHHHhCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVIS 134 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~ 134 (340)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 568999886542 23456899999999999999
Q ss_pred cceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCC
Q 019506 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (340)
Q Consensus 135 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlk 206 (340)
+++++. .....+++||++.+ ++...+..... ....+++..++.++.|++.||.|||+ .||+|||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 999883 33558899999985 56666554321 12368999999999999999999999 799999999
Q ss_pred CCCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCC
Q 019506 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 281 (340)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~ 281 (340)
|+||+++. ++.++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999995 78999999999876543321 1123446789999998653 48999999999999999998 778998
Q ss_pred CCChHHHHHHHHHhcCCCchhhhhc-cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 282 GENAVDQLVEIIKVSNIIYAKTIYQ-GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+..+.+................. .-.+......+...|+..+|.+|||+.||.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 7776666555544311111110000 0011223455666677778999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=275.39 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=184.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
.+|.+.+.||+|+||.||++.. .|..+|+|.++.+.. ...+|+.++++++|+|+++++++++. +....++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 4699999999999999999986 588899998865432 34579999999999999999987643 233478999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ ++.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceecccc
Confidence 99986 666655431 22357889999999999999999999 79999999999999995 889999999998765332
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+. ..+.... .+..
T Consensus 156 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~ 226 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD-----GCPP 226 (256)
T ss_pred C--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCC-----CCCH
Confidence 2 22234567999999855 458999999999999999997 99999877665554444332 1111111 1122
Q ss_pred ChhhHhhhcccccccCCCCcCcccc
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+...|+..+|.+|||++++.+
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3344556666678999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=288.03 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=182.7
Q ss_pred eeeeee--cceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
..||+| +||+||+|++..+|+.||+|++.... +...+|+.+++.++|+||++++++| ......++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 345666 99999999999999999999886432 2335688888999999999999998 4445588999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ ++.+.+.... ...+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhcc
Confidence 99996 5555555432 3468999999999999999999999 79999999999999995 788999999865433221
Q ss_pred Cccc--------eeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh-h
Q 019506 234 EANI--------SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK-T 303 (340)
Q Consensus 234 ~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 303 (340)
.... ...++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..++......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 1110 11235569999999653 347899999999999999999999998876655554444321110000 0
Q ss_pred -----------------------h-------------hcc---ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 -----------------------I-------------YQG---LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 -----------------------~-------------~~~---~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ++. -..+.....+...|+.++|.+|||++|++.|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0 000 001112345666677778999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=277.84 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=185.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|...+.||+|+||.||+|++..++. .+|+|.+.... .....|+++++.++|+||+++.+++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 468889999999999999999876554 79999886442 2235688999999999999999988 3444
Q ss_pred eeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||++++ |.+.+.. ....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccc
Confidence 578999999974 4444432 23568999999999999999999999 79999999999999995 888999999998
Q ss_pred cccccCCccce----eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEANIS----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
........... ...+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 233 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM 233 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC
Confidence 76643322111 112446999999865 447999999999999999997 999998877766666555433333222
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+ +......+...|...+|.+||+++++.+
T Consensus 234 ~------~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 234 D------CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred C------CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 1222334455566678999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.59 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=184.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-------CCcEEEEEEeccccc-----ChHHHHHHHHhC-CCCceeecceeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST 142 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 142 (340)
.++|.+++.||+|+||.||+|++.. ++..+|+|.+..+.. ...+|+++++.+ +|+||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3579999999999999999998643 235699998875321 234688899998 799999999988
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCC
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~N 209 (340)
......++||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 344458899999985 66666654221 12358889999999999999999999 799999999999
Q ss_pred eEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 019506 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (340)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 285 (340)
|+++. ++.+||+|||++......... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99995 788999999998765332211 112234679999998654 48999999999999999998 8899977665
Q ss_pred HHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 286 VDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+ +.+.++......... -+......+..-|+..+|.+||+++++..
T Consensus 249 ~~-~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EE-LFKLLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HH-HHHHHHcCCCCCCCC-----cCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 44 443343332211110 11223344556667778999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.82 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=188.4
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCc---E-EEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
-.+.++||+|+||.||+|+.+..+. . ||+|..+.+ ...+.+|+++|+.++|+|||+++|+. ...
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa-----~~~ 233 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA-----VLE 233 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCC
Confidence 3455899999999999998775432 3 899988742 23345799999999999999999988 444
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.-+++|||+|.| +|.+.|... ...++..+...++.+.+.||+|||+ +++|||||-.+|+|++. ++.+||+|||+
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCcccc
Confidence 458899999997 566666542 2369999999999999999999999 79999999999999995 67789999999
Q ss_pred ccccccCCcccee-eeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 227 AKVLVKGEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 227 a~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
++........... --...|+|||.+... .|+.++|||||||++||+++ |..||.+....+...++.+.........
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~- 386 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS- 386 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC-
Confidence 8765322111111 135679999999654 69999999999999999998 8899999999888888867554443332
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
....-...+..-|+..+|..|+++.++.
T Consensus 387 ----~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 387 ----KTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred ----CCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 1222334555667777799999998864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=281.69 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=183.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
+|++.+.||+|+||.||+|++.. ....+++|.+.... ....+|+.+++.++||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 47888999999999999998753 23578999876443 2345799999999999999999987 344
Q ss_pred eeeeeeeccccc-hHHHHHHHhh--------------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCC
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlk 206 (340)
...+++|||+.+ ++.+.+.... .....+++..++.++.|++.||.|||+ +||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 457899999995 5555554321 112357889999999999999999999 799999999
Q ss_pred CCCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 019506 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (340)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 282 (340)
|+|||++. ++.+||+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999995 78899999999976533221 112234567999999855 448999999999999999998 9999987
Q ss_pred CChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 283 ENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+....+.+......... .......+...|+..+|.+||+++|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRMERPEN------CSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCCCCCC------CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 776554443332222211111 1223345566677778999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.83 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=179.2
Q ss_pred eeEeeeeeeecceEEEEEEE----cCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
|.+.+.||+|+||+||++.. ..++..||+|.+.... ....+|+++++.++|+||+++++++.. .+...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 48899999999999988653 3578899999886532 234579999999999999999998743 23345
Q ss_pred eeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+++||||+.++ +.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeeccccc
Confidence 78999999964 4444432 468999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC----CCc
Q 019506 229 VLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN----IIY 300 (340)
Q Consensus 229 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----~~~ 300 (340)
........ ....++..|+|||.+.+ ..++.++|||||||++|+|+||..||...... +..+..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR 232 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence 76433221 11234567999999865 44899999999999999999999998654321 111111100 000
Q ss_pred hhhhhcc-------ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQG-------LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~-------~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....... --+......+...|+..+|..||+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 011233455667777778999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.37 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=186.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||+|++..++. .+|+|.++... ....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 469999999999999999999865443 79999876432 2345789999999999999999988 3344
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCcc
Confidence 58899999986 45555442 23568999999999999999999999 79999999999999985 788999999999
Q ss_pred cccccCCccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
.......... ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM 232 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence 8764432211 1122457999999965 448999999999999999886 999998877666555555432222211
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+...|+..+|.+||+++++..
T Consensus 233 ------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 ------DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11223355666777778999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=281.45 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=186.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-------CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS 141 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 141 (340)
...+|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3457999999999999999999753 234579999876432 2345789999999 899999999988
Q ss_pred cCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
......++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 344458899999986 66666654211 12357888899999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (340)
||+++. ++.+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+
T Consensus 167 Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999985 788999999999866432221 122345679999999654 48999999999999999998 889998877
Q ss_pred hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 285 AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+....+.......... -+......+..-|+..+|.+||++.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 245 VEELFKLLKEGHRMDKPA------NCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHHcCCcCCCCC------CCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 655554443222111111 12233445566667778999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=272.24 Aligned_cols=245 Identities=29% Similarity=0.476 Sum_probs=194.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+|.+.+.||+|++|.||++++..+++.|++|.+..... ...+|++++++++|+|++++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 48899999999999999999998999999998865532 2457899999999999999999883 345688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|||+++ ++.+.+.. ...+++..++.++.|++.+|.+||+ .||+||||||+||+++. ++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence 99999987 55444443 3678999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+...........
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG------ 222 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCC------
Confidence 544332 2345688899999986544 78999999999999999999999987766555555443222221111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+..-|+..+|.+||++++++.|||
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence 1222344555566677999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.94 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=188.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEeccccc-----ChHHHHHHHHhCC-CCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 143 (340)
..++|.+++.||+|+||.||+|++. .+++.||+|+++.... ...+|++++.++. |+||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--- 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT--- 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence 4456889999999999999999864 3456899999875422 2446999999997 999999999883
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc----------------------------------------------------
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (340)
....+++||||+.+ +|.+.+.....
T Consensus 112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 34458899999995 66666643210
Q ss_pred ------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 171 ------------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 171 ------------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 11246777888999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (340)
|||++. ++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||....
T Consensus 269 NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999995 78899999999976533221 1223457789999999654 48999999999999999998 899998766
Q ss_pred hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 285 AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.+...+.....+.... .+......+..-|+..+|..||+++||+.
T Consensus 347 ~~~~~~~~~~~~~~~~~p~-----~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPA-----HASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred chHHHHHHHHcCCCCCCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666655555432221111 12223345556677778999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.90 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=188.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeec
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 142 (340)
...++|.+.+.||+|+||.||++.+. .++..||+|.++... ....+|+++++++ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 108 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--- 108 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE---
Confidence 34457999999999999999999752 345689999886542 2245799999999 799999999988
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
......++||||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+|||++. ++.++|
T Consensus 109 --~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l 182 (302)
T cd05055 109 --TIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKI 182 (302)
T ss_pred --ecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEE
Confidence 334458899999985 55555543 112348999999999999999999999 79999999999999984 788999
Q ss_pred EeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 222 CDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
+|||++......... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+.+.+....
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence 999999765433211 1123467799999986544 7999999999999999998 9999988776666656555332
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...... ........+..-|+..+|.+||+++|++.
T Consensus 262 ~~~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 RMAQPE-----HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cCCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 211111 01122344556666777999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=278.82 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=183.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||+||+|++..+|. .||+|.+.... ....+|+.+++.+.|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------ 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------ 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence 469999999999999999999877776 48999876432 223468888999999999999988742
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++++||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~dfG~ 155 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDFGL 155 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCCCc
Confidence 125689999985 55555542 23568999999999999999999999 79999999999999985 77899999999
Q ss_pred ccccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++......... ...++..|+|||.+.+. .++.++|||||||++|||++ |..||........ ...+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 233 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQP 233 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCC
Confidence 98764333221 12235679999998654 48999999999999999998 9999977655443 3344433322211
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. .+......+...|+..+|..||++.++.+
T Consensus 234 ~-----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 234 P-----ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred c-----cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 12223345666677778999999999863
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.85 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=185.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcC-------CCcEEEEEEeccccc-----ChHHHHHHHHhC-CCCceeecceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFF 140 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~ 140 (340)
...++|.+.+.||+|+||.||+|++.. ....+|+|.++.... ...+|+++++.+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC- 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE-
Confidence 345679999999999999999998642 345799998764322 234688999988 699999999988
Q ss_pred ecCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCC
Q 019506 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp 207 (340)
.+...+++||||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||
T Consensus 88 ----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp 162 (314)
T cd05099 88 ----TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAA 162 (314)
T ss_pred ----ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 334458899999985 66666654221 12458889999999999999999999 7999999999
Q ss_pred CCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (340)
+|||++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999985 788999999999765432211 11123457999999865 458999999999999999999 89999877
Q ss_pred ChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 284 NAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+..+.+..+... ...... .-+......+..-|+..+|.+||+++|+.+
T Consensus 241 ~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREG-HRMDKP-----SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcC-CCCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665555544432 211110 011223344556677777999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.58 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=189.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..++|.+.++||+|+||.||+|.+. .+..+|||.+.... ....+|+.+++.++|+||+++++++ ......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 3457999999999999999999864 56789999887542 3345799999999999999999887 3344578
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceec
Confidence 99999986 56555543 223568999999999999999999999 79999999999999995 788999999998766
Q ss_pred ccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+....+..+......+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 228 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN---- 228 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC----
Confidence 432211 12223567999999965 448999999999999999998 9999998887777766655433222211
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|...+|.+||+++++..
T Consensus 229 --~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 --CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1223344555566667999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.97 Aligned_cols=244 Identities=29% Similarity=0.517 Sum_probs=192.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCC-CCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++++. |+||+++++++ .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 6999999999999999999999999999999886421 23356888999998 99999999988 44456
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++|||++. +++.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCcccc
Confidence 889999996 566666654 3479999999999999999999999 79999999999999995 7889999999987
Q ss_pred ccccCCc---------------------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 019506 229 VLVKGEA---------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (340)
Q Consensus 229 ~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (340)
....... .....++..|+|||++.+. .++.++|+||||++++++++|+.||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 6543221 1123467889999998654 47899999999999999999999999877655
Q ss_pred HHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCc----CcccccCC
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSM----HESKLYGF 340 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~----~~i~~hpf 340 (340)
.+..+... .......+ ......+.+.|+..+|.+||++ +++++|||
T Consensus 230 ~~~~~~~~-~~~~~~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 230 TFQKILKL-EYSFPPNF------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHhc-CCCCCCcc------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 55555432 22221111 1122344455555678899999 99999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.17 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=186.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCC-------CcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS 141 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 141 (340)
...+|++++.||+|+||.||+|++... +..||+|.+.... ....+|+++++++ +|+||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE--
Confidence 345799999999999999999986532 2368999876432 2345789999999 799999999988
Q ss_pred cCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
.....++++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 163 (334)
T cd05100 88 ---TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAAR 163 (334)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccc
Confidence 334458899999986 66666554211 12357888899999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (340)
|||++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+
T Consensus 164 Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999995 788999999999765432211 11223457999999965 448999999999999999998 889998877
Q ss_pred hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 285 AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+.+..+.......... .+......+..-|+..+|.+||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPA------NCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCC------CCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 655554443322111111 122234455666777779999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.37 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=186.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ....+|+.++++++|+||+++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEE
Confidence 347999999999999999999864 56779999887532 23457999999999999999988762 1 23679
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||+++ ++.+.+.. .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence 9999986 55555543 223568999999999999999999999 79999999999999995 7889999999997654
Q ss_pred cCCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
...... ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+.+..+......+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 227 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD----- 227 (260)
T ss_pred CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc-----
Confidence 332211 1234567999999854 448999999999999999999 8999988777666665544322222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|+..+|.+|||+.++..
T Consensus 228 -~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 228 -CPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1223445666667778999999998753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=273.57 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=185.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
++|.+.+.||+|+||.||+|.+..+ ..+|+|.+..+.. ...+|+++++.++|+|++++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 4699999999999999999987554 4699998765432 3457999999999999999988762 1 236799
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+.+ ++.+.+... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEccC
Confidence 999986 666666532 23457899999999999999999999 79999999999999995 88899999999976543
Q ss_pred CCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|+| |..||.+.+..+.+..+......+....
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQG------ 227 (260)
T ss_pred CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc------
Confidence 3221 12234667999999855 448999999999999999999 9999988777666655544322221111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|+..+|.+||+++++..
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122344556667778999999998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=307.66 Aligned_cols=141 Identities=25% Similarity=0.404 Sum_probs=122.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+|.+.++||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 57999999999999999999999999999999987542 3445788999999999999999887 44456
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||. +||+||||||+|||++. ++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCCc
Confidence 8999999975 55555543 3568899999999999999999999 79999999999999995 7889999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=280.84 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=185.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC----------------CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeec
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL 135 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~ 135 (340)
.+|++.+.||+|+||.||++.+.. ++..+|+|.+.... ....+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986532 34578999886432 234579999999999999999
Q ss_pred ceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCC
Q 019506 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM-------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (340)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp 207 (340)
++++. .....++||||+.+ ++.+.+...... ...+++..+..++.|++.||+|||+ +|++||||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 99883 33447899999985 666665542211 1347788899999999999999999 7999999999
Q ss_pred CCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCC
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 282 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~ 282 (340)
+|||++. ++.++|+|||++......... ....++..|+|||...+. .++.++|||||||++|||++ |..||..
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999985 888999999999765333211 112335679999988654 48999999999999999998 7799987
Q ss_pred CChHHHHHHHHHhcCCCc-hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 283 ENAVDQLVEIIKVSNIIY-AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+..+.+........... ...+...-.+......+...|+..+|.+||+++||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 766555443322111000 0000011123344566777788888999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.05 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=188.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|.+.++||+|+||.||++... .++..+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 46888999999999999999743 356789999876432 3356799999999999999999887 334
Q ss_pred eeeeeeeccccc-hHHHHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
...+++|||+++ ++.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence 457899999985 56555543211 11357889999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (340)
++.+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+.+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 88899999999876533221 1122346779999998654 48999999999999999998 9999987776666655
Q ss_pred HHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 292 IIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+.+........ .+......+...|+..+|.+||+++|+..
T Consensus 237 ~~~~~~~~~~~------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELERPR------TCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCCCCC------CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55433222111 12334556667778888999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=300.45 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=172.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCC----CcEEEEEEecccccChHHHHHH---HHhCCCCceeecceeeeecC-CCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQL---MRLMDHPNVISLKHCFFSTT-SKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~E~~~---l~~l~h~~iv~~~~~~~~~~-~~~ 146 (340)
..++|.+.+.||+|+||.||+|++..+ +..||+|++..... .|+.+ ++...+.++..+...+.... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 566899999999999999999999888 89999998764322 22222 22233344444433332211 134
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhc----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCC
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSS----------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~N 209 (340)
....++||||+++ +|.+.+..... .........+..++.||+.||.|||+ +||+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 4557899999996 45555542110 00112234567899999999999999 799999999999
Q ss_pred eEecCCCCcEEEEeeccccccccCC--ccceeeeeccccCcccccCCC---------------------CCCCcchhHHH
Q 019506 210 LLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGAT---------------------EYTTSIDIWSA 266 (340)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Diwsl 266 (340)
||++..++.+||+|||+|+...... ......+++.|+|||.+.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9998656789999999997653322 223457889999999764221 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc-------------CCh----hhHhhhcccccccCC
Q 019506 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS-------------NNH----EIMCELGSWYSYSGR 329 (340)
Q Consensus 267 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~----~~~~~l~~~~~~~~R 329 (340)
||+||||+++..++. +....+..+++........ |+..... +.. ..+.+.|+..+|.+|
T Consensus 366 GviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVA--WRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHH--HHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999766543 4444555555443332111 0000000 000 136666777889999
Q ss_pred CCcCcccccCC
Q 019506 330 NSMHESKLYGF 340 (340)
Q Consensus 330 ~~~~~i~~hpf 340 (340)
||++|++.|||
T Consensus 442 ~ta~e~L~Hpf 452 (566)
T PLN03225 442 ISAKAALAHPY 452 (566)
T ss_pred CCHHHHhCCcC
Confidence 99999999999
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.19 Aligned_cols=239 Identities=30% Similarity=0.471 Sum_probs=187.3
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||.|+||.||++++..+|+.+++|.+..... ...+|++++++++|+||+++++.+ ......|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988999999998865432 335688899999999999999887 4455688999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC--
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-- 234 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 234 (340)
.+ ++.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence 86 55555543 2478999999999999999999999 79999999999999995 8889999999987653332
Q ss_pred -------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 235 -------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 235 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.. .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~--- 224 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPEDV--- 224 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCccc---
Confidence 112345678899999986544 78999999999999999999999988776665555544 222222111
Q ss_pred ccccCChhhHhhhcccccccCCCCc---CcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSM---HESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~---~~i~~hpf 340 (340)
........+..-|+..+|.+|||+ .++++|||
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 012233445555666679999999 99999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.25 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=196.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
....|.+.+.||+|++|.||+|.+..++..|++|.+.... ....+|+++++.++|+||+++++++.. ....+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence 3456889999999999999999998889999999987543 234579999999999999999998843 35588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|+||+++ +|.+.+.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence 99999994 6666665421 378999999999999999999999 79999999999999995 888999999998665
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+..... +..... -.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---~~ 241 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNP---EK 241 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCcch---hh
Confidence 33322 1233567889999998654 489999999999999999999999988776655555443221 111110 00
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+.+.|+..+|..||++++++.|||
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 1122445666677778999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.57 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=186.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.++||+|+||.||+|.. .+++.||+|.+.... ....+|+.++++++|+||+++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence 35799999999999999999985 467889999887543 23457999999999999999988752 1 23789
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||+.+ ++.+.+.. .....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence 9999985 56655543 224568899999999999999999999 79999999999999995 8889999999997764
Q ss_pred cCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... ....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+.+..+....+......+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 226 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD------ 226 (260)
T ss_pred CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC------
Confidence 22221 12234667999999854 447899999999999999999 999998877655555544322222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+..-|+..+|.+||+++++..
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01223444555666667999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=272.06 Aligned_cols=241 Identities=22% Similarity=0.316 Sum_probs=185.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++. +....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 4689999999999999999987 588999999876543 3457999999999999999999884 34458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ ++.+.+... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEccccccccccc
Confidence 999995 666655432 12368999999999999999999999 79999999999999995 88899999999987633
Q ss_pred CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
... ....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+....+.+........ ...
T Consensus 155 ~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 225 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE------GCP 225 (256)
T ss_pred ccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCcc------CCC
Confidence 222 2334567999999865 458899999999999999997 999998776555444333321111111 012
Q ss_pred CChhhHhhhcccccccCCCCcCcccc
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.....+..-|+..+|.+||+++|++.
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 22334455577778999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.80 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=185.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||.||+|.+..+|. .+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 469999999999999999999876665 58999876543 233478999999999999999998753
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ ++.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCcc
Confidence 347899999985 55555543 23468999999999999999999999 79999999999999985 78899999999
Q ss_pred ccccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++.......... ..++..|+|||.+.. ..++.++|+|||||++||+++ |+.||.+....+....+.+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 987643332221 112457999999854 457999999999999999998 999998877655444444322222211
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
.+......+..-|+..+|..||++.++.
T Consensus 235 ------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 235 ------ICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred ------CCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 1223344556667777899999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.80 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=188.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
|....+||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++.+ ......++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence 334467999999999999999999999999875322 2245688999999999999999988 3445688999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
||++++.+..+.. ...+++..++.++.|++.+|+|||+ +|++||||+|+||+++. ++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceeccccc
Confidence 9999754433322 3468999999999999999999999 79999999999999995 7889999999987654332
Q ss_pred c-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 235 A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 235 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+.+..+.... ...... +.. ....
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~--~~~~ 245 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKN-LHK--VSPS 245 (292)
T ss_pred ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CcccCC-ccc--CCHH
Confidence 2 223457888999999854 447899999999999999999999998776655444433221 111111 000 1122
Q ss_pred hhhHhhhcccccccCCCCcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+...|+..+|.+||++++++.|||
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 334556667778999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=279.76 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=185.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCC--------------cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKH 137 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~ 137 (340)
.+|++.+.||+|+||.||+|++..++ ..||+|.+.... ....+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 47999999999999999999875432 358999886542 23457999999999999999999
Q ss_pred eeeecCCCCceeeeeeeccccc-hHHHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
++ ......++||||+.+ ++.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88 344458899999996 55555533110 11246888899999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGE 283 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~ 283 (340)
||+++. ++.+||+|||++......... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 159 Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999995 788999999999765433221 112346679999998654 48999999999999999998 67899877
Q ss_pred ChHHHHHHHHHhcCCCchhh-hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 284 NAVDQLVEIIKVSNIIYAKT-IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+..+.+..+.+......... ....-........+...|+..+|.+||++++|.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 76665555443211110000 0001112334566777778888999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.32 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=186.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 4579999999999999999998743 67889999886432 2345799999999999999999987 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhh------------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCC
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYS------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlk 206 (340)
+....++||||+++ ++.+.+.... .....+++..+..++.|++.||.|||+ +|++|||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 44457899999996 6666665321 112347888899999999999999999 799999999
Q ss_pred CCCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 019506 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (340)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 282 (340)
|+||+++. ++.++|+|||++........ ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999985 88899999999876533221 1122345679999998654 48999999999999999997 8899987
Q ss_pred CChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 283 ENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+..+.+..+......+.... .......+...|+..+|.+||+++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCPDN------CPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCCCCCCC------CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 776665554443222111111 1222344556666777999999999753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=270.57 Aligned_cols=237 Identities=29% Similarity=0.482 Sum_probs=187.7
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
||+|+||.||++.+..+++.+++|.+..... ....|+.+++.++|+||+++++.+ ......++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999988899999998865321 345788999999999999999887 5556689999999
Q ss_pred c-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC-Cc
Q 019506 158 P-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA 235 (340)
Q Consensus 158 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~ 235 (340)
+ +++.+.+.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence 5 566666543 3468999999999999999999999 79999999999999995 788999999999776443 22
Q ss_pred cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChh
Q 019506 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHE 315 (340)
Q Consensus 236 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (340)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. ......... .....
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~------~~~l~ 221 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFL------SPEAR 221 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCC------CHHHH
Confidence 3345678889999998654 478899999999999999999999987766444444443 222221111 22334
Q ss_pred hHhhhcccccccCCCCc---CcccccCC
Q 019506 316 IMCELGSWYSYSGRNSM---HESKLYGF 340 (340)
Q Consensus 316 ~~~~l~~~~~~~~R~~~---~~i~~hpf 340 (340)
.+.+.|+..+|..||++ +++++|||
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 45555666779999999 99999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=252.97 Aligned_cols=215 Identities=23% Similarity=0.407 Sum_probs=178.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHH-HHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++...+..||+|++|.|-+.++..+|..+|+|.+..... ...+|+.+ ++...+|.+|+++|.++.. ..+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccE
Confidence 345556779999999999999999999999999864322 22345555 3445699999999988543 338
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++.||.|..++.....+....+..++|..+.+|+..++.||.|||+.-.+||||+||+|||++. .+++|+||||.+..+
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEcccccceee
Confidence 8999999999888888878888999999999999999999999998558999999999999995 899999999999888
Q ss_pred ccCCccceeeeeccccCccccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcC
Q 019506 231 VKGEANISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVSN 297 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~~~~~~~ 297 (340)
.+.-..+-..|...|||||.+. +...|+.++||||||+++.||.+++.||.. .++-+++.++++..-
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 6666555567888899999984 233589999999999999999999999975 466777777776443
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=273.70 Aligned_cols=248 Identities=20% Similarity=0.336 Sum_probs=190.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcC-CCcEEEEEEecccc--------------cChHHHHHHHH-hCCCCceeecceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-LMDHPNVISLKHCFFS 141 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 141 (340)
+|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.+++ .++|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 37888999999999999999887 67899999875321 11234666665 47999999999988
Q ss_pred cCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.+....++||||+++ ++.+.+.........+++..++.++.|++.+|.|||+..|++|+||||+||+++. ++.++
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~ 154 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT 154 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence 444568999999986 6666665544445679999999999999999999995358999999999999995 88899
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+......+.
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 999999987655443445567889999999965 4479999999999999999999999987766555555544332221
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.... .......+.+.|+..+|.+||++.|+..
T Consensus 234 ~~~~-----~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 234 PEGM-----YSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred Cccc-----CCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 1111 1222344556677778999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=277.68 Aligned_cols=246 Identities=25% Similarity=0.413 Sum_probs=185.1
Q ss_pred CeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhC-CCCceeecceeeeecCCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 145 (340)
+|++.+.||+|+||.||+|++. .+|..||+|++.... ....+|+++++.+ +|+||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999874 478999999886421 2235689999999 589999999888 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.....++||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .|++||||||+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence 44568899999996 55555443 4568899999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCc--cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---hcCC
Q 019506 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VSNI 298 (340)
Q Consensus 225 g~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~ 298 (340)
|++........ .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||...+.......+.+ ....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC
Confidence 99977644322 1234578889999998643 2467899999999999999999999975433222222222 2222
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
+.... .......+.+-|+..+|.+|+ +++++++|||
T Consensus 230 ~~~~~------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 230 PYPQE------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred CCCcc------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 22111 112233445556666788886 8899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=275.33 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=177.3
Q ss_pred eeeeecceEEEEEEEcCCCc--EEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeeec
Q 019506 84 VVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
.||+|+||.||+|++..++. .+++|.++... ....+|+++++++ +|+||+++++++ ......++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence 58999999999999887775 46888776422 2334689999999 799999999988 34445789999
Q ss_pred cccc-hHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 156 YVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 156 ~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
|+++ +|.+.+.... .....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEEC
Confidence 9985 6666654321 112357899999999999999999999 79999999999999995 8889999
Q ss_pred eeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.........
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence 9999864322111111223556999999854 458999999999999999997 99999877665555444332111111
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. ........+..-|+..+|.+||++++++.
T Consensus 234 ~------~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 L------NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred C------cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 11223445566677778999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=272.64 Aligned_cols=236 Identities=25% Similarity=0.350 Sum_probs=179.4
Q ss_pred eeeeeecceEEEEEEEcCCC---cEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++||+|+||.||+|.+..++ ..+|+|.+..... ...+|+.+++.+.|+||+++++++. . ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence 46999999999999876655 7899998875433 3456899999999999999998762 1 2367999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ ++.+.+.. ...+++..+..++.|++.||+|||+ +|++||||||+|||++. ++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99985 56655543 3478999999999999999999999 79999999999999995 888999999999876443
Q ss_pred Cccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 234 EANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 234 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+...
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 221 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE------ 221 (257)
T ss_pred CcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCC------
Confidence 3221 1122457999999855 448999999999999999998 999998777655444443322211111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+......+...|+..+|.+||++.++.+
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 12223345666777778999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=280.41 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=179.3
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|.+++.+|.| |.||++++..+++.||||++.... ....+|+++++.++|+||+++++++. +....++
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYV 76 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEE
Confidence 3344444444 455556666699999999986541 23457999999999999999999883 4445789
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||++++ +.+.+... ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeec
Confidence 99999964 54555432 23468899999999999999999999 79999999999999994 7889999999886553
Q ss_pred cCCc--------cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc--
Q 019506 232 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-- 300 (340)
Q Consensus 232 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 300 (340)
.... .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||.+......+.+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 2211 1223456789999998653 3478999999999999999999999987665444433332111000
Q ss_pred ---hhhhhcccc----------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 ---AKTIYQGLF----------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ---~~~~~~~~~----------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+. -......+.+.|+..+|.+|||++|+++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000000 0011234566677778999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=275.65 Aligned_cols=249 Identities=19% Similarity=0.242 Sum_probs=186.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||++++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4579999999999999999999875 35789999876432 2235788999999999999999987532
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSM----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
....++++||+++ ++.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEEE
Confidence 3346799999984 666655443221 1568999999999999999999999 79999999999999985 788999
Q ss_pred EeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 222 CDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
+|||+++.+...... ....++..|+|||++.+. .++.++|||||||++|++++ |+.||.+.+..+....+.....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 999999865433221 112346679999999654 48999999999999999999 9999987766554333333221
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.... ..+......+.+.|+..+|.+|||++++..
T Consensus 238 ~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LAQP------INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCC------CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 111222344666677778999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=272.44 Aligned_cols=239 Identities=23% Similarity=0.329 Sum_probs=184.5
Q ss_pred eeeeeecceEEEEEEEcC-CC--cEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|++|.||+|.+.. .+ ..||||.+..+.. ...+|+.++++++|+||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999999865 33 3689998876543 34579999999999999999998743 4578999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ ++.+.+..... ..+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence 99974 66666654211 468999999999999999999999 79999999999999995 788999999999876443
Q ss_pred Ccc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 234 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 234 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.+..+...........
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE----- 224 (257)
T ss_pred ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc-----
Confidence 211 12345678999999854 448999999999999999998 9999988777766666654222211111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+...|+..+|.+||++.++.+
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 12234455677778888999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=315.90 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=195.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..+|.-+..||.|.||.||.|.+..+|+-.|+|.++.. .....+|..++..++|||+|+++|+-++. .-
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HH
Confidence 34677788899999999999999999999999977532 23346899999999999999999987443 23
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++|.||||.++.+..+... ++-.++...+.+..|++.|+.|||+ .|||||||||+||+++. ++.+|++|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccceeE
Confidence 7799999997544444332 4567788888899999999999999 79999999999999995 88999999999988
Q ss_pred cccCCcc-----ceeeeeccccCcccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 230 LVKGEAN-----ISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 230 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
+...... ....||+.|||||++.+.. ....++|||||||++.||+||+.||..-+++=++.-.+..+..|+.+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 7554322 2468999999999996543 35778999999999999999999998766555555555555555443
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+- +.+. --.+.+-|...+|.+|-++.||++|-|
T Consensus 1464 ~~----ls~~-g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1464 ER----LSSE-GRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred hh----hhHh-HHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 32 1222 233455666667889999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=294.95 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=207.6
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhC-CCCceeecceeeeecCCCCc
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+..++.|++.++||.|.+|+||+++++.+++..|+|+..-+.. ..+.|.++++.. .|||++.++++|.-......
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34455679999999999999999999999999999998764432 234466677765 59999999999977666667
Q ss_pred eeeeeeeccccchH-HHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPETM-YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~l-~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|||||||++|. .++++... +.++.|..+..|++.++.||.+||. +.++|||||-.|||++. ++.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeee
Confidence 78999999999754 45555444 7899999999999999999999999 69999999999999995 88999999999
Q ss_pred ccccccCCc-cceeeeeccccCcccccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc-
Q 019506 227 AKVLVKGEA-NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY- 300 (340)
Q Consensus 227 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~- 300 (340)
+........ ..+.+||++|||||++.... .|+.++|+||||++..||.-|.+|+-+..+...+.+|.++.....
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 877654433 33568999999999995432 378899999999999999999999988887777777666433221
Q ss_pred -hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 -AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 -~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.+. ..++.++..|+..++..||+..++++|||
T Consensus 250 rp~kWs------~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 250 RPKKWS------KKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred chhhHH------HHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 12221 12355666677778999999999999998
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=273.62 Aligned_cols=236 Identities=15% Similarity=0.166 Sum_probs=171.8
Q ss_pred eeeeeecceEEEEEEEcC------------CCcEEEEEEeccccc----ChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 83 RVVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
+.||+|+||.||+|.... ....+++|.+..... .+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 358999999999998532 223588887754322 2346788999999999999999884 3
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC-------cE
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QV 219 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-------~~ 219 (340)
....++||||++++.++.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++ .+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCcee
Confidence 344679999999765444432 223568999999999999999999999 79999999999999974 33 28
Q ss_pred EEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCC
Q 019506 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
+++|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+. ....... .
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~-~ 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ-C 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC-c
Confidence 99999998665322 23456788999999865566899999999999999998 58899876554332 2221111 1
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..... .......+...|+..+|.+||++++|+++
T Consensus 227 ~~~~~------~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 MLVTP------SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cCCCC------ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 10000 01122345566777789999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=271.00 Aligned_cols=243 Identities=20% Similarity=0.313 Sum_probs=185.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|++.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+++++.++|+||+++++++ ......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence 36899999999999999999875 47789999886542 3456799999999999999999987 444458899
Q ss_pred eccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+.++ |.+.+.. ....+++..++.++.|++.+|.|||+ +|++|+||||+||+++. ++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence 9999974 4444332 23467899999999999999999999 79999999999999985 78899999999876543
Q ss_pred CCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+.+..+.+.... .... .
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~ 225 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL-YKPR-----L 225 (256)
T ss_pred CcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC-CCCC-----C
Confidence 3221 12234567999999865 448999999999999999998 99999887766655555432221 1111 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|+..+|.+||+++|++.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2223344566666777999999999865
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=275.54 Aligned_cols=236 Identities=18% Similarity=0.183 Sum_probs=172.0
Q ss_pred eeeeecceEEEEEEEcCC------------------------CcEEEEEEecccc----cChHHHHHHHHhCCCCceeec
Q 019506 84 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISL 135 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~ 135 (340)
.||+|+||.||+|....+ ...|++|.+.... ..+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999975322 2458888775432 233467889999999999999
Q ss_pred ceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
++++. +....++||||++++.++.+.. .....+++.++..++.||+.||+|||+ +||+||||||+|||++..
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 99884 3345789999999764443332 224578999999999999999999999 799999999999999742
Q ss_pred ------CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHH
Q 019506 216 ------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288 (340)
Q Consensus 216 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~ 288 (340)
...+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 124899999988654222 12356778999999876566899999999999999995 69999987665443
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.....+....+. . .+ .....+..-|+..+|.+|||+++|+++
T Consensus 231 ~~~~~~~~~~~~--~-----~~-~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKHRLPE--P-----SC-KELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhccCCCC--C-----CC-hHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222222111111 0 11 123345556667789999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.21 Aligned_cols=245 Identities=19% Similarity=0.244 Sum_probs=175.1
Q ss_pred eeeeecceEEEEEEEcCC--CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeecc
Q 019506 84 VVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
.||+|+||+||+++.... ...+++|.+.... ....+|+.+++.++||||+++++.+ .+....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 589999999999975433 2356677665332 2345688889999999999999988 444558899999
Q ss_pred ccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-
Q 019506 157 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE- 234 (340)
Q Consensus 157 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 234 (340)
+++ +|.+.+..........++..++.++.||+.||+|||+ ++++||||||+|||++. ++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcchh
Confidence 995 6666665433333456777888999999999999999 79999999999999985 7889999999986432221
Q ss_pred --ccceeeeeccccCcccccCC------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 235 --ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 235 --~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
......++..|+|||++... ..++.++|||||||++|||++ |..||...+..+.+..+++..........+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 11234567889999998431 235789999999999999997 578998877777777766543322111111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+ ......+...|+ .+|.+||++++|..
T Consensus 235 ~~~~-~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPY-SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCC-cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1111 111222333343 56999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.05 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=190.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
......++++||+|.||.|.+|.- ..+..||||+++.+ +..+.+|+++|.+++||||++++++|...+.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----- 609 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----- 609 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----
Confidence 445678899999999999999984 44689999988743 4556789999999999999999999954333
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|+|+||++. +|.+.+..... ....-.....|+.||+.|++||.+ -++|||||.+.|+|++. ++++||+|||.++
T Consensus 610 icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR 685 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSR 685 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCccccc
Confidence 8899999995 45555543211 113344556799999999999999 59999999999999994 9999999999999
Q ss_pred ccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 229 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.+..++.... .+-...|||+|.++.+ +++.++|+|+||+++||+++ ...||..-++++.+...-.....+..+.
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 7766654332 3447889999999764 48999999999999999864 7899998888777766665554443322
Q ss_pred -hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 304 -IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 304 -~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+.+.-.|..-...+..-|+..+-.+||+|+++..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2333344433333333344444788999999754
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.48 Aligned_cols=235 Identities=17% Similarity=0.168 Sum_probs=173.3
Q ss_pred eeeeeecceEEEEEEEcCCCc-------EEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 83 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+.||+|+||.||+|.+..++. .+++|.+.... ....+|+.+++.++|+||+++++++.. ....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 358999999999999865544 38888775432 233568889999999999999998843 33478
Q ss_pred eeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC-------cEEEEe
Q 019506 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKLCD 223 (340)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-------~~kl~D 223 (340)
+||||++++ |...+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++..+. .++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999975 4444432 23468899999999999999999999 79999999999999985332 279999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCchh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
||++...... ....++..|+|||++.+...++.++|||||||++|+|++|. .||...+..............+..
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAP- 227 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCC-
Confidence 9998765322 23456788999999976556799999999999999999984 777665544433222221111111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. ......+..-|+..+|.+|||+++|..
T Consensus 228 -~------~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 228 -K------WTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred -C------cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 112345556677778999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.49 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=185.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC---CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|.+.+.||+|+||.||+|.+... ...|++|...... ....+|+.+++.++|+||+++++++. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-
Confidence 4689999999999999999987544 3568999876443 23457999999999999999998773 22
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ ++.+.+.. ....+++..++.++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCcee
Confidence 25799999985 55555543 23468999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccc--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 228 KVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 228 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
.......... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 232 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN- 232 (270)
T ss_pred eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCC-
Confidence 7654432211 1223457999999854 458999999999999999996 9999988877666655544332222111
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|...+|.+|||+.++++
T Consensus 233 -----~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 233 -----CPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2233445556677778999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=278.08 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=182.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.+.||+|+||.||+|.+..+|. .+|+|.+..... ...+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----C
Confidence 468899999999999999999887776 468887764432 23568899999999999999998742 1
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..++++||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEccccc
Confidence 24589999985 55555442 23468899999999999999999999 79999999999999985 78899999999
Q ss_pred ccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+ +..+++........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 233 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQP 233 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCC
Confidence 9876433221 12234668999999865 448999999999999999997 999998765433 34444433222111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. .+......+..-|+..+|.+||+++++..
T Consensus 234 ~-----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 234 P-----ICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred C-----CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 12233455566677778999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.14 Aligned_cols=237 Identities=23% Similarity=0.347 Sum_probs=179.6
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
++||+|+||.||+|.. .++..+|+|.+.... ....+|+++++.++|+||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 3689999999999985 478899999876442 13457899999999999999999883 344578999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
++ ++.+.+.. ....+++..+..++.|++.+|.|||+ +|++||||||+||+++. ++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence 86 44444432 23467899999999999999999999 79999999999999985 888999999998764332221
Q ss_pred c--eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 237 I--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 237 ~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
. ...++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+.......+.+........ .....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ------KCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCC------CCCHH
Confidence 1 1123567999999854 458999999999999999998 999998877655555444322211111 12234
Q ss_pred hhhHhhhcccccccCCCCcCcccc
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+..-|+..+|.+||+++|+..
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 455677777778999999998754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.21 Aligned_cols=242 Identities=25% Similarity=0.367 Sum_probs=187.6
Q ss_pred eEeeeeeeecceEEEEEEEcCCC----cEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+.+.||.|+||.||++++...+ ..||+|.+..... ....|+.+++.++|+||+++++++. +....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 46788999999999999998766 8999998865432 3457899999999999999999884 33458
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|||+++ ++.+.+.... ...+++..+..++.|++.||.+||+ .|++|+||||+||+++. ++.++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCcee
Confidence 899999986 5555554321 1228999999999999999999999 79999999999999995 77899999999977
Q ss_pred cccCCccce--eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEANIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
......... ..++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+....+..+.+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 228 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPEN--- 228 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCc---
Confidence 654422221 235678999999844 558999999999999999998 8899988776666655554332222111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+.+.|...+|.+|||++|+++
T Consensus 229 ---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 229 ---CPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---CCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 2333455667777778999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=271.29 Aligned_cols=233 Identities=18% Similarity=0.171 Sum_probs=174.7
Q ss_pred eeeeeecceEEEEEEEcCCC----------cEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 36899999999999988766 358888765443 344578899999999999999998743 23
Q ss_pred eeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC-------cEEE
Q 019506 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKL 221 (340)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-------~~kl 221 (340)
.++||||++++ +.+.+... ...+++..+..++.||+.||.|||+ +||+||||||+||+++. ++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence 67999999965 44444331 2368999999999999999999999 79999999999999985 44 6999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
+|||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+...........+
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 226 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC
Confidence 99999987543 2233456789999998654 358999999999999999999 578887765433322222111111
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. .......+..-|...+|.+||++.+++.
T Consensus 227 ~~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 227 MP--------DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC--------CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 1134445566677778999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.70 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=182.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+|+.+++.++|+||+++++++.. . ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999875 78899999886432 234579999999999999999988732 1 257999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ ++.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceecccc
Confidence 99985 666666542 23467899999999999999999999 79999999999999995 788999999998764322
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+..+....+.+......... ...
T Consensus 154 ~--~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 224 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEG------CPA 224 (254)
T ss_pred C--CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCc------CCH
Confidence 1 12233567999999854 458999999999999999997 9999988776555444433211111110 112
Q ss_pred ChhhHhhhcccccccCCCCcCcccc
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+.+.|+..+|..||+++++..
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2334566677777999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.66 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=180.4
Q ss_pred cCeeEeeeeeeecceEEEEEEE----cCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||++.. ..++..||+|.+.... ....+|+++++.++|+||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 4699999999999999999974 4578899999886442 2346799999999999999999877432 233
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCccc
Confidence 47899999985 66655543 12458899999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------------HH
Q 019506 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------------DQ 288 (340)
Q Consensus 228 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------------~~ 288 (340)
.......... ...++..|+|||++.+. .++.++|||||||++|||++|..++...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 8764332211 11224459999998654 4899999999999999999998776433211 00
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+..+++........ .-+......+...|+..+|.+|||++|+..
T Consensus 235 ~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 LIELLKNNGRLPAP-----PGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHhcCCcCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11111111100000 011223455666777778999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.98 Aligned_cols=249 Identities=21% Similarity=0.259 Sum_probs=187.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+|.+.+.||+|+||.||+|+++. +.+.|++|.+..... ...+|++++++++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 468999999999999999999754 346799998764332 346799999999999999999987 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
....++||||+++ +|.+.+...... ...+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence 4557899999985 665555542211 1168999999999999999999999 79999999999999995 78899
Q ss_pred EEeeccccccccCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 221 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 221 l~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+......+..+ +...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~-~~~~ 235 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL-QAGK 235 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH-HcCC
Confidence 99999986543221 11233557789999998654 47899999999999999998 88999876654444433 3222
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..... ...+......+...|+..+|.+||++.|++.+
T Consensus 236 ~~~~~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPV----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22110 01122344556677777789999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=267.25 Aligned_cols=218 Identities=34% Similarity=0.598 Sum_probs=180.8
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
+-.+.||.|+||.||.+.+.++|+.||+|++..- .+..-+|+.+|.-++|.|++..+++.....-.--..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3447799999999999999999999999988643 2344579999999999999998877632211111226788
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
+|++..+|...+ ...+.++...++.++.||++||+|||+ .||.||||||.|.|+++ +-.+||||||+++.-..+
T Consensus 136 TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEecccccccccchh
Confidence 888876554443 346789999999999999999999999 79999999999999995 888999999999876443
Q ss_pred Cc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 234 EA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 234 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.. .+..+-|-+|.|||++.|...|+.++||||.|||+.||+..+..|...++.+++..|....+.|..+.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 32 23345688999999999999999999999999999999999999999999999999999988876443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=267.87 Aligned_cols=244 Identities=22% Similarity=0.324 Sum_probs=183.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+++++.++|+||+++++++. + ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEE
Confidence 457999999999999999999854 56679999886543 23457999999999999999988873 2 34689
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||+++ ++.+.+... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence 9999985 666665432 23567888899999999999999999 79999999999999995 8899999999997654
Q ss_pred cCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... ....++..|+|||++.+ ..++.++|+|||||++|+++| |..||.+.+.......+......+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 227 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN----- 227 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCccc-----
Confidence 33221 12234567999999965 458999999999999999999 9999988766555544433222111111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+..-|+..+|.+||+++++..
T Consensus 228 -~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 -CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1112334455566667999999988753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=272.53 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=179.4
Q ss_pred eeeeeecceEEEEEEEcCCC------cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 83 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+.||+|+||.||+|++.... ..+|+|.+.... ....+|+.+++.++|+||+++++++. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 35899999999999976443 689999875432 23457899999999999999999883 334588
Q ss_pred eeeccccc-hHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC-----cEEEE
Q 019506 152 LVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLC 222 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-----~~kl~ 222 (340)
+||||+++ ++.+.+..... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++ .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999985 66666654221 22457889999999999999999999 79999999999999985 44 79999
Q ss_pred eeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 019506 223 DFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 223 Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|||++......... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 99998765333211 122346789999999654 48999999999999999998 99999877766555444332221
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..... .......+...|+..+|.+||+++++.+
T Consensus 233 ~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 QKPEN------CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCccc------chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11111 1122344556666778999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=266.27 Aligned_cols=237 Identities=23% Similarity=0.352 Sum_probs=178.6
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
++||+|+||.||+|.+.. ++.||+|.+.... ....+|++++++++|+||+++++++ .+....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 368999999999999877 9999999876432 2345799999999999999999988 3444588999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
.+ ++.+.+.. ....+++..+..++.|++.+|.|||+ +|++||||||+||+++. ++.++|+|||++.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence 86 55555433 23467889999999999999999999 79999999999999995 888999999999765422211
Q ss_pred c---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 237 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 237 ~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
. ....+..|+|||.+.+. .++.++|+|||||++|+|+| |..||.+.........+......+... ....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 222 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ------LCPE 222 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCc------cCCH
Confidence 1 11225569999998654 58999999999999999999 889998776654444443322211111 1122
Q ss_pred ChhhHhhhcccccccCCCCcCcccc
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+...|...+|.+||+++|+++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 3344555666677999999999865
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=268.67 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=174.7
Q ss_pred eeeeeecceEEEEEEEcC---CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 358999999999998653 34579999875321 233468889999999999999987642 223467999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+.+ ++.+.+.. .....++..+..++.|++.||.|||+ .|++||||||+|||++. ++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99985 55555442 12346777888899999999999999 79999999999999995 788999999999765332
Q ss_pred Cc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 234 EA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 234 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+......+...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPE----- 225 (262)
T ss_pred cceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC-----
Confidence 11 112234667999999865 458999999999999999999 567787766655444443322222111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........+...|+..+|.+||+++|++.
T Consensus 226 -~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 226 -YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11223445666677778999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.49 Aligned_cols=240 Identities=28% Similarity=0.419 Sum_probs=197.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCC----CcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..+.++||+|.||.||+|..... ...||||.-+.+ .+.+..|..+|+.++||||++++|++.+ . -
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-----~-P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-----Q-P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----c-c
Confidence 34557899999999999987533 345899988764 2344578899999999999999999832 1 2
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+||||+++ |.|...|.. ....++......++.||+.||.|||+ +.+|||||...|||+.+ ...+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhh
Confidence 789999999 455555553 34678999999999999999999999 79999999999999995 8889999999999
Q ss_pred ccccCCccceeee--eccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGEANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
.+.+...-....| ...|||||.+ +-..++.++|||.|||++||++. |..||.+-.+.+.+..+.+....|.+..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n-- 616 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN-- 616 (974)
T ss_pred hccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC--
Confidence 9876655444344 5669999999 55668999999999999999986 9999999988888888888777766554
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
|..-...+..-|+.++|.+||++.||+
T Consensus 617 ----CPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 617 ----CPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ----CChHHHHHHHHHhccCcccCCcHHHHH
Confidence 555566777889999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=269.79 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=183.4
Q ss_pred eeEeeeeeeecceEEEEEEEcC---CCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCc-e
Q 019506 79 YMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE-L 148 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~-~ 148 (340)
|.+.+.||+|+||.||+|.+.. ++..||||.+..+.. ...+|+++++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998653 578999998865422 23478999999999999999998754332222 2
Q ss_pred eeeeeeccccc-hHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++++||+.+ ++...+.... .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence 34688899985 4444433211 112357889999999999999999999 79999999999999985 8889999999
Q ss_pred cccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+++....... .....++..|++||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9986543321 1122345679999998554 47899999999999999999 89999877765555544443222211
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. .......+...|+..+|..||++.+++.
T Consensus 238 ~~------~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 238 PD------CLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CC------CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1223344556667778999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.33 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=179.5
Q ss_pred CeeEeeeeeeecceEEEEEEE----cCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.|++.+.||+|+||.||+|++ ..++..||+|.+.... ....+|+++++.++|+||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 478999999999999999974 4578899999886432 2345799999999999999999887432 234
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccc
Confidence 57899999986 55554432 12458999999999999999999999 79999999999999985 788999999999
Q ss_pred cccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------------hHHHH
Q 019506 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------------AVDQL 289 (340)
Q Consensus 228 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------------~~~~~ 289 (340)
......... ....++..|+|||++.+. .++.++|||||||++|+|+|+..|+.... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 876433221 123456679999998654 48899999999999999999876653211 11111
Q ss_pred HHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 290 VEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+....... ... -+......+...|+..+|.+||+++++..
T Consensus 236 ~~~~~~~~~~~---~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 236 VRVLEEGKRLP---RPP--NCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHcCccCC---CCC--CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11111111110 000 12233445566667778999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=286.32 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=200.0
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCC---cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..++.++||+|.||.|++|.|...+ ..||||.++.+. ..+.+|+.+|.+|+|+|++++||+..+ .-
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence 4566788999999999999997532 458999887543 456799999999999999999999843 12
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+.+|||+++ |+|++.|.. .....|.......++.||+.|+.||.+ +++|||||...|+|+-. ...|||+|||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeeccccee
Confidence 569999999 578887776 345678888999999999999999999 89999999999999986 7789999999999
Q ss_pred ccccCCccceeee----eccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 229 VLVKGEANISYIC----SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~~~~~~~----~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.+..++....... ...|+|||.+.. ..++.++|||++||++|||+| |+-||.+.....++++|-+....+.++.
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCC
Confidence 9877665543222 456999999954 558999999999999999998 8899999999888888886555555443
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
|+.....+..-|+..+|.+||||..|.
T Consensus 340 ------csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 340 ------CSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ------ChHHHHHHHHHhccCCccccccHHHHH
Confidence 555666677778888899999999885
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=270.11 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=183.0
Q ss_pred CeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhC-CCCceeecceeeeecCCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 145 (340)
+|.+.+.||+|++|.||++++. .+++.||||.+++.. ....+|+++++.+ +|+||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4889999999999999999864 467889999886421 2235789999999 599999999888 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.....++||||+.+ ++.+.+.. ...+++..++.++.|++.+|.|||+ .|++||||||+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence 44568899999986 55444432 3568899999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCcc--ceeeeeccccCcccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCC
Q 019506 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVSNI 298 (340)
Q Consensus 225 g~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~ 298 (340)
|++......... ....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.. ..+.+.......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP 229 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC
Confidence 998765433221 2245788999999985432 3678999999999999999999999644322 222222111211
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCc---CcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSM---HESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~---~~i~~hpf 340 (340)
+.... .......+..-|+..+|..|||+ +++++|||
T Consensus 230 ~~~~~------~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 230 PFPKT------MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred CCCcc------cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 11111 11223445555677789999985 56799998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.55 Aligned_cols=227 Identities=21% Similarity=0.244 Sum_probs=171.8
Q ss_pred ecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc-hHHHHHH
Q 019506 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK 166 (340)
Q Consensus 88 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 166 (340)
|.+|+||++++..+++.||+|.+..... ..+|...+....||||+++++++ .+....++||||+++ +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999876543 33455555666799999999988 444568899999996 5656554
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeecccc
Q 019506 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246 (340)
Q Consensus 167 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~ 246 (340)
. ...+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 2458999999999999999999999 79999999999999995 788999999988665332 22334567799
Q ss_pred CcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccc
Q 019506 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSY 326 (340)
Q Consensus 247 aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (340)
|||.+.+ ..++.++|+||+||++|+|++|..||....... .. .... ..+. ........+.+-|...+|
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~~---~~~~-~~~~-----~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI--NT---HTTL-NIPE-----WVSEEARSLLQQLLQFNP 217 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--cc---cccc-CCcc-----cCCHHHHHHHHHHccCCH
Confidence 9999854 447899999999999999999999886432210 00 0000 0000 012223445555666778
Q ss_pred cCCCCc-----CcccccCC
Q 019506 327 SGRNSM-----HESKLYGF 340 (340)
Q Consensus 327 ~~R~~~-----~~i~~hpf 340 (340)
.+|+++ +|+++|||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred HHhcCCCccchHHHHcCCC
Confidence 899986 99999999
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=280.25 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=199.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...+.....+||-|.||.||.|.|++-.-.||||.++.+.. .+..|..+|+.++|||+|+++++| ..+.-.|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFY 339 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFY 339 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeE
Confidence 33455667899999999999999999999999999987653 455799999999999999999999 4455578
Q ss_pred eeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||.|||. |+|+++|+.... ..++.-....++.||..|++||.. +++|||||...|+|+.. ++.+|++|||+++.+
T Consensus 340 IiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhh
Confidence 9999998 688888886433 456666778899999999999999 89999999999999995 899999999999988
Q ss_pred ccCCccce--eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEANIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
..+..... .-....|.|||.+.-+ .++.++|||+|||+|||+.| |-.||.+-+- .+++.+++........+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgyRM~~Pe---- 489 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGYRMDGPE---- 489 (1157)
T ss_pred cCCceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhccccccCCC----
Confidence 65544322 2235679999999544 48999999999999999998 8899998875 44555555444333322
Q ss_pred ccccCChhhHhhhcccccccCCCCcCccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
-|.....++++.|+.++|..||+|.||.
T Consensus 490 -GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 490 -GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 3566667888888888899999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.01 Aligned_cols=213 Identities=24% Similarity=0.408 Sum_probs=172.4
Q ss_pred CCCCCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cC---------hHHHHHHHHhCCCCceeecce
Q 019506 69 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RY---------KNRELQLMRLMDHPNVISLKH 137 (340)
Q Consensus 69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---------~~~E~~~l~~l~h~~iv~~~~ 137 (340)
....+...++|.+...||+|||+.||+|.+....+.||||+-.... +. .-+|.++-+.|.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3455666778999999999999999999999999999999764221 11 136889999999999999999
Q ss_pred eeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCceecCCCCCCeEecCC-
Q 019506 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPL- 215 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~iiH~dlkp~Nill~~~- 215 (340)
+|.. +....|-|+|||+|..+ ..+...++-+++++++.|+.||+.||.||.+. ..|||-||||.|||+...
T Consensus 535 yfsl----DtdsFCTVLEYceGNDL---DFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 535 YFSL----DTDSFCTVLEYCEGNDL---DFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeee----ccccceeeeeecCCCch---hHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 9843 23337899999998633 33344578899999999999999999999974 469999999999999642
Q ss_pred -CCcEEEEeeccccccccCCcc--------ceeeeeccccCcccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 216 -THQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 216 -~~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
.+.+||+|||+++.+.++... ....||-+|++||.+.-+ +..+.++||||+|||+|.++.|+.||..+
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 257999999999988655443 234689999999998643 45789999999999999999999999876
Q ss_pred ChHHH
Q 019506 284 NAVDQ 288 (340)
Q Consensus 284 ~~~~~ 288 (340)
.....
T Consensus 688 qsQQd 692 (775)
T KOG1151|consen 688 QSQQD 692 (775)
T ss_pred hhHHH
Confidence 55433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=261.79 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=205.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCC-Ccee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~ 149 (340)
.+|.-.+.+|.|+. .|..|.+.-.++.||+|++.... +...+|..++..++|+||++++.+|...... ....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36888888999998 78888888899999999875432 2335799999999999999999998543321 2234
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+|||++..++...+. -.++-..+..++.|++.|+.|||+ .||+||||||+||++.. +..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhcc
Confidence 78999999998777665 345667789999999999999999 79999999999999995 88899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
....-..+..+.|++|.|||++.+.+ |...+||||+||++.||++|...|.|.+..+++.+++...+.+...-+
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 65554556678899999999998876 899999999999999999999999999999999999998887653111
Q ss_pred -------------------------hccccccC-----ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -------------------------YQGLFCSN-----NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -------------------------~~~~~~~~-----~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+..+ ....+..-++.++|++|.++++++.|||
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 11111111 1223344567778999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=290.66 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=200.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCC---cEEEEEEecc-----cccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.-.|.++||.|.||.|++|+.+..| ..||||.++. .+..+..|+.+|-+++||||+++.|+. ....-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 3578899999999999999987655 5699999974 355667899999999999999999998 55555
Q ss_pred eeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+.||.|||+++ |...|+. ..+.|+..+...+++.|+.|++||-++ |+|||||...|||++. +..+|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNs-nLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeecc-ceEEEecccccee
Confidence 88999999965 4444443 246688889999999999999999995 9999999999999995 9999999999999
Q ss_pred ccccCCcc-ceee-e--eccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 229 VLVKGEAN-ISYI-C--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~~-~~~~-~--~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.+.++... .+.. | ...|.|||.+. ..+++.++||||+||++||.++ |..||.+.++.+.+..|.+.-..|.+.+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD 858 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD 858 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence 88655422 2222 2 56799999995 4568999999999999999875 9999999999999999999888887755
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
|....-.++.-|+..+-.+||+|.||.+
T Consensus 859 ------CP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 859 ------CPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ------CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 5555555555566666888999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=264.32 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=183.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEc----CCCcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..|.+.+.||+|+||.||+|++. .++..+|||.+..... ...+|+++++.+.|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 35788899999999999999864 3478999998875433 35679999999999999999987733 224
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ ++.+.+.. ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence 458899999985 56555543 12358999999999999999999999 79999999999999995 78899999999
Q ss_pred ccccccCCccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH--------------HH
Q 019506 227 AKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------------DQ 288 (340)
Q Consensus 227 a~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------------~~ 288 (340)
+.......... ...++..|+|||.+.+. .++.++||||||+++|+|+||..||...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 98765332211 12335569999998654 5899999999999999999999998654321 11
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+...++........ ..+......+...|+..+|.+||++.|+..
T Consensus 235 ~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLKEGERLPRP-----PSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHcCCcCCCC-----ccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222211111100 112223445666777778999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=269.38 Aligned_cols=198 Identities=28% Similarity=0.453 Sum_probs=172.0
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh------------HHHHHHHHhCC---CCceeecce
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRLMD---HPNVISLKH 137 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~~~~ 137 (340)
.....+|...+.||+|+||.|++|.++.....|+||.+.+++-.. --|+++|..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344557999999999999999999999999999999887764221 25999999998 999999999
Q ss_pred eeeecCCCCceeeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 138 CFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
+| ++..++||+||--+. +|++.+. ...+++|.++..|++|++.|+++||+ +||||||||-+|+.++.
T Consensus 637 fF-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~- 705 (772)
T KOG1152|consen 637 FF-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDS- 705 (772)
T ss_pred ee-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEec-
Confidence 99 777889999998875 4444444 46789999999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 019506 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (340)
+|-+||+|||.|.....+ ....+.||..|.|||++.|..+.+..-|||+||++||.++....||..
T Consensus 706 ~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 888999999999776444 455789999999999998877779999999999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=271.95 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=171.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEc----------------CCCcEEEEEEeccccc------------------ChHH
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR 119 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~------------------~~~~ 119 (340)
...++|.+.++||+|+||+||+|.+. ..++.||||.+..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34668999999999999999999752 2456799998864321 1123
Q ss_pred HHHHHHhCCCCce-----eecceeeeecCC---CCceeeeeeeccccc-hHHHHHHHhhc--------------------
Q 019506 120 ELQLMRLMDHPNV-----ISLKHCFFSTTS---KDELFLNLVMEYVPE-TMYRVLKHYSS-------------------- 170 (340)
Q Consensus 120 E~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------- 170 (340)
|+.++.+++|.++ ++++++|..... ......++||||+++ +|.+.+.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777776654 566666643211 122347899999996 55555432100
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcccee--eeeccccCc
Q 019506 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--ICSRYYRAP 248 (340)
Q Consensus 171 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~--~~~~~y~aP 248 (340)
....+++..++.++.|++.+|.|||+ ++|+||||||+|||++. ++.+||+|||++............ .+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234677889999999999999999 79999999999999995 788999999999765433222222 337889999
Q ss_pred ccccCCCC-------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCChHHH-H-------HH--HHHhc
Q 019506 249 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQ-L-------VE--IIKVS 296 (340)
Q Consensus 249 E~~~~~~~-------------------~--~~~~DiwslG~il~elltg~~-pf~~~~~~~~-~-------~~--~~~~~ 296 (340)
|.+..... | ..+.||||+||++|+|++|.. ||.+...... + .. ..+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99853211 1 234799999999999999985 7754221111 0 00 11111
Q ss_pred CCCchhhhhccccccCChhhHhhhccccc--ccCCCCcCcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYS--YSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~R~~~~~i~~hpf 340 (340)
...+. .+.. ....-++.+..++...+ +.+|+|++|+++|||
T Consensus 460 ~~~~~--~~d~-~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 460 KYDFS--LLDR-NKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCCcc--cccc-cChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 11111 1111 11223445555555433 368999999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=297.37 Aligned_cols=241 Identities=20% Similarity=0.269 Sum_probs=174.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
.|...+.||+|+||.||+|++..++..||+|.+.........|++.+++++|||||++++++. +....++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCC
Confidence 466678899999999999999889999999998766555667899999999999999999984 334478999999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH---TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
++ ++.+.+. .+++..+..++.|++.||+||| + ++|+||||||+||+++. +...++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-eccccccccC
Confidence 96 4554442 3788899999999999999999 6 69999999999999995 6666665 6655433211
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhc-CCCchhhhhcccccc
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVS-NIIYAKTIYQGLFCS 311 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~ 311 (340)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+.+..+.. .......+++..+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 22357889999999865 4589999999999999999999999953211 11111111111 111111122211111
Q ss_pred C---C------hhhHhhhcccccccCCCCcCcccc
Q 019506 312 N---N------HEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 312 ~---~------~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. + ...+...|+..+|.+||+++|+.+
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 1 1 112334567778999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=255.22 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=188.6
Q ss_pred ecCCCCCCCccc-----cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc-cccChHHHHHHH--HhCCCCceeecc
Q 019506 65 TIGGKNGEPKQT-----ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLM--RLMDHPNVISLK 136 (340)
Q Consensus 65 ~~~~~~~~~~~~-----~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l--~~l~h~~iv~~~ 136 (340)
+.|+..|.+... ..-.+.+.||+|.||.||+|++ .|+.||||++.. +.....+|.++. ..|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 445555665443 3578899999999999999999 799999999864 344445666665 467999999988
Q ss_pred eeeeecCCCCceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCceecCCCCC
Q 019506 137 HCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-------VPGVCHRDVKPQ 208 (340)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------~~~iiH~dlkp~ 208 (340)
+.=.... .....++||.+|.+ |+|++.|.. ..++......++.-++.||+|||. ...|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7643222 33456899999999 688888875 678889999999999999999995 146999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCc-----cceeeeeccccCcccccCCCC-----CCCcchhHHHHHHHHHHHhC--
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG-- 276 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg-- 276 (340)
||||.+ ++++-|+|+|+|........ ....+||..|||||++-..-. --..+||||||.++||++..
T Consensus 346 NILVKk-n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKK-NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEcc-CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 999995 99999999999977654432 234689999999999943221 11358999999999999742
Q ss_pred --------CCCCCCCCh-HHHHHHHHHhcCC----CchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 277 --------QPLFPGENA-VDQLVEIIKVSNI----IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 277 --------~~pf~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
++||.+-.+ ...++++.+.--. |...+.|...-+..-...+++-|+..+|.-|.|+--|+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 478864321 2233344433322 33333333333333355566667777788888875543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.70 Aligned_cols=247 Identities=23% Similarity=0.261 Sum_probs=184.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc-cccChHHHHHHHH--hCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMR--LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
....+.++||+|.||.||+|.. +++.||||++.. +...+..|-++.+ .++|+||+++++.-.... .+...++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 3466778899999999999987 779999999974 3455566766665 568999999987643222 224468899
Q ss_pred ecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCceecCCCCCCeEecCCCCcEEEEee
Q 019506 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------PGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
++|.+ |+|.+.|.. ..+++....+|+.-|++||+|||+- ..|+|||||..||||.. +.+..|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeecc
Confidence 99999 678888775 6789999999999999999999972 46999999999999995 899999999
Q ss_pred ccccccccCCc---cceeeeeccccCcccccCCCCCC-----CcchhHHHHHHHHHHHhCC------------CCCC---
Q 019506 225 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQ------------PLFP--- 281 (340)
Q Consensus 225 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltg~------------~pf~--- 281 (340)
|+|..+..+.. ....+||..|||||++.+..... .+.||||+|.+||||++.- .||+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99988764433 33478999999999997765544 3689999999999999753 3443
Q ss_pred --CCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCc
Q 019506 282 --GENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSM 332 (340)
Q Consensus 282 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~ 332 (340)
..+.++.....++....|..++.|++..--...-...+-|+-.++..|+|+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 123344445555666667777776665333333344444555556667665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=246.07 Aligned_cols=237 Identities=32% Similarity=0.540 Sum_probs=187.1
Q ss_pred cceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc-hHH
Q 019506 89 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMY 162 (340)
Q Consensus 89 ~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 162 (340)
+||.||+|.+..+|+.+|+|++.... ....+|++.+++++|+||+++++++.. ....++++|++++ ++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999986543 345689999999999999999998843 3457899999998 666
Q ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeeee
Q 019506 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242 (340)
Q Consensus 163 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 242 (340)
+.+.. ...++...+..++.+++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence 65543 2338899999999999999999999 79999999999999995 788999999999887655444456678
Q ss_pred ccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcc
Q 019506 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGS 322 (340)
Q Consensus 243 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (340)
..|++||.+.+ ..++.++||||||+++|+|++|..||......+.+.+.............. ........+...|+
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l 225 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW---KISPEAKDLIRKLL 225 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccc---cCCHHHHHHHHHHc
Confidence 88999999864 447889999999999999999999998744445555554433333211100 02233445666677
Q ss_pred cccccCCCCcCcccccCC
Q 019506 323 WYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 323 ~~~~~~R~~~~~i~~hpf 340 (340)
..+|++||++.++++|||
T Consensus 226 ~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 226 VKDPEKRLTAEEALQHPF 243 (244)
T ss_pred cCCchhccCHHHHhhCCC
Confidence 778999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=273.22 Aligned_cols=245 Identities=27% Similarity=0.343 Sum_probs=181.3
Q ss_pred eeEeeeeeeecceE-EEEEEEcCCCcEEEEEEeccccc-ChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeeeec
Q 019506 79 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 79 y~~~~~Lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
|.-.+++|.|+.|+ ||+|.. .|+.||||++..+.- ...+|+..|+.-+ |||||++++.- .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 44456789999875 799988 889999998876654 5578999998874 99999987654 77888999999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC----CCCcEEEEeeccccccc
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----~~~~~kl~Dfg~a~~~~ 231 (340)
.|..+|.+++...........-...+.+..|++.||++||+ -+||||||||.|||++. ...+++|+|||+++...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999998887621100111113456788899999999999 59999999999999975 23579999999999886
Q ss_pred cCCccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
.+.... +..||-+|+|||++.... -+.++|||||||++|+.++| ..||.+.- +.-..|++.......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~----- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVH----- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceee-----
Confidence 554432 346899999999997655 47799999999999999995 79997543 333344442221110
Q ss_pred cccccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+-+.. -...+..-+...+|..||++.++++|||
T Consensus 735 -L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 735 -LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred -eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 00000 1223334445556779999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=268.99 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=190.5
Q ss_pred CeeEeeeeeeecceEEEEEEEcC-------CCcEEEEEEecccc-----cChHHHHHHHHhCC-CCceeecceeeeecCC
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 144 (340)
+..+.+.||+|.||.|++|.-.. ....||||..+... .....|+++|+.+. |+||+.+++++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t---- 372 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT---- 372 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec----
Confidence 34566799999999999997431 14579999886443 34457999998885 999999999984
Q ss_pred CCceeeeeeecccc-chHHHHHHHhh---cC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeE
Q 019506 145 KDELFLNLVMEYVP-ETMYRVLKHYS---SM-------N--QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (340)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~-------~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nil 211 (340)
....+++|+||+. |.|.+.+++.. .. + ..++......++.||+.|++||++ .++|||||-..|||
T Consensus 373 -~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 -QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL 450 (609)
T ss_pred -cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence 3555889999999 57777777644 11 1 138889999999999999999999 79999999999999
Q ss_pred ecCCCCcEEEEeeccccccccCCccce--ee--eeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 019506 212 VDPLTHQVKLCDFGSAKVLVKGEANIS--YI--CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (340)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 286 (340)
+.. +..+||+|||+|+.......... .. -...|||||.+.. ..|+.++|||||||+|||++| |..||.+-...
T Consensus 451 i~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 995 88999999999986544333221 11 2345999999976 569999999999999999998 88999986533
Q ss_pred HHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 287 DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.+.++.+.....+. .|......+++.|+..+|.+||+|.++.+
T Consensus 529 ~~l~~~l~~G~r~~~P~-----~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPE-----HCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44455666555544433 35555666777888778999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=262.25 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=188.9
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCc----EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+..++||+|+||+||+|.+.-.|+ +||+|++.... ....+|+-+|.+++|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 4556789999999999999875554 57888775432 33457888999999999999999985432
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+.||++|++ |.|++.++.. ...+..+....|..||++|+.|||. ++++||||-.+||||.+ -..+||+|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchhh
Confidence 669999999 5677766643 4678888999999999999999999 79999999999999996 6779999999999
Q ss_pred ccccCCccceeee---eccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 229 VLVKGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
....+.......+ .+.|||-|.+.. ..|+.++|||||||++||++| |..||.+....++-..+.+....+.+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP--- 922 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP--- 922 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---
Confidence 8866655444333 566999999854 559999999999999999998 99999887765444433333333333
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHES 335 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i 335 (340)
-.|..+...+.--|++.++..||+|+++
T Consensus 923 ---piCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 923 ---PICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred ---CCccHHHHHHHHHHhccCcccCccHHHH
Confidence 2466666777777888899999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=260.18 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=203.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+..++|.|+||.||+|+++.+++..|+|+++.+. .....|+-+++.++|+||+.+++.|. ....++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-----r~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-----hhcCcE
Confidence 457999999999999999999999999999999997542 33467999999999999999999984 344488
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+.||||+++.++.+. ...+.+++.++..++++.+++|+|||+ .|-+|||||-.|||++. .+.+|++|||.+..+.
T Consensus 89 icMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhhh
Confidence 999999987555443 346789999999999999999999999 69999999999999995 8889999999986553
Q ss_pred cC-CccceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-chhhhhcc
Q 019506 232 KG-EANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII-YAKTIYQG 307 (340)
Q Consensus 232 ~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 307 (340)
.- .....+.||++|||||+.. ..+.|...+|||++|++..|+-.-++|-.+-.....+..+-+....+ .+++-
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk--- 240 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK--- 240 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC---
Confidence 22 2334678999999999973 23458999999999999999999998877777777777777655433 22221
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.--..-+..+.+.++-.+|++||+++-++.|||
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence 111223355667777778889999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=243.84 Aligned_cols=207 Identities=30% Similarity=0.502 Sum_probs=167.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcC---CCcEEEEEEeccc--ccChHHHHHHHHhCC-CCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD--RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 148 (340)
....|.++++||+|.|++||++.+.. .++.||+|.+... ......|+++|..+. +.||+++.+++ ..+.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence 34469999999999999999999877 7889999988644 344568999998885 89999999998 6677
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+.+||||++..-...+. ..++...++.+++.++.||.++|. +|||||||||+|+|.+...+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHH
Confidence 789999999975444443 356788999999999999999999 7999999999999999888899999999997
Q ss_pred ccccC---------------------------------------------CccceeeeeccccCcccccCCCCCCCcchh
Q 019506 229 VLVKG---------------------------------------------EANISYICSRYYRAPELIFGATEYTTSIDI 263 (340)
Q Consensus 229 ~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 263 (340)
..... .......||++|.|||++...+.-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21000 000124689999999999888778999999
Q ss_pred HHHHHHHHHHHhCCCCCCC-CChHHHHHHHH
Q 019506 264 WSAGCVLAELLLGQPLFPG-ENAVDQLVEII 293 (340)
Q Consensus 264 wslG~il~elltg~~pf~~-~~~~~~~~~~~ 293 (340)
||.|||+.-++++..||-. .++.+.+.++.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHH
Confidence 9999999999999988753 34444444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=224.90 Aligned_cols=206 Identities=33% Similarity=0.590 Sum_probs=168.7
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
|.+.+.||+|++|.||++.+..+++.+++|.+... .....+|++.++.++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56788999999999999999888999999998754 334457899999999999999999873 33457899
Q ss_pred eccccc-hHHHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|++++ ++.+.+.. ... +++..+..++.+++.+|.+||+ .+++|+||+++||+++. ++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence 999998 66665543 223 7899999999999999999999 79999999999999995 7889999999998775
Q ss_pred cCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 019506 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKV 295 (340)
Q Consensus 232 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~~~~~ 295 (340)
... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+.+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 543 333456778899999984444578899999999999999999999977 5555455554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=225.66 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=194.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
.|+++++||+|+||.++.|++.-+++.||||.-.... -....|.+..+.|. .++|...+.+- ++..+..|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 6999999999999999999999999999999654333 33456888888875 67887775443 6666677999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC----CCCcEEEEeecccccc
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVL 230 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----~~~~~kl~Dfg~a~~~ 230 (340)
|+++.+|.+++.- .+++|+.+++..++.||+.-++|+|+ +.+|+|||||+|+||.. +.+.|.|+|||+|+.+
T Consensus 104 dLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9999999888764 36899999999999999999999999 79999999999999963 2346999999999988
Q ss_pred ccCCcc--------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---
Q 019506 231 VKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII--- 299 (340)
Q Consensus 231 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 299 (340)
.+.... .+..||..||+-...+|.. -+.+.|+-|||-++++.|-|..||++-.....-.+..+.++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 655432 3467899999999988765 6999999999999999999999999754433333334444333
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+ ||..-. .++..+..+.+|++|+|-+||.|
T Consensus 259 ~i~~-----Lc~g~P---~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 259 PIEV-----LCEGFP---EEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred CHHH-----HHhcCH---HHHHHHHHHHHhcCcccCCCHHH
Confidence 3333 344433 35666777889999999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=210.89 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=186.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCC-CceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..+|+++++||+|+||.+|+|....+|..||||.-++.. .....|..+.+.+++ ..|..+..+. .+..+-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccccccee
Confidence 347999999999999999999999999999999766543 234578889888875 4565665555 56666779
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeecccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a~~~ 230 (340)
|||+++.+|.+++.-. ++.++.+++..++.|++.-++|+|. +++|||||||+|+|+.- ..+++.|+|||+|+.+
T Consensus 89 VMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999988877643 4789999999999999999999999 89999999999999853 2357999999999887
Q ss_pred ccCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 231 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
.+... .....||..|.+-....+.. -+.+.|+-|+|.+|.++..|..||++-......++..+..+.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 54332 23467899999887775544 5889999999999999999999999876555544444433322211
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
. -+.+|+--...+.. ..++-+-+.|+|-+||
T Consensus 244 ~--ie~LC~G~P~EF~m---yl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 244 P--IEVLCKGFPAEFAM---YLNYCRGLGFEEKPDY 274 (341)
T ss_pred C--HHHHhCCCcHHHHH---HHHHHhhcCCCCCCcH
Confidence 1 12245544433333 3344467777777665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=224.35 Aligned_cols=196 Identities=23% Similarity=0.340 Sum_probs=151.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHH-HHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+.|.|.+.||+|-||++-+|+++.++..+++|.+.... +.+.+|... +..-.|.||+.-+++.+ +...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF----qt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF----QTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh----hcCceEE
Confidence 456999999999999999999999999999999886543 444556544 22335999999887655 3344678
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-CCCcEEEEeeccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~~~~~kl~Dfg~a~~ 229 (340)
+++||++. +|...+. ...+.+.....++.|+++||+|||+ +++||||||.+|||+-. +..++||||||+.+.
T Consensus 99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999995 4433332 3678888999999999999999999 89999999999999843 345899999999865
Q ss_pred cccCCccceeeeeccccCcccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 230 LVKGEANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
...-- ...-.+..|.+||++... -...+.+|+|.||+++|.++||.+||+..
T Consensus 173 ~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 173 VGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 42111 111225569999987422 22567899999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=210.96 Aligned_cols=208 Identities=33% Similarity=0.510 Sum_probs=166.3
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeecccc-
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP- 158 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 158 (340)
||+|++|.||++....+++.+++|++..... ...+|++.++.+.|++|+++++++. .....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 6899999999999987899999999976643 4678999999999999999999883 3355889999999
Q ss_pred chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-ccc
Q 019506 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANI 237 (340)
Q Consensus 159 ~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~ 237 (340)
+++.+.+... ...++...++.++.+++.+|.+||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 4666555431 1468899999999999999999999 7999999999999999436789999999998764432 122
Q ss_pred eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhH
Q 019506 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIM 317 (340)
Q Consensus 238 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (340)
...+...|++||.+.....++.++|+|+||+++++| .....+
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~~~ 193 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELKDL 193 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHHHH
Confidence 345677899999986543578999999999999999 111223
Q ss_pred hhhcccccccCCCCcCcccccC
Q 019506 318 CELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 318 ~~l~~~~~~~~R~~~~~i~~hp 339 (340)
...|...+|.+||+++++..|+
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 3333445677999999998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=254.30 Aligned_cols=202 Identities=17% Similarity=0.128 Sum_probs=137.6
Q ss_pred hCCC-CceeecceeeeecC--CCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCcee
Q 019506 126 LMDH-PNVISLKHCFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (340)
Q Consensus 126 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH 202 (340)
.++| .||+++++.|-... ......++++||+++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3445 57777777762211 112234668899999988888753 24569999999999999999999999 79999
Q ss_pred cCCCCCCeEecC------------------CCCcEEEEeeccccccccCC-----------------ccceeeeeccccC
Q 019506 203 RDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVKGE-----------------ANISYICSRYYRA 247 (340)
Q Consensus 203 ~dlkp~Nill~~------------------~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~a 247 (340)
|||||+|||++. .++.+|++|||+++...... ......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999953 23456777777765421100 0011357888999
Q ss_pred cccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhccccccc
Q 019506 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYS 327 (340)
Q Consensus 248 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (340)
||++.+. .|+.++|||||||+||||++|..||.... ..+..+.... .+. .... .......++..|+..+|.
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~--~~~~---~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP--QILL---NWPKEASFCLWLLHPEPS 254 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh--hhhh---cCHHHHHHHHHhCCCChh
Confidence 9999664 48999999999999999999999876432 1222222111 111 1000 011122334456677899
Q ss_pred CCCCcCcccccCC
Q 019506 328 GRNSMHESKLYGF 340 (340)
Q Consensus 328 ~R~~~~~i~~hpf 340 (340)
+||+++|+++|||
T Consensus 255 ~Rps~~eil~h~~ 267 (793)
T PLN00181 255 CRPSMSELLQSEF 267 (793)
T ss_pred hCcChHHHhhchh
Confidence 9999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=215.09 Aligned_cols=250 Identities=19% Similarity=0.218 Sum_probs=183.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCC-----cEEEEEEecccccC-----hHHHHHHHHhCCCCceeecceeeeecC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRRY-----KNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
....++++...+-+|.||.||.|.++..+ +.|-+|.++..... ...|.-++.-+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-- 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-- 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee--
Confidence 34456888888999999999999776433 34556655543221 2246666777889999999988754
Q ss_pred CCCceeeeeeecccc-chHHHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc
Q 019506 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~ 218 (340)
+....++++.+.+ |+|...|..... ..+.++..+...++.|++.|++|||+ .|+||.||...|.++++ .-+
T Consensus 359 --~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~Lq 434 (563)
T KOG1024|consen 359 --DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQ 434 (563)
T ss_pred --ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-hee
Confidence 2333567778877 566666653221 23446667778899999999999999 79999999999999995 789
Q ss_pred EEEEeeccccccccCCccce---eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 219 VKLCDFGSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
+||+|=.+++.+.+.+.+.- ......||++|.+.+ ..|+.++|+|||||+||||+| |+.||..-++.+....+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 99999999988766655431 223567999999965 459999999999999999998 9999988887665554444
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
.-...++- =|.+-...++-+|+...|.+||+++|+.
T Consensus 514 GyRlaQP~------NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 514 GYRLAQPF------NCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred cceecCCC------CCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 33333332 2555555566666677799999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=217.86 Aligned_cols=201 Identities=22% Similarity=0.264 Sum_probs=162.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCC-cEEEEEEecccc----cChHHHHHHHHhCCC----CceeecceeeeecCCCCce
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRLMDH----PNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~ 148 (340)
+|.+.+.||+|+||.||++.+..++ ..+|+|...... .....|..++..+.. .++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987764 678999776432 145679999888873 56777766552 2455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC----CcEEEEee
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT----HQVKLCDF 224 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~----~~~kl~Df 224 (340)
+.++||+.++.+|.++..... .+.++..++..++.|++.+|++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 678999999999988765543 6899999999999999999999999 7999999999999998543 56999999
Q ss_pred cccc--ccccCC--------c-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 019506 225 GSAK--VLVKGE--------A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (340)
Q Consensus 225 g~a~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (340)
|+++ ...... . .....||..|+++.+..+. ..+.+.|+||++.++.+++.|..||.+....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 9998 321111 1 1234589999999998664 4799999999999999999999999776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=210.98 Aligned_cols=157 Identities=19% Similarity=0.270 Sum_probs=119.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-CCcEEEEEEeccc---------ccChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+|.+.+.||+|+||+||+|++.. +++.+|||++... ...+.+|+++|+.++|+||+..+..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 3469999999999999999999876 6788899986432 22356899999999999998533221
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCC-CCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dl-kp~Nill~~~~~~~kl~Df 224 (340)
...++||||++|+.+.... ... ...++.|++.+|.|||+ +||+|||| ||+|||++. ++.+||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCEEEEEC
Confidence 1267999999985443211 111 14578899999999999 79999999 999999984 778999999
Q ss_pred ccccccccCCcc---------ceeeeeccccCccccc
Q 019506 225 GSAKVLVKGEAN---------ISYICSRYYRAPELIF 252 (340)
Q Consensus 225 g~a~~~~~~~~~---------~~~~~~~~y~aPE~~~ 252 (340)
|+|+........ ....++..|+|||.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999876433211 2345677899999983
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=192.56 Aligned_cols=164 Identities=18% Similarity=0.155 Sum_probs=118.0
Q ss_pred chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccce
Q 019506 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238 (340)
Q Consensus 159 ~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 238 (340)
|+|.+.+... +..+++..++.++.|++.||.|||+ ++ ||+|||++. ++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeecccc----
Confidence 3555665432 4569999999999999999999999 67 999999985 788888 99998754322
Q ss_pred eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCchhh--hhccccccCChh
Q 019506 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVSNIIYAKT--IYQGLFCSNNHE 315 (340)
Q Consensus 239 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 315 (340)
..|++.|+|||++.+. .++.++|||||||++|||+||+.||....... .+..+........... ............
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 2578999999999654 48999999999999999999999997655433 2333333222111100 000000001245
Q ss_pred hHhhhcccccccCCCCcCcccccCC
Q 019506 316 IMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 316 ~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+...|+..+|.+||++.|++.|+|
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHH
Confidence 5666677778999999999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=190.12 Aligned_cols=211 Identities=36% Similarity=0.509 Sum_probs=164.5
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCC-ceeecceeeeecCCCCceee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 150 (340)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+|+.+++.+.|+ +|+++.+.+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 778899999999999999975 7889998864422 345788899999988 799999988 233337
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+++++++.++.+..+.........+....+..++.|++.++.|+|+ .+++|||+||+||+++..+..++++|||.+...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 8999999975443222211000378999999999999999999999 799999999999999963337999999999865
Q ss_pred ccCC-------ccceeeeeccccCcccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Q 019506 231 VKGE-------ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVSNI 298 (340)
Q Consensus 231 ~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~ 298 (340)
.... ......++..|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4433 23456789999999999763 4689999999999999999999999887764 4455555544443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=217.84 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=174.3
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccC--------hHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRY--------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
....++|.|++|.|+.+......+.++.|.+... ... ...|.-+-..+.|+|++..+..++....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 4567899999999998888777777777755411 000 1124444557889999887776643222
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..-+||||+++|+..+.. ...+...++..++.|++.||.|||+ .||.|||||++|+++.. ++.+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecCccee
Confidence 334499999977766654 3578889999999999999999999 69999999999999995 88999999999876
Q ss_pred cccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCC---Cc
Q 019506 230 LVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVSNI---IY 300 (340)
Q Consensus 230 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~---~~ 300 (340)
..-+.. ....+|+..|+|||++.+........||||.|++++.|.+|+.||......+.. ..+....+. ..
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 643322 345688999999999977665666799999999999999999999765443332 111111111 11
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+ -..+.......+.+ ++..+|.+|.|+++|++-+|
T Consensus 550 ~~~~-~~~lp~~~~~~~~~-~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 550 PNRL-LSLLPRETRIIIYR-MLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred hHHH-HHhchhhHHHHHHH-HccCChhheecHHHHhhChH
Confidence 1111 11122222222222 33346889999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=179.45 Aligned_cols=135 Identities=16% Similarity=0.210 Sum_probs=103.4
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------------C-----------------hHHHHHHHHhCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------Y-----------------KNRELQLMRLMDHPN 131 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~-----------------~~~E~~~l~~l~h~~ 131 (340)
...||+|+||.||+|.+. +|+.||||+++.+.. . ..+|+++++++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999976 899999999865421 1 123888999998877
Q ss_pred eeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCceecCCCCCCe
Q 019506 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVCHRDVKPQNL 210 (340)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~iiH~dlkp~Ni 210 (340)
+........ .+ .++||||++++.+.... .....+++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus 81 v~~p~~~~~----~~---~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPILL----KS---HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEEe----cC---CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 744332211 11 36999999985332211 1135789999999999999999999 68 7999999999999
Q ss_pred EecCCCCcEEEEeecccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~ 230 (340)
|++ ++.++|+|||+|...
T Consensus 150 li~--~~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH--DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEE--CCcEEEEEccccccC
Confidence 998 467999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-26 Score=206.22 Aligned_cols=229 Identities=27% Similarity=0.423 Sum_probs=175.8
Q ss_pred eeeeecceEEEEEEE---cCCCcEEEEEEecccc------cChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeee
Q 019506 84 VVGTGSFGIVFQAKC---LETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
++|+|+||.|++++- ...|.-+|+|+.++.. .....|..++..++ ||.+|+++.+| +....++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 379999999998752 2356778888775432 12335777888887 99999999888 444447899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
+++..|+ +.+. .......+.+...+.+...++-+++++|+ .+|+|||+|++||+++. +|.+++.|||+++...+.
T Consensus 76 ld~~rgg--~lft-~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGG--DLFT-RLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccc--hhhh-ccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence 9999975 2222 22335677888889999999999999999 69999999999999996 888999999999887655
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-C-----CCchhhhhcc
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS-N-----IIYAKTIYQG 307 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~ 307 (340)
... +||..|||||++. ....++|.||||+++++|+||..||.+ +....|.+.. . ....+++++.
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ 220 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence 544 8899999999995 368899999999999999999999987 5666666622 2 2346777788
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++..+|.+++.. .--..+||++|+|
T Consensus 221 l~~r~p~nrLg~--------~~~~~~eik~h~f 245 (612)
T KOG0603|consen 221 LFKRNPENRLGA--------GPDGVDEIKQHEF 245 (612)
T ss_pred HHhhCHHHHhcc--------CcchhHHHhccch
Confidence 888888765552 1134567777775
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=177.81 Aligned_cols=171 Identities=13% Similarity=0.127 Sum_probs=124.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----c---------ChHHHHHHHHhCCCCceeecceeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----R---------YKNRELQLMRLMDHPNVISLKHCFFST 142 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~ 142 (340)
..+|++.++||+|+||.||++.. ++..+|+|.+.... . ..++|++.+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45799999999999999999765 57789999886321 1 145788899999999999998886542
Q ss_pred CCC---CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcE
Q 019506 143 TSK---DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (340)
Q Consensus 143 ~~~---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~ 219 (340)
... .....++||||++|..+..+. .+++ ....+++.+|..||+ .|++|||+||+||+++. ++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-E
Confidence 211 123467999999985222221 1222 235599999999999 79999999999999985 66 9
Q ss_pred EEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHH
Q 019506 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 274 (340)
+|+|||............. .++. ..|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence 9999998866522221110 2222 33678999999999887553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=168.26 Aligned_cols=182 Identities=17% Similarity=0.099 Sum_probs=132.2
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--------ChHHHHHHHHhCC-CCceeecceeeeecCCCCceee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+...|++|+||+||++.. .+..++.+.+..... ...+|+++|+++. |++|.+++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3567899999999998765 788888777654432 3568999999995 47788887642 15
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCC-CCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dl-kp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|||+.|..+.... +.. ...++.|++.+|.++|+ +||+|||| ||+|||++. ++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence 7999999985332111 011 13467899999999999 79999999 799999985 77899999999986
Q ss_pred cccCCcc--------------ceeeeeccccCcccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCC
Q 019506 230 LVKGEAN--------------ISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284 (340)
Q Consensus 230 ~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~ 284 (340)
....... .....++.|++|+...--...+ ...++++.|+-+|.++|+..++-+++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 5433211 0012366677777643222223 56789999999999999998886554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=180.91 Aligned_cols=203 Identities=26% Similarity=0.309 Sum_probs=126.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChH-------HHHHHHHhCC----------CCceeecceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMD----------HPNVISLKHCFF 140 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~E~~~l~~l~----------h~~iv~~~~~~~ 140 (340)
.+..++.||.|+++.||.+.+..||+.+|||++........ +|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46788999999999999999999999999998864432222 2221122211 111121122111
Q ss_pred --------ecCC-CCce---eeeeeeccccchHHHHHHHhhcCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCceecCC
Q 019506 141 --------STTS-KDEL---FLNLVMEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (340)
Q Consensus 141 --------~~~~-~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dl 205 (340)
.... .... ..+++|+-+.++|...+......... +.......+..|+++.+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 1110 1111 23678888888877665543322222 2223334556899999999999 79999999
Q ss_pred CCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCC-------CCCCCcchhHHHHHHHHHHHhCCC
Q 019506 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 278 (340)
Q Consensus 206 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~ 278 (340)
||+|++++. +|.++|+||+........... ...+..|.+||..... ..++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-T-TS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcC-CCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999996 899999999988765333222 2345779999987332 247889999999999999999999
Q ss_pred CCCCCC
Q 019506 279 LFPGEN 284 (340)
Q Consensus 279 pf~~~~ 284 (340)
||....
T Consensus 249 Pf~~~~ 254 (288)
T PF14531_consen 249 PFGLSS 254 (288)
T ss_dssp STCCCG
T ss_pred CCCCCC
Confidence 998553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=168.96 Aligned_cols=136 Identities=17% Similarity=0.197 Sum_probs=105.4
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------------------------------ChHHHHHHHHhCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN 131 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~~ 131 (340)
.+.||+|+||.||+|++. +|+.||||++..... ...+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999976 899999998875321 0136788899999988
Q ss_pred eeecceeeeecCCCCceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 132 VISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
+.....+... . .++||||++|+ +...... ...++...+..++.|++.+|.+||+.+||+||||||+||
T Consensus 81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec-----C--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 7554443321 1 36999999975 2222111 246788889999999999999999834999999999999
Q ss_pred EecCCCCcEEEEeeccccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~ 231 (340)
+++ ++.++|+|||++....
T Consensus 150 ll~--~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH--DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE--CCCEEEEEcccceecC
Confidence 998 5789999999997753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-24 Score=201.25 Aligned_cols=200 Identities=25% Similarity=0.429 Sum_probs=145.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
..+|..++.|-.|+||.||+++++.+.+.+|+| +.++... ++ ||..+.+ . .+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lR-----nilt~a~---------n--pfvv-- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LR-----NILTFAG---------N--PFVV-- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hh-----ccccccC---------C--ccee--
Confidence 357999999999999999999999999999996 4333221 11 2333211 1 1122
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE- 234 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 234 (340)
|+-...+.. -+.++. +++.+++|||+ .||+|||+||+|.++.. -+.+|++|||+++......
T Consensus 136 ---gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhhhcc
Confidence 211112221 123333 44789999999 69999999999999996 7889999999986541110
Q ss_pred ---------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--
Q 019506 235 ---------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN-- 297 (340)
Q Consensus 235 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-- 297 (340)
.....+||+.|.|||++...+ |+..+|+|++|+|+||.+-|..||.+++.++.+.+.+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 011347899999999997544 89999999999999999999999999999988888776432
Q ss_pred -------CCchhhhhccccccCChhhHhh
Q 019506 298 -------IIYAKTIYQGLFCSNNHEIMCE 319 (340)
Q Consensus 298 -------~~~~~~~~~~~~~~~~~~~~~~ 319 (340)
.+..++++..++..++..++..
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 2456778888888888866654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=177.64 Aligned_cols=151 Identities=22% Similarity=0.337 Sum_probs=113.9
Q ss_pred CCCceeecceeeeecCC----------------------CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHH
Q 019506 128 DHPNVISLKHCFFSTTS----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185 (340)
Q Consensus 128 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~ 185 (340)
+|||||++.++|.+.-. .....+|+||.-.+.+|...+.. +..+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 59999999988843211 12345789999999888877764 5567788889999
Q ss_pred HHHHHHHHHHcCCCceecCCCCCCeEecCCCC---cEEEEeeccccccccC-------CccceeeeeccccCcccccCCC
Q 019506 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVLVKG-------EANISYICSRYYRAPELIFGAT 255 (340)
Q Consensus 186 qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~---~~kl~Dfg~a~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~ 255 (340)
|+++|+.|||. +||.|||||.+|||+.-++. .+.|+|||++-..... .......|...-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 79999999999999953222 5889999988543221 1112234677789999984322
Q ss_pred C-----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 019506 256 E-----YTTSIDIWSAGCVLAELLLGQPLFPGEN 284 (340)
Q Consensus 256 ~-----~~~~~DiwslG~il~elltg~~pf~~~~ 284 (340)
. .-.++|.|+.|.+.||+++...||.+..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 1 1247899999999999999999998744
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=188.37 Aligned_cols=192 Identities=23% Similarity=0.377 Sum_probs=144.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCC---CCceeecceeeeecCCCCceee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
....|.|.+.||+|+||+||+|...+ |+.||||+-+... ..+---.+++.+|+ -+.|..+..+++- .+. -
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~---~~~--S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF---QNA--S 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc---CCc--c
Confidence 34569999999999999999999766 9999999654321 22211233455555 2334444443322 222 4
Q ss_pred eeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec------CCCCcEEEEe
Q 019506 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD------PLTHQVKLCD 223 (340)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~------~~~~~~kl~D 223 (340)
+||+||.+ |+|++++. .++.+++..+..++.||+..|++||. .+||||||||+|+||. .+...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 59999999 56666665 46789999999999999999999999 6999999999999994 2234699999
Q ss_pred ecccccc---ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 019506 224 FGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278 (340)
Q Consensus 224 fg~a~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 278 (340)
||.+--+ .++.......+|-.+-.+|+..| ..|+..+|.|.|+.+++-||.|++
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998543 34444455667888999999865 559999999999999999999973
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=164.39 Aligned_cols=237 Identities=17% Similarity=0.252 Sum_probs=172.4
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc------cccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+..+..+|.+...|..|+|++ .|..+++|++.- ..+.++.|.-.|+.+.||||+.+++.+ .....+.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence 345667789999999999999 666777786642 245667788899999999999999998 4445578
Q ss_pred eeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceec-CCCCCCeEecCCCCcEEEE--eeccc
Q 019506 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR-DVKPQNLLVDPLTHQVKLC--DFGSA 227 (340)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~-dlkp~Nill~~~~~~~kl~--Dfg~a 227 (340)
++..|++ |+|+..+.. ..+-..+-.++.+++.+|++|++|||++..++-| -|....+++|+ +.+.+|. |--++
T Consensus 264 ~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceee
Confidence 9999999 577777653 2234456678889999999999999997556655 58888999985 6555543 43332
Q ss_pred cccccCCccceeeeeccccCcccccCCCCC--CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCchhhh
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS-NIIYAKTI 304 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 304 (340)
-. .......+.||+||.++..+.. -.++|+|||.+++|||.|...||.+-.+.+.=.++.-.+ ...-++.+
T Consensus 341 fq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 341 FQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 11 1223447889999999765432 347999999999999999999999888777655554333 22222232
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
+-...++...|-..+|.+||+|++|.
T Consensus 415 ------s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 ------SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ------cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 22335566667777899999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=190.74 Aligned_cols=240 Identities=28% Similarity=0.365 Sum_probs=161.1
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChH---HHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKN---RELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+|...+.||.+.|=+|.+|++. .| .|+||++-+.. +... +|++ ....++||.+.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 4777889999999999999863 34 49999885432 1122 3444 5677899999987664 33444
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.|+|-+|+..+|++.+.. ..-+..-+.+-|+.|++.||.-+|. .||+|||||.+|||+++=+ =+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence 679999999988887653 2345666777889999999999999 7999999999999999644 489999987654
Q ss_pred cccCCc---cce-eee----eccccCcccccCCC----------CCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019506 230 LVKGEA---NIS-YIC----SRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (340)
Q Consensus 230 ~~~~~~---~~~-~~~----~~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (340)
..-... ... +.. -.+|.|||.+.... ..+++.||||+||+++||++ |++||.- .++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 321111 111 122 33599999985421 15678999999999999998 7999941 1222
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...... .-..+..+.++-.. ....+...|...+|..|.++++.++
T Consensus 246 aYr~~~-~~~~e~~Le~Ied~-~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 246 AYRSGN-ADDPEQLLEKIEDV-SLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred hHhccC-ccCHHHHHHhCcCc-cHHHHHHHHHccCchhccCHHHHHH
Confidence 222211 11222222222222 3333445555566778999888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=157.65 Aligned_cols=134 Identities=17% Similarity=0.225 Sum_probs=98.7
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhC-----CCCceeecceeeeecCCCCceeeee
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLM-----DHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ .||||+++++++....+ ....+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEEE
Confidence 46799999999995 5666665 69987643 33456899999999 57999999999854321 1222347
Q ss_pred eecccc---chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCceecCCCCCCeEecC---CCCcEEEEeec
Q 019506 153 VMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL-AYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFG 225 (340)
Q Consensus 153 v~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~iiH~dlkp~Nill~~---~~~~~kl~Dfg 225 (340)
||||++ ++|.+.+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. .+..++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 899955 466666643 345555 35577888777 99999 79999999999999974 23479999954
Q ss_pred cc
Q 019506 226 SA 227 (340)
Q Consensus 226 ~a 227 (340)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=163.98 Aligned_cols=140 Identities=16% Similarity=0.133 Sum_probs=105.2
Q ss_pred CeeEeeeeeeecceEEEEEE-EcCCCcEEEEEEeccccc----------------------------ChHHHHHHHHhCC
Q 019506 78 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRLMD 128 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~----------------------------~~~~E~~~l~~l~ 128 (340)
.|.+.+.||+|+||.||+|. +..+|+.||+|++..... ...+|+++++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 667999999998864321 1246888888887
Q ss_pred CCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-ceecCCCC
Q 019506 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKP 207 (340)
Q Consensus 129 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-iiH~dlkp 207 (340)
+. ++.+...+.. . ..++||||+++..+.... .....+....+..++.|++.+|.+||+ +| |+||||||
T Consensus 109 ~~-~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW---R---RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe---c---CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 3333333311 1 136999999985322211 113445666778999999999999999 79 99999999
Q ss_pred CCeEecCCCCcEEEEeecccccc
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhcc
Confidence 999998 678999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=147.25 Aligned_cols=132 Identities=18% Similarity=0.165 Sum_probs=99.5
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--------------------------ChHHHHHHHHhCCCCce
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------------------------YKNRELQLMRLMDHPNV 132 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~E~~~l~~l~h~~i 132 (340)
|.+.+.||+|+||.||++.+. +|+.||||++..... ...+|..++..+.|.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999864 799999998653220 12457778888877743
Q ss_pred --eecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 133 --ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 133 --v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
...++. ...++||||++|..+..+.. ......++.+++.++.++|+ .||+||||||+||
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI 156 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence 222221 12479999999853332211 13356788899999999999 7999999999999
Q ss_pred EecCCCCcEEEEeeccccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~ 231 (340)
+++. ++.++|+|||.+....
T Consensus 157 ll~~-~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDD-DEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcC-CCcEEEEECCccccCC
Confidence 9995 8899999999996653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-19 Score=147.34 Aligned_cols=130 Identities=21% Similarity=0.320 Sum_probs=101.5
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
+.||+|++|.||+|.+ .|..+++|...... ....+|++++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5689999999999987 77889999754321 1234688899999999987776665332 236
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||++| ++.+.+.. . .. ....++.+++.+|.+||+ .|++|||++|.|||++ ++.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 799999987 44444432 1 11 678889999999999999 7999999999999998 57799999999876
Q ss_pred c
Q 019506 230 L 230 (340)
Q Consensus 230 ~ 230 (340)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 3
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-20 Score=164.89 Aligned_cols=177 Identities=26% Similarity=0.337 Sum_probs=128.8
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++||.|++|.. +|.+.+.+ .......+......++.|++.+++| +|.+|+|+||.||++.. +.++||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence 3468899999996 55555543 3445567788899999999999999 48999999999999984 7789999999
Q ss_pred cccccccCC-------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 226 SAKVLVKGE-------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 226 ~a~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
+........ ..+...||..||+||.+.+. .|+.++||||||++|+|++. =...|.- ......++.+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCC
Confidence 988776555 55677899999999999764 59999999999999999997 3333321 11222233333
Q ss_pred CCchhhhhccccccCChh-hHhhhcccccccCCCCcCcccccCC
Q 019506 298 IIYAKTIYQGLFCSNNHE-IMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+| +.+ +..+|.+ .+++.++...|.+||++.+.--|.|
T Consensus 477 ip--~~~----~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 477 IP--PEF----LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred CC--hHH----hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 33 222 3345554 6667777777889997665554443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=143.73 Aligned_cols=125 Identities=21% Similarity=0.290 Sum_probs=94.2
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
||+|+||.||+|.+ +|..+++|...... ....+|+++++.+.|+++.....++.. ....++
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~l 74 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKTI 74 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCEE
Confidence 79999999999985 67889999754321 122368999999998876554444422 122569
Q ss_pred eeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||++|. +.+.+.. ... .++.+++.+|.+||+ .|++|||++|+||+++ ++.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~-----~~~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEE-----GND------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhh-----cHH------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcCC
Confidence 99999874 3333321 110 678899999999999 7999999999999998 678999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=162.02 Aligned_cols=132 Identities=20% Similarity=0.273 Sum_probs=99.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEec-cc-----------ccChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
..|...+.||+|+||+||++.+. +..+++|+.. +. .....+|+++++.++|++++....++..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 34567889999999999999874 4444444321 11 1123579999999999999877655532
Q ss_pred CCceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
....++||||+++. +.+.+. ....++.|++.+|.+||+ .|++||||||+|||++ ++.++|+|
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~liD 470 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLID 470 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEEe
Confidence 22256999999974 433332 246788999999999999 7999999999999994 67899999
Q ss_pred ecccccc
Q 019506 224 FGSAKVL 230 (340)
Q Consensus 224 fg~a~~~ 230 (340)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=157.70 Aligned_cols=205 Identities=23% Similarity=0.290 Sum_probs=145.1
Q ss_pred HHhCCCCceeecceeeeecCCCCceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCcee
Q 019506 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (340)
Q Consensus 124 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH 202 (340)
|+.+.|.|+.+++|.++.. ...++|.+||. |++.+.+.. ....++......+.++|+.||.|||......|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 4578899999999998654 44789999999 566666654 35677888888999999999999998533499
Q ss_pred cCCCCCCeEecCCCCcEEEEeeccccccccC---CccceeeeeccccCcccccCCCC------CCCcchhHHHHHHHHHH
Q 019506 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAEL 273 (340)
Q Consensus 203 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~------~~~~~DiwslG~il~el 273 (340)
+.|+..|.+++. ...+||+|||+....... .......-..-|.|||.+.+... .+.+.||||||++++|+
T Consensus 73 g~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 999999999995 999999999998766320 11111122445999999965311 36779999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 274 LLGQPLFPGEN----AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 274 ltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
++...||.... ..+.+.++.+....+..+.+...-...+..-.+..-|+...|..||++++|..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99999997532 22344443332444455554433211122334445555556999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-19 Score=172.36 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=173.7
Q ss_pred CeeEeeeeeeecceEEEEEEEcC-CCcEEEEEEecccc---cCh---HHHHHHHHhCC-CCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYK---NRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~---~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.|.+.+.||+|+|+.|-++.... ....+|+|.+.... ... ..|..+-+.+. |.|++++++.. .+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 57888889999999998887643 34456777654332 111 23666777776 99999999887 55556
Q ss_pred eeeeeccccch-HHHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHH-cCCCceecCCCCCCeEecCCCC-cEEEEeec
Q 019506 150 LNLVMEYVPET-MYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAYIH-TVPGVCHRDVKPQNLLVDPLTH-QVKLCDFG 225 (340)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~~iiH~dlkp~Nill~~~~~-~~kl~Dfg 225 (340)
.+++++|..|+ +..... .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++. ++ .++++|||
T Consensus 96 ~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~df~ 170 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIADFG 170 (601)
T ss_pred cccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCCch
Confidence 78999997764 222221 2222 5677788899999999999999 8 79999999999999995 66 89999999
Q ss_pred ccccccc-CCc---cceeee-eccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCC
Q 019506 226 SAKVLVK-GEA---NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVSNII 299 (340)
Q Consensus 226 ~a~~~~~-~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~ 299 (340)
+|..... ... ....+| ++.|+|||.+.+........|+||+|+++..+++|..|+......... ....... ..
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~ 249 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GR 249 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cc
Confidence 9987755 222 223567 999999999987666789999999999999999999999765443321 1111111 11
Q ss_pred chhhhhccccccCChhhHhhhccc--ccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSW--YSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~R~~~~~i~~hpf 340 (340)
+... .+.+.....+..+... .++..|.+.+++..+||
T Consensus 250 ~~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 250 FTQL----PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred cccC----ccccCChhhhhcccccccCCchhcccccccccccc
Confidence 0111 1112222222222222 45889999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=135.55 Aligned_cols=131 Identities=24% Similarity=0.197 Sum_probs=90.5
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh----------------------------HHHHHHHHhCCCCc--
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRLMDHPN-- 131 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~h~~-- 131 (340)
.+.||+|+||+||+|.+. +|+.||||++....... ..|.+.+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999975 89999999876432111 12334444443332
Q ss_pred eeecceeeeecCCCCceeeeeeeccccchHH--HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCC
Q 019506 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMY--RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (340)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~N 209 (340)
+.+.+++ ...++||||++++.. ..+.... .. ..++.++.+++.++.++|...||+|+||||+|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222211 114799999997211 1122111 01 56788999999999999983499999999999
Q ss_pred eEecCCCCcEEEEeecccccc
Q 019506 210 LLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+++ ++.++|+|||.+...
T Consensus 146 ili~--~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD--DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE--CCcEEEEECcccccc
Confidence 9998 678999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=136.10 Aligned_cols=134 Identities=18% Similarity=0.228 Sum_probs=96.8
Q ss_pred eeee-eecceEEEEEEEcCCCcEEEEEEecccc-----------------cChHHHHHHHHhCCCCce--eecceeeeec
Q 019506 83 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNV--ISLKHCFFST 142 (340)
Q Consensus 83 ~~Lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~E~~~l~~l~h~~i--v~~~~~~~~~ 142 (340)
..|| .|+.|+||.+.. .+..++||.+.... ....+|++++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 888899998876 57889999774311 123469999999998885 5555543221
Q ss_pred CCCCceeeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 143 TSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
. ......++|||+++| ++.+.+.. ..+++.. +.|++.+|.+||+ +||+||||||+|||++. ++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence 1 112223599999996 45444432 3455543 5689999999999 79999999999999985 67899
Q ss_pred EEeecccccc
Q 019506 221 LCDFGSAKVL 230 (340)
Q Consensus 221 l~Dfg~a~~~ 230 (340)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=124.55 Aligned_cols=131 Identities=19% Similarity=0.247 Sum_probs=102.7
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--ChHHHHHHHHhCCC--CceeecceeeeecCCCCceeeeeeecc
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
+.+.||+|.++.||++.. .+..+++|....... ...+|+.+++.++| .++.+++..+ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 357799999999999997 447899998866543 56789999999976 4777777665 223457899999
Q ss_pred ccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+.+.....+ +......++.+++.+|.+||.. .+++|+|++|+||+++. ++.++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 987522211 4455667788999999999984 26999999999999995 78899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.6e-16 Score=141.53 Aligned_cols=199 Identities=25% Similarity=0.297 Sum_probs=156.2
Q ss_pred ccccCeeEeeeeee--ecceEEEEEEE--cCCCcEEEEEEec------ccccChHHHHHHHHhCC-CCceeecceeeeec
Q 019506 74 KQTISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRLMD-HPNVISLKHCFFST 142 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~--G~~g~V~~~~~--~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 142 (340)
.....+.+...+|. |.+|.||.+.. ..++..+|+|.-+ .......+|+...++++ |+|.++.+..+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--- 187 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--- 187 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc---
Confidence 34456778888999 99999999998 7889999999743 22334456777766665 99999977766
Q ss_pred CCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCceecCCCCCCeEecCCCCc
Q 019506 143 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR----GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~iiH~dlkp~Nill~~~~~~ 218 (340)
.+...+++-+|+|+.++..... ....-++...++.++.+... ||.++|+ ++++|-|+||+||++..+...
T Consensus 188 --e~~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 188 --EGSGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred --ccCCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccce
Confidence 5566688999999976555443 23345788889999999999 9999999 899999999999999863278
Q ss_pred EEEEeeccccccccCCccce------eeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 219 VKLCDFGSAKVLVKGEANIS------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
.+++|||+...+.+...... ..+...|++||.+.+ -++...|+++||.+..+..+|..++...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99999999988766653322 145667999999843 3799999999999999999998766544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.7e-14 Score=115.68 Aligned_cols=131 Identities=19% Similarity=0.222 Sum_probs=92.1
Q ss_pred eeeeeecceEEEEEEEcC------CCcEEEEEEeccc--------------ccC----------------hHHHHHHHHh
Q 019506 83 RVVGTGSFGIVFQAKCLE------TGETVAIKKVLQD--------------RRY----------------KNRELQLMRL 126 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~------~~~~vavK~~~~~--------------~~~----------------~~~E~~~l~~ 126 (340)
..||.|.-+.||.|.... .+..+|||+.+.. .+. .++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 3579999987421 000 0268888887
Q ss_pred CCCC--ceeecceeeeecCCCCceeeeeeeccccch-HH-HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCce
Q 019506 127 MDHP--NVISLKHCFFSTTSKDELFLNLVMEYVPET-MY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVC 201 (340)
Q Consensus 127 l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~ii 201 (340)
+..- ++..++.+. . -+|||||++++ +. ..+. +..++...+..+..+++.+|..| |+ .|||
T Consensus 83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNLV 147 (197)
T ss_pred HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCee
Confidence 7543 333333321 1 45999999863 21 1122 12345556677889999999999 88 7999
Q ss_pred ecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 202 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||++.||+++ ++.+.|+|||.+...
T Consensus 148 HGDLs~~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 148 HADLSEYNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred cCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence 999999999997 467999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=127.06 Aligned_cols=139 Identities=19% Similarity=0.230 Sum_probs=89.3
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccccc--------------------------------------------Ch
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------------------------------------------YK 117 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------------~~ 117 (340)
.+.||.|++|.||+|+. .+|+.||||+.+.... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999985 5899999998743210 11
Q ss_pred HHHHHHHHhC----CCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHH
Q 019506 118 NRELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR-GLA 192 (340)
Q Consensus 118 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~-~l~ 192 (340)
.+|.+.+.++ +|.+-+.+-.++.... ...++||||++|.....+..... .... ...++.+++. .+.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence 1344443333 2333334333432211 12469999999853333322111 1111 2345555555 477
Q ss_pred HHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 193 ~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
.+|. .|++|+|+||.||+++. +++++++|||++.....
T Consensus 272 ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECCH
Confidence 8899 79999999999999985 78899999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=111.67 Aligned_cols=125 Identities=15% Similarity=0.173 Sum_probs=90.5
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceee-cceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
.+.|+.|.++.||+++. .+..|++|...... ....+|+.+++.+.+.+++. ++.+. .+. .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 35688999999999986 58899999876543 34568999999887655543 33222 111 35899999
Q ss_pred cchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCc-----eecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-----CHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 158 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~i-----iH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|...... . .....++.+++.+|..||. .++ +|||++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 98522111 0 1123456799999999999 574 9999999999998 45799999999854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=129.04 Aligned_cols=141 Identities=18% Similarity=0.227 Sum_probs=88.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------------------------------------------
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------------------ 115 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------------------ 115 (340)
+|.. +.||+|++|.||+|+.+.+|+.||||+...+..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 789999999999999887799999998863310
Q ss_pred --ChHHHHHHHHhC----CCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCC---CCCCHHHHHHHHHH
Q 019506 116 --YKNRELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTYQ 186 (340)
Q Consensus 116 --~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~---~~~~~~~~~~i~~q 186 (340)
...+|+..+.++ .+.+.+.+-.+|.+. ....+|||||+.|.-...+......+ ..+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 011233333322 233334443444221 11246999999985333332211111 12444444555555
Q ss_pred HHHHHHHHHcCCCceecCCCCCCeEecCCCC----cEEEEeecccccccc
Q 019506 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVK 232 (340)
Q Consensus 187 i~~~l~~LH~~~~iiH~dlkp~Nill~~~~~----~~kl~Dfg~a~~~~~ 232 (340)
++ . .|++|+|+||.||+++. ++ +++++|||++.....
T Consensus 276 if-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 54 4 59999999999999985 55 899999999987643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.2e-14 Score=118.71 Aligned_cols=233 Identities=15% Similarity=0.176 Sum_probs=154.2
Q ss_pred EEEEEEEcCCCcEEEEEEecc----cccCh--HHH--HHHHHhCCCCceeecceeeeecCCCCceeeeeeecccc-chHH
Q 019506 92 IVFQAKCLETGETVAIKKVLQ----DRRYK--NRE--LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMY 162 (340)
Q Consensus 92 ~V~~~~~~~~~~~vavK~~~~----~~~~~--~~E--~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 162 (340)
.||++.+...|..|+.-.+.. +.+.. +++ ..-+-.+.|.|||+++.++.+....+...+.++.||+. +++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777666676665543321 11111 111 12244567999999999987776667777889999999 5777
Q ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCceecCCCCCCeEecCCCCcEEEEeeccccccccC-----Ccc
Q 019506 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-----EAN 236 (340)
Q Consensus 163 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-----~~~ 236 (340)
..|++....+..+......+|+.||+.||.|||+. .-|+|+++..+-|++. .++-+|+..-.-...-..- ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhh
Confidence 88887777778899999999999999999999984 4699999999999999 4776776532211110000 011
Q ss_pred ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCC---hHHHHHHHHHhcCCCchhhhhccccccC
Q 019506 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGEN---AVDQLVEIIKVSNIIYAKTIYQGLFCSN 312 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (340)
....+-++|.|||.=. ....+.++|||+||....+|.-|..- -.+.. .++.+...+-...-.....++++++...
T Consensus 240 ~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~e 318 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGE 318 (458)
T ss_pred hccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCC
Confidence 1123467799998752 33467789999999999999988743 33322 2233333333333333444444444433
Q ss_pred ChhhHhhhcccccccCCCCcCcccccC
Q 019506 313 NHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 313 ~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
|..||++.+++-||
T Consensus 319 -------------P~~rp~ar~llfHp 332 (458)
T KOG1266|consen 319 -------------PNGRPDARLLLFHP 332 (458)
T ss_pred -------------CCCCcchhhhhcCc
Confidence 55899999998887
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.2e-13 Score=103.85 Aligned_cols=140 Identities=19% Similarity=0.228 Sum_probs=99.5
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEe-ccc-----------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
....|-+|+-+.|+++.+ .|+.++||.- .+. +....+|++++.++.--.|.-..-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 456789999999999987 8899888832 111 2233478998888875555544444433222
Q ss_pred eeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcE--EEEee
Q 019506 149 FLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDF 224 (340)
Q Consensus 149 ~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~--kl~Df 224 (340)
-+|+|||++| ++.+.+.... +..........+++.|-+.+.-||. ++||||||..+||++.++++++ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4599999998 4445444322 2233333336788899999999999 7999999999999998766655 89999
Q ss_pred cccccc
Q 019506 225 GSAKVL 230 (340)
Q Consensus 225 g~a~~~ 230 (340)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-12 Score=119.46 Aligned_cols=165 Identities=24% Similarity=0.310 Sum_probs=119.1
Q ss_pred EEEEcCCCcEEEEEEeccccc----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhc
Q 019506 95 QAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 170 (340)
Q Consensus 95 ~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~ 170 (340)
.|..+.++.+|.|..++.... ...+-+..|+.++||||+++++.+ +....+|||+|-+.. +...+..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~--- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE--- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH---
Confidence 355577889999988765443 134567789999999999999998 445568999999875 2234433
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc-cceeeeeccccCcc
Q 019506 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYICSRYYRAPE 249 (340)
Q Consensus 171 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE 249 (340)
+....+..-+.||+.||.|||+..+++|++|..+.|+|+. .|..||++|.++.....-.. .....---.|..|+
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 1245566677899999999985579999999999999996 88999999998865422221 11111122356666
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhC
Q 019506 250 LIFGATEYTTSIDIWSAGCVLAELLLG 276 (340)
Q Consensus 250 ~~~~~~~~~~~~DiwslG~il~elltg 276 (340)
.+.. -+-..|.|-|||++++++.|
T Consensus 176 ~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc---cccchhhhhHHHHHHHHhCc
Confidence 5521 12457999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-13 Score=132.35 Aligned_cols=250 Identities=20% Similarity=0.199 Sum_probs=164.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..+.+.+.+-+-+|.++.++.+.-..+|...+.|........ ...+-.++-...+|.++.....+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 345677888899999999999987777866666654332211 11222222233456666543332 233
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.-.+|+++|+.+ ++...+.. ....+..-++.....+..++++||. ..+.|+|++|.|++... ++..+++|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence 347799999976 44444432 2356666778888899999999999 57999999999999984 88899999984
Q ss_pred cccccc------C--------------------------CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHH
Q 019506 227 AKVLVK------G--------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274 (340)
Q Consensus 227 a~~~~~------~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 274 (340)
...... . .......+|+.|.+||.+++.. ....+|+|++|++++|.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 322100 0 0011246788999999998755 789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcC---cccccCC
Q 019506 275 LGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMH---ESKLYGF 340 (340)
Q Consensus 275 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~---~i~~hpf 340 (340)
+|.+||........+..|.... .+.+..- .+-....+.+....+...+.+|..+. +.+.|||
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~-~~~p~g~---~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD-IPWPEGP---EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC-CCCCCCc---cccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 9999999999877776666532 2221110 01111122222223334566777777 7777775
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5e-12 Score=99.88 Aligned_cols=126 Identities=18% Similarity=0.317 Sum_probs=87.2
Q ss_pred eeeeecceEEEEEEEcCCCcEEEEEEec-cc-----------ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 84 VVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+++|+-+.+|.+.+ -|..+++|.=. +. +....+|++++.+++--.|....-++++. +. ..
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~---~~--~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP---DN--GL 75 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC---CC--CE
Confidence 478999999999976 45567777332 11 11224688888887655554443333332 22 44
Q ss_pred eeeccccchHHH-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+|||++|.++. .+.. . . ..+++.+-.-+.-||. .||+|+||.++||++. ++.+.++|||++...
T Consensus 76 I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~--~~~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILS--GGRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEe--CCcEEEEECCccccc
Confidence 999999996554 3332 1 1 3455677777889999 7999999999999998 445999999999753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6e-11 Score=107.03 Aligned_cols=167 Identities=23% Similarity=0.347 Sum_probs=128.7
Q ss_pred eEEEEEEEcCCCcEEEEEEecccccC----hHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc--hHHHH
Q 019506 91 GIVFQAKCLETGETVAIKKVLQDRRY----KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE--TMYRV 164 (340)
Q Consensus 91 g~V~~~~~~~~~~~vavK~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~ 164 (340)
.+.|++....+|..|++|++..++.. ...-++.++++.|.|+|.+.++|.... -+...+++|++|.++ +|++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHH
Confidence 57899999999999999999544322 234688999999999999999986333 334558899999995 55554
Q ss_pred HHHh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 165 LKHY-----------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 165 l~~~-----------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
.... ...+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+||++. +.+++|...|.......+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecCC
Confidence 4321 1234567899999999999999999999 79999999999999994 558999988887766444
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 277 (340)
.. |.+. --.+-|.=.||.++..|.||.
T Consensus 447 ~~-------------~~le----~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 447 PT-------------EPLE----SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC-------------cchh----HHhhhhHHHHHHHHHHHhhcc
Confidence 31 1121 134669999999999999996
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-12 Score=120.30 Aligned_cols=194 Identities=21% Similarity=0.202 Sum_probs=139.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-CCCcEEEEEEecccccCh------HHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|..+..||.|.|+.|+.+... .++..|++|...+..... ..|+.+...+ .|.+++.+...+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----- 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----- 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----
Confidence 3456889999999999999988755 578889999876654333 2455555444 48888887666632
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
....|+-.|||.++....-. .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++...++..++.|||.
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence 22255889999864333222 123456777788899999999999999 79999999999999985347899999999
Q ss_pred ccccccCCccceeeeecccc-CcccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 019506 227 AKVLVKGEANISYICSRYYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (340)
+..+.-. .......-.+. ..|++.....+..++|++|||..+.+.++|...
T Consensus 414 ~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 414 WTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccee--cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 8642111 11122233344 356665556689999999999999999998744
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=97.65 Aligned_cols=121 Identities=26% Similarity=0.331 Sum_probs=75.7
Q ss_pred EEEEEEEcCCCcEEEEEEecccc--------------c----------------ChHHHHHHHHhCCCCc--eeecceee
Q 019506 92 IVFQAKCLETGETVAIKKVLQDR--------------R----------------YKNRELQLMRLMDHPN--VISLKHCF 139 (340)
Q Consensus 92 ~V~~~~~~~~~~~vavK~~~~~~--------------~----------------~~~~E~~~l~~l~h~~--iv~~~~~~ 139 (340)
.||.|.. .+|..+|||+.+... + ...+|.+.|.++..-+ +.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888884 467899999875321 0 0136899999998664 34443322
Q ss_pred eecCCCCceeeeeeecccc--chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCceecCCCCCCeEecCCC
Q 019506 140 FSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY-IHTVPGVCHRDVKPQNLLVDPLT 216 (340)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~iiH~dlkp~Nill~~~~ 216 (340)
. .+|||||++ |.....+.. ..++......++.+++..+.. +|. .||+||||.+.||+++. +
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence 1 349999999 643333332 111133456667788885555 578 79999999999999984 3
Q ss_pred CcEEEEeecccccc
Q 019506 217 HQVKLCDFGSAKVL 230 (340)
Q Consensus 217 ~~~kl~Dfg~a~~~ 230 (340)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 8999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-10 Score=98.41 Aligned_cols=134 Identities=10% Similarity=0.090 Sum_probs=90.5
Q ss_pred eEEEEEEEcCCCcEEEEEEecccc---------------cChHHHHHHHHhCCCCceeec--ceeeeecCCCCceeeeee
Q 019506 91 GIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISL--KHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 91 g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv 153 (340)
..|+++.. .|+.|.||...... ....+|.+.+.++...+|... +.+...........-++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555544 66778888653221 124578888887765555443 223322111112345699
Q ss_pred eccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC------CCCcEEEEeec
Q 019506 154 MEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------LTHQVKLCDFG 225 (340)
Q Consensus 154 ~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~------~~~~~kl~Dfg 225 (340)
||++++ ++.+.+.... ....+......++.+++..+.-||. .||+|+|+++.|||++. .+..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999997 4555554322 2445667788899999999999999 79999999999999974 24689999999
Q ss_pred cccc
Q 019506 226 SAKV 229 (340)
Q Consensus 226 ~a~~ 229 (340)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.2e-10 Score=95.01 Aligned_cols=140 Identities=19% Similarity=0.197 Sum_probs=91.7
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCc--eeecceeeeecCCCCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
+.|+.|..+.||++... +|+.+++|..... .....+|.++++.+.+.+ +.+++.+.... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999863 3689999987653 234578999999987644 44454443211 11123579999
Q ss_pred cccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 019506 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------- 197 (340)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------------------------------------- 197 (340)
|++|....... . ...+++.....++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99974221110 0 02344555555555666666666531
Q ss_pred -----------------CCceecCCCCCCeEecCC-CCcEEEEeeccccc
Q 019506 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV 229 (340)
Q Consensus 198 -----------------~~iiH~dlkp~Nill~~~-~~~~kl~Dfg~a~~ 229 (340)
..++|+|+.+.||+++.. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 357999999999999853 35589999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.4e-10 Score=92.32 Aligned_cols=132 Identities=20% Similarity=0.187 Sum_probs=92.0
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--------------------------cChHHHHHHHHhCCCC--
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRLMDHP-- 130 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~-- 130 (340)
+.++..||-|.-|.||.|.+ ..|..+|||.-+..+ ...++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 56788999999999999985 479999999653211 1124688888888654
Q ss_pred ceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 131 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
.+.+.++ .+.-.+|||+++|- .|.. -++.......++..|+.-+..+-. .||||||++.=||
T Consensus 172 ~VP~P~~---------~nRHaVvMe~ieG~---eL~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIA---------WNRHAVVMEYIEGV---ELYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCccc---------cccceeeeehcccc---eeec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 4444433 22356999999984 2221 111333444555566666555556 6999999999999
Q ss_pred EecCCCCcEEEEeecccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~ 230 (340)
+++. ++.+.++||-.+...
T Consensus 234 lV~~-dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 234 LVTE-DGDIVVIDWPQAVPI 252 (304)
T ss_pred EEec-CCCEEEEeCcccccC
Confidence 9995 778999999877543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.1e-09 Score=92.69 Aligned_cols=195 Identities=15% Similarity=0.187 Sum_probs=127.2
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-hHHHHHHHHhC-CCCceee----cceeeeecCCCCceeeeeee
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMRLM-DHPNVIS----LKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~E~~~l~~l-~h~~iv~----~~~~~~~~~~~~~~~~~lv~ 154 (340)
.++.||+|+-+.+|-.-. -...+.|++..-.-. ..+.++.|... .||-+-. -....+.. .....+-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEec
Confidence 457799999999996542 223456777544322 22333444333 3443221 11111111 2222366788
Q ss_pred ccccc--hHHHHHHH--hhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 155 EYVPE--TMYRVLKH--YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 155 e~~~~--~l~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
..+.| .....+.- ....-.-..+..+.++++.++.+.+.||. .|.+-||+.++|+|++. ++.+.|+|-..-..-
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceeec
Confidence 88875 22222221 01112235778899999999999999999 69999999999999994 888999975544333
Q ss_pred ccCCccceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhC-CCCCCC
Q 019506 231 VKGEANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLG-QPLFPG 282 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg-~~pf~~ 282 (340)
..+......+|...|.+||.-. .+-..+...|.|.||+++++++.| +.||.+
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 4555566678899999999852 122357789999999999999986 899975
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-10 Score=105.79 Aligned_cols=98 Identities=21% Similarity=0.409 Sum_probs=75.3
Q ss_pred HHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc--------cce--eeeeccccCcccccCCC
Q 019506 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA--------NIS--YICSRYYRAPELIFGAT 255 (340)
Q Consensus 186 qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~--------~~~--~~~~~~y~aPE~~~~~~ 255 (340)
+++.|+.|+|...++||++|.|++|.++. ++..||+.|+++.....+.. ... ..-...|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 33489999998789999999999999995 88899999998765433111 111 112455999999966 4
Q ss_pred CCCCcchhHHHHHHHHHHH-hCCCCCCCCCh
Q 019506 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285 (340)
Q Consensus 256 ~~~~~~DiwslG~il~ell-tg~~pf~~~~~ 285 (340)
..+.++|+|||||++|.+. .|+.-|...+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~ 215 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG 215 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC
Confidence 4789999999999999999 57777765543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-08 Score=83.70 Aligned_cols=134 Identities=18% Similarity=0.149 Sum_probs=90.1
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccccCh----------------------------HHHHHHHHhCCC--Cce
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRLMDH--PNV 132 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~h--~~i 132 (340)
-.|..|.-+.||+|. ..++..+|+|+++.....+ .+|...|+++.. -.+
T Consensus 54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 367888889999998 4578999999885332111 246666666542 233
Q ss_pred eecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe
Q 019506 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (340)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill 212 (340)
.+.+.+. . ..|||||++... ...-.-..-.+...++..+..++++.+.-|-...++||+||+.-|||+
T Consensus 133 P~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 133 PEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 3333333 2 349999998531 000000122333446777888888888888764699999999999999
Q ss_pred cCCCCcEEEEeeccccccc
Q 019506 213 DPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~ 231 (340)
. ++.+.|+|||.|....
T Consensus 201 ~--~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H--DGEPYIIDVSQAVTID 217 (268)
T ss_pred E--CCeEEEEECccccccC
Confidence 8 6779999999997653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-08 Score=82.78 Aligned_cols=108 Identities=19% Similarity=0.271 Sum_probs=75.3
Q ss_pred hHHHHHHHHhCCCCceee--cceeeeecCCCCceeeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 019506 117 KNRELQLMRLMDHPNVIS--LKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (340)
Q Consensus 117 ~~~E~~~l~~l~h~~iv~--~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 192 (340)
..+|.+.+..+..-+|.. .+.+........ ...++|+|++++ ++.+.+... ...+......++.+++..+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 346887777765444433 333332222112 445799999997 455555432 22566677889999999999
Q ss_pred HHHcCCCceecCCCCCCeEecCCC--CcEEEEeecccccc
Q 019506 193 YIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVL 230 (340)
Q Consensus 193 ~LH~~~~iiH~dlkp~Nill~~~~--~~~kl~Dfg~a~~~ 230 (340)
-||. .||+|+|+++.|||++..+ ..+.++||+.++..
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 7999999999999998633 27999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-07 Score=77.55 Aligned_cols=138 Identities=12% Similarity=0.078 Sum_probs=95.7
Q ss_pred eeecceEEEEEEEcCCCcEEEEEEecc----------cccChHHHHHHHHhCCCCcee--ecceeeeecCCCCceeeeee
Q 019506 86 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 86 g~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv 153 (340)
|+||-+.|++... .|+.+-+|.-.. .+..+.+|...++.+..-+|. ++. ++..........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6688888888765 455688886531 233456899998888654443 332 2211222334456799
Q ss_pred eccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc--EEEEeeccccc
Q 019506 154 MEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKV 229 (340)
Q Consensus 154 ~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~--~kl~Dfg~a~~ 229 (340)
+|-+++ +|.+.+... .-.+.+......++.+++.++.-||+ .|+.|+|+-+.||+++. ++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 998884 666555431 12345677778899999999999999 79999999999999984 345 99999987755
Q ss_pred c
Q 019506 230 L 230 (340)
Q Consensus 230 ~ 230 (340)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=77.41 Aligned_cols=138 Identities=15% Similarity=0.188 Sum_probs=86.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChH-------------HHHHHHHhCCCCceeec---ceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRLMDHPNVISL---KHCF 139 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~E~~~l~~l~h~~iv~~---~~~~ 139 (340)
..+|.+.+++-......|.+..- +|+.+++|..+......+ +.+..+.+++..++..+ +.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34688889998888888877765 789999997764322221 23333333333222222 2222
Q ss_pred eecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcE
Q 019506 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (340)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~ 219 (340)
.-....-....+++|||++|--+..+. .+++ .+...+.+++.-||+ .|+.|+|..|.|++++ ++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~--~~~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVS--NNGI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEE--CCcE
Confidence 111111222345899999984211111 1222 234567788999999 6999999999999998 4559
Q ss_pred EEEeeccccc
Q 019506 220 KLCDFGSAKV 229 (340)
Q Consensus 220 kl~Dfg~a~~ 229 (340)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.9e-08 Score=91.25 Aligned_cols=135 Identities=22% Similarity=0.269 Sum_probs=81.6
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc--------------------------------------------ChH
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------------------------------------------YKN 118 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~ 118 (340)
+.|+.++-|.||+|+. .+|+.||||+.+-+-+ +..
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5689999999999995 4599999997742110 011
Q ss_pred HHHHHHHhC----CCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHH-----HHHHHHHHHH
Q 019506 119 RELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY-----VKLYTYQIFR 189 (340)
Q Consensus 119 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~-----~~~i~~qi~~ 189 (340)
+|...+.++ ++..-+.+-.+|.+..+ .-.|+|||++|--...+..... ..++.+. +..++.|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHH-
Confidence 344444433 22222333344422111 1359999999832222222111 3333222 223333332
Q ss_pred HHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 190 ~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
. .|++|+|..|.||+++. ++++.+.|||+...+.+.
T Consensus 283 ------~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ------R-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ------h-cCccccCCCccceEEec-CCcEEEEcCcceecCCHH
Confidence 2 59999999999999995 789999999998776443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-09 Score=98.58 Aligned_cols=185 Identities=19% Similarity=0.107 Sum_probs=132.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCc-eeecceeeeecCCCCceeeeeeecc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPN-VISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
-|.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+ +.+.+.+++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 3556677899999999999876555444 7766554 33445889999999999 44443333 667778899999
Q ss_pred ccch--HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 157 VPET--MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 157 ~~~~--l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
+.++ ...... ...-.+..-....+.+.-++++++||+. --+|+| ||+.. ++..+..||+....+....
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGS--EEEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccc--ccccccccccCCcccCccc
Confidence 9864 111000 0112233334455566677899999983 458888 88876 4679999999988776665
Q ss_pred ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 019506 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280 (340)
Q Consensus 235 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 280 (340)
......+++.++|||+...+. +....|.|++|+-..+|.-|-+|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCC
Confidence 556678899999999986655 889999999998777777777664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.9e-07 Score=74.89 Aligned_cols=144 Identities=19% Similarity=0.227 Sum_probs=77.2
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCce--eecceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
++.|+.|..+.||++... +..+++|..... .....+|..+++.+....+ .+++... .........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--DGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEET--TSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEEC--CcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence 467999999999999863 359999987654 3344578888887764433 3444322 1122333468999999
Q ss_pred cch-HHH----------------HHHHhhcC---CCCCCHHH------HHHH---------------HHHHHH-HHHHHH
Q 019506 158 PET-MYR----------------VLKHYSSM---NQRMPLIY------VKLY---------------TYQIFR-GLAYIH 195 (340)
Q Consensus 158 ~~~-l~~----------------~l~~~~~~---~~~~~~~~------~~~i---------------~~qi~~-~l~~LH 195 (340)
+|. +.. .+...... ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 873 222 11111111 11111100 0000 011111 233333
Q ss_pred c------CCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 196 T------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 196 ~------~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
. ...++|+|+.+.||+++..++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 146999999999999994466678999988743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.3e-06 Score=69.01 Aligned_cols=127 Identities=20% Similarity=0.320 Sum_probs=84.0
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccc
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
+..+.|++|.+|.||++.+ .|..+|+|+-..+ +...+.|+++|..+.-.++..=+-.+ + . .++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhhh
Confidence 4557799999999999998 7779999976544 45567899999988866664422222 1 1 23679999
Q ss_pred cc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCC-CC-CeEecCCCCcEEEEeecccccc
Q 019506 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK-PQ-NLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlk-p~-Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
.| .|.+... ..+-+++ ..+++.---|-. .||-|+.|. |. ||++. +..+.|+||..|+.-
T Consensus 95 ~G~~L~~~~~-------~~~rk~l----~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEI-------GGDRKHL----LRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhh-------cccHHHH----HHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence 98 4333221 1122222 245555444555 589999886 44 55555 447999999999753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.1e-06 Score=66.97 Aligned_cols=126 Identities=25% Similarity=0.334 Sum_probs=87.1
Q ss_pred cCeeEeeeeeeecc-eEEEEEEEcCCCcEEEEEEecc-------------c------------ccChHHHHHHH---HhC
Q 019506 77 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ-------------D------------RRYKNRELQLM---RLM 127 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~-g~V~~~~~~~~~~~vavK~~~~-------------~------------~~~~~~E~~~l---~~l 127 (340)
.+++..+.||.|.- |.||+++. .|+.+|+|++.. . ...+..|.+.. +.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 35888999999999 99999987 888999998321 0 01123566654 444
Q ss_pred CCCce--eecceeeeecCC-------------CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 019506 128 DHPNV--ISLKHCFFSTTS-------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (340)
Q Consensus 128 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 192 (340)
.+.++ |+.+|++.-... .......||-||+.... .+.... +.+|.+-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 56677 889888854321 11122357888777531 222222 447888899
Q ss_pred HHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 193 ~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|. .||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence 9999 69999999999986 2 379999975
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.3e-06 Score=80.02 Aligned_cols=140 Identities=19% Similarity=0.231 Sum_probs=81.5
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----------------------------------------ChHHHH
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----------------------------------------YKNREL 121 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------------------------~~~~E~ 121 (340)
+.||..+.|.||+|+.+ +|+.||||+-+..-+ ++.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 56999999999999954 599999996532210 111233
Q ss_pred HH----HHhCCCCc---eeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 019506 122 QL----MRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194 (340)
Q Consensus 122 ~~----l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 194 (340)
+. .+.+.|-+ -|.+-.+|.+... .-.|+||||+|.-...+.... ...++...+..-+.+...- .-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~-qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLE-QIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHH-HHH
Confidence 32 22334544 2223333422111 145999999984222232221 1344444333222222111 112
Q ss_pred HcCCCceecCCCCCCeEecC---CCCcEEEEeecccccccc
Q 019506 195 HTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 195 H~~~~iiH~dlkp~Nill~~---~~~~~kl~Dfg~a~~~~~ 232 (340)
. .|++|+|=.|.||++++ .+..+.+.|||+...+..
T Consensus 319 -~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 -K-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -h-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2 58999999999999983 367899999999877643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=67.95 Aligned_cols=136 Identities=15% Similarity=0.101 Sum_probs=75.2
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCce--eecceeeeecCCCCceeeeeeecccc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVP 158 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (340)
..||+|..+.||+. .|..+++|...... ....+|.++++.+..-++ .+.+++. .+.....+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999983 35568899776432 234678988888764433 3333333 22223568999999
Q ss_pred ch--HH--------------HHHHH----hhcC-CCCCCHHHH-HHHHHH----------HHH-HHHHHHc---CCCcee
Q 019506 159 ET--MY--------------RVLKH----YSSM-NQRMPLIYV-KLYTYQ----------IFR-GLAYIHT---VPGVCH 202 (340)
Q Consensus 159 ~~--l~--------------~~l~~----~~~~-~~~~~~~~~-~~i~~q----------i~~-~l~~LH~---~~~iiH 202 (340)
|. +. ..+.. .... -...+.... ..+..+ +.. ...+|.. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 83 10 11111 1010 001111110 011001 111 1222221 135789
Q ss_pred cCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 203 RDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 203 ~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+.|.||+++. ++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~-~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSG-KG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcC-CC-cEEEechhcCc
Confidence 999999999985 55 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.2e-06 Score=73.10 Aligned_cols=137 Identities=17% Similarity=0.188 Sum_probs=96.4
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------------------------------ChHHHHHHHHhCCCC
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHP 130 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~ 130 (340)
|..+|..|.-+.||.|. ..+|..+|||+++.... ..+.|++.|+++..-
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45678889999999998 56888999998853210 013577788887765
Q ss_pred ceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 131 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
.|...--+.. . . ..|||++++..-+- .-.-.+..++...+..+-.|++.-+.-|-...++||.||.==|+
T Consensus 227 GIP~PePIlL----k--~-hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL----K--N-HVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee----e--c-ceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 5433222221 1 1 34999999853111 11112356777778888888888888887657999999999999
Q ss_pred EecCCCCcEEEEeecccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~ 230 (340)
|+. ++.+.|+|.+.+...
T Consensus 297 Lyh--dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYH--DGKLYIIDVSQSVEH 314 (520)
T ss_pred eEE--CCEEEEEEccccccC
Confidence 997 688999999988654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=80.46 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=50.0
Q ss_pred eeeeeeecceEEEEEEEcCCC--cEEEEEEeccc-----ccChHHHHHHHHhCC-CCce--eecceeeeecCCCCceeee
Q 019506 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRLMD-HPNV--ISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~--~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~ 151 (340)
.+.|+.|.++.+|+......+ ..+++|+.... .....+|.++++.+. |.++ .+++.++.+ .......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCce
Confidence 466899999999998764322 46788866432 234568999999986 6665 444444321 11123467
Q ss_pred eeeccccch
Q 019506 152 LVMEYVPET 160 (340)
Q Consensus 152 lv~e~~~~~ 160 (340)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.21 E-value=6e-06 Score=82.11 Aligned_cols=155 Identities=22% Similarity=0.330 Sum_probs=104.7
Q ss_pred HHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 019506 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196 (340)
Q Consensus 118 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 196 (340)
+.|...+.++.|+|++.++++-+...... ..+.+..++|.. ++...+.+ -...+...++.+..+++.||.|+|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34677788999999999987765433322 123345566765 44444433 4678889999999999999999999
Q ss_pred CCCceecCCCCC---CeEecCCCCcEEEE--eeccccccccCCccceeeeeccccCcccccCCC-CCCCcchhHHHHHHH
Q 019506 197 VPGVCHRDVKPQ---NLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVL 270 (340)
Q Consensus 197 ~~~iiH~dlkp~---Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il 270 (340)
....|.-|..+ +...+. .+.+.++ ||+.+....+.........+..+.++|...... ......|+|.+|..+
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 44544444333 222232 3445555 898888776666665666677788998885433 123347999999999
Q ss_pred HHHHhCCCC
Q 019506 271 AELLLGQPL 279 (340)
Q Consensus 271 ~elltg~~p 279 (340)
..+..|..+
T Consensus 383 ~~~~~~~~i 391 (1351)
T KOG1035|consen 383 LQLSQGEDI 391 (1351)
T ss_pred hhhhhcCcc
Confidence 999988644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=67.51 Aligned_cols=69 Identities=17% Similarity=0.114 Sum_probs=42.1
Q ss_pred eeeecc-eEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhCCC-CceeecceeeeecCCCCceeeeeeeccccch
Q 019506 85 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET 160 (340)
Q Consensus 85 Lg~G~~-g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 160 (340)
|-.|.. +.||+... .+..+.+|+.... .....+|+++++.+.. --+.+++++. ......++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCCc
Confidence 444544 78999864 3467888876543 1335679998888752 2233444443 1112356899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=60.57 Aligned_cols=132 Identities=19% Similarity=0.293 Sum_probs=83.4
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEecccc--------------------cChHHHHHHHHhCC------CCceeecc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRLMD------HPNVISLK 136 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~~ 136 (340)
..||+|+.=.||.- -.+....||+..... +...+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999989863 355667889876554 33346776655554 78889999
Q ss_pred eeeeecCCCCceeeeeeecccc---chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 137 HCFFSTTSKDELFLNLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
|+..+.. -..+|+|.+. |.....|..+.. ...++. ... ..+-.-..||-+ .+|+.+||+|.||++.
T Consensus 84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHH---HHHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 9874333 2557777764 322223332222 245555 333 344455667778 6999999999999995
Q ss_pred CCC--C-cEEEEe-ecccc
Q 019506 214 PLT--H-QVKLCD-FGSAK 228 (340)
Q Consensus 214 ~~~--~-~~kl~D-fg~a~ 228 (340)
..+ . .+.|+| ||...
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 322 2 577777 56543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00016 Score=61.57 Aligned_cols=69 Identities=17% Similarity=0.317 Sum_probs=43.8
Q ss_pred eeeeeeecceEEEEEEEcC-CCcEEEEEEecccc---cChHHHHHHHHhCCCCcee-ecceeeeecCCCCceeeeeeecc
Q 019506 82 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
.+.|..|-...+|++.... .++.|++|+..... ....+|+.+++.+...+++ ++++.+ .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 3567778888999987432 35789999775432 2234788898888654443 332221 11 279999
Q ss_pred ccc
Q 019506 157 VPE 159 (340)
Q Consensus 157 ~~~ 159 (340)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.8e-05 Score=63.55 Aligned_cols=31 Identities=39% Similarity=0.546 Sum_probs=25.1
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.+++|+|+.+.||+++. +...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEEC-CCEEEEEeCcccCc
Confidence 35899999999999984 44456999998743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=2.1e-05 Score=68.22 Aligned_cols=131 Identities=18% Similarity=0.190 Sum_probs=87.5
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----------cc----------------ChHHHHHHHHhCCC-Cc
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RR----------------YKNRELQLMRLMDH-PN 131 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~----------------~~~~E~~~l~~l~h-~~ 131 (340)
+.+++.||-|.-+.||.+-+ ..|++.++|+-+.. +. ...+|...|+.+.. -.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66788999999999999985 46889999954211 11 11367888877753 22
Q ss_pred -eeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 132 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
+.+.+ +....++|||++.|--+..+.+ ...+..+...+..-+--|.. +|+||||..-=||
T Consensus 173 pVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~---------v~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPI---------DHNRHCVVMELVDGYPLRQVRH---------VEDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCcc---------cccceeeHHHhhcccceeeeee---------cCChHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 12222 2233679999998732211111 11233445566666777888 7999999999999
Q ss_pred EecCCCCcEEEEeecccccc
Q 019506 211 LVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~ 230 (340)
+++. +..++++||-.+...
T Consensus 234 mv~d-d~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 234 MVKD-DDKIVVIDFPQMVST 252 (465)
T ss_pred EEec-CCCEEEeechHhhcc
Confidence 9995 778999999766443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=9.3e-05 Score=60.55 Aligned_cols=102 Identities=23% Similarity=0.188 Sum_probs=75.6
Q ss_pred HHHHHHHHhCCC-CceeecceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 019506 118 NRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195 (340)
Q Consensus 118 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 195 (340)
..|.-+++.+.+ +++.+++|.+ . -++|.||.+. +++.. ......-...++..+..|+.++++.+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 358888888876 6899999988 2 2478899985 33211 000011234688899999999999999999
Q ss_pred cC--CCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 196 TV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 196 ~~--~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
.. ..+.-+|++++|+-++. ++++|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeC-CCcEEEEechhcchh
Confidence 72 24777899999999994 788999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00089 Score=61.18 Aligned_cols=71 Identities=23% Similarity=0.333 Sum_probs=45.1
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecc------c-----ccChHHHHHHHHhCC---CCceeecceeeeecCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------D-----RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~------~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 147 (340)
.+.||.|.+..||++.....++.++||.-.. + ......|.+.|+.+. -.++.+++++- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~-- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E-- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence 3579999999999999753335899997431 1 112245777777653 23455555432 2
Q ss_pred eeeeeeeccccc
Q 019506 148 LFLNLVMEYVPE 159 (340)
Q Consensus 148 ~~~~lv~e~~~~ 159 (340)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 124599999875
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0011 Score=59.26 Aligned_cols=31 Identities=29% Similarity=0.297 Sum_probs=25.9
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||+|+.+.||+++. +...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEecccccC
Confidence 48999999999999983 54457999998854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0011 Score=58.51 Aligned_cols=74 Identities=4% Similarity=-0.047 Sum_probs=48.7
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCC---CceeecceeeeecCCCCceeeeeeecc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH---PNVISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
.+.||.|..+.||+... .+..+.+|..+.. ......|.+.|+.+.. -.+.++++++... ......++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEec
Confidence 45699999999999864 3335777875542 2466789999988754 2455555544221 112336799999
Q ss_pred ccc
Q 019506 157 VPE 159 (340)
Q Consensus 157 ~~~ 159 (340)
++|
T Consensus 95 i~G 97 (297)
T PRK10593 95 LRG 97 (297)
T ss_pred cCC
Confidence 886
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00074 Score=60.01 Aligned_cols=145 Identities=15% Similarity=0.045 Sum_probs=76.2
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCc--eeecceeeeec-CCCCceeeeeeecc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEY 156 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e~ 156 (340)
.+.++.|....+|++.. ++..+++|+.... ......|+++++.|...+ +.+++...... ........++++||
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45577777789998864 3446888977542 233346777777764323 23332211000 00112346789999
Q ss_pred ccchH------------HHHHHHhhcCCCC----------CCH-HH--HH----------HHHHHHHHHHHHHHc-----
Q 019506 157 VPETM------------YRVLKHYSSMNQR----------MPL-IY--VK----------LYTYQIFRGLAYIHT----- 196 (340)
Q Consensus 157 ~~~~l------------~~~l~~~~~~~~~----------~~~-~~--~~----------~i~~qi~~~l~~LH~----- 196 (340)
++|.. ...+......... .+. .. .. .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 87621 0111111100000 000 00 00 011122334555532
Q ss_pred -CCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 197 -~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..+++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDG-DSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEEC-CceEEEeecccccC
Confidence 158999999999999985 55568999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=57.05 Aligned_cols=132 Identities=19% Similarity=0.223 Sum_probs=73.4
Q ss_pred eeeecceEEEEEEEcCCCcEEEEEEeccccc----ChHHHHHHHHhCCCCceee-cceeeeecCCCCceeeeeeeccccc
Q 019506 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFLNLVMEYVPE 159 (340)
Q Consensus 85 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (340)
+..|-.+.+|+... ++..+++|....... ...+|.++++.+...+++. ++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 45577778898863 677888997654322 3467999999887544432 22211 1 2488999887
Q ss_pred hHH---------------HHHHHhhcC---CCCCCHH-HHHHHHHHH---------HHHHHHHHc-------CCCceecC
Q 019506 160 TMY---------------RVLKHYSSM---NQRMPLI-YVKLYTYQI---------FRGLAYIHT-------VPGVCHRD 204 (340)
Q Consensus 160 ~l~---------------~~l~~~~~~---~~~~~~~-~~~~i~~qi---------~~~l~~LH~-------~~~iiH~d 204 (340)
... +.+.+.... ..+++.. .+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 321 111111111 1122221 111221111 111222211 02589999
Q ss_pred CCCCCeEecCCCCcEEEEeeccccc
Q 019506 205 VKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+.+.||+++. ++ +.|+||..|..
T Consensus 153 l~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeC-CC-CEEEeccccCc
Confidence 9999999985 44 88999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00091 Score=59.05 Aligned_cols=145 Identities=14% Similarity=0.036 Sum_probs=77.0
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecc-cccChHHHHHHHHhCCCCc--eeecceeeeec-CCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 157 (340)
.+.|..|....+|+... .+..+++|+... .......|+++++.+.+.+ +.+++...... ........++|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 45577787789998864 445789998764 2233456888888775433 33332211000 001122356899998
Q ss_pred cchHH------------HHHHHhhcCCCC--------CCHHHHHH------------HHHHHHHHHHHHHc------CCC
Q 019506 158 PETMY------------RVLKHYSSMNQR--------MPLIYVKL------------YTYQIFRGLAYIHT------VPG 199 (340)
Q Consensus 158 ~~~l~------------~~l~~~~~~~~~--------~~~~~~~~------------i~~qi~~~l~~LH~------~~~ 199 (340)
+|... +.+......... ........ ....+..++.++.. ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 76221 111111100000 00000000 01112233344332 147
Q ss_pred ceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 200 iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~-~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDG-DELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeC-CceEEEeehhhhcC
Confidence 999999999999995 55568999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0017 Score=58.55 Aligned_cols=31 Identities=29% Similarity=0.630 Sum_probs=27.0
Q ss_pred CceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++|+|+++.|||++..++.+.++||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 6899999999999985456899999998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=5.4e-05 Score=77.57 Aligned_cols=157 Identities=15% Similarity=0.016 Sum_probs=104.9
Q ss_pred HHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 019506 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198 (340)
Q Consensus 120 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 198 (340)
|...++...|+++.....-... ......+.+++|+.+ .+.+.+.........+...-+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3334556688888765443322 223335688999885 556666554433334444444444444466666666532
Q ss_pred ----CceecCCCCCCeEecCCCCcEEEEeecccccccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHH
Q 019506 199 ----GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (340)
Q Consensus 199 ----~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (340)
-.+|++||+-|.++.. +..+|++++|+.+.... ........+++.|+++++. +.-.++.++|+|..|+-+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHH
Confidence 2678999999999995 88899999999983322 2223345678889999987 344577889999999999999
Q ss_pred HhCCCCCC
Q 019506 274 LLGQPLFP 281 (340)
Q Consensus 274 ltg~~pf~ 281 (340)
.-|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88887773
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0028 Score=56.79 Aligned_cols=30 Identities=23% Similarity=0.293 Sum_probs=25.0
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..++||||.+.||+++. ..++++|+..+..
T Consensus 192 ~~llHGDl~~gNi~~~~--~~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSE--HETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcC--CCCEEEcCccccc
Confidence 46899999999999974 4488999987754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0055 Score=54.50 Aligned_cols=30 Identities=30% Similarity=0.631 Sum_probs=25.5
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.+++|||+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccccc
Confidence 47999999999999984 5689999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.012 Score=52.15 Aligned_cols=32 Identities=31% Similarity=0.444 Sum_probs=26.7
Q ss_pred CCceecCCCCCCeEecCC---CCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~---~~~~kl~Dfg~a~~ 229 (340)
.+++|+|+.+.||+++.. ++.+.++||..|..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 368999999999999852 36799999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0015 Score=60.34 Aligned_cols=160 Identities=19% Similarity=0.175 Sum_probs=96.0
Q ss_pred HHHHHHHhCCCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 019506 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198 (340)
Q Consensus 119 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 198 (340)
....+++.+.|+|...++++... ... ...+|||++..++.+.+.... +-.. ++. . +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~--~~~--r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-~ 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRG--KHE--RVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-H 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecC--ccc--eEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-c
Confidence 45678889999999998776522 122 267999999999888776421 1000 111 1 2
Q ss_pred CceecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 019506 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 278 (340)
|+.|- | .++++| .++ | .| |- ...+++||||+|.++.++..|..
T Consensus 87 ~~~~~-----~--------~~~~td-~~~--------------t-~~--~~------~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----N--------IIYITD-HFL--------------T-KY--PS------PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----h--------hhhccc-ccc--------------c-cC--CC------CCCcchhhhhHHHHHHHHHHhhH
Confidence 33322 1 233334 010 0 01 11 12259999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCchhhhhc--cccccCChhh---HhhhcccccccCCCCcCcccccC
Q 019506 279 LFPGENAVDQLVEIIKVSNIIYAKTIYQ--GLFCSNNHEI---MCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 279 pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
.+..-...+++..+.+....+.....+. ..+.....++ ...-|.|..|+.||...+..+++
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 9988888888888888766554322110 0111111122 22335566688999888877764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.012 Score=52.80 Aligned_cols=30 Identities=20% Similarity=0.334 Sum_probs=26.3
Q ss_pred ceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 200 iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++|+|+.+.|||++..++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975467899999998854
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0062 Score=55.34 Aligned_cols=71 Identities=18% Similarity=0.214 Sum_probs=43.7
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc----------ccChHHHHHHHHhCC--CC-ceeecceeeeecCCCCce
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 148 (340)
.+.||.|.-..||++.+...++.|+||.-... ......|.+.|+... -| .+.+++.+ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence 56789999999999997434678999954311 111234777777653 23 34444432 2222
Q ss_pred eeeeeeccccc
Q 019506 149 FLNLVMEYVPE 159 (340)
Q Consensus 149 ~~~lv~e~~~~ 159 (340)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 3489999863
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.018 Score=52.64 Aligned_cols=69 Identities=19% Similarity=0.246 Sum_probs=44.0
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecc-----------cccChHHHHHHHHhCC---CCceeecceeeeecCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 147 (340)
.+.||.|....||+..+ .+..++||.-.. .......|.+.|+.+. ..++.+++.+. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 56789999999999886 456799996541 1122234666666554 23566666554 222
Q ss_pred eeeeeeeccccc
Q 019506 148 LFLNLVMEYVPE 159 (340)
Q Consensus 148 ~~~~lv~e~~~~ 159 (340)
-+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 3478999965
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.018 Score=51.23 Aligned_cols=31 Identities=19% Similarity=0.248 Sum_probs=26.9
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.+++|+|+.+.|||++. ++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhccc
Confidence 47999999999999985 67799999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.023 Score=49.56 Aligned_cols=30 Identities=33% Similarity=0.572 Sum_probs=24.9
Q ss_pred CceecCCCCCCeEecCCCCc-EEEEeeccccc
Q 019506 199 GVCHRDVKPQNLLVDPLTHQ-VKLCDFGSAKV 229 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~-~kl~Dfg~a~~ 229 (340)
.++|+|+++.||+++. ++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~-~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDE-DARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeC-CCCEEEEECcHhccc
Confidence 5899999999999984 344 56999999865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.03 Score=49.53 Aligned_cols=31 Identities=29% Similarity=0.498 Sum_probs=26.7
Q ss_pred CceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
.++|||+.+.||+++. +.-+-+.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~-~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDP-GRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeC-CCeeEEEeccccccC
Confidence 5899999999999996 555899999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.027 Score=50.28 Aligned_cols=76 Identities=17% Similarity=0.204 Sum_probs=57.8
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.+..+.|++|++-++.+... .....+++..++.+.+..++-+...-..-|||+...|||++ .|+|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 45567889999887653221 22345677888888888777777633688999999999999 678999999
Q ss_pred cccccc
Q 019506 225 GSAKVL 230 (340)
Q Consensus 225 g~a~~~ 230 (340)
-+++..
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.16 Score=46.46 Aligned_cols=29 Identities=28% Similarity=0.336 Sum_probs=24.5
Q ss_pred CceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..+|.|+-+.||+.+ +..+.++||-.|..
T Consensus 228 VfCHNDL~~gNIL~~--~~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDF--NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEec--CCCEEEEEeccccC
Confidence 679999999999986 45699999988754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.13 Score=46.18 Aligned_cols=29 Identities=24% Similarity=0.326 Sum_probs=24.5
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~--d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc--C-CcEEEeCCCCCC
Confidence 4799999999999995 3 478999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.24 Score=43.48 Aligned_cols=72 Identities=14% Similarity=0.104 Sum_probs=42.3
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhCC---CCceeecceeeeecCCCCceeeeeeecc
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
-.+.|+.|....+|+.. .+++.+.||+-... ...+..|.+-|+.|. --.+.+++++.... + .-+|||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~--~~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---D--DAFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---S--CCEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---C--CceEEEEe
Confidence 34668889999999987 57888999977633 445678888888774 33345555554221 1 23799999
Q ss_pred ccc
Q 019506 157 VPE 159 (340)
Q Consensus 157 ~~~ 159 (340)
++.
T Consensus 94 l~~ 96 (288)
T PF03881_consen 94 LEM 96 (288)
T ss_dssp ---
T ss_pred ecC
Confidence 874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.056 Score=49.05 Aligned_cols=58 Identities=26% Similarity=0.313 Sum_probs=39.5
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~ 214 (340)
++=+|..| ++...+.. ...+++..+.++.-.++|+--+--..+++|.|+.|.||++..
T Consensus 322 l~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 322 LVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 55556666 44444432 455666777777767777665554479999999999999953
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.024 Score=49.81 Aligned_cols=86 Identities=21% Similarity=0.150 Sum_probs=60.6
Q ss_pred CCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCC
Q 019506 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (340)
Q Consensus 128 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp 207 (340)
..|.+|.+... .|||-|++.. -+..-.-.+..++-.+.+..-.|+..++.-|-...-+||.||.-
T Consensus 348 pcP~vV~lkkh------------vLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSE 412 (531)
T KOG2269|consen 348 PCPQVVKLKKH------------VLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSE 412 (531)
T ss_pred CCCceeeeecc------------eEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhh
Confidence 35667666433 3899998742 11111122456777788887888888887775436799999999
Q ss_pred CCeEecCCCCcEEEEeecccccc
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
-|+|... +.+.++|...+...
T Consensus 413 yN~Lw~~--gKvw~IDVsQsvep 433 (531)
T KOG2269|consen 413 YNLLWTP--GKVWVIDVSQSVEP 433 (531)
T ss_pred hhheecC--CceEEEechhccCC
Confidence 9999984 58999999887554
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.8 Score=42.86 Aligned_cols=53 Identities=13% Similarity=0.122 Sum_probs=34.7
Q ss_pred EeeeeeeecceEEEEEEEcC--------CCcEEEEEEeccccc---ChHHHHHHHHhCCCCcee
Q 019506 81 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI 133 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv 133 (340)
-.+.|..|-.-.+|++.... .++.|.+|+.-.... ....|..+++.+...+|-
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~ 172 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIA 172 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCC
Confidence 45566677778899887542 156899997754432 235688888877655544
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.091 Score=46.98 Aligned_cols=30 Identities=33% Similarity=0.501 Sum_probs=25.0
Q ss_pred ceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 200 iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+||+|+.|.||+++.++..+.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999995332488999998754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.077 Score=47.03 Aligned_cols=53 Identities=28% Similarity=0.302 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHH---HHHHcCCCceecCCCCCCeEecCCCC-----------------cEEEEeecccccc
Q 019506 178 IYVKLYTYQIFRGL---AYIHTVPGVCHRDVKPQNLLVDPLTH-----------------QVKLCDFGSAKVL 230 (340)
Q Consensus 178 ~~~~~i~~qi~~~l---~~LH~~~~iiH~dlkp~Nill~~~~~-----------------~~kl~Dfg~a~~~ 230 (340)
.-++.++.||+.-. ..|-...+.+|-||||+|||+-+... .++|.||.++...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 44667777776543 12221247999999999999843221 3677788777553
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.07 Score=43.37 Aligned_cols=29 Identities=28% Similarity=0.339 Sum_probs=24.8
Q ss_pred CceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 199 ~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
-.+|+|+.|.||+++. ++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~-~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSA-SG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEEC-CC-EEEEeCCcccC
Confidence 4699999999999984 55 99999999865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 340 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-93 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-93 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-93 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-93 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-93 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-93 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-93 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-92 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-92 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-92 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-92 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-92 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-92 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-92 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-92 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-91 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-91 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-91 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-91 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-91 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-89 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-88 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-64 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-61 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-34 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-34 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-34 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-33 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-33 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-33 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-33 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-33 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-33 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-33 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-33 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-33 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-33 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-33 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-33 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-33 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-33 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-33 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-33 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-33 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-33 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-33 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-33 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-33 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-33 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-33 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-33 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-33 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-33 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-33 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-32 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-32 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-32 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-32 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-32 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-32 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-32 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-32 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-32 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-32 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-32 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-32 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-32 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-32 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-32 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-32 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-31 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-31 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-31 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-31 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-31 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-31 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-31 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-31 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-31 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-31 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-31 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-31 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-31 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-31 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-31 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-31 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-31 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-31 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-31 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-31 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-31 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-31 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-31 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-31 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-31 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-31 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-31 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-31 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-31 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-31 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-31 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-31 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-31 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-31 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-31 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-31 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-31 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-31 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-31 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-31 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-31 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-31 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-30 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-30 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-30 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-30 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-30 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-30 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-30 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-30 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-30 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-30 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-30 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-30 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-30 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-30 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-30 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-30 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-30 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-30 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-30 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-30 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-30 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-30 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-30 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-30 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-30 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-30 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-30 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-30 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-30 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-30 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-30 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-30 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-30 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-30 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-30 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-30 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-30 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-30 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-30 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-30 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-30 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-30 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-30 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-29 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-29 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-29 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-29 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-29 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-28 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-28 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-28 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-28 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-28 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-28 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-28 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-28 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-28 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-27 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-26 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-26 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-26 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-26 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-26 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-26 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-26 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-25 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-25 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-25 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-25 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-25 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-25 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-25 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-24 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-24 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-24 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-24 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-24 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-24 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-24 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-23 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-23 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-23 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-23 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-22 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-22 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-22 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-22 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-22 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-22 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-22 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-22 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-22 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-22 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-22 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-22 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-22 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-22 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-22 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-22 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-22 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-22 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-22 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-21 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-21 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-21 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-21 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-21 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-20 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-20 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-155
Identities = 154/255 (60%), Positives = 198/255 (77%), Gaps = 4/255 (1%)
Query: 42 SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 101
S+ ++ + D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 102 GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPET 160
E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K DE+FLNLV+EYVPET
Sbjct: 65 DE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
+YR +HY+ + Q MP++ +KLY YQ+ R LAYIH++ G+CHRD+KPQNLL+DP + +K
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLK 182
Query: 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
L DFGSAK+L+ GE N+SYICSRYYRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLF
Sbjct: 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
Query: 281 PGENAVDQLVEIIKV 295
PGE+ +DQLVEIIKV
Sbjct: 243 PGESGIDQLVEIIKV 257
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 436 bits (1122), Expect = e-153
Identities = 156/240 (65%), Positives = 200/240 (83%), Gaps = 4/240 (1%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ K DE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P+IYVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-151
Identities = 110/245 (44%), Positives = 162/245 (66%), Gaps = 8/245 (3%)
Query: 59 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 117 KNRELQLMRLM---DHPNVISLKHCFFSTTSK--DELFLNLVMEYVPETMYRVLKHYSSM 171
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP+T++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
E N++YICSRYYRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 291 EIIKV 295
EI++V
Sbjct: 243 EIVRV 247
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-141
Identities = 116/258 (44%), Positives = 168/258 (65%), Gaps = 34/258 (13%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 130
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+++DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 131 NVISLKHCFFSTTSK---------------------------------DELFLNLVMEYV 157
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
P+T+++VLK + + +P+ + +Y YQ+FR + +IH++ G+CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+KLCDFGSAK L+ E +++YICSR+YRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 278 PLFPGENAVDQLVEIIKV 295
PLF GE ++DQLV II++
Sbjct: 240 PLFSGETSIDQLVRIIQI 257
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-73
Identities = 79/218 (36%), Positives = 123/218 (56%), Gaps = 17/218 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F L+LV EY T+ L + +P VK T+Q + + + H
Sbjct: 71 FRRKRR-----LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ +KLCDFG A++L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+D+W+ GCV AELL G PL+PG++ VDQL I K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 9e-73
Identities = 76/218 (34%), Positives = 123/218 (56%), Gaps = 17/218 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
LV E+V T+ L+ + V+ Y +QI G+ + H+
Sbjct: 93 CKKKKR-----WYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+KP+N+LV + VKLCDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-71
Identities = 70/236 (29%), Positives = 125/236 (52%), Gaps = 27/236 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 133 ISLKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 183
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----Y 239
YQ+ RGL YIH+ V HRD+KP NL ++ +K+ DFG A+++ ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-70
Identities = 71/220 (32%), Positives = 117/220 (53%), Gaps = 13/220 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-LMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 257 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKV 295
Y S+D+WS GC+LA ++ +P F G + DQLV I KV
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-69
Identities = 68/235 (28%), Positives = 130/235 (55%), Gaps = 27/235 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I++ + + ++ + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YI 240
+H V HRD+KP NLL++ +K+CDFG A+++ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 4e-69
Identities = 77/223 (34%), Positives = 123/223 (55%), Gaps = 24/223 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ HRD+KP NLL+D +KL DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
GA Y +D+W+ GC+LAELLL P PG++ +DQL I +
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-68
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 25/234 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 123
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVK 181
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
+ Y I GL +H GV HRD+ P N+L+ + + +CDF A+ Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-67
Identities = 78/228 (34%), Positives = 125/228 (54%), Gaps = 20/228 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-67
Identities = 81/226 (35%), Positives = 125/226 (55%), Gaps = 21/226 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ GV HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARHA--DAEMTGYVVTRWYRAPE 193
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-67
Identities = 75/231 (32%), Positives = 125/231 (54%), Gaps = 30/231 (12%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMD 128
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQI 187
H N+++L + S L LV EY + + LK Y + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEY----LDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRY 244
RGLAY H V HRD+KPQNLL++ ++KL DFG A+ K +Y + + +
Sbjct: 110 LRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARA--KSIPTKTYDNEVVTLW 165
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
YR P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-67
Identities = 82/226 (36%), Positives = 127/226 (56%), Gaps = 20/226 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F + D+ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-66
Identities = 75/224 (33%), Positives = 120/224 (53%), Gaps = 25/224 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L+L+ EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 IHHNHR-----LHLIFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 199 GVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
HRD+KPQNLL+ +K+ DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +V
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-66
Identities = 71/220 (32%), Positives = 125/220 (56%), Gaps = 22/220 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++K+ DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 80/221 (36%), Positives = 124/221 (56%), Gaps = 22/221 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 295
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-65
Identities = 73/225 (32%), Positives = 124/225 (55%), Gaps = 27/225 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAY 193
+ L LV E++ + + + + + + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPEL 250
H + HRD+KPQNLL++ Q+KL DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-65
Identities = 73/248 (29%), Positives = 134/248 (54%), Gaps = 43/248 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRLM-DH 129
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+++L + + +D + LV +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----------- 238
+ Y+H+ G+ HRD+KP N+L++ VK+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 288 QLVEIIKV 295
QL II V
Sbjct: 239 QLERIIGV 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-65
Identities = 82/226 (36%), Positives = 126/226 (55%), Gaps = 20/226 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S +E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+++
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-65
Identities = 79/220 (35%), Positives = 127/220 (57%), Gaps = 22/220 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
+ HRD+KPQNLL++ +KL DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-65
Identities = 75/228 (32%), Positives = 120/228 (52%), Gaps = 24/228 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQI 187
N+I L + F S +E + +VME + + +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 247
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-64
Identities = 73/226 (32%), Positives = 121/226 (53%), Gaps = 20/226 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F + +E + LVME + + +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-63
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 29/230 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++L+ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 135 LK---HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRG 190
L S ++ + + LV ++ L S++ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYY 245
L YIH + HRD+K N+L+ +KL DFG A+ L K Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-62
Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 27/228 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRLMDHPNV 132
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L ++ + E+ + LV E+ + + L+ Y + +P +K Q RG
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRA 247
L ++H + HRD+KP+N+LV VKL DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
PE++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I +
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-60
Identities = 74/227 (32%), Positives = 121/227 (53%), Gaps = 27/227 (11%)
Query: 85 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRLMDHPNVI 133
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGL 191
L + + E L LV E+ + + L Y +P +K +Q+ RGL
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
++H+ V HRD+KPQN+LV + Q+KL DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
E++ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-59
Identities = 76/276 (27%), Positives = 114/276 (41%), Gaps = 67/276 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRLMDHP 130
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L L +V+E + ++ K + ++K Y + G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLG 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+IH G+ HRD+KP N L++ VK+CDFG A+ + +
Sbjct: 142 ENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ---------- 277
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 278 -PLFPG-----------------ENAVDQLVEIIKV 295
PLFPG ++ DQL I +
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-59
Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 75/284 (26%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHP 130
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVG 168
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+ Y+H+ G+ HRD+KP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 239 ----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 275
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 276 ----GQPLFPGENAV--------------------DQLVEIIKV 295
PLFPG + DQL I +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 75/236 (31%), Positives = 119/236 (50%), Gaps = 29/236 (12%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + + ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 196 TVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVLVKGEANISYICSR----YYRAP 248
V HRD+KP N+LV +VK+ D G A++ ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKV 295
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-54
Identities = 60/252 (23%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 70 NGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRE 120
+ Y+ + +G G F V + L G A+K++L QDR RE
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 121 LQLMRLMDHPNVISLKHCFF-STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLI 178
+ RL +HPN++ L +K E + L++ + T++ ++ +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG----- 233
+ I RGL IH G HRD+KP N+L+ Q L D GS
Sbjct: 135 QILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSR 192
Query: 234 -----EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ + C+ YRAPEL D+WS GCVL ++ G+ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 287 DQLVEIIKVSNI 298
V + + +
Sbjct: 253 GDSVALAVQNQL 264
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-52
Identities = 76/230 (33%), Positives = 118/230 (51%), Gaps = 27/230 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
NVI + F F N + E + +Y ++K Q L V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208
Query: 187 IFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
I + L +H + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
RAPE+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 28/272 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y + ++G GSFG V +A E VAIK + + + N E++L+ LM
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++ LK F F N LV E + +Y +L++ + + + L + + Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQ 165
Query: 187 IFRGLAYIHTV-PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ L ++ T + H D+KP+N LL +P +K+ DFGS+ G+ YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304
YR+PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++V I A +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
Query: 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336
Q E + + G+W ++ E K
Sbjct: 283 DQAPKARKFFEKLPD-GTWNLKKTKDGKREYK 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-52
Identities = 61/268 (22%), Positives = 103/268 (38%), Gaps = 19/268 (7%)
Query: 33 LKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGI 92
L S ++ + + + S E S+ +G GS+G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 93 VFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRLMDHPNVISLKHCFFSTTSK 145
VF+ + E G A+K+ + +DR K E+ ++ HP + L+ + +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----E 127
Query: 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205
+ L L E ++ + + + +P V Y LA++H+ G+ H DV
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDV 183
Query: 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 265
KP N+ + P + KL DFG L A Y APEL+ Y T+ D++S
Sbjct: 184 KPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFS 240
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEII 293
G + E+ L G QL +
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQLRQGY 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 294
I Y DIWS GC+L E+ Q F G+ + L + I+
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-50
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 18/228 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-49
Identities = 67/241 (27%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 131 NVISLKHC-----FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + H F+ + + + +V E + E + ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYI 240
Q+ GL Y+H G+ H D+KP+N+L++ + +K+ D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 294
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 295 V 295
+
Sbjct: 256 L 256
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 19/228 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 138
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 139 F-----------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +++ L + ME+ + T+ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
I +G+ YIH+ + +RD+KP N+ + T QVK+ DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 20/244 (8%)
Query: 60 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 112
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM 171
+R RE+ ++ M HPN++ + F ++ L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQK-- 118
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ + QI L ++H + HRD+K QN+ + V+L DFG A+VL
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 232 KGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
+ YY +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 291 EIIK 294
I
Sbjct: 235 LKII 238
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-48
Identities = 62/312 (19%), Positives = 106/312 (33%), Gaps = 58/312 (18%)
Query: 5 PLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIST 64
G P+ + A ++ H D+ L D S ++G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI--------- 57
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------ 118
Y + +G+G VFQ E + AIK V +
Sbjct: 58 --------------YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR 102
Query: 119 RELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
E+ + + + +I L + ++ +VME + LK + +
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSID 153
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
K Y + + IH G+ H D+KP N L+ +KL DFG A + +
Sbjct: 154 PWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 210
Query: 237 I---SYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG- 282
+ S + + Y PE I ++ + D+WS GC+L + G+ F
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 283 ENAVDQLVEIIK 294
N + +L II
Sbjct: 271 INQISKLHAIID 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-48
Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 22/245 (8%)
Query: 59 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 116
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM 175
+ EL + P ++ L ++ ++N+ ME + ++ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMG----CL 147
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P Y Q GL Y+HT + H DVK N+L+ + LCDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 236 NISYICSR------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 290 VEIIK 294
++I
Sbjct: 266 LKIAS 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 49/233 (21%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ A +Y ++D+WS G G F + E++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 62/252 (24%), Positives = 111/252 (44%), Gaps = 49/252 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 131 NVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N++ F ++ + L+ E + ++Y ++ + + +KLY +I
Sbjct: 97 NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEI 146
Query: 188 FRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------------QVKLCD 223
+ L Y+ + + H D+KP+N LL DP +KL D
Sbjct: 147 LKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
FG A K + + S I +R YRAPE+I + S D+WS GCVLAEL G LF
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 284 NAVDQLVEIIKV 295
++ L + +
Sbjct: 263 EHMEHLAMMESI 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-47
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 35/238 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V ++ + E+ + + +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 248 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK 294
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LMDHPNVIS 134
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R +HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
KD F + +E T+ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 194 IHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLVKGEANISY---IC-SRYY 245
+H++ + HRD+KP N+L+ + + DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 246 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVS 296
APE++ + T ++DI+SAGCV ++ G F + + S
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 49/233 (21%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ A +Y ++D+WS G G F + E++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-46
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 45/248 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F +V E + + Y +K L +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVD-----------------PLTHQVKLCDFGSA 227
QI + + ++H+ + H D+KP+N L V + +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YRAPE+I ++ D+WS GC+L E LG +FP ++ +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 288 QLVEIIKV 295
L + ++
Sbjct: 242 HLAMMERI 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-46
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 139 FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + + F+ + ME VP + R + + I YT QI GL Y+
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFG 253
H + HRD+K N+L++ + +K+ DFG++K L ++ + Y APE+I
Sbjct: 139 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 254 ATE-YTTSIDIWSAGCVLAELLLGQP 278
Y + DIWS GC + E+ G+P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-46
Identities = 57/248 (22%), Positives = 101/248 (40%), Gaps = 45/248 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F F + E + + + LK + Q PL +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------QVKLCDFGSA 227
Q+ L ++H + H D+KP+N L V+ +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YR PE+I + D+WS GC+L E G LF +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 288 QLVEIIKV 295
LV + K+
Sbjct: 247 HLVMMEKI 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 59/249 (23%), Positives = 102/249 (40%), Gaps = 35/249 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 136 KHCF--------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ T K + L + MEY T+Y ++ S N Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQ 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
I L+YIH+ G+ HRD+KP N+ +D + VK+ DFG AK + + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 244 ------------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y A E++ G Y ID++S G + E++ P G +++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME-RVNILK 239
Query: 292 IIKVSNIIY 300
++ +I +
Sbjct: 240 KLRSVSIEF 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR-LMDHPNVI 133
RV+ G F V++A+ + +G A+K++L + R +E+ M+ L HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 134 SLKHCFF-----STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
S T + E L+ E + LK S + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 189 RGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-------------E 234
R + ++H P + HRD+K +NLL+ +KLCDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 235 ANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
I+ + YR PE+I + DIW+ GC+L L Q F
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 53/238 (22%), Positives = 90/238 (37%), Gaps = 35/238 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 248 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK 294
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ ST + + LV E + T+ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
P + HRD+K N+ + T VK+ D G A + A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
+Y S+D+++ G + E+ + + Q+ +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 134 SLKHCFF-------STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S +++L + M+ E + + ++ +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
QI + ++H+ G+ HRD+KP N+ VK+ DFG + + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 244 -----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 293 IK 294
++
Sbjct: 240 VR 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 20/242 (8%)
Query: 67 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 119
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLN-LVMEYVP--ETMYRVLKH--YSSMNQR 174
E+Q+M+ ++HPNV+S + L L MEY + + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVK 232
+ I L Y+H + HRD+KP+N+++ P + K+ D G AK L +
Sbjct: 122 PIRTLLS----DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
GE ++ + Y APEL+ +YT ++D WS G + E + G F Q
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 293 IK 294
++
Sbjct: 236 VR 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 39/239 (16%), Positives = 79/239 (33%), Gaps = 35/239 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQ----LMRLMDHPN 131
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ + ++ + + EY ++ + + +K Q+ RG
Sbjct: 73 VVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVK 232
L YIH+ + H D+KP N+ + K+ D G +
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
+ + A E++ + DI++ + +PL + ++ +
Sbjct: 187 PQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 38/254 (14%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LM 127
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKH--YSSMNQRMPLIYVKLYT 184
DHPNVI +C + FL + +E V +
Sbjct: 67 DHPNVIRY-YCSE----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVD------------PLTHQVKLCDFGSAKVLVK 232
QI G+A++H++ + HRD+KPQN+LV ++ + DFG K L
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 233 GEANISY----IC-SRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 280
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 281 PGENAVDQLVEIIK 294
+ + II+
Sbjct: 241 GDKY--SRESNIIR 252
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 63/300 (21%), Positives = 120/300 (40%), Gaps = 20/300 (6%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
A G P P ++ + + +S+ +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYK 117
+ K+ Y +GTG+FG+V + TG A K V D+
Sbjct: 144 YPQPVEIKHDHVLDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+E+Q M ++ HP +++L F +D+ + ++ E++ E +V ++ M++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGE 234
+ Y++ Q+ +GL ++H H D+KP+N++ ++++KL DFG L +
Sbjct: 257 AVEYMR----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE+ G D+WS G + LL G F GEN + L +
Sbjct: 312 SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 6e-43
Identities = 31/239 (12%), Positives = 66/239 (27%), Gaps = 36/239 (15%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHP 130
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 131 NVISLKHCFFSTTSKDELFLN---------------------LVMEYVP---ETMYRVLK 166
+ + D + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226
++ + + T Q+ R A + + G+ H P NL + P ++ L D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 227 AKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 29/235 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQI 187
++ L F +D+ + LV E E ++ +S + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+H + HRD+KP+NLL++ + +++ DFG + + I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300
APE++ G Y D+WS G +L LL G P F G N +++ ++ +
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTF 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 32/252 (12%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 112
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL----- 165
E+++++ +DHPN+I + F +D + +VME E + R++
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 166 -KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLC 222
K S YV Q+ LAY H+ V H+D+KP+N+L + +K+
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFG A++ E + + + Y APE+ + T DIWSAG V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 283 ENAVDQLVEIIK 294
+ + +
Sbjct: 228 TSLEEVQQKATY 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 71 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 124
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
+ +DHPN+I L F +D + LVME E RV+ +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANIS 238
+ +AY H + V HRD+KP+N L + +KL DFG A G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 239 YIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ YY +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +D +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+H + HRD+KP+N+L++ +K+ DFG + + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300
APE++ G Y D+WSAG +L LL G P F G+N +++ ++ +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAF 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 30/253 (11%)
Query: 62 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 113
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 114 RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYS 169
E+ +++L+DHPN++ L F +D+ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 227
+ + Q+ G+ Y+H + HRD+KP+NLL++ +K+ DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
V + + + YY APE++ +Y D+WS G +L LL G P F G+
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD-Q 243
Query: 288 QLVEIIKVSNIIY 300
+++ ++ +
Sbjct: 244 EILRKVEKGKYTF 256
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 32/235 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYT 184
++HP +I +K+ F D +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC- 241
YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 242 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 23/223 (10%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 124
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLY 183
R + H +V+ F D +F +V+E ++ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEARYY 120
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYIC- 241
QI G Y+H V HRD+K NL ++ +VK+ DFG + KV GE +C
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGER-KKVLCG 177
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ Y APE++ ++ +D+WS GC++ LL+G+P F
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-41
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 49/284 (17%)
Query: 10 PQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGK 69
P P P +A P P KE+ ++
Sbjct: 2 PAPADPGKAGVPGVAAP--------GAPAAAPPAKEIPEVLV------------------ 35
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+P+ Y+ R +G G F F+ +T E A K +L + E+
Sbjct: 36 --DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 93
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ R + H +V+ F D +F +V+E ++ + K + + +
Sbjct: 94 IHRSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEAR 144
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
Y QI G Y+H V HRD+K NL ++ +VK+ DFG A + +C
Sbjct: 145 YYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLC 202
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ Y APE++ ++ +D+WS GC++ LL+G+P F
Sbjct: 203 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 38/239 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 121
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPL 177
L++ +DHPN+I L F +D+ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA 235
QI G+ Y+H + HRD+KP+N+L++ +K+ DFG + K
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + YY APE++ +Y D+WS G ++ LL G P F G+N D + ++ K
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 18/224 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +D+ + L++E++ E R+ M++ V Y Q GL
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 193 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + H D+KP+N++ VK+ DFG A L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 70/269 (26%), Positives = 109/269 (40%), Gaps = 59/269 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRLMDH 129
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKL----- 182
PN+ L + +DE ++ LVME + ++ + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 183 ------------------------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
QIF L Y+H G+CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 213 D-PLTHQVKLCDFGSAKVLVKGEANISYIC-----SRYYRAPELIFGATE-YTTSIDIWS 265
+ ++KL DFG +K K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIK 294
AG +L LL+G FPG N D + +++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-40
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F D + L++EY P T+YR L+ + Y ++ L+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ V HRD+KP+NLL+ ++K+ DFG + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ +D+WS G + E L+G+P F + I +V
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-40
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 71 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ + HP+++ L + F + ++ LV+E M R LK+ + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNR---VKPFSENEAR 115
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
+ +QI G+ Y+H+ G+ HRD+ NLL+ +K+ DFG A L +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ Y +PE+ + + D+WS GC+ LL+G+P F +
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-40
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKL 182
++HP +I +K+ F D +V+E + E +V+ + L
Sbjct: 72 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYI 240
Y YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 241 C-SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
C + Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-40
Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 29/249 (11%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 113
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 114 RRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--H 167
+ RE++L++ +DHPN++ L +D +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG 225
+S Q+F G+ Y+H + HRD+KP+N+L++ +K+ DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
+ + I + YY APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 286 VDQLVEIIK 294
D L +
Sbjct: 228 YDILKRVET 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 77/303 (25%), Positives = 112/303 (36%), Gaps = 42/303 (13%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
P P P P PPPQ P P P + V G I
Sbjct: 7 GQSPPVPFPAPAPPPQPPTPALPHPP-------AQPPPPPPQQFPQFHVKSGLQIKKNAI 59
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
I + +V+G G G V Q T E A+K +LQD RE+
Sbjct: 60 IDDY-------------KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREV 105
Query: 122 QLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLI 178
+L R P+++ + + L +VME + E R+ R
Sbjct: 106 ELHWRASQCPHIVRI-VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQA 157
Query: 179 Y----VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLV 231
+ I + Y+H++ + HRDVKP+NLL P +KL DFG AK
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT 215
Query: 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
+ + + YY APE + G +Y S D+WS G ++ LL G P F + +
Sbjct: 216 SHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274
Query: 292 IIK 294
+
Sbjct: 275 MKT 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 51/223 (22%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++ E++ + R+ +N+R + Y +Q+ L +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 194 IHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
+H+ + H D++P+N++ + +K+ +FG A+ L G+ N + + Y APE +
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPE-V 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+T+ D+WS G ++ LL G F E + I+
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 23/300 (7%)
Query: 3 SMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHII 62
++ + + N L P A I A H I
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN 118
+ K G + ++G G FG V + + TG +A K + ++D+
Sbjct: 78 ---VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
E+ +M +DH N+I L F + + + LVMEYV E R++ ++ +
Sbjct: 135 NEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEA 235
++++K QI G+ ++H + + H D+KP+N+L V+ Q+K+ DFG A+ E
Sbjct: 190 ILFMK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 244 KLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 53/270 (19%), Positives = 106/270 (39%), Gaps = 39/270 (14%)
Query: 54 NDAVTGHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK---- 108
D ++ + + E + I+ Y R + G F + + + + A+K
Sbjct: 7 KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEK 64
Query: 109 -KVLQDRRYKN----------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151
+ + R + ELQ++ + + ++ + T+ DE+++
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII---TNYDEVYI- 120
Query: 152 LVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
+ EY+ + + +P+ +K + +YIH +CHRDVK
Sbjct: 121 -IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY-TTSIDIW 264
P N+L+D +VKL DFG ++ +V + S + + PE + Y +DIW
Sbjct: 180 PSNILMDK-NGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 265 SAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
S G L + F + ++ +L I+
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIR 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRG 190
L+ + + LVM+ V E R+L+ Y+ ++ + ++ Q+
Sbjct: 71 LEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 247
+ Y+H G+ HRD+KP+NLL ++ + DFG +K+ G +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 37/313 (11%), Positives = 95/313 (30%), Gaps = 39/313 (12%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
PQ A P +D+ L+ + + + + T
Sbjct: 2 SPQMSSLGTVDAPNFIVGNP-WDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF 60
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYK 117
+ ++G G+F V++A + + +K +
Sbjct: 61 QLGSKL------VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+ ++ ++ + ++ L V E + + + ++ + M
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVM 169
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----------VKLCDFG 225
P V + ++ + +H + H D+KP N ++ + + L D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 226 SA---KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-P 281
+ K+ KG + + ++ E++ + ID + + +L G +
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 282 GENAVDQLVEIIK 294
E + + +
Sbjct: 288 NEGGECKPEGLFR 300
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 57 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 117 KNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSM 171
E++++ R HPN+I+LK + D ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK 228
+ I + + Y+H GV HRD+KP N+L +++CDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 229 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
L + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-39
Identities = 60/300 (20%), Positives = 115/300 (38%), Gaps = 43/300 (14%)
Query: 8 PQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIG 67
P P +LL + D+ + + + + +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 68 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRR 115
+ + Y + V+G G +V + TG A+K ++ + R
Sbjct: 90 KEFYQ-----KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 116 YKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSS 170
RE ++R + HP++I+L + + F+ LV + + E + + S
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
R + ++++H + HRD+KP+N+L+D Q++L DFG + L
Sbjct: 200 KETR-------SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHL 250
Query: 231 VKGEANISYIC-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGEN 284
GE + +C + Y APE++ + + Y +D+W+ G +L LL G P F
Sbjct: 251 EPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 16/221 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + + ME + ++ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG---A 254
V HRDVKP N+L++ QVK+CDFG + LV A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294
Y+ DIWS G + EL + + + QL ++++
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 34/235 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRLMDH 129
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLY 183
P+++ L + + L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYI 240
QI L Y H + HRDVKP +L+ + + VKL FG A L +
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 241 C-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII 245
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-38
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 49/274 (17%)
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 111
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 112 QDRRYKNR---------------------ELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
Q + R L++ +I ++ FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
M+ +T VL +SS ++ + T Q+ R LA +H G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----------FGATEYTTS 260
++D V L F V+ A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 261 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
D W+ G V+ + + A+ I +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWIFR 327
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 33/235 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L F +++ + L++E V E + + + +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H+ + H D+KP+N+++ + ++KL DFG A + G I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H V HRD+KP+NLL+ ++K+ DFG + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ +D+W AG + E L+G P F + + I+ V
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+F +V + + G+ A + + RE ++ RL+ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +E L+ + V E ++ +YS QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + H + GV HR++KP+NLL L VKL DFG A + + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLMDHPNV 132
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L ++E F LV + V E ++ YS + QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+AY H+ G+ HR++KP+NLL+ VKL DFG A + EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 141 STTSKDELFLNLVMEYVP--ETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ L ++ME + E R + + +R I + ++H+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHSH 147
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
+ HRDVKP+NLL +KL DFG AK + + C + YY APE + G
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+Y S D+WS G ++ LL G P F + +
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 35/256 (13%)
Query: 60 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 108
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 109 --KVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMY 162
K L R ++ RE ++ R + HPN++ L ++E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 163 RVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQ 218
++ YS + QI +AY H+ G+ HR++KP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
VKL DFG A + EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 279 LFPGENAVDQLVEIIK 294
F E+ +I
Sbjct: 229 PFWDEDQHRLYAQIKA 244
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-38
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 33/235 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPNVI+L + +++ + L++E V E + + + +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H++ + H D+KP+N+++ + ++K+ DFG A + G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 70 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 125
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVK 181
+ HPN+I LK F + ++LV+E V E R+++ +YS +R VK
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVK 155
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISY 239
QI +AY+H G+ HRD+KP+NLL P +K+ DFG +K++ +
Sbjct: 156 ----QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 39/240 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 124
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
++ HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + +H + + HRD+KP+N+L+D +KL DFG + L GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 241 C-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRLMDHP 130
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
NVI L ++ + + +VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRA 247
L Y+H+ G+ H+D+KP NLL+ +K+ G A+ L A+ S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 248 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284
PE+ G ++ +DIWSAG L + G F G+N
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
H NVI+L + ++ + L++E V E + + S +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296
+ + APE I D+WS G + LL G F G+ + L I VS
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 31/251 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG VF + TG+ A K L +R K R E +++ + ++S
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + F +K +L L VM + + Y + + N YT QI GL
Sbjct: 250 LAYAF---ETKTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D + V++ D G A L G+ + + APEL+
Sbjct: 304 HLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIY-------A 301
G EY S+D ++ G L E++ + F +L + + + Y +
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 302 KTIYQGLFCSN 312
K + L +
Sbjct: 421 KDFCEALLQKD 431
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + T + + ME M K M +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMEL----MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----F 252
GV HRDVKP N+L+D Q+KLCDFG + LV +A Y APE I
Sbjct: 143 KHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294
+Y D+WS G L EL GQ + + L ++++
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + ME + + + K+ YS ++ +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP N+L+D + +KLCDFG + LV A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 257 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294
Y D+WS G L EL G+ +P N+V DQL +++K
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L + ++ + L++E V E + + S +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296
+ + APE I D+WS G + LL G F G+ + L I VS
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 24/232 (10%)
Query: 63 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 116
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQR 174
RE+ R + HPN++ K + L ++MEY E R+ R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGELYERICNA-----GR 112
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKG 233
+ + Q+ G++Y H++ +CHRD+K +N L+D ++K+CDFG +K V
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 234 EANISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMD-HPNVISL 135
+ ++ +G GSF I + ++ + A+ K++ R N +E+ ++L + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGL 191
F D+L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 192 AYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYYRAP 248
+++H V GV HRD+KP+NLL D + ++K+ DFG A++ + C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
E + Y S D+WS G +L +L GQ F +
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----- 65
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--T 196
+ + L VMEY ++Y VL H + + + Q +G+AY+H
Sbjct: 66 LYGACLNPVCL--VMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP NLL+ +K+CDFG+A + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 69/322 (21%), Positives = 133/322 (41%), Gaps = 33/322 (10%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
Q ++ ++ + G+ + +
Sbjct: 77 CLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV 136
Query: 67 GGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ 119
+ + T++ + +++G G+FG V K TG A+K +L+ +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHT 195
Query: 120 --ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
E ++++ HP + +LK+ F + D L VMEY E + + S +
Sbjct: 196 LTENRVLQNSRHPFLTALKYSF---QTHDRLCF--VMEYANGGELFFHL-----SRERVF 245
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ Y +I L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGA 304
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APE++ +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL 362
Query: 295 VSNIIY-------AKTIYQGLF 309
+ I + AK++ GL
Sbjct: 363 MEEIRFPRTLGPEAKSLLSGLL 384
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS---------YICSRY 244
+H G+ HRD+KP+N+L++ H +++ DFG+AKVL Y+
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+PEL+ S D+W+ GC++ +L+ G P F N
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-36
Identities = 49/291 (16%), Positives = 96/291 (32%), Gaps = 53/291 (18%)
Query: 52 QGNDAVTGHIISTTIGGKNGEPKQTISYMAER--------VVGTGSFGIVFQAKCLETGE 103
+ + ++ST++ G+P + S + ER V+G +A ETGE
Sbjct: 46 EYMQSAADSLVSTSLW-NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 104
Query: 104 TVAIKKVLQDRRYKNRELQLMR--------------------------------LMDHPN 131
+ + R + ++ M+
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I ++ FL M+ +T VL +SS ++ + T Q+ R L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----YRA 247
A +H G+ H ++P ++++D V L F G + +S I + A
Sbjct: 225 ASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD--GASAVSPIGRGFAPPETTA 280
Query: 248 PELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ T T + D W+ G + + + A+ I +
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 61/250 (24%), Positives = 116/250 (46%), Gaps = 32/250 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +DE + +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF- 252
+ + HRD+KP N+L+D H V + DF A +L + + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 253 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNIIY-------AK 302
Y+ ++D WS G ELL G+ + ++ ++V + + + Y
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 303 TIYQGLFCSN 312
++ + L N
Sbjct: 249 SLLKKLLEPN 258
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 59/252 (23%), Positives = 114/252 (45%), Gaps = 36/252 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPN 131
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ + + F + D+L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL ++H V +RD+KP N+L+D H V++ D G A K + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVSNIIY------- 300
++ Y +S D +S GC+L +LL G F D ++ + +
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420
Query: 301 AKTIYQGLFCSN 312
+++ +GL +
Sbjct: 421 LRSLLEGLLQRD 432
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 19/229 (8%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 119
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLI 178
ELQ++ + P ++ F+S +++ ME++ ++ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLK----KAGRIPEQ 131
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ + + +GL Y+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHP 130
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 190 GLAYIHTV-PGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
G+ Y+ P + HRD++ N+ + K+ DFG ++ + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 245 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 46/253 (18%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 118
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 119 ----------------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156
+E+ +++ +DHPNV+ L ++D L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 157 VP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
V M + + + Y + +G+ Y+H + HRD+KP NLLV
Sbjct: 120 VNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT-EYT-TSIDIWSAGCVLA 271
+K+ DFG + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 272 ELLLGQPLFPGEN 284
+ GQ F E
Sbjct: 232 CFVFGQCPFMDER 244
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 70/228 (30%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ + QI + Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 167
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
C S Y APE+I G +DIWS G +L LL G F E+
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K L+ +R K R E Q++ ++ V+S
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + + +KD L L V+ + + + + Y P Y +I GL
Sbjct: 249 LAYAY---ETKDALCL--VLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLE 300
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 301 DLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIY-------AK 302
YT S D W+ GC+L E++ GQ F +++ ++K Y A+
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417
Query: 303 TIYQGLFCSN 312
++ L C +
Sbjct: 418 SLCSQLLCKD 427
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 42/232 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RLMDHPNVISLK 136
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLA 192
F ++E LV E + + + K H++ + + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSR---- 243
++H G+ HRD+KP+N+L H VK+CDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 244 ----YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y APE++ A+ Y D+WS G +L LL G P F G D
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDH-PNV 132
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ L P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFR 189
I+L + ++ + L++EY E L + +++ V QI
Sbjct: 92 INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
G+ Y+H + H D+KPQN+L+ + +K+ DFG ++ + + I + Y
Sbjct: 143 GVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLG 276
EL+ E+ +D+WS G VL +L G
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-35
Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 118
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
RE+++M++++HPN++ L ++ L+ L+MEY E + Y + RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
+ QI + Y H + HRD+K +NLL+D +K+ DFG + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 237 ISYIC-SRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK+ F + D L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF---QTHDRLCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKTI 304
+Y ++D W G V+ E++ G+ F ++ ++L E+I + I + AK++
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSL 235
Query: 305 YQGLFCSN 312
GL +
Sbjct: 236 LAGLLKKD 243
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 129 H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F D L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + + H GV HRD+K +N+L+D ++KL DFGS +L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAV 286
PE I Y S +WS G +L +++ G F + +
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPN 131
Y+ +G GSFG V A +T + VA+K + + + RE+ ++L+ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I L T+ ++ +V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIV--MVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y H + HRD+KP+NLL+D VK+ DFG + ++ G + C S Y APE+
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 178
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
I G +D+WS G VL +L+G+ F E
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 294
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 37/258 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YRAPELI 251
+H + HRD+KP N+L+D H ++L DFGS L++ S Y +PE++
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY------- 300
G Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 301 ----AKTIYQGLFCSNNH 314
AK + + L CS H
Sbjct: 309 VSENAKDLIRRLICSREH 326
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 34/249 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F +K+ LF VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF---QTKENLFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A + C Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKT 303
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I++ N Y AK
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 304 IYQGLFCSN 312
+ LF
Sbjct: 248 LLVKLFVRE 256
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++H G+ +RD+K N+L+D H KL DFG K + + C Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKTI 304
Y ++D W+ G +L E+L G F EN D L E I ++Y A I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVVYPTWLHEDATGI 254
Query: 305 YQGLFCSN 312
+ N
Sbjct: 255 LKSFMTKN 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 136 K-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
T L + V EY+ ++YR+L H S +++ Y + +G+ Y
Sbjct: 100 MGAV----TQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 194 IHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELI 251
+H P + HR++K NLLVD + VK+CDFG +++ + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
D++S G +L EL Q +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 34/246 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRLMDHPNVI 133
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L F + D+L+ V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF---QTADKLYF--VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
Y+H++ + +RD+KP+N+L+D H + L DFG K ++ + S C Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKT 303
+ Y ++D W G VL E+L G P F N ++ + I + A+
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPLQLKPNITNSARH 268
Query: 304 IYQGLF 309
+ +GL
Sbjct: 269 LLEGLL 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVI 133
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 134 SLK-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+L+ C + L L VME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGVC----LKEPNLCL--VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 192 AYIH--TVPGVCHRDVKPQNLLVD-------PLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y+H + + HRD+K N+L+ +K+ DFG A+ + S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGA 177
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 135
+V+G G+F V K +TG+ A+K + + K E+ ++ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +DE +L LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
+H + G HRD+KP N+L+D H ++L DFGS L S Y+
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 246 RAPELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+PE++ G Y D W+ G E+ GQ F ++
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 59/248 (23%), Positives = 114/248 (45%), Gaps = 35/248 (14%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRLMDHPN 131
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L + F + +L+L ++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF---QTGGKLYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N++++ H VKL DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------A 301
E++ + + ++D WS G ++ ++L G P F GEN + ++ I + A
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKILKCKLNLPPYLTQEA 248
Query: 302 KTIYQGLF 309
+ + + L
Sbjct: 249 RDLLKKLL 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 47/228 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKH 137
+ +V+G G G V Q T E A+ K+LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLYTYQIFRGL 191
+ L +VME + E R+ R + I +
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQAFTEREASEIMKSIGEAI 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSRYYR 246
Y+H++ + HRDVKP+NLL T + +KL DFG
Sbjct: 131 QYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFG--------------------F 166
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
A E +Y S D+WS G ++ LL G P F + + +
Sbjct: 167 AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 27/222 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 129 ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
HP VI L +F T ++ L V+E L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SR 243
Q+ + + H+ GV HRD+K +N+L+D KL DFGS +L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 244 YYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284
Y PE I +Y +WS G +L +++ G F +
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ 243
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 63/249 (25%), Positives = 122/249 (48%), Gaps = 33/249 (13%)
Query: 83 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRLMDHPNVI 133
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L + F ++ +L+L +++++ + R+ S VK Y ++ L
Sbjct: 90 KLHYAF---QTEGKLYL--ILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALAL 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKT 303
+ +T S D WS G ++ E+L G F G++ + + +I + + A++
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFLSPEAQS 255
Query: 304 IYQGLFCSN 312
+ + LF N
Sbjct: 256 LLRMLFKRN 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-33
Identities = 71/248 (28%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D L+ VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++ + G+ +RD+K N+++D H +K+ DFG K + C Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKTI 304
Y S+D W+ G +L E+L GQ F GE+ D+L + I N+ Y A I
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVAYPKSMSKEAVAI 251
Query: 305 YQGLFCSN 312
+GL +
Sbjct: 252 CKGLMTKH 259
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y + V+G+G+ +V A C E VAIK++ ++ + +E+Q M HPN++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 134 SLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
S F KDEL+ LVM+ V + + ++ + + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR---- 243
GL Y+H G HRDVK N+L+ V++ DFG SA + G+ + R
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 244 ---YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
+ APE++ Y DIWS G EL G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
IH++ G HRDVKP N+L+D H +KL DFG+ + K YI
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 246 RAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+PE++ G Y D WS G L E+L+G F ++
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 74/238 (31%), Positives = 111/238 (46%), Gaps = 25/238 (10%)
Query: 68 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ ++F +VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIF--MVMEYVSGGE-----LFDYICKNGRLDE 115
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ QI G+ Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 172
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
C S Y APE+I G +DIWS+G +L LL G F ++ V L + I
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 76/332 (22%), Positives = 126/332 (37%), Gaps = 42/332 (12%)
Query: 9 QPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGG 68
+ + P S+ + +
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKT 322
Query: 69 KNGEPKQTISYMAER----------VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN 118
N K + +R V+G GSFG V ++ T E A+K + +D ++
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 382
Query: 119 RELQ--------LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHY 168
+++ L P + L CF + D L+ VMEYV + MY + +
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV- 436
Query: 169 SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
R + Y +I GL ++ + G+ +RD+K N+++D H +K+ DFG K
Sbjct: 437 ----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCK 490
Query: 229 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
+ C + Y APE+I Y S+D W+ G +L E+L GQ F GE+ D
Sbjct: 491 ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-ED 548
Query: 288 QLVEIIKVSNIIY-------AKTIYQGLFCSN 312
+L + I N+ Y A I +GL +
Sbjct: 549 ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 580
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
S S +L+L + Y ++Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV Q + D G A + + + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 244 YYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 274
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 77/287 (26%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 134 SLKH----------------------------------------------------CFFS 141
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 142 TTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +++L + M+ E + + S+ R + + ++ QI + ++H+ G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------------VKGEANISYICSRYYRA 247
HRD+KP N+ VK+ DFG + + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
PE I G Y+ +DI+S G +L ELL V + ++
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRN 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G +G V+ K GE VA+K + RE + LM H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
T S +L+L + +Y ++Y LK + + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
T P + HRD+K +N+LV + D G A + + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKH 137
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ LN + EY+ T+ ++K SM+ + P + I G+AY+H+
Sbjct: 72 -FIGVLYKDKR-LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------------- 243
+ + HRD+ N LV V + DFG A+++V + + S
Sbjct: 127 M-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 244 --YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 42/251 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAP 248
+H+ + +RD+KP+N+L+D H +K+ DFG AK V YI AP
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKY-VPDVTYTLCGTPDYI------AP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------A 301
E++ Y SID WS G ++ E+L G F N + E I + + +
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELRFPPFFNEDV 230
Query: 302 KTIYQGLFCSN 312
K + L +
Sbjct: 231 KDLLSRLITRD 241
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRL 126
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++H N+I + F ++ LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + Y+ + HRD+K +N+++ +KL DFGSA L +G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLG 276
APE++ G Y +++WS G L L+
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFE 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 36/211 (17%), Positives = 77/211 (36%), Gaps = 22/211 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 135
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
S L+ ++P ++Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 195 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
HT+ P + + +++++D ++ + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 254 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F ++ +L + V ++ ++Y L + + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + + VK+ DFG A + + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 61/256 (23%), Positives = 117/256 (45%), Gaps = 39/256 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVSNIIY--- 300
G +Y S+D W+ G ++ E++ G+ F + D L ++I I
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 301 ----AKTIYQGLFCSN 312
A ++ + +
Sbjct: 242 LSVKAASVLKSFLNKD 257
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 34/243 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F KD L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEY 156
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +++ DFG AK + + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------AKTIY 305
Y ++D W+ G ++ E+ G P F + Q+ E I + + K +
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 306 QGL 308
+ L
Sbjct: 270 RNL 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 46/286 (16%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
M + + R D +++ + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD--------- 51
Query: 64 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----- 118
P++ + R +G GSFG V+ A+ + E VAIKK+ + N
Sbjct: 52 ---------PEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 119 --RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
+E++ ++ + HPN I + C+ + + LVMEY + +L+ + + +
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQ 152
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE 234
+ + T+ +GLAY+H+ + HRDVK N+L L+ VKL DFGSA ++
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPAN 208
Query: 235 ANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQP 278
S++ + Y+ APE+I E Y +D+WS G EL +P
Sbjct: 209 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 46/225 (20%), Positives = 88/225 (39%), Gaps = 25/225 (11%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
G V A+ TGE V ++++ + EL + +L +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ +EL+ +V ++ + ++ + M + + + + L YIH +
Sbjct: 96 I---ADNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA--------KVLVKGEANISYICSRYYRAPEL 250
G HR VK ++L+ + +V L S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 251 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ +L+L V +Y +++ L Y+ ++ + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV + D G A I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 60/256 (23%), Positives = 117/256 (45%), Gaps = 39/256 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVSNIIY--- 300
G +Y S+D W+ G ++ E++ G+ F + D L ++I I
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 301 ----AKTIYQGLFCSN 312
A ++ + +
Sbjct: 285 LSVKAASVLKSFLNKD 300
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 131 NVISLKHCFFSTTSKDELFLN-LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++ + F T + + +VMEYV +++ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
L+Y+H++ G+ + D+KP+N+++ Q+KL D G+ + + ++AP
Sbjct: 193 PALSYLHSI-GLVYNDLKPENIMLTE--EQLKLIDLGAVSRI--NSFG-YLYGTPGFQAP 246
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E++ T + DI++ G LA L L P G
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDH 129
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
P ++++ + T + +VMEYV T L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIA 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----IC 241
+ L + H G+ HRDVKP N+++ T+ VK+ DFG A+ + +++ I
Sbjct: 124 DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 182 TAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 39/241 (16%)
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 113
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 114 ---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYS 169
+R++ RE+ + H N++S+ +D+ + LVMEY+ T L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPT----LSEYI 102
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229
+ + + +T QI G+ + H + + HRD+KPQN+L+D +K+ DFG AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160
Query: 230 LVKGEANISY----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
L E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE A
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETA 217
Query: 286 V 286
V
Sbjct: 218 V 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 61/240 (25%), Positives = 117/240 (48%), Gaps = 31/240 (12%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHP 130
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++L + F ++ +L L +++Y+ E + S +R V++Y +I
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIV 169
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-IC-SRYYR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 247 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305
AP+++ G + ++D WS G ++ ELL G F + + EI + I+ ++ Y
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSEPPY 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 46/228 (20%), Positives = 89/228 (39%), Gaps = 41/228 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 136 K-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
C S L + + T+Y V++ + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--------Y 245
+H G+ H+D+K +N+ D +V + DFG + G + +
Sbjct: 146 LHA-KGILHKDLKSKNVFYD--NGKVVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200
Query: 246 RAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENA 285
APE+I + ++ D+++ G + EL + F + A
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 39/239 (16%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNV 132
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 133 IS-LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFR 189
+ + T+ +L+L + + + ++ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 190 GLAYIHT---------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
GLAY+H P + HRD+K +N+L+ + DFG A EA S
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKF---EAGKSAG 188
Query: 241 CSRY------YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
+ Y APE++ GA + ID+++ G VL EL G L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+PN+++ + DEL+ +VMEY+ + + M++ +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCR 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
+ + L ++H+ V HRD+K N+L+ + VKL DFG A I+ S+
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRS 174
Query: 244 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
Y+ APE++ Y +DIWS G + E++ G+P
Sbjct: 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-LMDHPNVIS 134
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 135 LKHCFF---STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
F D+L+ LVME+ + + K + ++ +I
Sbjct: 86 YYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSR 243
RGL+++H V HRD+K QN+L LT +VKL DFG + L G N ++I +
Sbjct: 139 LRGLSHLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 193
Query: 244 YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQP 278
Y+ APE+I Y D+WS G E+ G P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ +L+ ++MEY+ L +++ + +I +GL Y
Sbjct: 84 KYYGSYL---KDTKLW--IIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDY 134
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYYRAPELI 251
+H+ HRD+K N+L+ +VKL DFG A L + + N +++ + ++ APE+I
Sbjct: 135 LHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEVI 191
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQP 278
+ Y + DIWS G EL G+P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 28/220 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRLMDHP 130
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+V+ + D L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYY 245
L H G HRDVKP+N+LV L DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
APE + T DI++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 137 HCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+F +L+ +VMEY V + + N+ + + +GL
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTLKGL 138
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSRYYRA 247
Y+H + HRD+K N+L L KL DFG A L + N + I + ++ A
Sbjct: 139 EYLHFM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMA 193
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
PE+I Y DIWS G E+ G+P
Sbjct: 194 PEVIQEI-GYNCVADIWSLGITAIEMAEGKP 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
H NV+ + + +EL++ +ME++ + ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR 243
+ + LAY+H GV HRD+K ++L+ L +VKL DFG A++ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
Y+ APE+I + Y T +DIWS G ++ E++ G+P
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 71/282 (25%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLM-----DHP 130
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 131 N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N V+ L F + + + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLV----------------------------------- 212
+GL Y+HT + H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 213 -------------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ +VK+ D G+A + + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 260 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKV 295
DIWS C+ EL G LF + D + II++
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 134
+ +G G+FG V++AK ETG A K + ++ E++++ DHP ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 135 LKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
L ++ +L+ +++E+ V M +++ + +++ Q+
Sbjct: 81 LLGAYY---HDGKLW--IMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQMLE 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYR 246
L ++H+ + HRD+K N+L +T ++L DFG SAK L + S+I + Y+
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 247 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQP 278
APE++ T Y DIWS G L E+ +P
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 38/232 (16%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHC 138
++G G +G V++ VA+K +R+ E + R+ M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T+ + LVMEY P ++ + L ++ L + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129
Query: 197 --------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---------ANISY 239
P + HRD+ +N+LV + DFG + L A IS
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 240 ICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGEN 284
+ + Y APE++ GA +D+++ G + E+ + LFPGE+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I K C L LVMEYVP L+ Y + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+H + HRD+ +N+L+D VK+ DFG AK + +G YYR
Sbjct: 149 YLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + + + D+WS G L ELL +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ K S L L+MEY+P Y L+ Y +R+ I + YT QI +G+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + +++
Sbjct: 128 EYLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 46/231 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 133 ISLKH-CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIF 188
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+ + + HRD+ +N ++ V + DFG ++ + G+ YY
Sbjct: 148 CGMEYLSSRNFI----HRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YY 193
Query: 246 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R A E L YT D+W+ G + E++ GQ + G
Sbjct: 194 RQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 29/219 (13%), Positives = 44/219 (20%), Gaps = 48/219 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNR---ELQLMRLMDHPN 131
Y G +QA VA+ V + +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V + L +V E++ ++ V + +
Sbjct: 93 VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
H GV P + V V L
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
DI G L LL+ + P L
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 47/230 (20%), Positives = 87/230 (37%), Gaps = 45/230 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 190 GLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+ + + HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 159 GMEYLSNRNFL----HRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYR 204
Query: 247 ------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 38/214 (17%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRLMDHPNVI 133
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + YY+
Sbjct: 160 YLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------YYKVKEPGE 209
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 210 SPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGL 191
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + + YY
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + + + D+WS G L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 52/238 (21%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 59/252 (23%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPL 177
N+++L T ++ EY + + + L
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 178 IYVKLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDS- 199
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y APE IF YT D+WS G L EL LG +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 283 ENAVDQLVEIIK 294
+ ++IK
Sbjct: 251 MPVDSKFYKMIK 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ + + + L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ VK+ DFG AK+L + YY
Sbjct: 141 EYLGSRRCV-HRDLAARNILVES-EAHVKIADFGLAKLLPLDKD--------YYVVREPG 190
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++ D+WS G VL EL
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
HR++ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ ++ D+W+ G +L E+ G +PG
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 57/225 (25%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISL- 135
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSM--NQRMPLIYVKLYTYQIF 188
C ++E+ L + +Y+ +Y SM QR+ +I
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EIC 145
Query: 189 ----RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
RGL Y+HT + HRDVK N+L+D K+ DFG +K + + +++ +
Sbjct: 146 IGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQ--THLSTVV 201
Query: 245 -----YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 278
Y P EY T D++S G VL E+L +
Sbjct: 202 KGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRLMDHPN 131
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ + + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADEN--------YYKAQTHG 180
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 124
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-- 182
R ++HPNV++L E ++++ Y+ + L + + + L
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQF-IRSPQRNPTVKDLIS 128
Query: 183 YTYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ Q+ RG+ Y+ V HRD+ +N ++D + VK+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV----HRDLAARNCMLDE-SFTVKVADFGLARDILDRE----- 178
Query: 240 ICSRYYR--------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ----YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 41/221 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLAYIH 195
++ + +VME V + + L G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
+ + HRD+ +N LV + +K+ DFG ++ G Y
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGV---------YAASGGLRQVPV 279
Query: 247 ---APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L +G Y++ D+WS G +L E LG +P
Sbjct: 280 KWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV-HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAEGGK 180
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N ++D VK+ DFG A+ + E YY
Sbjct: 142 KYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKT 190
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 191 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 83 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHPN 131
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP---- 202
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 286 VDQLVEIIK 294
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE- 249
HRD+ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L + +++ D+W+ G +L E+ G +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 132
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ L L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ G+ HR++ +N+L+ QV++ DFG A +L +
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDK--------QLLYSEAK 178
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 179 TPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 63/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+V+G+G+FG V A VA+K + +R EL++M +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP------------------ETMYRVLKHYSSMN 172
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L + L + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 276
+ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 56/246 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKL-- 182
+ L S+ + L ++ME + LK Y ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMT---RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
+I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 143 MAGEIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD-------- 192
Query: 243 RYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
YYR +PE L G +TT D+WS G VL E+ L + + G + +Q
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQ 248
Query: 289 LVEIIK 294
++ +
Sbjct: 249 VLRFVM 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ +++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV T K+ DFG A+++ E Y
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +G +T D+WS G +L E++ G+ +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 62/296 (20%), Positives = 111/296 (37%), Gaps = 49/296 (16%)
Query: 12 PPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNG 71
P P P + ++D + S + + + + + K
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL 330
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLM 124
K+ +A+ +G G+FG V Q + VAIK + Q + E Q+M
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLY 183
+D+P ++ L + L LVME L + + +P+ V
Sbjct: 391 HQLDNPYIVRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAEL 441
Query: 184 TYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+Q+ G+ Y+ + V HR++ +N+L+ H K+ DFG +K L ++
Sbjct: 442 LHQVSMGMKYLEEKNFV----HRNLAARNVLLVN-RHYAKISDFGLSKALGADDS----- 491
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY APE + F ++++ D+WS G + E L GQ +
Sbjct: 492 ---YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+ +K+ ++ ++ E++ L + ++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV + K+ DFG A+V+ E Y
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + FG +T D+WS G +L E++ G+ +PG
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 117
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 118 N---RELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPET 160
EL+ + + + I + T K + +VME
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER---- 133
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQV 219
+ L+ S N V ++ L YIH H D+K NLL+ QV
Sbjct: 134 LGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSAG 267
L D+G + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 268 CVLAELLLGQ 277
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 60/252 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A G+ VA+K + ++ EL++M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY------------SSMNQRMPLI 178
N+++L T + ++ EY Y L ++ +
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCC---YGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 179 YVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
L ++ Q+ +G+A++ + HRDV +N+L+ H K+ DFG A+ ++
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDS-- 218
Query: 237 ISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPG 269
Query: 283 ENAVDQLVEIIK 294
+ +++K
Sbjct: 270 ILVNSKFYKLVK 281
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G GSFG++F+ L + VAIK + E + + L + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ ++ L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 205
Query: 192 AY---IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
+ V HRD+ +N ++D VK+ DFG A+ + E + +
Sbjct: 206 KFLASKKFV----HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFD------SVHNKT 254
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 255 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 132
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L + L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L ++ YY
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 64/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-------------------ETMYRVLKHYSSMN 172
VI L + L L++EY +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L L + +QI +G+ Y+ + + HRD+ +N+LV ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 276
+ + Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 59/259 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 123
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMN 172
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 173 QRMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ L ++ QI G+ Y+ + HRD+ +N LV VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 231 VKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 276
+ YYR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 277 -QPLFPGENAVDQLVEIIK 294
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 52/231 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRLMDHP 130
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 131 NVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIF 188
+++ C DE L V E+V + L Y + +++ Q+
Sbjct: 73 HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ-------VKLCDFGSAKVLVKGEANIS 238
+ ++ + H +V +N+L+ + +KL D G + ++ +
Sbjct: 124 AAMHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 239 YICSRYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ PE I + D WS G L E+ G
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 554
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ + ++ME P Y L HY + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 193 YI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--- 246
Y+ + V HRD+ +N+LV VKL DFG ++ + + YY+
Sbjct: 128 YLESINCV----HRDIAVRNILVAS-PECVKLGDFGLSRYIEDED---------YYKASV 173
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 174 TRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 44/223 (19%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMR-LMDHPNVISL 135
+ + +G G+FG + K L T E VAIK + + E + + L + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +V+E + ++ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ + +RDVKP+N L+ + + + DF AK YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L +K + + +V EY+ L + + + +I + I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+L++ K+ DFG +VL Y
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 213 PIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ L + +V EY+ L + + + + ++ + + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+LVD K+ DFG ++VL E + Y
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVL---EDDPDA----AYTTTGGKI 216
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 217 PIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L T L+ +++EY + + + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 257
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + +++E + LK + +Q L + L
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 185 YQIFRGLAY---IHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 188 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-15
Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 57/239 (23%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYV 180
V+ L +KD+ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 181 KL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
QI G+ Y+ + V H+D+ +N+LV VK+ D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 239 YICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
YY+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ + LV E++ + L+ + L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
V HRD+ +N LV +K+ DFG + ++ + Y
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWA 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE F Y++ D+WS G ++ E+ G+ +
Sbjct: 173 SPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 56/249 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
Q+ G+ Y+ + HRD+ +N LV VK+ DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 285
YYR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 286 VDQLVEIIK 294
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + ++ME + LK + +Q L + L
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 185 YQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y+ H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 147 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 198 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ SK+ +V EY+ L +Y S + + + Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LVD VK+ DFG + ++ + Y
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWS 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 173 APEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 56/240 (23%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 211
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 82 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRG 190
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +NLL+ VK+ DFG + L + + +Y
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQND--------DHYVMQEH 183
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L ++ + D W G L E+ GQ + G
Sbjct: 184 RKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 68/268 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYS 169
LM D+PN++ L + + L+ EY+ P T+ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 170 SMNQRMPLIYVKLYT--------YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221
S R+ + Q+ G+AY+ HRD+ +N LV VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 222 CDFGSAKVLVKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGC 268
DFG ++ + + YY+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 269 VLAELL-LG-QPLFPGENAVDQLVEIIK 294
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 1e-14
Identities = 43/247 (17%), Positives = 66/247 (26%), Gaps = 70/247 (28%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 123
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 124 MRLMDHPNVISLKHCFF---------------------------STTSKDELFLNLVMEY 156
I L D+LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216
+ ++ SS+ K +Q+ LA HRD+ N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 276
KL + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 277 QPLFPGE 283
+ LF G+
Sbjct: 246 EDLFTGD 252
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
I L SK + + ++ EY+ L + + ++ + I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N+LV+ K+ DFG ++VL Y
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAT------YTTSGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 213 PIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G+GSFG ++ + GE VAIK ++ E ++ + + + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C + + +VME + ++ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ HRDVKP N L+ + V + DFG AK Y +R YR
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ S G VL LG
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 46/220 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMN--QRMPLIYVKLYTYQIF- 188
T + L LV Y+ + + ++ +R +I
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIAL 138
Query: 189 ---RGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 243
RGLAY+H P + HRDVK N+L+D + + DFG AK++ + +++ +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTA 194
Query: 244 Y-----YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 42/252 (16%), Positives = 80/252 (31%), Gaps = 50/252 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 109
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 110 VLQDRRYKNRELQLMRLMDHPNVISLK-----------HCFFSTTSKDELFLNLVMEYVP 158
+D R N + R V K C +D+ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-H 217
++ L + V ++ L ++H H +V +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWS 265
QV L +G A +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 266 AGCVLAELLLGQ 277
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + + LVM+ + ++ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ HRD+KP N L+ +QV + DFG AK Y + YR
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y S+ D+ S G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LV+ VK+ DFG ++ ++ E Y
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRWS 188
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
PE L++ ++++ DIW+ G ++ E+ LG+ +
Sbjct: 189 PPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 56/236 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSRG----------- 191
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 44/217 (20%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRLMDHPNVIS 134
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 135 LK-HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL-------IYVKLYTYQ 186
L + D+L L V Y+P +L S ++ PL I
Sbjct: 95 LLGFS----SDGDDLCL--VYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
G+ ++H HRD+K N+L+D K+ DFG A+ K + + SR
Sbjct: 142 AANGINFLHENH-HIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQ--TVMTSRIVG 197
Query: 244 -Y-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
Y APE + G E T DI+S G VL E++ G P
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 46/251 (18%), Positives = 77/251 (30%), Gaps = 50/251 (19%)
Query: 59 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 113
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 114 RRYKNRELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPE 159
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQ 218
+ K Y + +R V + +I L YIH H D+K NLL++ Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQ 192
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSA 266
V L D+G A + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 267 GCVLAELLLGQ 277
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 116 YKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 173
YK + + + D+ I LK S TS + +E + +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-DLY 186
Query: 174 RMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ L L Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 232 KGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
K Y APE IF YT D+WS G +L E+ LG
Sbjct: 245 KDP---------DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 279 LFPGENAVDQLVEIIK 294
+PG ++ +K
Sbjct: 295 PYPGVKIDEEFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 340 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.97 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.16 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-62 Score=427.90 Aligned_cols=245 Identities=27% Similarity=0.456 Sum_probs=204.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.++|||||+++++| .+...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4699999999999999999999999999999998643 12346899999999999999999999 55566
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCCce
Confidence 9999999996 77777654 3679999999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.++.+.. ...+..+
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~- 257 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKF- 257 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTC-
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccc-
Confidence 764332 23456899999999999654 48999999999999999999999999988887777777643 3333221
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCc------ccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHE------SKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~------i~~hpf 340 (340)
+.....+..-|+..+|.+|+|++| |++|||
T Consensus 258 -----s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 258 -----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred -----CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCC
Confidence 122344555666678889999998 588888
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=423.04 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=193.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|++++++++|||||+++++| .+...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 57999999999999999999999999999999986432 2346899999999999999999998 45556
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+|||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLSNI 161 (275)
T ss_dssp EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC--
T ss_pred EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCCee
Confidence 899999999998888765 4689999999999999999999999 79999999999999995 88899999999988
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
........+.+||+.|||||++.+..+++.++|||||||++|+|+||+.||.+.+..+.+..+.+ .....+..
T Consensus 162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-~~~~~p~~------ 234 (275)
T 3hyh_A 162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-GVYTLPKF------ 234 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCTT------
T ss_pred cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCCC------
Confidence 76666666789999999999997766567899999999999999999999998877666665554 33333222
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1223345566677778999999999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-62 Score=433.33 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=203.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|++++|||||+++++| .+..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence 4568999999999999999999999999999999986542 2345899999999999999999999 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|||||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla 172 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEE
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccc
Confidence 68999999985 77777754 224567999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+...... .....+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+..+.+.++.+....+....
T Consensus 173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~--- 248 (350)
T 4b9d_A 173 RVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH--- 248 (350)
T ss_dssp SCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT---
T ss_pred eeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc---
Confidence 8765432 2335679999999999966 4589999999999999999999999999998888888877544332222
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 249 ---~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 249 ---YSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 1223455666677778999999999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-61 Score=426.99 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=205.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...|++.++||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++|||||+++++|. +...+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 34699999999999999999999999999999998643 334578999999999999999999994 445589
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||||+| +|.+.+.+ .++++..++.|+.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|+..
T Consensus 148 ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceec
Confidence 99999996 56655543 579999999999999999999999 79999999999999995 889999999999877
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+...... ..+. +..
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~-~~~-- 295 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKN-LHK-- 295 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSC-GGG--
T ss_pred CCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCc-ccc--
Confidence 544 33456789999999999965 45899999999999999999999999998888877777654321 1111 111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 1222344566677778999999999999999
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-61 Score=436.82 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=205.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...|++.++||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|. +...+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEE
Confidence 35799999999999999999999999999999998643 334568999999999999999999994 444589
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||||+| +|.+.+.. .++++..++.|+.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|+..
T Consensus 225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceEC
Confidence 99999996 56655543 579999999999999999999999 79999999999999995 889999999999876
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... +..+. +..
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~-~~~-- 372 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN-LHK-- 372 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSC-TTS--
T ss_pred CCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcc-ccc--
Confidence 544 34456789999999999965 4589999999999999999999999999888887777765432 11111 111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|+|++|+++|||
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 1223345666677778999999999999999
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=411.74 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=202.6
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++.++||+|+||+||+|++..++..||+|++.... ..+.+|++++++++|||||+++++|.... .....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 23468999999999999999999885432 23456889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|||||++ +|.+.+.. ...+++..++.|+.||+.||+|||+ +| ||||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999996 67666654 3679999999999999999999999 68 999999999999985578999999999986
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.. .....+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+....+.+.+.....+... .. .
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~---~~-~ 254 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF---DK-V 254 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG---GG-C
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC---Cc-c
Confidence 43 334456789999999999854 48999999999999999999999998877767666666544333211 11 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1222445666778888999999999999999
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=425.48 Aligned_cols=258 Identities=33% Similarity=0.535 Sum_probs=212.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecC-CCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 149 (340)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||++++++.... ..+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 479999999999999999999999999999999975432 2347999999999999999999875432 134456
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|||||||+|+|.+.+.. .+.+++..++.+++||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceeee
Confidence 899999999988777653 5789999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccC-----CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 230 LVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 230 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+... ....+.+||+.|||||++.+..+|+.++|||||||++|||++|++||.+.+..+++..|.+....+....+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 6432 22345689999999999988777899999999999999999999999999999999999988776543221
Q ss_pred h-----------ccc-----------cc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 Y-----------QGL-----------FC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~-----------~~~-----------~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ..+ +. +.....+..-|+..+|.+|+|++|+++|||
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0 000 00 011223455677778999999999999999
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=414.76 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=200.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
...|.+.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.+++.++|||||+++++| .+...+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEe
Confidence 3568999999999999999999999999999999976543 35799999999999999999998 44556899999
Q ss_pred cccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +|||||||||+|||++.++..+||+|||+|+......
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9995 77777754 3679999999999999999999999 7999999999999999633479999999998765432
Q ss_pred cc------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 235 AN------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 235 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.. ...+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+.++..... + ...+...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~- 281 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-P-IREIPPS- 281 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-G-GGGSCTT-
T ss_pred cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-C-chhcCcc-
Confidence 21 234799999999999764 589999999999999999999999998877666776665322 1 1111111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcc-------------cccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHES-------------KLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i-------------~~hpf 340 (340)
++.....+.+-|+..+|.+|||++|+ +.|||
T Consensus 282 -~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 282 -CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred -CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 12234455666777889999999997 67898
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=410.82 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
++|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+++|++++|||||+++++| .+.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999974 46789999998643 23456799999999999999999999 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+|||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEeccccc
Confidence 568999999995 66666654 3679999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+..+.+.. ...+..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~-- 248 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQF-- 248 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTT--
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCc--
Confidence 9865433 334467899999999999664 58999999999999999999999999998888887777643 232222
Q ss_pred ccccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
.+.....+.+-|+..+|.+|||+ +|+++|||
T Consensus 249 ----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 249 ----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 12233455666677788899985 79999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-57 Score=395.61 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=182.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCC-------
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------- 144 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 144 (340)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+++|++++|||||+++++|.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999986432 234579999999999999999999865432
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
....++|+|||||.+ +|.+.+... ......++..++.++.||+.||+|||+ +|||||||||+|||++. ++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEcc
Confidence 234468999999986 566665431 111234566788999999999999999 79999999999999995 78899999
Q ss_pred eccccccccCCc-------------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 019506 224 FGSAKVLVKGEA-------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (340)
Q Consensus 224 fg~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (340)
||+|+....... ..+.+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+.. +...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 999987654322 223579999999999965 458999999999999999996 886543 2333
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+........+..+ ... ......+.+.|+..+|.+|||++|+++|||
T Consensus 236 ~~~~~~~~~~p~~~-~~~--~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 236 TLTDVRNLKFPPLF-TQK--YPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHHHHTTCCCHHH-HHH--CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhcCCCCCCC-ccc--CHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 33322222222111 100 111233566677778999999999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=393.18 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=198.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|.+.+.||+|+||+||+|++. .++..||||+++.. .+.+.+|+++|++++|||||++++++ .+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ee
Confidence 457999999999999999999875 35789999998653 23456899999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~ 216 (340)
...++||||||++ +|.+.+.... .....+++..+..|+.||+.||.|||+ ++||||||||+|||++. +
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-G
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-C
Confidence 4458899999995 7777776431 234579999999999999999999999 79999999999999995 8
Q ss_pred CcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 019506 217 HQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (340)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~ 292 (340)
+.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 89999999999876444322 234689999999999654 58999999999999999999 89999998887777777
Q ss_pred HHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 293 IKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
.+....+.+.. ++.....+...|+..+|.+|||++||.
T Consensus 244 ~~~~~~~~p~~------~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 244 TQGRVLQRPRT------CPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HcCCCCCCCcc------chHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 66544333322 334455677778888899999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=400.63 Aligned_cols=211 Identities=27% Similarity=0.489 Sum_probs=174.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEeccccc--ChHHHHHHHHhC-CCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 147 (340)
...++|++.+.||+|+||+||+|+++ .+++.||+|.+..... ...+|+++|+.+ +|||||+++++| .+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EEC
Confidence 34567999999999999999999875 4678999998865432 345799999988 699999999999 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
.++|+|||||++ +|.+.+ +.+++.+++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 568999999985 555544 358999999999999999999999 79999999999999986558999999999
Q ss_pred ccccccCC-----------------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC
Q 019506 227 AKVLVKGE-----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (340)
Q Consensus 227 a~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 277 (340)
|+...+.. .....+||+.|+|||++.+...|+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 97653321 1223579999999999987777999999999999999999999
Q ss_pred CCCC-CCChHHHHHHHHHhcC
Q 019506 278 PLFP-GENAVDQLVEIIKVSN 297 (340)
Q Consensus 278 ~pf~-~~~~~~~~~~~~~~~~ 297 (340)
.||. +.++.+++.+|.+..+
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G 265 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRG 265 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHhcC
Confidence 9985 5566778888877554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=394.00 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=194.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|.+.++||+|+||+||+|++. .++..||||+++.. ...+.+|+++|++++|||||++++++ .+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 457999999999999999999875 36889999999743 23456899999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~ 214 (340)
...++||||||++ +|.+.+..... ...++++..+..|+.||+.||.|||+ ++||||||||+|||++.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 4558899999995 67666654221 23569999999999999999999999 79999999999999995
Q ss_pred CCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019506 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (340)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (340)
++.+||+|||+|+....... .....||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88999999999987644332 234578999999999965 458999999999999999999 899999988888777
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.+....+.+.. ++.....+...|+..+|.+|||++||..+
T Consensus 272 ~i~~g~~~~~p~~------~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRELERPRA------CPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCCCCCTT------CCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCccc------ccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7766544433322 33445667777888889999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=390.65 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=198.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..++++.++||+|+||+||+|++. .+++.||||+++... ..+.+|+.++++++|||||++++++ .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~ 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-----T 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----E
Confidence 346889999999999999999864 367899999986432 3456899999999999999999998 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill 212 (340)
+...++||||||++ +|.+.|.... .....+++..+..|+.||+.||+|||+ ++||||||||+|||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 44458899999995 7777775321 113468999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019506 213 DPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 288 (340)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 288 (340)
+. ++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+..+.
T Consensus 179 ~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 95 88999999999987644332 2345789999999999764 58999999999999999998 8999999888776
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+..+......+.+.+ +......+...|+..+|.+|||++||.++
T Consensus 257 ~~~i~~~~~~~~p~~------~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLPCPDD------CPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCccc------chHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666655433333222 33344566677788889999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=385.20 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=191.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+++.+.++||+|+||+||+|++. ..||||+++... ..+.+|++++++++|||||++++++. + .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~-~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----K-D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----C-C
Confidence 3457899999999999999999853 369999886322 33568999999999999999999762 1 1
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.++||||||++ +|.+.+.. ....+++..+..|+.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla 179 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLA 179 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSC
T ss_pred eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCc
Confidence 36899999995 66666543 34679999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCC---ccceeeeeccccCcccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-Cch
Q 019506 228 KVLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI-IYA 301 (340)
Q Consensus 228 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~ 301 (340)
+...... .....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..++..... +..
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL 259 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 8764322 23346799999999999642 35899999999999999999999999988877777777665432 222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+... ++.....+...|+..+|.+|||+.||.+
T Consensus 260 ~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 260 SKLYKN--CPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TTSCTT--SCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccccc--chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 222111 2233456677788888999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=413.85 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChH---HHHHHHHhCCCCceeecceeeee
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRLMDHPNVISLKHCFFS 141 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~---~E~~~l~~l~h~~iv~~~~~~~~ 141 (340)
.+...++|.+.++||+|+||+||+|+++.+|+.||||++.+.. .... +++.+++.++|||||+++++|
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-- 261 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-- 261 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--
Confidence 3456678999999999999999999999999999999996432 1112 235566778999999999999
Q ss_pred cCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.+...+|||||||.| +|...+.. .+.+++..++.|+.||+.||+|||+ +|||||||||+|||++. ++.+|
T Consensus 262 ---~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~vK 332 (689)
T 3v5w_A 262 ---HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVR 332 (689)
T ss_dssp ---ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCEE
T ss_pred ---EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCEE
Confidence 556679999999996 66666654 3679999999999999999999999 79999999999999995 88999
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCC
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVSNI 298 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~ 298 (340)
|+|||+|+...... ..+.+||+.|||||++.++..|+.++|||||||+||||++|.+||.+.+. ...+...+.....
T Consensus 333 L~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 333 ISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411 (689)
T ss_dssp ECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred ecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence 99999998765443 34578999999999997656699999999999999999999999976432 2233333333333
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
..+..+ +.....+..-++..+|.+|++ ++||++|||
T Consensus 412 ~~p~~~------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 412 ELPDSF------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CCCTTS------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred CCCccC------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 332221 112233444455556778887 699999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=412.20 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=208.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+.+.||+|+||+||+|+++.+|+.||+|++.... ....+|+++|+.++|||||+++++| .+...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999999999999999986532 3345799999999999999999999 5566699
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC-CCcEEEEeeccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~-~~~~kl~Dfg~a~~ 229 (340)
||||||+| +|.+.+. .....+++..++.+++||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999986 6665553 234679999999999999999999999 799999999999999853 37899999999998
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..........+||+.|||||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.... .....+..+
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~- 383 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFSGI- 383 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-CCSGGGTTS-
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-CCcccccCC-
Confidence 8777666778899999999999764 5899999999999999999999999999988888777664332 222222211
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+..-|+..+|.+|||++|+++|||
T Consensus 384 -s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 384 -SEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 122233445566678889999999999999
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=388.19 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEecccc-----cChHHHHHHHHhCCC-CceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMDH-PNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 143 (340)
..++|++++.||+|+||+||+|++..+ ++.||||.+.... +.+.+|+++|++++| ||||+++++|..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-- 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence 346899999999999999999998654 3689999886532 335679999999976 899999998843
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCe
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Ni 210 (340)
....++||||||++ +|.+.+..... ....+++..+..++.||+.||+|||+ ++||||||||+||
T Consensus 140 --~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 216 (353)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred --cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence 23347899999995 77777764322 13458999999999999999999999 7999999999999
Q ss_pred EecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChH
Q 019506 211 LVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (340)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 286 (340)
|++. ++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..
T Consensus 217 Ll~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9995 88999999999987644432 2245789999999999764 58999999999999999998 99999987766
Q ss_pred HHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 287 DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+.+.++++....+...+. ++.....+...|+..+|.+|||++||.+|
T Consensus 295 ~~~~~~i~~g~~~~~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 666666665544333221 23334556667777789999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=386.51 Aligned_cols=265 Identities=60% Similarity=1.024 Sum_probs=225.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCC-CCceeeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLV 153 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv 153 (340)
...+|.+.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++|+||++++++|+.... .+..++++|
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 3457999999999999999999999999999999998877777789999999999999999998865433 445678899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+++.....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 9999999888888776677889999999999999999999999 799999999999999965677999999999887666
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc-------
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ------- 306 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 306 (340)
.......||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++.++++..+.+....+..
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 6666678899999999997766799999999999999999999999999999999999998776665433211
Q ss_pred ------------cccc---cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 ------------GLFC---SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ------------~~~~---~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. ......+..-|+..+|.+||+++|++.|||
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 0011 112345566677778999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=382.58 Aligned_cols=265 Identities=45% Similarity=0.821 Sum_probs=225.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCC----------
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS---------- 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---------- 144 (340)
...+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+++++.++|+||++++++|.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3457999999999999999999999999999999998887777899999999999999999999865433
Q ss_pred -----------------------CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCce
Q 019506 145 -----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201 (340)
Q Consensus 145 -----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ii 201 (340)
.+..++++||||+++++.+.+..+...+..+++..++.++.||+.||.|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3455688999999999998888877778899999999999999999999999 7999
Q ss_pred ecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 019506 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (340)
Q Consensus 202 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 281 (340)
||||||+|||++..++.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999855789999999999987666666677889999999999776678999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCchhhhhcc-------------------cc---ccCChhhHhhhcccccccCCCCcCcccccC
Q 019506 282 GENAVDQLVEIIKVSNIIYAKTIYQG-------------------LF---CSNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
+.+..+++.++++..+.+....+... .+ .+.....+..-|+..+|.+|||++|++.||
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 99999999999988777654433211 01 111134566677777899999999999999
Q ss_pred C
Q 019506 340 F 340 (340)
Q Consensus 340 f 340 (340)
|
T Consensus 324 ~ 324 (383)
T 3eb0_A 324 F 324 (383)
T ss_dssp G
T ss_pred H
Confidence 8
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=373.08 Aligned_cols=251 Identities=19% Similarity=0.215 Sum_probs=183.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-Ch--HHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.++||+|+||+||+|++ +|+.||||++..... .. +.|+..+.+++|||||++++++..... ....+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence 3689999999999999999997 789999999865432 12 345556678899999999999865332 22357899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CceecCCCCCCeEecCCCCcEEEEee
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
||||++ +|.+.+.. ..+++..+..++.|++.||+|||+ + +||||||||+|||++. ++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence 999995 77776654 568999999999999999999997 5 8999999999999995 889999999
Q ss_pred ccccccccCCcc-----ceeeeeccccCcccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCC----------
Q 019506 225 GSAKVLVKGEAN-----ISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGEN---------- 284 (340)
Q Consensus 225 g~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~---------- 284 (340)
|+|+........ ...+||+.|||||++.+.. .++.++|||||||+||||+||..||....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999876544322 2357999999999996532 36779999999999999999987664221
Q ss_pred ----hHHHHHHHHHh-cCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 285 ----AVDQLVEIIKV-SNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 285 ----~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.+.+.+.. ...+..+..+...-+......+...|+..+|.+|||++||.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22333333322 222222222221111112344566677778999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=376.82 Aligned_cols=263 Identities=59% Similarity=0.982 Sum_probs=224.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCC-CCceeeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVM 154 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~ 154 (340)
..+|++.+.||+|+||+||+|++..++. ||+|++..+.....+|+++++.++|+||++++++|..... .+..++++||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4579999999999999999999876665 8999888777777789999999999999999999876544 5566788999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (340)
||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..++.+||+|||+++......
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 999999888887776677889999999999999999999999 7999999999999998558899999999998876666
Q ss_pred ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc-------
Q 019506 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG------- 307 (340)
Q Consensus 235 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 307 (340)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+++..+.+....+...
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH 276 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 6667788999999999977667999999999999999999999999999999999999988776654322110
Q ss_pred ------------cc---ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 ------------LF---CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ------------~~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+ .+.....+..-|+..+|.+|||++|++.|||
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00 1112335566677778999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=363.74 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=207.4
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...++|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++++.++||||+++++++ ...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 345689999999999999999999999999999999865432 234799999999999999999998 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ ++.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEeeccC
Confidence 568999999975 67666654 3679999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+..... ..+..
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~--- 236 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFY--- 236 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTT---
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCC---
Confidence 98876666666678999999999998766556899999999999999999999999887776666665332 22111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+.+.|+..+|.+|||++|+++|||
T Consensus 237 ---~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 237 ---MSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp ---SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred ---CCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 2223345566677778999999999999999
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=376.54 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=206.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999986532 233479999999999999999999854332 2335
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+|+||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC-
T ss_pred eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEeee
Confidence 678999999998776663 358999999999999999999999 79999999999999995 8889999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc--
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ-- 306 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 306 (340)
...........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+++.++++..+.+....+-.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 87666556667899999999999765 589999999999999999999999999999999999998877664432210
Q ss_pred --------c----------------ccc---------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 --------G----------------LFC---------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 --------~----------------~~~---------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. ++. +.....+.+-|+..+|.+|||++|+++|||
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0 000 011234566677778999999999999999
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=370.29 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=190.7
Q ss_pred cccCeeEe-eeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHH-HhCCCCceeecceeeeecCCCCceeeee
Q 019506 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 75 ~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..++|.+. +.||+|+||+||+|++..+|+.||||++... ....+|+.++ +..+|+||++++++|.... .+..++|+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 34568776 7899999999999999999999999988643 3456788876 5668999999999884321 23556899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~a~~ 229 (340)
||||+++ +|.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999985 77776653 123469999999999999999999999 799999999999999853 57899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD---QLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 306 (340)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+...+...........+.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 765555556788999999999954 458999999999999999999999998765322 1222333333222211111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 293 ~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 293 E--VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp T--SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred c--CCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 1 1223445666677778999999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=368.03 Aligned_cols=255 Identities=29% Similarity=0.564 Sum_probs=201.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC-CCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. |+||+++++++.. .+..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCC
Confidence 357999999999999999999999999999999885432 22347899999997 9999999999854 2334
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+|+||||+++++...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCcccc
Confidence 5889999999988877764 578999999999999999999999 79999999999999995 8899999999997
Q ss_pred ccccC----------------------CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 019506 229 VLVKG----------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (340)
Q Consensus 229 ~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (340)
..... ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 11234578999999999977667899999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCchhhhhcc-------------------------c---------------cccCChhhHhhhcccccc
Q 019506 287 DQLVEIIKVSNIIYAKTIYQG-------------------------L---------------FCSNNHEIMCELGSWYSY 326 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~-------------------------~---------------~~~~~~~~~~~l~~~~~~ 326 (340)
+++..++...+.+....+..- . -++.....+.+-|+..+|
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 999999987776654332110 0 112223456666777789
Q ss_pred cCCCCcCcccccCC
Q 019506 327 SGRNSMHESKLYGF 340 (340)
Q Consensus 327 ~~R~~~~~i~~hpf 340 (340)
.+|||++|+++|||
T Consensus 318 ~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 318 NKRISANDALKHPF 331 (388)
T ss_dssp GGSCCHHHHTTSTT
T ss_pred ccCCCHHHHhCCHH
Confidence 99999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=355.98 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=212.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCC---CCceeecceeeeecC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMD---HPNVISLKHCFFSTT 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~ 143 (340)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 457999999999999999999999999999999986332 23456777777664 999999999997765
Q ss_pred CCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
......+++||||+++++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEee
Confidence 5556678999999999888877642 22449999999999999999999999 79999999999999995 78999999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+.++.+....+....
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776666666678899999999997644 89999999999999999999999999999999999888766554333
Q ss_pred hhcccc--------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLF--------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~--------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+..... .+.....+..-|+..+|.+|||++|+++|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 211110 0111234566677778999999999999999
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=359.52 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=206.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
..+.|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.++||||++++++|
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----- 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----- 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence 3457999999999999999999999999999999987542 2246899999999999999999998
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC---cEE
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVK 220 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~---~~k 220 (340)
.+...+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence 445568999999975 66665543 4679999999999999999999999 79999999999999985332 799
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.. ..+
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~ 237 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS-YDF 237 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-CCC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC
Confidence 999999988766655566789999999999965 458999999999999999999999999988877776665533 333
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+..+ +.....+..-|+..+|.+|||++|+++|||
T Consensus 238 ~~~~~~~~--s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 238 DEEFFSQT--SELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CHHHHTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CchhccCC--CHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 33322221 222345566677778999999999999999
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=353.44 Aligned_cols=255 Identities=32% Similarity=0.556 Sum_probs=205.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+|+++++.++||||+++++++ .+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 3457999999999999999999985 58999999986432 2345799999999999999999998 4555
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCce
Confidence 6899999999988877754 24569999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc-
Q 019506 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ- 306 (340)
Q Consensus 229 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (340)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+....+-.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 764332 233457899999999997766789999999999999999999999999888888888887666544322110
Q ss_pred -----------cccc-----------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 -----------GLFC-----------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 -----------~~~~-----------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. ......+...|+..+|.+|||++|+++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000 011224566677778999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=373.52 Aligned_cols=259 Identities=30% Similarity=0.475 Sum_probs=195.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++|+||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 457999999999999999999999999999999986532 23457999999999999999999986654445566
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+||||+++++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCBC
T ss_pred EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccchh
Confidence 899999999988877753 4679999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCC----------------------------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh------
Q 019506 230 LVKGE----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------ 275 (340)
Q Consensus 230 ~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt------ 275 (340)
..... .....+||+.|+|||++.....|+.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 64221 22345779999999987666679999999999999999999
Q ss_pred -----CCCCCCCCC--------------------hHHHHHHHHHhcCCCchhhhhc-----------c-----------c
Q 019506 276 -----GQPLFPGEN--------------------AVDQLVEIIKVSNIIYAKTIYQ-----------G-----------L 308 (340)
Q Consensus 276 -----g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~-----------~-----------~ 308 (340)
|+++|.+.+ ..+++..+.+..+.+....+.. . .
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 778887654 3567777777766665432211 0 0
Q ss_pred cc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+. +.....+.+-|+..+|.+|||++|+++|||
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 00 112334566677778999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=349.66 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=206.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 47999999999999999999999999999999986432 22347999999999999999999984 44558
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence 89999999987777654 34679999999999999999999999 79999999999999995 888999999999876
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+....+....+-...
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4332 233457799999999997766689999999999999999988766 66777777788887766554432211000
Q ss_pred --------------------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 --------------------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 --------------------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 0 0111235666777778999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=362.91 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=201.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|.+.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.++||||+++++++ ...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 345799999999999999999999999999999998643 22356899999999999999999998 444
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..+++||||++|++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG~s 155 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGLS 155 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSSCT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEeccc
Confidence 45889999999998887765 3679999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.. .....+.
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~-~~~~~p~----- 229 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS-CVYVMPD----- 229 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS-SCCCCCT-----
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCcc-----
Confidence 8876666666778999999999997766458899999999999999999999987654322211111 0101110
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.....+.+.|+..+|.+|||++|+++|||
T Consensus 230 -~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 230 -FLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 11222345566677778999999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=353.04 Aligned_cols=257 Identities=31% Similarity=0.481 Sum_probs=196.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 47999999999999999999999999999999986432 2345799999999999999999998 4455688
Q ss_pred eeeccccchHHHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 152 LVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+||||++++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCcccee
Confidence 9999999998888765432 23468999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
..... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+....+
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 64332 2334578999999999976666899999999999999999999999999988888888876554321110
Q ss_pred --------------------hccc---cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 --------------------YQGL---FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 --------------------~~~~---~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+... ..+.....+...|+..+|.+|||++|+++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 0000 01112334566677778999999999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=364.35 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=199.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|.+.++||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||++++++| .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 456899999999999999999999999999999998642 23456899999999999999999998 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+||||+++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccce
Confidence 668999999975 66666543 468999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc---CC
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS---NI 298 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~ 298 (340)
|+....... ....+||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.+..+.+.++++.. ..
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence 987654432 23567999999999996543 27889999999999999999999999998888888887542 22
Q ss_pred CchhhhhccccccCChhhHhhhcccccccC--CCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSG--RNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--R~~~~~i~~hpf 340 (340)
+.... +...-.+.+..++ ..++.+ |++++||++|||
T Consensus 295 p~~~~-----~s~~~~~li~~lL-~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 295 PDDND-----ISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CTTCC-----CCHHHHHHHHHHS-SCGGGCTTSSCHHHHHTSGG
T ss_pred CCccc-----ccHHHHHHHHHHc-cChhhhCCCCCHHHHhcCcc
Confidence 21111 1111223333333 345666 999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=358.36 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=196.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|.++++.+ +||||+++++++ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 3467999999999999999999999999999999987532 2234688899887 699999999998 45
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DFG 169 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFG 169 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEcccc
Confidence 5568999999986 66666654 3679999999999999999999999 79999999999999995 7889999999
Q ss_pred ccccccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+|+.... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.... ...+..
T Consensus 170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~- 246 (353)
T 3txo_A 170 MCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTW- 246 (353)
T ss_dssp TCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTT-
T ss_pred ceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCC-
Confidence 9986432 3334456799999999999654 48999999999999999999999999988877777776643 222221
Q ss_pred hccccccCChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|+++ +||++|||
T Consensus 247 -----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 247 -----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred -----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 11223344555566678899999 89999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=352.40 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=200.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+++++.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 457999999999999999999999999999999986531 2345799999999999999999998 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccch
Confidence 68999999986 66665543 3678999999999999999999999 79999999999999995 789999999999
Q ss_pred cccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+... ....+..
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~--- 227 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRT--- 227 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT---
T ss_pred hhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCC---
Confidence 8643 2334456789999999999965 45899999999999999999999999988876666666553 2222211
Q ss_pred cccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|| +++||++|||
T Consensus 228 ---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 122234455556666788998 8999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=347.13 Aligned_cols=253 Identities=28% Similarity=0.520 Sum_probs=202.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+|+++++.++||||+++++++. +....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 4799999999999999999998 679999999986432 23457999999999999999999984 34458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence 89999999988877753 23678999999999999999999999 79999999999999995 889999999999875
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc---
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ--- 306 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 306 (340)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+....+-.
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 4322 223456799999999997666689999999999999999999999999998888888887655443221100
Q ss_pred -----------------cccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 -----------------GLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 -----------------~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... +.....+...|+..+|.+|||++|+++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 111224666677788999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=365.32 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=199.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.++||+|+||+||+|++..+++.||+|++.+. .....+|..+++.++||||++++++| .+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence 346899999999999999999999999999999998642 23357899999999999999999998 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhh
Confidence 568999999975 66666653 24679999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc--ceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CC
Q 019506 227 AKVLVKGEAN--ISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN-II 299 (340)
Q Consensus 227 a~~~~~~~~~--~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~ 299 (340)
|+........ ...+||+.|+|||++. +...++.++|||||||++|||++|+.||.+.+..+.+.+++.... ..
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence 9776444332 2357899999999996 244589999999999999999999999999998888888765321 11
Q ss_pred chhhhhccccccCChhhHhhhcccccccC--CCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSG--RNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--R~~~~~i~~hpf 340 (340)
.+.. +.. +...-.+.+..++ ..++.+ |++++|+++|||
T Consensus 302 ~p~~-~~~-~s~~~~dLi~~lL-~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 302 FPTQ-VTD-VSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp CCSS-CCC-SCHHHHHHHHTTS-SCGGGCTTTTTTHHHHTSGG
T ss_pred CCcc-ccc-CCHHHHHHHHHHh-cccccccCCCCHHHHhCCCc
Confidence 1111 000 1111122222222 224455 999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=352.48 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=204.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+++++.++|+||+++++++ .+....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 479999999999999999999999999999998864322 234699999999999999999998 3444588
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence 99999999888877642 4568999999999999999999999 79999999999999995 7889999999997654
Q ss_pred cCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+....+ ...+.
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~ 230 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILS 230 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTGGG
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc-hhhhc
Confidence 3322 234567999999999977667899999999999999999999999999999999998887766543322 11111
Q ss_pred ------------------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 ------------------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ------------------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+..-|+..+|.+|||++|+++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 111235666677778999999999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=357.29 Aligned_cols=264 Identities=40% Similarity=0.730 Sum_probs=208.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC---hHHHHHHHHhCCCCceeecceeeeecCC--CCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRLMDHPNVISLKHCFFSTTS--KDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~ 150 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++..+... ..++++.++.++||||++++++|..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 45799999999999999999999999999999988655433 3356666788899999999999866433 344567
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
++||||+++++...+.........+++..++.++.|++.||.||| + +||+||||||+|||++..++.+||+|||++.
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 899999999988888776667788999999999999999999999 8 7999999999999998557899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh---
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY--- 305 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 305 (340)
............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+....+....+-
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 87666666667789999999999776668999999999999999999999999999989998888866555332110
Q ss_pred ----------------cccc------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ----------------QGLF------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ----------------~~~~------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+ .+.....+...|+..+|.+|||++|+++|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0000 0112345667777788999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=353.73 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=204.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+++++.++||||+++++++. +..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence 4457999999999999999999999999999999986432 23458999999999999999999984 445
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC----CCCcEEEEee
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDF 224 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----~~~~~kl~Df 224 (340)
.+++||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 5889999999988887765 4569999999999999999999999 79999999999999952 2456999999
Q ss_pred ccccccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 225 GSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 225 g~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
|++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+....+....
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 999876433 2233456799999999997766689999999999999999999999999999999988888765544322
Q ss_pred hhcc--------c---------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQG--------L---------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~--------~---------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+-.. . ..+.....+.+.|+..+|.+|||++|+++|||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 1000 0 01122335666677788999999999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=351.33 Aligned_cols=252 Identities=20% Similarity=0.313 Sum_probs=206.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++. +...+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEE
Confidence 457999999999999999999999999999999886442 23457999999999999999999984 4445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC-CCcEEEEeecccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 230 (340)
||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999986 66665532 23579999999999999999999999 799999999999999853 578999999999887
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..... ....+.. .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~--~ 230 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKE--I 230 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-CHHHHTT--S
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC-Chhhhcc--C
Confidence 666666667889999999999654 47999999999999999999999999988877777776644332 2222221 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+.+.|+..+|.+|||++|+++|||
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 223345566677778999999999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.01 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=198.1
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 145 (340)
....+|++.++||+|+||+||+|+++.+++.||+|++++.. ....+|..+++++ +||||++++++| .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 34568999999999999999999999999999999987542 2235788888766 899999999998 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+...+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEEeec
Confidence 55568999999986 66655554 3679999999999999999999999 79999999999999995 888999999
Q ss_pred cccccc-ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHh
Q 019506 225 GSAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------NAVDQLVEIIKV 295 (340)
Q Consensus 225 g~a~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~~~~~ 295 (340)
|+|+.. .........+||+.|+|||++.+. .++.++|||||||++|||++|+.||... +..+.+.+.+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999863 334445567899999999999664 5899999999999999999999999642 223444444444
Q ss_pred cCCCchhhhhccccccCChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 296 SNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
.....+..+ +.....+..-|+..+|.+|+++ +||++|||
T Consensus 277 ~~~~~p~~~------s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 277 KQIRIPRSL------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp CCCCCCTTS------CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred cccCCCCcC------CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 444333221 1223445555666678899986 69999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=344.63 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 457999999999999999999999999999999986433 234579999999999999999999843 34588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCceec
Confidence 99999975 66666543 468999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+........... --
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~ 241 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EK 241 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG----GG
T ss_pred CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc----cc
Confidence 54433 3345789999999999664 489999999999999999999999999888777777766543322110 01
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 1222345666777778999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=360.74 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=198.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|..++..++|+||++++++| .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 456899999999999999999999999999999998642 24456899999999999999999998 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+||||+++ +|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence 668999999974 777766542 3479999999999999999999999 79999999999999995 88899999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc--
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS-- 296 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 296 (340)
++....... ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+.++++..
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 987654432 223578999999999962 3458999999999999999999999999998888887777532
Q ss_pred -CCC--------chhhhhccccccCChhhHhhhcccccccCC---CCcCcccccCC
Q 019506 297 -NII--------YAKTIYQGLFCSNNHEIMCELGSWYSYSGR---NSMHESKLYGF 340 (340)
Q Consensus 297 -~~~--------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R---~~~~~i~~hpf 340 (340)
..+ ..+++++.|++ +|.+| ++++||+.|||
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~--------------~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC--------------PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS--------------CGGGCTTTTTHHHHHTSGG
T ss_pred cCCCccccCCCHHHHHHHHHHcC--------------ChhhcCCCCCHHHHhcCCC
Confidence 111 12334444443 34444 69999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=347.46 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=200.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+|++.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 457999999999999999999999999999999986431 2335789999999999999999998 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCcc
Confidence 68999999986 66666654 4679999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
+.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+.++.... ...+..
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~---- 225 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPF---- 225 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTT----
T ss_pred eecCC--ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCC----
Confidence 87533 2345678999999999965 458999999999999999999999999988877777777643 222111
Q ss_pred ccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+.....+..-++..+|.+|+ +++|+++|||
T Consensus 226 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 112233444555556788898 9999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=360.77 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=205.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++|+||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457999999999999999999999999999999986532 23457999999999999999999986543333356
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCccc
Confidence 899999999988877753 4679999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCCc-----------------------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-----------
Q 019506 230 LVKGEA-----------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL----------- 275 (340)
Q Consensus 230 ~~~~~~-----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt----------- 275 (340)
...... ....+||+.|+|||++.....++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 644321 2456789999999997666779999999999999999998
Q ss_pred CCCCCCCCC-----------------hHHHHHHHHHhcCCCchhhhhc-----------ccc-------------ccCCh
Q 019506 276 GQPLFPGEN-----------------AVDQLVEIIKVSNIIYAKTIYQ-----------GLF-------------CSNNH 314 (340)
Q Consensus 276 g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~-----------~~~-------------~~~~~ 314 (340)
|.++|.+.+ ..+++..+....+.+....+.. .+- .+...
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 455565543 3577777777777665432211 000 11123
Q ss_pred hhHhhhcccccccCCCCcCcccccCC
Q 019506 315 EIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 315 ~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.+-|+..+|.+|||++|+++|||
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChh
Confidence 34666777778999999999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=355.70 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=201.5
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+++++.++||||++++++| .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34568999999999999999999999999999999986432 2345799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEeccc
Confidence 5568999999986 55555543 5679999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~ 301 (340)
++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+ ....+...+.......+
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p 240 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC
Confidence 9988766666667889999999999964 2348999999999999999999999997533 33334444443333333
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCC-cCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNS-MHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~-~~~i~~hpf 340 (340)
..+ +.....+...|+..+|.+||+ ++++++|||
T Consensus 241 ~~~------s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 241 SAW------SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp TTS------CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred CcC------CHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 221 222344555666667889998 899999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=348.39 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=205.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 83 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----- 83 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 3457999999999999999999999999999999986532 2346899999999999999999998
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC----cE
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QV 219 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~----~~ 219 (340)
.+....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~~ 157 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPRI 157 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCCE
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCCE
Confidence 445568899999975 66665543 4679999999999999999999999 79999999999999985 44 79
Q ss_pred EEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 019506 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..... .
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~ 235 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-E 235 (326)
T ss_dssp EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-C
T ss_pred EEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-C
Confidence 9999999988765555556789999999999954 4589999999999999999999999998887777776665432 2
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 236 ~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 236 FEDEYFSN--TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp CCHHHHTT--SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred cCcccccc--CCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 22222211 1222345666677778999999999999999
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=350.90 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=199.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|.+.+.||+|+||+||+|+++.+|+.||||++.+.. .....|..+++.+ +||||+++++++ .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 3457999999999999999999999999999999986532 2234688888766 999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeECh
Confidence 5568999999985 66666654 3579999999999999999999999 79999999999999995 7889999999
Q ss_pred cccccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+++..... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+... ....+..
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~- 240 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRW- 240 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT-
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcc-
Confidence 99864332 334456889999999999664 4899999999999999999999999988877766666553 2222211
Q ss_pred hccccccCChhhHhhhcccccccCCCCcC-cccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMH-ESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~-~i~~hpf 340 (340)
.+.....+..-|+..+|.+||++. ||+.|||
T Consensus 241 -----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 241 -----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred -----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 122234455556666788999998 9999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=353.51 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=204.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 457999999999999999999999999999999986542 2345799999999999999999998 45556
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeecc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~ 226 (340)
.++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 8899999986 66655543 4678999999999999999999999 799999999999999853 24699999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... .......+.
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 255 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWD 255 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTGGG
T ss_pred ceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCccccc
Confidence 988765555556789999999999965 458999999999999999999999999888766666665543 222222111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|+..+|.+||+++|+++|||
T Consensus 256 ~--~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 256 T--VTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp G--SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred C--CCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 1 1223445666677778999999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=359.81 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=203.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+++++.++||||+++++++ .+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 3457999999999999999999999999999999986543 2345899999999999999999998 4555
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg 225 (340)
..++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 68899999986 66666654 4679999999999999999999999 79999999999999984 25689999999
Q ss_pred cccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...... .....
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~ 236 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPE 236 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCTTT
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCccc
Confidence 9987654432 235678999999999965 45899999999999999999999999988877777766654332 22211
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 237 ~~~--~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 237 WDT--VTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp TTT--SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ccc--CCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 111 1233455666777778999999999999999
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=348.08 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=197.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.++|+||+++++++ .+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 45799999999999999999999999999999988543 24457899999999999999999988 455568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeeccce
Confidence 899999986 443333 345679999999999999999999999 79999999999999995 78899999999976
Q ss_pred cccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.................. +.
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 232 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WK 232 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT--GG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc--cc
Confidence 54332 22345789999999999776656889999999999999999999998766543333333322211110 00
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .......+..-|+..+|.+|||++|+++|||
T Consensus 233 ~--~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 233 K--IDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp G--SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred c--CCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 0 1122334556667778999999999999999
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=350.41 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=206.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCC-----CCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----HPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~ 145 (340)
...++|++.++||+|+||+||+|++..+++.||||++.... ....+|+.+++.+. |+||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~---- 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY---- 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----
Confidence 34568999999999999999999999999999999986432 33456899999886 9999999999843
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-----------
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------- 214 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----------- 214 (340)
....++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 108 -~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 108 -YDHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred -CCeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchh
Confidence 4458899999988888887752 23468999999999999999999999 79999999999999973
Q ss_pred -------------CCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 019506 215 -------------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (340)
Q Consensus 215 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 281 (340)
.++.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCC
Confidence 267899999999986533 23356789999999999764 48999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCchhhhhccccc----------------------------------------cCChhhHhhhc
Q 019506 282 GENAVDQLVEIIKVSNIIYAKTIYQGLFC----------------------------------------SNNHEIMCELG 321 (340)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~ 321 (340)
+.+..+.+..+...........+ ..... ......+...|
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNML-YEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHH-HHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHhcCCCCHHHH-hhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 98888888777765544332111 10000 01112566677
Q ss_pred ccccccCCCCcCcccccCC
Q 019506 322 SWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 322 ~~~~~~~R~~~~~i~~hpf 340 (340)
+..+|.+|||++|+++|||
T Consensus 340 L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGG
T ss_pred hcCChhhCCCHHHHhcCcc
Confidence 7888999999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=351.62 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=212.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|++++++++||||+++++++...........+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 47999999999999999999999999999999986432 2345799999999999999999998654444445688
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+++++.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEecC
Confidence 9999999998887764 569999999999999999999999 79999999999999995 8889999999998764
Q ss_pred cCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 232 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 232 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+....+-..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 4322 234578999999999877667899999999999999999999999999988888888877666544322100
Q ss_pred ----------------------cc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 ----------------------LF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ----------------------~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00 0112345666677778999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=351.66 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=202.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc---------ccChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----- 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 345799999999999999999999999999999998532 233568999999999999999999984
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEE
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLC 222 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~ 222 (340)
+...+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.. ...+||+
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEe
Confidence 44558999999995 7766666554555678999999999999999999999 799999999999999752 2349999
Q ss_pred eeccccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 223 DFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 223 Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+.+..+.+.. ....
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~-~~~~ 252 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK-YKMN 252 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC-CCCC
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC-CCCC
Confidence 9999987654433 3345789999999999654 48999999999999999999999998753 34445554433 2222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 253 ~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 253 PRQWSH--ISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp HHHHTT--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccc--CCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 222211 1223445666777778999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=354.02 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=194.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-------hHHHHHH-HHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|++.+.||+|+||+||+|+++.+++.||||++.+.... ..+|..+ ++.++||||++++++| .+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 35799999999999999999999999999999998754321 2234444 4678999999999998 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~DFG~ 185 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGL 185 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCB
T ss_pred CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEeeCcc
Confidence 568999999986 66666654 3578999999999999999999999 79999999999999995 88999999999
Q ss_pred cccccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..++... ......
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~-- 261 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPN-- 261 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSS--
T ss_pred ccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCC--
Confidence 986433 334445689999999999965 458999999999999999999999999988877777776642 111111
Q ss_pred ccccccCChhhHhhhcccccccCCCCc----CcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSM----HESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~----~~i~~hpf 340 (340)
.+.....+.+-|+..+|.+|+++ +||+.|||
T Consensus 262 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 262 ----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 11223344555556678899987 58999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=351.58 Aligned_cols=255 Identities=34% Similarity=0.555 Sum_probs=203.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++..... .+...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 47999999999999999999999999999999985432 223579999999999999999999854322 12244
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeecccc
Confidence 689999998888777764 578999999999999999999999 79999999999999995 88899999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.+....+
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 533 2345678999999999977566899999999999999999999999999999999999887766543211
Q ss_pred ------hc-----------cccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------YQ-----------GLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~~-----------~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+. ..+. +.....+.+-|+..+|.+|||++|+++|||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 00 0011 112334556667778999999999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=346.82 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=196.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|++.+.||+|+||+||+|+++.+++.||+|++.+... ...+|..+++++ +||||+++++++ .+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----Ee
Confidence 45679999999999999999999999999999999975431 234688888887 899999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~DFG 155 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYG 155 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEEecc
Confidence 5568999999986 66666654 3579999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHhc
Q 019506 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------NAVDQLVEIIKVS 296 (340)
Q Consensus 226 ~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~~~~~~ 296 (340)
+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||... .....+.+.+...
T Consensus 156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 156 MCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp GCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred ccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 998643 23344456889999999999654 5899999999999999999999999752 2223333344333
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCc------CcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSM------HESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~------~~i~~hpf 340 (340)
....+.. .+.....+..-|+..+|.+||++ +||++|||
T Consensus 235 ~~~~p~~------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 235 QIRIPRS------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp CCCCCTT------SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred CCCCCCC------CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 3332221 11223345555666778899996 79999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=348.75 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=209.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC---C
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~ 145 (340)
...+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++++.++|+||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 34689999999999999999999999999999998854321 23579999999999999999999855321 1
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
....+++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEccch
Confidence 2446889999999988777754 23579999999999999999999999 79999999999999995 7899999999
Q ss_pred cccccccC-----CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99875422 2223456799999999997766689999999999999999999999999998888888887655443
Q ss_pred hhhhhcccc--------------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLF--------------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~--------------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
... +...- .......+...|+..+|.+|||++|+++|||
T Consensus 250 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 250 PEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TTT-STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhh-ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 221 11110 0111335666777888999999999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=352.74 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=201.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
..++|.+.+.||+|+||+||+|+++.+|+.||||++.+......+|++++.++ +||||+++++++ .+...+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence 34579999999999999999999999999999999988777778899988877 799999999998 455668999
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC---cEEEEeeccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKV 229 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~---~~kl~Dfg~a~~ 229 (340)
|||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+...++ .+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999986 66666543 4679999999999999999999999 79999999999999854333 599999999987
Q ss_pred cccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. .....+...+...........+.
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 64433 33456789999999999653 4789999999999999999999999863 23333444444344333222221
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+.+-|+..+|.+||+++|+++|||
T Consensus 249 ~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 249 S--VSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp T--SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred c--CCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 1 1223445566677778999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=353.08 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=204.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+++++.++||||+++++++ .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 45799999999999999999999999999999988653 23456799999999999999999998 4455688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-CCCcEEEEeeccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~~~~~kl~Dfg~a~~ 229 (340)
+||||+.+ +|.+.+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||++..
T Consensus 125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999986 5555443 223579999999999999999999999 79999999999999974 246799999999988
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.... .....+..
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~-- 276 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSS-- 276 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTTTT--
T ss_pred cCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccccc--
Confidence 766555556678999999999965 45899999999999999999999999998887777776654322 11111111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 1223345566667778899999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=344.70 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=196.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------------------------cChHHHHHH
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQL 123 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~~~ 123 (340)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34568999999999999999999999999999999986432 234579999
Q ss_pred HHhCCCCceeecceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceec
Q 019506 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (340)
Q Consensus 124 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~ 203 (340)
++.++||||+++++++.. .....+++||||++++.+..+ .....+++..++.++.||+.||.|||+ +||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 999999999999998853 224568899999986422211 124579999999999999999999999 799999
Q ss_pred CCCCCCeEecCCCCcEEEEeeccccccccCCc-cceeeeeccccCcccccCCCC--CCCcchhHHHHHHHHHHHhCCCCC
Q 019506 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 280 (340)
Q Consensus 204 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf 280 (340)
||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||
T Consensus 162 Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999995 78899999999987654332 234578999999999965432 477899999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 281 PGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.+.......+.... ...... .-.......+...|+..+|.+|||++|+++|||
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQA-LEFPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp CCSSHHHHHHHHHHCC-CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CCccHHHHHHHHhccc-CCCCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 8877655555544422 211100 011223455666777778999999999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=348.22 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=189.2
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+|++++++++||||+++++++ .+....+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEE
Confidence 3456799999999999999999999999999999998754 33456799999999999999999998 4445588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeecccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK 228 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a~ 228 (340)
+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+++
T Consensus 125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999985 66665543 4678999999999999999999999 79999999999999973 36789999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+...+..........++..
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~- 277 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE- 277 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT-
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh-
Confidence 76555445566789999999999654 4899999999999999999999999887766644444443333322222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+.+.|+..+|.+|||++|+++|||
T Consensus 278 -~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 278 -VSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp -SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1122345666677778999999999999999
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=348.29 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=202.6
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+++++.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34568999999999999999999999999999999986432 2345799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~DFg 186 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDFG 186 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcccc
Confidence 5568999999975 77766654 2579999999999999999999999 79999999999999995 8889999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... ....+..
T Consensus 187 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~-- 260 (350)
T 1rdq_E 187 FAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSH-- 260 (350)
T ss_dssp TCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT--
T ss_pred cceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCC--
Confidence 99876433 3456899999999999654 4899999999999999999999999988877777776653 2222211
Q ss_pred ccccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|++ ++||++|||
T Consensus 261 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1223344555666667889998 999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=351.86 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=197.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 457999999999999999999999999999999986532 223479999999999999999999854321 2234
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++||||+++++.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC--
T ss_pred ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeeccc
Confidence 688999999998877764 458999999999999999999999 79999999999999995 7899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++....+....+
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 77555445566889999999999664 5899999999999999999999999999988888888776554432111
Q ss_pred ---------------------hcccc-c---------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ---------------------YQGLF-C---------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ---------------------~~~~~-~---------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.... . ......+...|+..+|.+|||++|+++|||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00000 0 112345666677778999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=348.97 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=205.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------------cChHHHHHHHHhCCCCceeecceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISLKHCFF 140 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~ 140 (340)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+|+++++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 357999999999999999999975 49999999885432 23458999999999999999999997
Q ss_pred ecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.........+++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCEE
Confidence 766566667899999999988877763 34579999999999999999999999 79999999999999995 78899
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998765555555677899999999997656689999999999999999999999999999899988888766654
Q ss_pred hhhhh-----------ccccc--------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIY-----------QGLFC--------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~-----------~~~~~--------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.. ...+. ......+...|+..+|.+|||++|+++|||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 33221 11111 111345666777788999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=348.57 Aligned_cols=255 Identities=31% Similarity=0.531 Sum_probs=204.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++ .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----ee
Confidence 357999999999999999999999999999999886421 2345799999999999999999998 44
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
....++||||+++++...+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGG
T ss_pred CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEeccc
Confidence 455889999999987776653 23568899999999999999999999 79999999999999995 78999999999
Q ss_pred ccccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+....+....+-
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 98764332 23345789999999999766668999999999999999999999999999999999988876555433221
Q ss_pred ccc-------------------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGL-------------------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~-------------------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
... + .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 100 0 0112344566677778999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=362.45 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=204.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|.+++.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ ...
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 4567999999999999999999999999999999986432 2346899999999999999999998 444
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ +|.+.+. .+..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEeccc
Confidence 558899999975 6555543 35679999999999999999999999 79999999999999995 78899999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+.++..... ..+..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~--- 238 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQY--- 238 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTT---
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCcc---
Confidence 98876666556678999999999997766568899999999999999999999998887776666654322 11111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 239 ---~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 239 ---LNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ---CCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 1222344556667778999999999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=340.17 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=192.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------hHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..++...++.++||||+++++++. +...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 45799999999999999999999999999999998654221 123444577889999999999984 3445
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++++.+.+.........+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGISG 158 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC----
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCcc
Confidence 88999999999888887766667889999999999999999999999 7 9999999999999995 7899999999998
Q ss_pred ccccCCccceeeeeccccCcccc---cCCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCchhhh
Q 019506 229 VLVKGEANISYICSRYYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
............||+.|+|||++ .....++.++|||||||++|+|++|+.||.. ......+...............
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 77665555556789999999997 3445689999999999999999999999986 4445555555554433322211
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 239 -----~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 239 -----FSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -----CCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 1223345566677778999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=348.80 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=199.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3467999999999999999999999999999999986532 2234688888877 799999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeCC
Confidence 5568999999986 66666654 3579999999999999999999999 79999999999999995 8889999999
Q ss_pred cccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.... ...+..
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~- 243 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKS- 243 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTT-
T ss_pred cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCC-
Confidence 998643 23334456889999999999654 48999999999999999999999999888877777776632 222221
Q ss_pred hccccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+||+ ++||++|||
T Consensus 244 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 244 -----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp -----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred -----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 1222344555566667889995 599999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=346.45 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=203.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.++ |+||+++++++.. ......++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEEE
Confidence 45799999999999999999999999999999998743 344568999999997 9999999998853 224457899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|||+.++.+..+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++..+..+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999975333332 348899999999999999999999 799999999999999964558999999999877666
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCchhhhhccc----
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVSNIIYAKTIYQGL---- 308 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 308 (340)
.......++..|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+.+....+...+.+...
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 655567889999999999775678999999999999999999999985 445566666665544433221111110
Q ss_pred -------------------c-------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 -------------------F-------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 -------------------~-------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|+..+|.+|||++|+++|||
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0 1222344666777778999999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=339.11 Aligned_cols=254 Identities=33% Similarity=0.565 Sum_probs=199.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+|++++++++|+||+++++++. +....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 479999999999999999999999999999998865432 2347999999999999999999984 44458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||++++++..+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchhc
Confidence 89999999875555443 34679999999999999999999999 79999999999999995 889999999999876
Q ss_pred ccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh------
Q 019506 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT------ 303 (340)
Q Consensus 231 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 303 (340)
.... ......+|..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 4332 233457899999999997766789999999999999999999999999998888877776544322110
Q ss_pred --hhccc----------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 --IYQGL----------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 --~~~~~----------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+... -.+.....+...|+..+|.+|||++|+++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 00000 01111334666777788999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=353.27 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=184.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++. +...+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEEE
Confidence 347999999999999999999999999999999987543 33458999999999999999999984 4455889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC--cEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~--~~kl~Dfg~a~~ 229 (340)
||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCcccc
Confidence 9999975 66666654 3579999999999999999999999 79999999999999984 44 499999999986
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---cCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---SNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~ 306 (340)
...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+++. ........
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--- 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT---
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc---
Confidence 555555556689999999999977664445599999999999999999999875443222222221 11111111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.-.+.....+...|+..+|.+|||++|+++|||
T Consensus 245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 245 -IRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 001122344566677778999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=336.82 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=198.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|.+.+.||+|+||.||+|++..++..||+|++.... ....+|+++++.++||||+++++++ .+....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 357999999999999999999999999999999987543 3346899999999999999999998 444558
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeeccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a 227 (340)
++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. .++.+||+|||++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 899999986 7777776655556789999999999999999999999 79999999999999953 2467999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.............+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+..... ...... .
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-~- 249 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAVEC-R- 249 (285)
T ss_dssp CC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCC---C-
T ss_pred eecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-cccccc-C-
Confidence 8776655555677899999999984 3479999999999999999999999998876655554443222 111110 0
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+...|+..+|.+|||++|+++|||
T Consensus 250 -~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 250 -PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp -CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 01122345566677778999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=355.04 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=206.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhC------CCCceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM------DHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 145 (340)
...+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.+ +|+||+++++++ .
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----~ 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----T 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----E
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----c
Confidence 3457999999999999999999999999999999997653 2334688887776 577999999988 3
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc--EEEEe
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCD 223 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~--~kl~D 223 (340)
....+++||||+++++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEECC
T ss_pred cCCeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEee
Confidence 44568999999999988887753 23468999999999999999999999 79999999999999995 554 99999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
||++..... ......||+.|+|||++.+.. ++.++|||||||++|||+||.+||.+.+..+.+..+++....+....
T Consensus 246 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 999976532 333567899999999997654 89999999999999999999999999999999999988766554321
Q ss_pred hhcc-------------------------------------------------ccc---cCChhhHhhhcccccccCCCC
Q 019506 304 IYQG-------------------------------------------------LFC---SNNHEIMCELGSWYSYSGRNS 331 (340)
Q Consensus 304 ~~~~-------------------------------------------------~~~---~~~~~~~~~l~~~~~~~~R~~ 331 (340)
+-.. .+. ......+.+.|+..+|.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 1000 000 011235666777888999999
Q ss_pred cCcccccCC
Q 019506 332 MHESKLYGF 340 (340)
Q Consensus 332 ~~~i~~hpf 340 (340)
++|+++|||
T Consensus 403 a~e~L~Hpw 411 (429)
T 3kvw_A 403 PGQALRHPW 411 (429)
T ss_dssp HHHHHTSTT
T ss_pred HHHHhCChh
Confidence 999999999
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=349.83 Aligned_cols=255 Identities=33% Similarity=0.519 Sum_probs=192.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
.+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+++++.++||||+++++++..... .+...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 57999999999999999999999999999999986432 223479999999999999999999854321 22345
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|||+++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeecccccc
Confidence 789999998877666543 579999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.+....+
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 533 2345678999999999977567899999999999999999999999999999999999887766543221
Q ss_pred ------hccccc-------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------YQGLFC-------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~~~~~~-------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++.+.. ......+.+.|+..+|.+|||++|+++|||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 111100 111234566677788999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=345.37 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=203.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 45999999999999999999999999999999986432 234579999999999999999999843 345
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||||+.|++.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence 8899999999888777542 4678999999999999999999999 79999999999999995 88999999999977
Q ss_pred cccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+.+.........
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 276 (348)
T 1u5q_A 204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG---- 276 (348)
T ss_dssp SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCT----
T ss_pred cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----
Confidence 5432 34578999999999853 34589999999999999999999999998888777777766443322111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.....+.+.|+..+|.+|||++++++|||
T Consensus 277 -~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 277 -HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -CCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11223455667777888999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=352.77 Aligned_cols=260 Identities=30% Similarity=0.469 Sum_probs=193.5
Q ss_pred cCeeE-eeeeeeecceEEEEEEEc--CCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~-~~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
+.|.+ +++||+|+||+||+|++. .+++.||||++.... ....+|+.+++.++||||+++++++.. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence 34776 568999999999999976 578999999987543 335689999999999999999999865 2344588
Q ss_pred eeeccccchHHHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec---CCCCcEEEEe
Q 019506 152 LVMEYVPETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCD 223 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~---~~~~~~kl~D 223 (340)
+||||+++++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999998888764332 12358999999999999999999999 7999999999999993 2367899999
Q ss_pred eccccccccC----CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 019506 224 FGSAKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLV 290 (340)
Q Consensus 224 fg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~ 290 (340)
||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+. .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999876433 2223457899999999997766689999999999999999999999986654 47788
Q ss_pred HHHHhcCCCchhhhhcc----------------cc---------------ccCChhhHhhhcccccccCCCCcCcccccC
Q 019506 291 EIIKVSNIIYAKTIYQG----------------LF---------------CSNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~----------------~~---------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
.+++..+.+....+-.- .. .......+..-|+..+|.+|||++|+++||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 88877766554322100 00 012223456677778899999999999999
Q ss_pred C
Q 019506 340 F 340 (340)
Q Consensus 340 f 340 (340)
|
T Consensus 336 ~ 336 (405)
T 3rgf_A 336 Y 336 (405)
T ss_dssp G
T ss_pred h
Confidence 8
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=337.56 Aligned_cols=264 Identities=30% Similarity=0.485 Sum_probs=212.7
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEc-CCCcEEEEEEecccc------cChHHHHHHHHhC---CCCceeecceeeee
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFS 141 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~ 141 (340)
......+|++.+.||+|+||.||+|++. .+|+.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3345568999999999999999999985 678999999886432 2345788777766 89999999999864
Q ss_pred cCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
.........++||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEE
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEEE
Confidence 433456678999999999888887653 23458999999999999999999999 79999999999999995 789999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+|||++.............++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++....+..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999999876555444556789999999999654 4899999999999999999999999999998888888876655443
Q ss_pred hhhhccc------------------cc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGL------------------FC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~------------------~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+.... .. ......+...|+..+|.+||+++|+++|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 3221110 00 111235666777788999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=343.37 Aligned_cols=258 Identities=27% Similarity=0.499 Sum_probs=207.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++|+||+++++++...........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457999999999999999999999999999999986432 223479999999999999999998754433444668
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++||||+++++.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEeccccccc
Confidence 89999999988877764 579999999999999999999999 79999999999999995 888999999999876
Q ss_pred ccCCc-----------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 019506 231 VKGEA-----------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 231 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43221 1224679999999998766678999999999999999999999999999888888877765544
Q ss_pred chhhhhcc------------c-------------cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 300 YAKTIYQG------------L-------------FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 300 ~~~~~~~~------------~-------------~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.. + -.+.....+...|+..+|.+|||++|+++|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 32111110 0 01112235666777788999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=339.76 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=192.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
...+|++.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF---- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence 3457999999999999999999985 689999999986532 2345799999999999999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
.....+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~ 163 (327)
T 3a62_A 91 -QTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHVKLT 163 (327)
T ss_dssp -ECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCEEEC
T ss_pred -EcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcEEEE
Confidence 344558899999985 66666654 3578999999999999999999999 79999999999999995 7899999
Q ss_pred eeccccccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 223 DFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 223 Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+... ..+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p 241 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLP 241 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCC
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCC
Confidence 99999764332 223345789999999999654 489999999999999999999999999888777777766432 111
Q ss_pred hhhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.. .......+..-|+..+|.+|| +++|++.|||
T Consensus 242 ~~------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 242 PY------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp TT------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred CC------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 11 122234455556666788998 7789999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=358.94 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=200.1
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+++++.++||||++++++| .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 34568999999999999999999999999999999986432 2245799999999999999999988 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||++| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeecc
Confidence 5568999999985 6666665443335679999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCcc-ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~ 301 (340)
+++........ ...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+ ....+.+.+.......+
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p 413 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC
T ss_pred eeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC
Confidence 99876554433 34589999999999966 458999999999999999999999998753 22333333333332222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
.. .+.....+...|+..+|.+||++ ++|++|||
T Consensus 414 ~~------~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 414 DK------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp TT------SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred cc------cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 11 12223445556666778899965 78999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=354.58 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=195.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|++++++++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 467999999999999999999999999999999986432 23568999999999999999999872
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK 220 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~k 220 (340)
... .++||||+++ +|.+. ......+++..++.++.|++.||+|||+ +||+||||||+|||++.. +..+|
T Consensus 211 --~~~-~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AED-YYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SSE-EEEEEECCTTCBGGGG----TSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cCc-eEEEEEcCCCCcHHHH----HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 222 6799999986 44333 3345789999999999999999999999 799999999999999742 33599
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+......+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999988766555556789999999999853 345788999999999999999999999877665556666665555
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+..+ +.....+...|+..+|.+|||++|++.|||
T Consensus 363 ~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 363 NFIPEVWAEV--SEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp CCCHHHHTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCchhhccc--CHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 5444433321 233445566677778999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=331.25 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=204.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.++++++|+||+++++++ .+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 3457999999999999999999999999999999986543 2345799999999999999999998 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg 225 (340)
..++||||+.+ ++.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.. +..+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 67899999986 66666554 3578999999999999999999999 799999999999999742 2349999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+...... .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEW 231 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCTTTT
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-CCchhh
Confidence 99877666555567789999999999654 4899999999999999999999999988876666666554322 211111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 232 ~~--~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 232 DT--VTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp TT--SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred cc--cCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 11 1223445666677778999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=338.33 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=204.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 457999999999999999999999999999999986532 2246899999999999999999998 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC----cEE
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVK 220 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~----~~k 220 (340)
+....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++ .+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~-~~~~~~~~k 159 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLD-KNIPIPHIK 159 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESC-TTSSSCCEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEec-CCCCcCCEE
Confidence 44568899999975 66666643 4678999999999999999999999 79999999999999985 44 799
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~ 237 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-DF 237 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-CC
T ss_pred EccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-cc
Confidence 999999988766555556678999999999965 4589999999999999999999999998887777766655332 22
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+... .+.....+...|+..+|.+|||++|+++|||
T Consensus 238 ~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 238 DEEFFSH--TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CHHHHTT--CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred Chhhhcc--cCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 2222111 1222345666677778999999999999999
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=359.98 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=200.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
....+|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+++++.++||||+++++++ .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 44567999999999999999999999999999999986431 2245799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||++| +|...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEecc
Confidence 5568999999985 66655543 223459999999999999999999999 79999999999999995 7899999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCchh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~ 302 (340)
+++...........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+ ....+...+.........
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~ 410 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc
Confidence 99887666555567899999999999654 48999999999999999999999998754 234444444433332221
Q ss_pred hhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
. .+.....+..-|+..+|.+|| +++|+++|||
T Consensus 411 ~------~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 411 R------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp T------SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred c------CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 1 122234445555666788899 7899999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=357.82 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=203.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+|+++++.++||||+++++++ .+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCE
Confidence 45799999999999999999999999999999998532 23345899999999999999999998 45556
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeecc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGS 226 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~ 226 (340)
+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 8999999986 66666654 3579999999999999999999999 79999999999999963 245799999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+........... +.
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~ 247 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-WR 247 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG-GG
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-cC
Confidence 987766655556789999999999964 489999999999999999999999999888777777766443322211 11
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+..-|+..+|.+|||++|+++|||
T Consensus 248 ~--~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 248 T--ISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp G--SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred C--CCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 1 1233455666677778999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=339.54 Aligned_cols=257 Identities=31% Similarity=0.554 Sum_probs=202.3
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...++|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++ .+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecC
Confidence 345689999999999999999999999999999998864432 234799999999999999999998 444
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
...++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFA 171 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCc
Confidence 55889999999876665543 34679999999999999999999999 79999999999999995 789999999999
Q ss_pred cccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh--
Q 019506 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI-- 304 (340)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (340)
....... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+............
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 7654332 2334568999999999977656899999999999999999999999999988888887765443221110
Q ss_pred -----------hcccc-----------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 -----------YQGLF-----------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 -----------~~~~~-----------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.... .+.....+...|+..+|.+|||++|+++|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000 1112345566677778999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=330.03 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=205.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|++.+.||+|+||.||+|++..++..||+|++.... ....+|+++++.++||||+++++++ .+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 457999999999999999999999999999999986532 3346799999999999999999998 4455688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe---cCCCCcEEEEeeccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA 227 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill---~~~~~~~kl~Dfg~a 227 (340)
+||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||++ + .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSS-TTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCC-CCCcEEEEecccc
Confidence 99999986 66666554 3568999999999999999999999 799999999999999 5 4778999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+.+..+.+......... +..
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-WLN 233 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-HTT
T ss_pred eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-hhc
Confidence 88766666666788999999999854 389999999999999999999999998888777776666443332221 111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+||+++|+++|||
T Consensus 234 --~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 234 --VSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp --SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 1233455666677778999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.92 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=198.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++.. ....++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEE
Confidence 4888889999999999999999999999999986443 224579999999999999999999843 3458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ +|.+.+. ...+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeeeeeccc
Confidence 999986 5554443 3579999999999999999999999 79999999999999995 78899999999987644
Q ss_pred CC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+........ .. ....+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~---~~~~~ 268 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KN---SHKVS 268 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TT---GGGSC
T ss_pred CccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-Cc---cccCC
Confidence 32 2345678999999999965 4589999999999999999999999998887776666555322211 11 00112
Q ss_pred CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+...|+..+|.+|||++|+++|||
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 22345666677778999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=338.18 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=179.2
Q ss_pred cCeeEe---eeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCC-CCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~---~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
++|.+. +.||+|+||.||+|++..+|+.||||++.+.. ....+|+.+++.+. ||||+++++++ .+....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence 346664 78999999999999999999999999987543 44568999999997 99999999998 4555688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC--CcEEEEeecccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAK 228 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~--~~~kl~Dfg~a~ 228 (340)
+||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+ ..+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999986 66666654 4679999999999999999999999 7999999999999997522 279999999998
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCch
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVSNIIYA 301 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~~~~~~~~~~~ 301 (340)
....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. ...+...+........
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 6544332 234567999999999965 4589999999999999999999999986532 1223333333333332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+.. .+.....+...|+..+|.+|||++|++.|||
T Consensus 237 ~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 237 GEAWKN--VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp SHHHHT--SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred cccccC--CCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 222222 1223445666677778999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=343.98 Aligned_cols=254 Identities=34% Similarity=0.567 Sum_probs=203.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCC-Cce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 148 (340)
..+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357999999999999999999999999999999987532 2334799999999999999999998543321 112
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++||||+++++.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 121 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCccc
Confidence 34899999999876654 2459999999999999999999999 79999999999999995 8889999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
..... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..... ..+
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~ 269 (371)
T 4exu_A 193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV-QKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH-TTC
T ss_pred ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH-HHh
Confidence 65332 334578999999999977567899999999999999999999999999999999998887665543211 100
Q ss_pred -----------------------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 -----------------------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 -----------------------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|+..+|.+|||++|+++|||
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0 1122345566677778999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=359.75 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=206.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++ .+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 3457999999999999999999999999999999985432 2345899999999999999999998 455
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEee
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF 224 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Df 224 (340)
...++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 568999999985 66665543 4679999999999999999999999 79999999999999952 3678999999
Q ss_pred ccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
|++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+.........
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~- 250 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ- 250 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG-
T ss_pred eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc-
Confidence 99988766665566789999999999965 489999999999999999999999999888877777766443222111
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 251 ~~~--~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 251 WKK--VSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp GGG--SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ccc--CCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 111 1223445666777778999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=337.54 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=188.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccCh------HHHHHHH-HhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.++||+|+||+||+|++..+|+.||||++....... ..|+..+ +..+|+||+++++++ .+..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCC
Confidence 357999999999999999999999999999999886533221 2344333 444899999999998 4455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++||||+++++.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeee
Confidence 68999999999988877653 4579999999999999999999999 79999999999999985 8899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
............||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... ..+.+ ... ...+...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~-~~~--~~~~~~~- 276 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ-GYL--PPEFTAG- 276 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT-TCC--CHHHHTT-
T ss_pred ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc-cCC--CcccccC-
Confidence 8766555556678999999999864 4899999999999999999998776554322 22221 111 1111111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 277 -~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 277 -LSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp -SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 1223445666677778999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=342.28 Aligned_cols=241 Identities=21% Similarity=0.367 Sum_probs=196.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 457999999999999999999999999999999987542 2345799999999999999999998
Q ss_pred CCCceeeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 144 SKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
.+....++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcEEE
Confidence 455568899999864 56655543 4679999999999999999999999 79999999999999995 789999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||.+... ..... ..
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~-~~-- 242 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAA-IH-- 242 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTC-CC--
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhc-cC--
Confidence 9999998876666666778999999999997766558899999999999999999999975321 01100 00
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.....+...|+..+|.+|||++|+++|||
T Consensus 243 ----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 243 ----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 01112223445566677778999999999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=347.49 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=196.9
Q ss_pred cccCeeEeeeeeee--cceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..++|++.+.||+| +||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++. +
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence 34579999999999 99999999999999999999997543 23356999999999999999999984 3
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+++ ++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccc
Confidence 4458999999985 666666542 23569999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCC--------ccceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 019506 226 SAKVLVKGE--------ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 226 ~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 296 (340)
.+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..++...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 986543221 11223678889999999763 458999999999999999999999998877666555444321
Q ss_pred CCCch-------hhhh--------------------------------ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 297 NIIYA-------KTIY--------------------------------QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 297 ~~~~~-------~~~~--------------------------------~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..... ..+. ..-..+.....+.+.|+..+|.+|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11000 0000 00001112334666777788999999999999
Q ss_pred cCC
Q 019506 338 YGF 340 (340)
Q Consensus 338 hpf 340 (340)
|||
T Consensus 334 hp~ 336 (389)
T 3gni_B 334 HSF 336 (389)
T ss_dssp SGG
T ss_pred CHH
Confidence 998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=356.53 Aligned_cols=251 Identities=26% Similarity=0.463 Sum_probs=203.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----------------cChHHHHHHHHhCCCCceeecce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNVISLKH 137 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~ 137 (340)
...+|.++++||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3457999999999999999999999999999999986432 22357999999999999999999
Q ss_pred eeeecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC
Q 019506 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~ 216 (340)
++ .+...+++|||||++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKN 183 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTT
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCC
Confidence 98 455568999999986 66666654 3579999999999999999999999 7999999999999998533
Q ss_pred --CcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019506 217 --HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 217 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 294 (340)
..+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2699999999988766656666789999999999853 489999999999999999999999999888777777766
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... .....+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 262 ~~~~-~~~~~~~~--~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 262 GKYY-FDFNDWKN--ISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CCCC-CCHHHHTT--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCC-CCccccCC--CCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 4332 22222222 1223445666677778999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=345.75 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=203.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCC--------CCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD--------HPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~ 144 (340)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+++++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 457999999999999999999999999999999987543 33457999998885 788999999885322
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCC-------
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLT------- 216 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~------- 216 (340)
.+...+++||||+++++.+.+... ....+++..++.++.||+.||.|||+ + ||+||||||+|||++..+
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 245678999999999888877652 23579999999999999999999999 8 999999999999998532
Q ss_pred -----------------------------------------CcEEEEeeccccccccCCccceeeeeccccCcccccCCC
Q 019506 217 -----------------------------------------HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255 (340)
Q Consensus 217 -----------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 255 (340)
..+||+|||++...... .....||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 27999999999876433 33457899999999997654
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCchhhhhccccc-------------------
Q 019506 256 EYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVSNIIYAKTIYQGLFC------------------- 310 (340)
Q Consensus 256 ~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 310 (340)
++.++|||||||++|+|+||+.||.+.+ ..+.+..+.+..+......+...-..
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 8999999999999999999999998654 45566666665554332211110000
Q ss_pred ----------------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 ----------------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ----------------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+|||++|+++|||
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 001235666777888999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=336.37 Aligned_cols=246 Identities=25% Similarity=0.366 Sum_probs=200.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 357999999999999999999999999999999986542 2345799999999999999999998 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeeccCc
Confidence 68899999995 66665543 3578999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
...... .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.. ......
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~--- 263 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKH--- 263 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTT---
T ss_pred eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCcc---
Confidence 876432 223345689999999999654 47999999999999999999999999888776666655532 221111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+||+++|+++|||
T Consensus 264 ---~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 264 ---INPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1122345666777778999999999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=347.12 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=197.0
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeeec
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 155 (340)
...+.||+|+||.||+|++..+|+.||+|++... .....+|++++++++||||+++++++ .+...+++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence 3367899999999999999999999999998753 23456899999999999999999998 44455889999
Q ss_pred cccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec-CCCCcEEEEeeccccccccC
Q 019506 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~-~~~~~~kl~Dfg~a~~~~~~ 233 (340)
|+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|||+++.....
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9985 66666543 23468999999999999999999999 7999999999999994 23678999999999887666
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCC
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNN 313 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (340)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........... +.. .+..
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~--~~~~ 318 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE-FQD--ISEE 318 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG-GTT--SCHH
T ss_pred cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh-hcc--CCHH
Confidence 55556679999999999954 4589999999999999999999999999988888888877543322211 111 1223
Q ss_pred hhhHhhhcccccccCCCCcCcccccCC
Q 019506 314 HEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 314 ~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+...|+..+|.+|||++|+++|||
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 345566677778899999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=339.23 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=198.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|++++++++||||+++++++.. .+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 347999999999999999999999999999999986432 234589999999999999999998854 233357
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe----cCCCCcEEEEeec
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFG 225 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill----~~~~~~~kl~Dfg 225 (340)
++||||+++ +|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTT-SCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCC-CCceEEEccCC
Confidence 899999985 666666543 223449999999999999999999999 799999999999998 5 36679999999
Q ss_pred cccccccCCccceeeeeccccCcccccC-------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 294 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~~~~ 294 (340)
+++............||+.|+|||++.. ...++.++|||||||++|+|+||+.||.... ..+.+..++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9988766666666789999999999852 3458999999999999999999999997432 3445555554
Q ss_pred hcCCCchhhh---------hccccc---------cCChhhHhhhcccccccCCCCcCcccccC
Q 019506 295 VSNIIYAKTI---------YQGLFC---------SNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 295 ~~~~~~~~~~---------~~~~~~---------~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
.........+ +...+. ......+.+.|+..+|.+|||++|+++||
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 3221110000 000000 01233455667777899999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=355.54 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=202.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..+|++.+.||+|+||+||+|++..++..||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 346999999999999999999999999999999986432 2345799999999999999999998 44556
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeecc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~ 226 (340)
+++|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 8899999986 66666654 3578999999999999999999999 799999999999999742 34599999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+.+....... ..+.
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 262 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS-PEWK 262 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-GGGT
T ss_pred CeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-hhcc
Confidence 98876666666678999999999984 34899999999999999999999999998887777777664433222 2122
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|+..+|.+|||++|+++|||
T Consensus 263 ~--~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 263 N--VSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp T--SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred c--CCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 1 1223445666677778999999999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=328.18 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=198.4
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|++.+.||+|+||.||+|++..++..||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 3456899999999999999999999999999999988543 22345799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
....++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEecc
Confidence 4558899999995 66666654 2568999999999999999999999 79999999999999995 8889999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+..... .....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-- 229 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDF-- 229 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTT--
T ss_pred ccccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-CCCCc--
Confidence 98665333 2335578999999999965 4579999999999999999999999998887776666655332 22111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+|||++|+++|||
T Consensus 230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 230 ----VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ----CCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 1222345666677778999999999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=338.50 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=190.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCC------
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------ 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 144 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|++++++++||||++++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999999999999999986432 334579999999999999999998865332
Q ss_pred ----------------------------------------------CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCH
Q 019506 145 ----------------------------------------------KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPL 177 (340)
Q Consensus 145 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~ 177 (340)
....++++||||+++ +|.+.+... ......++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence 122357899999997 565555432 22234566
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCC-------------ccceeeeecc
Q 019506 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-------------ANISYICSRY 244 (340)
Q Consensus 178 ~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~~~ 244 (340)
..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...... ......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6789999999999999999 79999999999999995 7899999999998765442 2233568999
Q ss_pred ccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccc
Q 019506 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWY 324 (340)
Q Consensus 245 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (340)
|+|||++.+. .++.++|||||||++|+|++|..|+. ..............+....- .......+...|+..
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLFTQ-----KYPQEHMMVQDMLSP 312 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHHHH-----HCHHHHHHHHHHHCS
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCccccc-----CChhHHHHHHHHccC
Confidence 9999999764 48999999999999999999877652 11222222222222221110 011224455667777
Q ss_pred cccCCCCcCcccccCC
Q 019506 325 SYSGRNSMHESKLYGF 340 (340)
Q Consensus 325 ~~~~R~~~~~i~~hpf 340 (340)
+|.+|||++|+++|||
T Consensus 313 ~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 313 SPTERPEATDIIENAI 328 (332)
T ss_dssp SGGGSCCHHHHHHSTT
T ss_pred CCCcCCCHHHHhhchh
Confidence 8999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=335.59 Aligned_cols=259 Identities=28% Similarity=0.478 Sum_probs=199.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecC--------
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT-------- 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 143 (340)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357999999999999999999999999999999886432 33457999999999999999999874321
Q ss_pred -CCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 144 -SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 144 -~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
..+....++||||+++++.+.+. ...+++..++.++.|++.||+|||+ +||+||||||+|||++..++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 12345688999999998877764 3678999999999999999999999 7999999999999998557799999
Q ss_pred eeccccccccCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 223 DFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 223 Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|||++....... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998754321 1223456888999999876567899999999999999999999999999888887777765433
Q ss_pred Cchhhh---h------------------ccc--cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTI---Y------------------QGL--FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~---~------------------~~~--~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...... . ... -.+.....+...|+..+|.+|||++|+++|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 221110 0 000 01223445666777778999999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=352.79 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=194.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++. +.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence 4567999999999999999999999999999999986431 23346888899999999999999984 44
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG~ 295 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGL 295 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCCC
T ss_pred CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCCC
Confidence 458899999986 56555543 3578999999999999999999996249999999999999995 78999999999
Q ss_pred cccccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+... ....+..
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~-- 371 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRT-- 371 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT--
T ss_pred ceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCCcc--
Confidence 986433 2333456789999999999654 5899999999999999999999999988876666666553 2222221
Q ss_pred ccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|| +++|+++|||
T Consensus 372 ----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 372 ----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 122234555666777888999 9999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=341.39 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=199.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 457999999999999999999999999999999886432 3345799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhc------------------------------------CCCCCCHHHHHHHHHHHHH
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSS------------------------------------MNQRMPLIYVKLYTYQIFR 189 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~qi~~ 189 (340)
....++||||+++ +|.+.+..+.. ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 5568999999975 66555532111 1223467888999999999
Q ss_pred HHHHHHcCCCceecCCCCCCeEecCCCC--cEEEEeeccccccccCCc-----cceeeeeccccCcccccCC-CCCCCcc
Q 019506 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFGA-TEYTTSI 261 (340)
Q Consensus 190 ~l~~LH~~~~iiH~dlkp~Nill~~~~~--~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~ 261 (340)
||.|||+ +||+||||||+|||++. ++ .+||+|||++........ .....||+.|+|||++.+. ..++.++
T Consensus 180 ~l~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 180 ALHYLHN-QGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHH-TTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHH-CCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 79999999999999985 44 899999999986543221 2345789999999999642 5589999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
|||||||++|+|++|+.||.+.+..+.+..+............ .. .+.....+.+-|+..+|.+||+++|+++|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY-NV--LSPLARDLLSNLLNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG-GG--SCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc-cc--CCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence 9999999999999999999999888888777765433222111 10 1223445666777778999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=339.15 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=203.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 56999999999999999999999899999999886432 2235788999998 799999999988
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
......++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~ 242 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS 242 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence 445568899999986 66666653 3578999999999999999999999 79999999999999995 8899999
Q ss_pred eeccccccccCCccceeeeeccccCcccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 019506 223 DFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 297 (340)
|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999988766655566789999999999853 23478999999999999999999999998877666666655333
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..... .+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 323 ~~~~~-~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 323 QFSSP-EWDD--RSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp CCCHH-HHSS--SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCc-cccc--CCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 22211 1111 1223455666777778999999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=337.25 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=199.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 347999999999999999999999999999999886432 235689999999999999999998732
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC--CcEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVK 220 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~--~~~k 220 (340)
.. .++||||+++ +|.+.+. .+..+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+|
T Consensus 87 ---~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ---ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred ---Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence 22 6899999986 6655553 35679999999999999999999999 7999999999999998522 2499
Q ss_pred EEeeccccccccCCccceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||.+......+...+.....
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 99999998765544444557899999999974 3455899999999999999999999999876654445555554444
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+.. .......+..-|+..+|.+||+++|+++|||
T Consensus 238 ~~~~~~~~~--~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 238 NFIPEVWAE--VSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp CCCHHHHTT--SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCchhhhh--cCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 433332222 1223445666777778999999999999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=326.57 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=192.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence 4468999999999999999999999999999999986432 2345799999999999999999988 344
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeeccc
Confidence 558899999985 77776654 2568999999999999999999999 79999999999999995 78899999999
Q ss_pred ccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+.............+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+....+..+... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--- 233 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VFYIPEY--- 233 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT---
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-cccCchh---
Confidence 987765554555678999999999976554578999999999999999999999887766655555442 2221111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+|||++|+++|||
T Consensus 234 ---~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 234 ---LNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ---cCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 1222345566677778999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=363.91 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=201.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|.+.++||+|+||+||+|++..+++.||||++++.. .....|..++..+ +|+||+.++++| .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4568999999999999999999999999999999987431 2234688888877 699999999988 55
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +|||||||||+|||++. ++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeecc
Confidence 5668999999986 66666654 3579999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccc-cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+++... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+++. ....+..+
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 565 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKSM 565 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-CCCCCTTS
T ss_pred eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-CCCCCccC
Confidence 998643 3334455789999999999965 45899999999999999999999999998887777777653 23332221
Q ss_pred hccccccCChhhHhhhcccccccCCCCc-----CcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSM-----HESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~-----~~i~~hpf 340 (340)
+.....+.+-++..+|.+|+++ +||++|||
T Consensus 566 ------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 566 ------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp ------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred ------CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 2223445555666678899998 99999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=344.05 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=190.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC--CCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|.+.+.||+|+||+||+|.+.. ++.||||++.... ....+|+++++.++ |+||+++++++. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 359999999999999999999754 8999999986542 23457999999997 599999999884 344
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 5899999877888887765 3578999999999999999999999 7999999999999996 5789999999998
Q ss_pred ccccCCc---cceeeeeccccCcccccC----------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH
Q 019506 229 VLVKGEA---NISYICSRYYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 294 (340)
Q Consensus 229 ~~~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~ 294 (340)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+... ...+..++.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 7644332 234578999999999864 13589999999999999999999999987644 334444433
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......... ........+...|+..+|.+||+++|+++|||
T Consensus 283 ~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 283 PNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp TTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccCCCCc-----cchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 221111111 11223455666777888999999999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=326.69 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=197.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.++++++||||+++++++ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 46999999999999999999999999999999886432 2346899999999999999999998 34
Q ss_pred ceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC----cEEE
Q 019506 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKL 221 (340)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~----~~kl 221 (340)
....++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++ .+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~~~~kl 153 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLD-KNVPNPRIKL 153 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESC-SSSSSCCEEE
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEec-CCCCCCceEE
Confidence 455889999997 477766654 3578999999999999999999999 79999999999999985 44 7999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+|||++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+..... ...
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 231 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-DFD 231 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCC
T ss_pred EecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-CCc
Confidence 99999987765555555678999999999965 4589999999999999999999999998887666666554332 222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...... .......+...|+..+|.+||+++|+++|||
T Consensus 232 ~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 232 EEYFSN--TSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp HHHHTT--CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred chhccc--CCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 222111 1222345566677778999999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=323.10 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=200.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++.... .+...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence 35899999999999999999999999999999886432 22457999999999999999999885432 345668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++..++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 899999976 77766654 3578999999999999999999999 78 9999999999999855789999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+.... .
T Consensus 180 ~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~ 253 (290)
T 1t4h_A 180 TLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD---K 253 (290)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG---G
T ss_pred cccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC---C
Confidence 765333 3345578999999999853 489999999999999999999999998766666655554433222110 0
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
........+...|+..+|.+|||++|+++|||
T Consensus 254 -~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 254 -VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -CCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 11122455666677778999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=334.20 Aligned_cols=248 Identities=17% Similarity=0.224 Sum_probs=195.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.+ +|+||+++++++. +....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCccEE
Confidence 35799999999999999999999999999999988643 34567899999999 9999999999884 3455889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc-----EEEEeeccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSA 227 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~-----~kl~Dfg~a 227 (340)
||||++++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|||++
T Consensus 83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCTTC
T ss_pred EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEcccc
Confidence 9999977888877643 4689999999999999999999999 79999999999999985 555 999999999
Q ss_pred cccccCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhc
Q 019506 228 KVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVS 296 (340)
Q Consensus 228 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~ 296 (340)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+ ..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 87644332 235678999999999966 448999999999999999999999998743 333344443322
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...+ . ....+.+.|+..+|.+||++++|.+
T Consensus 237 ~~~~~~~~~~~~--p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEVLCENF--P-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHHHTTTC--H-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHHHhccC--h-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222222211111 1 4455666777778999999988764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=339.82 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=204.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCC-CC-----ceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-HP-----NVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~ 145 (340)
..++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+++++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~----- 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM----- 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-----
Confidence 4568999999999999999999999999999999997543 22346888888775 44 4888888884
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCceecCCCCCCeEecC-CCCcEEEEe
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDP-LTHQVKLCD 223 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~iiH~dlkp~Nill~~-~~~~~kl~D 223 (340)
.....++||||++++|.+.+.... ...+++..++.++.|++.||.|||+. .||+||||||+|||++. .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 345688999999999888887532 25689999999999999999999941 59999999999999952 367899999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
||+++.... ......+|+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.+....+....
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987633 23456789999999999764 489999999999999999999999999999999998888766543221
Q ss_pred ---------hhcccccc------------------------------------------------CChhhHhhhcccccc
Q 019506 304 ---------IYQGLFCS------------------------------------------------NNHEIMCELGSWYSY 326 (340)
Q Consensus 304 ---------~~~~~~~~------------------------------------------------~~~~~~~~l~~~~~~ 326 (340)
++..+... .....+.+.|+..+|
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 11111000 012356666777889
Q ss_pred cCCCCcCcccccCC
Q 019506 327 SGRNSMHESKLYGF 340 (340)
Q Consensus 327 ~~R~~~~~i~~hpf 340 (340)
.+|||++|+++|||
T Consensus 362 ~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 362 KTRIQPYYALQHSF 375 (382)
T ss_dssp TTSCCHHHHTTSGG
T ss_pred hhCCCHHHHhcCcc
Confidence 99999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=324.95 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=199.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence 3457999999999999999999999999999999886542 2345799999999999999999998 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~ 161 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGL 161 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEeccC
Confidence 568899999995 66655543 3578999999999999999999999 79999999999999995 78899999999
Q ss_pred ccccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 227 a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+.+. .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-- 237 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKH-- 237 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTT--
T ss_pred ceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCCccc--
Confidence 9876432 22334568999999999965 44799999999999999999999999988776666555442 2221111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+|||++|+++|||
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 238 ----INPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ----cCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1122345566677778999999999999997
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=324.15 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence 47999999999999999999999999999999986433 33457999999999999999999883 445588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+ .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCcccc
Confidence 99999986 544433 335679999999999999999999999 79999999999999995 788999999999765
Q ss_pred ccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ......|++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.................. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~- 232 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WK- 232 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT--GG-
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc--hh-
Confidence 4332 12345689999999999765545789999999999999999999998765533322222221111100 00
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.......+...|+..+|.+|||++|+++|||
T Consensus 233 -~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 233 -KIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp -GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -hcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 01223345667777778999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=324.50 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=201.2
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...++|.+.+.||+|+||.||+|++..+++.||+|++... .....+|+++++.++|+||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 3456899999999999999999999999999999998543 13346799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEeccc
Confidence 4568899999985 77776654 2568999999999999999999999 79999999999999995 7889999999
Q ss_pred cccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
++...... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+... .......
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-- 234 (284)
T 2vgo_A 160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPF-- 234 (284)
T ss_dssp TCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTT--
T ss_pred ccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccCCCCc--
Confidence 98765432 23345789999999999654 4799999999999999999999999988776666555542 2222111
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+||+++|+++|||
T Consensus 235 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 235 ----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred ----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 1223345666677778999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=324.43 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=203.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCc
Confidence 3457999999999999999999999999999999986432 234579999999999999999998754 2344
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----ceecCCCCCCeEecCCCCcEEEE
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
..++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +| |+||||||+||+++. ++.+||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~kl~ 158 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLG 158 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEEEC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEEEe
Confidence 58899999985 8888877655555679999999999999999999999 68 999999999999995 7889999
Q ss_pred eeccccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 223 DFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 223 Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|||++........ .....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 9999987643322 2234678999999999654 4899999999999999999999999988776665555553322221
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .+.....+...|+..+|.+||+++|+++|+|
T Consensus 238 ~~------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 238 YR------YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp TT------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cc------cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11 2233455667777788999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=335.05 Aligned_cols=254 Identities=33% Similarity=0.565 Sum_probs=201.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCC-Ccee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~ 149 (340)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 47999999999999999999999999999999986532 2235799999999999999999998543221 1123
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||||+++++.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeecccccC
Confidence 5899999998755443 2469999999999999999999999 79999999999999995 78899999999986
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh-----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI----- 304 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (340)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+.....
T Consensus 176 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 5332 334578999999999976566899999999999999999999999999988888888876655432110
Q ss_pred ------h-----------cccc--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------Y-----------QGLF--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------~-----------~~~~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+ .... .+.....+..-|+..+|.+|||++|+++|||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 0000 1122345666677778999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=324.60 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=204.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------------cChHHHHHHHHhCC-CCceeecceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCFF 140 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~ 140 (340)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++++. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 3457999999999999999999999999999999986432 22347899999995 99999999998
Q ss_pred ecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcE
Q 019506 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~ 219 (340)
.+....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~ 163 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNI 163 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCcE
Confidence 445568899999985 77776654 3578999999999999999999999 79999999999999995 7889
Q ss_pred EEEeeccccccccCCccceeeeeccccCccccc-----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019506 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 294 (340)
||+|||++.............++..|+|||++. ....++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999999998876655555667899999999985 234578999999999999999999999998887666666655
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....... ..+.. .+.....+...|+..+|.+|||++|+++|||
T Consensus 244 ~~~~~~~-~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 244 GNYQFGS-PEWDD--YSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp TCCCCCT-TTGGG--SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCcccCc-ccccc--cCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 4322111 11111 1223455666777788999999999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=326.19 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=176.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 357999999999999999999999999999999986432 3346799999999999999999998 4455
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecce
Confidence 68899999985 66555542 23578999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~----- 232 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMP----- 232 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCC-----
T ss_pred eeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCc-----
Confidence 8764322 2234568999999999965 44799999999999999999999999876654443332211 11110
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+.....+...|+..+|.+|||++++++|||
T Consensus 233 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 233 -SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred -cccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 011223345666677778999999999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=336.70 Aligned_cols=246 Identities=23% Similarity=0.285 Sum_probs=189.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCC--CceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||+|.+ .+++.||||++.... ....+|+++++.++| +||+++++++ .+..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCC
Confidence 4699999999999999999986 568999999986442 234579999999987 9999999988 4455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeeccccc
Confidence 6899999888888887765 4678999999999999999999999 7999999999999997 5779999999998
Q ss_pred ccccCCc---cceeeeeccccCcccccC----------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 019506 229 VLVKGEA---NISYICSRYYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294 (340)
Q Consensus 229 ~~~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~ 294 (340)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.... ..+..++.
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7644332 234578999999999853 245889999999999999999999999875442 33333332
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......... ........+...|+..+|.+|||++|++.|||
T Consensus 236 ~~~~~~~~~-----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 236 PNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp TTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCcccCCcc-----cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 221111111 11122345666777788999999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.27 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=196.5
Q ss_pred ccCeeEe-eeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC-CCceeecceeeeecCCCCc
Q 019506 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|.+. +.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.+. ||||+++++++ .+.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~ 101 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT 101 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence 4468887 89999999999999999999999999886532 23457899999885 69999999998 445
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEee
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF 224 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Df 224 (340)
...++||||+.+ +|.+.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 558899999987 44443321 224679999999999999999999999 79999999999999984 2578999999
Q ss_pred ccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
|++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+....... ..
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~ 256 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-ET 256 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-TT
T ss_pred ccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-hh
Confidence 99988765555556678999999999965 45899999999999999999999999998887777776664432221 11
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.. .......+...|+..+|.+|||++|+++|||
T Consensus 257 ~~~--~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 257 FSS--VSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp TTT--SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred hcc--cCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 111 1222345566677778999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=328.90 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=201.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++.++|+||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 357999999999999999999999999999999986432 334679999999999999999998853 233
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
...++||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeeccccc
Confidence 457899999999877776653 24679999999999999999999999 79999999999999995 789999999999
Q ss_pred cccccCC---ccceeeeeccccCcccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGE---ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ......|+..|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 235 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGD 235 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSS
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCc
Confidence 8764322 223456799999999986532 24779999999999999999999999887766666555432 221111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+......+...|+..+|.+|||++|+++|||
T Consensus 236 ------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 236 ------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ------SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ------cCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 2233455667777788999999999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.53 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=186.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
...+|++.+.||+|+||+||+|++ +|..||||++.... ....+|++++++++||||+++++++ .+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 345799999999999999999987 78899999986543 2235799999999999999999998 4444
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++||||+++ +|.+.+... .....+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCC
Confidence 58899999986 666666531 111248999999999999999999999 79 999999999999995 8899999999
Q ss_pred cccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 226 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+............
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred CCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 9976543322 2345789999999999654 4899999999999999999999999988877666665443332221111
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+.+.|+..+|.+|||++|+++
T Consensus 264 -----~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 264 -----LNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1223455666777778999999999865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=323.38 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=188.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 457999999999999999999999999999999885432 2345799999999999999999988 4555
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCCCc
Confidence 68899999986 66666654 3579999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 228 KVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 228 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
........ .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+...+.+............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 87644322 2235689999999999764 47999999999999999999999999988777666655543332222211
Q ss_pred ccccccCChhhHhhhcccccccCCC-CcCc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRN-SMHE 334 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~-~~~~ 334 (340)
.. .......+..-|+..+|.+|| ++++
T Consensus 238 ~~--~~~~l~~li~~~l~~dp~~R~~~~~~ 265 (294)
T 4eqm_A 238 KD--IPQSLSNVILRATEKDKANRYKTIQE 265 (294)
T ss_dssp TT--SCHHHHHHHHHHSCSSGGGSCSSHHH
T ss_pred cC--CCHHHHHHHHHHhcCCHhHccccHHH
Confidence 11 112234455556666788888 4444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=330.17 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=190.9
Q ss_pred ccCeeEe-eeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHh-CCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+.|.+. +.||+|+||.||+|++..+++.||||++.... ....+|++++++ ++||||+++++++. +...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 4579885 78999999999999999999999999986543 234579999988 57999999999984 3445
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc---EEEEeec
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ---VKLCDFG 225 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~---~kl~Dfg 225 (340)
.++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++. +||+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH-PNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESC-SSSSCSEEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEcc-CCCcCceEEEEcc
Confidence 889999998 477776654 3578999999999999999999999 79999999999999985 443 9999999
Q ss_pred cccccccCC--------ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--------
Q 019506 226 SAKVLVKGE--------ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------- 285 (340)
Q Consensus 226 ~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------- 285 (340)
++....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987653221 1123458999999999853 13478999999999999999999999987542
Q ss_pred ------HHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 286 ------VDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+...+...........+.. .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAH--ISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTT--SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred ccchhHHHHHHHHHhccCcccCchhccc--CCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 2233333333333332221111 1223455666777778999999999999999
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.98 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=196.4
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEc-------CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~ 140 (340)
...++|.+++.||+|+||.||+|++. .++..||||+++... ....+|+++++.+ +||||+++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence 44578999999999999999999875 345679999986542 2345799999999 899999999998
Q ss_pred ecCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCC
Q 019506 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp 207 (340)
.+...+|+||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 157 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp 231 (370)
T 2psq_A 157 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 231 (370)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCG
T ss_pred ----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccch
Confidence 444558899999986 77777765321 12458999999999999999999999 7999999999
Q ss_pred CCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (340)
+|||++. ++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||+| |..||.+.
T Consensus 232 ~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 232 RNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hhEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999995 88999999999986543322 2234567889999999764 48999999999999999999 99999988
Q ss_pred ChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 284 NAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+..+.+..+.......... .+......+...|+..+|.+||+++|+.++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRMDKPA------NCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665555444332222211 123344556677777889999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=322.60 Aligned_cols=248 Identities=18% Similarity=0.190 Sum_probs=196.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhC-CCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+..+..+ +||||+++++++. +.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence 3457999999999999999999999999999999987532 2234678888888 8999999999984 34
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC------------
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------ 214 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~------------ 214 (340)
...++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 458899999976 8888887655555779999999999999999999999 79999999999999973
Q ss_pred ------CCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 019506 215 ------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288 (340)
Q Consensus 215 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 288 (340)
....+||+|||++....... ...||+.|+|||++.+...++.++|||||||++|+|++|.+++.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 23479999999998764433 345899999999997665677899999999999999999988765432
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+.+. ..+.... ..+.....+...|+..+|.+|||++|+++|||
T Consensus 237 ~~~~~~~-~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 237 WHEIRQG-RLPRIPQ-----VLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HHHHHTT-CCCCCSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HHHHHcC-CCCCCCc-----ccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 3333322 2211111 12233455666777778999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.01 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=200.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC-cEEEEEEecccc---cChHHHHHHHHhCCCCc------eeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRLMDHPN------VISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~ 145 (340)
.++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+|+++++.++|++ ++.+++++ .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence 457999999999999999999998777 689999987532 33457889999887665 88888877 3
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-----------
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------- 214 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----------- 214 (340)
.....++||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eCCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccc
Confidence 34468899999999988877652 23579999999999999999999999 79999999999999932
Q ss_pred -------CCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 019506 215 -------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (340)
Q Consensus 215 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (340)
.++.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 367899999999986533 23345789999999999654 58999999999999999999999999988888
Q ss_pred HHHHHHHhcCCCchhhhhccc---------------------------------c-----ccCChhhHhhhcccccccCC
Q 019506 288 QLVEIIKVSNIIYAKTIYQGL---------------------------------F-----CSNNHEIMCELGSWYSYSGR 329 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~---------------------------------~-----~~~~~~~~~~l~~~~~~~~R 329 (340)
.+..+.+......... +... . .......+...|+..+|.+|
T Consensus 247 ~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHM-IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHCCCCHHH-HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHcCCCcHHH-hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 7777776654432211 0000 0 00112356667777889999
Q ss_pred CCcCcccccCC
Q 019506 330 NSMHESKLYGF 340 (340)
Q Consensus 330 ~~~~~i~~hpf 340 (340)
||++|+++|||
T Consensus 326 pt~~e~l~hp~ 336 (355)
T 2eu9_A 326 ITLAEALLHPF 336 (355)
T ss_dssp CCHHHHTTSGG
T ss_pred cCHHHHhcChh
Confidence 99999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=330.43 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=196.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+|+.+++.++||||+++++++..... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CC
Confidence 34579999999999999999999999999999999875422 23578888999999999999998854322 23
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeeccC
Confidence 346899999975 66666654 3579999999999999999999999 79999999999999995 78899999999
Q ss_pred ccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+...
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence 987644322 2234689999999999664 58999999999999999999999999988877777776654433221
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .. -.+.....+..-|+..+|.+||+..+++.|+|
T Consensus 242 ~-~~--~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 242 R-HE--GLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp H-ST--TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred c-cC--CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 1 11 11223445666677778999999998887765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=329.10 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=200.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEE-cCCCcEEEEEEecccc---cChHHHHHHHHhCCCC------ceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~ 145 (340)
..+|++.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+++++.++|+ +|+++++++ .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----E 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----E
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----c
Confidence 35799999999999999999998 5688999999987543 3345788888888665 489999988 3
Q ss_pred CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC----------
Q 019506 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---------- 215 (340)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~---------- 215 (340)
+....++||||+++++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcc
Confidence 44468999999988988887652 23468999999999999999999999 799999999999999853
Q ss_pred --------CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 019506 216 --------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (340)
Q Consensus 216 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (340)
++.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 45799999999976533 23345789999999999654 48999999999999999999999999988877
Q ss_pred HHHHHHHhcCCCchhhhhcccc--------------------------------------ccCChhhHhhhcccccccCC
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLF--------------------------------------CSNNHEIMCELGSWYSYSGR 329 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~l~~~~~~~~R 329 (340)
.+..+.+....... .++.... .......+.+.|+..+|.+|
T Consensus 242 ~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAMMERILGPLPK-HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHCSCCH-HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHhCCCCH-HHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 77776665543221 1111000 00112356677778889999
Q ss_pred CCcCcccccCC
Q 019506 330 NSMHESKLYGF 340 (340)
Q Consensus 330 ~~~~~i~~hpf 340 (340)
||++|+++|||
T Consensus 321 pt~~ell~hp~ 331 (339)
T 1z57_A 321 ITLREALKHPF 331 (339)
T ss_dssp CCHHHHTTSGG
T ss_pred cCHHHHhcCHH
Confidence 99999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=324.25 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 46999999999999999999999999999999986432 334679999999999999999999843 34588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeecccceec
Confidence 99999986 5555543 3679999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.+........ -
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~ 242 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------N 242 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS------S
T ss_pred CccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcc------c
Confidence 54432 234568999999999965 447999999999999999999999999887766665555432221111 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.......+...|+..+|.+|||++|+++|||
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1223456667777788999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=325.23 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=200.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 347999999999999999999999999999999987542 2346899999999999999999988 4445688
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe---cCCCCcEEEEeeccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA 227 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill---~~~~~~~kl~Dfg~a 227 (340)
+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||++ + .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPE-ENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCC-CCCCEEEccCCcc
Confidence 99999985 77666654 3568999999999999999999999 799999999999999 4 4778999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.. .......+..
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 233 (304)
T 2jam_A 157 KMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-YEFESPFWDD 233 (304)
T ss_dssp CCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-CCCCTTTTTT
T ss_pred eecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCcccccc
Confidence 765332 2334568999999999965 458999999999999999999999999888766666665533 2221111111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+||+++|+++|||
T Consensus 234 --~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 234 --ISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp --SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1223345666677778999999999999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=349.12 Aligned_cols=249 Identities=17% Similarity=0.131 Sum_probs=183.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHH---HHHHhCCCCceeecce-------e
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL---QLMRLMDHPNVISLKH-------C 138 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~---~~l~~l~h~~iv~~~~-------~ 138 (340)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+ ++++.++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457999999999999999999998899999999986431 2345788 4555668999999984 4
Q ss_pred eeecCC---------CCc---eeeeeeeccccchHHHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCceec
Q 019506 139 FFSTTS---------KDE---LFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (340)
Q Consensus 139 ~~~~~~---------~~~---~~~~lv~e~~~~~l~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~ 203 (340)
+..... .+. ...++||||++|+|.+.+...... ...+++..++.++.||+.||+|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 322110 111 137899999999988888754221 1234457888899999999999999 799999
Q ss_pred CCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCC----------CCCCCcchhHHHHHHHHHH
Q 019506 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL 273 (340)
Q Consensus 204 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el 273 (340)
||||+|||++. ++.+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 231 Dikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999995 7899999999998642 23334566 999999999754 2589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 274 LLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
++|+.||.+.+....+..+.... . -.......+...|+..+|.+||+++|+++|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRSC---------K--NIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHSSCCC------CCSGGGGSSC---------C--CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHCCCCCcccccccchhhhhhhc---------c--CCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 99999997765433222221110 0 11223345566677778999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=332.25 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=193.9
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhC-CCCceeecceeee
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFF 140 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~ 140 (340)
.....+|++.+.||+|+||.||+|++. .+|+.||||+++... ....+|+++++.+ +|+||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 344568999999999999999999984 589999999886431 2345699999999 6999999999883
Q ss_pred ecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcE
Q 019506 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~ 219 (340)
.....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus 130 -----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~ 198 (355)
T 1vzo_A 130 -----TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHV 198 (355)
T ss_dssp -----ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCE
T ss_pred -----eCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcE
Confidence 34458899999986 77666654 2578999999999999999999999 79999999999999995 8899
Q ss_pred EEEeeccccccccCCc--cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHH
Q 019506 220 KLCDFGSAKVLVKGEA--NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEII 293 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~ 293 (340)
||+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+ ....+...+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 9999999986533222 2345789999999999753 347899999999999999999999997543 223333333
Q ss_pred HhcCCCchhhhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 294 KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
.....+.... .+.....+...|+..+|.+|| +++|+++|||
T Consensus 279 ~~~~~~~~~~------~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 279 LKSEPPYPQE------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHCCCCCCTT------SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred hccCCCCCcc------cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 2222222221 112234566677777899999 9999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=336.61 Aligned_cols=255 Identities=16% Similarity=0.159 Sum_probs=193.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC-----CcEEEEEEecccccChHHHH---------------HHHHhCCCCceeecc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNREL---------------QLMRLMDHPNVISLK 136 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~E~---------------~~l~~l~h~~iv~~~ 136 (340)
.+|++.+.||+|+||.||+|.+..+ ++.||||++........+|+ ..++.++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4799999999999999999998764 58899999876544333333 345566799999999
Q ss_pred eeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-C
Q 019506 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-L 215 (340)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~ 215 (340)
+++.... .+..+.++||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9886532 23466889999997777777754 24679999999999999999999999 79999999999999982 2
Q ss_pred CCcEEEEeeccccccccCCcc--------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH
Q 019506 216 THQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (340)
++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 678999999999776433221 234589999999999654 48999999999999999999999998654434
Q ss_pred HHHHHHHhcCCCchhhhhcccc----ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLF----CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......+.........++..++ +......+.+.|+..+|.+||++++|.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 4443333332233333333332 2334556667777888999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.77 Aligned_cols=262 Identities=26% Similarity=0.444 Sum_probs=200.9
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCC-----------CCceeecce
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKH 137 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~ 137 (340)
.+....+|++.+.||+|+||.||+|++..+++.||||++..+. ....+|+.++++++ |+||+++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3445568999999999999999999999999999999987543 33457888888776 899999999
Q ss_pred eeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecC--
Q 019506 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDP-- 214 (340)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~-- 214 (340)
++.... .+...+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ + ||+||||||+|||++.
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEE
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccC
Confidence 985432 2344688999999888888877532 3568999999999999999999999 8 9999999999999952
Q ss_pred ---CCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------h
Q 019506 215 ---LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------A 285 (340)
Q Consensus 215 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~ 285 (340)
..+.+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|+||..||.+.+ .
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 2347999999999876432 3345789999999999764 48999999999999999999999998654 4
Q ss_pred HHHHHHHHHhcCCCchhhhh---------------cc---------------cc-----ccCChhhHhhhcccccccCCC
Q 019506 286 VDQLVEIIKVSNIIYAKTIY---------------QG---------------LF-----CSNNHEIMCELGSWYSYSGRN 330 (340)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~---------------~~---------------~~-----~~~~~~~~~~l~~~~~~~~R~ 330 (340)
.+.+..+++..+......+. .+ .. .......+..-|+..+|.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 45566666544433221100 00 00 001123456667777899999
Q ss_pred CcCcccccCC
Q 019506 331 SMHESKLYGF 340 (340)
Q Consensus 331 ~~~~i~~hpf 340 (340)
|++|+++|||
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.37 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=187.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhC----CCCceeecceeeeec
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLM----DHPNVISLKHCFFST 142 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~~~ 142 (340)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++++ +|+||+++++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~--- 107 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--- 107 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE---
Confidence 46999999999999999999999999999999986432 2334699999988 899999999988
Q ss_pred CCCCceeeeeeecc-cc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 143 TSKDELFLNLVMEY-VP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 143 ~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.+....++|||+ +. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+|
T Consensus 108 --~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 --ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEE
T ss_pred --ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEE
Confidence 344457899998 55 577777654 3568999999999999999999999 79999999999999985578999
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||++....... .....|+..|+|||++.+....+.++|||||||++|+|++|+.||..... +... ....
T Consensus 181 l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-~~~~ 252 (312)
T 2iwi_A 181 LIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA-ELHF 252 (312)
T ss_dssp ECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT-CCCC
T ss_pred EEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh-ccCC
Confidence 99999998765433 33557899999999987655456689999999999999999999975321 1111 1111
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
... .......+...|+..+|.+|||++|+++|||
T Consensus 253 ~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 253 PAH------VSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp CTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ccc------CCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111 1222345566677778999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=321.02 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=201.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|++++++++||||+++++++ .+....
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCeE
Confidence 46999999999999999999999999999999986432 2345799999999999999999998 344558
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeeccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~a 227 (340)
++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.. +..+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 899999975 66666654 2578999999999999999999999 799999999999999753 347999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.+......... +..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 248 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-WRT 248 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG-GTT
T ss_pred eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh-hhh
Confidence 87755555455678999999999854 389999999999999999999999998887766666655332211111 111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 249 --~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 249 --ISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred --cCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 1223455667777788999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=337.81 Aligned_cols=252 Identities=17% Similarity=0.197 Sum_probs=197.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEE-----cCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
...+|++.+.||+|+||+||+|++ ..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----- 143 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 143 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 456899999999999999999994 4577899999986432 2345799999999999999999998
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCc
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQ 218 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~ 218 (340)
.+....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. +..
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence 444457899999975 77777765432 23468999999999999999999999 799999999999999842 335
Q ss_pred EEEEeeccccccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 219 VKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999997653222 22234568899999999654 48999999999999999998 9999998887776666655
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
......... +......+...|+..+|.+||+++|+++|.
T Consensus 302 ~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 302 GGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp TCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCcc------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 443332222 233345677778888899999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=324.52 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=197.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc---ccChHHHHHHHHhC-CCCceeecceeeeecCCC-Cce
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DEL 148 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~ 148 (340)
...++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++++ +|+||+++++++...... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3456799999999999999999999999999999998643 23456799999988 799999999998653321 145
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCcCc
Confidence 68899999986 7777766422 3578999999999999999999999 79999999999999995 888999999999
Q ss_pred cccccCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
....... ......|++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.+........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence 7754332 2234568999999999852 3458899999999999999999999999888776666655533222111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.-.+.....+.+.|+..+|.+||+++|+++|||
T Consensus 257 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 257 -----KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp -----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred -----cccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 011233455666777778999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.22 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=195.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|++.+.||+|+||.||+|++..+++ .||||++.... ..+.+|+.+++.++||||+++++++ .+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34579999999999999999999986554 59999987532 2345799999999999999999998 45
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
....++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCCC
Confidence 5568899999986 66666543 24579999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+++........ ....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence 99876443221 122346789999999654 48999999999999999999 9999999888777777666544433
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... +......+...|+..+|.+|||++|+++
T Consensus 276 ~~~------~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 PMG------CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC------cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 322 2233455667777788999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=323.30 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=196.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
...+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++||||+++++++.. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence 3457999999999999999999999999999999886432 234579999999999999999999843 3458
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSAK 166 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHHH
T ss_pred EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCcc
Confidence 899999986 45444433 24679999999999999999999999 79999999999999995 78899999999754
Q ss_pred cccC-CccceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 230 LVKG-EANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 230 ~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
.... .......|+..|+|||++. ....++.++|||||||++|+|++|..||...+....+..+.+.......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 243 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL--- 243 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC---
Confidence 3221 1223456899999999984 3455899999999999999999999999988877777666654322111
Q ss_pred hccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+.....+...|+..+|.+|||++|+++|||
T Consensus 244 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 244 -TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp -SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred -CccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 00011223455666777788999999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=318.78 Aligned_cols=249 Identities=18% Similarity=0.252 Sum_probs=197.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +|+|++++++++ .+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEE
Confidence 34799999999999999999999999999999988643 34567899999999 799999999887 44455889
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc-----EEEEeeccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSA 227 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~-----~kl~Dfg~a 227 (340)
||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++. +||+|||++
T Consensus 84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTTC
T ss_pred EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECccc
Confidence 9999987888877642 3569999999999999999999999 79999999999999974 443 999999999
Q ss_pred cccccCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhc
Q 019506 228 KVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVS 296 (340)
Q Consensus 228 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~~~~~~ 296 (340)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+. +....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 87654322 234568999999999965 44899999999999999999999999874 3444444444433
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+... .......+...|+..+|.+||++++|.+
T Consensus 238 ~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPLRELCAG--FPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCHHHHTTT--SCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccHHHHHhh--CcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 33333332211 1233455666777788999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.38 Aligned_cols=254 Identities=23% Similarity=0.239 Sum_probs=191.2
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
....+|++.+.||+|+||+||+|++ .++.||||++.... ....+|+.+++.++||||+++++++..... ....+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEE
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceE
Confidence 3456799999999999999999987 58999999986543 223458888999999999999999865332 23457
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------CceecCCCCCCeEecCCCCcE
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP----------GVCHRDVKPQNLLVDPLTHQV 219 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------~iiH~dlkp~Nill~~~~~~~ 219 (340)
++||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ . ||+||||||+|||++. ++.+
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~ 170 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTA 170 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCE
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeE
Confidence 899999986 77777654 569999999999999999999999 8 9999999999999995 8899
Q ss_pred EEEeeccccccccCCc---cceeeeeccccCcccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------
Q 019506 220 KLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENA------- 285 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~------- 285 (340)
||+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|||+||+.||.+...
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999977644332 2235789999999999653 2356788999999999999999999976432
Q ss_pred --------HHHHHHHH-HhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 286 --------VDQLVEII-KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 286 --------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+.... .....+.....+...-+......+.+.|+..+|.+|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12222221 11122222222221111112455677788888999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=322.13 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=197.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
..+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++||||+++++++.. ....++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence 346999999999999999999999999999999987543 334689999999999999999999843 3458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhhhh
Confidence 999986 66666542 24679999999999999999999999 79999999999999995 78899999999977644
Q ss_pred CCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccccc
Q 019506 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCS 311 (340)
Q Consensus 233 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (340)
... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.......... ....+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 252 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK----PELWS 252 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS----GGGSC
T ss_pred hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCC----cccCC
Confidence 322 2345689999999999654 48999999999999999999999999887766665554433221110 00112
Q ss_pred CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 312 NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 312 ~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.....+...|+..+|.+|||++++++|||
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 33455667777888999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=328.81 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=174.8
Q ss_pred ccccCeeEee-eeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 74 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 74 ~~~~~y~~~~-~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
...++|.+.+ .||+|+||+||+|++..+|+.||||++........+....++.++|+||+++++++.... .+...+++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence 3456799954 699999999999999999999999998766554444555678889999999999885432 23556889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~a~~ 229 (340)
||||+++ +|.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999986 77777654 223579999999999999999999999 799999999999999742 34599999999986
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHhcCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI---IKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~ 306 (340)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+ +...........+.
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp C------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred cccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 5433 2334577999999999854 45899999999999999999999999876543332211 11111111111111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.+.....+...|+..+|.+|||++|+++|||
T Consensus 259 --~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 259 --EVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred --cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 11223445666777788999999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=333.80 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=197.9
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
......+|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++||||+++++++ .+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 183 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQ 183 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ec
Confidence 3345568999999999999999999999899999999886432 3456799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG 258 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFG 258 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCC
Confidence 4458899999984 777766542 3468999999999999999999999 79999999999999995 7899999999
Q ss_pred cccccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+++......... ...++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+....+.+
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP 337 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998654332211 12357789999999654 48999999999999999998 99999988776655555443333322
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+...|+..+|.+|||++++.+
T Consensus 338 ~~------~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 338 EL------CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11 2333455667778888999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.56 Aligned_cols=257 Identities=26% Similarity=0.321 Sum_probs=176.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-----ChHHHHH-HHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+. +++.++||||+++++++. +..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 44689999999999999999999999999999999865422 1223444 677789999999999984 344
Q ss_pred eeeeeeccccchHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..++||||+++++.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCC
Confidence 5889999999988877764322 35789999999999999999999999 8 9999999999999995 88999999999
Q ss_pred ccccccCCccceeeeeccccCccccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 302 (340)
+.............||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+.. +.+..+.+. ..+...
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 251 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLS 251 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCC
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCC
Confidence 98775555444557899999999983 2345899999999999999999999999875432 222211111 111100
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
... ..-.......+...|+..+|.+||+++|+++|||
T Consensus 252 ~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 252 NSE-EREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred Ccc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 000 0011223455667777888999999999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=332.28 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=193.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++. +....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence 457999999999999999999999999999999987542 23457999999999999999999984 34458
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|||++.
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGVSG 180 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCCCH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCCCc
Confidence 899999986 77776654 3578999999999999999999998 5 8999999999999995 7889999999997
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc--------
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY-------- 300 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------- 300 (340)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 65332 2334578999999999965 4589999999999999999999999987765443222110000000
Q ss_pred ------------------hhhhhc----c-------ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 ------------------AKTIYQ----G-------LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ------------------~~~~~~----~-------~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....+. . -..+.....+...|+..+|.+|||++|+++|||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000000 0 001112345566677788999999999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=315.19 Aligned_cols=246 Identities=18% Similarity=0.291 Sum_probs=196.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...+|++.+.||+|+||.||+|++. +++.||+|++.... ....+|++++++++||||+++++++ .+....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3457999999999999999999976 57789999987543 3356899999999999999999998 4445588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEeccccccccc
Confidence 99999986 56665543 24568999999999999999999999 79999999999999985 788999999999865
Q ss_pred ccCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+....+...........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 231 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---- 231 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT----
T ss_pred cccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCc----
Confidence 3322 1223445778999999965 448999999999999999999 9999998887776666655433222211
Q ss_pred ccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.....+...|+..+|.+||+++|+++|
T Consensus 232 --~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 232 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22334556667777889999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=327.36 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=195.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+|++.+.||+|+||.||+|++. .+++.||||++.... ....+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 120 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 120 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----c
Confidence 457999999999999999999987 345899999987542 2346799999999999999999998 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecC
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSM--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~d 204 (340)
+....++||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 199 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 199 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 44558899999986 777777653211 2578999999999999999999999 7999999
Q ss_pred CCCCCeEecCCCCcEEEEeeccccccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 019506 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 280 (340)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf 280 (340)
|||+|||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|+| |..||
T Consensus 200 lkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999995 7899999999997654332 12234568889999999654 48999999999999999999 99999
Q ss_pred CCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 281 PGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.+..+.+..+........... +......+.+.|+..+|.+||+++++.++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILACPEN------CPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChHHHHHHHhCCCcCCCCCC------CCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 98887666665554332222111 22334556677777889999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=338.18 Aligned_cols=255 Identities=12% Similarity=0.034 Sum_probs=174.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-------ChHHHH---HHHHhCCCCceeecce-------e
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL---QLMRLMDHPNVISLKH-------C 138 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~---~~l~~l~h~~iv~~~~-------~ 138 (340)
..+|.+.+.||+|+||.||+|++..+|+.||||++..... ...+|+ ..++. +||||++++. +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3459999999999999999999999999999999976432 223564 44555 7999888553 3
Q ss_pred eeecCCC------------CceeeeeeeccccchHHHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCc
Q 019506 139 FFSTTSK------------DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV------KLYTYQIFRGLAYIHTVPGV 200 (340)
Q Consensus 139 ~~~~~~~------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~i 200 (340)
+...... ....+++||||++++|.+.+..... .++.... ..++.||+.||+|||+ +||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~i 215 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGL 215 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCC
Confidence 3221110 1145789999999999988876422 3344444 5677999999999999 799
Q ss_pred eecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCC
Q 019506 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPL 279 (340)
Q Consensus 201 iH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~p 279 (340)
+||||||+|||++. ++.+||+|||+++..... .....+|+.|+|||++.+. ..++.++|||||||++|+|+||+.|
T Consensus 216 vHrDikp~NIll~~-~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMP-DGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECT-TSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECC-CCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999995 788999999999876322 2244567999999999641 4589999999999999999999999
Q ss_pred CCCCChHHH--HHHHH--HhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 280 FPGENAVDQ--LVEII--KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 280 f~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
|.+...... +.... ............. -.+.....+...|+..+|.+|||++|+++|||
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT--PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSS--CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhcc--CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 987643210 00000 0000000000000 11223445666777778999999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=327.78 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=198.0
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCC-------CcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceee
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCF 139 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~ 139 (340)
....++|.+.+.||+|+||.||+|++..+ +..||||++.... ....+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34456899999999999999999997543 3579999986542 2345799999999 899999999998
Q ss_pred eecCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCC
Q 019506 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (340)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlk 206 (340)
.+....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+|||||
T Consensus 145 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlk 218 (382)
T 3tt0_A 145 -----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLA 218 (382)
T ss_dssp -----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCC
T ss_pred -----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCC
Confidence 444458899999986 77777765321 12469999999999999999999999 799999999
Q ss_pred CCCeEecCCCCcEEEEeeccccccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 019506 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (340)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 282 (340)
|+|||++. ++.+||+|||+++...... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 219 p~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 219 ARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGGEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999995 7899999999998764432 2223456788999999976 448999999999999999999 9999998
Q ss_pred CChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 283 ENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+..+....+.......... .+......+...|+..+|.+|||++|++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCCCCCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87766555554433322221 123344566677777889999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=329.17 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=196.3
Q ss_pred cccCeeEeeeeeeecceEEEEEE-----EcCCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
..++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence 34579999999999999999998 45567899999987532 2345799999999 78999999998843
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcC---------------------------------------------------
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------------------------------------- 171 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------------------------------------- 171 (340)
....+++||||+++ +|.+.+......
T Consensus 98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 22347899999986 777766543210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCc---cc
Q 019506 172 -----------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NI 237 (340)
Q Consensus 172 -----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~ 237 (340)
...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........ ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhcc
Confidence 1228999999999999999999999 79999999999999995 78899999999986543322 22
Q ss_pred eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhh
Q 019506 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEI 316 (340)
Q Consensus 238 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (340)
...+|..|+|||++.+ ..++.++|||||||++|+|+| |..||.+.+..+.+...+........... .......
T Consensus 254 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~ 327 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-----TTPEMYQ 327 (359)
T ss_dssp -CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT-----CCHHHHH
T ss_pred ccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC-----CCHHHHH
Confidence 3567889999999965 448999999999999999998 99999988766666666655443322221 2223455
Q ss_pred HhhhcccccccCCCCcCccccc
Q 019506 317 MCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 317 ~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+...|+..+|.+|||++|+++|
T Consensus 328 li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHH
Confidence 6667777789999999998875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=318.94 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=192.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCC--------
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTS-------- 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------- 144 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 347999999999999999999999999999999986533 334579999999999999999998865321
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
......++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEee
Confidence 235678899999985 77777653 23567889999999999999999999 79999999999999995 78899999
Q ss_pred eccccccccC---------------CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 019506 224 FGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288 (340)
Q Consensus 224 fg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 288 (340)
||++...... .......|++.|+|||++.+...++.++|||||||++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765422 122345689999999999765568999999999999999998 6654433333
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...++......+..+... .......+.+.|+..+|.+|||++|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDN--KMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTT--TSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHhccccccccCcccccc--chHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 4444443332222221110 0111355667777788999999999999999
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.88 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=181.1
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
....+|++.+.||+|+||.||+|++..+|+.||||++..... ...++..+++.++||||+++++++. +.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TN 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cC
Confidence 345689999999999999999999999999999999865422 1223445688889999999999984 44
Q ss_pred eeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++.+...... ....+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEECCC
Confidence 46889999997655444432 24678999999999999999999998 5 9999999999999995 78899999999
Q ss_pred ccccccCCccceeeeeccccCccccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~ 301 (340)
+.............+++.|+|||++. ....++.++|||||||++|+|++|+.||.... ..+.+..+.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 98765555555567899999999985 23457899999999999999999999998744 44455555543222111
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. .-.......+...|+..+|.+||+++|+++|||
T Consensus 252 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 252 GH----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp SS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred cc----CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 00 011223455666777778999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=324.91 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=184.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
...+|++.+.||+|+||.||+|++..+++.||||.+... .....+|+.+++.++||||+++++++.. ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence 345799999999999999999998889999999987543 2334578889999999999999999843 334
Q ss_pred eeeeeccccc-hHHHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEec
Confidence 8899999975 77776654322 24568999999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCC------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 019506 225 GSAKVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNI 298 (340)
Q Consensus 225 g~a~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 298 (340)
|++....... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+.........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654322 1223468999999999865445899999999999999999999999987776655544443222
Q ss_pred Cchhhhh-ccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 299 IYAKTIY-QGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 299 ~~~~~~~-~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....... ..... ......+...|+..+|.+||+++|+++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 1111100 00111 112345667778888999999999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=324.13 Aligned_cols=258 Identities=19% Similarity=0.245 Sum_probs=184.6
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
....+|++.+.||+|+||.||+|++..++. .||||++.... ....+|+++++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345579999999999999999999877665 89999886432 334579999999999999999999854332
Q ss_pred CC-ceeeeeeeccccc-hHHHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 145 KD-ELFLNLVMEYVPE-TMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 145 ~~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.. ....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~k 177 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVC 177 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEE
Confidence 21 1234899999986 67666654322 12268999999999999999999999 79999999999999995 78999
Q ss_pred EEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 019506 221 LCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 296 (340)
|+|||+++........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999876443322 233457789999999654 48999999999999999999 999999888877777666654
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCC-------cCcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNS-------MHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~-------~~~i~~hpf 340 (340)
....... .......+...|+..+|.+||| ++++++|||
T Consensus 257 ~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 257 RLKQPPE------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CCCCCTT------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCCCCCc------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 4333322 1223455666777778999999 777888887
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.98 Aligned_cols=246 Identities=21% Similarity=0.312 Sum_probs=192.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcE----EEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
...+|++.+.||+|+||+||+|++..+++. ||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 345799999999999999999999888876 677766432 234457999999999999999999872
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+ ...++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECCC
Confidence 2 237799999985 66666543 23578899999999999999999999 79999999999999985 788999999
Q ss_pred ccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 225 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 225 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+++....... .....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+.+......
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ 238 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 99987644432 2234567789999999654 48999999999999999999 9999998776555555544333322
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
... +......+...|+..+|.+||+++|+.+|
T Consensus 239 ~~~------~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQI------CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTT------BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCc------CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222 34445567777888889999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.71 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=194.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCC--CCceeecceeeeec
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFST 142 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 142 (340)
...+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.++++++ |+||+++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--- 117 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence 4567999999999999999999999999999999986542 23457999999996 59999999998
Q ss_pred CCCCceeeeeeecccc--chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEE
Q 019506 143 TSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~k 220 (340)
.+....++|||++. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+|
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEE
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEE
Confidence 44455889999997 577777654 3678999999999999999999999 79999999999999985578999
Q ss_pred EEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
|+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+. +... ....
T Consensus 191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~ 262 (320)
T 3a99_A 191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFF 262 (320)
T ss_dssp ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCC
T ss_pred EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccc
Confidence 9999999876443 233457899999999997666557899999999999999999999975421 1111 1111
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. -.......+.+.|+..+|.+|||++|+++|||
T Consensus 263 ~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 263 RQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp SS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cc------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 11 11223445666677778999999999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=310.77 Aligned_cols=246 Identities=18% Similarity=0.278 Sum_probs=196.6
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..++|++.+.||+|+||.||+|++. ++..||+|++.... ....+|+++++.++||||+++++++ .+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4467999999999999999999865 57789999987543 3346799999999999999999998 4555588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ ++.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccceec
Confidence 99999975 577666542 3468999999999999999999999 79999999999999995 889999999999876
Q ss_pred ccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH----- 228 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-----
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC-----
Confidence 444322 223456779999999654 48999999999999999999 999999888777666665543322221
Q ss_pred ccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+.....+...|+..+|.+|||++|++++
T Consensus 229 -~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 229 -LASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123334566777778889999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.36 Aligned_cols=242 Identities=25% Similarity=0.419 Sum_probs=189.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|.+++.||+|+||+||+|++..+++.||+|++... .....+|+++++.++||||+++++++. +....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 45799999999999999999999999999999988543 233458999999999999999999984 344588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeecccceec
Confidence 99999986 66666653 24679999999999999999999999 79999999999999995 888999999999876
Q ss_pred ccCCcc---------------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-----HHH
Q 019506 231 VKGEAN---------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-----QLV 290 (340)
Q Consensus 231 ~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~ 290 (340)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 433221 14568999999999965 458999999999999999999999987542211 111
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
........ .-+......+...|+..+|.+|||++|+.+
T Consensus 238 ~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLDRYCP---------PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHTCC---------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111100 112334555667777778999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=313.14 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=183.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|++.+.||+|+||.||+|++ +|..||||++.... ....+|+++++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 45799999999999999999998 58999999886432 2345799999999999999999998 444
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---ceecCCCCCCeEecC-------CC
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG---VCHRDVKPQNLLVDP-------LT 216 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~---iiH~dlkp~Nill~~-------~~ 216 (340)
...++||||+++ ++.+.+. ...+++..++.++.|++.||.|||+ +| |+||||||+|||++. .+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence 558899999986 4444442 4679999999999999999999999 78 999999999999984 25
Q ss_pred CcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 019506 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 296 (340)
+.+||+|||++....... .....|++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 679999999998654433 2345789999999999654 48999999999999999999999999888766655555433
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
....... .+......+...|+..+|.+|||++|+++|
T Consensus 231 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 LALPIPS-----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCc-----ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 2222111 122334556667777789999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=316.65 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=184.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|+||+++++++.. ...
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCc
Confidence 4699999999999999999999999999999998642 1234579999999999999999999843 345
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEecccee
Confidence 8899999986 7777777666666789999999999999999999999 79999999999999995 8899999999997
Q ss_pred ccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCchhhhhc
Q 019506 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 229 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
....... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.. ....+...+.....+....
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--- 260 (310)
T ss_dssp --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT---
T ss_pred eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc---
Confidence 7644322 234568999999999965 458999999999999999999999997653 2233333333333222110
Q ss_pred cccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.........+...|+..+|.+|||++++.++
T Consensus 261 -~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 261 -DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0112234556667777889999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.68 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=195.5
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
....+|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+|+++++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 34568999999999999999999973 456899999986542 2345799999999999999999998
Q ss_pred CCCceeeeeeecccc-chHHHHHHHhhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCcee
Q 019506 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH 202 (340)
.+....++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+|
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 173 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVH 173 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 44445889999998 577777765322 12458999999999999999999999 79999
Q ss_pred cCCCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCC
Q 019506 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 278 (340)
Q Consensus 203 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~ 278 (340)
|||||+||+++. ++.+||+|||++......... ....+++.|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus 174 ~dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999995 888999999999876443321 223457889999999654 48999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 279 LFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 279 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
||.+.+.......+........... .......+...|+..+|.+||+++|+.++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDN------CSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCcc------CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988877555544443322222111 22334566677777889999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=316.35 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
|.....||+|+||.||+|++..+++.||||.+.... ....+|+.+++.++||||+++++++. +....++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEEE
Confidence 444558999999999999999999999999886542 23457999999999999999999984 344588999
Q ss_pred ccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||+++ +|.+.+... .....+++..++.++.|++.||.|||+ +||+||||||+||+++..++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99975 666666542 223456788999999999999999999 799999999999999865789999999999876433
Q ss_pred Cc-cceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCchhhhhccccc
Q 019506 234 EA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 234 ~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
.. .....|+..|+|||++.+. ..++.++||||||+++|+|++|+.||.+...... ..........+.... ..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 251 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE-----SM 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT-----TS
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc-----cC
Confidence 22 2345689999999998643 2378999999999999999999999976543332 222222111111111 01
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......+...|+..+|.+||+++|+++|||
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 223345666777788999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=321.78 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=178.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCC-CCceeecceeeeecCC---CCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTS---KDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~ 148 (340)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++++. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999885432 23457889999996 9999999998854322 4455
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..++||||++++|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++. ++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence 688999999999888876543 34579999999999999999999999 79 999999999999995 78899999999
Q ss_pred ccccccCCcc-------------ceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 019506 227 AKVLVKGEAN-------------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291 (340)
Q Consensus 227 a~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 291 (340)
+......... ....+|+.|+|||++. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876443221 1345899999999983 234578999999999999999999999976554332221
Q ss_pred HHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 292 IIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.. ..+.. .........+.+.|+..+|.+|||++|+++|
T Consensus 265 ~~---~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 265 KY---SIPPH------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp -C---CCCTT------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc---cCCcc------cccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 11111 1122234566777778889999999998765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=314.33 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecC-----------C
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT-----------S 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~ 144 (340)
..+|++.+.||+|+||.||+|++..+|+.||+|++........+|+++++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 35799999999999999999999989999999999887778889999999999999999999874311 1
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
.....+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D 165 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGD 165 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEECc
Confidence 234558899999996 7777776432 3578999999999999999999999 79999999999999995 88999999
Q ss_pred eccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 224 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
||++.............+++.|+|||++.+. .++.++|||||||++|+|++|..||... ......+.....+
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~~~---- 237 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGIIS---- 237 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTCCC----
T ss_pred chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhccccc----
Confidence 9999887665555566789999999999654 4899999999999999999999888532 2222222221111
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
. ........+...|+..+|.+|||++|+++|.
T Consensus 238 ---~-~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 238 ---D-IFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp ---T-TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---c-cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 1122234556667777899999999998774
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=333.08 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=194.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|++++++++||||+++++++... +....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 347999999999999999999999999999999986432 2345899999999999999999988542 33357
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe----cCCCCcEEEEeec
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFG 225 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill----~~~~~~~kl~Dfg 225 (340)
++||||+++ +|.+.+... .....+++..++.++.||+.||+|||+ +||+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 899999985 666665432 223449999999999999999999999 799999999999998 5 36679999999
Q ss_pred cccccccCCccceeeeeccccCcccccCC-------CCCCCcchhHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHH
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPG----ENAVDQLVEIIK 294 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~----~~~~~~~~~~~~ 294 (340)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.. ....+.+..++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99887666555567789999999998531 3478899999999999999999999964 334455555555
Q ss_pred hcCCCchhhh---------hccccc---------cCChhhHhhhcccccccCCCCcCcccc
Q 019506 295 VSNIIYAKTI---------YQGLFC---------SNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 295 ~~~~~~~~~~---------~~~~~~---------~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.........+ |...+. ......+.+.|+..+|.+|++++|+.+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 3221110000 000000 012234556677778999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.38 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=197.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------------------cChHHHHHHHHhCCCCcee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRLMDHPNVI 133 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv 133 (340)
...+|++.+.||+|+||.||+|++ +|+.||||++.... ....+|+++++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 456899999999999999999998 99999999986431 4456899999999999999
Q ss_pred ecceeeeecCCCCceeeeeeeccccc-hHHHHHHHh--hcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY--SSM--NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
++++++. +....++||||+++ +|.+.+... ... ...+++..++.++.|++.||.|||+.+||+||||||+
T Consensus 107 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred eEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 9999984 44568899999997 544431100 111 5679999999999999999999997239999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA-V 286 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~-~ 286 (340)
||+++. ++.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .
T Consensus 182 Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 182 NILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp GEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred hEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999995 789999999999876443 3334578999999999976534555 99999999999999999999998776 4
Q ss_pred HHHHHHHHhcCCCchhh---hhcc----------ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 287 DQLVEIIKVSNIIYAKT---IYQG----------LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.+..+.. ........ +... ...+.....+...|+..+|.+|||++|+++|||
T Consensus 260 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 260 ELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 44444433 32222210 0000 111223445666677778999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=331.62 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=183.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
.+|.+.+.||+|+||+||. ....+|+.||||++..+ .....+|+++++.+ +||||+++++++ .+....++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence 3699999999999999764 33568999999998654 34467899999999 799999999988 4555689999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC----CCCcEEEEeecccccc
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVL 230 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----~~~~~kl~Dfg~a~~~ 230 (340)
|||+++|.+.+... ...+.+..++.++.||+.||.|||+ +||+||||||+|||++. ....+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999988877642 2344555677899999999999999 79999999999999953 1236889999999876
Q ss_pred ccCC----ccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 231 VKGE----ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 231 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|+| |..||....... ...+.........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~-- 250 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGACSLDCL-- 250 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTTCCCCTTS--
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhccCCcccc--
Confidence 5432 2234578999999999964 3446889999999999999999 999997654432 2222221111110
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
............+.+.|+..+|.+|||++|++.|||
T Consensus 251 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 251 -HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp -CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred -CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 000000111234666677778999999999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=319.24 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=195.6
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEc-------CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeeccee
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHC 138 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~ 138 (340)
.....++|++.+.||+|+||.||+|++. .++..||||++.... ....+|+++++++ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3445578999999999999999999975 356789999886542 2345799999999 89999999999
Q ss_pred eeecCCCCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCC
Q 019506 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (340)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dl 205 (340)
+ .+...+++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||
T Consensus 110 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dl 183 (334)
T 2pvf_A 110 C-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDL 183 (334)
T ss_dssp E-----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred E-----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCC
Confidence 8 444558899999986 77777664321 12358999999999999999999999 79999999
Q ss_pred CCCCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 019506 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 281 (340)
Q Consensus 206 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~ 281 (340)
||+|||++. ++.+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 184 kp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 184 AARNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp SGGGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999995 88899999999987644322 2233457889999999654 48999999999999999999 999999
Q ss_pred CCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 282 GENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+.+..+....+........... +......+...|+..+|.+||+++|+.++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPAN------CTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCcc------CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8877666655555433222211 22334556677777889999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=312.65 Aligned_cols=247 Identities=17% Similarity=0.253 Sum_probs=194.1
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
....+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+++++.++|+||+++++++ .+....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 34557999999999999999999865 67789999997543 3346899999999999999999998 445558
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEcccccccc
Confidence 899999975 666666432 3569999999999999999999999 79999999999999995 88899999999986
Q ss_pred cccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
...... .....+|..|+|||++.+. .++.++||||||+++|+|+| |+.||.+.+..+....+.+........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 244 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---- 244 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT----
T ss_pred ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC----
Confidence 533221 1223457789999999654 48999999999999999998 999999888777666666543322221
Q ss_pred cccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
........+...|+..+|.+|||++|+++|
T Consensus 245 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 245 --LASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 122334556677777789999999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=312.29 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=189.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----------cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
...+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++|+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---- 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence 3457999999999999999999999999999999885322 3345799999999999999999988
Q ss_pred CCCceeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCc--
Q 019506 144 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQ-- 218 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~-- 218 (340)
.+.. ++||||++ +++.+.+.. ....+++..++.++.|++.||.|||+ +| |+||||||+|||++. ++.
T Consensus 93 -~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~~ 164 (287)
T 4f0f_A 93 -HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDENA 164 (287)
T ss_dssp -TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTTC
T ss_pred -cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCCC
Confidence 3332 58999998 466665543 34679999999999999999999999 79 999999999999985 444
Q ss_pred ---EEEEeeccccccccCCccceeeeeccccCcccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 019506 219 ---VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEI 292 (340)
Q Consensus 219 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~ 292 (340)
+||+|||+++.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999975432 3344678999999999843 33478899999999999999999999987654332 3333
Q ss_pred HHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 293 IKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......+.... -+......+...|+..+|.+|||++|+++
T Consensus 243 ~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 REEGLRPTIPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHSCCCCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33222221111 12233456667777788999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=322.23 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=195.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEE--EEEEeccc-----ccChHHHHHHHHhC-CCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+++++++ +||||+++++++ .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 3457999999999999999999998888865 99988642 23356799999999 899999999998 34
Q ss_pred ceeeeeeeccccc-hHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
....++||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 176 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence 4558899999975 7777765432 223579999999999999999999999 7999999999999998
Q ss_pred CCCCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 019506 214 PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (340)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~ 292 (340)
. ++.+||+|||++.............++..|+|||++.+ ..++.++|||||||++|+|+| |..||.+.+..+....+
T Consensus 177 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 5 78899999999975543333344456888999999965 447999999999999999998 99999988876655554
Q ss_pred HHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 293 IKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.......... -.......+...|+..+|.+|||++|++++
T Consensus 255 ~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGYRLEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTCCCCCCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4332222211 122334556667777789999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=327.47 Aligned_cols=253 Identities=14% Similarity=0.128 Sum_probs=184.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcC---CCcEEEEEEecccccC---------------hHHHHHHHHhCCCCceeeccee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRLMDHPNVISLKHC 138 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~~ 138 (340)
.+|.+.+.||+|+||.||+|++.. ++..+|+|++...... ..+|+..++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 479999999999999999999987 7889999988754322 2356677888899999999999
Q ss_pred eeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC-
Q 019506 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH- 217 (340)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~- 217 (340)
+.... .+....++||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~ 189 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KNP 189 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SST
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CCC
Confidence 86532 23567899999996677666543 3479999999999999999999999 79999999999999985 55
Q ss_pred -cEEEEeeccccccccCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHH
Q 019506 218 -QVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVD 287 (340)
Q Consensus 218 -~~kl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~ 287 (340)
.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 899999999977643321 1345789999999999764 58999999999999999999999996532 222
Q ss_pred HHHHHHHhcCCCchhhhh---ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 288 QLVEIIKVSNIIYAKTIY---QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+..............+. ..--.+.....+...|+..+|.+||+++++.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222221111111111 10012334556667777888999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=313.49 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=193.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|++++..+..+.. +....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence 457999999999999999999999999999999886443 345689999999999988877766543 33457899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec--CCCCcEEEEeeccccccc
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~--~~~~~~kl~Dfg~a~~~~ 231 (340)
|||++++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++ ..++.+||+|||++....
T Consensus 84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99998788877763 24579999999999999999999999 7999999999999994 247789999999998765
Q ss_pred cCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCc
Q 019506 232 KGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNIIY 300 (340)
Q Consensus 232 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~ 300 (340)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.+..+........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4432 2345789999999999654 48999999999999999999999998643 2233333333222111
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+... .+.....+.+.|+..+|.+|||++++.+
T Consensus 239 ~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKG--YPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTT--SCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhh--CCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111111 1223455666777778999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.45 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=189.3
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcC---CCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
....+|.+.+.||+|+||.||+|.+.. ++..||+|++.... ....+|+.++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345679999999999999999998765 45689999886432 224579999999999999999999865544
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
......++||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEE
Confidence 434456899999996 6666664322 234679999999999999999999999 79999999999999995 788999
Q ss_pred EeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 019506 222 CDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSN 297 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 297 (340)
+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999987644321 123356788999999965 458999999999999999999 8999998887666666655433
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
...... +......+...|+..+|.+|||+++++++
T Consensus 268 ~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQPED------CLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCBTT------CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCcc------ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333222 12234556667777789999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=321.72 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=196.5
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEeccc-----ccChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
...+|.+.+.||+|+||.||+|++. .++..||||++... .....+|+.+++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 4568999999999999999999973 46678999998643 23346899999999 899999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceec
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~ 203 (340)
......++||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 196 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR 196 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 344458899999985 777777642210 1347899999999999999999999 799999
Q ss_pred CCCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 019506 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 279 (340)
Q Consensus 204 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p 279 (340)
||||+|||++. ++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..|
T Consensus 197 Dikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999995 889999999999876444322 234567889999999654 48999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 280 FPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
|.+......+..++.......... .+......+...|+..+|.+|||++|+.+|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPF-----YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 998876666666666443222111 123344556677777889999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.99 Aligned_cols=245 Identities=20% Similarity=0.266 Sum_probs=193.6
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
....+|++.+.||+|+||.||+|.+ .|+.||||+++.+. ..+.+|++++++++||||+++++++... ...++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 4456899999999999999999988 57899999997653 3456899999999999999999987532 22478
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCcccc
Confidence 99999985 777777642 22347899999999999999999999 79999999999999995 789999999999864
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... .....++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+.+....+.+..
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~------ 410 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG------ 410 (450)
T ss_dssp C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT------
T ss_pred ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc------
Confidence 322 2223568889999999654 48999999999999999998 9999998777666665554333222211
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+.+.|+..+|.+|||++++.+
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2334455667777888999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.75 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=187.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHh--CCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++.... ......++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence 45799999999999999999987 79999999986543 233456677666 79999999999875432 33456889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCceecCCCCCCeEecCCCCcEEEEe
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
||||+++ +|.+.+. ...+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEECC
T ss_pred ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEEee
Confidence 9999986 6666663 367999999999999999999999 8 79999999999999995 88999999
Q ss_pred eccccccccCCcc-----ceeeeeccccCcccccCCC-----CCCCcchhHHHHHHHHHHHhC----------CCCCCCC
Q 019506 224 FGSAKVLVKGEAN-----ISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLFPGE 283 (340)
Q Consensus 224 fg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg----------~~pf~~~ 283 (340)
||+++........ ....||+.|+|||++.+.. .++.++|||||||++|||+|| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999765443332 2237899999999996543 244789999999999999999 8898653
Q ss_pred C----hHHHHHHHHHhcC-CCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 284 N----AVDQLVEIIKVSN-IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 284 ~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. ....+........ .+.....+...-+......+...|+..+|.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 2233333332211 1111110000011122445667777778999999999865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=333.14 Aligned_cols=254 Identities=25% Similarity=0.277 Sum_probs=182.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhC-CCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
..|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+++++.+ +||||+++++++ .+...+++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence 357788999999999998754 5689999999886543 3346799999875 899999999887 4555689999
Q ss_pred ccccchHHHHHHHhhcCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC------------CCcE
Q 019506 155 EYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL------------THQV 219 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~------------~~~~ 219 (340)
|||+++|.+.+......... .++..++.++.||+.||+|||+ +||+||||||+|||++.. +..+
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99999988887653221111 1333457799999999999999 799999999999999742 3489
Q ss_pred EEEeeccccccccCCc-----cceeeeeccccCcccccC------CCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 019506 220 KLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 287 (340)
Q Consensus 220 kl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 287 (340)
||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||+| |..||.+.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999987654332 123578999999999965 2458999999999999999999 999997665433
Q ss_pred HHHHHHHhcCC-CchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 288 QLVEIIKVSNI-IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 288 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+++.... +..... ...-.+.....+...|+..+|.+|||++|+++|||
T Consensus 248 --~~i~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 248 --SNIIRGIFSLDEMKCL-HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp --HHHHHTCCCCCCCTTC-CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred --HHHhcCCCCccccccc-ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 233332211 111100 00000112345566677778999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=316.00 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=197.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEE-----cCCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
...+|.+.+.||+|+||.||+|++ ..+++.||+|++.... ....+|+.+++++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 345799999999999999999985 3577899999987542 3345799999999 999999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS--------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
.+....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~ 174 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence 344457899999986 77777765321 12358999999999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (340)
||+++. ++.+||+|||++......... ....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+..
T Consensus 175 Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999995 889999999999876544322 234567889999998654 48999999999999999999 999999877
Q ss_pred hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 285 AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
....+..+++......... ........+...|+..+|.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPE-----HAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcc-----cCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6666666665443322111 122334556677777789999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=313.61 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=199.5
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.....+|++.+.||+|+||.||+|.+..++..||+|++..+. ....+|+++++.++|+||+++++++ .+...
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCC
Confidence 345568999999999999999999999999999999987553 3345799999999999999999988 44455
Q ss_pred eeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||++ ++|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCccce
Confidence 889999999 4777776542 23568999999999999999999999 79999999999999985 7889999999998
Q ss_pred ccccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+.......+.+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG-- 236 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT--
T ss_pred eccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC--
Confidence 76544322 234567889999999654 48999999999999999999 9999998776655555544333322221
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+|||++|+.+
T Consensus 237 ----~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 237 ----CPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1223455667777778999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=317.48 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=185.6
Q ss_pred cccCeeEeeeeeeecceEEEEEE----EcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|++.+.||+|+||+||+|+ +..+++.||||++.... ....+|+++++.++||||+++++++.. .+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 44679999999999999999998 56689999999987543 334689999999999999999998843 22
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccCc
Confidence 3347899999975 777776542 2458999999999999999999999 79999999999999995 7899999999
Q ss_pred cccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH------------H--
Q 019506 226 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV------------D-- 287 (340)
Q Consensus 226 ~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------------~-- 287 (340)
++........ .....++..|+|||++.+. .++.++|||||||++|+|+||..||...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 9987644322 1223457779999999654 4899999999999999999999998643211 0
Q ss_pred -HHHHHHHhc-CCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 288 -QLVEIIKVS-NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 288 -~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+...+... ..+... -+......+.+.|+..+|.+|||++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPD------GCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCCCCCCT------TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCcCCCCc------CcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111111 111111 12233455667777888999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=319.46 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=198.0
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCc-----EEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
...+|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+|+++++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 34579999999999999999999877664 79999886542 3345799999999 899999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill 212 (340)
.+....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 444458899999985 77777765322 14568999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019506 213 DPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 288 (340)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 288 (340)
+. ++.+||+|||++......... ....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+......
T Consensus 198 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EG-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CC-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 95 789999999999866443321 234567889999998654 48999999999999999998 9999998776666
Q ss_pred HHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 289 LVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+..+.+......... .+......+...|+..+|.+|||++|+.++
T Consensus 276 ~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCC-----CCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666666543322111 122334556677777789999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.93 Aligned_cols=242 Identities=16% Similarity=0.141 Sum_probs=188.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC-------cEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
.++|.+.+.||+|+||+||+|++..++ ..||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 457999999999999999999988777 479999886543 33457999999999999999999983
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCc-----
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----- 218 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~----- 218 (340)
+....++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~~~ 156 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKTGN 156 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGGTB
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCcccccc
Confidence 34457899999985 777776542 2348999999999999999999999 79999999999999985 554
Q ss_pred ---EEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 019506 219 ---VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~ 294 (340)
+||+|||++...... ....++..|+|||++.+...++.++|||||||++|+|++|. +||...+..........
T Consensus 157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp CCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred cceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 999999999765322 23457889999999976566899999999999999999955 55655554333332222
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
....+. ........+...|+..+|.+|||++|+++|
T Consensus 234 ~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111111 113344566677778889999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.95 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++|++++..+..+.. +....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence 35799999999999999999999999999999976543 4456789999999999998887776643 33457899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEe---cCCCCcEEEEeecccccc
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill---~~~~~~~kl~Dfg~a~~~ 230 (340)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||++...
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEEC
T ss_pred EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccC-CCCeEEEecCccceec
Confidence 999988888777632 4579999999999999999999999 799999999999999 5 4788999999999876
Q ss_pred ccCCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCC
Q 019506 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVSNII 299 (340)
Q Consensus 231 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~ 299 (340)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. ..+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54432 2245789999999999654 4899999999999999999999999864322 2333333322212
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+... .+.....+.+.|+..+|.+|||++++.+
T Consensus 238 ~~~~~~~~--~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKG--YPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTT--SCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhcc--CCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 21111111 1223455666777778999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=312.45 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=184.4
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCC---CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
....+|++.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 4456899999999999999999998654 4579999876432 23457999999999999999999872
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+ ...++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 160 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF 160 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-
T ss_pred c-CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECcc
Confidence 1 236799999996 66666653 23468999999999999999999999 79999999999999995 789999999
Q ss_pred ccccccccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 225 g~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239 (281)
T ss_dssp ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence 999876443322 22345778999999964 448999999999999999997 99999988877766666554333322
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.. +......+...|+..+|.+|||++|+.++
T Consensus 240 ~~------~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PN------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC------CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21 22334556677777889999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=336.34 Aligned_cols=247 Identities=20% Similarity=0.319 Sum_probs=196.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...+|.+.+.||+|+||.||+|++..++..||||++..+. ..+.+|++++++++||||+++++++ .+...++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence 4567999999999999999999999889999999987543 3345899999999999999999998 4444588
Q ss_pred eeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+. ++|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceec
Confidence 9999998 5777777642 23568999999999999999999999 79999999999999985 788999999999876
Q ss_pred ccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ....++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+........
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 442 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE----- 442 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT-----
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Confidence 433221 223456789999999654 48999999999999999999 999999887665555444332222211
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+......+...|+..+|.+|||+++|.+
T Consensus 443 -~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 443 -GCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 12333455667778888999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.54 Aligned_cols=202 Identities=16% Similarity=0.222 Sum_probs=165.5
Q ss_pred cccCeeEeeeeeeecceEEEEE-----EEcCCCcEEEEEEecccc-cChHHHHHHHHhCC---CCceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~ 145 (340)
...+|.+.+.||+|+||+||+| .+..+++.||||++.... ....+|+++++.++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~----- 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL----- 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-----
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee-----
Confidence 3457999999999999999999 467789999999987543 34457888888887 899999999984
Q ss_pred Cceeeeeeecccc-chHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--------
Q 019506 146 DELFLNLVMEYVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-------- 215 (340)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~-------- 215 (340)
.....++||||++ ++|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccc
Confidence 3344789999998 577777765433 35679999999999999999999999 799999999999999831
Q ss_pred --CCcEEEEeeccccccc---cCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 216 --THQVKLCDFGSAKVLV---KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 216 --~~~~kl~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
++.+||+|||+|+... .........||+.|+|||++.+.. ++.++|||||||++|||+||+.||...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccC
Confidence 5789999999996543 223334467899999999997654 899999999999999999999999644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=318.92 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=186.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEE----EEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|++.+.||+|+||+||+|++..+++.+ |+|.+... ...+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 457999999999999999999998887754 77766432 2334579999999999999999998843
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
.. .++|+||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg 162 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFG 162 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCTT
T ss_pred CC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEccCc
Confidence 22 5688888885 66666653 24679999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+++......... ...+|..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+......+..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence 998764443322 23457789999999754 48999999999999999999 99999887765554444443333322
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.. +......+...|+..+|.+||+++|++.+
T Consensus 242 ~~------~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PI------CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TT------BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cc------CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 21 23334556677788889999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.13 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=187.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCC--CCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||+|++. +++.||||++.... ....+|++++++++ |+||+++++++ .+..
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----ECSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ecCC
Confidence 46999999999999999999974 58999999986432 23457999999997 59999999988 3445
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++.
T Consensus 102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSSC
T ss_pred EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccccc
Confidence 5889999888888888765 4578999999999999999999999 7999999999999997 5789999999998
Q ss_pred ccccCCc---cceeeeeccccCcccccCC----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 019506 229 VLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294 (340)
Q Consensus 229 ~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~ 294 (340)
....... .....|++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.... ..+..+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 7644332 1234689999999998541 35788999999999999999999999876443 33333332
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......... ........+...|+..+|.+||+++|+++|||
T Consensus 255 ~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 255 PNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp TTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccCCcc-----cchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 211111111 11223445666777788999999999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=315.55 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=197.4
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeec
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFST 142 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 142 (340)
.....+|++.+.||+|+||.||+|++. .+++.||||.+.... ....+|+.+++.++|+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--- 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--- 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE---
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE---
Confidence 344568999999999999999999876 357889999886432 2245799999999999999999998
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
.+....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 98 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~- 173 (322)
T 1p4o_A 98 --SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE- 173 (322)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-
T ss_pred --ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-
Confidence 444457899999985 77777765321 12467899999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (340)
++.+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 78999999999986543322 1234568889999998654 48999999999999999999 8999998877666655
Q ss_pred HHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 292 IIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+........... +......+...|+..+|.+|||++|+++|
T Consensus 253 ~~~~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLDKPDN------CPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCCCCCC------CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 554332222111 22234556677778889999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=325.63 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=182.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...+|.+.+.||+|+||.||+|++. .++..||||++.... ..+.+|+.++++++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3457999999999999999999876 467789999986432 3345799999999999999999998 44
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
....++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECcCc
Confidence 4558899999975 77666653 23578999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+......+.
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~ 271 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP 271 (373)
T ss_dssp ---------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99876443221 11234678999999965 458999999999999999998 9999998887666665554333322
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... +......+...|+..+|.+||+++|+.+
T Consensus 272 ~~~------~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 PMD------CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CTT------CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccc------ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 211 2233455666777778999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=329.22 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=196.2
Q ss_pred CccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 73 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.....+|.+.+.||+|+||.||+|.+. ++..||||+++... ..+.+|+++++.++||||+++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 345568999999999999999999974 57789999997543 33468999999999999999999873 123
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+++||||+.+ +|.+.+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCce
Confidence 7899999985 7777775422 2367889999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
....... .....++..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~-- 409 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN-- 409 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT--
T ss_pred EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC--
Confidence 7643221 1223457789999999654 48999999999999999999 9999999888777776665444333222
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+|||+++|..
T Consensus 410 ----~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 ----CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 2333455667777888999999998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=328.39 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=194.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..++|++.++||+|+||.||+|++..+++.||||++... .....+|+++++.++|.+++..+..+. .+....++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEEE
Confidence 345799999999999999999999999999999987643 345678999999999866555555443 23445789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec--CCCCcEEEEeecccccc
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~--~~~~~~kl~Dfg~a~~~ 230 (340)
||||++++|.+.+... ...+++..++.|+.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++..
T Consensus 81 vme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999988888877642 4679999999999999999999999 7999999999999993 24788999999999876
Q ss_pred ccCCcc--------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC
Q 019506 231 VKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVSNII 299 (340)
Q Consensus 231 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~ 299 (340)
...... ....||..|+|||++.+. .++.++|||||||+||||++|+.||.+... ...+..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 544322 245789999999999654 489999999999999999999999987543 33344443332222
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
....+... +......+...|+..+|.+||++++|.+
T Consensus 236 ~~~~l~~~--~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRG--YPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTT--SCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcC--CcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22222221 1223455666777778999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=322.27 Aligned_cols=251 Identities=14% Similarity=0.132 Sum_probs=189.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC--------CcEEEEEEecccccChHHHHHHHHhCCCCceeec-------------
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISL------------- 135 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~------------- 135 (340)
.+|++.+.||+|+||.||+|++..+ ++.||||++... ....+|++++++++|+||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4799999999999999999999874 889999988755 456789999999999999984
Q ss_pred --ceeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEec
Q 019506 136 --KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (340)
Q Consensus 136 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~ 213 (340)
++++.. +....++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 344321 245688999999778888876521 3679999999999999999999999 7999999999999999
Q ss_pred CCCC--cEEEEeeccccccccCCcc--------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 019506 214 PLTH--QVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (340)
Q Consensus 214 ~~~~--~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (340)
. ++ .+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 P-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp T-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred C-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 5 66 8999999999776433221 234789999999999654 5899999999999999999999999876
Q ss_pred C-hHHHHHHHHHhc-C-CC-chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 284 N-AVDQLVEIIKVS-N-II-YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 284 ~-~~~~~~~~~~~~-~-~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. ....+....... . .. .........-.......+.+.|+..+|.+||+++++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 333333333211 1 11 11100000011233455666777788999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=319.84 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=189.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
..++|.+.+.||+|+||.||+|+ ..+|+.||||++.... ....+|+++++.++|+||+++++++ .+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTPTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCSSC
T ss_pred HhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-----ecCCc
Confidence 34579999999999999999998 4578999999886532 2356899999999999999999998 34445
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC---CceecCCCCCCeEecCCCCcEEEEeec
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
.++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence 7899999986 7777776544445569999999999999999999999 8 9999999999999995 7899999999
Q ss_pred cccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHHhc-CC
Q 019506 226 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG----ENAVDQLVEIIKVS-NI 298 (340)
Q Consensus 226 ~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~----~~~~~~~~~~~~~~-~~ 298 (340)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.. ......+....+.. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred cccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9987643332 2234589999999999654 489999999999999999999999952 11111111111111 11
Q ss_pred Cchhhhhcccccc-------CChhhHhhhcccccccCCCCcCccccc
Q 019506 299 IYAKTIYQGLFCS-------NNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 299 ~~~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.....+....+.. .....+...|+..+|.+|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 1111111100000 113344556777789999999998875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.91 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=191.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++.... ......++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 4799999999999999999999999999999988543 233457999999999999999999885432 23456789
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcchhcc
Confidence 9999996 8888887765566789999999999999999999999 79999999999999985 7889999999987643
Q ss_pred cCCcc----------ceeeeeccccCcccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh-cC
Q 019506 232 KGEAN----------ISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKV-SN 297 (340)
Q Consensus 232 ~~~~~----------~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~-~~ 297 (340)
..... ....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..... ...+...... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 21111 1234688999999986433 268899999999999999999999953110 0111112221 11
Q ss_pred CCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 298 IIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+... ........+...|+..+|.+||+++|++++
T Consensus 266 ~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 266 IPQSP------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccc------cCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11111 112234556677777889999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.45 Aligned_cols=253 Identities=17% Similarity=0.190 Sum_probs=191.7
Q ss_pred cccCeeEeeeeeeecceEEEEEE-----EcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 144 (340)
...+|++.+.||+|+||.||+|+ +..++..||||.+.... ....+|+.++++++||||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 34579999999999999999998 55678899999985432 2345799999999999999999998
Q ss_pred CCceeeeeeecccc-chHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCc
Q 019506 145 KDELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQ 218 (340)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~ 218 (340)
.+....++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+..
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 34445789999996 577777765322 12458999999999999999999999 79999999999999983 2346
Q ss_pred EEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019506 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (340)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 294 (340)
+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+.+..+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999999976533322 2234568899999999654 48999999999999999998 9999998877666655554
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
......... +......+...|+..+|.+||+++|+++|.|
T Consensus 261 ~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 261 GGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp TCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCC------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 333222211 2233456677778888999999999988753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=314.56 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=187.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCC----cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
...+|.+.+.||+|+||.||+|++..++ ..||||++.... ....+|+++++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 3457999999999999999999986553 459999986532 2345799999999999999999998 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+....++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEECCC
Confidence 44558899999986 66666643 24679999999999999999999999 79999999999999995 889999999
Q ss_pred ccccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 019506 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 225 g~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
|++......... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 999876443221 122346789999999654 48999999999999999999 999999888766666655443333
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.... +......+...|+..+|.+||++.++.+
T Consensus 271 ~~~~------~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 271 TPMD------CPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCTT------CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Cccc------CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2221 2233456667777788999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=307.45 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=182.9
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...++|++.+.||+|+||.||+|++ ...||+|++.... ....+|+++++.++|+||++++++. . .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-S
T ss_pred cCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-C
Confidence 3445799999999999999999985 3459999886443 2345799999999999999998854 1 2
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+.+ +|.+.+. .....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEcccee
Confidence 236799999985 5555553 234678999999999999999999999 79999999999999995 78999999999
Q ss_pred ccccccCC---ccceeeeeccccCccccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGE---ANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~---~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+....... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+..++........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 97654322 223356899999999985 2345788999999999999999999999988777777777665544332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+.. -+......+...|+..+|.+|||++|+++
T Consensus 247 ~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCT-TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccc-cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111 11223455666777778999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=304.92 Aligned_cols=245 Identities=18% Similarity=0.292 Sum_probs=195.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..+|++.+.||+|+||.||+|++. +++.||+|++.... ....+|+++++.++||||+++++++ .+....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeEE
Confidence 457999999999999999999975 67889999987543 3456899999999999999999998 34445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccccccc
Confidence 9999985 67666653 23568999999999999999999999 79999999999999985 7889999999997653
Q ss_pred cCC--ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 232 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+....+..........
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------ 228 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------ 228 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT------
T ss_pred cccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc------
Confidence 321 1123356778999999965 448999999999999999999 899999888766666655432222111
Q ss_pred cccCChhhHhhhcccccccCCCCcCccccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+.....+...|+..+|.+||+++++.++
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 123334566777788889999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=339.23 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=188.2
Q ss_pred ccCeeEee-eeeeecceEEEEEEEc--CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~-~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..++.+.+ .||+|+||.||+|.+. .++..||||+++... ..+.+|+++++.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------
Confidence 44566666 8999999999999875 356679999987532 334689999999999999999998732
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGl 482 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGL 482 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCST
T ss_pred CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccC
Confidence 127899999996 55555532 24569999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+.+.......
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9876433221 12234678999999965 458999999999999999998 99999998887766666554332222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+...|+..+|.+||+++++.+
T Consensus 562 ~~------~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 PE------CPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TT------CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred Cc------CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 2334456667778888999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.28 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred ccCeeEeeeeeeecceEEEEEEE-----cCCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.++|++.+.||+|+||.||+|++ ..+++.||||++.... ....+|+.+++++ +||||+++++++..
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 102 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 102 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec---
Confidence 45799999999999999999985 3567899999987543 2345799999999 69999999998843
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeE
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nil 211 (340)
....+++||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 103 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 103 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp -TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 23347899999985 777766542211 1238999999999999999999999 79999999999999
Q ss_pred ecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 019506 212 VDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 287 (340)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 287 (340)
++. ++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+
T Consensus 181 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 985 788999999999876443322 234568899999999654 48999999999999999998 999998877655
Q ss_pred HHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+...+........... .......+...|+..+|.+|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccCCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55555554432221111 12233455566777789999999998875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=309.40 Aligned_cols=245 Identities=23% Similarity=0.266 Sum_probs=182.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence 457999999999999999999999999999999986542 23457999999999999999999984 344
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEEEecCccC
Confidence 58899999986 77776654 3578999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 228 KVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 228 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.. .+...+.... +......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~ 258 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-PRPSTVR 258 (309)
T ss_dssp ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-CCGGGTS
T ss_pred ccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-CCccccC
Confidence 77644322 224568999999999965 45899999999999999999999999876654 3434333222 1111111
Q ss_pred ccccccCChhhHhhhcccccccCCC-CcCccc
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRN-SMHESK 336 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~-~~~~i~ 336 (340)
. -.......+...|+..+|.+|| +++++.
T Consensus 259 ~--~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 259 P--GIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp T--TCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred C--CCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 1 1122345566677777889998 787764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=319.53 Aligned_cols=256 Identities=22% Similarity=0.247 Sum_probs=189.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
....+|.+.+.||+|+||.||+|++ .+|+.||||++.... ....+|+++++.++||||+++++++ .+...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence 4556899999999999999999995 578999999876543 2345799999999999999999988 44455
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeeccccc
Confidence 8899999986 5555443322223468999999999999999999999 79999999999999995 8899999999997
Q ss_pred ccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCchh
Q 019506 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVSNIIYAK 302 (340)
Q Consensus 229 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~~ 302 (340)
...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+....+.. .............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 643322 22335689999999999654 4899999999999999999999999765432211 1111111111111
Q ss_pred hhhcccc-cc------CChhhHhhhcccccccCCCCcCccccc
Q 019506 303 TIYQGLF-CS------NNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 303 ~~~~~~~-~~------~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.++...+ .. .....+...|+..+|.+|||++|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111000 00 112344556777889999999998765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=303.65 Aligned_cols=245 Identities=16% Similarity=0.196 Sum_probs=193.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||.||+|++ +++.||||++.... ....+|+.+++.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 345799999999999999999998 58999999987542 2345788999999999999999988432 224
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeec
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
..++||||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ +| |+||||||+||+++. ++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEecc
Confidence 57899999985 77777654 222358999999999999999999999 79 999999999999995 7889999998
Q ss_pred cccccccCCccceeeeeccccCcccccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 226 SAKVLVKGEANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
++..... ....+|+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+....+......+....
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 8755322 23467999999999975432 23379999999999999999999999888777777766544332221
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. .......+...|+..+|.+|||++|+++
T Consensus 235 ~-----~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 G-----ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp T-----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 2233455666777888999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.07 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=187.2
Q ss_pred CeeE-eeeeeeecceEEEEEEE--cCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 78 SYMA-ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 78 ~y~~-~~~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+.+ .+.||+|+||.||+|.+ ..+++.||||+++... ....+|++++++++|||||++++++. +.
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~- 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE- 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-
Confidence 3444 34899999999999955 4567899999987542 23467999999999999999999872 22
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla 516 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLS 516 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHH
T ss_pred CEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCc
Confidence 26799999985 66666643 4679999999999999999999999 79999999999999995 789999999999
Q ss_pred cccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 228 KVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 228 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
+....... .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+.+........
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 87644332 122345778999999965 458999999999999999998 999999988876666665543332222
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. +......+...|+..+|.+||+++++.+
T Consensus 596 ~------~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 596 G------CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp T------CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C------CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1 2334456677788888999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=326.80 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=190.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
....+|++.+.||+|+||.||+|.+.. +..||||+++... ..+.+|++++++++||||+++++++. + ...
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cce
Confidence 445679999999999999999999864 4679999987543 34568999999999999999999873 2 237
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCcccee
Confidence 899999985 7777775422 2468999999999999999999999 79999999999999985 78899999999987
Q ss_pred cccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
....... ....++..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+....
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~--- 405 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--- 405 (452)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---
T ss_pred cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC---
Confidence 6443221 233457789999999654 48999999999999999999 9999998888776666655433332221
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+|||++++..
T Consensus 406 ---~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 406 ---CPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2333455667777888999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=307.21 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=191.6
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcC---CCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
....+|.+.+.||+|+||.||+|++.. ++..||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence 445689999999999999999998754 3446999988754 233457999999999999999999873
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+. ..++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 157 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGDF 157 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECCC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCcc
Confidence 22 25799999995 666666542 3568999999999999999999999 79999999999999995 789999999
Q ss_pred ccccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 225 g~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 99987644332 123345778999999964 448999999999999999998 99999887776666655554433332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.. +......+...|+..+|.+||+++|+.++
T Consensus 237 ~~------~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DL------CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC------CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 21 22334566677777889999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=306.42 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=189.7
Q ss_pred cccCeeEee-eeeeecceEEEEEEE--cCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 75 QTISYMAER-VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 75 ~~~~y~~~~-~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
...+|.+.+ .||+|+||.||+|.+ ..+++.||||++.... ....+|+++++.++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 345799988 999999999999954 5667899999987542 33457999999999999999999872
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
. ...++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 89 ~-~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Df 161 (291)
T 1xbb_A 89 A-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDF 161 (291)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCC
T ss_pred C-CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccC
Confidence 1 236799999985 66666654 4569999999999999999999999 79999999999999995 789999999
Q ss_pred ccccccccCCccc----eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 019506 225 GSAKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 225 g~a~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
|++.......... ...++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 240 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998764443221 22346789999999654 47899999999999999999 999999887766555544432222
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... .+......+...|+..+|.+||+++++.+
T Consensus 241 ~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 241 CPA------GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 211 12333456677778888999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=305.98 Aligned_cols=247 Identities=20% Similarity=0.269 Sum_probs=187.6
Q ss_pred CCccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 72 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
......+|++.+.||+|+||.||+|.+ +|+.||||++..+. ....+|+++++.++|+||+++++++.. ....
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 89 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 89 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--C
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCc
Confidence 334556899999999999999999987 68999999987543 334579999999999999999998743 2335
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|.+.+.... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTK 165 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC--
T ss_pred eEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeeccccc
Confidence 7899999986 7777776432 1247889999999999999999999 79999999999999995 7899999999997
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ....++..|+|||++.+ ..++.++||||||+++|+|+| |..||...+..+....+.+.........
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 238 (278)
T 1byg_A 166 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG---- 238 (278)
T ss_dssp ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT----
T ss_pred cccccc--cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCccc----
Confidence 653322 23456888999999965 448999999999999999998 9999988776655555443322221111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+.+.|+..+|.+||+++|+.+
T Consensus 239 --~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 239 --CPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 2233455667777888999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=305.67 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=192.3
Q ss_pred cccCeeEee-eeeeecceEEEEEEEc--CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~-~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..++|.+.+ .||+|+||.||+|.+. .++..||||++.... ....+|+++++.++||||+++++++. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----C
Confidence 345677776 9999999999999864 467889999987532 23457999999999999999999872 1
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg 155 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFG 155 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCT
T ss_pred -CCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECccc
Confidence 127899999996 56555532 34569999999999999999999999 79999999999999995 7899999999
Q ss_pred cccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
++......... ....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 234 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence 99876433321 123457889999999644 48999999999999999998 9999998887666655554332222
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccccC
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYG 339 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hp 339 (340)
... +......+...|+..+|.+||+++|+.+|.
T Consensus 235 ~~~------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 235 PPE------CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CTT------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCC------cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 211 223345566777778899999999988763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.06 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=192.3
Q ss_pred ccccCeeEeeeeeeecceEEEEEE----EcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
....+|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|++++++++|+||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 445689999999999999999999 46789999999986543 235689999999999999999998754 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+....++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEccc
Confidence 44568899999965 677666543 2468999999999999999999999 79999999999999985 889999999
Q ss_pred ccccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH--------------
Q 019506 225 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------------- 286 (340)
Q Consensus 225 g~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------------- 286 (340)
|++........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 99987644332 1233567889999999654 4799999999999999999999999654321
Q ss_pred HHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 287 DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+...+......... ..+......+...|+..+|.+|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAP-----PACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHTTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcccCCCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222222221111110 0122234556677778889999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=309.46 Aligned_cols=243 Identities=27% Similarity=0.362 Sum_probs=178.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
..+|++.+.||+|+||.||+|++ .++.||||.+.... ..+.+|++++++++||||+++++++. +. .++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 35799999999999999999987 58899999986543 34568999999999999999999873 22 6799
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--CCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|||+++ +|.+.+... .....+++..+..++.|++.||.|||+. +||+||||||+|||++..+..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999986 666666532 1122478899999999999999999983 389999999999999864445899999999765
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCC-chhhhhccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVSNII-YAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 308 (340)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+.........+ ....
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN----- 228 (307)
T ss_dssp ----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT-----
T ss_pred ccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc-----
Confidence 332 233468999999999965 4589999999999999999999999986433 22222222222221 1111
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.......+...|+..+|.+|||++|+.+
T Consensus 229 -~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 229 -LPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1223455666677778999999998865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=315.72 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=183.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-ChHHHHHH--HHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..++|++.+.||+|+||.||+|++ +++.||||++..... ....|.++ ++.++|+||+++++.+......+...++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 456899999999999999999987 789999999864432 22334444 4458999999999877655556666788
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------CceecCCCCCCeEecCCCCcEEE
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---------GVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------~iiH~dlkp~Nill~~~~~~~kl 221 (340)
+||||+++ +|.+.+.. ...++..++.++.||+.||.|||+ + ||+||||||+|||++. ++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCEEE
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcEEE
Confidence 99999975 77777654 456889999999999999999999 8 9999999999999995 789999
Q ss_pred EeeccccccccCC---------ccceeeeeccccCcccccCC------CCCCCcchhHHHHHHHHHHHhCCCCCC-CCCh
Q 019506 222 CDFGSAKVLVKGE---------ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFP-GENA 285 (340)
Q Consensus 222 ~Dfg~a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~-~~~~ 285 (340)
+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||. +...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764322 11234689999999999652 335678999999999999999976653 2221
Q ss_pred ----------------HHHHHHHHHhcC-CCc-hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 286 ----------------VDQLVEIIKVSN-IIY-AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 286 ----------------~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+.+........ .+. ...+.....+......+...|+..+|.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111111111 111 1111000111112456677788888999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=313.13 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=184.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEE----EEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..+|++.+.||+|+||.||+|++..+++.+ |+|.+... .....+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 457999999999999999999998888765 56655432 2234579999999999999999998843
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
.. .++|+||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFG 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCTT
T ss_pred CC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEccCc
Confidence 22 5688888885 66666654 24579999999999999999999999 79999999999999985 7899999999
Q ss_pred cccccccCCccc---eeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 226 SAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 226 ~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+++......... ...+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+....+..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp C----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998764433222 2345778999999965 448999999999999999999 99999988776555554443333332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+.+.|+..+|.+||+++|+++
T Consensus 242 ~~------~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 242 PI------CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TT------BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22 2233455667777888999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.32 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=189.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCC---cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.+|++.+.||+|+||.||+|++..++ ..+|+|.+.... ....+|+.++++++||||+++++++.. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCC
Confidence 46999999999999999999975433 468999886432 234579999999999999999998643 334
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECccccc
Confidence 47899999997 66666643 34668999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 228 KVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 228 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 86643322 2234567889999999654 48999999999999999999 66888877766666555554333222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+...|+..+|.+|||++|+++
T Consensus 255 ~~------~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EY------CPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 21 2334556667777888999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.09 Aligned_cols=252 Identities=20% Similarity=0.235 Sum_probs=189.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHh--CCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.+.||+|+||.||+|++ +|+.||||++.... ....+|+++++. ++||||+++++++..... .....++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence 4799999999999999999998 69999999986543 334578888887 789999999998854321 12357899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
|||+++ +|.+.+.. ..+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEEC
Confidence 999996 77777754 46899999999999999999999 8 79999999999999995 789999999
Q ss_pred ccccccccCCc-----cceeeeeccccCcccccCCCC-----CCCcchhHHHHHHHHHHHhC----------CCCCCCCC
Q 019506 225 GSAKVLVKGEA-----NISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 284 (340)
Q Consensus 225 g~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~~~ 284 (340)
|++........ .....||+.|+|||++.+... ++.++|||||||++|+|+|| ..||.+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987654432 233468999999999965422 23689999999999999999 78987642
Q ss_pred ----hHHHHHHHHHhc-CCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 285 ----AVDQLVEIIKVS-NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 285 ----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+.+...+... ..+.....+...-+......+...|+..+|.+|||++|+.+|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 233333333221 112211111111112234456677777889999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=331.44 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=193.9
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...+|++.+.||+|+||.||+|.+.. +..||||+++... ..+.+|+++|++++|+||+++++++. + ..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccce
Confidence 34579999999999999999999754 4679999987543 34568999999999999999999873 2 2378
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+.+ +|.+.+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceec
Confidence 99999985 7777775422 2468999999999999999999999 79999999999999985 788999999999876
Q ss_pred ccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
..... .....++..|+|||++.+. .++.++|||||||+||||++ |+.||.+.+..+.+..+.+....+....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~---- 488 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE---- 488 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT----
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC----
Confidence 43221 1223457789999999654 48999999999999999999 9999998887776666654333222211
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+......+...|+..+|.+|||+++|.+
T Consensus 489 --~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 489 --CPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2233455667777788999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.00 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=191.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
....+|++.+.||+|+||.||+|++. ++..||+|.+.... ....+|+++++.++|+||+++++++. + ...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----Q-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----C-CCc
Confidence 34568999999999999999999964 56789999987543 33468999999999999999999873 2 126
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||+++ +|.+.+.... ...+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCccccc
Confidence 799999975 6666554311 1368999999999999999999999 79999999999999995 88899999999987
Q ss_pred cccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
....... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 233 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---- 233 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT----
T ss_pred ccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcc----
Confidence 6443322 22345778999999964 347999999999999999999 999999888766666554432222211
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+......+...|+..+|.+|||++++.+
T Consensus 234 --~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12233455666777778999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=318.64 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=182.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC---cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...|.+.+.||+|+||.||+|++..++ ..||+|.+.... ..+.+|+.++++++||||++++++++. ..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence 346899999999999999999876433 468999886432 234578999999999999999998643 23
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeeccc
Confidence 346799999986 66666643 34568899999999999999999999 79999999999999995 78999999999
Q ss_pred ccccccCCc-----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 227 AKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 227 a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
++....... .....++..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+....+.+......
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~ 317 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 317 (373)
T ss_dssp -------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC
T ss_pred cccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 986543321 123456778999999965 458999999999999999999 7789987766555555444332222
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. .+......+...|+..+|.+||+++|+.+
T Consensus 318 p~------~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 318 PE------YCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 23344566777788888999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=309.35 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=184.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc-ChHHHHHHHHh--CCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++.+.||+|+||.||+|++ +|+.||||++..... ...+|.+++.. ++|+||+++++++..... .....++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence 35799999999999999999998 589999998865432 23345555554 489999999998855322 2256889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CceecCCCCCCeEecCCCCcEEEEe
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCD 223 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------~iiH~dlkp~Nill~~~~~~~kl~D 223 (340)
||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEEe
Confidence 9999986 77777753 579999999999999999999998 7 9999999999999995 78999999
Q ss_pred eccccccccCCcc-----ceeeeeccccCcccccCCCCCCCc------chhHHHHHHHHHHHhC----------CCCCCC
Q 019506 224 FGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTS------IDIWSAGCVLAELLLG----------QPLFPG 282 (340)
Q Consensus 224 fg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~------~DiwslG~il~elltg----------~~pf~~ 282 (340)
||++......... ....||+.|+|||++.+.. ++.. +|||||||++|||+|| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999766443322 1346899999999996544 3443 9999999999999999 777764
Q ss_pred CC----hHHHHHHHHHhcCC-CchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 283 EN----AVDQLVEIIKVSNI-IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 283 ~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.. ....+......... +.....+..--+......+...|+..+|.+|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 32 22333333322211 1111111111112224566777888889999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.43 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=187.1
Q ss_pred ccCeeEeeeeeeecceEEEEEE----EcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
...|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+++++.++|+||+++++++... +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3469999999999999999998 56789999999987432 3346899999999999999999988542 2
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
...+++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECccc
Confidence 2457899999986 777766432 3569999999999999999999999 79999999999999985 7899999999
Q ss_pred cccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------------ChHH
Q 019506 226 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------------NAVD 287 (340)
Q Consensus 226 ~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------------~~~~ 287 (340)
++........ .....+|..|+|||++.+. .++.++|||||||++|+|+||..||... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 9987654432 2234567789999999654 4789999999999999999999876422 1222
Q ss_pred HHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+...+.......... -.+.....+...|+..+|.+|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPP-----NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCC-----CCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222222111100 11223455666777778999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.92 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=188.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.|..++.||+|+||.||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCc
Confidence 356678999999999999986 78899999886431 2345799999999999999999988 44445
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++||||+++ +|.+.+... .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence 8899999975 676666542 334679999999999999999999999 79999999999999995 8899999999997
Q ss_pred ccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCchhh
Q 019506 229 VLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS--NIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 303 (340)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+.+.. .......
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6543322 223468999999999854 37899999999999999999999998765433332222211 1111222
Q ss_pred hhccccccC------ChhhHhhhcccccccCCCCcCccccc
Q 019506 304 IYQGLFCSN------NHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 304 ~~~~~~~~~------~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
++...+... ....+...|+..+|.+|||++++.++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 222222111 13345666777889999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=302.02 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=188.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...|.+.+.||+|+||.||+|++..++. .||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 3468889999999999999999765554 79999886432 2345799999999999999999998432 2
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+.+ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCcCCC
Confidence 234799999974 66666543 34678999999999999999999999 79999999999999995 78999999999
Q ss_pred ccccccCC-----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCc
Q 019506 227 AKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 227 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|. +||.+.+..+....+......+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC
Confidence 97653322 2223456888999999965 45899999999999999999955 55666665554444444333333
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... .+.....+...|+..+|.+|||++++++
T Consensus 250 ~~~------~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 250 PEY------CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccc------chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 221 2233455667777788999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.79 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=192.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCC-CCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 150 (340)
++|++.+.||+|+||.||+|.+..+|+.||||++... .....+|++++++++||||+++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5799999999999999999999999999999988654 2234579999999999999999988733111 224557
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC--cEEEEeeccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~--~~kl~Dfg~a 227 (340)
++||||+++ +|.+.+... .....+++..++.++.|++.||+|||+ +||+||||||+||+++..+. .+||+|||++
T Consensus 94 ~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 899999975 666666542 223468999999999999999999999 79999999999999985322 4999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC------ch
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII------YA 301 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------~~ 301 (340)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+...+...... ..
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 88766666666788999999999965 458999999999999999999999998765433221111100000 00
Q ss_pred --hhhhccc------c---ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 --KTIYQGL------F---CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 --~~~~~~~------~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...+... + .......+...|+..+|.+|||++|+++|||
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 0000000 0 0112445666777788999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=325.01 Aligned_cols=249 Identities=17% Similarity=0.114 Sum_probs=182.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCC-Cceeecc---------ee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDH-PNVISLK---------HC 138 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~---------~~ 138 (340)
...|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|+.+++.++| .|+..+. ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346899999999999999999999999999999887322 234578888888887 3221111 11
Q ss_pred e------------eecCCCCceeeeeeeccccchHHHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceec
Q 019506 139 F------------FSTTSKDELFLNLVMEYVPETMYRVLKHY---SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (340)
Q Consensus 139 ~------------~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~ 203 (340)
. ...........+++|+++.++|.+.+... ...+..+++..+..++.||+.||+|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 1 10000112346788999998888777533 2234567888899999999999999999 799999
Q ss_pred CCCCCCeEecCCCCcEEEEeeccccccccCCccceeeeeccccCccccc---------CCCCCCCcchhHHHHHHHHHHH
Q 019506 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 274 (340)
Q Consensus 204 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ell 274 (340)
||||+|||++. ++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999995 788999999998775433 334567 9999999993 3345788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 275 LGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 275 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
||+.||.+.+..+....+.... . -.+.....+...|+..+|.+||+++|+++|||
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFRSC---------K--NIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGSSC---------C--CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HCCCCCCCcchhhhHHHHHhhc---------c--cCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 9999998765433222221100 0 11223445566677778999999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.76 Aligned_cols=243 Identities=27% Similarity=0.351 Sum_probs=184.0
Q ss_pred eeEeeeeeeecceEEEEEEE----cCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 79 YMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
|++.+.||+|+||+||++.+ ..+++.||||++.... ....+|+++++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 59999999999999988764 3478999999987543 2346899999999999999999998542 2345
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+++||||+++ +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECCccccc
Confidence 8899999986 66665543 458999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH--------------HHHH
Q 019506 229 VLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------------DQLV 290 (340)
Q Consensus 229 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------------~~~~ 290 (340)
....... .....++..|+|||++.+. .++.++|||||||++|+|+||..||...... ..+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654432 2234567889999999654 4789999999999999999999999754221 1112
Q ss_pred HHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 291 EIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..++......... .++.....+...|+..+|.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPD-----KCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCc-----cccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222221111110 12233455666777778999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=300.98 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=177.2
Q ss_pred cccCeeEe-eeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHH-HhCCCCceeecceeeeecCCCCceeeee
Q 019506 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 75 ~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
..++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+...+++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence 44568877 7899999999999999999999999988653 3456788877 7779999999999884321 23566889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~a~~ 229 (340)
||||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999986 77777765 223579999999999999999999999 799999999999999853 56899999999865
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---cCCCchhhhhc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---SNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~ 306 (340)
.. ...++.++|||||||++|+|++|..||.+.+.......+... .........+.
T Consensus 170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (299)
T 3m2w_A 170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227 (299)
T ss_dssp CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence 31 234788999999999999999999999876543322111111 11111110000
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.+.....+...|+..+|.+|||++|+++|||
T Consensus 228 --~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 228 --EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp --TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --cCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 11223445666777778999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=301.27 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=183.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-CCc--EEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
..+|++.+.||+|+||.||+|++.. ++. .||||++.... ....+|+++++.++|+||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 3479999999999999999998643 333 68999886431 234579999999999999999998842
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.. .++||||+.+ ++.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 93 -~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df 165 (291)
T 1u46_A 93 -PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 165 (291)
T ss_dssp -SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred -CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence 22 6799999984 777766542 2568999999999999999999999 79999999999999985 789999999
Q ss_pred ccccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 019506 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 225 g~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
|++......... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+.+..+.+.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 999876443322 123457789999999654 47899999999999999999 999999888777666665543222
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.... ........+...|+..+|.+|||++++.++
T Consensus 245 ~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 PRPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCc-----CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2111 122334556667777789999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=303.90 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=187.2
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
...+|++.+.||+|+||.||+|++.. .+|+|++... .....+|+.+++.++|+||+++++++. +..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 34579999999999999999999743 4999988643 233457999999999999999999984 334
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCCc
Confidence 58899999985 65555532 23468999999999999999999999 7999999999999998 568999999998
Q ss_pred cccccC------CccceeeeeccccCcccccC--------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 019506 228 KVLVKG------EANISYICSRYYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (340)
Q Consensus 228 ~~~~~~------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 293 (340)
...... .......|+..|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 654211 12223457899999999864 2347889999999999999999999999887766665554
Q ss_pred HhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 294 KVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
......... .-.......+...|+..+|.+|||++++.+
T Consensus 257 ~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 432221111 113344566777788888999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.65 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=188.2
Q ss_pred ccccCeeEeeeeeeecceEEEEEEE----cCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
....+|++.+.||+|+||.||+|++ ..+|+.||||++.... ....+|+++++.++|+||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 3445799999999999999999984 5689999999986543 2345899999999999999999987432
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+...+++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CCcEEEecC
Confidence 23357899999985 777766542 3568999999999999999999999 79999999999999995 789999999
Q ss_pred ccccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChH--------------
Q 019506 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------------- 286 (340)
Q Consensus 225 g~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------------- 286 (340)
|++......... ....++..|+|||++.+. .++.++|||||||++|+|+||..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 999876544321 223457789999999654 4789999999999999999999998643110
Q ss_pred -HHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 287 -DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 287 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+...++........ -.+......+.+.|+..+|.+|||++|+.+
T Consensus 269 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCCCCC-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCCCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111222211111110 012233456677777888999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.60 Aligned_cols=246 Identities=26% Similarity=0.326 Sum_probs=192.7
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCC---CcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
....+|.+.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 3456799999999999999999998653 4679999876432 33457999999999999999999872
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+ ...++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DF 535 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF 535 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEec
Confidence 2 236799999995 66666653 23468999999999999999999999 79999999999999995 889999999
Q ss_pred ccccccccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 225 g~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|+++........ ....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+......+..
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999876443322 123457789999999654 58999999999999999997 99999998887777777665444332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+..-|+..+|.+|||++|+.+
T Consensus 615 ~~------~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 615 PN------CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22 2233455666777788999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=313.30 Aligned_cols=191 Identities=19% Similarity=0.169 Sum_probs=153.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCC---------CCceeec
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMD---------HPNVISL 135 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~~ 135 (340)
++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+++++.++ |+||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 78999999997543 33468999988886 6666666
Q ss_pred ceeeeecC-------------------------CCCceeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 019506 136 KHCFFSTT-------------------------SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189 (340)
Q Consensus 136 ~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 189 (340)
.+++.... ..+...+|+||||+.++ +++.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 55542211 01245689999999764 444442 267899999999999999
Q ss_pred HHHHHH-cCCCceecCCCCCCeEecCCCC--------------------cEEEEeeccccccccCCccceeeeeccccCc
Q 019506 190 GLAYIH-TVPGVCHRDVKPQNLLVDPLTH--------------------QVKLCDFGSAKVLVKGEANISYICSRYYRAP 248 (340)
Q Consensus 190 ~l~~LH-~~~~iiH~dlkp~Nill~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aP 248 (340)
||.||| + +||+||||||+|||++. ++ .+||+|||+|+..... ...||+.|+||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP 246 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence 999999 8 79999999999999985 44 8999999999876432 45789999999
Q ss_pred ccccCCCCCCCcchhHHHHHH-HHHHHhCCCCCCC
Q 019506 249 ELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPG 282 (340)
Q Consensus 249 E~~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~ 282 (340)
|++.+.. +.++||||||++ .+++++|..||.+
T Consensus 247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 9996543 889999998777 7788899999954
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.12 Aligned_cols=193 Identities=25% Similarity=0.402 Sum_probs=161.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
.++|++.+.||+|+||+||+|++.. +|+.||||++.... ..+.+|+++++.++||||+++++++..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4689999999999999999999976 78999999886432 23457899999999999999999987655444445
Q ss_pred eeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.|+||||++++ |.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++. +.+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~--~~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE--EQLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS--SCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC--CcEEEEecccch
Confidence 78999999964 33322 2379999999999999999999999 79999999999999984 479999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (340)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 76443 345789999999998543 48999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.79 Aligned_cols=218 Identities=15% Similarity=0.016 Sum_probs=164.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++. +...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence 47999999999999999999999999999999987542 23457899999999999999999984 3445
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.|+||||++| +|.+.+.. ......+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEEecc---
Confidence 8899999986 66665532 23556788899999999999999 79999999999999995 7889988543
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH--hcCCCchhhhhc
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--VSNIIYAKTIYQ 306 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~ 306 (340)
|++ .++.++|||||||++|+|+||+.||.+.+..+.+....+ ....+....+..
T Consensus 175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T 3uqc_A 175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230 (286)
T ss_dssp ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT
T ss_pred ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc
Confidence 333 268999999999999999999999987765332211111 111111111111
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
. .......+..-|+..+|.+| |++|+++
T Consensus 231 ~--~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 231 D--IPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp T--SCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred C--CCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 1 12224556666777778899 9888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=276.87 Aligned_cols=180 Identities=19% Similarity=0.101 Sum_probs=124.3
Q ss_pred eeeeecceEEEEEEEcCCCcEEEEEEecccc--------------cChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 84 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++.|++|.+..++....|+.|++|++.++. +.+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4677888888887777789999999986431 2345799999999 699999999998 6666
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
..||||||++| +|.+.+.. .+++++. .|+.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence 79999999997 66666653 4566654 478999999999999 79999999999999995 889999999999
Q ss_pred cccccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 019506 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (340)
Q Consensus 228 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (340)
+..... ....+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 876443 33445689999999999964 367889999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=238.93 Aligned_cols=179 Identities=17% Similarity=0.200 Sum_probs=133.7
Q ss_pred eEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------------cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
...+.||+|+||.||+|.. .+..+++|...... ....+|++++++++||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 4467899999999999954 67889999764321 1236899999999999999665555422
Q ss_pred eeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+++ +|.+.+.. +..++.|++.||.|||+ +||+||||||+|||++. .+||+|||+
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred CccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 225799999984 66555432 55789999999999999 79999999999999994 899999999
Q ss_pred ccccccCCcc--------ceeeeeccccCcccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 019506 227 AKVLVKGEAN--------ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 281 (340)
Q Consensus 227 a~~~~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 281 (340)
++........ ....||+.|+|||++.+. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9887543221 246789999999999541 237888999999999888888777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=199.11 Aligned_cols=138 Identities=17% Similarity=0.197 Sum_probs=109.2
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------------------cChHHHHHHHHhCCCCceeecc
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK 136 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~ 136 (340)
|.+++.||+|+||.||+|++ .+|+.||||+++... ....+|++++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55669999999999999998 889999999986322 12458999999999 5 7777
Q ss_pred eeeeecCCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
+++.. ...++||||++| +|.+ + .......++.|++.||.|||+ +||+||||||+|||++
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-- 227 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-- 227 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--
T ss_pred eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--
Confidence 75521 336899999987 4433 2 112355789999999999999 7999999999999999
Q ss_pred CCcEEEEeeccccccccCCccceeeeeccccCccccc
Q 019506 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 252 (340)
++.+||+|||+|+. +..++|||++.
T Consensus 228 ~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 78899999999964 34478888873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=177.14 Aligned_cols=134 Identities=19% Similarity=0.246 Sum_probs=102.7
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcE--EEEEEecccc----------------------------cChHHHHHHHHhCC
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRLMD 128 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~E~~~l~~l~ 128 (340)
|.+.+.||+|+||.||+|.+..+|+. ||||+++... ....+|+++++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778999 9999865321 12457999999998
Q ss_pred CCceeecceeeeecCCCCceeeeeeeccccc------hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCce
Q 019506 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE------TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-TVPGVC 201 (340)
Q Consensus 129 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~ii 201 (340)
|+++.....+.. ...++||||+++ .+.+... ..++..+..++.|++.+|.||| + .||+
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AELV 193 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCEE
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCEE
Confidence 886532221111 125799999953 3333221 1234567889999999999999 8 7999
Q ss_pred ecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 202 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC---cEEEEECcccccC
Confidence 9999999999984 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=159.23 Aligned_cols=140 Identities=14% Similarity=0.097 Sum_probs=91.9
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC------------------hHHHHHHHHhCCCCceeecceeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------------------KNRELQLMRLMDHPNVISLKHCFF 140 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~E~~~l~~l~h~~iv~~~~~~~ 140 (340)
|.+++.||+|+||.||+|.+ .+|+.||||+++..... ...+.++.....|+|+++++...+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999996 47999999987532110 011222222223444444332211
Q ss_pred ecCC-CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC--
Q 019506 141 STTS-KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-- 217 (340)
Q Consensus 141 ~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~-- 217 (340)
.... -.....+|||||++|..+ ... .....+..++.|++.+|.+||+ .|||||||||.|||++. ++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L---~~l------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~-dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPM---RQV------SSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIRE-EKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEG---GGC------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEE-EECS
T ss_pred CCCeeeeccCceEEEEecCCccH---hhh------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeC-CCCc
Confidence 0000 000113699999997522 111 1122356788999999999999 79999999999999984 33
Q ss_pred --------cEEEEeecccccc
Q 019506 218 --------QVKLCDFGSAKVL 230 (340)
Q Consensus 218 --------~~kl~Dfg~a~~~ 230 (340)
.+.|+||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.2e-13 Score=114.22 Aligned_cols=136 Identities=15% Similarity=0.111 Sum_probs=100.3
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecc----cccChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|++...++.|+.+.||++.. .+..+++|+... ......+|+++++.+. +..+.++++++. +....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence 588889999999999999974 478999998863 3345778999999885 556667777663 3345789
Q ss_pred eeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 019506 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------- 197 (340)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------------------------- 197 (340)
|||+++|..+... . .+......++.+++.+|..||+.
T Consensus 88 v~e~i~G~~l~~~--~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--Y------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--C------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--c------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998432221 0 01122346778999999999971
Q ss_pred -----------------------CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 -----------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 -----------------------~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..++|+|+++.||+++. +..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhccc
Confidence 24899999999999984 55567999998743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=105.69 Aligned_cols=134 Identities=16% Similarity=0.089 Sum_probs=90.2
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-ccChHHHHHHHHhCCCCce--eecceeeeecCCCCceeeeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~ 154 (340)
.|.+....+.|..+.||++. ..+|..+++|+.... .....+|+++++.+.+.++ .+++++.. +....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence 35555444466679999996 456788999987654 2445789999998865454 44666542 223467999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------ 198 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------ 198 (340)
||++|.... . .... ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999984222 1 0111 1245667777777777631
Q ss_pred ---------------------CceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 199 ---------------------GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 199 ---------------------~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+++|+|++|.||+++. +..+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhccc
Confidence 2999999999999984 55566999999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=5e-11 Score=107.10 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=98.3
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEec--cc-----ccChHHHHHHHHhCCC--CceeecceeeeecCCCCceeee
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..+.|+.|.++.||++.. .+..+++|+.. .. .....+|.++++.+.. ..+.+++.++... ......+
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 356789999999999875 45688999775 22 3456789999998874 3456666655221 1113467
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------- 197 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------- 197 (340)
+||||++|.... . .....++......++.+++..|..||+.
T Consensus 118 ~vme~v~G~~l~---~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLW---D--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCC---C--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecC---C--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999984211 0 1123467778888899999999999962
Q ss_pred -----------------------CCceecCCCCCCeEecCCCC-cEEEEeeccccc
Q 019506 198 -----------------------PGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKV 229 (340)
Q Consensus 198 -----------------------~~iiH~dlkp~Nill~~~~~-~~kl~Dfg~a~~ 229 (340)
.+++|||+++.|||++.++. .+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999985332 368999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.2e-11 Score=106.83 Aligned_cols=187 Identities=14% Similarity=0.170 Sum_probs=109.2
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCC-CCceeecceee-eecCCCCceeeeeeecccc
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMD-HPNVISLKHCF-FSTTSKDELFLNLVMEYVP 158 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~~~~~~~~lv~e~~~ 158 (340)
+.++.|....||++. ..+++|+.... .....+|.++++.+. +..+. +-..+ ...........|+||++++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~-vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLP-IPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSC-CCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCC-CCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999863 46899976543 234568999998874 33321 11222 1111111223578999999
Q ss_pred ch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 019506 159 ET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------------- 197 (340)
Q Consensus 159 ~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------- 197 (340)
|. +..... ..++..+...++.+++..|..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 73 221111 2345556666667777777777641
Q ss_pred -----------------CCceecCCCCCCeEecCC-CCcEEEEeeccccccccCCccceeeeeccccCccccc---C-CC
Q 019506 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---G-AT 255 (340)
Q Consensus 198 -----------------~~iiH~dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~-~~ 255 (340)
..++|+|+++.||+++.+ +..+.|+||+.+.................-..++... . .+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 247999999999999853 3457899999986532211100000000001121110 0 00
Q ss_pred ---------CCCCcchhHHHHHHHHHHHhCCCCCC
Q 019506 256 ---------EYTTSIDIWSAGCVLAELLLGQPLFP 281 (340)
Q Consensus 256 ---------~~~~~~DiwslG~il~elltg~~pf~ 281 (340)
....-.+.|++|.++|.+.+|..+|.
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01123689999999999999987773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2e-07 Score=81.62 Aligned_cols=70 Identities=11% Similarity=-0.033 Sum_probs=45.6
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCc---eeecceeeeecCCCCceeeeeeecc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
.+.++.|....||+. |..+++|+.... .....+|.++|+.+.+.. +.+++.+.. ......++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 345788888899987 567899976432 234568999999987532 233333321 112335699999
Q ss_pred ccch
Q 019506 157 VPET 160 (340)
Q Consensus 157 ~~~~ 160 (340)
++|.
T Consensus 95 i~G~ 98 (306)
T 3tdw_A 95 VQGQ 98 (306)
T ss_dssp CCSE
T ss_pred cCCe
Confidence 9973
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.3e-06 Score=71.52 Aligned_cols=131 Identities=15% Similarity=0.154 Sum_probs=79.5
Q ss_pred eeeecce-EEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCCC-CceeecceeeeecCCCCceeeeeeeccccch-
Q 019506 85 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET- 160 (340)
Q Consensus 85 Lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~- 160 (340)
+..|..| .||+......+..+++|+..... ....+|...|+.+.. --+.+++.++ .+....++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCcc
Confidence 3445444 68998866677889999765432 334678888887752 2234444544 2223467999999973
Q ss_pred HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 019506 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 197 (340)
Q Consensus 161 l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------- 197 (340)
+.+.... .......+..++...|..||..
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 3222211 0011222334444444444421
Q ss_pred --------------CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 --------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 --------------~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..++|+|+.+.|||++. ++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECccccc
Confidence 12789999999999984 55567999998854
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.36 E-value=1.2e-06 Score=77.69 Aligned_cols=31 Identities=26% Similarity=0.547 Sum_probs=26.9
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.+++|||+++.||+++. ++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhccc
Confidence 58999999999999974 56799999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.8e-06 Score=75.86 Aligned_cols=77 Identities=13% Similarity=0.091 Sum_probs=48.4
Q ss_pred Eeeee-eeecceEEEEEEEc--C----CCcEEEEEEecccc-------cChHHHHHHHHhCCC---CceeecceeeeecC
Q 019506 81 AERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRLMDH---PNVISLKHCFFSTT 143 (340)
Q Consensus 81 ~~~~L-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~ 143 (340)
..+.| +.|....+|+.... . ++..+++|+..... ....+|+++++.+.. -.+.+++.+....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~- 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG- 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence 34667 88888999988752 0 16789999765432 345789998887753 2344555543211
Q ss_pred CCCceeeeeeeccccc
Q 019506 144 SKDELFLNLVMEYVPE 159 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~ 159 (340)
......++|||+++|
T Consensus 103 -~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 -DVLGTPFFLMDYVEG 117 (357)
T ss_dssp -TTTSSCEEEEECCCC
T ss_pred -CccCCceEEEEecCC
Confidence 111235689999986
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.3e-06 Score=76.54 Aligned_cols=71 Identities=17% Similarity=0.204 Sum_probs=43.6
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----------cChHHHHHHHHhCCC--Ccee-ecceeeeecCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDH--PNVI-SLKHCFFSTTSKDE 147 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h--~~iv-~~~~~~~~~~~~~~ 147 (340)
.+.||.|.++.||++....+++.++||...... .....|.++++.+.. +..+ +++.+ + .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 467899999999999765567889999754221 122568888887642 3333 33322 1 121
Q ss_pred eeeeeeeccccc
Q 019506 148 LFLNLVMEYVPE 159 (340)
Q Consensus 148 ~~~~lv~e~~~~ 159 (340)
.++|||++++
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 4589999975
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.90 E-value=5e-05 Score=65.97 Aligned_cols=65 Identities=15% Similarity=0.098 Sum_probs=41.3
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCcee-ecceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
.+.|+.|....+|++ ..+++|+..... ....+|..+++.+...++. ++++.. .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 577888999999998 568899776432 2346788888776533333 333322 211 24789999
Q ss_pred -cc
Q 019506 158 -PE 159 (340)
Q Consensus 158 -~~ 159 (340)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=66.09 Aligned_cols=79 Identities=11% Similarity=-0.048 Sum_probs=47.6
Q ss_pred HcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCccceeee--eccccCcccccCCCC--CCCcchhHHHHHHH
Q 019506 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATE--YTTSIDIWSAGCVL 270 (340)
Q Consensus 195 H~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~--~~~~~DiwslG~il 270 (340)
+. ..++|||+++.|||++. ++ ++|+||+.+..-........... ...|++|+....... .....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 35 68999999999999984 44 99999999865422211111111 234666665521110 11234555777788
Q ss_pred HHHHhC
Q 019506 271 AELLLG 276 (340)
Q Consensus 271 ~elltg 276 (340)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0012 Score=56.64 Aligned_cols=71 Identities=18% Similarity=0.178 Sum_probs=48.1
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCc---eeecceeeeecCCCCceeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPN---VISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~ 151 (340)
..-++.+|.|..+.||+.+ ..+|+.|.+|+..... ..+.+|.+.|+.+.... +.+++++ + . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~---~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D---D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E---T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c---C----ce
Confidence 4456789999999999998 5678999999765432 23568999998875322 2223221 1 1 25
Q ss_pred eeeccccc
Q 019506 152 LVMEYVPE 159 (340)
Q Consensus 152 lv~e~~~~ 159 (340)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 88999863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00011 Score=64.28 Aligned_cols=145 Identities=13% Similarity=0.044 Sum_probs=73.9
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecc--cccChHHHHHHHHhCCCCce--eecceeeeecC-CCCceeeeeeecc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRLMDHPNV--ISLKHCFFSTT-SKDELFLNLVMEY 156 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~-~~~~~~~~lv~e~ 156 (340)
.+.|+.|....+|++.. ++..+++|+... .......|+.+++.+...++ .+++....... .......+++|++
T Consensus 27 ~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEe--CCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 45678888899999875 334788998865 33445678888776643222 22221100000 0011235689999
Q ss_pred ccchH------------HHHHHHhhcC----CCC----CCHHHHHH---------------HHHHHHHHHHHHHc-----
Q 019506 157 VPETM------------YRVLKHYSSM----NQR----MPLIYVKL---------------YTYQIFRGLAYIHT----- 196 (340)
Q Consensus 157 ~~~~l------------~~~l~~~~~~----~~~----~~~~~~~~---------------i~~qi~~~l~~LH~----- 196 (340)
++|.. ...+...... ... .....-.. +...+...++.+..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 88621 1111111110 000 01000000 00113334445542
Q ss_pred -CCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 197 -~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..+++|+|+.+.|||++. +..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLG-DELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeC-CceEEEecchhccC
Confidence 147999999999999984 44457999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00043 Score=60.91 Aligned_cols=33 Identities=39% Similarity=0.406 Sum_probs=27.2
Q ss_pred CCceecCCCCCCeEecCC---CCcEEEEeecccccc
Q 019506 198 PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKVL 230 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~---~~~~kl~Dfg~a~~~ 230 (340)
..++|||+.+.||+++.+ .+.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 579999999999999842 157999999988653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0013 Score=60.44 Aligned_cols=70 Identities=13% Similarity=0.227 Sum_probs=45.5
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCcee-ecceeeeecCCCCceeeeeeecc
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEY 156 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~ 156 (340)
-.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.+...++. ++++++ .+ .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 34568888889999998644357899998754322 236899999988765553 455444 22 158888
Q ss_pred ccc
Q 019506 157 VPE 159 (340)
Q Consensus 157 ~~~ 159 (340)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00024 Score=61.90 Aligned_cols=71 Identities=14% Similarity=0.040 Sum_probs=49.5
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCC---CCceeecceeeeecCCCCceeeeeeeccc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (340)
.+.|+.|....+|+... ++..+++|+..... ....+|.+.|+.+. ...+.+++.+.. .....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence 46689999999999874 57788999775442 34567888888774 244555555442 223477999999
Q ss_pred cc
Q 019506 158 PE 159 (340)
Q Consensus 158 ~~ 159 (340)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 85
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0007 Score=61.86 Aligned_cols=69 Identities=16% Similarity=0.254 Sum_probs=45.7
Q ss_pred eeeeeeecceEEEEEEEcC-------CCcEEEEEEecc-cc-cChHHHHHHHHhCCCCce-eecceeeeecCCCCceeee
Q 019506 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~ 151 (340)
.+.|+.|....||++.... ++..+++|+... .. ....+|..+++.+...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4568888889999998642 257899998844 22 334568888887754444 3455443 22 2
Q ss_pred eeeccccc
Q 019506 152 LVMEYVPE 159 (340)
Q Consensus 152 lv~e~~~~ 159 (340)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 78888875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00051 Score=61.38 Aligned_cols=69 Identities=13% Similarity=0.139 Sum_probs=40.7
Q ss_pred eeeeeeecceEEEEEEEcC--------CCcEEEEEEeccccc---ChHHHHHHHHhCCCCcee-ecceeeeecCCCCcee
Q 019506 82 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELF 149 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~ 149 (340)
.+.|+.|....+|++.... .+..+++|+...... ....|.++++.+...+++ ++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 4567788888999998632 126899997754322 236788888877544433 444332 1
Q ss_pred eeeeeccccc
Q 019506 150 LNLVMEYVPE 159 (340)
Q Consensus 150 ~~lv~e~~~~ 159 (340)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1478888875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00088 Score=58.66 Aligned_cols=73 Identities=14% Similarity=0.027 Sum_probs=42.2
Q ss_pred eeeeeecceEEEEEEEcCCCcEEEEEEeccc---ccChHHHHHHHHhCCCCc--eeecceeeeecCC--CCceeeeeeec
Q 019506 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPN--VISLKHCFFSTTS--KDELFLNLVME 155 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e 155 (340)
..|+ |....||++.. .+|+.+++|+.... ......|..+++.+.... +.+++.. .... ......+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3456 77789998763 35668999988632 233456788777664322 3333322 0000 01223568899
Q ss_pred cccc
Q 019506 156 YVPE 159 (340)
Q Consensus 156 ~~~~ 159 (340)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0011 Score=59.36 Aligned_cols=138 Identities=15% Similarity=0.235 Sum_probs=75.9
Q ss_pred eeeeeecceEEEEEEEcC-------CCcEEEEEEeccc---ccChHHHHHHHHhCCCCce-eecceeeeecCCCCceeee
Q 019506 83 RVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 83 ~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~ 151 (340)
+.|..|-...+|++.... +++.+++|+.-.. .....+|.++++.+...++ .++++++ .+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence 457778888899987532 3578999976332 2233478888887753333 3444443 22 1
Q ss_pred eeeccccch---------------HHHHHHHhhcC----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 019506 152 LVMEYVPET---------------MYRVLKHYSSM----NQRMP--LIYVKLYTYQIFR-------------------GL 191 (340)
Q Consensus 152 lv~e~~~~~---------------l~~~l~~~~~~----~~~~~--~~~~~~i~~qi~~-------------------~l 191 (340)
+||||++|. +.+.|...-.. ..... +..+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 789998751 11222222121 11111 3445555544322 12
Q ss_pred HHHH----cC---CCceecCCCCCCeEecCC---CCcEEEEeeccccc
Q 019506 192 AYIH----TV---PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV 229 (340)
Q Consensus 192 ~~LH----~~---~~iiH~dlkp~Nill~~~---~~~~kl~Dfg~a~~ 229 (340)
..|. .. ..++|+|+.+.||+++.. .+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 21 259999999999999853 26799999998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0013 Score=58.12 Aligned_cols=31 Identities=23% Similarity=0.486 Sum_probs=26.6
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
..++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence 36999999999999984 56799999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.26 E-value=0.031 Score=45.43 Aligned_cols=117 Identities=17% Similarity=0.066 Sum_probs=69.0
Q ss_pred hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcccee
Q 019506 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239 (340)
Q Consensus 160 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 239 (340)
+|.+.|..+ +.+++++++|.++.|.+.+|.-+-..+.-..+=+.|..|++.. +|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR-DGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET-TSCEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec-CCceeccc-cccc-----------
Confidence 577777654 5899999999999999999877621011112234467888885 67666553 1110
Q ss_pred eeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 019506 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 294 (340)
Q Consensus 240 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~ 294 (340)
.....+.+||... ...+.+.=|||||+++|..+--. .+=....-.+.+.+++.
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLID 151 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHH
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHH
Confidence 1123467888863 33578899999999999999644 43333333344444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.048 Score=49.46 Aligned_cols=69 Identities=12% Similarity=0.166 Sum_probs=44.2
Q ss_pred eeeeeeecceEEEEEEEcCC-------CcEEEEEEecccc---cChHHHHHHHHhCCCCcee-ecceeeeecCCCCceee
Q 019506 82 ERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFL 150 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~ 150 (340)
.+.|..|-...+|++..... +..+++|+..... ....+|.++++.+...+++ ++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence 45577788889999986421 5789999765432 2336899988887543343 333322 2 2
Q ss_pred eeeeccccc
Q 019506 151 NLVMEYVPE 159 (340)
Q Consensus 151 ~lv~e~~~~ 159 (340)
++||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 478999886
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.48 E-value=0.064 Score=49.29 Aligned_cols=56 Identities=14% Similarity=0.058 Sum_probs=17.0
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEE------EEecccc------cChHHHHHHHHhCCCCceeecceeee
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAI------KKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFF 140 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~ 140 (340)
.+.|| ||.||++.+......||+ |..+... ..+.+|..+++.++|+|+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45666 999999998665567888 6554321 22346777888889999999988663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.16 E-value=0.45 Score=42.68 Aligned_cols=30 Identities=27% Similarity=0.487 Sum_probs=24.8
Q ss_pred ceecCCCCCCeEec-----CCCCcEEEEeeccccc
Q 019506 200 VCHRDVKPQNLLVD-----PLTHQVKLCDFGSAKV 229 (340)
Q Consensus 200 iiH~dlkp~Nill~-----~~~~~~kl~Dfg~a~~ 229 (340)
++|+|+.+.|||+. ..+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 2356799999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 340 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-48 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-45 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 4e-76
Identities = 157/256 (61%), Positives = 200/256 (78%), Gaps = 3/256 (1%)
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 122 QLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
Q+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300
CSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 301 AKTIYQGLFCSNNHEI 316
+ I + +
Sbjct: 244 REQIREMNPNYTEFKF 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-56
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 16/230 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F+ + +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFY-----SDGEISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303
T Y+ DIWS G L E+ +G+ P +A + + A+T
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 2e-53
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 134
Y +GTG+FG+V + TG A K V+ D+ +E+Q M ++ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + ++ E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 195 HTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H H D+KP+N++ ++++KL DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 6e-52
Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 196 T-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
T P + HRD+K N+ + T VK+ D G A L + + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+Y S+D+++ G + E+ + + Q+ +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-52
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 18/225 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F E L +++E+ + + + +++ Q L Y+
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFG 253
H + HRD+K N+L +KL DFG + + S+I + Y+ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 254 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
T Y D+WS G L E+ +P N + L++I K
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 2e-51
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + C+ E LVMEY + + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
AY+H+ + HRDVK N+L+ VKL DFGSA ++ S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-51
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 18/224 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPEL 250
+H G+ HRD+KP+NLL+D +K+ DFG A V + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + +D+WS G VL +L G+ + + Q K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 8e-51
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + L++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 195 HTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H + H D+KP+N++ + VK+ DFG A L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 10/217 (4%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 200 VCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP+NLL +KL DFG AK + + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
S D+WS G ++ LL G P F + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-50
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 19/224 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L F D + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+Y H+ V HRD+KP+NLL+ ++K+ DFG + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-49
Identities = 79/226 (34%), Positives = 126/226 (55%), Gaps = 16/226 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRLMDHPNVI 133
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPE 249
IH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-49
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 19/229 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + L +VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSYL-----VGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ L ++H+ V HRD+K N+L+ VKL DFG + ++ S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
APE++ Y +DIWS G + E++ G+P + EN + L I
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-48
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L F +D+ L + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAP 248
Y+H G+ HRD+KP+N+L++ +++ DFG+AKVL S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
EL+ S D+W+ GC++ +L+ G P F N +IIK
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 73/223 (32%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L F + ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H + HRD+KP NLL+D +KL DFG AK ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
GA Y +D+W+ GC+LAELLL P PG++ +DQL I +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-48
Identities = 66/231 (28%), Positives = 116/231 (50%), Gaps = 19/231 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++L+ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 133 ISLKHCFFSTTS---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++L + S + + + LV ++ + S++ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-----SYICSRY 244
GL YIH + HRD+K N+L+ +KL DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 8e-48
Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 13/220 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RLMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ + Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSR---TPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 257 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV 295
Y S+D+WS GC+LA ++ + P F G + DQLV I KV
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 48/221 (21%), Positives = 96/221 (43%), Gaps = 15/221 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + L ++ E++ ++ + + + + Y +Q+ L ++
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H+ + H D++P+N++ +K+ +FG A+ L G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+T+ D+WS G ++ LL G F E + I+
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 2e-47
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 29/235 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 125
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 126 -LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
+ HPN+I LK + + F LV + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ + +H + HRD+KP+N+L+D + +KL DFG + L GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 245 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-47
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+L + + L L+M+ V L +Q+ + Y
Sbjct: 71 ALDDIY-----ESGGHLYLIMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+H + + HRD+KP+NLL L ++ + DFG +K+ G + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 9e-46
Identities = 78/227 (34%), Positives = 125/227 (55%), Gaps = 15/227 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRLM---D 128
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
RGL ++H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-45
Identities = 76/224 (33%), Positives = 128/224 (57%), Gaps = 16/224 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L E L LV E++ + + + + S +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHP 130
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ + F + + L VMEY+ L ++ + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H+ G+ +RD+K N+L+D H K+ DFG K + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ G +Y S+D WS G +L E+L+GQ F G++ + I
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 2e-45
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + F +D + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+H+ + +RD+KP+N+L+D H +K+ DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 6e-45
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD 128
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ + + F L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
GL ++H V +RD+KP N+L+D H V++ D G A K + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
E++ Y +S D +S GC+L +LL G F D+
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 81/224 (36%), Positives = 128/224 (57%), Gaps = 16/224 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F + D+ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 26/225 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L +V ++ ++Y L + + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + VK+ DFG A V + + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 252 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (384), Expect = 1e-44
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 18/227 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++++ + + +VMEYV L+ M + L
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRA 247
+ H G+ HRDVKP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
PE G D++S GCVL E+L G+P F G++ V + ++
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 5e-44
Identities = 70/224 (31%), Positives = 125/224 (55%), Gaps = 18/224 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIA 114
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++K+ DFG A+ + I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-43
Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 74 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 121
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 181
+++ + HPNVI+L + +++ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKVLVKGEANIS 238
+ QI G+ Y+H+ + H D+KP+N+++ ++K+ DFG A + G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-43
Identities = 77/223 (34%), Positives = 120/223 (53%), Gaps = 14/223 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F S +E ++ ++ + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
YIH+ + HRD+KP NL V+ K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y ++DIWS GC++AELL G+ LFPG + +DQL I+++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-43
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD 128
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 129 --HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F L++E + L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPE--PVQDLFDFITERGALQEELARSFFWQ 118
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
+ + + H GV HRD+K +N+L+D ++KL DFGS L+K + +R Y
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-43
Identities = 78/225 (34%), Positives = 125/225 (55%), Gaps = 18/225 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ ++KL +FG A+ + + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKV 295
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 1e-41
Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 23/233 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G GSFG++F+ L + VAIK + E + +L+ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ F + L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQ----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 197 VPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANI--------SYICSRY 244
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN 297
Y + G E + D+ + G V L G + G A + ++
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-41
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+++ L +V EY+ + ++ L+ S + + ++ + + Y+
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
HRD+ +N+LV + K+ DFG K + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 260 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
D+WS G +L E+ G+ +P D + + K
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-40
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 17/219 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAF-----QTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ V +RD+K +NL++D +K+ DFG K + A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+Y ++D W G V+ E++ G+ F ++ I+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 6e-40
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 21/234 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ + + +VME + ++ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGA----EGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 197 VPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYR 246
HRDVKP N L+ + V + DFG AK + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIY 300
+ G E + D+ S G VL LG + G A + + ++S
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-39
Identities = 72/236 (30%), Positives = 125/236 (52%), Gaps = 18/236 (7%)
Query: 69 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 120
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
L LM+ ++H N+ISL + F + +E + LVME + + +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ YQ+ G+ ++H+ + HRD+KP N++V +K+ DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ +RYYRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (346), Expect = 2e-38
Identities = 72/277 (25%), Positives = 130/277 (46%), Gaps = 29/277 (10%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM 127
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 128 DHPNVISLKH----------CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 177
+ + F+ + + + +V E + E + ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 232
IYVK + Q+ GL Y+H G+ H D+KP+N+L++ + Q+K+ D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 286
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 287 DQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSW 323
D + +II++ + + + G + L +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 1e-36
Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+NLL+D +++ DFG AK + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y ++D W+ G ++ E+ G P F + + +I+
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 17/222 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+++ ++ ++ EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIY--IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFG 253
HRD++ N+LV K+ DFG A+++ E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 254 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-36
Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 24/226 (10%)
Query: 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRLMDHPNV 132
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
Y+ + HRD+ +NLL+ VK+ DFG + L + + + + +
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 8e-36
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 25/232 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDH 129
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PNVI L+ + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------ 243
G+ Y+ HRD+ +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 1e-35
Identities = 44/218 (20%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
E ++ E++ Q + + + QI + Y+
Sbjct: 82 CT-----REPPFYIITEFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++++ A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ D+W+ G +L E+ + Q+ E+++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 43/217 (19%), Positives = 90/217 (41%), Gaps = 16/217 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
++ + LV E++ + + + + + G+AY+
Sbjct: 70 L-----EQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATEY 257
V HRD+ +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 44/218 (20%), Positives = 92/218 (42%), Gaps = 17/218 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + ++ EY+ +L + M R + + + Y+ +
Sbjct: 69 T-----KQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAPELIFGATEY 257
HRD+ +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 258 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
++ DIW+ G ++ E+ LG+ + + I +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 43/248 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RLMDHP 130
+V+G+G+FG V A +T VA+K + + EL++M +L H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK-------------------HYSS 170
N+++L + L+ EY + L+
Sbjct: 102 NIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ + + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 231 VKGEANISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 287 DQLVEIIK 294
++I+
Sbjct: 274 ANFYKLIQ 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-35
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR---YYRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE 227
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-35
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 17/219 (7%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S++ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD++ N+LV K+ DFG A+++ E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 257 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+T D+WS G +L EL G+ +PG + L ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-34
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 23/227 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
SL + E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ + HRD+ +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
E + ++TT D+WS G +L EL+ G P +P N D V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-34
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRLM 127
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
+ H F + E L+L+++Y L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAF----QTETKLHLILDY---INGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC---SRY 244
L ++H G+ +RD+K +N+L+D V L DFG +K V E +Y Y
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 46/228 (20%), Positives = 87/228 (38%), Gaps = 30/228 (13%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVIS 134
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + L LV +Y +++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 194 IHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----YIC 241
+H P + HRD+K +N+LV + D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 242 SRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
++ Y APE++ + E DI++ G V E+ +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-34
Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 25/226 (11%)
Query: 82 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPE 249
+ HRD+ +N+L+ H K+ DFG +K L E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-34
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVIS 134
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAPEL 250
HRD+ +N+L+ H K+ DFG +K L ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
I ++++ D+WS G + E L GQ + + + I +
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 23/230 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMD 128
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC----SRY 244
G+ Y+ HRD+ +N+LV+ K+ DFG ++VL
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 227
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-32
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHY--------------SSMNQRM 175
N+++L ++ EY + L+ +
Sbjct: 88 NIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + ++YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 236 NISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 291
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 292 IIK 294
+IK
Sbjct: 260 MIK 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-32
Identities = 55/235 (23%), Positives = 100/235 (42%), Gaps = 30/235 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLK------------HYSSMNQRMPLIYV 180
+L +L L +EY P + L+ +S + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+ A E + + YTT+ D+WS G +L E++ LG + G + ++ +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-31
Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 22/227 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHP 130
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAP 248
LAY+ + HRD+ +N+LV VKL DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294
E I +T++ D+W G + E+L+ G F G D + I
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 1e-31
Identities = 55/247 (22%), Positives = 91/247 (36%), Gaps = 43/247 (17%)
Query: 83 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP---------------------ETMYRVLKHYSSM 171
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ Q+ G+AY+ HRD+ +N LV VK+ DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 232 KGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
+ A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 288 QLVEIIK 294
+ +
Sbjct: 251 VIYYVRD 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 6e-30
Identities = 53/246 (21%), Positives = 104/246 (42%), Gaps = 39/246 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 125
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMN 172
+ H N+I+L + L +++EY + + L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 173 QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232
+++ + YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 233 GEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 289 LVEIIK 294
L +++K
Sbjct: 246 LFKLLK 251
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-29
Identities = 53/244 (21%), Positives = 99/244 (40%), Gaps = 35/244 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRLM 127
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMNQR 174
H NV++L L +++E+ + L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+ L ++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 235 ANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 290
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 291 EIIK 294
+K
Sbjct: 248 RRLK 251
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 29/234 (12%)
Query: 82 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
V+ L ++ME + R + + L +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--- 241
+I G+AY++ HRD+ +N +V VK+ DFG + + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 3e-19
Identities = 32/204 (15%), Positives = 55/204 (26%), Gaps = 32/204 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------------RELQLMRLMD 128
+++G G VF E +K +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L+ ++ME + R+ + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
+A + G+ H D+ N+LV + + DF + + GE I R R
Sbjct: 114 EEVAKFYH-RGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 249 ELIFGATEYTTSIDIWSAGCVLAE 272
F Y T DI SA + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 340 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.59 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=405.49 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=200.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|++++++++|||||++++++. +...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 45799999999999999999999999999999998643 234568999999999999999999994 44568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+|||||++ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhee
Confidence 999999996 544443 345789999999999999999999999 79999999999999995 78899999999987
Q ss_pred cccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... .....+||+.|+|||++.+...++.++|||||||++|||+||+.||.+.+.................. +.
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 230 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WK 230 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT--GG
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc--cc
Confidence 64432 23456799999999999776656788999999999999999999998766544444444433222111 11
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+..-|+..+|.+|||++|+++|||
T Consensus 231 ~--~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 231 K--IDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp G--SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred c--CCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 1 1122234556677778999999999999999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-59 Score=400.17 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=203.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+++++.++|||||++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 45799999999999999999999999999999998632 12345799999999999999999999 4555
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence 68999999995 66666654 3679999999999999999999999 79999999999999995 788999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
...... ......||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.+.. ...+..
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~---- 226 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDF---- 226 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTT----
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCcc----
Confidence 876443 33456799999999999764 58999999999999999999999999888777666665432 222221
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 227 --~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 227 --VTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 2233445666677778999999999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=402.79 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=197.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||+||+|+++.+|+.||||.+.... ....+|++++++++|||||++++++.+ .....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 57999999999999999999999999999999986543 224579999999999999999998854 233447
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----ceecCCCCCCeEecCCCCcEEEEee
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
|+|||||++ +|.+.+......+..+++..++.++.||+.||.|||+ +| ||||||||+|||++. ++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEeec
Confidence 899999985 7777777665567789999999999999999999998 56 999999999999995 789999999
Q ss_pred ccccccccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 225 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 225 g~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
|+|+....... .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+..+.+..+...........
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 99988754433 345678999999999965 4589999999999999999999999998887776666655433222221
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+.+.|+..+|.+|||++|+++|||
T Consensus 238 ------~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 238 ------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ------cCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 2233456667777788999999999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=403.91 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=205.0
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|++++++++|||||+++++|. +...+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 47999999999999999999999999999999986433 23468999999999999999999994 4445899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
|||||++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence 9999996 55444332 579999999999999999999999 79999999999999995 7889999999998765
Q ss_pred cCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||.+.+..+.+..+.......... .. -.
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~--~~ 242 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PE--KL 242 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSS--GG--GS
T ss_pred cccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC--cc--cC
Confidence 443 3445679999999999966 458999999999999999999999999998888888877755432210 00 11
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+...|+..+|.+|||++|+++|||
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 233455667777788999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=408.95 Aligned_cols=262 Identities=61% Similarity=1.021 Sum_probs=223.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHHhCCCCceeecceeeeecCC-CCceeeeeeecc
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVMEY 156 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~e~ 156 (340)
+|+..++||+|+||+||+|++..+|+.||||++.++.....+|+++|++++|+||++++++|..... .+..++++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 6999999999999999999999999999999998887777899999999999999999999866433 456678999999
Q ss_pred ccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccCCcc
Q 019506 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (340)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (340)
|++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++........
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~ 179 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCccc
Confidence 9999888887776777889999999999999999999999 799999999999999965568999999999988777767
Q ss_pred ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc--------
Q 019506 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL-------- 308 (340)
Q Consensus 237 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 308 (340)
....||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+++.++++..+.+....+....
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 259 (350)
T d1q5ka_ 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259 (350)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCC
T ss_pred ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccc
Confidence 778899999999998877779999999999999999999999999999999999998876654432221100
Q ss_pred -----------c---ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 -----------F---CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 -----------~---~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+...|+..+|.+|||++|+++|||
T Consensus 260 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0 0111223555677778999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-58 Score=398.98 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=203.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
+.|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++|++++|||||++++++. +...+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 4699999999999999999999999999999998643 244568999999999999999999984 4445889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
|||||++ +|.+.+.. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhccC
Confidence 9999996 55554443 24679999999999999999999999 79999999999999995 7889999999997654
Q ss_pred cCC-ccceeeeeccccCcccccC----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
... ......||+.|+|||++.. ...|+.++|||||||++|||+||+.||.+.+..+.+.++.+.........
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--- 238 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP--- 238 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG---
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc---
Confidence 332 2335678999999999842 34588999999999999999999999999888888888777543221100
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.-.+.....+..-|+..+|.+|||++|+++|||
T Consensus 239 -~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 239 -SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp -GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred -ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 012223345666677788999999999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=390.23 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=201.4
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
|++.++||+|+||+||+|++..+++.||+|++.... ..+.+|+++|++++|||||+++++|.... .+...+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 478889999999999999999999999999886432 23458999999999999999999985532 33456889
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--ceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999996 66666654 3679999999999999999999999 68 999999999999975578899999999986
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.. ........||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+.+.+.....+.. +. . .
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--~~-~-~ 237 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FD-K-V 237 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GG-G-C
T ss_pred cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--cC-c-c
Confidence 43 333446789999999999854 4899999999999999999999999887766666555544332221 11 1 1
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+.+.|+..+|.+|||++|+++|||
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 2223456677778888999999999999999
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-57 Score=400.60 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=191.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 456999999999999999999999999999999986432 2335799999999999999999998 455668
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeeccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA 227 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a 227 (340)
|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+.. .++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999985 67666653 5689999999999999999999999 79999999999999953 3678999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
+...........+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+.+.... ........
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 235 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE-FDSPYWDD 235 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC-CCTTTTTT
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CCCccccC
Confidence 887666666677899999999999654 5899999999999999999999999998887777766664332 21111111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 236 --~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 236 --ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 1222345666677778999999999999999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-57 Score=405.19 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=208.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+++|++++|||||+++++| .+...+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 357999999999999999999999999999999986543 2345799999999999999999998 4455689
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-CCCcEEEEeeccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~~~~~kl~Dfg~a~~ 229 (340)
+|||||++ +|.+.+. .....+++..++.++.||+.||+|||+ +|||||||||+|||++. .++.+||+|||+|+.
T Consensus 100 ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999996 6655553 234679999999999999999999999 79999999999999964 357899999999998
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
...........||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+......... ..+..
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~-- 251 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-SAFSG-- 251 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-GGGGG--
T ss_pred cccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-ccccC--
Confidence 8777777778899999999999764 4899999999999999999999999998888888777765433221 11111
Q ss_pred ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+..-|+..+|.+|||++|+++|||
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1222344566677778999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-57 Score=399.24 Aligned_cols=245 Identities=28% Similarity=0.423 Sum_probs=204.8
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++|++++|||||++++++. +...+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence 5999999999999999999999999999999986543 22457999999999999999999984 34458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+|||||.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|...
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeeccccccc
Confidence 99999999876654432 24689999999999999999999999 79999999999999995 889999999999875
Q ss_pred ccCCccceeeeeccccCcccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
... ....||+.|+|||++.+ ...|+.++|||||||++|||++|..||.+.+..+.+..+.+.........
T Consensus 166 ~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----- 237 (309)
T d1u5ra_ 166 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG----- 237 (309)
T ss_dssp SSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT-----
T ss_pred CCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCC-----
Confidence 432 34679999999999864 23589999999999999999999999999988888888877554332221
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-.+.....+.+.|+..+|.+|||++|+++|||
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 12233456667778888999999999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=395.44 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=199.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|++++++++||||++++++| .+...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 4799999999999999999999999999999998642 12346899999999999999999998 45556
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
+|+|||||++ +|.+.+.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccccce
Confidence 8999999996 66665543 3679999999999999999999999 79999999999999995 7889999999998
Q ss_pred ccccCC---ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh
Q 019506 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY 305 (340)
Q Consensus 229 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (340)
...... .....+||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++.+.. ...+..
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~-- 232 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEK-- 232 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTT--
T ss_pred ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCcc--
Confidence 764332 23346799999999999664 48999999999999999999999999988877777766532 222222
Q ss_pred ccccccCChhhHhhhcccccccCCCCcCc------ccccCC
Q 019506 306 QGLFCSNNHEIMCELGSWYSYSGRNSMHE------SKLYGF 340 (340)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~R~~~~~------i~~hpf 340 (340)
.+.....+.+-|+..+|.+|||++| |++|||
T Consensus 233 ----~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 233 ----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp ----CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCc
Confidence 1223344566677778889999998 477887
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-57 Score=403.29 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=207.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|++++|||||+++++| .+...+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 46999999999999999999999999999999986542 2345799999999999999999998 45566899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC-CCCcEEEEeecccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~-~~~~~kl~Dfg~a~~~ 230 (340)
|||||+| +|.+.+. ....++++.+++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+|...
T Consensus 104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999996 5444332 334579999999999999999999999 79999999999999973 3678999999999988
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||.+.+..+.+..+.+.... .....+.. .
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~--~ 255 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSS--V 255 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTTTT--S
T ss_pred CCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccccC--C
Confidence 77777777889999999999965 45899999999999999999999999999888888777764432 22221111 1
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+..-|+..+|.+|||++|+++|||
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 122345666677778889999999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=390.98 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=207.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|++++|||||+++++| .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 457999999999999999999999999999999986431 2246899999999999999999999 5
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC---cEEE
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKL 221 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~---~~kl 221 (340)
+...+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+. .+||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence 55668999999995 66666654 3579999999999999999999999 79999999999999985332 5999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
+|||+|.............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+..+.+..+.+... ...
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~~ 236 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFE 236 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCC
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCC
Confidence 99999998876666667789999999999965 4589999999999999999999999999888777777665432 222
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...... .+.....+..-|+..+|.+|||++|+++|||
T Consensus 237 ~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 237 DEYFSN--TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp HHHHTT--SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred chhcCC--CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 222221 1222344566677778999999999999999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-57 Score=396.62 Aligned_cols=244 Identities=26% Similarity=0.429 Sum_probs=197.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||++++++ .+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCC
Confidence 35799999999999999999999999999999998643 12345799999999999999999998 4555
Q ss_pred eeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|+|||||.|+ +...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence 689999999975 333333 35678999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
+..... ....+||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++.+... ..+..+
T Consensus 152 ~~~~~~--~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~--- 224 (316)
T d1fota_ 152 KYVPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFF--- 224 (316)
T ss_dssp EECSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTS---
T ss_pred eEeccc--cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCC---
Confidence 886433 3456899999999999654 489999999999999999999999999988888877776432 221111
Q ss_pred ccccCChhhHhhhcccccccCC-----CCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGR-----NSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R-----~~~~~i~~hpf 340 (340)
+.....+.+.|+..+|.+| +|++||++|||
T Consensus 225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 1112223333344445555 59999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=397.82 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=202.6
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|++++||||++++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 457999999999999999999999999999999986431 2345799999999999999999999 5566
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|+|||||+| +|...+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence 69999999996 55555443 4689999999999999999999999 79999999999999995 789999999999
Q ss_pred ccccc-CCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.. .....++.+
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-~~~~~p~~~-- 228 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-EEIRFPRTL-- 228 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTTS--
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-CCCCCCccC--
Confidence 87644 3344567899999999999664 489999999999999999999999999887666666555 334433322
Q ss_pred cccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
+.....+...|+..+|.+|++ ++||++|||
T Consensus 229 ----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 229 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ----CHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 122233445556677889984 899999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=399.71 Aligned_cols=198 Identities=29% Similarity=0.509 Sum_probs=169.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++.+. ....+|+.+|+.++|||||+++++| .+...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 467999999999999999999999999999999986542 2345799999999999999999999 445568
Q ss_pred eeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
|+|||||++ +|.+.+.. .+.+++..++.++.||+.||.|||+.+||+||||||+|||++. ++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccc
Confidence 999999996 66666654 3579999999999999999999996138999999999999995 88999999999987
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 285 (340)
..+. ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 6443 33456899999999999764 489999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=386.66 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=212.7
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCC-CcEEEEEEeccc------ccChHHHHHHHHhC---CCCceeecceeeeecCC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRLM---DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~ 144 (340)
..++|++.+.||+|+||+||+|++..+ ++.||||++... .....+|+++++.+ +||||++++++|.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 456899999999999999999999765 667999998643 22345788877665 79999999999876555
Q ss_pred CCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
.....++++|||+.+++...... .....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecch
Confidence 56678899999999886655443 345679999999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI 304 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (340)
|+++............||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+.++++....+....+
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 999887666666678899999999999664 5899999999999999999999999999999999999887665543322
Q ss_pred hccc------------------cccC--ChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 YQGL------------------FCSN--NHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ~~~~------------------~~~~--~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
-... .... ....+...|+..+|.+|||++|+++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 1110 0000 1123555677788999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=390.18 Aligned_cols=250 Identities=30% Similarity=0.522 Sum_probs=203.9
Q ss_pred EeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---------cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 81 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..++||+|+||+||+|+++.+|+.||||+++... ....+|+.+++.++|||||++++++ .+...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 3578999999999999999999999999886432 2245799999999999999999999 4555689
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+||||+.+++...+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence 999999987655543 345679999999999999999999999 79999999999999995 8899999999998765
Q ss_pred cCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc-
Q 019506 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF- 309 (340)
Q Consensus 232 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 309 (340)
... .....+||+.|+|||++.+...|+.++|||||||++|||+||.+||.+.+..+++.++.+....+....+.....
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 334567899999999997777789999999999999999999999999999999999998766554332211100
Q ss_pred ------------------c--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 ------------------C--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 ------------------~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. +.....+..-|+..+|.+|||++|+++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 0 011223456677778999999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-56 Score=396.12 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=198.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 468999999999999999999999999999999986421 2245799999999999999999998 4555
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ +|||||||||+|||++. ++.+||+|||+|
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~DFG~a 188 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeeeceee
Confidence 68899999996 55555543 3579999999999999999999999 79999999999999995 789999999999
Q ss_pred cccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC------ch
Q 019506 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII------YA 301 (340)
Q Consensus 228 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------~~ 301 (340)
+..... .....||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+....+.++.+..... ..
T Consensus 189 ~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 265 (350)
T d1rdqe_ 189 KRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265 (350)
T ss_dssp EECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred eecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHH
Confidence 886433 3456899999999999764 48999999999999999999999999988877777776643221 23
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.++++.|+..+|.+|+. ..|+|++|++.|||
T Consensus 266 ~~li~~~L~~dP~kR~~--------~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFG--------NLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHHHHHSCSCTTTCTT--------SSTTTTHHHHTSGG
T ss_pred HHHHHHHhhhCHHhccc--------cccccHHHHHcCcc
Confidence 33444444444443321 23469999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-55 Score=380.42 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=207.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------------cChHHHHHHHHhCC-CCceeecceeeeec
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCFFST 142 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 142 (340)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+.++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 57999999999999999999999999999999986532 12347999999997 99999999999
Q ss_pred CCCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEE
Q 019506 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (340)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl 221 (340)
.+...+|+|||||++ +|.+.+.. +..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeEE
Confidence 556668999999985 77777654 3679999999999999999999999 79999999999999995 889999
Q ss_pred EeeccccccccCCccceeeeeccccCcccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 019506 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS 296 (340)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 296 (340)
+|||+++............||..|+|||++.+ ...++.++||||+||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999998877666667789999999999852 3447889999999999999999999999998888777777654
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
....... +.+ .+.....+..-|+..+|.+|||++|+++|||
T Consensus 232 ~~~~~~~-~~~--~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 232 YQFGSPE-WDD--YSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CCCCTTT-GGG--SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCCcc-ccc--CCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 3222111 111 1223344556677778999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=386.77 Aligned_cols=254 Identities=31% Similarity=0.575 Sum_probs=208.6
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|++++++++|||||+++++| .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 57999999999999999999999999999999986432 2345799999999999999999999 444558
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
|+||||+.+++...+.. .....+++..++.++.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence 99999999987766643 335679999999999999999999999 79999999999999995 788999999999876
Q ss_pred ccC-CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+....+....+ ....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~ 231 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW-PGVT 231 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc-cccc
Confidence 543 33445678999999999877777799999999999999999999999999999999888876554332111 1000
Q ss_pred -----------------------ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 310 -----------------------CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 310 -----------------------~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 0011233556677778999999999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=390.11 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=208.4
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ...+|+++|+.++|||||+++++| .+...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 3579999999999999999999999999999999975432 345899999999999999999999 44556899
Q ss_pred eeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC-CCcEEEEeecccccc
Q 019506 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (340)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 230 (340)
|||||+| +|.+.+.. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.. ...+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999996 66665542 23479999999999999999999999 799999999999999742 357999999999887
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLFC 310 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (340)
..........+|+.|+|||.+.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+..... ....+..+
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~-- 230 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKEI-- 230 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-CHHHHTTS--
T ss_pred ccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-ChhhccCC--
Confidence 66666667788999999999965 458999999999999999999999999999888888877754332 22222221
Q ss_pred cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 311 SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 311 ~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+.....+..-|+..+|.+|||++|+++|||
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 222344566677778899999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=383.06 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=199.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHH-HhCCCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
++|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.++ +.++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999999999999999996431 1223555554 579999999999999 5556
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccchh
Confidence 68999999996 66666543 4678999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCC-ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
+...... ......||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.. .....++.
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~p~~--- 225 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-DNPFYPRW--- 225 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT---
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCcc---
Confidence 8764433 33346789999999999764 589999999999999999999999999887776666654 33333322
Q ss_pred cccccCChhhHhhhcccccccCCCCcC-cccccCC
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMH-ESKLYGF 340 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~-~i~~hpf 340 (340)
.+.....+.+-|+..+|.+||+++ |+++|||
T Consensus 226 ---~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 226 ---LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred ---CCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 123344556667777899999996 8999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-55 Score=391.59 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=194.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChH---HHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|++.++||+|+||+||+|+++.+|+.||||++.+.. .... +|+++++.++|||||+++++| .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 457999999999999999999999999999999985432 1122 346667778899999999998 4
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEee
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Df 224 (340)
+...+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +|||||||||+|||++. ++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence 45568999999995 66666654 3678999999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCchh
Q 019506 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN--IIYAK 302 (340)
Q Consensus 225 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~ 302 (340)
|+|+...... .....||+.|+|||++.+...|+.++|||||||+||||+||+.||.+.+..+.......... .....
T Consensus 152 Gla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 152 GLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred ceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 9998765443 34568999999999997666689999999999999999999999987654333222222111 11111
Q ss_pred hhhccccccCChhhHhhhcccccccCCCC-----cCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNS-----MHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~-----~~~i~~hpf 340 (340)
. .+.....+..-|+..+|.+||| ++|+++|||
T Consensus 231 ~------~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 231 S------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp S------SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred C------CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 1 1122344556666778889999 699999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=383.71 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=194.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc----------cChHHHHHHHHhCC--CCceeecceeeeecCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFSTTS 144 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 144 (340)
++|++++.||+|+||+||+|++..+|+.||||++.+.. ....+|+.++++++ |||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 47999999999999999999999999999999986432 22357999999987 89999999998
Q ss_pred CCceeeeeeeccccc--hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 145 KDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
.+....++||||+.+ .+.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 445568899999974 45555543 3679999999999999999999999 7999999999999998656799999
Q ss_pred eeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
|||+|+..... ......||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+ .+.+ .......
T Consensus 154 DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~-~~~~~~~ 225 (273)
T d1xwsa_ 154 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR-GQVFFRQ 225 (273)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-CCCCCSS
T ss_pred ccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh-cccCCCC
Confidence 99999875433 34457899999999999766666788999999999999999999997542 2222 1222211
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
. .+.....+.+.|+..+|.+|||++|+++|||
T Consensus 226 ~------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 226 R------VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp C------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred C------CCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 1 1233445566677778999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=384.93 Aligned_cols=257 Identities=23% Similarity=0.288 Sum_probs=198.7
Q ss_pred ccCeeEee-eeeeecceEEEEEEEcCCCcEEEEEEecccccChHHHHHHHH-hCCCCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~-~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|.+.. .||+|+||+||+|++..+|+.||||+++.. ....+|+.++. ..+|||||+++++|.+.. ....++|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence 45798864 699999999999999999999999988654 44567998854 568999999999885422 235668999
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC--CCcEEEEeecccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVL 230 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 230 (340)
||||+| +|.+.+.. .....+++.+++.++.||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence 999985 77777753 234579999999999999999999999 799999999999999852 357999999999988
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc---CCCchhhhhcc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVS---NIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 307 (340)
..........||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||.+.+.......+.... ....+...+..
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred cCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 77777777889999999999955 458999999999999999999999998776555444443322 22221111111
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.+.....+...|+..+|.+|||++|+++|||
T Consensus 244 --~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 244 --VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 1222344556667778999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-53 Score=371.64 Aligned_cols=253 Identities=28% Similarity=0.515 Sum_probs=204.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.++||+|+||+||+|+++ +|+.||||++.... ....+|+.+|++++||||++++++|. +....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 47999999999999999999975 78999999986432 23458999999999999999999994 44458
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+++||++.+++...+.. ..+.+++..++.++.||+.||+|||+ .|||||||||+|||++. ++.+||+|||.|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence 89999999987666643 35789999999999999999999999 79999999999999995 889999999999876
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc---
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ--- 306 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 306 (340)
..... .....+++.|+|||.+.+...++.++|||||||++|||++|+.||.+.+..+++.++.+....+....+..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 54333 33456899999999998777789999999999999999999999999998898888887665543222100
Q ss_pred -----------------cccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 -----------------GLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 -----------------~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. +.....+.+.|+..+|.+|||++|+++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000 001224566777888999999999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-53 Score=371.81 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=198.4
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc---ChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
..++|++.+.||+|+||+||+|++..+|+.||||+++.+.. .+.+|+++|++++|||||++++++ .+...++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence 34579999999999999999999999999999999875533 346899999999999999999998 4445588
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+|||||++ ++.+.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeec
Confidence 99999995 66666543 334678999999999999999999999 79999999999999995 789999999999876
Q ss_pred ccCCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhccc
Q 019506 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGL 308 (340)
Q Consensus 231 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (340)
...... ....|+..|+|||++.+. .|+.++|||||||++|||++|..||........+.+++.....+....
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~----- 239 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE----- 239 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT-----
T ss_pred CCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc-----
Confidence 544332 234578899999999654 489999999999999999997766655555555666655443322221
Q ss_pred cccCChhhHhhhcccccccCCCCcCcccc
Q 019506 309 FCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.++.....+...|+..+|.+|||++|+..
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12334556677788888999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=379.17 Aligned_cols=256 Identities=34% Similarity=0.556 Sum_probs=203.8
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
..+|++++.||+|+||+||+|+++.+|+.||||++++... ...+|+++|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999999999999999999875322 23579999999999999999999855432 2344
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.+|+||||++.++...... .++++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-cccccccccccee
Confidence 5789999998777666543 679999999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhh----
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTI---- 304 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (340)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+....+....+
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 7643 3345678999999999987777899999999999999999999999999988888888876665432211
Q ss_pred ------------------hccccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 305 ------------------YQGLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 305 ------------------~~~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
+...+. +.....+..-|+..+|.+|||++|+++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000110 111223556677778999999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=373.64 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=185.2
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCc---EEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..+|++.+.||+|+||+||+|+++.+|+ .||||.+... .+.+.+|+++|++++|||||++++++ .+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence 3469999999999999999999887665 5889987543 23456899999999999999999998 344
Q ss_pred eeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++|||||+++ |.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCccc
Confidence 4588999999975 444443 224579999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc------ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 019506 227 AKVLVKGEAN------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNII 299 (340)
Q Consensus 227 a~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (340)
|+........ ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9876543322 123568899999999654 58999999999999999998 899999988877777666544444
Q ss_pred chhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 300 YAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
...+ +......+...|+..+|.+|||++||.+
T Consensus 254 ~~~~------~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 254 PPMD------CPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp CCTT------CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcc------chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3322 2333456677788888999999988754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=372.85 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=204.1
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCC---CC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 146 (340)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++|++++|+||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 568999999999999999999999999999999885432 223589999999999999999998854321 22
Q ss_pred ceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...+++||||+++++..... .....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEeeecce
Confidence 45688999999988665443 345789999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCC-----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (340)
++...... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+.+..+.+....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97654322 2233568999999999987777899999999999999999999999999988888888876655433
Q ss_pred hhhhcc-------------------------ccccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 302 KTIYQG-------------------------LFCSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 302 ~~~~~~-------------------------~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
...... .........+...|+..+|.+|+|++|+++|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 221110 000000112455677778999999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=367.32 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=191.8
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
..++|++.+.||+|+||+||+|++ +..||||+++... ..+.+|++++++++|||||++++++. + .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-c
Confidence 345799999999999999999984 3469999986432 23457999999999999999998762 1 2
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+++|||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla 151 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLA 151 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCS
T ss_pred EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEccccce
Confidence 36899999995 66666543 34679999999999999999999999 79999999999999995 889999999999
Q ss_pred cccccCC---ccceeeeeccccCcccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-ch
Q 019506 228 KVLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNII-YA 301 (340)
Q Consensus 228 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~ 301 (340)
+...... ......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..++...... ..
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence 8764332 22345789999999999643 347899999999999999999999999888777776666654432 22
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
..+... ++.....+..-|+..+|.+|||++||..+
T Consensus 232 ~~~~~~--~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 232 SKVRSN--CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GGSCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccc--chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 222111 22334556677777889999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=375.62 Aligned_cols=257 Identities=32% Similarity=0.531 Sum_probs=206.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
.+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++||||+++++++..........++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46999999999999999999999999999999986432 2335799999999999999999998665544555677
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+++++++++|.+.+.. ..+++..++.++.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|....
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceeecc
Confidence 8888887888888764 579999999999999999999999 79999999999999995 7899999999998764
Q ss_pred cCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc-
Q 019506 232 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ- 306 (340)
Q Consensus 232 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (340)
.... ....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+......+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 4322 23456899999999997767789999999999999999999999999988888877776655543222100
Q ss_pred ---------------------cccc--cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 307 ---------------------GLFC--SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 307 ---------------------~~~~--~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+. +.....+..-|+..+|.+|||++|+++|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0000 111234566677778999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=364.60 Aligned_cols=244 Identities=18% Similarity=0.293 Sum_probs=186.1
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|++.+.||+|+||+||+|++. +++.||||++..+. ..+.+|++++++++|||||++++++. +....++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence 36999999999999999999975 57789999987543 33468999999999999999999983 34458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheeccC
Confidence 999996 55555442 34678999999999999999999999 79999999999999995 88999999999987654
Q ss_pred CCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ....||..|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+........+. .
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~------~ 226 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------L 226 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT------T
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc------c
Confidence 4332 235678999999999654 58999999999999999999 567777776666666655543332222 2
Q ss_pred ccCChhhHhhhcccccccCCCCcCccccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
++.....+...|+..+|.+|||++||++|
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 33344566677788889999999998765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=375.72 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=198.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCc-----EEEEEEeccc-----ccChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.++|+++++||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+++++ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 4579999999999999999999876554 6999988543 22345799999887 899999999999
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecC
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSS-------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~d 204 (340)
.+...+++|||||++ +|.+.+..... ....+++..++.++.||+.||+|||+ +||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD 189 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 189 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence 445558899999985 67776653211 12458999999999999999999999 7999999
Q ss_pred CCCCCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 019506 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 280 (340)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf 280 (340)
|||+|||++. ++.+||+|||+|+........ ....||+.|||||++.+. .++.++|||||||++|||+| |..||
T Consensus 190 lKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred Cchhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999995 889999999999876554432 245679999999999654 58999999999999999998 89999
Q ss_pred CCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 281 PGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+.+..+.+.++++....+.... .++.....+...|+..+|.+|||++||.+|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPF-----YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCC-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98877777877777654333221 123334566777778889999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-53 Score=376.45 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=203.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeeee
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.++|+++++||+|+||+||+|+++.+|+.||||+++... ....+|+++|+.++ ||||++++++|.. .....+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEE
Confidence 357999999999999999999999999999999987543 44568999999985 9999999998854 234458899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccccC
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (340)
||||.++.+.. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++..++.+||+|||+|......
T Consensus 111 ~e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999763221 23679999999999999999999999 799999999999999865667999999999988776
Q ss_pred CccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCchhhhh-------
Q 019506 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVSNIIYAKTIY------- 305 (340)
Q Consensus 234 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~------- 305 (340)
.......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.... ..++...+.+..+.+...++.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 666677889999999999877778999999999999999999999997654 445555555443322111110
Q ss_pred ----------------ccccc-------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ----------------QGLFC-------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ----------------~~~~~-------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..... +.....+.+.|+..+|.+|||++|+++|||
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00000 011223556677778999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=360.84 Aligned_cols=244 Identities=18% Similarity=0.265 Sum_probs=197.8
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
++|++.++||+|+||+||+|++ .+++.||||+++++. ..+.+|+.++++++||||+++++++ .+...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence 4689999999999999999997 478899999987643 3456899999999999999999998 344458899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccccc
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (340)
|||+++ ++...+. .....+++..+..++.|+++||.|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheeccC
Confidence 999985 5454433 234578899999999999999999999 79999999999999995 88899999999987644
Q ss_pred CCcc--ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 233 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
.... ....+|..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....+.+ . .
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p-~-----~ 225 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP-H-----L 225 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC-T-----T
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc-c-----c
Confidence 4332 235678999999999654 48999999999999999998 89999999887766666554333322 2 2
Q ss_pred ccCChhhHhhhcccccccCCCCcCccccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+......+..-|+..+|.+|||++||++|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 33345566777788889999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=373.40 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=197.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC-CCcee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 149 (340)
.+|++.++||+|+||+||+|+++.+|+.||||++.+... ...+|+.++++++||||++++++|..... .+...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999975422 24579999999999999999999854332 34567
Q ss_pred eeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
+|+|||||.+++++.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhhc
Confidence 8999999999877655 3578999999999999999999999 79999999999999995 78899999999988
Q ss_pred cccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh----
Q 019506 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY---- 305 (340)
Q Consensus 230 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 305 (340)
...........+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+.+++.....+....+.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7777766777899999999999764 58999999999999999999999999999888888888766654322110
Q ss_pred ------cc---------------ccc----------cCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 ------QG---------------LFC----------SNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 ------~~---------------~~~----------~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.. ... +.....+..-|+..+|.+|||++|+++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00 000 011223455677788999999999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-52 Score=361.79 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=193.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc-------cChHHHHHHHHhCCCCceeecceeeeecCCCCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 148 (340)
.++|++.+.||+|+||+||+|++..+|+.||||+++.+. ..+.+|+++++.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 357999999999999999999999999999999986432 22457999999999999999999886543 2344
Q ss_pred eeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccc
Q 019506 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a 227 (340)
.+|+|||||+| +|.+.+.. .+.+++.+++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhhhh
Confidence 57899999996 45544433 3679999999999999999999999 79999999999999995 888999999998
Q ss_pred cccccCC----ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 228 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+..+.+.++++....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237 (277)
T ss_dssp EECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred hhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence 7653332 2334578999999999965 4589999999999999999999999999998888888877554432211
Q ss_pred hhccccccCChhhHhhhcccccccCCC-CcCccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRN-SMHESK 336 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~-~~~~i~ 336 (340)
... .+.....+.+-|+..+|.+|| |+++++
T Consensus 238 -~~~--~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 238 -HEG--LSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp -SSS--CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -ccC--CCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 111 122234566667777899999 666654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=362.66 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=192.1
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...+|++.+.||+|+||+||+|++. ++..||||++.... +.+.+|++++++++|||||++++++. +. .++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeE
Confidence 3467999999999999999999964 67889999997543 33568999999999999999999762 21 267
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEc
Confidence 99999996 554444322 12468999999999999999999999 79999999999999995 889999999999887
Q ss_pred ccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCchhhhhcc
Q 019506 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVSNIIYAKTIYQG 307 (340)
Q Consensus 231 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (340)
..... .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.+......+..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---- 234 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN---- 234 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT----
T ss_pred cCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc----
Confidence 54432 2335678999999999654 489999999999999999995 566666666555555554333332222
Q ss_pred ccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 308 LFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
++.....+...|+..+|.+|||++|+.+
T Consensus 235 --~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 235 --CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2334566777788888999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=361.63 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=192.0
Q ss_pred cccCeeEeee-eeeecceEEEEEEEcC--CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 75 QTISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 75 ~~~~y~~~~~-Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++... ..+.+|+++|++++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----
Confidence 3457888885 9999999999998754 45579999986432 334579999999999999999998732
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
. .+++|||||++ +|.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 81 ~-~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFG 154 (285)
T d1u59a_ 81 E-ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFG 154 (285)
T ss_dssp S-SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCT
T ss_pred C-eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccch
Confidence 1 26899999996 5555443 234679999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+.
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred hhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99876543322 234578899999999654 48999999999999999998 9999998887666665554333333
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
+.. ++.....+...|+..+|.+|||+.+|.
T Consensus 234 p~~------~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 234 PPE------CPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp CTT------CCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCc------CCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 222 233345667778888899999999884
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=362.00 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=186.1
Q ss_pred eeEe-eeeeeecceEEEEEEEc--CCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCcee
Q 019506 79 YMAE-RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (340)
Q Consensus 79 y~~~-~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 149 (340)
+.+. ++||+|+||+||+|.+. .+++.||||+++... ..+.+|+++|++++|||||++++++. +. .
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~-~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SS-S
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cC-C
Confidence 3443 46999999999999864 356789999986432 23458999999999999999999873 22 2
Q ss_pred eeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
.++|||||++ +|.+.+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~ 155 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSK 155 (277)
T ss_dssp EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhh
Confidence 5799999996 56555543 5679999999999999999999999 79999999999999995 8899999999998
Q ss_pred ccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 229 VLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 229 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
........ ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 234 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 76443322 234578999999999654 48999999999999999998 8999998887665555544333332222
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
++.....+...|+..+|.+|||+++|.
T Consensus 235 ------~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 235 ------CPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp ------CCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ------cCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 233445667778888899999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=357.11 Aligned_cols=244 Identities=20% Similarity=0.256 Sum_probs=181.9
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCC----cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
..|.+.++||+|+||+||+|.+..++ ..||||++.... ..+.+|++++++++|||||++++++ .+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence 36999999999999999999987654 469999986432 2345899999999999999999998 344
Q ss_pred eeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
...++||||+.++ +.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence 4578999999975 333333 234679999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCc----cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCch
Q 019506 227 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVSNIIYA 301 (340)
Q Consensus 227 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~ 301 (340)
|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..| |.+.+..+.+..+......+..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 987644322 123457889999999965 4589999999999999999996544 5555554444444333233332
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.. +......+...|+..+|.+|||++||.+
T Consensus 236 ~~------~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 236 MD------CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TT------CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh------hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 22 2334566777788888999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-52 Score=358.00 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=186.0
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCC---cEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.++|++++.||+|+||+||+|++..++ ..||||.++... ..+.+|+.++++++|||||++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence 457999999999999999999986543 568899875432 23457999999999999999999872 2
Q ss_pred eeeeeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
..+++||||++++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchh
Confidence 2378999999964 444433 234678999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhh
Q 019506 227 AKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKT 303 (340)
Q Consensus 227 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (340)
|+....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+..+......+....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233 (273)
T ss_dssp ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred heeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 987644332 233457899999999965 458999999999999999998 8999999888777777665444443332
Q ss_pred hhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 304 IYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
++.....+..-|+..+|.+|||++||+.|
T Consensus 234 ------~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 234 ------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 23445667777888889999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=355.74 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=201.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc------cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+|+.+++.++|+||+++++++ .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 47999999999999999999999999999999986443 2235899999999999999999998 445558
Q ss_pred eeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
++|+|++.++.+..+. ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence 8999999987555444 345788999999999999999999999 79999999999999995 788999999999877
Q ss_pred ccCCc-cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCchhhhhcc-
Q 019506 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVSNIIYAKTIYQG- 307 (340)
Q Consensus 231 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~- 307 (340)
..... .....++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+.++......+....+-..
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54433 333456888999999977666899999999999999999999875 556666667776665554332111000
Q ss_pred -------------------cccc--CChhhHhhhcccccccCCCCcCcccccCC
Q 019506 308 -------------------LFCS--NNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 308 -------------------~~~~--~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
.... .....+...|+..+|.+|||++|++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 0000 01123455667778999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=367.02 Aligned_cols=256 Identities=33% Similarity=0.528 Sum_probs=201.3
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc------ChHHHHHHHHhCCCCceeecceeeeecCC-CCce
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 148 (340)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|+|||++++++..... .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3579999999999999999999999999999999875432 23579999999999999999999854433 2333
Q ss_pred eeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccc
Q 019506 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (340)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (340)
..++++++++++|.+.+. .+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence 455555555567766553 3679999999999999999999999 79999999999999995 8899999999997
Q ss_pred ccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhh---
Q 019506 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIY--- 305 (340)
Q Consensus 229 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 305 (340)
... .......|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+....+......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 653 333456789999999998777778999999999999999999999999999888888888776554322110
Q ss_pred --------ccc-----------c--ccCChhhHhhhcccccccCCCCcCcccccCC
Q 019506 306 --------QGL-----------F--CSNNHEIMCELGSWYSYSGRNSMHESKLYGF 340 (340)
Q Consensus 306 --------~~~-----------~--~~~~~~~~~~l~~~~~~~~R~~~~~i~~hpf 340 (340)
..+ + .+.....+...|+..+|.+|||++|+++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 000 0 0111233556677788999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=361.89 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=188.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCc----EEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCc
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 147 (340)
.+|++.++||+|+||+||+|++..+|+ .||+|.+... .+.+.+|++++++++|||||++++++.. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 369999999999999999999988876 5788877532 2335689999999999999999999843 2
Q ss_pred eeeeeeecccc-chHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecc
Q 019506 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (340)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~ 226 (340)
. .+++||++. +++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence 2 456677766 566665543 35689999999999999999999999 79999999999999995 88999999999
Q ss_pred ccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchh
Q 019506 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAK 302 (340)
Q Consensus 227 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (340)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+....+.+.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~ 236 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9876544332 234579999999999764 48999999999999999998 789998877655555444433333322
Q ss_pred hhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 303 TIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
. +......+...|+..+|.+|||++||+.|
T Consensus 237 ~------~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 237 I------CTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp T------BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c------cCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 2 23344566777788889999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=354.55 Aligned_cols=246 Identities=23% Similarity=0.293 Sum_probs=187.0
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCCCCceeecceeeeecCCCCceee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 150 (340)
...++|++++.||+|+||+||+|++..+ +.||||++.... ..+.+|+.++++++|+|||++++++. +. .+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-PI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-Ce
Confidence 3456899999999999999999997654 679999987543 34568999999999999999999872 22 26
Q ss_pred eeeeccccch-HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
++||||++++ +...+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++++||+|||+|+.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhh
Confidence 7999999964 44444332 23569999999999999999999999 79999999999999995 88999999999987
Q ss_pred cccCCc--cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 230 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
...... .....||+.|+|||++.+ ..++.++|||||||++|||+||. +||.+....+.+..+.+....+....
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~--- 238 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--- 238 (285)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---
T ss_pred ccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---
Confidence 644332 233567999999999965 45899999999999999999965 55556665555555555443333322
Q ss_pred cccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
++.....+...|+..+|.+||++++|..
T Consensus 239 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 239 ---CPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2333456667777778999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=349.10 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=189.8
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc--cChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...++|++.+.||+|+||.||+|++ +|..||||+++++. +.+.+|++++++++||||+++++++.. +...++
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 3456799999999999999999998 68899999997653 345689999999999999999998743 223478
Q ss_pred eeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeecccccc
Q 019506 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (340)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (340)
+||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 78 lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC----
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceec
Confidence 99999985 6666665321 2358999999999999999999999 79999999999999995 888999999999875
Q ss_pred ccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCchhhhhcccc
Q 019506 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIYAKTIYQGLF 309 (340)
Q Consensus 231 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (340)
... .....++..|+|||++.+. .++.++|||||||++|||+| |++||...+..+.+..+.+....+.+..
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 224 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG------ 224 (262)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT------
T ss_pred CCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc------
Confidence 332 2334678899999999764 58999999999999999998 7899988877666666654333333222
Q ss_pred ccCChhhHhhhcccccccCCCCcCccccc
Q 019506 310 CSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
+......+.+.|+..+|.+|||++|+.++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22334566777888889999999987653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-50 Score=352.11 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=194.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecCCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 145 (340)
.++|++.+.||+|+||+||+|+++ .++..||||++.... ..+.+|++++++++||||+++++++ .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-----c
Confidence 457999999999999999999975 356789999986432 3356899999999999999999998 3
Q ss_pred Cceeeeeeeccccc-hHHHHHHHhh--------------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecC
Q 019506 146 DELFLNLVMEYVPE-TMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (340)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~d 204 (340)
+....++||||+++ +|.+.+.... .....+++..+..++.|++.||+|||+ +||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 44458899999985 6666664311 122358899999999999999999999 7999999
Q ss_pred CCCCCeEecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCC
Q 019506 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 280 (340)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf 280 (340)
|||+|||++. ++.+||+|||+|+....... .....+++.|+|||.+.+ ..|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999995 88999999999986644322 224567899999999965 45899999999999999999985 788
Q ss_pred CCCChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 281 PGENAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+.+..+.+..+.+....+.+.. +......+...|+..+|.+|||++||.+
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~p~~------~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILACPEN------CPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCcc------chHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88887777666554433222222 1223456777788888999999999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=354.38 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=195.4
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcE--EEEEEeccc-----ccChHHHHHHHHhC-CCCceeecceeeeecCCCCce
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 148 (340)
++|++.++||+|+||+||+|+++.+|.. ||||.+... ...+.+|+++|+++ +|||||++++++. +..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 5799999999999999999999888874 677776432 23456899999998 7999999999984 344
Q ss_pred eeeeeeccccc-hHHHHHHHh------------hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCC
Q 019506 149 FLNLVMEYVPE-TMYRVLKHY------------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (340)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~ 215 (340)
.+++||||+++ +|.+.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcC-
Confidence 58899999995 666666432 1235679999999999999999999999 79999999999999995
Q ss_pred CCcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 019506 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK 294 (340)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~ 294 (340)
++.+||+|||+|+............||..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 789999999999876655555556789999999999654 4899999999999999999975 67887776666655544
Q ss_pred hcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 295 VSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
......... ++.....+...|+..+|.+|||++||++|
T Consensus 242 ~~~~~~~~~------~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTT------BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333322222 23345566677788889999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=350.65 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=184.7
Q ss_pred ccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecCC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 144 (340)
.++|++++.||+|+||+||+|++.. +++.||||+++... ....+|+.++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 3579999999999999999999754 44789999886432 2233455655554 78999999887743
Q ss_pred CCceeeeeeeccccc-hHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeE
Q 019506 145 KDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (340)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nil 211 (340)
+...+++|||||++ +|.+.+..... ....+++..+..++.||+.||.|||+ +|||||||||+|||
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence 23347899999995 66666654321 13458999999999999999999999 79999999999999
Q ss_pred ecCCCCcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChHH
Q 019506 212 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD 287 (340)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~ 287 (340)
++. ++.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||+|| .+||.+.+..+
T Consensus 167 l~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ECG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 995 88999999999986543332 234578999999999976 4589999999999999999996 57898877667
Q ss_pred HHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 288 QLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+..+++....+...+. ++.....+...|+..+|.+|||++||++|
T Consensus 245 ~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77777665544432221 22234456666777789999999999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=349.82 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=187.2
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCC-C--cEEEEEEeccc-------ccChHHHHHHHHhCCCCceeecceeeeecCCCC
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 146 (340)
.+|++.+.||+|+||.||+|++..+ + ..||||++.+. .+.+.+|+.+|++++||||+++++++. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 4699999999999999999986533 3 36899987643 123468999999999999999999883 2
Q ss_pred ceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
. ..++||||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccch
Confidence 2 36799999985 55555443 23569999999999999999999999 79999999999999995 8899999999
Q ss_pred cccccccCCcc----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCc
Q 019506 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVSNIIY 300 (340)
Q Consensus 226 ~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (340)
+++........ ....++..|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+.+..+.+....+.
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 99876444332 22346788999999975 458999999999999999998 8999999998888888777654433
Q ss_pred hhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 301 AKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
... ..+.....+.+.|+..+|.+|||++||.+
T Consensus 236 ~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 RPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccc-----cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222 12334456777788888999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=352.56 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=193.5
Q ss_pred ccCeeEeeeeeeecceEEEEEEEc---CCCcEEEEEEecccc--------cChHHHHHHHHhCCC-CceeecceeeeecC
Q 019506 76 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDH-PNVISLKHCFFSTT 143 (340)
Q Consensus 76 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 143 (340)
.++|++++.||+|+||+||+|++. .+|+.||||++.+.. ....+|++++++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 467999999999999999999874 478999999885431 234579999999977 7999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEE
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~ 222 (340)
.+...++++|||+.+ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~ 171 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLT 171 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEES
T ss_pred -ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEEe
Confidence 445568899999996 56655544 3577899999999999999999999 79999999999999995 7899999
Q ss_pred eeccccccccCCc--cceeeeeccccCcccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---c
Q 019506 223 DFGSAKVLVKGEA--NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---S 296 (340)
Q Consensus 223 Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~ 296 (340)
|||+|+....... .....|++.|+|||.+.+.. .++.++|||||||+||+|+||+.||.+.+..+....+.+. .
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 9999987643332 33467899999999997543 4788999999999999999999999876554444444332 2
Q ss_pred CCCchhhhhccccccCChhhHhhhcccccccCCC-----CcCcccccCC
Q 019506 297 NIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRN-----SMHESKLYGF 340 (340)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~-----~~~~i~~hpf 340 (340)
..+..+. .+.....+..-|+..+|.+|+ |++|+++|||
T Consensus 252 ~~~~~~~------~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 252 EPPYPQE------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp CCCCCTT------SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCCCccc------CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 2222221 122234455666667788998 4799999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-49 Score=345.33 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=188.5
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 154 (340)
++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|+|++..++.+. .+....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEEEE
Confidence 3699999999999999999999999999999987643 345678999999999888776655553 2334578999
Q ss_pred ccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC--CCCcEEEEeecccccccc
Q 019506 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVLVK 232 (340)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~--~~~~~kl~Dfg~a~~~~~ 232 (340)
||+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+....
T Consensus 83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999987766543 35689999999999999999999999 79999999999999863 245799999999987754
Q ss_pred CCc--------cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---CCch
Q 019506 233 GEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSN---IIYA 301 (340)
Q Consensus 233 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~ 301 (340)
... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.........+.+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 332 2345789999999999654 489999999999999999999999987665444443332211 1112
Q ss_pred hhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 302 KTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
..+..+ ++.....+.+.|+..+|.+||++++|.
T Consensus 238 ~~~~~~--~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 238 EVLCKG--YPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHHTTT--SCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred hHhccC--CCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 222111 122234566777778899999998653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-48 Score=339.76 Aligned_cols=248 Identities=18% Similarity=0.258 Sum_probs=193.3
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc--ccChHHHHHHHHhCCC-CceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|++++.||+|+||+||+|++..+|+.||||++... .....+|++.++.+.| +|++.+++++ ......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence 4799999999999999999999999999999987543 3446789999999976 8999998887 444557899
Q ss_pred eccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecC----CCCcEEEEeeccccc
Q 019506 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKV 229 (340)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~----~~~~~kl~Dfg~a~~ 229 (340)
|||+++++.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .++.+||+|||+|+.
T Consensus 80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999988877654 34579999999999999999999999 79999999999999963 246799999999987
Q ss_pred cccCC--------ccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCC
Q 019506 230 LVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVSNI 298 (340)
Q Consensus 230 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~ 298 (340)
..... ......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.. ....+.++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64332 2234578999999999966 458999999999999999999999998643 33334444433333
Q ss_pred CchhhhhccccccCChhhHhhhcccccccCCCCcCccc
Q 019506 299 IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESK 336 (340)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~ 336 (340)
...+.+..++ ......+.+.|...+|.+||+++.+.
T Consensus 235 ~~~~~l~~~~--p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 235 TPLRELCAGF--PEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp SCHHHHTTTS--CHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CChHHhcCCC--CHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 3333332221 11234455566777899999887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=345.75 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=188.3
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcCCC-------cEEEEEEeccccc-----ChHHHHHHHHhC-CCCceeecceeee
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFF 140 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~ 140 (340)
...++|++++.||+|+||.||+|++..++ ..||||+++.+.. ...+|+..+.++ +|||||++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~- 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc-
Confidence 34568999999999999999999976554 4799998865432 233577777776 899999999999
Q ss_pred ecCCCCceeeeeeeccccc-hHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCC
Q 019506 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp 207 (340)
.+...+++||||+.+ ++.+.+.... .....+++..+..++.||+.||+|||+ +|||||||||
T Consensus 89 ----~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp 163 (299)
T d1fgka_ 89 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 163 (299)
T ss_dssp ----CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred ----ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecc
Confidence 444558899999995 6666664321 123568999999999999999999999 7999999999
Q ss_pred CCeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 019506 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (340)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (340)
+|||++. ++.+||+|||+++........ ....+++.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 164 ~NiLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 164 RNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GGEEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999995 888999999999876544322 23567899999999965 458999999999999999998 78999887
Q ss_pred ChHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 284 NAVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
+....+.. ++....+..... ++.....+...|+..+|.+|||++|+++
T Consensus 242 ~~~~~~~~-i~~~~~~~~p~~-----~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKL-LKEGHRMDKPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHH-HHTTCCCCCCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHH-HHcCCCCCCCcc-----chHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77655444 443333322211 2233456777778888999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=342.18 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=197.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEc-----CCCcEEEEEEecccc-----cChHHHHHHHHhC-CCCceeecceeeeecC
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 143 (340)
..++|+++++||+|+||.||+|++. .+++.||||+++... ..+.+|+.+++++ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---- 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 3468999999999999999999863 466789999987543 2345788999988 699999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhh--------------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCC
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYS--------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~ 208 (340)
.+....++|||||++ ++.+.+.... .....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence 444558899999995 5666655422 123468999999999999999999999 79999999999
Q ss_pred CeEecCCCCcEEEEeeccccccccCCcc---ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 019506 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (340)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (340)
||+++. ++.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 175 NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999995 889999999999876543322 23577999999999965 458999999999999999998 677788877
Q ss_pred hHHHHHHHHHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 285 AVDQLVEIIKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.+.++++....+..... .+.....+...|+..+|.+|||++||++
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~-----~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEH-----APAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCccc-----ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77778887776554433221 2233445666677778999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=341.80 Aligned_cols=250 Identities=21% Similarity=0.248 Sum_probs=196.6
Q ss_pred ccccCeeEeeeeeeecceEEEEEEEcC-----CCcEEEEEEecccc-----cChHHHHHHHHhCCCCceeecceeeeecC
Q 019506 74 KQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (340)
Q Consensus 74 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 143 (340)
...++|.+++.||+|+||+||+|.+.. ++..||||+++... ..+.+|++++++++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~---- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence 445689999999999999999998752 35789999986432 2245899999999999999999998
Q ss_pred CCCceeeeeeeccccc-hHHHHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC
Q 019506 144 SKDELFLNLVMEYVPE-TMYRVLKHYS------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (340)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~ 216 (340)
......++||||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. +
T Consensus 93 -~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~ 169 (308)
T d1p4oa_ 93 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-D 169 (308)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-T
T ss_pred -ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-C
Confidence 344458899999985 5655554321 122457889999999999999999999 79999999999999995 8
Q ss_pred CcEEEEeeccccccccCCc---cceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 019506 217 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEI 292 (340)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~ 292 (340)
+++||+|||+|+....... .....+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8999999999987644332 2334689999999999654 489999999999999999998 5889888877777766
Q ss_pred HHhcCCCchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 293 IKVSNIIYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
.+....+.+.. ++.....+...|+..+|.+|||++||.+
T Consensus 249 ~~~~~~~~p~~------~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLDKPDN------CPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCccc------chHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55333222221 2334556667778888999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=342.79 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=183.7
Q ss_pred eEeeeeeeecceEEEEEEEcCCC---cEEEEEEeccc-----ccChHHHHHHHHhCCCCceeecceeeeecCCCCceeee
Q 019506 80 MAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 80 ~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 151 (340)
...++||+|+||+||+|++..++ ..||||+++.. ...+.+|+++|++++||||+++++++... ....+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceE
Confidence 44688999999999999986543 36899988642 23356899999999999999999987532 23478
Q ss_pred eeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCCcEEEEeeccccccc
Q 019506 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (340)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (340)
+|||||+++.+..+.. .....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 106 lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCCTT
T ss_pred EEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchhhcc
Confidence 9999999754433332 334567888899999999999999999 79999999999999995 8899999999998764
Q ss_pred cCCcc-----ceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCchhhhhc
Q 019506 232 KGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVSNIIYAKTIYQ 306 (340)
Q Consensus 232 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (340)
..... ....||..|+|||.+.+. .++.++|||||||++|||+||..||........+...+.....+..+.
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~--- 257 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE--- 257 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT---
T ss_pred ccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc---
Confidence 43222 234678999999999654 589999999999999999998877765544444444343333332222
Q ss_pred cccccCChhhHhhhcccccccCCCCcCccccc
Q 019506 307 GLFCSNNHEIMCELGSWYSYSGRNSMHESKLY 338 (340)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~h 338 (340)
.+......+..-|+..+|.+||+++||.+|
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 133445667777888889999999998765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=342.19 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=183.7
Q ss_pred cCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccccC-h--HHHHHHHHhCCCCceeecceeeeecCCCCceeeeee
Q 019506 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (340)
Q Consensus 77 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 153 (340)
.+|.+.+.||+|+||.||+|++ +|+.||||++...... . +.|+..++.++|||||++++++.... .....+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence 4699999999999999999987 7899999998654322 2 23444556789999999999986543 234468899
Q ss_pred eccccc-hHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCceecCCCCCCeEecCCCCcEEEEeec
Q 019506 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (340)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------~~iiH~dlkp~Nill~~~~~~~kl~Dfg 225 (340)
|||+++ +|.+.+.. ..+++..+..++.|++.||.|||+. +||+||||||+|||++. ++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEecC
Confidence 999985 67777654 4689999999999999999999961 59999999999999995 8899999999
Q ss_pred cccccccCCc-----cceeeeeccccCcccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCC-----------
Q 019506 226 SAKVLVKGEA-----NISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGEN----------- 284 (340)
Q Consensus 226 ~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~----------- 284 (340)
+++....... .....||+.|+|||++.+.. .++.++|||||||+||||+||..||....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987754432 22457899999999985432 25678999999999999999988774321
Q ss_pred ---hHHHHHHHHHhcCC-CchhhhhccccccCChhhHhhhcccccccCCCCcCcccc
Q 019506 285 ---AVDQLVEIIKVSNI-IYAKTIYQGLFCSNNHEIMCELGSWYSYSGRNSMHESKL 337 (340)
Q Consensus 285 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~R~~~~~i~~ 337 (340)
..+.+......... +.....+...-+......+..-|+..+|.+|||++||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22333333322211 221122111111112345566677778999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-45 Score=327.51 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=186.3
Q ss_pred cccCeeEeeeeeeecceEEEEEEEcCCCcEEEEEEecccc---cChHHHHHHHHhCC-----------CCceeecceeee
Q 019506 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKHCFF 140 (340)
Q Consensus 75 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~ 140 (340)
..++|+++++||+|+||+||+|+++.+|+.||||+++++. ....+|+++++.++ |+||+++++++.
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 3456999999999999999999999999999999997653 23457888888775 578999998874
Q ss_pred ecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCCC---
Q 019506 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--- 217 (340)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~~--- 217 (340)
... ......++.++++.++...... ......+++..++.++.||+.||.|||+..||+||||||+|||++..+.
T Consensus 91 ~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred ecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 322 2222333333444444333333 3445788999999999999999999996358999999999999974222
Q ss_pred --cEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 019506 218 --QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQL 289 (340)
Q Consensus 218 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~ 289 (340)
.++++|||.+..... ......||+.|+|||++.+. .++.++||||+||++++|++|+.||.... ..+.+
T Consensus 168 ~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986533 33456789999999999764 48999999999999999999999997543 23445
Q ss_pred HHHHHhcCCCchhhhhc------------------------------cccc-----cCChhhHhhhcccccccCCCCcCc
Q 019506 290 VEIIKVSNIIYAKTIYQ------------------------------GLFC-----SNNHEIMCELGSWYSYSGRNSMHE 334 (340)
Q Consensus 290 ~~~~~~~~~~~~~~~~~------------------------------~~~~-----~~~~~~~~~l~~~~~~~~R~~~~~ 334 (340)
...++..+......... .... ......+.+-|+..+|.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 55554443321111100 0000 001223455677778999999999
Q ss_pred ccccCC
Q 019506 335 SKLYGF 340 (340)
Q Consensus 335 i~~hpf 340 (340)
++.|||
T Consensus 325 ~L~Hp~ 330 (362)
T d1q8ya_ 325 LVNHPW 330 (362)
T ss_dssp HHTCGG
T ss_pred HhcCcc
Confidence 999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.8e-27 Score=193.76 Aligned_cols=165 Identities=16% Similarity=0.085 Sum_probs=116.2
Q ss_pred eeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccccc----------------------ChHHHHHHHHhCCCCceeecc
Q 019506 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------------------YKNRELQLMRLMDHPNVISLK 136 (340)
Q Consensus 79 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~E~~~l~~l~h~~iv~~~ 136 (340)
+.++++||+|+||+||+|++. +|+.||||+++.... ...+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999974 789999998752210 112477788899999998876
Q ss_pred eeeeecCCCCceeeeeeeccccchHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCceecCCCCCCeEecCCC
Q 019506 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (340)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~dlkp~Nill~~~~ 216 (340)
++. . .+++|||+++... ..++...+..++.|++.+|.|||+ +||+||||||+|||++.
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET--
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC--
Confidence 543 1 2599999997411 224455577889999999999999 79999999999999983
Q ss_pred CcEEEEeeccccccccCCccceeeeeccccCcccccCCCCCCCcchhHHHHHH
Q 019506 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 269 (340)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 269 (340)
+.++|+|||+|..........-....... -.+.+ . ..|+.++|+||+.--
T Consensus 139 ~~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWREILERDVRN-IITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp TEEEECCCTTCEETTSTTHHHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcHHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHHH
Confidence 45999999999765433221100000000 01222 2 347899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.4e-06 Score=72.05 Aligned_cols=76 Identities=17% Similarity=0.135 Sum_probs=48.9
Q ss_pred CeeEeeeeeeecceEEEEEEEcCCCcEEEEEEeccc----ccChHHHHHHHHhCC-CCceeecceeeeecCCCCceeeee
Q 019506 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (340)
Q Consensus 78 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 152 (340)
.|++.+..+.++.+.||+.. .++..++||+.... .....+|..+++.+. +--+.+++.+. .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 46777665556667899886 36777889977543 234567888887664 22234444443 23344679
Q ss_pred eeccccch
Q 019506 153 VMEYVPET 160 (340)
Q Consensus 153 v~e~~~~~ 160 (340)
||++++|.
T Consensus 88 v~~~l~G~ 95 (263)
T d1j7la_ 88 LMSEADGV 95 (263)
T ss_dssp EEECCSSE
T ss_pred EEEecccc
Confidence 99999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=1.5e-05 Score=69.86 Aligned_cols=71 Identities=18% Similarity=0.142 Sum_probs=41.9
Q ss_pred eeeeeeecceEEEEEEEcCCCcEEEEEEeccc-----------ccChHHHHHHHHhCC-C--CceeecceeeeecCCCCc
Q 019506 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD-H--PNVISLKHCFFSTTSKDE 147 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 147 (340)
.+.||.|....||++.+..+++.++||..... ......|.+.|+.+. + ..+.+++.+ + .+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence 45689999999999987777889999965321 111245888877653 2 233344332 2 222
Q ss_pred eeeeeeeccccc
Q 019506 148 LFLNLVMEYVPE 159 (340)
Q Consensus 148 ~~~~lv~e~~~~ 159 (340)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3489999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.7e-05 Score=65.02 Aligned_cols=69 Identities=14% Similarity=0.106 Sum_probs=43.6
Q ss_pred eeeec-ceEEEEEEEcCCCcEEEEEEecccc-cChHHHHHHHHhCCCCce--eecceeeeecCCCCceeeeeeeccccc
Q 019506 85 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVPE 159 (340)
Q Consensus 85 Lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (340)
+..|. .+.||+.. ...+..+++|...... ....+|.+.++.+....+ .+++.+. .+....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence 34444 36789887 4567778999776443 345678888887654333 3444443 223346799999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00043 Score=58.65 Aligned_cols=29 Identities=21% Similarity=0.177 Sum_probs=23.9
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.++||+|+.+.|||++ ++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~--~~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWR--DG-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEES--SS-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEe--CC-ceEEechhccc
Confidence 4799999999999997 33 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.99 E-value=0.0015 Score=56.70 Aligned_cols=69 Identities=16% Similarity=0.231 Sum_probs=44.6
Q ss_pred eeeeeeecceEEEEEEEcC-------CCcEEEEEEecccc--cChHHHHHHHHhCCCCcee-ecceeeeecCCCCceeee
Q 019506 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLN 151 (340)
Q Consensus 82 ~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~ 151 (340)
++.|+.|-.-.+|++.... ..+.|.+++.-... ....+|..+++.+.-.++. ++++++ .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 3568888889999998643 34568888765322 2235788888877644544 555554 22 3
Q ss_pred eeeccccc
Q 019506 152 LVMEYVPE 159 (340)
Q Consensus 152 lv~e~~~~ 159 (340)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.59 E-value=0.0042 Score=51.93 Aligned_cols=31 Identities=29% Similarity=0.244 Sum_probs=26.3
Q ss_pred CCceecCCCCCCeEecCCCCcEEEEeeccccc
Q 019506 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (340)
Q Consensus 198 ~~iiH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (340)
.|+||+|+.++||+++. +...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhccc-ccceeEeccccccc
Confidence 47999999999999994 55568999998854
|